data_1gxi_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1gxi _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.724 0 CA-C-O 122.534 1.159 . . . . 1.54 112.944 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 46.4 m-20 -123.86 -178.17 3.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 128.02 2.528 . . . . 1.0 110.842 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -91.43 83.92 5.5 Favored 'General case' 0 C--N 1.364 1.235 0 C-N-CA 127.78 2.432 . . . . 3.9399999999999999 112.62 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 142.22 -9.06 2.44 Favored Glycine 0 CA--C 1.486 -1.74 0 CA-C-O 123.642 1.69 . . . . 0.75 110.872 -173.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 6' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -81.63 47.98 1.13 Allowed 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 128.227 2.611 . . . . 0.45000000000000001 114.837 -172.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . 0.421 0.0 OUTLIER -11.91 97.33 0.01 OUTLIER 'General case' 0 C--N 1.361 1.089 1 C-N-CA 132.761 4.425 . . . . 2.54 117.763 -176.161 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.8 151.54 4.1 Favored 'Isoleucine or valine' 0 C--N 1.364 1.232 0 O-C-N 119.738 -1.851 . . . . 1.03 111.18 -171.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 17.1 ttt85 -97.61 105.86 18.08 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 115.153 1.538 . . . . 0.17000000000000001 115.153 -176.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 1.3 mp -53.83 104.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.37 1.481 0 C-N-CA 129.108 2.963 . . . . 1.03 115.339 174.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . 0.562 ' HZ1' ' HA3' ' E' ' 19' ' ' GLY . 34.8 mmtm -123.78 55.95 1.24 Allowed 'General case' 0 C--N 1.365 1.255 0 C-N-CA 123.762 0.825 . . . . 0.29999999999999999 109.131 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -72.75 -72.91 0.22 Allowed 'General case' 0 C--N 1.362 1.146 0 C-N-CA 126.053 1.741 . . . . 2.7599999999999998 115.188 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 84.9 m 127.44 -61.92 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.734 1 C-N-CA 133.077 4.551 . . . . 0.46999999999999997 104.774 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -77.1 72.24 3.63 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 128.241 2.616 . . . . 1.8899999999999999 111.383 173.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 42.6 t -167.44 159.79 12.68 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 106.823 -1.547 . . . . 1.3999999999999999 106.823 -174.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -90.15 -2.09 58.03 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 127.412 2.285 . . . . 1.1599999999999999 110.585 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -119.43 24.36 10.72 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 125.564 1.546 . . . . 0.94999999999999996 111.082 -176.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -67.49 110.49 3.66 Favored 'General case' 0 C--N 1.369 1.425 0 C-N-CA 126.975 2.11 . . . . 0.95999999999999996 113.802 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 19' ' ' GLY . . . . . 0.562 ' HA3' ' HZ1' ' E' ' 11' ' ' LYS . . . 92.99 16.67 46.85 Favored Glycine 0 C--N 1.356 1.69 0 C-N-CA 125.819 1.676 . . . . 0.39000000000000001 111.272 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -108.91 164.2 12.61 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 126.305 1.842 . . . . 1.3999999999999999 110.155 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -110.27 173.29 2.21 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 C-N-CA 125.946 1.698 . . . . 1.03 108.257 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.55 174.92 42.65 Favored Glycine 0 CA--C 1.474 -2.523 0 N-CA-C 107.517 -2.233 . . . . 0.27000000000000002 107.517 167.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 23' ' ' THR . . . . . 0.661 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 23.5 m -90.21 120.05 31.05 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 126.293 1.837 . . . . 1.1000000000000001 112.219 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 7.9 p -72.25 80.94 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 125.279 2.466 . . . . 1.1100000000000001 116.571 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.31 45.12 1.15 Allowed 'General case' 0 C--N 1.35 0.597 0 O-C-N 118.643 -2.535 . . . . 1.0600000000000001 111.885 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 13.7 t -85.08 -68.95 0.69 Allowed 'General case' 0 CA--C 1.498 -1.043 1 C-N-CA 133.149 4.58 . . . . 0.87 114.076 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 1.3 m -79.88 28.98 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.229 0 C-N-CA 127.69 2.396 . . . . 0.60999999999999999 116.04 -157.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -112.4 -60.67 1.83 Allowed 'General case' 0 N--CA 1.425 -1.675 1 C-N-CA 132.38 4.272 . . . . 1.6100000000000001 106.972 177.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . 0.547 ' HZ3' HD12 ' E' ' 37' ' ' ILE . 0.3 OUTLIER -111.53 -27.63 8.51 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 115.422 1.638 . . . . 4.3200000000000003 115.422 -177.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.54 35.08 0.76 Allowed 'General case' 0 C--N 1.354 0.786 0 N-CA-C 115.477 1.658 . . . . 4.7999999999999998 115.477 -173.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.14 52.44 3.34 Favored Glycine 0 C--N 1.349 1.266 0 C-N-CA 129.053 3.216 . . . . 2.21 112.561 163.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 32' ' ' ILE . . . . . 0.42 ' CG2' ' H ' ' E' ' 33' ' ' LEU . 0.4 OUTLIER -133.94 -157.64 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.988 0 C-N-CA 129.311 3.044 . . . . 1.6399999999999999 109.93 -175.098 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 33' ' ' LEU . . . . . 0.42 ' H ' ' CG2' ' E' ' 32' ' ' ILE . 36.6 tp -62.93 -42.47 99.81 Favored 'General case' 0 C--N 1.358 0.935 1 C-N-CA 132.238 4.215 . . . . 0.64000000000000001 117.673 -177.3 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -110.17 134.61 20.7 Favored Pre-proline 0 C--N 1.366 1.302 0 N-CA-C 102.471 -3.159 . . . . 1.52 102.471 172.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.4 -53.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.424 2.083 . . . . 0.67000000000000004 115.933 -167.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 69.7 t -105.54 105.38 18.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.889 0 N-CA-C 119.316 3.08 . . . . 1.1599999999999999 119.316 -161.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . 0.547 HD12 ' HZ3' ' E' ' 29' ' ' LYS . 59.9 mt -83.1 125.08 40.04 Favored 'Isoleucine or valine' 0 C--N 1.38 1.895 0 O-C-N 119.247 -2.158 . . . . 1.28 106.25 171.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 55.2 t -122.72 162.64 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 119.333 0.97 . . . . 1.04 108.927 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 39' ' ' ARG . . . . . 0.661 ' HB3' ' H ' ' E' ' 23' ' ' THR 0.256 30.8 ttp180 -82.16 147.39 29.05 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 129.825 3.25 . . . . 3.1400000000000001 110.833 172.267 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -139.96 126.22 20.0 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 124.742 1.217 . . . . 1.26 107.987 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -82.48 -15.25 53.17 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 124.343 1.057 . . . . 1.8100000000000001 112.051 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -115.59 75.07 0.92 Allowed 'General case' 0 C--N 1.368 1.375 0 C-N-CA 126.854 2.061 . . . . 1.29 112.285 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.366 1.306 0 C-N-CA 126.581 1.952 . . . . 1.7 115.729 -179.177 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 109.835 -0.432 . . . . 2.6800000000000002 109.835 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 21.4 p -104.29 117.15 33.52 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 129.864 3.265 . . . . 1.1399999999999999 107.269 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -148.22 136.94 21.68 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.734 1.214 . . . . 1.9399999999999999 108.253 -174.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -86.59 118.51 26.05 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 127.684 2.394 . . . . 2.2200000000000002 116.047 -175.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -105.95 171.53 7.29 Favored 'General case' 0 CA--C 1.507 -0.682 0 O-C-N 119.856 -1.778 . . . . 0.23999999999999999 112.547 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.42 101.53 10.88 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 129.649 3.179 . . . . 1.01 108.711 169.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -19.94 -29.18 0.0 OUTLIER 'General case' 0 C--N 1.36 1.043 1 C-N-CA 136.467 5.907 . . . . 1.72 119.602 171.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.26 -30.69 66.78 Favored 'General case' 0 C--N 1.365 1.254 0 C-N-CA 128.629 2.772 . . . . 0.20000000000000001 113.958 171.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.52 20.47 18.49 Favored 'General case' 0 C--N 1.368 1.375 0 C-N-CA 125.777 1.631 . . . . 1.1799999999999999 110.788 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 52.0 mt -137.59 116.91 12.72 Favored 'General case' 0 C--N 1.374 1.667 0 N-CA-C 116.282 1.956 . . . . 1.0900000000000001 116.282 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -106.83 138.12 43.6 Favored 'General case' 0 C--N 1.364 1.229 0 O-C-N 120.589 -1.32 . . . . 2.0499999999999998 111.604 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.35 136.72 53.41 Favored 'General case' 0 C--N 1.366 1.29 1 C-N-CA 131.909 4.084 . . . . 0.28999999999999998 118.434 174.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 10.0 t -132.7 -40.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.618 -1.301 . . . . 1.1799999999999999 114.121 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 69' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -104.83 120.87 42.43 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 123.486 1.612 . . . . 2.1899999999999999 114.883 -172.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.0 51.72 0.15 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.265 2.226 . . . . 0.0 115.511 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.49 60.66 6.15 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 127.036 2.134 . . . . 0.0 112.295 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.63 114.16 26.04 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 125.991 1.716 . . . . 0.0 110.179 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 50.5 mttp . . . . . 0 C--O 1.262 1.741 0 CA-C-O 117.351 -1.309 . . . . 0.0 111.484 178.135 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.409 0 N-CA-C 114.833 1.42 . . . . 1.54 114.833 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . 0.257 1.0 OUTLIER -142.47 -175.56 4.51 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 104.62 -2.363 . . . . 1.0 104.62 176.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.39 60.42 5.22 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 130.135 3.374 . . . . 3.9399999999999999 116.594 -175.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.63 1.07 0.04 OUTLIER Glycine 0 CA--C 1.477 -2.341 0 O-C-N 120.088 -1.633 . . . . 0.75 113.457 -175.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 6' ' ' ASP . . . . . 0.462 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 65.5 t0 -76.76 136.29 39.02 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.797 2.039 . . . . 0.45000000000000001 113.454 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . 0.413 ' H ' ' HB3' ' E' ' 69' ' ' GLN . 86.4 mttt -80.8 80.52 7.25 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 127.05 2.14 . . . . 2.54 108.07 169.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 8' ' ' VAL . . . . . 0.4 HG23 ' H ' ' E' ' 8' ' ' VAL . 13.9 m -89.97 135.6 25.89 Favored 'Isoleucine or valine' 0 C--N 1.374 1.672 0 N-CA-C 103.365 -2.828 . . . . 1.03 103.365 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -95.52 110.38 22.46 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 120.89 1.677 . . . . 0.17000000000000001 114.544 -172.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 10.5 mm -52.18 108.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.378 1.807 0 N-CA-C 118.19 2.663 . . . . 1.03 118.19 175.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -117.9 48.82 1.32 Allowed 'General case' 0 C--N 1.37 1.486 0 CA-C-O 123.203 1.478 . . . . 0.29999999999999999 107.923 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -101.62 128.97 47.65 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 130.277 3.431 . . . . 2.7599999999999998 109.485 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 20.9 p -74.69 -58.67 3.14 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 128.8 2.84 . . . . 0.46999999999999997 113.268 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -66.07 48.75 0.03 OUTLIER 'General case' 0 C--N 1.359 0.998 0 C-N-CA 129.295 3.038 . . . . 1.8899999999999999 116.529 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 53.3 m -167.48 166.5 14.26 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 119.575 -1.953 . . . . 1.3999999999999999 106.631 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -92.96 15.56 14.65 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 119.645 -1.91 . . . . 1.1599999999999999 113.727 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -116.44 13.14 15.39 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 126.811 2.045 . . . . 0.94999999999999996 111.86 -175.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -61.82 105.98 0.63 Allowed 'General case' 0 C--N 1.367 1.34 0 C-N-CA 127.519 2.328 . . . . 0.95999999999999996 114.598 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.58 9.01 44.88 Favored Glycine 0 C--N 1.363 2.047 0 C-N-CA 123.959 0.79 . . . . 0.39000000000000001 112.975 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -107.99 174.57 5.82 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 127.984 2.514 . . . . 1.3999999999999999 109.948 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 p -108.68 178.74 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.437 0 C-N-CA 125.482 1.513 . . . . 1.03 110.492 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.29 174.55 47.04 Favored Glycine 0 CA--C 1.477 -2.335 0 O-C-N 119.829 -1.795 . . . . 0.27000000000000002 108.918 171.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 23' ' ' THR . . . . . 0.563 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 8.3 m -106.65 115.09 29.6 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 125.054 1.342 . . . . 1.1000000000000001 110.43 -177.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 p -68.79 85.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 125.779 1.632 . . . . 1.1100000000000001 113.545 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.96 50.0 1.88 Allowed 'General case' 0 C--N 1.355 0.804 0 O-C-N 119.947 -1.721 . . . . 1.0600000000000001 110.967 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 26' ' ' SER . . . . . 0.459 ' HB3' ' H ' ' E' ' 37' ' ' ILE . 19.3 p -94.71 -71.8 0.65 Allowed 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 120.298 3.444 . . . . 0.87 120.298 -174.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.13 56.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.755 2 C-N-CA 132.84 4.456 . . . . 0.60999999999999999 111.823 -167.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -141.82 -45.62 0.35 Allowed 'General case' 0 N--CA 1.411 -2.399 2 CA-C-N 107.49 -4.414 . . . . 1.6100000000000001 102.126 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -109.3 -39.21 5.29 Favored 'General case' 0 C--N 1.368 1.41 0 C-N-CA 129.67 3.188 . . . . 4.3200000000000003 113.643 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 23.6 m -69.87 53.36 0.12 Allowed 'General case' 0 C--N 1.364 1.216 0 C-N-CA 131.228 3.811 . . . . 4.7999999999999998 118.527 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.6 47.0 3.39 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 109.65 -3.432 . . . . 2.21 111.368 153.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 32' ' ' ILE . . . . . 0.434 ' CG2' ' H ' ' E' ' 33' ' ' LEU . 0.5 OUTLIER -140.15 -153.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.246 0 C-N-CA 126.98 2.112 . . . . 1.6399999999999999 110.031 -175.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 33' ' ' LEU . . . . . 0.434 ' H ' ' CG2' ' E' ' 32' ' ' ILE . 40.8 tp -65.8 -43.25 89.24 Favored 'General case' 0 C--N 1.354 0.798 1 C-N-CA 132.565 4.346 . . . . 0.64000000000000001 117.0 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -108.8 128.3 25.77 Favored Pre-proline 0 C--N 1.356 0.888 0 O-C-N 120.367 -1.458 . . . . 1.52 107.176 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.19 -28.61 4.63 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 124.411 3.408 . . . . 0.67000000000000004 112.791 -174.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 59.4 t -110.72 138.34 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 130.4 3.48 . . . . 1.1599999999999999 108.188 -177.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . 0.459 ' H ' ' HB3' ' E' ' 26' ' ' SER . 63.5 mt -138.29 121.92 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 2 N-CA-C 95.13 -5.878 . . . . 1.28 95.13 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 62.3 t -124.25 157.49 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 CA-C-N 122.492 2.406 . . . . 1.04 111.901 -170.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 39' ' ' ARG . . . . . 0.563 ' HB3' ' H ' ' E' ' 23' ' ' THR . 0.0 OUTLIER -83.64 144.01 29.71 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 128.035 2.534 . . . . 3.1400000000000001 112.176 174.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -129.78 128.57 42.66 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 114.636 -1.166 . . . . 1.26 107.933 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -98.35 -15.44 19.72 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 126.18 1.792 . . . . 1.8100000000000001 110.805 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -115.35 60.56 0.7 Allowed 'General case' 0 C--N 1.355 0.823 0 C-N-CA 131.048 3.739 . . . . 1.29 110.424 -177.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 C--N 1.355 0.809 0 C-N-CA 126.494 1.918 . . . . 1.7 109.114 178.349 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 25.3 p30 . . . . . 0 C--O 1.224 -0.238 0 CA-C-O 121.267 0.556 . . . . 2.6800000000000002 112.415 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 2.9 p -132.17 129.28 39.58 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 130.202 3.401 . . . . 1.1399999999999999 105.582 -177.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -154.43 150.38 27.81 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 104.734 -2.321 . . . . 1.9399999999999999 104.734 -174.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -78.51 125.21 29.05 Favored 'General case' 0 C--N 1.353 0.717 1 C-N-CA 131.811 4.044 . . . . 2.2200000000000002 116.334 -169.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 60' ' ' PHE . . . . . 0.466 ' HB3' HD22 ' E' ' 65' ' ' LEU . 19.3 m-85 -128.89 154.91 46.04 Favored 'General case' 0 C--N 1.36 1.06 0 CA-C-O 124.042 1.877 . . . . 0.23999999999999999 114.036 -173.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.42 101.92 10.59 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 112.337 -2.21 . . . . 1.01 109.941 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -27.27 -26.95 0.0 OUTLIER 'General case' 0 C--N 1.372 1.553 1 C-N-CA 132.155 4.182 . . . . 1.72 121.132 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -46.9 -49.64 20.07 Favored 'General case' 0 C--N 1.374 1.66 0 C-N-CA 131.028 3.731 . . . . 0.20000000000000001 113.601 167.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 11.6 pm0 -95.07 10.02 37.35 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-N 114.121 -1.399 . . . . 1.1799999999999999 112.942 -172.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . 0.466 HD22 ' HB3' ' E' ' 60' ' ' PHE . 0.2 OUTLIER -115.3 120.64 40.32 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.824 1.65 . . . . 1.0900000000000001 111.215 -177.603 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -100.15 115.15 29.16 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 125.763 1.625 . . . . 2.0499999999999998 111.116 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.56 132.02 46.75 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 129.087 2.955 . . . . 0.28999999999999998 118.535 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.63 -39.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.275 0 C-N-CA 124.407 1.083 . . . . 1.1799999999999999 113.436 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 69' ' ' GLN . . . . . 0.462 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 25.6 tt0 -112.22 106.86 15.54 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 116.327 1.973 . . . . 2.1899999999999999 116.327 -171.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.27 63.85 0.15 Allowed 'General case' 0 CA--C 1.557 1.225 0 O-C-N 119.734 -1.854 . . . . 0.0 115.957 170.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.35 53.72 0.41 Allowed 'General case' 0 C--N 1.369 1.453 0 C-N-CA 128.112 2.565 . . . . 0.0 117.12 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.74 160.07 15.13 Favored 'General case' 0 C--N 1.35 0.591 0 C-N-CA 128.313 2.645 . . . . 0.0 116.089 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt . . . . . 0 C--O 1.261 1.708 0 C-N-CA 128.905 2.882 . . . . 0.0 108.83 176.976 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.447 0 N-CA-C 116.718 2.118 . . . . 1.54 116.718 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.31 153.85 44.21 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 129.1 2.96 . . . . 1.0 104.43 177.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . 0.282 0.0 OUTLIER -86.29 121.62 29.13 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 119.55 3.167 . . . . 3.9399999999999999 119.55 -171.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.4 -0.69 14.24 Favored Glycine 0 C--N 1.365 2.19 0 C-N-CA 126.372 1.939 . . . . 0.75 110.856 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 6' ' ' ASP . . . . . 0.42 ' HA ' ' HB2' ' E' ' 69' ' ' GLN . 56.2 t0 -70.26 146.16 50.84 Favored 'General case' 0 N--CA 1.423 -1.818 1 C-N-CA 132.937 4.495 . . . . 0.45000000000000001 112.054 -178.763 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . 0.498 ' HZ3' HH21 ' E' ' 39' ' ' ARG . 70.3 mmtt -82.48 76.53 9.34 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 125.315 1.446 . . . . 2.54 108.743 171.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 28.8 m -87.6 144.97 8.15 Favored 'Isoleucine or valine' 0 C--N 1.371 1.532 0 O-C-N 119.815 -1.803 . . . . 1.03 107.312 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -109.99 117.12 32.94 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 114.754 1.39 . . . . 0.17000000000000001 114.754 -169.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 14.2 mm -63.96 126.03 21.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.834 0 C-N-CA 128.508 2.723 . . . . 1.03 118.012 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.87 39.38 3.53 Favored 'General case' 0 C--N 1.365 1.281 0 N-CA-C 115.945 1.831 . . . . 0.29999999999999999 115.945 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -108.47 147.57 31.47 Favored 'General case' 0 C--N 1.368 1.371 0 O-C-N 118.942 -2.349 . . . . 2.7599999999999998 110.685 174.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 13.3 t -105.14 24.17 12.46 Favored 'General case' 0 C--N 1.364 1.231 0 C-N-CA 125.314 1.446 . . . . 0.46999999999999997 112.347 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -90.83 11.51 22.28 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 127.763 2.425 . . . . 1.8899999999999999 112.832 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 3.3 t -169.12 -173.66 1.82 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.012 1.325 . . . . 1.3999999999999999 107.657 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -92.77 21.12 5.82 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 130.001 3.321 . . . . 1.1599999999999999 112.266 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -111.51 6.96 20.5 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 127.99 2.516 . . . . 0.94999999999999996 110.012 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -64.1 101.46 0.4 Allowed 'General case' 0 C--N 1.367 1.363 0 C-N-CA 127.988 2.515 . . . . 0.95999999999999996 114.911 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.77 40.36 4.69 Favored Glycine 0 C--N 1.359 1.809 0 C-N-CA 125.758 1.647 . . . . 0.39000000000000001 111.368 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -132.93 146.18 51.56 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 123.399 1.571 . . . . 1.3999999999999999 113.254 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.32 147.8 4.98 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 C-N-CA 130.211 3.404 . . . . 1.03 112.019 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.96 -179.21 34.6 Favored Glycine 0 CA--C 1.478 -2.225 0 N-CA-C 107.995 -2.042 . . . . 0.27000000000000002 107.995 173.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 23' ' ' THR . . . . . 0.628 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 30.1 m -88.93 129.12 35.68 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 124.861 1.264 . . . . 1.1000000000000001 109.711 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.64 92.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 124.795 2.236 . . . . 1.1100000000000001 113.624 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.55 23.55 2.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.824 2.05 . . . . 1.0600000000000001 113.236 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 28.6 t -64.82 -66.09 0.59 Allowed 'General case' 0 C--N 1.364 1.211 1 C-N-CA 131.85 4.06 . . . . 0.87 115.315 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -85.44 53.88 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.745 0 CA-C-O 124.017 1.865 . . . . 0.60999999999999999 113.054 -166.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.81 -67.09 0.05 OUTLIER 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 127.377 2.271 . . . . 1.6100000000000001 107.422 -171.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -104.28 -9.17 18.77 Favored 'General case' 0 C--N 1.363 1.181 0 N-CA-C 115.083 1.512 . . . . 4.3200000000000003 115.083 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.23 24.51 1.85 Allowed 'General case' 0 C--N 1.363 1.17 0 N-CA-C 115.532 1.679 . . . . 4.7999999999999998 115.532 -176.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.77 46.71 0.16 Allowed Glycine 0 C--N 1.364 2.124 0 C-N-CA 130.05 3.691 . . . . 2.21 115.806 168.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -130.94 -159.33 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.672 1 C-N-CA 132.995 4.518 . . . . 1.6399999999999999 107.418 -176.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 39.7 tp -69.24 -34.37 74.7 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 130.411 3.484 . . . . 0.64000000000000001 117.821 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -106.45 146.44 33.01 Favored Pre-proline 0 C--N 1.358 0.953 0 C-N-CA 125.092 1.357 . . . . 1.52 109.211 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.52 -43.66 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.624 2.883 . . . . 0.67000000000000004 114.597 -170.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 60.9 t -109.43 128.02 65.74 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 115.305 1.594 . . . . 1.1599999999999999 115.305 -170.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 19.0 mt -109.09 142.22 22.23 Favored 'Isoleucine or valine' 0 C--N 1.36 1.054 0 N-CA-C 103.7 -2.704 . . . . 1.28 103.7 162.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 17.8 t -134.8 159.22 41.72 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 N-CA-C 107.308 -1.367 . . . . 1.04 107.308 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 39' ' ' ARG . . . . . 0.628 ' HB3' ' H ' ' E' ' 23' ' ' THR . 41.1 ttp85 -83.82 147.48 27.54 Favored 'General case' 0 C--N 1.354 0.766 1 C-N-CA 131.854 4.062 . . . . 3.1400000000000001 111.914 172.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -133.68 128.13 34.36 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 125.07 1.348 . . . . 1.26 108.218 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.24 -16.95 30.04 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 128.445 2.698 . . . . 1.8100000000000001 112.299 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -99.03 61.6 1.26 Allowed 'General case' 0 C--N 1.356 0.863 1 C-N-CA 132.119 4.168 . . . . 1.29 110.765 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.361 1.106 0 C-N-CA 129.13 2.972 . . . . 1.7 104.153 169.087 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.544 0.733 0 CA-C-O 119.654 -0.212 . . . . 2.6800000000000002 111.442 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 22.9 p -126.29 134.78 51.05 Favored 'General case' 0 C--N 1.362 1.128 0 O-C-N 119.927 -1.733 . . . . 1.1399999999999999 110.164 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -162.06 161.58 28.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.871 1.668 . . . . 1.9399999999999999 107.194 175.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -97.1 154.45 17.33 Favored 'General case' 0 C--N 1.361 1.101 0 CA-C-O 124.032 1.872 . . . . 2.2200000000000002 113.897 -176.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -135.94 169.55 17.41 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 112.481 -2.145 . . . . 0.23999999999999999 113.489 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -109.46 108.58 19.14 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 111.064 -2.789 . . . . 1.01 107.788 172.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -25.66 -17.94 0.0 OUTLIER 'General case' 0 C--N 1.367 1.341 2 C-N-CA 134.395 5.078 . . . . 1.72 122.0 176.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -65.99 -32.41 73.88 Favored 'General case' 0 C--N 1.371 1.502 0 C-N-CA 130.97 3.708 . . . . 0.20000000000000001 110.937 166.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -84.85 -11.76 54.99 Favored 'General case' 0 C--N 1.364 1.217 0 O-C-N 120.742 -1.224 . . . . 1.1799999999999999 110.705 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.81 108.57 20.14 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 115.708 1.744 . . . . 1.0900000000000001 115.708 -171.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -96.43 133.17 41.19 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 125.596 1.558 . . . . 2.0499999999999998 108.772 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . 0.297 2.4 pt? -87.36 153.09 21.73 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-N 123.1 2.682 . . . . 0.28999999999999998 117.017 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 t -125.44 -27.42 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.121 0 C-N-CA 126.088 1.755 . . . . 1.1799999999999999 110.782 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 69' ' ' GLN . . . . . 0.42 ' HB2' ' HA ' ' E' ' 6' ' ' ASP . 2.5 mm-40 -113.85 160.98 18.15 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 127.018 3.294 . . . . 2.1899999999999999 114.786 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.73 56.36 0.7 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 108.886 -3.779 . . . . 0.0 111.651 173.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.71 58.78 1.89 Allowed 'General case' 0 C--N 1.365 1.253 0 O-C-N 120.205 -1.56 . . . . 0.0 114.553 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.95 91.93 7.13 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 128.753 2.821 . . . . 0.0 112.308 -176.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 75.7 mttt . . . . . 0 C--O 1.262 1.738 0 CA-C-O 117.624 -1.179 . . . . 0.0 109.104 174.463 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 2' ' ' LEU . . . . . 0.402 ' HB2' ' H ' ' E' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 117.998 2.592 . . . . 1.54 117.998 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . 0.402 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 1.0 OUTLIER -135.61 178.49 7.0 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 129.11 2.964 . . . . 1.0 110.127 -175.66 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . 0.443 ' CZ ' ' H ' ' E' ' 4' ' ' ARG . 0.0 OUTLIER -94.65 104.98 16.91 Favored 'General case' 0 C--N 1.376 1.753 0 C-N-CA 128.699 2.8 . . . . 3.9399999999999999 114.423 173.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 5' ' ' GLY . . . . . 0.517 ' H ' ' CG1' ' E' ' 24' ' ' VAL . . . 113.34 -3.34 25.13 Favored Glycine 0 CA--C 1.485 -1.799 0 O-C-N 118.079 -2.888 . . . . 0.75 110.175 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 6' ' ' ASP . . . . . 0.514 ' HA ' ' HB2' ' E' ' 69' ' ' GLN . 43.5 t0 -68.4 127.79 34.25 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 130.292 3.437 . . . . 0.45000000000000001 110.381 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . 0.702 ' HZ3' HH21 ' E' ' 39' ' ' ARG . 60.7 mttm -82.56 80.17 8.78 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 106.711 -1.588 . . . . 2.54 106.711 174.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 8' ' ' VAL . . . . . 0.403 ' H ' HG21 ' E' ' 8' ' ' VAL . 12.7 m -84.51 142.32 13.49 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 O-C-N 121.665 -0.647 . . . . 1.03 109.951 -173.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -108.02 129.28 55.14 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 118.322 -0.847 . . . . 0.17000000000000001 111.838 -172.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 3.7 mm -74.01 118.53 19.69 Favored 'Isoleucine or valine' 0 C--N 1.365 1.272 0 N-CA-C 115.141 1.534 . . . . 1.03 115.141 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -107.59 36.89 2.57 Favored 'General case' 0 C--N 1.373 1.621 0 O-C-N 119.574 -1.954 . . . . 0.29999999999999999 114.072 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -102.52 99.26 9.27 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 129.853 3.261 . . . . 2.7599999999999998 112.663 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 13' ' ' THR . . . . . 0.555 ' HA ' ' CG ' ' E' ' 18' ' ' TYR . 4.1 m -58.58 -34.37 71.0 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 129.081 2.953 . . . . 0.46999999999999997 117.912 -175.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.72 44.01 0.21 Allowed 'General case' 0 C--N 1.346 0.442 0 C-N-CA 129.199 2.999 . . . . 1.8899999999999999 115.003 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 17.1 t -172.2 175.1 3.8 Favored 'General case' 0 C--N 1.365 1.257 0 C-N-CA 125.343 1.457 . . . . 1.3999999999999999 107.4 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -92.19 7.13 43.99 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 129.975 3.31 . . . . 1.1599999999999999 111.124 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 38.5 m0 -106.32 10.51 31.63 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 127.247 2.219 . . . . 0.94999999999999996 109.478 178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 18' ' ' TYR . . . . . 0.555 ' CG ' ' HA ' ' E' ' 13' ' ' THR . 18.5 t80 -69.79 101.68 1.76 Allowed 'General case' 0 C--N 1.374 1.635 0 C-N-CA 126.333 1.853 . . . . 0.95999999999999996 113.276 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.18 39.69 6.34 Favored Glycine 0 C--N 1.356 1.667 0 C-N-CA 125.359 1.457 . . . . 0.39000000000000001 111.898 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -109.86 135.7 50.32 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 119.043 1.421 . . . . 1.3999999999999999 109.065 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -97.17 164.82 2.18 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 125.579 1.552 . . . . 1.03 110.582 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.19 177.67 47.08 Favored Glycine 0 CA--C 1.47 -2.772 0 N-CA-C 107.056 -2.418 . . . . 0.27000000000000002 107.056 170.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 23' ' ' THR . . . . . 0.449 ' H ' ' CB ' ' E' ' 39' ' ' ARG . 6.9 m -86.77 130.47 34.46 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 125.348 2.499 . . . . 1.1000000000000001 110.801 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 24' ' ' VAL . . . . . 0.517 ' CG1' ' H ' ' E' ' 5' ' ' GLY . 11.8 p -62.32 73.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 131.176 3.79 . . . . 1.1100000000000001 116.062 174.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.96 25.65 0.36 Allowed 'General case' 0 CA--C 1.551 1.012 0 O-C-N 116.475 -3.891 . . . . 1.0600000000000001 114.131 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . 0.271 1.5 m -73.86 -25.65 60.16 Favored 'General case' 0 CA--C 1.5 -0.964 1 C-N-CA 136.376 5.87 . . . . 0.87 117.155 175.488 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -114.27 49.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 124.778 1.231 . . . . 0.60999999999999999 109.083 -171.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.34 -56.93 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 124.024 0.93 . . . . 1.6100000000000001 108.905 -169.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -109.43 8.86 25.51 Favored 'General case' 0 C--N 1.36 1.049 0 C-N-CA 126.357 1.863 . . . . 4.3200000000000003 111.799 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 4.9 m -27.22 -41.12 0.01 OUTLIER 'General case' 0 C--N 1.361 1.08 1 C-N-CA 135.909 5.684 . . . . 4.7999999999999998 121.05 -175.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.35 42.27 0.13 Allowed Glycine 0 C--N 1.348 1.244 1 C-N-CA 131.845 4.545 . . . . 2.21 118.172 -171.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.78 -167.24 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.457 0 C-N-CA 125.04 1.336 . . . . 1.6399999999999999 110.292 176.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 38.0 tp -65.34 -33.89 77.03 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 129.629 3.172 . . . . 0.64000000000000001 116.86 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -135.12 132.82 20.37 Favored Pre-proline 0 N--CA 1.469 0.499 0 N-CA-C 101.501 -3.518 . . . . 1.52 101.501 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.02 -46.63 1.44 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.779 2.986 . . . . 0.67000000000000004 116.573 -160.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 54.3 t -80.83 103.02 7.24 Favored 'Isoleucine or valine' 0 C--N 1.368 1.372 0 N-CA-C 114.417 1.266 . . . . 1.1599999999999999 114.417 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 20.5 mt -89.82 118.72 35.65 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 N-CA-C 106.05 -1.833 . . . . 1.28 106.05 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 37.7 t -109.7 145.56 16.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 O-C-N 119.685 -1.884 . . . . 1.04 109.646 176.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 39' ' ' ARG . . . . . 0.702 HH21 ' HZ3' ' E' ' 7' ' ' LYS . 8.1 tmm_? -42.85 -32.65 0.65 Allowed 'General case' 0 C--N 1.359 0.994 2 C-N-CA 134.467 5.107 . . . . 3.1400000000000001 123.564 -177.243 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.22 129.44 34.5 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 120.794 3.627 . . . . 1.26 120.794 -162.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -88.53 38.02 0.85 Allowed 'General case' 0 C--N 1.356 0.875 0 C-N-CA 128.934 2.894 . . . . 1.8100000000000001 113.324 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -96.08 36.13 1.35 Allowed 'General case' 0 C--N 1.348 0.535 1 C-N-CA 131.97 4.108 . . . . 1.29 110.428 -176.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . 0.263 10.9 m . . . . . 0 N--CA 1.449 -0.487 0 C-N-CA 127.725 2.41 . . . . 1.7 110.978 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 121.693 0.759 . . . . 2.6800000000000002 112.491 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 16.1 p -114.78 125.3 53.54 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 101.388 -3.56 . . . . 1.1399999999999999 101.388 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -122.8 133.48 54.45 Favored 'General case' 0 C--N 1.358 0.939 0 O-C-N 120.098 -1.626 . . . . 1.9399999999999999 113.131 -168.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -88.13 112.5 22.76 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 129.294 3.038 . . . . 2.2200000000000002 115.7 -174.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -115.46 173.5 6.49 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 115.47 1.655 . . . . 0.23999999999999999 115.47 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.53 85.85 4.65 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 129.503 3.121 . . . . 1.01 110.755 172.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -15.91 -23.4 0.0 OUTLIER 'General case' 0 C--N 1.36 1.043 1 C-N-CA 138.108 6.563 . . . . 1.72 121.331 172.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.07 -37.26 69.66 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 130.366 3.466 . . . . 0.20000000000000001 113.831 171.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . 0.275 2.0 pp20? -97.46 16.03 21.43 Favored 'General case' 0 C--N 1.373 1.624 0 C-N-CA 126.35 1.86 . . . . 1.1799999999999999 111.331 -177.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.96 104.58 12.55 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 128.427 2.691 . . . . 1.0900000000000001 108.206 172.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -94.53 150.48 20.2 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 125.867 1.667 . . . . 2.0499999999999998 111.15 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -74.47 142.04 44.9 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 117.851 2.537 . . . . 0.28999999999999998 117.851 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 3.4 t -135.6 -27.9 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.072 0 C-N-CA 126.206 1.802 . . . . 1.1799999999999999 110.499 171.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 69' ' ' GLN . . . . . 0.514 ' HB2' ' HA ' ' E' ' 6' ' ' ASP 0.342 19.8 mt-30 -118.59 113.58 21.47 Favored 'General case' 0 C--N 1.361 1.075 0 CA-C-O 123.489 1.614 . . . . 2.1899999999999999 113.613 174.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.86 56.96 0.99 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 127.804 2.442 . . . . 0.0 111.523 169.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.02 58.2 0.22 Allowed 'General case' 0 C--N 1.355 0.834 0 C-N-CA 128.365 2.666 . . . . 0.0 117.796 -169.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.06 73.02 0.89 Allowed 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt . . . . . 0 C--O 1.262 1.746 0 C-N-CA 127.661 2.384 . . . . 0.0 111.704 177.969 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 2' ' ' LEU . . . . . . . . . . . . 0.328 1.8 pp . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 115.969 1.841 . . . . 1.54 115.969 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -144.36 176.08 9.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 129.773 3.229 . . . . 1.0 111.223 -171.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.59 102.7 14.52 Favored 'General case' 0 C--N 1.37 1.462 0 O-C-N 119.51 -1.994 . . . . 3.9399999999999999 112.165 174.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.47 4.58 11.9 Favored Glycine 0 C--N 1.363 2.059 0 CA-C-O 124.087 1.937 . . . . 0.75 112.241 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 6' ' ' ASP . . . . . 0.482 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 65.3 t0 -74.89 136.81 41.46 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 130.446 3.498 . . . . 0.45000000000000001 109.508 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -91.75 79.1 5.4 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 104.96 -2.237 . . . . 2.54 104.96 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 13.4 m -86.32 143.18 11.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 106.336 -1.727 . . . . 1.03 106.336 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' E' ' 21' ' ' VAL . 23.4 ttt85 -104.16 117.74 34.97 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 113.495 0.924 . . . . 0.17000000000000001 113.495 -172.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 13.8 mm -56.66 111.66 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.376 0 N-CA-C 117.466 2.395 . . . . 1.03 117.466 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -115.35 47.63 1.29 Allowed 'General case' 0 C--N 1.368 1.408 0 C-N-CA 126.225 1.81 . . . . 0.29999999999999999 109.912 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -106.64 127.09 53.07 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 128.31 2.644 . . . . 2.7599999999999998 106.147 174.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 18.3 p -71.34 -58.67 3.31 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 129.74 3.216 . . . . 0.46999999999999997 113.496 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.11 67.43 2.41 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 130.944 3.698 . . . . 1.8899999999999999 110.04 174.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 27.8 t -163.43 159.9 22.79 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.344 -2.095 . . . . 1.3999999999999999 105.344 -172.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -92.49 -1.81 56.7 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 127.159 2.184 . . . . 1.1599999999999999 110.914 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 9.1 m0 -119.83 24.43 10.55 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 126.253 1.821 . . . . 0.94999999999999996 111.721 -172.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -68.98 101.17 1.33 Allowed 'General case' 0 C--N 1.371 1.507 0 C-N-CA 125.637 1.575 . . . . 0.95999999999999996 112.758 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.96 14.66 35.92 Favored Glycine 0 C--N 1.358 1.805 0 C-N-CA 125.035 1.302 . . . . 0.39000000000000001 112.192 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -113.06 154.03 27.2 Favored 'General case' 0 C--N 1.362 1.145 0 C-N-CA 125.316 1.446 . . . . 1.3999999999999999 109.782 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' E' ' 9' ' ' ARG . 1.4 p -92.02 -176.8 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.383 0 C-N-CA 127.525 2.33 . . . . 1.03 113.423 -175.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.24 176.72 46.42 Favored Glycine 0 CA--C 1.479 -2.159 0 N-CA-C 108.839 -1.704 . . . . 0.27000000000000002 108.839 166.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 23' ' ' THR . . . . . 0.442 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 29.0 m -101.89 120.73 40.85 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 124.516 1.127 . . . . 1.1000000000000001 109.99 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 7.1 p -75.29 88.02 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 123.292 1.52 . . . . 1.1100000000000001 113.272 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.6 43.95 1.15 Allowed 'General case' 0 C--N 1.353 0.75 0 C-N-CA 126.596 1.958 . . . . 1.0600000000000001 110.775 171.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 13.7 t -81.51 -73.27 0.39 Allowed 'General case' 0 CA--C 1.488 -1.429 1 C-N-CA 131.78 4.032 . . . . 0.87 113.753 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 p -82.1 54.11 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.571 0 CA-C-O 126.5 3.048 . . . . 0.60999999999999999 113.145 -160.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.57 -72.05 0.69 Allowed 'General case' 0 N--CA 1.418 -2.039 0 C-N-CA 130.663 3.585 . . . . 1.6100000000000001 103.053 175.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.34 -17.6 13.1 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 125.696 1.598 . . . . 4.3200000000000003 112.754 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 1.8 t -92.41 46.92 1.27 Allowed 'General case' 0 C--N 1.367 1.344 0 O-C-N 119.435 -2.041 . . . . 4.7999999999999998 114.375 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.14 51.09 4.51 Favored Glycine 0 C--N 1.341 0.809 1 C-N-CA 130.89 4.09 . . . . 2.21 111.537 162.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.84 -166.6 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.882 0 C-N-CA 130.045 3.338 . . . . 1.6399999999999999 108.695 -176.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 22.1 tp -61.37 -38.27 86.37 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 130.578 3.551 . . . . 0.64000000000000001 117.027 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -113.81 115.54 46.09 Favored Pre-proline 0 C--N 1.356 0.855 0 N-CA-C 101.521 -3.511 . . . . 1.52 101.521 172.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -82.12 -55.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.905 2.403 . . . . 0.67000000000000004 115.533 -169.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 24.9 t -75.21 95.69 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.019 0 N-CA-C 119.65 3.204 . . . . 1.1599999999999999 119.65 -166.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 68.1 mt -87.34 119.45 35.03 Favored 'Isoleucine or valine' 0 C--N 1.368 1.41 0 N-CA-C 104.97 -2.233 . . . . 1.28 104.97 172.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 14.0 t -123.21 163.61 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-N 120.186 1.357 . . . . 1.04 111.62 -172.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 39' ' ' ARG . . . . . 0.442 ' HB3' ' H ' ' E' ' 23' ' ' THR . 43.6 ttm-85 -84.43 142.09 30.35 Favored 'General case' 0 C--N 1.363 1.193 0 C-N-CA 128.859 2.864 . . . . 3.1400000000000001 113.92 174.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -137.33 128.59 27.95 Favored 'General case' 0 CA--C 1.514 -0.437 0 O-C-N 121.301 -0.874 . . . . 1.26 111.474 173.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -90.27 -38.44 13.41 Favored 'General case' 0 C--N 1.366 1.325 0 C-N-CA 126.356 1.862 . . . . 1.8100000000000001 111.38 172.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -77.97 59.59 2.18 Favored 'General case' 0 C--N 1.37 1.468 0 C-N-CA 129.459 3.104 . . . . 1.29 112.767 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.353 0.726 0 C-N-CA 127.125 2.17 . . . . 1.7 105.538 172.948 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 123.316 1.531 . . . . 2.6800000000000002 110.48 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 67.9 p -115.97 104.5 11.65 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 127.97 2.508 . . . . 1.1399999999999999 106.472 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -110.29 138.88 46.07 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 107.5 -1.296 . . . . 1.9399999999999999 107.5 -176.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -100.01 112.01 24.31 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-O 122.222 1.01 . . . . 2.2200000000000002 109.868 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -104.16 172.7 6.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 123.909 1.814 . . . . 0.23999999999999999 115.274 -175.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -102.42 94.13 5.52 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 112.218 -2.265 . . . . 1.01 109.24 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -7.43 -37.79 0.0 OUTLIER 'General case' 0 C--N 1.367 1.351 1 C-N-CA 134.778 5.231 . . . . 1.72 121.21 172.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -45.61 -46.53 14.45 Favored 'General case' 0 C--N 1.364 1.212 1 C-N-CA 132.715 4.406 . . . . 0.20000000000000001 113.1 168.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -89.86 1.61 55.98 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 125.822 1.649 . . . . 1.1799999999999999 112.168 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.96 108.53 16.37 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 126.664 1.986 . . . . 1.0900000000000001 114.126 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -106.44 143.0 35.18 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 125.721 1.608 . . . . 2.0499999999999998 111.907 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -64.62 146.34 54.81 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 119.988 3.329 . . . . 0.28999999999999998 119.988 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -144.47 -29.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.372 1.585 0 C-N-CA 126.91 2.084 . . . . 1.1799999999999999 112.028 173.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 69' ' ' GLN . . . . . 0.482 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 0.0 OUTLIER -114.51 116.47 28.88 Favored 'General case' 0 C--N 1.358 0.937 0 O-C-N 119.554 -1.966 . . . . 2.1899999999999999 111.849 177.574 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.33 59.57 1.05 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.254 2.622 . . . . 0.0 113.125 174.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.47 58.46 2.66 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 129.021 2.928 . . . . 0.0 113.51 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.0 78.66 1.18 Allowed 'General case' 0 C--N 1.356 0.879 0 C-N-CA 128.189 2.596 . . . . 0.0 115.32 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt . . . . . 0 C--O 1.262 1.716 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 176.124 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 2' ' ' LEU . . . . . . . . . . . . 0.271 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 118.11 2.633 . . . . 1.54 118.11 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -136.3 -169.26 2.4 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 127.438 2.295 . . . . 1.0 111.321 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -96.44 110.27 22.66 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 127.568 2.347 . . . . 3.9399999999999999 114.528 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.25 -0.28 14.43 Favored Glycine 0 CA--C 1.477 -2.295 0 O-C-N 121.025 -1.047 . . . . 0.75 111.998 165.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 6' ' ' ASP . . . . . 0.481 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 46.1 t0 -72.83 137.51 45.78 Favored 'General case' 0 N--CA 1.408 -2.555 1 C-N-CA 133.153 4.581 . . . . 0.45000000000000001 113.469 -176.233 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . 0.49 ' H ' ' CB ' ' E' ' 69' ' ' GLN . 13.7 mptt -87.87 77.37 8.54 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 106.485 -1.672 . . . . 2.54 106.485 171.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 15.0 m -87.42 138.93 18.14 Favored 'Isoleucine or valine' 0 C--N 1.369 1.438 0 C-N-CA 127.168 2.187 . . . . 1.03 106.224 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -105.35 113.93 27.81 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 120.77 -1.206 . . . . 0.17000000000000001 112.55 -171.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mm -52.89 120.89 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 N-CA-C 117.727 2.491 . . . . 1.03 117.727 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -121.06 48.48 1.64 Allowed 'General case' 0 C--N 1.372 1.563 0 C-N-CA 125.519 1.528 . . . . 0.29999999999999999 113.606 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 12' ' ' ARG . . . . . 0.509 ' CZ ' ' HG ' ' E' ' 15' ' ' SER . 13.7 ttt180 -102.25 111.73 24.14 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 128.237 2.615 . . . . 2.7599999999999998 110.075 177.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 47.0 p -50.74 -59.13 4.41 Favored 'General case' 0 C--N 1.369 1.454 0 C-N-CA 131.279 3.831 . . . . 0.46999999999999997 119.742 -175.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -87.77 65.55 8.45 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 127.927 2.491 . . . . 1.8899999999999999 110.736 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 15' ' ' SER . . . . . 0.509 ' HG ' ' CZ ' ' E' ' 12' ' ' ARG . 4.5 t -145.15 169.2 18.63 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-O 123.392 1.568 . . . . 1.3999999999999999 111.287 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -95.67 -1.49 50.0 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 124.996 1.318 . . . . 1.1599999999999999 109.561 166.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -118.13 23.67 11.47 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 126.347 1.859 . . . . 0.94999999999999996 110.898 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -75.03 94.92 2.94 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 125.817 1.647 . . . . 0.95999999999999996 112.193 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.95 34.24 4.38 Favored Glycine 0 C--N 1.359 1.809 0 C-N-CA 126.077 1.799 . . . . 0.39000000000000001 110.16 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -110.66 152.16 26.84 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 126.829 2.052 . . . . 1.3999999999999999 108.537 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.06 170.26 3.59 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 CA-C-N 120.216 1.371 . . . . 1.03 108.456 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.98 176.49 44.24 Favored Glycine 0 CA--C 1.474 -2.5 0 O-C-N 120.079 -1.638 . . . . 0.27000000000000002 109.255 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 23' ' ' THR . . . . . 0.437 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 15.1 m -94.63 120.14 34.4 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 125.617 1.567 . . . . 1.1000000000000001 110.478 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 6.9 p -76.66 101.84 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 124.395 2.045 . . . . 1.1100000000000001 112.69 173.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.89 46.1 1.3 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.167 1.387 . . . . 1.0600000000000001 114.232 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 62.0 p -73.18 -86.3 0.03 OUTLIER 'General case' 0 C--N 1.354 0.794 0 C-N-CA 130.203 3.401 . . . . 0.87 114.863 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 27' ' ' VAL . . . . . 0.443 ' H ' HG11 ' E' ' 27' ' ' VAL . 2.4 p -79.54 59.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.616 0 CA-C-O 126.519 3.057 . . . . 0.60999999999999999 112.905 -169.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -160.62 -62.79 0.06 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.732 3.213 . . . . 1.6100000000000001 107.233 -173.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.56 -18.19 16.73 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 127.202 2.201 . . . . 4.3200000000000003 115.802 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -26.82 0.3 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.039 2 C-N-CA 134.866 5.266 . . . . 4.7999999999999998 123.404 -172.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.54 43.54 1.86 Allowed Glycine 0 C--O 1.224 -0.496 1 C-N-CA 131.991 4.615 . . . . 2.21 114.939 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 32' ' ' ILE . . . . . 0.472 HG21 ' H ' ' E' ' 33' ' ' LEU . 1.1 mt -131.77 -169.68 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 127.984 2.514 . . . . 1.6399999999999999 105.853 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 33' ' ' LEU . . . . . 0.472 ' H ' HG21 ' E' ' 32' ' ' ILE . 32.2 tp -68.51 -44.49 74.53 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 117.287 2.328 . . . . 0.64000000000000001 117.287 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -123.02 157.9 59.14 Favored Pre-proline 0 C--N 1.356 0.887 0 N-CA-C 106.261 -1.755 . . . . 1.52 106.261 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.68 -46.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.365 1.427 0 C-N-CA 123.439 2.759 . . . . 0.67000000000000004 115.568 -166.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 73.3 t -90.51 97.04 6.76 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 CA-C-O 122.688 1.232 . . . . 1.1599999999999999 112.445 -170.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 56.9 mt -86.66 105.08 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 C-N-CA 127.958 2.503 . . . . 1.28 104.34 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 21.1 t -105.38 156.21 6.38 Favored 'Isoleucine or valine' 0 C--N 1.349 0.547 0 CA-C-N 121.058 1.754 . . . . 1.04 111.546 -174.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 39' ' ' ARG . . . . . 0.437 ' HB3' ' H ' ' E' ' 23' ' ' THR . 17.5 tpp180 -81.8 131.83 35.27 Favored 'General case' 0 C--N 1.36 1.06 0 C-N-CA 127.785 2.434 . . . . 3.1400000000000001 110.983 172.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -128.91 150.46 50.35 Favored 'General case' 0 CA--C 1.512 -0.489 0 O-C-N 121.743 -0.598 . . . . 1.26 110.648 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -96.16 -48.42 5.65 Favored 'General case' 0 C--N 1.36 1.045 0 C-N-CA 126.0 1.72 . . . . 1.8100000000000001 109.81 173.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 86.4 mtm-85 -82.82 85.55 7.07 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 125.893 1.677 . . . . 1.29 114.837 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 14.4 t . . . . . 0 C--N 1.357 0.913 0 C-N-CA 127.111 2.164 . . . . 1.7 112.324 176.822 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 112.634 0.605 . . . . 2.6800000000000002 112.634 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 7.2 p -126.15 121.39 32.68 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 128.723 2.809 . . . . 1.1399999999999999 104.764 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -150.32 144.45 25.53 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.695 0.798 . . . . 1.9399999999999999 109.561 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 59' ' ' ASN . . . . . 0.429 HD22 HD11 ' E' ' 32' ' ' ILE . 11.2 m120 -81.46 106.27 13.3 Favored 'General case' 0 C--N 1.352 0.677 0 C-N-CA 130.812 3.645 . . . . 2.2200000000000002 120.117 -174.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -109.67 175.84 5.29 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 119.282 -2.136 . . . . 0.23999999999999999 113.793 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -114.27 115.7 27.82 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 113.958 -1.474 . . . . 1.01 109.578 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -16.94 -38.13 0.0 OUTLIER 'General case' 0 C--N 1.367 1.351 1 C-N-CA 136.581 5.952 . . . . 1.72 118.496 173.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -49.84 -48.47 51.02 Favored 'General case' 0 C--N 1.37 1.492 0 C-N-CA 130.926 3.69 . . . . 0.20000000000000001 113.932 169.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 13.2 pm0 -95.32 17.44 14.41 Favored 'General case' 0 C--N 1.363 1.175 0 C-N-CA 124.202 1.001 . . . . 1.1799999999999999 112.16 -172.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.76 138.15 54.15 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 107.524 -1.288 . . . . 1.0900000000000001 107.524 173.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -110.39 126.28 54.11 Favored 'General case' 0 C--N 1.351 0.67 0 C-N-CA 124.501 1.12 . . . . 2.0499999999999998 111.717 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.14 139.56 58.15 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 128.301 2.64 . . . . 0.28999999999999998 117.695 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 t -135.26 -43.32 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.765 0 C-N-CA 126.35 1.86 . . . . 1.1799999999999999 109.691 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 69' ' ' GLN . . . . . 0.49 ' CB ' ' H ' ' E' ' 7' ' ' LYS . 1.6 tp60 -106.09 113.19 26.58 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 128.284 2.633 . . . . 2.1899999999999999 117.743 -168.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.76 68.1 6.88 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.958 171.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.31 53.39 0.07 Allowed 'General case' 0 C--N 1.373 1.594 0 N-CA-C 117.454 2.391 . . . . 0.0 117.454 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.05 130.96 35.42 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 126.92 2.088 . . . . 0.0 111.871 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 mptt . . . . . 0 C--O 1.262 1.729 0 C-N-CA 125.995 1.718 . . . . 0.0 110.356 179.019 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.722 0 CA-C-O 123.992 1.853 . . . . 1.54 115.637 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -140.56 -166.11 2.06 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 127.755 2.422 . . . . 1.0 109.417 -175.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -85.26 104.96 15.59 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 128.061 2.544 . . . . 3.9399999999999999 117.24 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 112.72 -9.5 25.75 Favored Glycine 0 CA--C 1.485 -1.84 0 O-C-N 119.409 -2.057 . . . . 0.75 110.904 173.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.13 42.13 0.07 Allowed 'General case' 0 N--CA 1.438 -1.066 1 C-N-CA 133.903 4.881 . . . . 0.45000000000000001 115.596 -176.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . 0.545 ' HZ3' ' HG1' ' E' ' 23' ' ' THR . 73.0 mmtt -5.74 93.21 0.01 OUTLIER 'General case' 0 C--N 1.362 1.15 1 C-N-CA 133.777 4.831 . . . . 2.54 117.058 -176.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 28.5 m -92.4 154.42 3.19 Favored 'Isoleucine or valine' 0 C--N 1.361 1.074 0 CA-C-N 121.149 1.795 . . . . 1.03 111.488 -172.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -103.17 109.0 20.42 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 121.446 -0.784 . . . . 0.17000000000000001 111.92 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . 0.612 ' CD1' ' H ' ' E' ' 10' ' ' ILE . 1.3 mp -56.96 103.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.213 0 C-N-CA 129.805 3.242 . . . . 1.03 114.494 174.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -120.48 52.36 1.16 Allowed 'General case' 0 C--N 1.37 1.493 0 C-N-CA 124.43 1.092 . . . . 0.29999999999999999 109.903 -172.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -72.17 -115.39 0.0 OUTLIER 'General case' 0 C--N 1.364 1.212 0 N-CA-C 118.792 2.886 . . . . 2.7599999999999998 118.792 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -170.71 142.58 2.01 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 101.719 -3.438 . . . . 0.46999999999999997 101.719 -174.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . 0.257 3.7 mm-40 -5.86 69.38 0.0 OUTLIER 'General case' 0 C--N 1.368 1.384 1 C-N-CA 134.343 5.057 . . . . 1.8899999999999999 119.316 -174.65 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 75.3 m -138.39 154.57 48.92 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 130.182 3.393 . . . . 1.3999999999999999 104.087 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -61.29 -11.17 8.67 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 130.127 3.371 . . . . 1.1599999999999999 117.151 -176.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 22.9 m0 -113.26 -3.5 13.85 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 128.882 2.873 . . . . 0.94999999999999996 113.371 -177.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -80.26 88.7 5.49 Favored 'General case' 0 C--N 1.373 1.602 0 C-N-CA 126.337 1.855 . . . . 0.95999999999999996 110.291 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.34 -11.71 3.01 Favored Glycine 0 C--N 1.36 1.903 0 C-N-CA 126.74 2.114 . . . . 0.39000000000000001 111.285 -175.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -97.75 162.59 13.19 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 119.66 1.73 . . . . 1.3999999999999999 114.924 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -103.12 169.79 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.208 0 C-N-CA 126.717 2.007 . . . . 1.03 108.444 172.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.99 -179.78 41.25 Favored Glycine 0 CA--C 1.476 -2.406 0 N-CA-C 108.491 -1.844 . . . . 0.27000000000000002 108.491 170.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 23' ' ' THR . . . . . 0.606 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 4.0 m -94.33 120.3 34.36 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 125.323 1.449 . . . . 1.1000000000000001 111.496 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 14.5 p -68.02 69.57 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 131.571 3.948 . . . . 1.1100000000000001 112.862 175.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.58 45.15 1.21 Allowed 'General case' 0 C--N 1.362 1.149 0 O-C-N 118.401 -2.687 . . . . 1.0600000000000001 110.095 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 13.2 m -87.96 -62.1 1.57 Allowed 'General case' 0 CA--C 1.465 -2.29 1 C-N-CA 135.959 5.704 . . . . 0.87 119.323 -171.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 m -80.23 19.14 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.093 0 N-CA-C 116.586 2.069 . . . . 0.60999999999999999 116.586 -156.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -111.28 -50.27 2.95 Favored 'General case' 0 N--CA 1.43 -1.473 1 C-N-CA 135.187 5.395 . . . . 1.6100000000000001 109.311 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -103.19 -12.4 17.36 Favored 'General case' 0 C--N 1.366 1.283 0 C-N-CA 128.232 2.613 . . . . 4.3200000000000003 113.194 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 8.4 t -43.53 -17.91 0.02 OUTLIER 'General case' 0 C--N 1.376 1.744 1 C-N-CA 132.084 4.153 . . . . 4.7999999999999998 117.97 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.53 45.46 0.27 Allowed Glycine 0 C--N 1.355 1.589 0 C-N-CA 130.221 3.772 . . . . 2.21 117.058 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.78 -159.36 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.913 0 C-N-CA 129.005 2.922 . . . . 1.6399999999999999 111.031 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 22.0 tp -69.31 -23.06 63.75 Favored 'General case' 0 C--N 1.355 0.839 1 C-N-CA 133.335 4.654 . . . . 0.64000000000000001 118.378 -177.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -134.55 152.72 78.32 Favored Pre-proline 0 C--N 1.362 1.131 0 N-CA-C 105.735 -1.95 . . . . 1.52 105.735 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.8 -45.74 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.9 3.067 . . . . 0.67000000000000004 117.65 -173.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 54.6 t -109.01 106.11 20.08 Favored 'Isoleucine or valine' 0 C--N 1.353 0.748 0 N-CA-C 115.296 1.591 . . . . 1.1599999999999999 115.296 -167.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mp -85.33 118.31 31.97 Favored 'Isoleucine or valine' 0 C--N 1.37 1.492 0 C-N-CA 125.977 1.711 . . . . 1.28 106.921 173.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 92.8 t -115.81 155.59 17.09 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 CA-C-O 122.128 0.966 . . . . 1.04 112.256 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 39' ' ' ARG . . . . . 0.606 ' HB3' ' H ' ' E' ' 23' ' ' THR . 1.9 tpm_? -75.47 139.55 42.32 Favored 'General case' 0 C--N 1.362 1.136 0 C-N-CA 130.118 3.367 . . . . 3.1400000000000001 112.932 173.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 40' ' ' PHE . . . . . 0.41 ' H ' ' NH2' ' E' ' 39' ' ' ARG . 60.9 m-85 -145.66 109.17 4.7 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 129.16 2.984 . . . . 1.26 107.915 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -104.71 -11.11 17.03 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 129.116 2.966 . . . . 1.8100000000000001 113.875 -176.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -94.16 9.7 36.84 Favored 'General case' 0 C--N 1.366 1.284 0 C-N-CA 126.503 1.921 . . . . 1.29 113.226 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.351 0.638 0 C-N-CA 128.16 2.584 . . . . 1.7 111.522 178.631 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 27.7 t30 . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 113.515 0.931 . . . . 2.6800000000000002 113.515 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 71.4 p -109.43 108.02 18.38 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.139 1.376 . . . . 1.1399999999999999 108.653 176.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.83 146.99 36.69 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 125.828 1.651 . . . . 1.9399999999999999 109.548 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -89.27 113.93 25.24 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 129.812 3.245 . . . . 2.2200000000000002 111.226 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -107.0 174.39 5.91 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.95 1.7 . . . . 0.23999999999999999 113.66 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.7 89.38 3.67 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 130.195 3.398 . . . . 1.01 110.643 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -26.16 -18.39 0.0 OUTLIER 'General case' 0 C--N 1.354 0.797 1 C-N-CA 136.072 5.749 . . . . 1.72 120.39 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.89 -32.8 72.25 Favored 'General case' 0 C--N 1.367 1.335 0 C-N-CA 129.148 2.979 . . . . 0.20000000000000001 112.729 168.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.27 18.07 21.88 Favored 'General case' 0 C--N 1.371 1.516 0 C-N-CA 125.832 1.653 . . . . 1.1799999999999999 110.285 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 74.1 mt -128.18 118.81 24.03 Favored 'General case' 0 C--N 1.366 1.295 0 CA-C-O 123.526 1.631 . . . . 1.0900000000000001 111.934 177.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -111.18 134.5 52.73 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.863 1.665 . . . . 2.0499999999999998 109.145 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.65 133.76 36.22 Favored 'General case' 0 C--N 1.366 1.318 1 C-N-CA 132.161 4.185 . . . . 0.28999999999999998 118.547 175.468 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . 0.269 3.1 t -132.13 -33.43 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.372 1.556 0 N-CA-C 114.758 1.392 . . . . 1.1799999999999999 114.758 178.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 69' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -111.13 139.69 46.3 Favored 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 119.443 -2.036 . . . . 2.1899999999999999 109.685 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.12 64.61 6.88 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.55 1.94 . . . . 0.0 114.045 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 71' ' ' ALA . . . . . 0.605 ' HB1' ' HZ2' ' E' ' 73' ' ' LYS . . . -95.9 68.25 2.77 Favored 'General case' 0 C--N 1.362 1.129 0 CA-C-O 123.444 1.592 . . . . 0.0 110.792 175.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.08 64.66 4.62 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 125.717 1.607 . . . . 0.0 109.849 176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 73' ' ' LYS . . . . . 0.605 ' HZ2' ' HB1' ' E' ' 71' ' ' ALA . 19.0 pttm . . . . . 0 C--O 1.261 1.694 0 C-N-CA 127.486 2.314 . . . . 0.0 107.143 176.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 2' ' ' LEU . . . . . . . . . . . . 0.279 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 123.773 1.749 . . . . 1.54 111.957 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.09 172.79 12.58 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 124.2 1.952 . . . . 1.0 114.418 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.09 94.34 7.89 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 127.124 2.17 . . . . 3.9399999999999999 112.86 176.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.27 3.44 9.61 Favored Glycine 0 C--N 1.365 2.172 0 O-C-N 120.697 -1.252 . . . . 0.75 111.388 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 6' ' ' ASP . . . . . 0.403 ' HA ' ' HB2' ' E' ' 69' ' ' GLN . 18.3 t0 -69.28 143.94 53.72 Favored 'General case' 0 N--CA 1.417 -2.092 0 C-N-CA 130.739 3.615 . . . . 0.45000000000000001 112.752 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -94.15 83.72 4.32 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 104.93 -2.248 . . . . 2.54 104.93 171.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 17.5 m -89.79 144.31 9.37 Favored 'Isoleucine or valine' 0 C--N 1.365 1.252 0 N-CA-C 107.517 -1.29 . . . . 1.03 107.517 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 69.1 ttt-85 -104.05 122.68 45.77 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 120.154 -1.591 . . . . 0.17000000000000001 110.817 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -67.75 120.93 15.96 Favored 'Isoleucine or valine' 0 C--N 1.363 1.165 0 C-N-CA 126.939 2.096 . . . . 1.03 113.808 177.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -126.96 52.82 1.75 Allowed 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 127.997 2.519 . . . . 0.29999999999999999 110.481 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -92.46 -138.86 0.18 Allowed 'General case' 0 C--N 1.372 1.564 0 O-C-N 120.221 -1.549 . . . . 2.7599999999999998 109.946 172.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 13' ' ' THR . . . . . 0.467 ' HA ' ' CD2' ' E' ' 18' ' ' TYR 0.251 23.0 m -152.76 -60.43 0.15 Allowed 'General case' 0 C--N 1.357 0.899 0 O-C-N 118.256 -2.777 . . . . 0.46999999999999997 108.764 174.352 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -75.23 67.34 1.84 Allowed 'General case' 0 C--N 1.354 0.796 0 O-C-N 119.962 -1.711 . . . . 1.8899999999999999 114.453 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 23.8 t -162.12 159.68 26.34 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 125.459 1.504 . . . . 1.3999999999999999 111.746 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -77.03 -27.45 54.53 Favored 'General case' 0 C--N 1.363 1.153 0 C-N-CA 130.941 3.697 . . . . 1.1599999999999999 110.179 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 24.5 m0 -93.71 17.97 10.97 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 129.368 3.067 . . . . 0.94999999999999996 113.052 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 18' ' ' TYR . . . . . 0.467 ' CD2' ' HA ' ' E' ' 13' ' ' THR . 2.6 t80 -74.63 112.17 10.55 Favored 'General case' 0 C--N 1.368 1.411 0 C-N-CA 126.362 1.865 . . . . 0.95999999999999996 108.421 173.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.53 34.14 6.47 Favored Glycine 0 C--N 1.354 1.534 0 C-N-CA 128.651 3.025 . . . . 0.39000000000000001 113.923 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -105.42 163.86 12.31 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 118.968 1.384 . . . . 1.3999999999999999 113.09 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.25 149.47 25.67 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 N-CA-C 105.603 -1.999 . . . . 1.03 105.603 175.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.08 178.35 47.54 Favored Glycine 0 CA--C 1.472 -2.629 0 C-N-CA 118.146 -1.978 . . . . 0.27000000000000002 110.226 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 7.0 m -90.01 120.93 31.63 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 124.844 1.258 . . . . 1.1000000000000001 113.222 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.57 91.54 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 125.374 2.512 . . . . 1.1100000000000001 110.768 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.62 53.76 2.9 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 119.879 -1.763 . . . . 1.0600000000000001 111.268 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 22.1 m -87.69 -59.82 2.14 Favored 'General case' 0 CA--C 1.476 -1.868 0 C-N-CA 130.169 3.387 . . . . 0.87 117.667 -174.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -84.41 62.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.767 0 CA-C-O 126.421 3.01 . . . . 0.60999999999999999 112.843 -164.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -148.27 -66.51 0.24 Allowed 'General case' 0 N--CA 1.415 -2.209 2 C-N-CA 132.282 4.233 . . . . 1.6100000000000001 104.988 -177.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -110.31 5.02 21.32 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 128.089 2.556 . . . . 4.3200000000000003 114.642 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 3.8 t -50.96 -18.96 0.87 Allowed 'General case' 0 C--N 1.369 1.44 0 C-N-CA 130.043 3.337 . . . . 4.7999999999999998 118.304 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.59 43.89 0.47 Allowed Glycine 0 C--N 1.349 1.295 0 C-N-CA 129.856 3.598 . . . . 2.21 116.949 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 32' ' ' ILE . . . . . 0.467 HG21 ' H ' ' E' ' 33' ' ' LEU . 0.7 OUTLIER -133.1 -166.02 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.834 0 C-N-CA 128.651 2.78 . . . . 1.6399999999999999 109.599 -179.472 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 33' ' ' LEU . . . . . 0.467 ' H ' HG21 ' E' ' 32' ' ' ILE . 49.1 tp -69.85 -22.55 63.26 Favored 'General case' 0 C--N 1.359 0.98 1 C-N-CA 131.829 4.052 . . . . 0.64000000000000001 116.786 -177.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -137.28 127.75 15.92 Favored Pre-proline 0 C--N 1.359 0.989 0 N-CA-C 105.316 -2.105 . . . . 1.52 105.316 176.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -82.3 -42.68 0.1 OUTLIER 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 124.702 3.601 . . . . 0.67000000000000004 117.111 -171.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 76.4 t -84.18 101.37 8.67 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 C-N-CA 127.728 2.411 . . . . 1.1599999999999999 113.4 -168.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 78.5 mt -101.68 81.04 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.206 0 C-N-CA 124.973 1.309 . . . . 1.28 107.692 -176.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 57.0 t -89.23 164.82 2.13 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 O-C-N 119.488 -2.008 . . . . 1.04 112.644 -173.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 39' ' ' ARG . . . . . . . . . . . . . 29.1 mmt85 -82.25 142.05 32.44 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 128.729 2.812 . . . . 3.1400000000000001 113.461 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -132.09 138.63 48.19 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.413 1.085 . . . . 1.26 111.9 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -101.19 -34.79 9.54 Favored 'General case' 0 C--N 1.374 1.638 0 C-N-CA 125.836 1.654 . . . . 1.8100000000000001 113.094 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 34.4 mtt180 -83.91 49.87 1.71 Allowed 'General case' 0 C--N 1.36 1.049 0 C-N-CA 128.494 2.718 . . . . 1.29 116.242 -170.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . 0.308 4.3 p . . . . . 0 CA--C 1.541 0.601 0 O-C-N 119.4 -2.062 . . . . 1.7 105.79 167.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 30.5 m120 . . . . . 0 N--CA 1.469 0.518 0 CA-C-O 121.132 0.491 . . . . 2.6800000000000002 111.733 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 1.9 p -121.63 128.57 52.05 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 104.056 -2.572 . . . . 1.1399999999999999 104.056 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.74 132.03 11.96 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 108.119 -1.067 . . . . 1.9399999999999999 108.119 -168.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -80.69 110.82 16.55 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 130.071 3.348 . . . . 2.2200000000000002 116.018 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -114.31 179.86 3.83 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 127.422 2.289 . . . . 0.23999999999999999 114.035 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.82 109.41 16.54 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 114.706 1.373 . . . . 1.01 114.706 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -19.74 0.4 0.0 OUTLIER 'General case' 0 C--N 1.374 1.638 2 C-N-CA 137.357 6.263 . . . . 1.72 124.489 172.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.09 -45.04 6.06 Favored 'General case' 0 N--CA 1.438 -1.055 1 C-N-CA 132.241 4.217 . . . . 0.20000000000000001 106.322 171.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -88.68 18.25 4.84 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 120.083 -1.635 . . . . 1.1799999999999999 110.867 -170.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . . . . . . . . 0.313 0.1 OUTLIER -134.17 157.7 45.55 Favored 'General case' 0 N--CA 1.43 -1.464 1 C-N-CA 132.768 4.427 . . . . 1.0900000000000001 106.317 172.186 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -137.39 149.25 46.8 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 105.665 -1.976 . . . . 2.0499999999999998 105.665 162.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . 0.252 2.5 pt? -91.54 149.01 21.87 Favored 'General case' 0 C--N 1.363 1.187 0 O-C-N 118.798 -2.439 . . . . 0.28999999999999998 117.511 -177.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 4.4 t -112.09 -37.48 2.84 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 C-N-CA 126.794 2.038 . . . . 1.1799999999999999 110.346 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 69' ' ' GLN . . . . . 0.403 ' HB2' ' HA ' ' E' ' 6' ' ' ASP . 24.7 mt-30 -103.41 153.78 20.12 Favored 'General case' 0 C--N 1.356 0.875 0 CA-C-O 126.916 3.246 . . . . 2.1899999999999999 115.286 -174.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.26 68.74 0.77 Allowed 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 108.476 -3.966 . . . . 0.0 109.584 170.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.5 74.3 3.23 Favored 'General case' 0 C--N 1.362 1.137 0 O-C-N 120.076 -1.64 . . . . 0.0 112.465 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.1 80.21 7.72 Favored 'General case' 0 C--N 1.36 1.065 0 C-N-CA 129.08 2.952 . . . . 0.0 111.753 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 71.7 tttt . . . . . 0 C--O 1.264 1.826 0 C-N-CA 127.089 2.156 . . . . 0.0 107.93 176.02 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.169 0 N-CA-C 117.93 2.567 . . . . 1.54 117.93 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.97 177.06 9.44 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 130.794 3.638 . . . . 1.0 107.298 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -78.66 117.74 20.1 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 120.69 3.589 . . . . 3.9399999999999999 120.69 -172.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.63 5.93 53.33 Favored Glycine 0 C--N 1.376 2.784 0 O-C-N 118.184 -2.823 . . . . 0.75 114.332 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.65 145.89 30.34 Favored 'General case' 0 N--CA 1.411 -2.4 1 C-N-CA 132.024 4.13 . . . . 0.45000000000000001 110.983 -176.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . 0.579 ' H ' ' CB ' ' E' ' 69' ' ' GLN . 49.3 mttm -93.08 71.76 4.62 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 128.524 2.73 . . . . 2.54 107.973 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 15.8 m -88.69 148.64 4.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 C-N-CA 123.684 0.794 . . . . 1.03 110.891 -173.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -105.95 123.92 48.76 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 119.314 -0.374 . . . . 0.17000000000000001 110.917 -173.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 mm -73.29 114.68 13.09 Favored 'Isoleucine or valine' 0 C--N 1.36 1.06 0 C-N-CA 125.755 1.622 . . . . 1.03 114.968 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -115.91 57.27 0.75 Allowed 'General case' 0 C--N 1.375 1.675 0 C-N-CA 124.172 0.989 . . . . 0.29999999999999999 113.669 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.62 123.14 48.58 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 126.08 1.752 . . . . 2.7599999999999998 109.059 171.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 24.6 p -72.66 -6.56 45.2 Favored 'General case' 0 C--N 1.368 1.412 0 C-N-CA 128.941 2.896 . . . . 0.46999999999999997 117.273 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -97.16 41.12 1.12 Allowed 'General case' 0 C--N 1.357 0.906 0 C-N-CA 128.54 2.736 . . . . 1.8899999999999999 112.27 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 35.3 t -164.8 166.19 19.98 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 119.97 -1.706 . . . . 1.3999999999999999 107.247 -178.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -89.59 -5.6 57.04 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 127.123 2.169 . . . . 1.1599999999999999 110.369 171.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 29.6 m0 -94.76 16.68 15.18 Favored 'General case' 0 C--N 1.372 1.573 0 C-N-CA 129.166 2.986 . . . . 0.94999999999999996 110.478 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -73.34 102.5 3.73 Favored 'General case' 0 C--N 1.364 1.221 0 C-N-CA 128.159 2.584 . . . . 0.95999999999999996 110.873 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.58 32.97 6.05 Favored Glycine 0 C--N 1.358 1.757 0 C-N-CA 126.203 1.859 . . . . 0.39000000000000001 112.602 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -106.93 135.19 48.9 Favored 'General case' 0 C--N 1.366 1.288 0 CA-C-N 119.255 1.528 . . . . 1.3999999999999999 112.255 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.72 145.84 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 C-N-CA 128.299 2.64 . . . . 1.03 107.257 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -174.03 178.1 46.02 Favored Glycine 0 CA--C 1.473 -2.563 0 N-CA-C 108.864 -1.694 . . . . 0.27000000000000002 108.864 172.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 20.7 m -86.18 125.4 33.5 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.505 1.122 . . . . 1.1000000000000001 112.002 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 12.6 p -80.92 95.87 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 126.078 1.751 . . . . 1.1100000000000001 111.473 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.74 51.43 1.85 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.067 2.147 . . . . 1.0600000000000001 112.803 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 2.6 p -73.08 -73.12 0.22 Allowed 'General case' 0 CA--C 1.504 -0.817 1 C-N-CA 136.257 5.823 . . . . 0.87 120.114 -173.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 4.4 m -81.23 18.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.553 0 C-N-CA 128.085 2.554 . . . . 0.60999999999999999 117.058 -163.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -98.26 -69.43 0.76 Allowed 'General case' 0 N--CA 1.431 -1.416 1 C-N-CA 132.011 4.125 . . . . 1.6100000000000001 107.693 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -106.81 -26.89 11.07 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 115.849 1.796 . . . . 4.3200000000000003 115.849 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.45 22.03 3.12 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 117.432 2.382 . . . . 4.7999999999999998 117.432 -170.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.25 46.49 0.81 Allowed Glycine 0 C--N 1.353 1.525 0 C-N-CA 127.97 2.7 . . . . 2.21 114.505 167.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 32' ' ' ILE . . . . . 0.439 ' CG2' ' H ' ' E' ' 33' ' ' LEU . 1.9 mt -122.32 -146.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 130.962 3.705 . . . . 1.6399999999999999 104.664 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 33' ' ' LEU . . . . . 0.439 ' H ' ' CG2' ' E' ' 32' ' ' ILE . 39.8 tp -62.08 -61.57 2.39 Favored 'General case' 0 C--N 1.345 0.379 0 C-N-CA 129.392 3.077 . . . . 0.64000000000000001 115.181 176.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -97.67 111.01 57.63 Favored Pre-proline 0 C--N 1.363 1.177 0 C-N-CA 124.208 1.003 . . . . 1.52 109.688 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.86 -38.52 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.727 1 C-N-CA 125.318 4.012 . . . . 0.67000000000000004 116.141 -173.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 59.4 t -88.44 94.21 4.62 Favored 'Isoleucine or valine' 0 C--N 1.349 0.553 0 N-CA-C 116.19 1.922 . . . . 1.1599999999999999 116.19 -169.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 96.4 mt -89.82 99.92 10.14 Favored 'Isoleucine or valine' 0 C--N 1.36 1.03 0 C-N-CA 126.461 1.904 . . . . 1.28 106.719 176.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 81.3 t -104.93 156.3 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 120.769 -1.207 . . . . 1.04 111.945 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 39' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -79.97 139.5 37.0 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 130.581 3.552 . . . . 3.1400000000000001 111.973 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -137.29 149.08 46.83 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.317 -1.49 . . . . 1.26 111.929 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -103.55 -23.76 13.47 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 127.071 2.148 . . . . 1.8100000000000001 111.282 172.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 67.2 mtt-85 -82.04 40.37 0.62 Allowed 'General case' 0 C--N 1.366 1.287 0 C-N-CA 129.397 3.079 . . . . 1.29 111.855 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.448 -0.549 0 C-N-CA 126.925 2.09 . . . . 1.7 110.377 -175.114 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 14.6 t30 . . . . . 0 CA--C 1.532 0.254 0 CA-C-O 121.683 0.754 . . . . 2.6800000000000002 112.893 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 31.8 p -129.21 121.71 28.21 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 128.612 2.765 . . . . 1.1399999999999999 106.57 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.75 139.79 15.4 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 119.513 1.051 . . . . 1.9399999999999999 112.399 -175.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -63.05 119.78 10.15 Favored 'General case' 0 C--N 1.358 0.937 1 C-N-CA 132.035 4.134 . . . . 2.2200000000000002 119.9 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -124.67 170.26 11.15 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 123.514 1.626 . . . . 0.23999999999999999 113.44 174.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.92 92.32 6.05 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 129.765 3.226 . . . . 1.01 109.05 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -18.15 -21.72 0.0 OUTLIER 'General case' 0 C--N 1.358 0.95 1 C-N-CA 136.434 5.893 . . . . 1.72 121.68 173.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -73.58 -29.67 62.56 Favored 'General case' 0 C--N 1.362 1.149 0 C-N-CA 129.443 3.097 . . . . 0.20000000000000001 113.173 169.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -84.33 -14.81 48.64 Favored 'General case' 0 C--N 1.375 1.692 0 C-N-CA 127.217 2.207 . . . . 1.1799999999999999 108.351 -175.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.48 108.48 19.93 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 128.395 2.678 . . . . 1.0900000000000001 115.41 -176.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -89.9 149.4 22.64 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 129.735 3.214 . . . . 2.0499999999999998 112.076 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -82.77 141.61 32.22 Favored 'General case' 0 C--N 1.366 1.316 0 CA-C-N 121.638 2.017 . . . . 0.28999999999999998 115.677 174.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 18.9 t -130.61 -19.4 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.873 0 CA-C-O 123.528 1.632 . . . . 1.1799999999999999 108.226 171.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 69' ' ' GLN . . . . . 0.579 ' CB ' ' H ' ' E' ' 7' ' ' LYS . 4.9 tp-100 -110.28 155.24 22.33 Favored 'General case' 0 N--CA 1.424 -1.729 0 C-N-CA 127.173 2.189 . . . . 2.1899999999999999 111.848 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.02 42.06 1.26 Allowed 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 128.478 2.711 . . . . 0.0 114.316 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.95 63.11 7.9 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 125.243 1.417 . . . . 0.0 108.278 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.9 80.16 2.98 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 128.05 2.54 . . . . 0.0 112.097 -173.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? . . . . . 0 C--O 1.257 1.459 0 N-CA-C 103.039 -2.949 . . . . 0.0 103.039 172.196 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 2' ' ' LEU . . . . . . . . . . . . 0.306 2.0 pp . . . . . 0 N--CA 1.446 -0.627 0 CA-C-O 123.489 1.614 . . . . 1.54 111.844 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -140.23 168.71 19.17 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 129.303 3.041 . . . . 1.0 111.7 -172.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -95.11 96.8 9.48 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 126.677 1.991 . . . . 3.9399999999999999 112.233 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.62 17.26 3.55 Favored Glycine 0 C--N 1.368 2.329 0 O-C-N 119.922 -1.736 . . . . 0.75 113.145 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 6' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -90.84 143.04 27.13 Favored 'General case' 0 N--CA 1.411 -2.375 1 C-N-CA 131.8 4.04 . . . . 0.45000000000000001 109.325 -178.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . 0.478 ' H ' ' HB3' ' E' ' 69' ' ' GLN . 63.7 mmtt -92.9 82.23 4.66 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 104.966 -2.235 . . . . 2.54 104.966 173.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 m -88.43 133.56 30.5 Favored 'Isoleucine or valine' 0 C--N 1.359 1.015 0 N-CA-C 105.078 -2.193 . . . . 1.03 105.078 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -91.71 110.38 21.71 Favored 'General case' 0 CA--C 1.502 -0.887 0 O-C-N 121.237 -0.915 . . . . 0.17000000000000001 111.354 -174.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . 0.502 HG21 ' CE2' ' E' ' 60' ' ' PHE . 5.4 mm -53.37 107.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.503 0 N-CA-C 119.839 3.274 . . . . 1.03 119.839 175.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 13.8 mtmm -119.02 49.77 1.29 Allowed 'General case' 0 C--N 1.379 1.887 0 C-N-CA 127.163 2.185 . . . . 0.29999999999999999 111.485 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -76.49 -118.54 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 120.178 3.399 . . . . 2.7599999999999998 120.178 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 3.5 m -150.55 -49.09 0.13 Allowed 'General case' 0 C--N 1.358 0.938 0 O-C-N 120.258 -1.526 . . . . 0.46999999999999997 108.553 -176.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -85.59 89.94 7.86 Favored 'General case' 0 C--N 1.363 1.167 0 N-CA-C 115.509 1.67 . . . . 1.8899999999999999 115.509 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 15' ' ' SER . . . . . . . . . . . . 0.285 1.4 m -53.68 28.96 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 1 N-CA-C 121.989 4.07 . . . . 1.3999999999999999 121.989 179.968 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.45 -51.26 4.42 Favored 'General case' 0 C--N 1.352 0.691 1 C-N-CA 131.788 4.035 . . . . 1.1599999999999999 102.274 163.284 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -114.97 35.15 4.45 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.66 1.584 . . . . 0.94999999999999996 111.186 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -139.42 133.82 31.54 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 106.418 -1.697 . . . . 0.95999999999999996 106.418 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.3 46.75 1.52 Allowed Glycine 0 C--N 1.358 1.779 0 C-N-CA 127.202 2.334 . . . . 0.39000000000000001 109.449 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -168.72 176.24 5.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.363 -1.717 . . . . 1.3999999999999999 106.363 -171.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 p -109.57 175.9 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 127.579 2.352 . . . . 1.03 108.348 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.79 169.49 41.48 Favored Glycine 0 CA--C 1.476 -2.381 0 N-CA-C 108.231 -1.948 . . . . 0.27000000000000002 108.231 173.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 23' ' ' THR . . . . . 0.522 ' HG1' ' CZ ' ' E' ' 39' ' ' ARG . 10.9 m -97.72 114.75 26.82 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 125.727 1.611 . . . . 1.1000000000000001 110.587 -177.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 24' ' ' VAL . . . . . 0.539 HG23 ' HG ' ' E' ' 26' ' ' SER . 12.3 p -76.35 86.84 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-O 125.974 2.797 . . . . 1.1100000000000001 112.097 176.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -94.72 57.4 2.17 Favored 'General case' 0 C--O 1.225 -0.213 0 O-C-N 119.172 -2.205 . . . . 1.0600000000000001 108.995 175.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 26' ' ' SER . . . . . 0.539 ' HG ' HG23 ' E' ' 24' ' ' VAL . 10.6 p -79.76 -81.45 0.12 Allowed 'General case' 0 CA--C 1.495 -1.165 1 C-N-CA 134.67 5.188 . . . . 0.87 118.705 -168.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 5.7 p -83.82 59.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 128.976 2.91 . . . . 0.60999999999999999 111.51 -169.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -145.71 -50.88 0.24 Allowed 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 127.329 2.252 . . . . 1.6100000000000001 106.4 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -105.42 -22.93 12.92 Favored 'General case' 0 C--N 1.37 1.483 0 C-N-CA 127.748 2.419 . . . . 4.3200000000000003 113.45 175.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 58.8 m -68.35 55.81 0.08 Allowed 'General case' 0 C--N 1.378 1.824 0 C-N-CA 128.698 2.799 . . . . 4.7999999999999998 117.831 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.71 32.88 5.91 Favored Glycine 0 C--O 1.222 -0.6 1 C-N-CA 131.608 4.432 . . . . 2.21 111.197 162.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 32' ' ' ILE . . . . . 0.427 ' CG2' ' H ' ' E' ' 33' ' ' LEU . 2.3 mt -112.19 -136.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.577 0 C-N-CA 129.014 2.925 . . . . 1.6399999999999999 107.405 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 33' ' ' LEU . . . . . 0.427 ' H ' ' CG2' ' E' ' 32' ' ' ILE . 12.5 tp -90.57 -69.45 0.73 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 128.731 2.812 . . . . 0.64000000000000001 112.822 177.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -96.94 156.99 35.79 Favored Pre-proline 0 C--N 1.372 1.571 0 O-C-N 120.185 -1.572 . . . . 1.52 110.809 -175.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.82 -51.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 123.809 3.006 . . . . 0.67000000000000004 116.595 -170.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 95.2 t -79.48 110.28 15.0 Favored 'Isoleucine or valine' 0 C--N 1.348 0.504 0 C-N-CA 129.426 3.09 . . . . 1.1599999999999999 113.068 -170.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 70.5 mt -107.81 97.55 5.83 Favored 'Isoleucine or valine' 0 C--N 1.372 1.578 0 N-CA-C 104.403 -2.443 . . . . 1.28 104.403 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 37.8 t -107.38 141.88 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 O-C-N 120.497 -1.377 . . . . 1.04 114.125 -167.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 39' ' ' ARG . . . . . 0.522 ' CZ ' ' HG1' ' E' ' 23' ' ' THR . 21.3 ttm180 -69.95 144.83 52.26 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 128.448 2.699 . . . . 3.1400000000000001 114.189 174.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -153.52 166.98 31.01 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 106.37 -1.715 . . . . 1.26 106.37 171.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -106.38 -27.92 10.68 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 129.357 3.063 . . . . 1.8100000000000001 108.888 165.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -75.77 45.18 0.32 Allowed 'General case' 0 C--N 1.371 1.536 0 C-N-CA 127.359 2.264 . . . . 1.29 115.169 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 8.7 m . . . . . 0 N--CA 1.446 -0.627 0 CA-C-O 123.877 1.798 . . . . 1.7 110.628 178.344 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 . . . . . 0 N--CA 1.473 0.692 0 CA-C-O 122.736 1.255 . . . . 2.6800000000000002 114.092 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 2.8 p -150.83 149.33 29.58 Favored 'General case' 0 C--N 1.356 0.874 1 C-N-CA 133.708 4.803 . . . . 1.1399999999999999 107.371 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . 0.323 11.8 p30 -159.31 168.41 26.48 Favored 'General case' 0 C--N 1.364 1.225 0 CA-C-N 121.606 2.003 . . . . 1.9399999999999999 108.351 170.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -97.75 113.28 25.02 Favored 'General case' 0 C--N 1.363 1.175 0 C-N-CA 126.736 2.014 . . . . 2.2200000000000002 116.225 -172.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 60' ' ' PHE . . . . . 0.502 ' CE2' HG21 ' E' ' 10' ' ' ILE . 16.1 m-85 -118.16 170.22 9.05 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 127.529 2.332 . . . . 0.23999999999999999 113.243 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.34 113.27 19.17 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.992 2.117 . . . . 1.01 112.231 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -26.54 -18.08 0.0 OUTLIER 'General case' 0 C--N 1.371 1.532 1 C-N-CA 134.652 5.181 . . . . 1.72 121.309 174.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -59.39 -49.19 78.76 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 131.418 3.887 . . . . 0.20000000000000001 111.887 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -94.44 12.54 26.83 Favored 'General case' 0 C--N 1.361 1.107 0 CA-C-N 114.598 -1.183 . . . . 1.1799999999999999 112.836 -170.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . 0.463 HD22 ' HB3' ' E' ' 60' ' ' PHE 0.261 1.0 OUTLIER -120.91 119.15 31.77 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 127.723 2.409 . . . . 1.0900000000000001 114.209 -177.601 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -111.03 136.47 49.99 Favored 'General case' 0 C--N 1.362 1.129 0 O-C-N 120.958 -1.089 . . . . 2.0499999999999998 111.482 171.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.69 140.51 51.14 Favored 'General case' 0 C--N 1.365 1.268 0 C-N-CA 130.84 3.656 . . . . 0.28999999999999998 120.096 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . 0.255 2.0 t -139.78 -33.95 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.373 1.593 0 C-N-CA 126.728 2.011 . . . . 1.1799999999999999 114.092 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 69' ' ' GLN . . . . . 0.478 ' HB3' ' H ' ' E' ' 7' ' ' LYS . 16.6 tt0 -112.53 104.81 12.92 Favored 'General case' 0 C--N 1.361 1.087 0 O-C-N 119.887 -1.758 . . . . 2.1899999999999999 109.585 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.77 62.52 0.07 Allowed 'General case' 0 C--N 1.349 0.546 0 C-N-CA 127.909 2.484 . . . . 0.0 114.808 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.05 67.67 9.76 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 128.939 2.896 . . . . 0.0 109.514 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.24 47.65 0.02 OUTLIER 'General case' 0 C--N 1.362 1.128 0 C-N-CA 130.201 3.401 . . . . 0.0 116.835 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 25.4 tptp . . . . . 0 N--CA 1.42 -1.944 1 C-N-CA 133.582 4.753 . . . . 0.0 104.878 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 2' ' ' LEU . . . . . . . . . . . . 0.31 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.686 0 N-CA-C 119.794 3.257 . . . . 1.54 119.794 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.49 177.86 9.6 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 125.633 1.573 . . . . 1.0 110.805 -170.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 23.3 ptt-85 -65.88 67.85 0.05 OUTLIER 'General case' 0 C--N 1.365 1.249 1 C-N-CA 132.816 4.446 . . . . 3.9399999999999999 119.515 -174.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 125.38 25.38 1.46 Allowed Glycine 0 CA--C 1.491 -1.463 0 C-N-CA 126.72 2.105 . . . . 0.75 111.942 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 6' ' ' ASP . . . . . 0.514 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 20.8 t0 -71.04 129.88 40.13 Favored 'General case' 0 C--N 1.367 1.353 0 C-N-CA 125.302 1.441 . . . . 0.45000000000000001 111.553 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . 0.451 ' H ' ' CB ' ' E' ' 69' ' ' GLN . 31.6 mtmm -89.01 85.85 6.8 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 102.99 -2.967 . . . . 2.54 102.99 171.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 1.5 m -89.68 138.48 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 127.638 2.375 . . . . 1.03 106.323 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -101.5 86.1 2.9 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 121.438 -0.789 . . . . 0.17000000000000001 111.677 -174.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 mm -41.4 121.49 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.713 0 N-CA-C 120.751 3.611 . . . . 1.03 120.751 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -118.84 37.81 3.98 Favored 'General case' 0 C--N 1.373 1.609 0 C-N-CA 126.868 2.067 . . . . 0.29999999999999999 111.301 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.66 127.3 42.51 Favored 'General case' 0 C--N 1.365 1.255 0 C-N-CA 130.402 3.481 . . . . 2.7599999999999998 110.028 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 25.0 p -76.8 -55.95 5.04 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 129.585 3.154 . . . . 0.46999999999999997 113.819 -174.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -78.56 68.68 4.6 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 129.79 3.236 . . . . 1.8899999999999999 110.55 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 46.9 t -163.42 167.5 21.53 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 127.844 2.458 . . . . 1.3999999999999999 104.426 -175.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 16' ' ' TYR . . . . . 0.492 ' HH ' ' CZ ' ' E' ' 42' ' ' ARG . 53.1 t80 -94.37 -9.23 36.44 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 127.914 2.485 . . . . 1.1599999999999999 111.521 175.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -125.83 45.19 2.67 Favored 'General case' 0 C--N 1.366 1.287 0 O-C-N 120.703 -1.248 . . . . 0.94999999999999996 111.879 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -71.83 107.31 4.54 Favored 'General case' 0 C--N 1.367 1.329 0 C-N-CA 127.453 2.301 . . . . 0.95999999999999996 111.062 175.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.73 46.71 4.77 Favored Glycine 0 C--N 1.363 2.054 0 CA-C-O 122.196 0.887 . . . . 0.39000000000000001 111.995 -175.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -143.51 166.0 26.01 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 125.346 1.458 . . . . 1.3999999999999999 107.194 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.37 170.45 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.565 0 C-N-CA 126.357 1.863 . . . . 1.03 110.116 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.39 161.86 26.13 Favored Glycine 0 CA--C 1.483 -1.915 0 O-C-N 121.228 -0.92 . . . . 0.27000000000000002 111.924 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 23' ' ' THR . . . . . 0.482 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 12.8 m -94.98 135.26 36.72 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 128.359 2.664 . . . . 1.1000000000000001 115.959 -175.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 25.3 t -66.86 91.78 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.501 0 CA-C-O 124.711 2.196 . . . . 1.1100000000000001 116.308 170.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -99.35 15.8 25.1 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 130.737 3.615 . . . . 1.0600000000000001 108.777 170.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 26' ' ' SER . . . . . 0.455 ' HA ' ' HB ' ' E' ' 37' ' ' ILE . 0.9 OUTLIER -77.18 -15.02 59.68 Favored 'General case' 0 CA--C 1.48 -1.738 1 C-N-CA 135.391 5.476 . . . . 0.87 118.632 -176.947 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 24.8 t -86.18 59.72 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.495 0 CA-C-O 125.428 2.537 . . . . 0.60999999999999999 108.982 -173.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -145.13 -100.66 0.1 Allowed 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 111.262 -2.699 . . . . 1.6100000000000001 107.695 -174.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt -87.31 25.65 1.36 Allowed 'General case' 0 N--CA 1.437 -1.116 1 C-N-CA 132.032 4.133 . . . . 4.3200000000000003 115.303 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.08 -1.05 0.84 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 131.128 3.771 . . . . 4.7999999999999998 117.255 176.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.91 44.02 3.26 Favored Glycine 0 C--N 1.355 1.591 0 C-N-CA 128.472 2.939 . . . . 2.21 114.491 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 32' ' ' ILE . . . . . 0.447 HG21 ' H ' ' E' ' 33' ' ' LEU . 0.3 OUTLIER -137.5 -172.16 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.061 0 C-N-CA 128.072 2.549 . . . . 1.6399999999999999 109.538 -178.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' E' E ' 33' ' ' LEU . . . . . 0.447 ' H ' HG21 ' E' ' 32' ' ' ILE . 41.1 tp -82.87 -22.73 33.92 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 131.432 3.893 . . . . 0.64000000000000001 111.913 178.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -118.24 91.04 39.67 Favored Pre-proline 0 C--N 1.35 0.603 0 N-CA-C 103.286 -2.857 . . . . 1.52 103.286 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.64 -31.25 0.46 Allowed 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 124.919 3.746 . . . . 0.67000000000000004 116.675 -170.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . 0.265 75.3 t -96.91 98.38 7.46 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 C-N-CA 127.232 2.213 . . . . 1.1599999999999999 116.403 -166.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . 0.455 ' HB ' ' HA ' ' E' ' 26' ' ' SER . 3.8 mp -87.51 117.03 30.71 Favored 'Isoleucine or valine' 0 C--N 1.362 1.145 0 C-N-CA 128.11 2.564 . . . . 1.28 105.557 174.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 53.0 t -125.36 156.58 34.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.451 0 CA-C-N 119.424 1.011 . . . . 1.04 111.276 -173.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 39' ' ' ARG . . . . . 0.482 ' HB3' ' H ' ' E' ' 23' ' ' THR . 36.5 ttm-85 -82.39 156.75 24.01 Favored 'General case' 0 C--N 1.365 1.272 0 C-N-CA 130.661 3.584 . . . . 3.1400000000000001 110.888 175.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -151.01 -178.81 6.82 Favored 'General case' 0 CA--C 1.513 -0.462 0 O-C-N 119.467 -2.02 . . . . 1.26 106.953 174.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -98.62 -39.37 8.73 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 127.077 2.151 . . . . 1.8100000000000001 114.948 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 42' ' ' ARG . . . . . 0.492 ' CZ ' ' HH ' ' E' ' 16' ' ' TYR 0.269 20.8 mtm180 -69.18 -86.37 0.02 OUTLIER 'General case' 0 C--N 1.37 1.49 0 N-CA-C 121.602 3.927 . . . . 1.29 121.602 -170.243 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . 0.341 4.7 p . . . . . 0 C--N 1.367 1.327 0 CA-C-O 127.15 3.357 . . . . 1.7 108.757 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 . . . . . 0 CA--C 1.534 0.334 0 CA-C-O 122.894 1.33 . . . . 2.6800000000000002 112.432 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' E' E ' 57' ' ' THR . . . . . 0.429 ' HB ' HG21 ' E' ' 37' ' ' ILE . 40.2 p -86.61 106.83 17.85 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 125.899 1.68 . . . . 1.1399999999999999 113.99 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.61 132.66 47.16 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 128.695 2.798 . . . . 1.9399999999999999 106.283 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -100.31 103.38 14.8 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 124.829 1.252 . . . . 2.2200000000000002 109.639 -178.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 60' ' ' PHE . . . . . 0.406 ' CB ' HD23 ' E' ' 65' ' ' LEU . 24.4 m-85 -98.78 169.27 9.59 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 126.791 2.036 . . . . 0.23999999999999999 116.267 -174.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -102.86 101.86 11.93 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.857 2.463 . . . . 1.01 110.717 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -18.72 -29.65 0.0 OUTLIER 'General case' 0 C--N 1.373 1.624 1 C-N-CA 135.135 5.374 . . . . 1.72 120.914 173.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.68 -42.67 79.44 Favored 'General case' 0 C--N 1.369 1.449 0 C-N-CA 128.212 2.605 . . . . 0.20000000000000001 111.777 167.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -85.43 -7.48 58.9 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.126 -1.397 . . . . 1.1799999999999999 111.848 -171.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . 0.406 HD23 ' CB ' ' E' ' 60' ' ' PHE . 0.2 OUTLIER -100.46 109.47 21.61 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 120.882 -1.136 . . . . 1.0900000000000001 110.568 178.504 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -90.7 128.63 36.72 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 123.659 0.784 . . . . 2.0499999999999998 112.407 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.62 137.35 57.78 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 120.542 3.534 . . . . 0.28999999999999998 120.542 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.79 -42.68 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.371 1.504 0 C-N-CA 125.738 1.615 . . . . 1.1799999999999999 111.342 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 69' ' ' GLN . . . . . 0.514 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 0.0 OUTLIER -112.12 97.54 6.72 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 126.504 1.922 . . . . 2.1899999999999999 114.134 -175.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.67 57.93 0.09 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.404 2.682 . . . . 0.0 114.804 175.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.76 53.45 0.45 Allowed 'General case' 0 C--N 1.353 0.734 0 C-N-CA 129.309 3.044 . . . . 0.0 116.475 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -100.09 94.51 6.29 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 127.556 2.342 . . . . 0.0 109.367 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt . . . . . 0 C--O 1.259 1.564 0 C-N-CA 125.502 1.521 . . . . 0.0 109.236 179.943 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.795 0 N-CA-C 115.967 1.84 . . . . 1.54 115.967 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -122.02 -173.8 2.74 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 128.658 2.783 . . . . 1.0 114.046 -170.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.92 104.86 17.24 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 128.638 2.775 . . . . 3.9399999999999999 111.757 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.99 -3.64 22.59 Favored Glycine 0 C--N 1.353 1.494 0 O-C-N 119.984 -1.698 . . . . 0.75 111.896 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 6' ' ' ASP . . . . . 0.413 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 3.6 t0 -77.85 72.02 4.36 Favored 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 130.529 3.531 . . . . 0.45000000000000001 114.115 -174.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -35.97 87.64 0.0 OUTLIER 'General case' 0 C--N 1.351 0.64 1 C-N-CA 132.78 4.432 . . . . 2.54 114.743 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.96 137.76 20.3 Favored 'Isoleucine or valine' 0 C--N 1.361 1.092 0 N-CA-C 107.102 -1.444 . . . . 1.03 107.102 -172.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -96.52 87.78 4.5 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 115.813 1.783 . . . . 0.17000000000000001 115.813 -170.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . 0.408 ' CD1' ' H ' ' E' ' 10' ' ' ILE . 0.9 OUTLIER -26.4 98.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 N-CA-C 119.517 3.154 . . . . 1.03 119.517 173.161 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -113.43 43.57 1.73 Allowed 'General case' 0 C--N 1.366 1.311 0 O-C-N 120.115 -1.615 . . . . 0.29999999999999999 113.261 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.79 137.16 39.55 Favored 'General case' 0 C--N 1.366 1.286 0 C-N-CA 125.902 1.681 . . . . 2.7599999999999998 111.006 174.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 22.3 p -73.02 -58.01 3.62 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 128.491 2.716 . . . . 0.46999999999999997 114.516 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -76.02 64.33 1.9 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 127.945 2.498 . . . . 1.8899999999999999 114.929 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 27.1 t -167.69 176.78 6.19 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 126.531 1.932 . . . . 1.3999999999999999 105.868 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -93.5 0.33 56.66 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 128.612 2.765 . . . . 1.1599999999999999 111.607 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -117.28 25.54 10.38 Favored 'General case' 0 C--N 1.36 1.034 0 O-C-N 120.48 -1.388 . . . . 0.94999999999999996 113.807 -172.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -70.04 108.94 4.29 Favored 'General case' 0 C--N 1.368 1.377 0 C-N-CA 126.338 1.855 . . . . 0.95999999999999996 114.228 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.66 30.36 18.65 Favored Glycine 0 C--N 1.366 2.206 0 CA-C-O 121.538 0.521 . . . . 0.39000000000000001 112.218 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -121.02 173.28 7.36 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 126.807 2.043 . . . . 1.3999999999999999 105.751 177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.59 175.75 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 C-N-CA 125.613 1.565 . . . . 1.03 110.042 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.07 175.21 40.22 Favored Glycine 0 CA--C 1.479 -2.211 1 N-CA-C 101.314 -4.714 . . . . 0.27000000000000002 101.314 165.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 23' ' ' THR . . . . . 0.6 ' H ' ' HB2' ' E' ' 39' ' ' ARG . 11.1 m -96.39 141.28 29.89 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 126.131 1.772 . . . . 1.1000000000000001 108.666 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 p -79.76 112.76 18.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 124.776 2.227 . . . . 1.1100000000000001 109.043 166.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.14 31.8 6.18 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 111.134 -2.757 . . . . 1.0600000000000001 108.573 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 26' ' ' SER . . . . . 0.513 ' CB ' ' H ' ' E' ' 37' ' ' ILE . 0.3 OUTLIER -86.62 -39.99 15.58 Favored 'General case' 0 CA--C 1.49 -1.329 0 C-N-CA 126.727 2.011 . . . . 0.87 115.874 178.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . 0.259 0.3 OUTLIER -83.23 70.21 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.915 0 CA-C-O 127.888 3.709 . . . . 0.60999999999999999 110.842 -172.133 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -161.2 -54.32 0.05 OUTLIER 'General case' 0 N--CA 1.424 -1.752 1 CA-C-N 107.896 -4.229 . . . . 1.6100000000000001 105.595 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp -109.43 -22.98 11.76 Favored 'General case' 0 C--N 1.364 1.228 0 N-CA-C 116.868 2.173 . . . . 4.3200000000000003 116.868 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -22.26 -15.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 2 C-N-CA 138.626 6.77 . . . . 4.7999999999999998 122.629 -168.59 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.51 43.37 2.74 Favored Glycine 0 C--N 1.338 0.685 1 C-N-CA 130.906 4.098 . . . . 2.21 115.757 -175.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.23 -170.18 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.752 0 C-N-CA 126.758 2.023 . . . . 1.6399999999999999 110.806 -177.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 46.6 tp -68.89 -30.87 69.45 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 128.639 2.776 . . . . 0.64000000000000001 114.965 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -108.06 117.96 53.78 Favored Pre-proline 0 C--N 1.36 1.033 0 N-CA-C 103.838 -2.653 . . . . 1.52 103.838 175.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -75.14 -39.58 1.12 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.475 3.45 . . . . 0.67000000000000004 113.584 -167.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 62.3 t -109.62 115.17 48.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.708 0 C-N-CA 125.681 1.592 . . . . 1.1599999999999999 112.881 -177.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . 0.513 ' H ' ' CB ' ' E' ' 26' ' ' SER . 6.5 mt -88.87 128.07 41.25 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 C-N-CA 127.091 2.156 . . . . 1.28 105.273 166.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 24.8 t -122.98 150.17 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 O-C-N 120.343 -1.473 . . . . 1.04 109.041 -178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 39' ' ' ARG . . . . . 0.6 ' HB2' ' H ' ' E' ' 23' ' ' THR . 42.5 mtp180 -74.28 168.62 19.28 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 127.34 2.256 . . . . 3.1400000000000001 111.322 172.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . 0.25 21.4 m-85 -139.66 123.83 17.88 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 124.269 1.985 . . . . 1.26 111.329 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -54.37 -43.8 71.66 Favored 'General case' 0 N--CA 1.439 -1.0 1 C-N-CA 137.565 6.346 . . . . 1.8100000000000001 119.109 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 46.6 mtm105 -131.9 93.61 3.33 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 107.486 -1.302 . . . . 1.29 107.486 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 C--N 1.369 1.418 0 CA-C-O 125.33 2.491 . . . . 1.7 109.912 174.86 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 20.7 m120 . . . . . 0 C--O 1.224 -0.242 0 N-CA-C 109.065 -0.717 . . . . 2.6800000000000002 109.065 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 12.2 p -125.67 123.46 39.0 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 130.747 3.619 . . . . 1.1399999999999999 109.592 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -116.83 151.78 35.8 Favored 'General case' 0 C--N 1.365 1.246 0 C-N-CA 126.714 2.005 . . . . 1.9399999999999999 109.887 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -78.28 129.37 34.97 Favored 'General case' 0 C--N 1.364 1.227 0 C-N-CA 126.386 1.874 . . . . 2.2200000000000002 112.56 176.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 60' ' ' PHE . . . . . 0.405 ' CE2' HG21 ' E' ' 10' ' ' ILE . 0.2 OUTLIER -127.78 169.6 13.68 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 117.177 2.288 . . . . 0.23999999999999999 117.177 -177.163 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.87 88.2 2.77 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 110.129 -3.214 . . . . 1.01 111.693 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -18.25 -24.77 0.0 OUTLIER 'General case' 0 C--N 1.355 0.811 1 C-N-CA 136.276 5.83 . . . . 1.72 120.377 171.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.03 -34.14 71.56 Favored 'General case' 0 C--N 1.371 1.531 0 C-N-CA 129.615 3.166 . . . . 0.20000000000000001 113.856 167.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.37 17.46 21.43 Favored 'General case' 0 C--N 1.368 1.378 0 C-N-CA 125.92 1.688 . . . . 1.1799999999999999 110.738 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 74.0 mt -128.27 113.44 15.65 Favored 'General case' 0 C--N 1.363 1.156 0 N-CA-C 115.301 1.593 . . . . 1.0900000000000001 115.301 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -100.46 129.83 46.46 Favored 'General case' 0 C--N 1.363 1.166 0 C-N-CA 124.837 1.255 . . . . 2.0499999999999998 111.731 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.1 128.24 35.99 Favored 'General case' 0 C--N 1.368 1.397 0 C-N-CA 130.255 3.422 . . . . 0.28999999999999998 116.49 172.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.3 -28.98 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.167 0 CA-C-N 120.639 1.563 . . . . 1.1799999999999999 113.607 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 69' ' ' GLN . . . . . 0.413 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 3.5 tp-100 -104.48 138.06 41.42 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 125.32 2.486 . . . . 2.1899999999999999 114.342 -175.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.01 57.94 4.57 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 128.918 2.887 . . . . 0.0 111.528 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.13 52.55 0.9 Allowed 'General case' 0 C--N 1.362 1.113 0 C-N-CA 126.369 1.868 . . . . 0.0 108.989 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.85 146.81 25.57 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 126.062 1.745 . . . . 0.0 110.928 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt . . . . . 0 C--O 1.261 1.686 0 C-N-CA 125.839 1.656 . . . . 0.0 108.548 177.059 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' E' E ' 2' ' ' LEU . . . . . . . . . . . . 0.318 2.5 pp . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 123.017 1.389 . . . . 1.54 114.344 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -143.82 173.39 11.73 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 130.56 3.544 . . . . 1.0 110.753 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . 0.51 ' HD2' ' HZ3' ' E' ' 73' ' ' LYS . 91.9 mtt180 -95.62 109.71 21.92 Favored 'General case' 0 C--N 1.367 1.356 0 C-N-CA 127.703 2.401 . . . . 3.9399999999999999 112.815 175.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.61 14.34 41.08 Favored Glycine 0 CA--C 1.473 -2.535 0 O-C-N 119.474 -2.016 . . . . 0.75 114.016 172.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 6' ' ' ASP . . . . . 0.468 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 19.8 t0 -84.02 146.96 27.68 Favored 'General case' 0 N--CA 1.421 -1.884 1 C-N-CA 132.106 4.162 . . . . 0.45000000000000001 105.559 178.019 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -93.65 89.82 6.37 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 105.283 -2.118 . . . . 2.54 105.283 173.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 5.4 m -86.33 142.85 12.53 Favored 'Isoleucine or valine' 0 C--N 1.366 1.31 0 N-CA-C 107.652 -1.24 . . . . 1.03 107.652 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -96.64 100.92 12.46 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 117.103 2.26 . . . . 0.17000000000000001 117.103 -169.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . 0.431 HG22 ' CE2' ' E' ' 60' ' ' PHE . 1.8 mm -38.33 97.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.575 1.909 0 C-N-CA 129.46 3.104 . . . . 1.03 119.07 171.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -117.1 45.33 1.9 Allowed 'General case' 0 C--N 1.372 1.583 0 O-C-N 118.642 -2.536 . . . . 0.29999999999999999 111.969 -175.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 12' ' ' ARG . . . . . 0.478 ' HD2' ' CE1' ' E' ' 60' ' ' PHE . 10.1 ptm180 -99.68 128.35 45.78 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 128.4 2.68 . . . . 2.7599999999999998 107.995 175.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 24.6 p -70.74 -62.18 1.49 Allowed 'General case' 0 C--N 1.359 0.989 0 C-N-CA 130.194 3.398 . . . . 0.46999999999999997 114.088 -175.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.71 72.15 0.52 Allowed 'General case' 0 C--N 1.362 1.129 0 C-N-CA 130.636 3.574 . . . . 1.8899999999999999 110.26 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 3.7 t -156.71 172.77 18.02 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 124.802 2.239 . . . . 1.3999999999999999 111.091 -170.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -97.02 -17.81 19.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 130.649 3.58 . . . . 1.1599999999999999 108.622 171.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -121.04 17.04 11.68 Favored 'General case' 0 C--N 1.367 1.367 0 N-CA-C 116.762 2.134 . . . . 0.94999999999999996 116.762 -167.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -60.66 113.14 2.3 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 117.717 2.488 . . . . 0.95999999999999996 117.717 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.47 25.94 22.05 Favored Glycine 0 C--N 1.365 2.141 0 C-N-CA 124.701 1.143 . . . . 0.39000000000000001 112.841 170.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -136.78 171.29 14.72 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 104.977 -2.231 . . . . 1.3999999999999999 104.977 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.96 176.91 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 125.124 1.37 . . . . 1.03 113.922 -173.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.78 168.75 41.6 Favored Glycine 0 C--N 1.36 1.89 0 N-CA-C 105.716 -2.954 . . . . 0.27000000000000002 105.716 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 23' ' ' THR . . . . . 0.612 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 7.5 m -89.69 137.69 32.11 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 124.692 1.197 . . . . 1.1000000000000001 110.208 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.22 113.05 20.9 Favored 'Isoleucine or valine' 0 C--N 1.348 0.517 0 CA-C-O 124.341 2.019 . . . . 1.1100000000000001 111.195 167.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.08 24.25 13.27 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 128.216 2.606 . . . . 1.0600000000000001 109.461 172.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 26' ' ' SER . . . . . 0.454 ' HB2' ' H ' ' E' ' 37' ' ' ILE . 21.1 t -81.21 -52.2 7.6 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 127.382 2.273 . . . . 0.87 116.203 -177.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.49 51.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-O 125.627 2.632 . . . . 0.60999999999999999 114.091 -164.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.89 -60.07 0.26 Allowed 'General case' 0 N--CA 1.424 -1.731 0 C-N-CA 129.269 3.028 . . . . 1.6100000000000001 105.086 -174.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -112.04 7.14 19.68 Favored 'General case' 0 C--N 1.364 1.237 0 N-CA-C 115.08 1.511 . . . . 4.3200000000000003 115.08 -177.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -35.82 -28.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 1 C-N-CA 134.193 4.997 . . . . 4.7999999999999998 119.787 -176.539 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.39 46.72 0.19 Allowed Glycine 0 C--N 1.35 1.352 1 C-N-CA 130.854 4.074 . . . . 2.21 117.606 -178.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -113.5 -155.76 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.502 0 CA-C-O 123.332 1.539 . . . . 1.6399999999999999 111.65 178.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 62.6 tp -72.55 -34.75 67.74 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 130.054 3.342 . . . . 0.64000000000000001 113.778 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -125.43 157.77 66.75 Favored Pre-proline 0 C--N 1.355 0.824 0 N-CA-C 101.736 -3.431 . . . . 1.52 101.736 174.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.96 -59.28 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 123.861 2.415 . . . . 0.67000000000000004 112.805 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 52.6 t -70.06 105.86 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.222 0 N-CA-C 117.762 2.504 . . . . 1.1599999999999999 117.762 -169.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . 0.454 ' H ' ' HB2' ' E' ' 26' ' ' SER . 18.0 mt -89.82 107.37 18.13 Favored 'Isoleucine or valine' 0 C--N 1.37 1.481 0 N-CA-C 105.748 -1.945 . . . . 1.28 105.748 170.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 38' ' ' VAL . . . . . . . . . . . . 0.26 19.4 t -112.18 149.24 14.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.473 0 CA-C-O 121.053 0.454 . . . . 1.04 110.132 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 39' ' ' ARG . . . . . 0.612 ' HB3' ' H ' ' E' ' 23' ' ' THR . 8.5 tmm_? -84.09 147.06 27.57 Favored 'General case' 0 C--N 1.366 1.311 0 C-N-CA 129.125 2.97 . . . . 3.1400000000000001 108.892 173.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -151.72 144.94 24.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 104.206 -2.516 . . . . 1.26 104.206 172.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -105.46 -2.75 23.33 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 125.523 1.529 . . . . 1.8100000000000001 112.191 175.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -86.44 45.72 1.27 Allowed 'General case' 0 C--N 1.357 0.898 0 C-N-CA 129.498 3.119 . . . . 1.29 110.49 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 C--N 1.354 0.788 1 C-N-CA 131.927 4.091 . . . . 1.7 110.467 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 . . . . . 0 CA--C 1.531 0.213 0 CA-C-O 119.822 -0.132 . . . . 2.6800000000000002 111.214 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 62.7 p -107.33 96.29 6.31 Favored 'General case' 0 C--N 1.363 1.185 0 C-N-CA 125.087 1.355 . . . . 1.1399999999999999 108.479 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -112.5 145.38 40.34 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 125.285 1.434 . . . . 1.9399999999999999 111.022 -174.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.76 95.5 9.59 Favored 'General case' 0 C--N 1.361 1.085 0 C-N-CA 127.43 2.292 . . . . 2.2200000000000002 110.392 -177.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 60' ' ' PHE . . . . . 0.478 ' CE1' ' HD2' ' E' ' 12' ' ' ARG . 0.5 OUTLIER -101.71 164.77 11.57 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 126.697 1.999 . . . . 0.23999999999999999 114.039 -171.494 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . 0.441 ' H ' ' HD1' ' E' ' 60' ' ' PHE . . . -97.63 90.32 4.97 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 127.656 2.382 . . . . 1.01 111.818 -177.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -16.39 -40.98 0.0 OUTLIER 'General case' 0 C--N 1.365 1.281 1 C-N-CA 134.308 5.043 . . . . 1.72 120.087 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.48 -26.4 42.32 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 128.507 2.723 . . . . 0.20000000000000001 115.964 171.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -97.55 5.21 49.85 Favored 'General case' 0 C--N 1.364 1.235 0 C-N-CA 127.171 2.188 . . . . 1.1799999999999999 111.712 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . 0.425 HD23 ' CZ ' ' E' ' 60' ' ' PHE . 0.6 OUTLIER -116.68 109.6 17.39 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 126.026 1.73 . . . . 1.0900000000000001 112.097 -175.922 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -106.08 147.7 28.64 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 124.748 1.219 . . . . 2.0499999999999998 110.383 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -75.17 142.54 43.51 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 127.323 2.249 . . . . 0.28999999999999998 116.459 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 t -127.2 -28.6 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.963 0 C-N-CA 125.646 1.578 . . . . 1.1799999999999999 108.386 173.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 69' ' ' GLN . . . . . 0.468 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 7.9 tt0 -114.02 142.39 46.23 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 124.933 2.302 . . . . 2.1899999999999999 113.173 -177.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.36 57.46 0.94 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 128.449 2.7 . . . . 0.0 111.189 174.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.07 53.23 0.6 Allowed 'General case' 0 C--N 1.367 1.355 0 C-N-CA 127.518 2.327 . . . . 0.0 115.312 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.2 137.24 40.72 Favored 'General case' 0 C--N 1.348 0.509 0 C-N-CA 127.447 2.299 . . . . 0.0 107.156 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 73' ' ' LYS . . . . . 0.51 ' HZ3' ' HD2' ' E' ' 4' ' ' ARG . 2.1 mppt? . . . . . 0 C--O 1.261 1.699 0 CA-C-O 118.477 -0.773 . . . . 0.0 110.114 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.616 0 N-CA-C 115.559 1.688 . . . . 1.54 115.559 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -134.63 -172.29 2.99 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 128.688 2.795 . . . . 1.0 108.954 -176.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -95.85 104.87 16.83 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 129.004 2.922 . . . . 3.9399999999999999 115.357 -176.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.37 3.51 33.09 Favored Glycine 0 C--N 1.366 2.23 0 CA-C-O 124.43 2.128 . . . . 0.75 111.45 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 6' ' ' ASP . . . . . . . . . . . . 0.34 16.2 t70 -90.35 51.41 2.02 Favored 'General case' 0 N--CA 1.424 -1.761 1 C-N-CA 132.96 4.504 . . . . 0.45000000000000001 108.945 -178.202 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -28.75 105.85 0.03 OUTLIER 'General case' 0 C--N 1.367 1.329 1 C-N-CA 133.666 4.786 . . . . 2.54 117.035 -174.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 35.1 m -90.62 150.49 3.72 Favored 'Isoleucine or valine' 0 C--N 1.36 1.036 0 C-N-CA 123.279 0.632 . . . . 1.03 111.111 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 19.4 ttm-85 -98.76 88.34 4.01 Favored 'General case' 0 C--N 1.36 1.025 0 O-C-N 120.629 -1.294 . . . . 0.17000000000000001 112.909 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -33.53 101.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.598 0 N-CA-C 119.988 3.329 . . . . 1.03 119.988 176.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 11' ' ' LYS . . . . . 0.681 ' HZ3' ' HH ' ' E' ' 18' ' ' TYR . 13.2 mmmt -103.01 42.74 1.13 Allowed 'General case' 0 C--N 1.368 1.374 0 C-N-CA 125.783 1.633 . . . . 0.29999999999999999 113.399 -174.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -98.49 123.53 42.7 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 129.389 3.075 . . . . 2.7599999999999998 111.226 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 26.4 p -71.42 -61.75 1.66 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 128.201 2.6 . . . . 0.46999999999999997 116.204 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -78.96 65.69 4.21 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 127.001 2.12 . . . . 1.8899999999999999 113.611 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 3.9 m -173.68 163.35 4.24 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 126.561 1.944 . . . . 1.3999999999999999 106.129 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -90.93 18.78 6.21 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 129.159 2.984 . . . . 1.1599999999999999 112.65 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 36.1 m0 -113.68 0.07 14.45 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 129.246 3.019 . . . . 0.94999999999999996 111.636 -175.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 18' ' ' TYR . . . . . 0.681 ' HH ' ' HZ3' ' E' ' 11' ' ' LYS . 1.2 t80 -58.3 105.57 0.3 Allowed 'General case' 0 C--N 1.37 1.49 0 C-N-CA 127.163 2.185 . . . . 0.95999999999999996 116.176 -174.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.82 26.33 53.89 Favored Glycine 0 C--N 1.366 2.243 0 O-C-N 121.137 -0.977 . . . . 0.39000000000000001 115.11 -177.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -106.34 152.94 22.91 Favored 'General case' 0 C--N 1.362 1.149 0 N-CA-C 105.989 -1.856 . . . . 1.3999999999999999 105.989 175.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -88.11 151.72 3.48 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-O 123.716 1.722 . . . . 1.03 109.969 174.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.95 167.7 28.26 Favored Glycine 0 CA--C 1.471 -2.712 0 N-CA-C 105.872 -2.891 . . . . 0.27000000000000002 105.872 170.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 23' ' ' THR . . . . . 0.45 ' HG1' ' CZ ' ' E' ' 39' ' ' ARG . 17.3 m -97.24 113.92 25.59 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 124.901 1.28 . . . . 1.1000000000000001 112.147 -175.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.16 71.79 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 128.729 2.811 . . . . 1.1100000000000001 118.307 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.01 53.93 2.96 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 116.699 -3.751 . . . . 1.0600000000000001 112.53 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 67.0 m -88.77 -58.03 2.69 Favored 'General case' 0 CA--C 1.477 -1.831 1 C-N-CA 133.549 4.74 . . . . 0.87 118.443 -173.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 m -82.51 49.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.368 1.393 0 CA-C-O 127.706 3.622 . . . . 0.60999999999999999 114.817 -163.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -135.39 -58.17 0.79 Allowed 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 110.817 -2.901 . . . . 1.6100000000000001 105.386 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -110.87 5.25 20.41 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 127.181 2.193 . . . . 4.3200000000000003 114.001 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 26.5 t -46.14 -26.35 0.75 Allowed 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 129.516 3.126 . . . . 4.7999999999999998 116.935 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.35 44.21 0.06 OUTLIER Glycine 0 C--N 1.357 1.709 1 C-N-CA 130.809 4.052 . . . . 2.21 118.327 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.54 -156.61 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.972 0 C-N-CA 128.972 2.909 . . . . 1.6399999999999999 113.144 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 25.6 tp -87.79 -12.95 43.56 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 130.849 3.66 . . . . 0.64000000000000001 114.248 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -135.25 141.62 38.53 Favored Pre-proline 0 C--N 1.358 0.966 0 N-CA-C 101.912 -3.366 . . . . 1.52 101.912 175.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -83.88 -45.1 0.06 OUTLIER 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.882 2.388 . . . . 0.67000000000000004 115.954 -168.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 55.4 t -106.23 131.12 56.69 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 N-CA-C 115.597 1.702 . . . . 1.1599999999999999 115.597 -166.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 57.0 mt -105.72 126.08 61.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 C-N-CA 127.702 2.401 . . . . 1.28 105.302 172.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 74.3 t -134.43 144.4 35.22 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 O-C-N 120.703 -1.248 . . . . 1.04 109.161 -176.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 39' ' ' ARG . . . . . 0.45 ' CZ ' ' HG1' ' E' ' 23' ' ' THR . 8.1 mtm180 -69.79 163.48 25.7 Favored 'General case' 0 C--N 1.372 1.578 0 C-N-CA 127.815 2.446 . . . . 3.1400000000000001 115.827 173.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -149.02 139.12 22.19 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 124.543 1.137 . . . . 1.26 110.113 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -94.1 -32.6 13.69 Favored 'General case' 0 C--N 1.366 1.319 0 C-N-CA 125.995 1.718 . . . . 1.8100000000000001 111.508 171.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 -79.69 57.99 2.65 Favored 'General case' 0 C--N 1.373 1.59 0 C-N-CA 129.397 3.079 . . . . 1.29 112.617 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 C--N 1.351 0.664 0 C-N-CA 127.11 2.164 . . . . 1.7 110.225 -178.893 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 . . . . . 0 C--O 1.225 -0.235 0 CA-C-O 121.403 0.621 . . . . 2.6800000000000002 109.442 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 72.7 p -105.0 115.95 31.14 Favored 'General case' 0 C--N 1.35 0.611 0 C-N-CA 126.891 2.077 . . . . 1.1399999999999999 108.585 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -105.95 147.11 29.18 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 108.639 -0.875 . . . . 1.9399999999999999 108.639 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -90.52 110.45 21.58 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 128.332 2.653 . . . . 2.2200000000000002 107.669 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -122.22 173.58 7.51 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 126.791 2.036 . . . . 0.23999999999999999 115.797 -172.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -108.15 97.31 7.02 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 130.077 3.351 . . . . 1.01 113.909 -176.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -14.34 -34.9 0.0 OUTLIER 'General case' 0 C--N 1.366 1.297 1 C-N-CA 134.683 5.193 . . . . 1.72 121.122 171.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -46.2 -46.74 17.72 Favored 'General case' 0 C--N 1.369 1.426 1 C-N-CA 132.661 4.384 . . . . 0.20000000000000001 112.606 170.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.97 16.6 25.49 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 112.744 -2.025 . . . . 1.1799999999999999 111.218 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 75.4 mt -129.65 98.01 4.7 Favored 'General case' 0 C--N 1.369 1.449 0 N-CA-C 114.942 1.46 . . . . 1.0900000000000001 114.942 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -105.97 143.87 33.49 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 125.692 1.597 . . . . 2.0499999999999998 111.638 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -62.45 137.23 58.22 Favored 'General case' 0 C--N 1.365 1.276 0 C-N-CA 129.307 3.043 . . . . 0.28999999999999998 117.481 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 39.3 t -132.75 -27.27 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.292 0 C-N-CA 126.815 2.046 . . . . 1.1799999999999999 110.104 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.95 146.82 41.77 Favored 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 125.9 1.68 . . . . 2.1899999999999999 108.156 177.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.67 79.75 1.39 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 129.622 3.169 . . . . 0.0 112.685 173.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.25 77.83 1.45 Allowed 'General case' 0 C--N 1.352 0.683 0 O-C-N 119.403 -2.061 . . . . 0.0 109.484 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.45 -165.89 0.77 Allowed 'General case' 0 C--N 1.353 0.723 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt . . . . . 0 C--O 1.262 1.739 0 C-N-CA 127.647 2.379 . . . . 0.0 108.399 176.1 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 108.015 -1.106 . . . . 2.6400000000000001 108.015 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.26 -161.02 0.73 Allowed 'General case' 0 C--N 1.353 0.734 0 C-N-CA 125.331 1.452 . . . . 1.54 112.944 176.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 46.4 m-20 -123.86 -178.17 3.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 128.02 2.528 . . . . 1.0 110.842 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -91.43 83.92 5.5 Favored 'General case' 0 C--N 1.364 1.235 0 C-N-CA 127.78 2.432 . . . . 3.9399999999999999 112.62 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 142.22 -9.06 2.44 Favored Glycine 0 CA--C 1.486 -1.74 0 CA-C-O 123.642 1.69 . . . . 0.75 110.872 -173.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 6' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -81.63 47.98 1.13 Allowed 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 128.227 2.611 . . . . 0.45000000000000001 114.837 -172.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . 0.421 0.0 OUTLIER -11.91 97.33 0.01 OUTLIER 'General case' 0 C--N 1.361 1.089 1 C-N-CA 132.761 4.425 . . . . 2.54 117.763 -176.161 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.8 151.54 4.1 Favored 'Isoleucine or valine' 0 C--N 1.364 1.232 0 O-C-N 119.738 -1.851 . . . . 1.03 111.18 -171.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 17.1 ttt85 -97.61 105.86 18.08 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 115.153 1.538 . . . . 0.17000000000000001 115.153 -176.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 1.3 mp -53.83 104.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.37 1.481 0 C-N-CA 129.108 2.963 . . . . 1.03 115.339 174.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . 0.562 ' HZ1' ' HA3' ' E' ' 19' ' ' GLY . 34.8 mmtm -123.78 55.95 1.24 Allowed 'General case' 0 C--N 1.365 1.255 0 C-N-CA 123.762 0.825 . . . . 0.29999999999999999 109.131 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -72.75 -72.91 0.22 Allowed 'General case' 0 C--N 1.362 1.146 0 C-N-CA 126.053 1.741 . . . . 2.7599999999999998 115.188 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 84.9 m 127.44 -61.92 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.734 1 C-N-CA 133.077 4.551 . . . . 0.46999999999999997 104.774 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -77.1 72.24 3.63 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 128.241 2.616 . . . . 1.8899999999999999 111.383 173.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 42.6 t -167.44 159.79 12.68 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 106.823 -1.547 . . . . 1.3999999999999999 106.823 -174.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -90.15 -2.09 58.03 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 127.412 2.285 . . . . 1.1599999999999999 110.585 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -119.43 24.36 10.72 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 125.564 1.546 . . . . 0.94999999999999996 111.082 -176.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -67.49 110.49 3.66 Favored 'General case' 0 C--N 1.369 1.425 0 C-N-CA 126.975 2.11 . . . . 0.95999999999999996 113.802 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 19' ' ' GLY . . . . . 0.562 ' HA3' ' HZ1' ' E' ' 11' ' ' LYS . . . 92.99 16.67 46.85 Favored Glycine 0 C--N 1.356 1.69 0 C-N-CA 125.819 1.676 . . . . 0.39000000000000001 111.272 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -108.91 164.2 12.61 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 126.305 1.842 . . . . 1.3999999999999999 110.155 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -110.27 173.29 2.21 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 C-N-CA 125.946 1.698 . . . . 1.03 108.257 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.55 174.92 42.65 Favored Glycine 0 CA--C 1.474 -2.523 0 N-CA-C 107.517 -2.233 . . . . 0.27000000000000002 107.517 167.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 23' ' ' THR . . . . . 0.661 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 23.5 m -90.21 120.05 31.05 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 126.293 1.837 . . . . 1.1000000000000001 112.219 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 7.9 p -72.25 80.94 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 125.279 2.466 . . . . 1.1100000000000001 116.571 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.31 45.12 1.15 Allowed 'General case' 0 C--N 1.35 0.597 0 O-C-N 118.643 -2.535 . . . . 1.0600000000000001 111.885 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 13.7 t -85.08 -68.95 0.69 Allowed 'General case' 0 CA--C 1.498 -1.043 1 C-N-CA 133.149 4.58 . . . . 0.87 114.076 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 1.3 m -79.88 28.98 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.229 0 C-N-CA 127.69 2.396 . . . . 0.60999999999999999 116.04 -157.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -112.4 -60.67 1.83 Allowed 'General case' 0 N--CA 1.425 -1.675 1 C-N-CA 132.38 4.272 . . . . 1.6100000000000001 106.972 177.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . 0.547 ' HZ3' HD12 ' E' ' 37' ' ' ILE . 0.3 OUTLIER -111.53 -27.63 8.51 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 115.422 1.638 . . . . 4.3200000000000003 115.422 -177.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.54 35.08 0.76 Allowed 'General case' 0 C--N 1.354 0.786 0 N-CA-C 115.477 1.658 . . . . 4.7999999999999998 115.477 -173.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.14 52.44 3.34 Favored Glycine 0 C--N 1.349 1.266 0 C-N-CA 129.053 3.216 . . . . 2.21 112.561 163.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 32' ' ' ILE . . . . . 0.42 ' CG2' ' H ' ' E' ' 33' ' ' LEU . 0.4 OUTLIER -133.94 -157.64 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.988 0 C-N-CA 129.311 3.044 . . . . 1.6399999999999999 109.93 -175.098 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 33' ' ' LEU . . . . . 0.42 ' H ' ' CG2' ' E' ' 32' ' ' ILE . 36.6 tp -62.93 -42.47 99.81 Favored 'General case' 0 C--N 1.358 0.935 1 C-N-CA 132.238 4.215 . . . . 0.64000000000000001 117.673 -177.3 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -110.17 134.61 20.7 Favored Pre-proline 0 C--N 1.366 1.302 0 N-CA-C 102.471 -3.159 . . . . 1.52 102.471 172.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.4 -53.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.424 2.083 . . . . 0.67000000000000004 115.933 -167.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 69.7 t -105.54 105.38 18.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.889 0 N-CA-C 119.316 3.08 . . . . 1.1599999999999999 119.316 -161.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . 0.547 HD12 ' HZ3' ' E' ' 29' ' ' LYS . 59.9 mt -83.1 125.08 40.04 Favored 'Isoleucine or valine' 0 C--N 1.38 1.895 0 O-C-N 119.247 -2.158 . . . . 1.28 106.25 171.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 55.2 t -122.72 162.64 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 119.333 0.97 . . . . 1.04 108.927 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 39' ' ' ARG . . . . . 0.661 ' HB3' ' H ' ' E' ' 23' ' ' THR 0.256 30.8 ttp180 -82.16 147.39 29.05 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 129.825 3.25 . . . . 3.1400000000000001 110.833 172.267 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -139.96 126.22 20.0 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 124.742 1.217 . . . . 1.26 107.987 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -82.48 -15.25 53.17 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 124.343 1.057 . . . . 1.8100000000000001 112.051 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -115.59 75.07 0.92 Allowed 'General case' 0 C--N 1.368 1.375 0 C-N-CA 126.854 2.061 . . . . 1.29 112.285 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 m -92.93 21.65 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.306 0 C-N-CA 126.581 1.952 . . . . 1.7 115.729 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . 0.436 0.3 OUTLIER 47.68 72.7 0.24 Allowed 'General case' 0 N--CA 1.443 -0.798 1 C-N-CA 132.122 4.169 . . . . 2.1800000000000002 119.079 -177.42 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -56.24 36.45 0.0 OUTLIER 'General case' 0 C--N 1.365 1.248 1 C-N-CA 134.615 5.166 . . . . 2.6899999999999999 118.667 -177.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -101.69 76.35 1.65 Allowed 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 128.781 2.832 . . . . 4.6200000000000001 106.142 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -46.77 -22.81 1.24 Allowed Glycine 0 C--N 1.369 2.362 0 C-N-CA 129.528 3.442 . . . . 5.3300000000000001 121.378 -170.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -104.19 -0.02 28.97 Favored 'General case' 0 C--N 1.361 1.085 0 C-N-CA 125.449 1.5 . . . . 5.2699999999999996 113.916 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 2.5 t -105.84 -51.28 3.02 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.193 1.797 . . . . 7.5999999999999996 110.912 172.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . -127.0 -95.29 0.91 Allowed Glycine 0 C--N 1.365 2.152 0 N-CA-C 110.414 -1.074 . . . . 6.8700000000000001 110.414 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 8.0 t -168.24 175.63 6.39 Favored 'General case' 0 C--N 1.358 0.953 0 N-CA-C 108.298 -1.001 . . . . 7.5099999999999998 108.298 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.97 -5.65 23.22 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 126.968 2.107 . . . . 5.5599999999999996 112.557 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 12.0 t -141.68 37.94 1.65 Allowed 'General case' 0 C--N 1.35 0.591 0 O-C-N 121.141 -0.975 . . . . 4.4299999999999997 109.626 -176.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.66 -102.59 0.47 Allowed Glycine 0 C--N 1.359 1.809 0 N-CA-C 118.118 2.007 . . . . 3.3900000000000001 118.118 -169.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . 0.314 4.0 p -108.55 86.67 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.611 0 CA-C-O 124.955 2.312 . . . . 1.79 113.921 -175.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -92.24 -38.01 12.34 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 129.685 3.194 . . . . 2.6800000000000002 109.835 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 21.4 p -104.29 117.15 33.52 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 129.864 3.265 . . . . 1.1399999999999999 107.269 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -148.22 136.94 21.68 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.734 1.214 . . . . 1.9399999999999999 108.253 -174.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -86.59 118.51 26.05 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 127.684 2.394 . . . . 2.2200000000000002 116.047 -175.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -105.95 171.53 7.29 Favored 'General case' 0 CA--C 1.507 -0.682 0 O-C-N 119.856 -1.778 . . . . 0.23999999999999999 112.547 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.42 101.53 10.88 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 129.649 3.179 . . . . 1.01 108.711 169.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -19.94 -29.18 0.0 OUTLIER 'General case' 0 C--N 1.36 1.043 1 C-N-CA 136.467 5.907 . . . . 1.72 119.602 171.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.26 -30.69 66.78 Favored 'General case' 0 C--N 1.365 1.254 0 C-N-CA 128.629 2.772 . . . . 0.20000000000000001 113.958 171.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.52 20.47 18.49 Favored 'General case' 0 C--N 1.368 1.375 0 C-N-CA 125.777 1.631 . . . . 1.1799999999999999 110.788 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 52.0 mt -137.59 116.91 12.72 Favored 'General case' 0 C--N 1.374 1.667 0 N-CA-C 116.282 1.956 . . . . 1.0900000000000001 116.282 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -106.83 138.12 43.6 Favored 'General case' 0 C--N 1.364 1.229 0 O-C-N 120.589 -1.32 . . . . 2.0499999999999998 111.604 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.35 136.72 53.41 Favored 'General case' 0 C--N 1.366 1.29 1 C-N-CA 131.909 4.084 . . . . 0.28999999999999998 118.434 174.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 10.0 t -132.7 -40.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.618 -1.301 . . . . 1.1799999999999999 114.121 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 69' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -104.83 120.87 42.43 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 123.486 1.612 . . . . 2.1899999999999999 114.883 -172.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.0 51.72 0.15 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.265 2.226 . . . . 0.0 115.511 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.49 60.66 6.15 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 127.036 2.134 . . . . 0.0 112.295 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.63 114.16 26.04 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 125.991 1.716 . . . . 0.0 110.179 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 50.5 mttp . . . . . 0 C--O 1.262 1.741 0 CA-C-O 117.351 -1.309 . . . . 0.0 111.484 178.135 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 107.302 -1.37 . . . . 2.6400000000000001 107.302 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.73 -157.83 0.62 Allowed 'General case' 0 C--N 1.351 0.646 0 C-N-CA 126.564 1.946 . . . . 1.54 114.833 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . 0.257 1.0 OUTLIER -142.47 -175.56 4.51 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 104.62 -2.363 . . . . 1.0 104.62 176.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.39 60.42 5.22 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 130.135 3.374 . . . . 3.9399999999999999 116.594 -175.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.63 1.07 0.04 OUTLIER Glycine 0 CA--C 1.477 -2.341 0 O-C-N 120.088 -1.633 . . . . 0.75 113.457 -175.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 6' ' ' ASP . . . . . 0.462 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 65.5 t0 -76.76 136.29 39.02 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.797 2.039 . . . . 0.45000000000000001 113.454 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . 0.413 ' H ' ' HB3' ' E' ' 69' ' ' GLN . 86.4 mttt -80.8 80.52 7.25 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 127.05 2.14 . . . . 2.54 108.07 169.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 8' ' ' VAL . . . . . 0.4 HG23 ' H ' ' E' ' 8' ' ' VAL . 13.9 m -89.97 135.6 25.89 Favored 'Isoleucine or valine' 0 C--N 1.374 1.672 0 N-CA-C 103.365 -2.828 . . . . 1.03 103.365 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -95.52 110.38 22.46 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 120.89 1.677 . . . . 0.17000000000000001 114.544 -172.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 10.5 mm -52.18 108.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.378 1.807 0 N-CA-C 118.19 2.663 . . . . 1.03 118.19 175.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -117.9 48.82 1.32 Allowed 'General case' 0 C--N 1.37 1.486 0 CA-C-O 123.203 1.478 . . . . 0.29999999999999999 107.923 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -101.62 128.97 47.65 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 130.277 3.431 . . . . 2.7599999999999998 109.485 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 20.9 p -74.69 -58.67 3.14 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 128.8 2.84 . . . . 0.46999999999999997 113.268 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -66.07 48.75 0.03 OUTLIER 'General case' 0 C--N 1.359 0.998 0 C-N-CA 129.295 3.038 . . . . 1.8899999999999999 116.529 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 53.3 m -167.48 166.5 14.26 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 119.575 -1.953 . . . . 1.3999999999999999 106.631 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -92.96 15.56 14.65 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 119.645 -1.91 . . . . 1.1599999999999999 113.727 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -116.44 13.14 15.39 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 126.811 2.045 . . . . 0.94999999999999996 111.86 -175.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -61.82 105.98 0.63 Allowed 'General case' 0 C--N 1.367 1.34 0 C-N-CA 127.519 2.328 . . . . 0.95999999999999996 114.598 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.58 9.01 44.88 Favored Glycine 0 C--N 1.363 2.047 0 C-N-CA 123.959 0.79 . . . . 0.39000000000000001 112.975 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -107.99 174.57 5.82 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 127.984 2.514 . . . . 1.3999999999999999 109.948 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 p -108.68 178.74 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.437 0 C-N-CA 125.482 1.513 . . . . 1.03 110.492 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.29 174.55 47.04 Favored Glycine 0 CA--C 1.477 -2.335 0 O-C-N 119.829 -1.795 . . . . 0.27000000000000002 108.918 171.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 23' ' ' THR . . . . . 0.563 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 8.3 m -106.65 115.09 29.6 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 125.054 1.342 . . . . 1.1000000000000001 110.43 -177.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 p -68.79 85.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 125.779 1.632 . . . . 1.1100000000000001 113.545 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.96 50.0 1.88 Allowed 'General case' 0 C--N 1.355 0.804 0 O-C-N 119.947 -1.721 . . . . 1.0600000000000001 110.967 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 26' ' ' SER . . . . . 0.459 ' HB3' ' H ' ' E' ' 37' ' ' ILE . 19.3 p -94.71 -71.8 0.65 Allowed 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 120.298 3.444 . . . . 0.87 120.298 -174.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.13 56.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.755 2 C-N-CA 132.84 4.456 . . . . 0.60999999999999999 111.823 -167.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -141.82 -45.62 0.35 Allowed 'General case' 0 N--CA 1.411 -2.399 2 CA-C-N 107.49 -4.414 . . . . 1.6100000000000001 102.126 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -109.3 -39.21 5.29 Favored 'General case' 0 C--N 1.368 1.41 0 C-N-CA 129.67 3.188 . . . . 4.3200000000000003 113.643 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 23.6 m -69.87 53.36 0.12 Allowed 'General case' 0 C--N 1.364 1.216 0 C-N-CA 131.228 3.811 . . . . 4.7999999999999998 118.527 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.6 47.0 3.39 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 109.65 -3.432 . . . . 2.21 111.368 153.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 32' ' ' ILE . . . . . 0.434 ' CG2' ' H ' ' E' ' 33' ' ' LEU . 0.5 OUTLIER -140.15 -153.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.246 0 C-N-CA 126.98 2.112 . . . . 1.6399999999999999 110.031 -175.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 33' ' ' LEU . . . . . 0.434 ' H ' ' CG2' ' E' ' 32' ' ' ILE . 40.8 tp -65.8 -43.25 89.24 Favored 'General case' 0 C--N 1.354 0.798 1 C-N-CA 132.565 4.346 . . . . 0.64000000000000001 117.0 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -108.8 128.3 25.77 Favored Pre-proline 0 C--N 1.356 0.888 0 O-C-N 120.367 -1.458 . . . . 1.52 107.176 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.19 -28.61 4.63 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 124.411 3.408 . . . . 0.67000000000000004 112.791 -174.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 59.4 t -110.72 138.34 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 130.4 3.48 . . . . 1.1599999999999999 108.188 -177.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . 0.459 ' H ' ' HB3' ' E' ' 26' ' ' SER . 63.5 mt -138.29 121.92 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 2 N-CA-C 95.13 -5.878 . . . . 1.28 95.13 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 62.3 t -124.25 157.49 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 CA-C-N 122.492 2.406 . . . . 1.04 111.901 -170.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 39' ' ' ARG . . . . . 0.563 ' HB3' ' H ' ' E' ' 23' ' ' THR . 0.0 OUTLIER -83.64 144.01 29.71 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 128.035 2.534 . . . . 3.1400000000000001 112.176 174.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -129.78 128.57 42.66 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 114.636 -1.166 . . . . 1.26 107.933 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -98.35 -15.44 19.72 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 126.18 1.792 . . . . 1.8100000000000001 110.805 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -115.35 60.56 0.7 Allowed 'General case' 0 C--N 1.355 0.823 0 C-N-CA 131.048 3.739 . . . . 1.29 110.424 -177.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -88.85 175.78 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.809 0 C-N-CA 126.494 1.918 . . . . 1.7 109.114 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -85.77 69.63 10.61 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 127.473 2.309 . . . . 2.1800000000000002 108.443 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -50.42 -8.33 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.537 1 C-N-CA 132.083 4.153 . . . . 2.6899999999999999 119.028 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -97.63 125.17 42.24 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 129.102 2.961 . . . . 4.6200000000000001 108.211 175.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.92 105.22 1.77 Allowed Glycine 0 C--N 1.36 1.877 0 N-CA-C 120.069 2.788 . . . . 5.3300000000000001 120.069 -170.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -92.43 -162.59 0.94 Allowed 'General case' 0 C--N 1.355 0.805 0 C-N-CA 127.138 2.175 . . . . 5.2699999999999996 112.565 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 19.7 m -51.83 -39.3 58.58 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 131.351 3.861 . . . . 7.5999999999999996 116.924 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . -104.1 30.88 9.37 Favored Glycine 0 C--N 1.356 1.647 0 C-N-CA 126.109 1.814 . . . . 6.8700000000000001 111.247 171.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 51' ' ' SER . . . . . . . . . . . . 0.338 15.3 p 76.36 -156.68 0.04 OUTLIER 'General case' 0 C--N 1.355 0.829 0 C-N-CA 126.988 2.115 . . . . 7.5099999999999998 116.439 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -96.59 -105.64 0.17 Allowed 'General case' 0 C--N 1.354 0.768 0 C-N-CA 124.817 1.247 . . . . 5.5599999999999996 113.584 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 9.8 m -68.51 43.73 0.04 OUTLIER 'General case' 0 C--N 1.35 0.61 0 C-N-CA 129.778 3.231 . . . . 4.4299999999999997 117.306 -173.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.53 -54.93 5.26 Favored Glycine 0 C--N 1.357 1.7 0 C-N-CA 126.395 1.95 . . . . 3.3900000000000001 115.706 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . 0.348 7.8 p -84.28 75.98 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.533 0 CA-C-O 126.62 3.105 . . . . 1.79 114.884 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -94.48 -28.77 15.29 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 110.056 -3.247 . . . . 2.6800000000000002 112.415 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 2.9 p -132.17 129.28 39.58 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 130.202 3.401 . . . . 1.1399999999999999 105.582 -177.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -154.43 150.38 27.81 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 104.734 -2.321 . . . . 1.9399999999999999 104.734 -174.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -78.51 125.21 29.05 Favored 'General case' 0 C--N 1.353 0.717 1 C-N-CA 131.811 4.044 . . . . 2.2200000000000002 116.334 -169.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 60' ' ' PHE . . . . . 0.466 ' HB3' HD22 ' E' ' 65' ' ' LEU . 19.3 m-85 -128.89 154.91 46.04 Favored 'General case' 0 C--N 1.36 1.06 0 CA-C-O 124.042 1.877 . . . . 0.23999999999999999 114.036 -173.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.42 101.92 10.59 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 112.337 -2.21 . . . . 1.01 109.941 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -27.27 -26.95 0.0 OUTLIER 'General case' 0 C--N 1.372 1.553 1 C-N-CA 132.155 4.182 . . . . 1.72 121.132 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -46.9 -49.64 20.07 Favored 'General case' 0 C--N 1.374 1.66 0 C-N-CA 131.028 3.731 . . . . 0.20000000000000001 113.601 167.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 11.6 pm0 -95.07 10.02 37.35 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-N 114.121 -1.399 . . . . 1.1799999999999999 112.942 -172.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.466 HD22 ' HB3' ' E' ' 60' ' ' PHE . 0.2 OUTLIER -115.3 120.64 40.32 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.824 1.65 . . . . 1.0900000000000001 111.215 -177.603 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -100.15 115.15 29.16 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 125.763 1.625 . . . . 2.0499999999999998 111.116 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.56 132.02 46.75 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 129.087 2.955 . . . . 0.28999999999999998 118.535 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.63 -39.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.275 0 C-N-CA 124.407 1.083 . . . . 1.1799999999999999 113.436 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 69' ' ' GLN . . . . . 0.462 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 25.6 tt0 -112.22 106.86 15.54 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 116.327 1.973 . . . . 2.1899999999999999 116.327 -171.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.27 63.85 0.15 Allowed 'General case' 0 CA--C 1.557 1.225 0 O-C-N 119.734 -1.854 . . . . 0.0 115.957 170.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.35 53.72 0.41 Allowed 'General case' 0 C--N 1.369 1.453 0 C-N-CA 128.112 2.565 . . . . 0.0 117.12 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.74 160.07 15.13 Favored 'General case' 0 C--N 1.35 0.591 0 C-N-CA 128.313 2.645 . . . . 0.0 116.089 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt . . . . . 0 C--O 1.261 1.708 0 C-N-CA 128.905 2.882 . . . . 0.0 108.83 176.976 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 108.605 -0.887 . . . . 2.6400000000000001 108.605 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -156.51 0.51 Allowed 'General case' 0 C--N 1.352 0.713 0 N-CA-C 116.718 2.118 . . . . 1.54 116.718 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.31 153.85 44.21 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 129.1 2.96 . . . . 1.0 104.43 177.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . 0.282 0.0 OUTLIER -86.29 121.62 29.13 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 119.55 3.167 . . . . 3.9399999999999999 119.55 -171.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.4 -0.69 14.24 Favored Glycine 0 C--N 1.365 2.19 0 C-N-CA 126.372 1.939 . . . . 0.75 110.856 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 6' ' ' ASP . . . . . 0.42 ' HA ' ' HB2' ' E' ' 69' ' ' GLN . 56.2 t0 -70.26 146.16 50.84 Favored 'General case' 0 N--CA 1.423 -1.818 1 C-N-CA 132.937 4.495 . . . . 0.45000000000000001 112.054 -178.763 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . 0.498 ' HZ3' HH21 ' E' ' 39' ' ' ARG . 70.3 mmtt -82.48 76.53 9.34 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 125.315 1.446 . . . . 2.54 108.743 171.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 28.8 m -87.6 144.97 8.15 Favored 'Isoleucine or valine' 0 C--N 1.371 1.532 0 O-C-N 119.815 -1.803 . . . . 1.03 107.312 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -109.99 117.12 32.94 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 114.754 1.39 . . . . 0.17000000000000001 114.754 -169.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 14.2 mm -63.96 126.03 21.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.834 0 C-N-CA 128.508 2.723 . . . . 1.03 118.012 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.87 39.38 3.53 Favored 'General case' 0 C--N 1.365 1.281 0 N-CA-C 115.945 1.831 . . . . 0.29999999999999999 115.945 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -108.47 147.57 31.47 Favored 'General case' 0 C--N 1.368 1.371 0 O-C-N 118.942 -2.349 . . . . 2.7599999999999998 110.685 174.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 13.3 t -105.14 24.17 12.46 Favored 'General case' 0 C--N 1.364 1.231 0 C-N-CA 125.314 1.446 . . . . 0.46999999999999997 112.347 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -90.83 11.51 22.28 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 127.763 2.425 . . . . 1.8899999999999999 112.832 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 3.3 t -169.12 -173.66 1.82 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.012 1.325 . . . . 1.3999999999999999 107.657 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -92.77 21.12 5.82 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 130.001 3.321 . . . . 1.1599999999999999 112.266 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -111.51 6.96 20.5 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 127.99 2.516 . . . . 0.94999999999999996 110.012 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -64.1 101.46 0.4 Allowed 'General case' 0 C--N 1.367 1.363 0 C-N-CA 127.988 2.515 . . . . 0.95999999999999996 114.911 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.77 40.36 4.69 Favored Glycine 0 C--N 1.359 1.809 0 C-N-CA 125.758 1.647 . . . . 0.39000000000000001 111.368 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -132.93 146.18 51.56 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 123.399 1.571 . . . . 1.3999999999999999 113.254 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.32 147.8 4.98 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 C-N-CA 130.211 3.404 . . . . 1.03 112.019 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.96 -179.21 34.6 Favored Glycine 0 CA--C 1.478 -2.225 0 N-CA-C 107.995 -2.042 . . . . 0.27000000000000002 107.995 173.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 23' ' ' THR . . . . . 0.628 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 30.1 m -88.93 129.12 35.68 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 124.861 1.264 . . . . 1.1000000000000001 109.711 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.64 92.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 124.795 2.236 . . . . 1.1100000000000001 113.624 174.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.55 23.55 2.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.824 2.05 . . . . 1.0600000000000001 113.236 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 28.6 t -64.82 -66.09 0.59 Allowed 'General case' 0 C--N 1.364 1.211 1 C-N-CA 131.85 4.06 . . . . 0.87 115.315 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -85.44 53.88 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.745 0 CA-C-O 124.017 1.865 . . . . 0.60999999999999999 113.054 -166.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.81 -67.09 0.05 OUTLIER 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 127.377 2.271 . . . . 1.6100000000000001 107.422 -171.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -104.28 -9.17 18.77 Favored 'General case' 0 C--N 1.363 1.181 0 N-CA-C 115.083 1.512 . . . . 4.3200000000000003 115.083 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.23 24.51 1.85 Allowed 'General case' 0 C--N 1.363 1.17 0 N-CA-C 115.532 1.679 . . . . 4.7999999999999998 115.532 -176.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.77 46.71 0.16 Allowed Glycine 0 C--N 1.364 2.124 0 C-N-CA 130.05 3.691 . . . . 2.21 115.806 168.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -130.94 -159.33 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.672 1 C-N-CA 132.995 4.518 . . . . 1.6399999999999999 107.418 -176.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 39.7 tp -69.24 -34.37 74.7 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 130.411 3.484 . . . . 0.64000000000000001 117.821 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -106.45 146.44 33.01 Favored Pre-proline 0 C--N 1.358 0.953 0 C-N-CA 125.092 1.357 . . . . 1.52 109.211 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.52 -43.66 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.624 2.883 . . . . 0.67000000000000004 114.597 -170.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 60.9 t -109.43 128.02 65.74 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 115.305 1.594 . . . . 1.1599999999999999 115.305 -170.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 19.0 mt -109.09 142.22 22.23 Favored 'Isoleucine or valine' 0 C--N 1.36 1.054 0 N-CA-C 103.7 -2.704 . . . . 1.28 103.7 162.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 17.8 t -134.8 159.22 41.72 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 N-CA-C 107.308 -1.367 . . . . 1.04 107.308 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 39' ' ' ARG . . . . . 0.628 ' HB3' ' H ' ' E' ' 23' ' ' THR . 41.1 ttp85 -83.82 147.48 27.54 Favored 'General case' 0 C--N 1.354 0.766 1 C-N-CA 131.854 4.062 . . . . 3.1400000000000001 111.914 172.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -133.68 128.13 34.36 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 125.07 1.348 . . . . 1.26 108.218 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.24 -16.95 30.04 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 128.445 2.698 . . . . 1.8100000000000001 112.299 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -99.03 61.6 1.26 Allowed 'General case' 0 C--N 1.356 0.863 1 C-N-CA 132.119 4.168 . . . . 1.29 110.765 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 p -95.96 128.61 47.0 Favored 'Isoleucine or valine' 0 C--N 1.361 1.106 0 C-N-CA 129.13 2.972 . . . . 1.7 104.153 169.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -79.16 45.42 0.64 Allowed 'General case' 0 C--N 1.356 0.864 0 O-C-N 117.47 -3.269 . . . . 2.1800000000000002 115.759 -169.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 9.85 -18.6 0.0 OUTLIER 'General case' 0 C--N 1.367 1.327 2 C-N-CA 140.943 7.697 . . . . 2.6899999999999999 121.881 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -76.28 40.79 0.22 Allowed 'General case' 0 C--N 1.346 0.422 0 C-N-CA 131.365 3.866 . . . . 4.6200000000000001 115.35 -173.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.99 -10.25 83.18 Favored Glycine 0 C--N 1.359 1.831 0 C-N-CA 127.992 2.71 . . . . 5.3300000000000001 113.93 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -106.95 1.36 24.45 Favored 'General case' 0 C--N 1.361 1.109 0 CA-C-O 124.256 1.979 . . . . 5.2699999999999996 110.645 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 20.0 m -106.23 -56.26 2.21 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 128.72 2.808 . . . . 7.5999999999999996 110.093 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.66 -76.71 0.03 OUTLIER Glycine 0 C--N 1.357 1.704 0 O-C-N 120.999 -1.063 . . . . 6.8700000000000001 113.122 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 21.2 t -131.89 130.25 41.39 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 124.982 1.313 . . . . 7.5099999999999998 111.058 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.45 -2.53 51.69 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 125.882 1.673 . . . . 5.5599999999999996 111.534 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 53' ' ' SER . . . . . . . . . . . . 0.277 13.8 m 41.95 -25.8 0.0 OUTLIER 'General case' 0 C--N 1.359 1.017 1 C-N-CA 137.76 6.424 . . . . 4.4299999999999997 121.084 177.127 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.94 -154.46 11.71 Favored Glycine 0 CA--C 1.501 -0.799 0 C-N-CA 130.214 3.769 . . . . 3.3900000000000001 108.025 171.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 13.9 p -155.66 -175.61 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 N-CA-C 106.529 -1.656 . . . . 1.79 106.529 -176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.26 -29.84 11.85 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 128.103 2.561 . . . . 2.6800000000000002 111.442 176.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 22.9 p -126.29 134.78 51.05 Favored 'General case' 0 C--N 1.362 1.128 0 O-C-N 119.927 -1.733 . . . . 1.1399999999999999 110.164 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -162.06 161.58 28.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.871 1.668 . . . . 1.9399999999999999 107.194 175.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -97.1 154.45 17.33 Favored 'General case' 0 C--N 1.361 1.101 0 CA-C-O 124.032 1.872 . . . . 2.2200000000000002 113.897 -176.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -135.94 169.55 17.41 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 112.481 -2.145 . . . . 0.23999999999999999 113.489 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -109.46 108.58 19.14 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 111.064 -2.789 . . . . 1.01 107.788 172.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -25.66 -17.94 0.0 OUTLIER 'General case' 0 C--N 1.367 1.341 2 C-N-CA 134.395 5.078 . . . . 1.72 122.0 176.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -65.99 -32.41 73.88 Favored 'General case' 0 C--N 1.371 1.502 0 C-N-CA 130.97 3.708 . . . . 0.20000000000000001 110.937 166.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -84.85 -11.76 54.99 Favored 'General case' 0 C--N 1.364 1.217 0 O-C-N 120.742 -1.224 . . . . 1.1799999999999999 110.705 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.81 108.57 20.14 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 115.708 1.744 . . . . 1.0900000000000001 115.708 -171.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -96.43 133.17 41.19 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 125.596 1.558 . . . . 2.0499999999999998 108.772 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . 0.297 2.4 pt? -87.36 153.09 21.73 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-N 123.1 2.682 . . . . 0.28999999999999998 117.017 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 t -125.44 -27.42 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.121 0 C-N-CA 126.088 1.755 . . . . 1.1799999999999999 110.782 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 69' ' ' GLN . . . . . 0.42 ' HB2' ' HA ' ' E' ' 6' ' ' ASP . 2.5 mm-40 -113.85 160.98 18.15 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 127.018 3.294 . . . . 2.1899999999999999 114.786 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.73 56.36 0.7 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 108.886 -3.779 . . . . 0.0 111.651 173.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.71 58.78 1.89 Allowed 'General case' 0 C--N 1.365 1.253 0 O-C-N 120.205 -1.56 . . . . 0.0 114.553 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.95 91.93 7.13 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 128.753 2.821 . . . . 0.0 112.308 -176.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 75.7 mttt . . . . . 0 C--O 1.262 1.738 0 CA-C-O 117.624 -1.179 . . . . 0.0 109.104 174.463 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.996 0 N-CA-C 108.306 -0.998 . . . . 2.6400000000000001 108.306 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 2' ' ' LEU . . . . . 0.402 ' HB2' ' H ' ' E' ' 3' ' ' ASN . 0.0 OUTLIER -99.69 -154.86 0.48 Allowed 'General case' 0 C--N 1.351 0.647 0 N-CA-C 117.998 2.592 . . . . 1.54 117.998 -175.66 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . 0.402 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 1.0 OUTLIER -135.61 178.49 7.0 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 129.11 2.964 . . . . 1.0 110.127 -175.66 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . 0.443 ' CZ ' ' H ' ' E' ' 4' ' ' ARG . 0.0 OUTLIER -94.65 104.98 16.91 Favored 'General case' 0 C--N 1.376 1.753 0 C-N-CA 128.699 2.8 . . . . 3.9399999999999999 114.423 173.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 5' ' ' GLY . . . . . 0.517 ' H ' ' CG1' ' E' ' 24' ' ' VAL . . . 113.34 -3.34 25.13 Favored Glycine 0 CA--C 1.485 -1.799 0 O-C-N 118.079 -2.888 . . . . 0.75 110.175 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 6' ' ' ASP . . . . . 0.514 ' HA ' ' HB2' ' E' ' 69' ' ' GLN . 43.5 t0 -68.4 127.79 34.25 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 130.292 3.437 . . . . 0.45000000000000001 110.381 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . 0.702 ' HZ3' HH21 ' E' ' 39' ' ' ARG . 60.7 mttm -82.56 80.17 8.78 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 106.711 -1.588 . . . . 2.54 106.711 174.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 8' ' ' VAL . . . . . 0.403 ' H ' HG21 ' E' ' 8' ' ' VAL . 12.7 m -84.51 142.32 13.49 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 O-C-N 121.665 -0.647 . . . . 1.03 109.951 -173.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -108.02 129.28 55.14 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 118.322 -0.847 . . . . 0.17000000000000001 111.838 -172.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 3.7 mm -74.01 118.53 19.69 Favored 'Isoleucine or valine' 0 C--N 1.365 1.272 0 N-CA-C 115.141 1.534 . . . . 1.03 115.141 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -107.59 36.89 2.57 Favored 'General case' 0 C--N 1.373 1.621 0 O-C-N 119.574 -1.954 . . . . 0.29999999999999999 114.072 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -102.52 99.26 9.27 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 129.853 3.261 . . . . 2.7599999999999998 112.663 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 13' ' ' THR . . . . . 0.555 ' HA ' ' CG ' ' E' ' 18' ' ' TYR . 4.1 m -58.58 -34.37 71.0 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 129.081 2.953 . . . . 0.46999999999999997 117.912 -175.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.72 44.01 0.21 Allowed 'General case' 0 C--N 1.346 0.442 0 C-N-CA 129.199 2.999 . . . . 1.8899999999999999 115.003 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 17.1 t -172.2 175.1 3.8 Favored 'General case' 0 C--N 1.365 1.257 0 C-N-CA 125.343 1.457 . . . . 1.3999999999999999 107.4 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -92.19 7.13 43.99 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 129.975 3.31 . . . . 1.1599999999999999 111.124 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 38.5 m0 -106.32 10.51 31.63 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 127.247 2.219 . . . . 0.94999999999999996 109.478 178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 18' ' ' TYR . . . . . 0.555 ' CG ' ' HA ' ' E' ' 13' ' ' THR . 18.5 t80 -69.79 101.68 1.76 Allowed 'General case' 0 C--N 1.374 1.635 0 C-N-CA 126.333 1.853 . . . . 0.95999999999999996 113.276 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.18 39.69 6.34 Favored Glycine 0 C--N 1.356 1.667 0 C-N-CA 125.359 1.457 . . . . 0.39000000000000001 111.898 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -109.86 135.7 50.32 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 119.043 1.421 . . . . 1.3999999999999999 109.065 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -97.17 164.82 2.18 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 125.579 1.552 . . . . 1.03 110.582 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.19 177.67 47.08 Favored Glycine 0 CA--C 1.47 -2.772 0 N-CA-C 107.056 -2.418 . . . . 0.27000000000000002 107.056 170.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 23' ' ' THR . . . . . 0.449 ' H ' ' CB ' ' E' ' 39' ' ' ARG . 6.9 m -86.77 130.47 34.46 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 125.348 2.499 . . . . 1.1000000000000001 110.801 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 24' ' ' VAL . . . . . 0.517 ' CG1' ' H ' ' E' ' 5' ' ' GLY . 11.8 p -62.32 73.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 131.176 3.79 . . . . 1.1100000000000001 116.062 174.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.96 25.65 0.36 Allowed 'General case' 0 CA--C 1.551 1.012 0 O-C-N 116.475 -3.891 . . . . 1.0600000000000001 114.131 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . 0.271 1.5 m -73.86 -25.65 60.16 Favored 'General case' 0 CA--C 1.5 -0.964 1 C-N-CA 136.376 5.87 . . . . 0.87 117.155 175.488 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -114.27 49.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 124.778 1.231 . . . . 0.60999999999999999 109.083 -171.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.34 -56.93 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 124.024 0.93 . . . . 1.6100000000000001 108.905 -169.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -109.43 8.86 25.51 Favored 'General case' 0 C--N 1.36 1.049 0 C-N-CA 126.357 1.863 . . . . 4.3200000000000003 111.799 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 4.9 m -27.22 -41.12 0.01 OUTLIER 'General case' 0 C--N 1.361 1.08 1 C-N-CA 135.909 5.684 . . . . 4.7999999999999998 121.05 -175.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.35 42.27 0.13 Allowed Glycine 0 C--N 1.348 1.244 1 C-N-CA 131.845 4.545 . . . . 2.21 118.172 -171.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.78 -167.24 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.457 0 C-N-CA 125.04 1.336 . . . . 1.6399999999999999 110.292 176.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 38.0 tp -65.34 -33.89 77.03 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 129.629 3.172 . . . . 0.64000000000000001 116.86 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -135.12 132.82 20.37 Favored Pre-proline 0 N--CA 1.469 0.499 0 N-CA-C 101.501 -3.518 . . . . 1.52 101.501 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.02 -46.63 1.44 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.779 2.986 . . . . 0.67000000000000004 116.573 -160.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 54.3 t -80.83 103.02 7.24 Favored 'Isoleucine or valine' 0 C--N 1.368 1.372 0 N-CA-C 114.417 1.266 . . . . 1.1599999999999999 114.417 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 20.5 mt -89.82 118.72 35.65 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 N-CA-C 106.05 -1.833 . . . . 1.28 106.05 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 37.7 t -109.7 145.56 16.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 O-C-N 119.685 -1.884 . . . . 1.04 109.646 176.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 39' ' ' ARG . . . . . 0.702 HH21 ' HZ3' ' E' ' 7' ' ' LYS . 8.1 tmm_? -42.85 -32.65 0.65 Allowed 'General case' 0 C--N 1.359 0.994 2 C-N-CA 134.467 5.107 . . . . 3.1400000000000001 123.564 -177.243 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.22 129.44 34.5 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 120.794 3.627 . . . . 1.26 120.794 -162.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -88.53 38.02 0.85 Allowed 'General case' 0 C--N 1.356 0.875 0 C-N-CA 128.934 2.894 . . . . 1.8100000000000001 113.324 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -96.08 36.13 1.35 Allowed 'General case' 0 C--N 1.348 0.535 1 C-N-CA 131.97 4.108 . . . . 1.29 110.428 -176.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . 0.263 10.9 m -88.55 -162.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 127.725 2.41 . . . . 1.7 110.978 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.52 83.57 1.91 Allowed 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 119.361 -2.087 . . . . 2.1800000000000002 112.49 -176.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -40.28 17.16 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.563 2 C-N-CA 136.664 5.985 . . . . 2.6899999999999999 121.853 -176.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -102.9 75.36 1.39 Allowed 'General case' 0 C--N 1.359 0.984 0 C-N-CA 127.125 2.17 . . . . 4.6200000000000001 105.975 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.11 -8.15 61.1 Favored Glycine 0 C--N 1.357 1.711 0 N-CA-C 119.979 2.751 . . . . 5.3300000000000001 119.979 -173.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -95.19 -9.35 33.62 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 126.671 1.988 . . . . 5.2699999999999996 115.796 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 17.8 t -101.31 -12.2 18.85 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 128.208 2.603 . . . . 7.5999999999999996 111.507 175.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 159.96 125.55 0.8 Allowed Glycine 0 C--N 1.353 1.476 0 N-CA-C 106.295 -2.722 . . . . 6.8700000000000001 106.295 -175.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 2.8 m -68.39 63.57 0.1 Allowed 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 119.729 3.233 . . . . 7.5099999999999998 119.729 -173.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -101.28 0.68 37.75 Favored 'General case' 0 C--N 1.372 1.562 0 C-N-CA 127.353 2.261 . . . . 5.5599999999999996 116.157 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 8.0 p -84.75 -34.86 22.76 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 127.603 2.361 . . . . 4.4299999999999997 115.678 -175.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -102.66 9.89 55.74 Favored Glycine 0 C--N 1.354 1.54 0 C-N-CA 126.547 2.022 . . . . 3.3900000000000001 112.797 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 p -128.11 75.46 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.383 0 N-CA-C 103.788 -2.671 . . . . 1.79 103.788 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -93.79 -11.34 31.51 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 130.061 3.344 . . . . 2.6800000000000002 112.491 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 16.1 p -114.78 125.3 53.54 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 101.388 -3.56 . . . . 1.1399999999999999 101.388 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -122.8 133.48 54.45 Favored 'General case' 0 C--N 1.358 0.939 0 O-C-N 120.098 -1.626 . . . . 1.9399999999999999 113.131 -168.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -88.13 112.5 22.76 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 129.294 3.038 . . . . 2.2200000000000002 115.7 -174.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -115.46 173.5 6.49 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 115.47 1.655 . . . . 0.23999999999999999 115.47 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.53 85.85 4.65 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 129.503 3.121 . . . . 1.01 110.755 172.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -15.91 -23.4 0.0 OUTLIER 'General case' 0 C--N 1.36 1.043 1 C-N-CA 138.108 6.563 . . . . 1.72 121.331 172.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.07 -37.26 69.66 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 130.366 3.466 . . . . 0.20000000000000001 113.831 171.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . 0.275 2.0 pp20? -97.46 16.03 21.43 Favored 'General case' 0 C--N 1.373 1.624 0 C-N-CA 126.35 1.86 . . . . 1.1799999999999999 111.331 -177.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.96 104.58 12.55 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 128.427 2.691 . . . . 1.0900000000000001 108.206 172.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -94.53 150.48 20.2 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 125.867 1.667 . . . . 2.0499999999999998 111.15 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -74.47 142.04 44.9 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 117.851 2.537 . . . . 0.28999999999999998 117.851 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 3.4 t -135.6 -27.9 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.072 0 C-N-CA 126.206 1.802 . . . . 1.1799999999999999 110.499 171.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 69' ' ' GLN . . . . . 0.514 ' HB2' ' HA ' ' E' ' 6' ' ' ASP 0.342 19.8 mt-30 -118.59 113.58 21.47 Favored 'General case' 0 C--N 1.361 1.075 0 CA-C-O 123.489 1.614 . . . . 2.1899999999999999 113.613 174.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.86 56.96 0.99 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 127.804 2.442 . . . . 0.0 111.523 169.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.02 58.2 0.22 Allowed 'General case' 0 C--N 1.355 0.834 0 C-N-CA 128.365 2.666 . . . . 0.0 117.796 -169.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.06 73.02 0.89 Allowed 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt . . . . . 0 C--O 1.262 1.746 0 C-N-CA 127.661 2.384 . . . . 0.0 111.704 177.969 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.956 0 N-CA-C 109.102 -0.703 . . . . 2.6400000000000001 109.102 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 2' ' ' LEU . . . . . . . . . . . . 0.328 1.8 pp -101.85 -154.87 0.5 Allowed 'General case' 0 C--N 1.356 0.867 0 N-CA-C 115.969 1.841 . . . . 1.54 115.969 -174.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -144.36 176.08 9.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 129.773 3.229 . . . . 1.0 111.223 -171.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.59 102.7 14.52 Favored 'General case' 0 C--N 1.37 1.462 0 O-C-N 119.51 -1.994 . . . . 3.9399999999999999 112.165 174.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.47 4.58 11.9 Favored Glycine 0 C--N 1.363 2.059 0 CA-C-O 124.087 1.937 . . . . 0.75 112.241 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 6' ' ' ASP . . . . . 0.482 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 65.3 t0 -74.89 136.81 41.46 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 130.446 3.498 . . . . 0.45000000000000001 109.508 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -91.75 79.1 5.4 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 104.96 -2.237 . . . . 2.54 104.96 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 13.4 m -86.32 143.18 11.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 106.336 -1.727 . . . . 1.03 106.336 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' E' ' 21' ' ' VAL . 23.4 ttt85 -104.16 117.74 34.97 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 113.495 0.924 . . . . 0.17000000000000001 113.495 -172.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 13.8 mm -56.66 111.66 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.376 0 N-CA-C 117.466 2.395 . . . . 1.03 117.466 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -115.35 47.63 1.29 Allowed 'General case' 0 C--N 1.368 1.408 0 C-N-CA 126.225 1.81 . . . . 0.29999999999999999 109.912 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -106.64 127.09 53.07 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 128.31 2.644 . . . . 2.7599999999999998 106.147 174.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 18.3 p -71.34 -58.67 3.31 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 129.74 3.216 . . . . 0.46999999999999997 113.496 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.11 67.43 2.41 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 130.944 3.698 . . . . 1.8899999999999999 110.04 174.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 27.8 t -163.43 159.9 22.79 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.344 -2.095 . . . . 1.3999999999999999 105.344 -172.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -92.49 -1.81 56.7 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 127.159 2.184 . . . . 1.1599999999999999 110.914 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 9.1 m0 -119.83 24.43 10.55 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 126.253 1.821 . . . . 0.94999999999999996 111.721 -172.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -68.98 101.17 1.33 Allowed 'General case' 0 C--N 1.371 1.507 0 C-N-CA 125.637 1.575 . . . . 0.95999999999999996 112.758 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.96 14.66 35.92 Favored Glycine 0 C--N 1.358 1.805 0 C-N-CA 125.035 1.302 . . . . 0.39000000000000001 112.192 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -113.06 154.03 27.2 Favored 'General case' 0 C--N 1.362 1.145 0 C-N-CA 125.316 1.446 . . . . 1.3999999999999999 109.782 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' E' ' 9' ' ' ARG . 1.4 p -92.02 -176.8 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.383 0 C-N-CA 127.525 2.33 . . . . 1.03 113.423 -175.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.24 176.72 46.42 Favored Glycine 0 CA--C 1.479 -2.159 0 N-CA-C 108.839 -1.704 . . . . 0.27000000000000002 108.839 166.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 23' ' ' THR . . . . . 0.442 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 29.0 m -101.89 120.73 40.85 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 124.516 1.127 . . . . 1.1000000000000001 109.99 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 7.1 p -75.29 88.02 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 123.292 1.52 . . . . 1.1100000000000001 113.272 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.6 43.95 1.15 Allowed 'General case' 0 C--N 1.353 0.75 0 C-N-CA 126.596 1.958 . . . . 1.0600000000000001 110.775 171.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 13.7 t -81.51 -73.27 0.39 Allowed 'General case' 0 CA--C 1.488 -1.429 1 C-N-CA 131.78 4.032 . . . . 0.87 113.753 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 p -82.1 54.11 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.571 0 CA-C-O 126.5 3.048 . . . . 0.60999999999999999 113.145 -160.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.57 -72.05 0.69 Allowed 'General case' 0 N--CA 1.418 -2.039 0 C-N-CA 130.663 3.585 . . . . 1.6100000000000001 103.053 175.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.34 -17.6 13.1 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 125.696 1.598 . . . . 4.3200000000000003 112.754 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 1.8 t -92.41 46.92 1.27 Allowed 'General case' 0 C--N 1.367 1.344 0 O-C-N 119.435 -2.041 . . . . 4.7999999999999998 114.375 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.14 51.09 4.51 Favored Glycine 0 C--N 1.341 0.809 1 C-N-CA 130.89 4.09 . . . . 2.21 111.537 162.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.84 -166.6 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.882 0 C-N-CA 130.045 3.338 . . . . 1.6399999999999999 108.695 -176.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 22.1 tp -61.37 -38.27 86.37 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 130.578 3.551 . . . . 0.64000000000000001 117.027 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -113.81 115.54 46.09 Favored Pre-proline 0 C--N 1.356 0.855 0 N-CA-C 101.521 -3.511 . . . . 1.52 101.521 172.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -82.12 -55.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.905 2.403 . . . . 0.67000000000000004 115.533 -169.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 24.9 t -75.21 95.69 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.019 0 N-CA-C 119.65 3.204 . . . . 1.1599999999999999 119.65 -166.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 68.1 mt -87.34 119.45 35.03 Favored 'Isoleucine or valine' 0 C--N 1.368 1.41 0 N-CA-C 104.97 -2.233 . . . . 1.28 104.97 172.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 14.0 t -123.21 163.61 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-N 120.186 1.357 . . . . 1.04 111.62 -172.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 39' ' ' ARG . . . . . 0.442 ' HB3' ' H ' ' E' ' 23' ' ' THR . 43.6 ttm-85 -84.43 142.09 30.35 Favored 'General case' 0 C--N 1.363 1.193 0 C-N-CA 128.859 2.864 . . . . 3.1400000000000001 113.92 174.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -137.33 128.59 27.95 Favored 'General case' 0 CA--C 1.514 -0.437 0 O-C-N 121.301 -0.874 . . . . 1.26 111.474 173.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -90.27 -38.44 13.41 Favored 'General case' 0 C--N 1.366 1.325 0 C-N-CA 126.356 1.862 . . . . 1.8100000000000001 111.38 172.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -77.97 59.59 2.18 Favored 'General case' 0 C--N 1.37 1.468 0 C-N-CA 129.459 3.104 . . . . 1.29 112.767 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.85 158.78 3.01 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 127.125 2.17 . . . . 1.7 105.538 172.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -80.11 -31.0 39.18 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 127.307 2.243 . . . . 2.1800000000000002 113.187 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 64.74 44.6 3.7 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 117.371 2.359 . . . . 2.6899999999999999 117.371 174.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -98.01 52.7 1.06 Allowed 'General case' 0 C--N 1.365 1.241 0 C-N-CA 125.237 1.415 . . . . 4.6200000000000001 110.283 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.67 70.59 3.15 Favored Glycine 0 C--N 1.363 2.06 0 O-C-N 120.489 -1.382 . . . . 5.3300000000000001 116.198 -170.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -92.72 -172.12 2.94 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 127.161 2.184 . . . . 5.2699999999999996 109.906 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 8.2 t -39.65 16.59 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.353 2 C-N-CA 133.777 4.831 . . . . 7.5999999999999996 122.318 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . -146.58 -74.65 0.02 OUTLIER Glycine 0 C--N 1.34 0.76 0 C-N-CA 129.143 3.259 . . . . 6.8700000000000001 109.041 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 5.8 t -162.29 -174.5 4.09 Favored 'General case' 0 C--N 1.358 0.936 0 O-C-N 121.006 -1.291 . . . . 7.5099999999999998 108.83 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.9 -12.0 59.94 Favored 'General case' 0 C--N 1.366 1.318 1 C-N-CA 131.87 4.068 . . . . 5.5599999999999996 117.167 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 53' ' ' SER . . . . . . . . . . . . 0.295 5.4 t 75.31 -24.28 0.22 Allowed 'General case' 0 C--N 1.358 0.96 0 C-N-CA 129.091 2.957 . . . . 4.4299999999999997 116.76 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -110.92 -174.68 20.21 Favored Glycine 0 C--N 1.35 1.353 0 C-N-CA 125.478 1.513 . . . . 3.3900000000000001 111.026 167.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.09 149.38 20.48 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 C-N-CA 125.523 1.529 . . . . 1.79 108.697 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -101.97 -44.66 5.42 Favored 'General case' 0 C--N 1.365 1.25 0 C-N-CA 128.493 2.717 . . . . 2.6800000000000002 110.48 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 67.9 p -115.97 104.5 11.65 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 127.97 2.508 . . . . 1.1399999999999999 106.472 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -110.29 138.88 46.07 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 107.5 -1.296 . . . . 1.9399999999999999 107.5 -176.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -100.01 112.01 24.31 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-O 122.222 1.01 . . . . 2.2200000000000002 109.868 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -104.16 172.7 6.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 123.909 1.814 . . . . 0.23999999999999999 115.274 -175.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -102.42 94.13 5.52 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 112.218 -2.265 . . . . 1.01 109.24 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -7.43 -37.79 0.0 OUTLIER 'General case' 0 C--N 1.367 1.351 1 C-N-CA 134.778 5.231 . . . . 1.72 121.21 172.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -45.61 -46.53 14.45 Favored 'General case' 0 C--N 1.364 1.212 1 C-N-CA 132.715 4.406 . . . . 0.20000000000000001 113.1 168.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -89.86 1.61 55.98 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 125.822 1.649 . . . . 1.1799999999999999 112.168 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.96 108.53 16.37 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 126.664 1.986 . . . . 1.0900000000000001 114.126 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -106.44 143.0 35.18 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 125.721 1.608 . . . . 2.0499999999999998 111.907 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -64.62 146.34 54.81 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 119.988 3.329 . . . . 0.28999999999999998 119.988 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -144.47 -29.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.372 1.585 0 C-N-CA 126.91 2.084 . . . . 1.1799999999999999 112.028 173.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 69' ' ' GLN . . . . . 0.482 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 0.0 OUTLIER -114.51 116.47 28.88 Favored 'General case' 0 C--N 1.358 0.937 0 O-C-N 119.554 -1.966 . . . . 2.1899999999999999 111.849 177.574 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.33 59.57 1.05 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.254 2.622 . . . . 0.0 113.125 174.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.47 58.46 2.66 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 129.021 2.928 . . . . 0.0 113.51 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.0 78.66 1.18 Allowed 'General case' 0 C--N 1.356 0.879 0 C-N-CA 128.189 2.596 . . . . 0.0 115.32 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt . . . . . 0 C--O 1.262 1.716 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 176.124 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 2.432 0 N-CA-C 108.684 -0.858 . . . . 2.6400000000000001 108.684 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 2' ' ' LEU . . . . . . . . . . . . 0.271 0.0 OUTLIER -95.59 -165.8 1.35 Allowed 'General case' 0 C--N 1.358 0.961 0 N-CA-C 118.11 2.633 . . . . 1.54 118.11 -175.171 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -136.3 -169.26 2.4 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 127.438 2.295 . . . . 1.0 111.321 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -96.44 110.27 22.66 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 127.568 2.347 . . . . 3.9399999999999999 114.528 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.25 -0.28 14.43 Favored Glycine 0 CA--C 1.477 -2.295 0 O-C-N 121.025 -1.047 . . . . 0.75 111.998 165.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 6' ' ' ASP . . . . . 0.481 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 46.1 t0 -72.83 137.51 45.78 Favored 'General case' 0 N--CA 1.408 -2.555 1 C-N-CA 133.153 4.581 . . . . 0.45000000000000001 113.469 -176.233 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . 0.49 ' H ' ' CB ' ' E' ' 69' ' ' GLN . 13.7 mptt -87.87 77.37 8.54 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 106.485 -1.672 . . . . 2.54 106.485 171.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 15.0 m -87.42 138.93 18.14 Favored 'Isoleucine or valine' 0 C--N 1.369 1.438 0 C-N-CA 127.168 2.187 . . . . 1.03 106.224 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -105.35 113.93 27.81 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 120.77 -1.206 . . . . 0.17000000000000001 112.55 -171.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mm -52.89 120.89 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 N-CA-C 117.727 2.491 . . . . 1.03 117.727 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -121.06 48.48 1.64 Allowed 'General case' 0 C--N 1.372 1.563 0 C-N-CA 125.519 1.528 . . . . 0.29999999999999999 113.606 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 12' ' ' ARG . . . . . 0.509 ' CZ ' ' HG ' ' E' ' 15' ' ' SER . 13.7 ttt180 -102.25 111.73 24.14 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 128.237 2.615 . . . . 2.7599999999999998 110.075 177.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 47.0 p -50.74 -59.13 4.41 Favored 'General case' 0 C--N 1.369 1.454 0 C-N-CA 131.279 3.831 . . . . 0.46999999999999997 119.742 -175.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -87.77 65.55 8.45 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 127.927 2.491 . . . . 1.8899999999999999 110.736 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 15' ' ' SER . . . . . 0.509 ' HG ' ' CZ ' ' E' ' 12' ' ' ARG . 4.5 t -145.15 169.2 18.63 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-O 123.392 1.568 . . . . 1.3999999999999999 111.287 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -95.67 -1.49 50.0 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 124.996 1.318 . . . . 1.1599999999999999 109.561 166.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 17' ' ' TRP . . . . . 0.455 ' CZ2' ' HA3' ' E' ' 54' ' ' GLY . 20.9 m0 -118.13 23.67 11.47 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 126.347 1.859 . . . . 0.94999999999999996 110.898 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -75.03 94.92 2.94 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 125.817 1.647 . . . . 0.95999999999999996 112.193 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.95 34.24 4.38 Favored Glycine 0 C--N 1.359 1.809 0 C-N-CA 126.077 1.799 . . . . 0.39000000000000001 110.16 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -110.66 152.16 26.84 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 126.829 2.052 . . . . 1.3999999999999999 108.537 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.06 170.26 3.59 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 CA-C-N 120.216 1.371 . . . . 1.03 108.456 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.98 176.49 44.24 Favored Glycine 0 CA--C 1.474 -2.5 0 O-C-N 120.079 -1.638 . . . . 0.27000000000000002 109.255 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 23' ' ' THR . . . . . 0.437 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 15.1 m -94.63 120.14 34.4 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 125.617 1.567 . . . . 1.1000000000000001 110.478 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 6.9 p -76.66 101.84 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 124.395 2.045 . . . . 1.1100000000000001 112.69 173.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.89 46.1 1.3 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.167 1.387 . . . . 1.0600000000000001 114.232 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 62.0 p -73.18 -86.3 0.03 OUTLIER 'General case' 0 C--N 1.354 0.794 0 C-N-CA 130.203 3.401 . . . . 0.87 114.863 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 27' ' ' VAL . . . . . 0.443 ' H ' HG11 ' E' ' 27' ' ' VAL . 2.4 p -79.54 59.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.616 0 CA-C-O 126.519 3.057 . . . . 0.60999999999999999 112.905 -169.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -160.62 -62.79 0.06 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.732 3.213 . . . . 1.6100000000000001 107.233 -173.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.56 -18.19 16.73 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 127.202 2.201 . . . . 4.3200000000000003 115.802 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -26.82 0.3 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.039 2 C-N-CA 134.866 5.266 . . . . 4.7999999999999998 123.404 -172.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.54 43.54 1.86 Allowed Glycine 0 C--O 1.224 -0.496 1 C-N-CA 131.991 4.615 . . . . 2.21 114.939 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 32' ' ' ILE . . . . . 0.472 HG21 ' H ' ' E' ' 33' ' ' LEU . 1.1 mt -131.77 -169.68 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 127.984 2.514 . . . . 1.6399999999999999 105.853 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 33' ' ' LEU . . . . . 0.472 ' H ' HG21 ' E' ' 32' ' ' ILE . 32.2 tp -68.51 -44.49 74.53 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 117.287 2.328 . . . . 0.64000000000000001 117.287 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -123.02 157.9 59.14 Favored Pre-proline 0 C--N 1.356 0.887 0 N-CA-C 106.261 -1.755 . . . . 1.52 106.261 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.68 -46.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.365 1.427 0 C-N-CA 123.439 2.759 . . . . 0.67000000000000004 115.568 -166.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 73.3 t -90.51 97.04 6.76 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 CA-C-O 122.688 1.232 . . . . 1.1599999999999999 112.445 -170.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 56.9 mt -86.66 105.08 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 C-N-CA 127.958 2.503 . . . . 1.28 104.34 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 21.1 t -105.38 156.21 6.38 Favored 'Isoleucine or valine' 0 C--N 1.349 0.547 0 CA-C-N 121.058 1.754 . . . . 1.04 111.546 -174.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 39' ' ' ARG . . . . . 0.437 ' HB3' ' H ' ' E' ' 23' ' ' THR . 17.5 tpp180 -81.8 131.83 35.27 Favored 'General case' 0 C--N 1.36 1.06 0 C-N-CA 127.785 2.434 . . . . 3.1400000000000001 110.983 172.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -128.91 150.46 50.35 Favored 'General case' 0 CA--C 1.512 -0.489 0 O-C-N 121.743 -0.598 . . . . 1.26 110.648 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -96.16 -48.42 5.65 Favored 'General case' 0 C--N 1.36 1.045 0 C-N-CA 126.0 1.72 . . . . 1.8100000000000001 109.81 173.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 86.4 mtm-85 -82.82 85.55 7.07 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 125.893 1.677 . . . . 1.29 114.837 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 14.4 t -88.09 81.85 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.913 0 C-N-CA 127.111 2.164 . . . . 1.7 112.324 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . 0.429 0.0 OUTLIER 47.04 74.36 0.16 Allowed 'General case' 0 C--N 1.355 0.84 0 C-N-CA 131.626 3.971 . . . . 2.1800000000000002 120.743 175.608 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -98.71 -60.54 1.52 Allowed 'General case' 0 C--N 1.345 0.379 0 C-N-CA 124.347 1.059 . . . . 2.6899999999999999 110.37 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -101.36 151.99 21.25 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 125.821 1.648 . . . . 4.6200000000000001 107.959 173.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.45 159.89 19.16 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 110.747 -0.941 . . . . 5.3300000000000001 110.747 168.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -133.48 -169.96 2.39 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 128.714 2.806 . . . . 5.2699999999999996 107.643 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 5.2 t -54.59 -7.34 0.15 Allowed 'General case' 0 C--N 1.36 1.022 0 C-N-CA 131.21 3.804 . . . . 7.5999999999999996 120.577 -174.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.17 43.62 0.52 Allowed Glycine 0 CA--C 1.49 -1.494 0 N-CA-C 105.754 -2.938 . . . . 6.8700000000000001 105.754 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 24.0 p 80.6 -169.22 0.03 OUTLIER 'General case' 0 C--N 1.362 1.147 0 C-N-CA 129.038 2.935 . . . . 7.5099999999999998 114.364 -176.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.61 -14.42 32.46 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 125.887 1.675 . . . . 5.5599999999999996 112.544 173.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m 67.49 -29.2 0.15 Allowed 'General case' 0 C--N 1.358 0.976 0 N-CA-C 119.178 3.029 . . . . 4.4299999999999997 119.178 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 54' ' ' GLY . . . . . 0.455 ' HA3' ' CZ2' ' E' ' 17' ' ' TRP . . . -28.94 121.62 0.08 OUTLIER Glycine 0 C--N 1.355 1.588 2 C-N-CA 136.775 6.893 . . . . 3.3900000000000001 123.638 -174.506 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 48.8 t -153.15 167.86 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.634 1 N-CA-C 99.895 -4.113 . . . . 1.79 99.895 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -80.06 -43.63 21.51 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 127.647 2.379 . . . . 2.6800000000000002 112.634 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 7.2 p -126.15 121.39 32.68 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 128.723 2.809 . . . . 1.1399999999999999 104.764 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -150.32 144.45 25.53 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.695 0.798 . . . . 1.9399999999999999 109.561 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 59' ' ' ASN . . . . . 0.429 HD22 HD11 ' E' ' 32' ' ' ILE . 11.2 m120 -81.46 106.27 13.3 Favored 'General case' 0 C--N 1.352 0.677 0 C-N-CA 130.812 3.645 . . . . 2.2200000000000002 120.117 -174.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -109.67 175.84 5.29 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 119.282 -2.136 . . . . 0.23999999999999999 113.793 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -114.27 115.7 27.82 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 113.958 -1.474 . . . . 1.01 109.578 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -16.94 -38.13 0.0 OUTLIER 'General case' 0 C--N 1.367 1.351 1 C-N-CA 136.581 5.952 . . . . 1.72 118.496 173.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -49.84 -48.47 51.02 Favored 'General case' 0 C--N 1.37 1.492 0 C-N-CA 130.926 3.69 . . . . 0.20000000000000001 113.932 169.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 13.2 pm0 -95.32 17.44 14.41 Favored 'General case' 0 C--N 1.363 1.175 0 C-N-CA 124.202 1.001 . . . . 1.1799999999999999 112.16 -172.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.76 138.15 54.15 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 107.524 -1.288 . . . . 1.0900000000000001 107.524 173.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -110.39 126.28 54.11 Favored 'General case' 0 C--N 1.351 0.67 0 C-N-CA 124.501 1.12 . . . . 2.0499999999999998 111.717 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.14 139.56 58.15 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 128.301 2.64 . . . . 0.28999999999999998 117.695 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 t -135.26 -43.32 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.765 0 C-N-CA 126.35 1.86 . . . . 1.1799999999999999 109.691 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 69' ' ' GLN . . . . . 0.49 ' CB ' ' H ' ' E' ' 7' ' ' LYS . 1.6 tp60 -106.09 113.19 26.58 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 128.284 2.633 . . . . 2.1899999999999999 117.743 -168.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.76 68.1 6.88 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.958 171.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.31 53.39 0.07 Allowed 'General case' 0 C--N 1.373 1.594 0 N-CA-C 117.454 2.391 . . . . 0.0 117.454 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.05 130.96 35.42 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 126.92 2.088 . . . . 0.0 111.871 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 mptt . . . . . 0 C--O 1.262 1.729 0 C-N-CA 125.995 1.718 . . . . 0.0 110.356 179.019 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 108.752 -0.833 . . . . 2.6400000000000001 108.752 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.08 -164.19 0.78 Allowed 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.506 1.922 . . . . 1.54 115.637 177.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -140.56 -166.11 2.06 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 127.755 2.422 . . . . 1.0 109.417 -175.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -85.26 104.96 15.59 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 128.061 2.544 . . . . 3.9399999999999999 117.24 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 112.72 -9.5 25.75 Favored Glycine 0 CA--C 1.485 -1.84 0 O-C-N 119.409 -2.057 . . . . 0.75 110.904 173.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.13 42.13 0.07 Allowed 'General case' 0 N--CA 1.438 -1.066 1 C-N-CA 133.903 4.881 . . . . 0.45000000000000001 115.596 -176.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . 0.545 ' HZ3' ' HG1' ' E' ' 23' ' ' THR . 73.0 mmtt -5.74 93.21 0.01 OUTLIER 'General case' 0 C--N 1.362 1.15 1 C-N-CA 133.777 4.831 . . . . 2.54 117.058 -176.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 28.5 m -92.4 154.42 3.19 Favored 'Isoleucine or valine' 0 C--N 1.361 1.074 0 CA-C-N 121.149 1.795 . . . . 1.03 111.488 -172.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -103.17 109.0 20.42 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 121.446 -0.784 . . . . 0.17000000000000001 111.92 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . 0.612 ' CD1' ' H ' ' E' ' 10' ' ' ILE . 1.3 mp -56.96 103.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.213 0 C-N-CA 129.805 3.242 . . . . 1.03 114.494 174.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -120.48 52.36 1.16 Allowed 'General case' 0 C--N 1.37 1.493 0 C-N-CA 124.43 1.092 . . . . 0.29999999999999999 109.903 -172.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -72.17 -115.39 0.0 OUTLIER 'General case' 0 C--N 1.364 1.212 0 N-CA-C 118.792 2.886 . . . . 2.7599999999999998 118.792 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -170.71 142.58 2.01 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 101.719 -3.438 . . . . 0.46999999999999997 101.719 -174.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . 0.257 3.7 mm-40 -5.86 69.38 0.0 OUTLIER 'General case' 0 C--N 1.368 1.384 1 C-N-CA 134.343 5.057 . . . . 1.8899999999999999 119.316 -174.65 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 75.3 m -138.39 154.57 48.92 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 130.182 3.393 . . . . 1.3999999999999999 104.087 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -61.29 -11.17 8.67 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 130.127 3.371 . . . . 1.1599999999999999 117.151 -176.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 22.9 m0 -113.26 -3.5 13.85 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 128.882 2.873 . . . . 0.94999999999999996 113.371 -177.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -80.26 88.7 5.49 Favored 'General case' 0 C--N 1.373 1.602 0 C-N-CA 126.337 1.855 . . . . 0.95999999999999996 110.291 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.34 -11.71 3.01 Favored Glycine 0 C--N 1.36 1.903 0 C-N-CA 126.74 2.114 . . . . 0.39000000000000001 111.285 -175.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -97.75 162.59 13.19 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 119.66 1.73 . . . . 1.3999999999999999 114.924 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -103.12 169.79 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.208 0 C-N-CA 126.717 2.007 . . . . 1.03 108.444 172.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.99 -179.78 41.25 Favored Glycine 0 CA--C 1.476 -2.406 0 N-CA-C 108.491 -1.844 . . . . 0.27000000000000002 108.491 170.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 23' ' ' THR . . . . . 0.606 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 4.0 m -94.33 120.3 34.36 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 125.323 1.449 . . . . 1.1000000000000001 111.496 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 14.5 p -68.02 69.57 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 131.571 3.948 . . . . 1.1100000000000001 112.862 175.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.58 45.15 1.21 Allowed 'General case' 0 C--N 1.362 1.149 0 O-C-N 118.401 -2.687 . . . . 1.0600000000000001 110.095 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 13.2 m -87.96 -62.1 1.57 Allowed 'General case' 0 CA--C 1.465 -2.29 1 C-N-CA 135.959 5.704 . . . . 0.87 119.323 -171.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 m -80.23 19.14 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.093 0 N-CA-C 116.586 2.069 . . . . 0.60999999999999999 116.586 -156.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -111.28 -50.27 2.95 Favored 'General case' 0 N--CA 1.43 -1.473 1 C-N-CA 135.187 5.395 . . . . 1.6100000000000001 109.311 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -103.19 -12.4 17.36 Favored 'General case' 0 C--N 1.366 1.283 0 C-N-CA 128.232 2.613 . . . . 4.3200000000000003 113.194 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 8.4 t -43.53 -17.91 0.02 OUTLIER 'General case' 0 C--N 1.376 1.744 1 C-N-CA 132.084 4.153 . . . . 4.7999999999999998 117.97 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.53 45.46 0.27 Allowed Glycine 0 C--N 1.355 1.589 0 C-N-CA 130.221 3.772 . . . . 2.21 117.058 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.78 -159.36 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.913 0 C-N-CA 129.005 2.922 . . . . 1.6399999999999999 111.031 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 22.0 tp -69.31 -23.06 63.75 Favored 'General case' 0 C--N 1.355 0.839 1 C-N-CA 133.335 4.654 . . . . 0.64000000000000001 118.378 -177.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -134.55 152.72 78.32 Favored Pre-proline 0 C--N 1.362 1.131 0 N-CA-C 105.735 -1.95 . . . . 1.52 105.735 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.8 -45.74 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.9 3.067 . . . . 0.67000000000000004 117.65 -173.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 54.6 t -109.01 106.11 20.08 Favored 'Isoleucine or valine' 0 C--N 1.353 0.748 0 N-CA-C 115.296 1.591 . . . . 1.1599999999999999 115.296 -167.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mp -85.33 118.31 31.97 Favored 'Isoleucine or valine' 0 C--N 1.37 1.492 0 C-N-CA 125.977 1.711 . . . . 1.28 106.921 173.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 92.8 t -115.81 155.59 17.09 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 CA-C-O 122.128 0.966 . . . . 1.04 112.256 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 39' ' ' ARG . . . . . 0.606 ' HB3' ' H ' ' E' ' 23' ' ' THR . 1.9 tpm_? -75.47 139.55 42.32 Favored 'General case' 0 C--N 1.362 1.136 0 C-N-CA 130.118 3.367 . . . . 3.1400000000000001 112.932 173.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 40' ' ' PHE . . . . . 0.41 ' H ' ' NH2' ' E' ' 39' ' ' ARG . 60.9 m-85 -145.66 109.17 4.7 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 129.16 2.984 . . . . 1.26 107.915 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -104.71 -11.11 17.03 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 129.116 2.966 . . . . 1.8100000000000001 113.875 -176.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -94.16 9.7 36.84 Favored 'General case' 0 C--N 1.366 1.284 0 C-N-CA 126.503 1.921 . . . . 1.29 113.226 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.39 149.62 7.52 Favored 'Isoleucine or valine' 0 C--N 1.351 0.638 0 C-N-CA 128.16 2.584 . . . . 1.7 111.522 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -69.99 42.97 0.05 Allowed 'General case' 0 C--N 1.353 0.75 0 C-N-CA 131.582 3.953 . . . . 2.1800000000000002 115.748 -172.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -38.7 -42.4 0.8 Allowed 'General case' 0 C--N 1.359 0.998 1 C-N-CA 135.462 5.505 . . . . 2.6899999999999999 117.747 -175.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -101.26 135.22 43.1 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.079 -1.013 . . . . 4.6200000000000001 108.345 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.22 38.22 2.58 Favored Glycine 0 C--N 1.364 2.139 0 C-N-CA 127.143 2.306 . . . . 5.3300000000000001 114.734 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -135.1 21.4 3.47 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 128.27 2.628 . . . . 5.2699999999999996 107.463 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 76.2 p -102.45 -95.88 0.29 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 128.749 2.82 . . . . 7.5999999999999996 109.441 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . -125.33 -60.37 0.17 Allowed Glycine 0 C--N 1.35 1.345 0 C-N-CA 127.04 2.257 . . . . 6.8700000000000001 109.772 176.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 17.2 t -165.11 146.23 7.49 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 102.699 -3.075 . . . . 7.5099999999999998 102.699 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.91 31.72 1.05 Allowed 'General case' 0 C--N 1.36 1.034 0 CA-C-O 124.402 2.049 . . . . 5.5599999999999996 113.149 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 20.4 m -85.39 49.64 1.79 Allowed 'General case' 0 C--N 1.344 0.351 0 C-N-CA 131.121 3.768 . . . . 4.4299999999999997 113.292 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -115.63 165.4 12.16 Favored Glycine 0 C--N 1.353 1.48 0 C-N-CA 126.016 1.769 . . . . 3.3900000000000001 112.171 176.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 22.2 t -107.18 153.78 8.3 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 105.044 -2.206 . . . . 1.79 105.044 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -96.63 -76.55 0.51 Allowed 'General case' 0 C--N 1.355 0.82 0 O-C-N 120.31 -1.494 . . . . 2.6800000000000002 113.515 -173.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 71.4 p -109.43 108.02 18.38 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.139 1.376 . . . . 1.1399999999999999 108.653 176.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.83 146.99 36.69 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 125.828 1.651 . . . . 1.9399999999999999 109.548 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -89.27 113.93 25.24 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 129.812 3.245 . . . . 2.2200000000000002 111.226 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -107.0 174.39 5.91 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.95 1.7 . . . . 0.23999999999999999 113.66 -176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.7 89.38 3.67 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 130.195 3.398 . . . . 1.01 110.643 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -26.16 -18.39 0.0 OUTLIER 'General case' 0 C--N 1.354 0.797 1 C-N-CA 136.072 5.749 . . . . 1.72 120.39 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.89 -32.8 72.25 Favored 'General case' 0 C--N 1.367 1.335 0 C-N-CA 129.148 2.979 . . . . 0.20000000000000001 112.729 168.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.27 18.07 21.88 Favored 'General case' 0 C--N 1.371 1.516 0 C-N-CA 125.832 1.653 . . . . 1.1799999999999999 110.285 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 74.1 mt -128.18 118.81 24.03 Favored 'General case' 0 C--N 1.366 1.295 0 CA-C-O 123.526 1.631 . . . . 1.0900000000000001 111.934 177.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -111.18 134.5 52.73 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.863 1.665 . . . . 2.0499999999999998 109.145 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.65 133.76 36.22 Favored 'General case' 0 C--N 1.366 1.318 1 C-N-CA 132.161 4.185 . . . . 0.28999999999999998 118.547 175.468 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . 0.269 3.1 t -132.13 -33.43 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.372 1.556 0 N-CA-C 114.758 1.392 . . . . 1.1799999999999999 114.758 178.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 69' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -111.13 139.69 46.3 Favored 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 119.443 -2.036 . . . . 2.1899999999999999 109.685 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.12 64.61 6.88 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.55 1.94 . . . . 0.0 114.045 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 71' ' ' ALA . . . . . 0.605 ' HB1' ' HZ2' ' E' ' 73' ' ' LYS . . . -95.9 68.25 2.77 Favored 'General case' 0 C--N 1.362 1.129 0 CA-C-O 123.444 1.592 . . . . 0.0 110.792 175.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.08 64.66 4.62 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 125.717 1.607 . . . . 0.0 109.849 176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 73' ' ' LYS . . . . . 0.605 ' HZ2' ' HB1' ' E' ' 71' ' ' ALA . 19.0 pttm . . . . . 0 C--O 1.261 1.694 0 C-N-CA 127.486 2.314 . . . . 0.0 107.143 176.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.851 0 N-CA-C 111.563 0.209 . . . . 2.6400000000000001 111.563 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 2' ' ' LEU . . . . . . . . . . . . 0.279 1.0 OUTLIER -103.85 -140.91 0.36 Allowed 'General case' 0 C--N 1.356 0.85 0 C-N-CA 127.495 2.318 . . . . 1.54 111.957 175.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.09 172.79 12.58 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 124.2 1.952 . . . . 1.0 114.418 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.09 94.34 7.89 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 127.124 2.17 . . . . 3.9399999999999999 112.86 176.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.27 3.44 9.61 Favored Glycine 0 C--N 1.365 2.172 0 O-C-N 120.697 -1.252 . . . . 0.75 111.388 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 6' ' ' ASP . . . . . 0.403 ' HA ' ' HB2' ' E' ' 69' ' ' GLN . 18.3 t0 -69.28 143.94 53.72 Favored 'General case' 0 N--CA 1.417 -2.092 0 C-N-CA 130.739 3.615 . . . . 0.45000000000000001 112.752 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -94.15 83.72 4.32 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 104.93 -2.248 . . . . 2.54 104.93 171.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 17.5 m -89.79 144.31 9.37 Favored 'Isoleucine or valine' 0 C--N 1.365 1.252 0 N-CA-C 107.517 -1.29 . . . . 1.03 107.517 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 69.1 ttt-85 -104.05 122.68 45.77 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 120.154 -1.591 . . . . 0.17000000000000001 110.817 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -67.75 120.93 15.96 Favored 'Isoleucine or valine' 0 C--N 1.363 1.165 0 C-N-CA 126.939 2.096 . . . . 1.03 113.808 177.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -126.96 52.82 1.75 Allowed 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 127.997 2.519 . . . . 0.29999999999999999 110.481 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -92.46 -138.86 0.18 Allowed 'General case' 0 C--N 1.372 1.564 0 O-C-N 120.221 -1.549 . . . . 2.7599999999999998 109.946 172.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 13' ' ' THR . . . . . 0.467 ' HA ' ' CD2' ' E' ' 18' ' ' TYR 0.251 23.0 m -152.76 -60.43 0.15 Allowed 'General case' 0 C--N 1.357 0.899 0 O-C-N 118.256 -2.777 . . . . 0.46999999999999997 108.764 174.352 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -75.23 67.34 1.84 Allowed 'General case' 0 C--N 1.354 0.796 0 O-C-N 119.962 -1.711 . . . . 1.8899999999999999 114.453 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 23.8 t -162.12 159.68 26.34 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 125.459 1.504 . . . . 1.3999999999999999 111.746 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -77.03 -27.45 54.53 Favored 'General case' 0 C--N 1.363 1.153 0 C-N-CA 130.941 3.697 . . . . 1.1599999999999999 110.179 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 24.5 m0 -93.71 17.97 10.97 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 129.368 3.067 . . . . 0.94999999999999996 113.052 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 18' ' ' TYR . . . . . 0.467 ' CD2' ' HA ' ' E' ' 13' ' ' THR . 2.6 t80 -74.63 112.17 10.55 Favored 'General case' 0 C--N 1.368 1.411 0 C-N-CA 126.362 1.865 . . . . 0.95999999999999996 108.421 173.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.53 34.14 6.47 Favored Glycine 0 C--N 1.354 1.534 0 C-N-CA 128.651 3.025 . . . . 0.39000000000000001 113.923 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -105.42 163.86 12.31 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 118.968 1.384 . . . . 1.3999999999999999 113.09 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.25 149.47 25.67 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 N-CA-C 105.603 -1.999 . . . . 1.03 105.603 175.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.08 178.35 47.54 Favored Glycine 0 CA--C 1.472 -2.629 0 C-N-CA 118.146 -1.978 . . . . 0.27000000000000002 110.226 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 7.0 m -90.01 120.93 31.63 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 124.844 1.258 . . . . 1.1000000000000001 113.222 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.57 91.54 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 125.374 2.512 . . . . 1.1100000000000001 110.768 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.62 53.76 2.9 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 119.879 -1.763 . . . . 1.0600000000000001 111.268 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 22.1 m -87.69 -59.82 2.14 Favored 'General case' 0 CA--C 1.476 -1.868 0 C-N-CA 130.169 3.387 . . . . 0.87 117.667 -174.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -84.41 62.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.767 0 CA-C-O 126.421 3.01 . . . . 0.60999999999999999 112.843 -164.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -148.27 -66.51 0.24 Allowed 'General case' 0 N--CA 1.415 -2.209 2 C-N-CA 132.282 4.233 . . . . 1.6100000000000001 104.988 -177.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -110.31 5.02 21.32 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 128.089 2.556 . . . . 4.3200000000000003 114.642 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 3.8 t -50.96 -18.96 0.87 Allowed 'General case' 0 C--N 1.369 1.44 0 C-N-CA 130.043 3.337 . . . . 4.7999999999999998 118.304 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.59 43.89 0.47 Allowed Glycine 0 C--N 1.349 1.295 0 C-N-CA 129.856 3.598 . . . . 2.21 116.949 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 32' ' ' ILE . . . . . 0.467 HG21 ' H ' ' E' ' 33' ' ' LEU . 0.7 OUTLIER -133.1 -166.02 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.834 0 C-N-CA 128.651 2.78 . . . . 1.6399999999999999 109.599 -179.472 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 33' ' ' LEU . . . . . 0.467 ' H ' HG21 ' E' ' 32' ' ' ILE . 49.1 tp -69.85 -22.55 63.26 Favored 'General case' 0 C--N 1.359 0.98 1 C-N-CA 131.829 4.052 . . . . 0.64000000000000001 116.786 -177.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -137.28 127.75 15.92 Favored Pre-proline 0 C--N 1.359 0.989 0 N-CA-C 105.316 -2.105 . . . . 1.52 105.316 176.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -82.3 -42.68 0.1 OUTLIER 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 124.702 3.601 . . . . 0.67000000000000004 117.111 -171.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 76.4 t -84.18 101.37 8.67 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 C-N-CA 127.728 2.411 . . . . 1.1599999999999999 113.4 -168.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 78.5 mt -101.68 81.04 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.206 0 C-N-CA 124.973 1.309 . . . . 1.28 107.692 -176.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 57.0 t -89.23 164.82 2.13 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 O-C-N 119.488 -2.008 . . . . 1.04 112.644 -173.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 39' ' ' ARG . . . . . . . . . . . . . 29.1 mmt85 -82.25 142.05 32.44 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 128.729 2.812 . . . . 3.1400000000000001 113.461 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -132.09 138.63 48.19 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.413 1.085 . . . . 1.26 111.9 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -101.19 -34.79 9.54 Favored 'General case' 0 C--N 1.374 1.638 0 C-N-CA 125.836 1.654 . . . . 1.8100000000000001 113.094 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 34.4 mtt180 -83.91 49.87 1.71 Allowed 'General case' 0 C--N 1.36 1.049 0 C-N-CA 128.494 2.718 . . . . 1.29 116.242 -170.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . 0.308 4.3 p -98.8 151.47 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 119.4 -2.062 . . . . 1.7 105.79 167.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -89.1 5.67 43.47 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 119.064 -2.272 . . . . 2.1800000000000002 115.067 -174.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 53.76 -47.18 0.02 OUTLIER 'General case' 0 C--N 1.363 1.195 0 C-N-CA 131.449 3.899 . . . . 2.6899999999999999 121.479 173.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -102.09 120.77 40.98 Favored 'General case' 0 C--N 1.355 0.804 0 C-N-CA 126.929 2.092 . . . . 4.6200000000000001 114.556 -172.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.31 27.12 8.82 Favored Glycine 0 C--N 1.364 2.133 0 O-C-N 119.88 -1.763 . . . . 5.3300000000000001 116.816 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -117.01 -22.14 8.58 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-O 124.036 1.874 . . . . 5.2699999999999996 114.521 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 8.1 t -104.03 0.02 29.35 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 130.994 3.717 . . . . 7.5999999999999996 113.219 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.04 -123.86 1.5 Allowed Glycine 0 C--N 1.346 1.114 0 N-CA-C 106.172 -2.771 . . . . 6.8700000000000001 106.172 -173.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 8.6 t -153.4 166.27 33.19 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 104.39 -2.448 . . . . 7.5099999999999998 104.39 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.61 -53.15 37.36 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 126.898 2.079 . . . . 5.5599999999999996 113.976 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 4.8 t 69.02 -21.96 0.15 Allowed 'General case' 0 C--N 1.351 0.638 0 N-CA-C 118.878 2.918 . . . . 4.4299999999999997 118.878 174.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.77 -166.72 16.97 Favored Glycine 0 C--N 1.347 1.171 0 C-N-CA 128.336 2.874 . . . . 3.3900000000000001 112.992 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -138.62 175.95 7.39 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 C-N-CA 128.696 2.798 . . . . 1.79 105.667 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -105.77 -34.09 7.79 Favored 'General case' 0 C--N 1.365 1.257 0 C-N-CA 124.696 1.198 . . . . 2.6800000000000002 111.733 174.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 1.9 p -121.63 128.57 52.05 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 104.056 -2.572 . . . . 1.1399999999999999 104.056 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.74 132.03 11.96 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 108.119 -1.067 . . . . 1.9399999999999999 108.119 -168.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -80.69 110.82 16.55 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 130.071 3.348 . . . . 2.2200000000000002 116.018 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -114.31 179.86 3.83 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 127.422 2.289 . . . . 0.23999999999999999 114.035 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.82 109.41 16.54 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 114.706 1.373 . . . . 1.01 114.706 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -19.74 0.4 0.0 OUTLIER 'General case' 0 C--N 1.374 1.638 2 C-N-CA 137.357 6.263 . . . . 1.72 124.489 172.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.09 -45.04 6.06 Favored 'General case' 0 N--CA 1.438 -1.055 1 C-N-CA 132.241 4.217 . . . . 0.20000000000000001 106.322 171.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -88.68 18.25 4.84 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 120.083 -1.635 . . . . 1.1799999999999999 110.867 -170.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . 0.313 0.1 OUTLIER -134.17 157.7 45.55 Favored 'General case' 0 N--CA 1.43 -1.464 1 C-N-CA 132.768 4.427 . . . . 1.0900000000000001 106.317 172.186 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -137.39 149.25 46.8 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 105.665 -1.976 . . . . 2.0499999999999998 105.665 162.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . 0.252 2.5 pt? -91.54 149.01 21.87 Favored 'General case' 0 C--N 1.363 1.187 0 O-C-N 118.798 -2.439 . . . . 0.28999999999999998 117.511 -177.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 4.4 t -112.09 -37.48 2.84 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 C-N-CA 126.794 2.038 . . . . 1.1799999999999999 110.346 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 69' ' ' GLN . . . . . 0.403 ' HB2' ' HA ' ' E' ' 6' ' ' ASP . 24.7 mt-30 -103.41 153.78 20.12 Favored 'General case' 0 C--N 1.356 0.875 0 CA-C-O 126.916 3.246 . . . . 2.1899999999999999 115.286 -174.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.26 68.74 0.77 Allowed 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 108.476 -3.966 . . . . 0.0 109.584 170.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.5 74.3 3.23 Favored 'General case' 0 C--N 1.362 1.137 0 O-C-N 120.076 -1.64 . . . . 0.0 112.465 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.1 80.21 7.72 Favored 'General case' 0 C--N 1.36 1.065 0 C-N-CA 129.08 2.952 . . . . 0.0 111.753 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 71.7 tttt . . . . . 0 C--O 1.264 1.826 0 C-N-CA 127.089 2.156 . . . . 0.0 107.93 176.02 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 2.613 0 N-CA-C 114.336 1.235 . . . . 2.6400000000000001 114.336 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.12 -158.05 0.65 Allowed 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 131.693 3.997 . . . . 1.54 117.93 -175.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.97 177.06 9.44 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 130.794 3.638 . . . . 1.0 107.298 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -78.66 117.74 20.1 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 120.69 3.589 . . . . 3.9399999999999999 120.69 -172.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.63 5.93 53.33 Favored Glycine 0 C--N 1.376 2.784 0 O-C-N 118.184 -2.823 . . . . 0.75 114.332 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.65 145.89 30.34 Favored 'General case' 0 N--CA 1.411 -2.4 1 C-N-CA 132.024 4.13 . . . . 0.45000000000000001 110.983 -176.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . 0.579 ' H ' ' CB ' ' E' ' 69' ' ' GLN . 49.3 mttm -93.08 71.76 4.62 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 128.524 2.73 . . . . 2.54 107.973 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 15.8 m -88.69 148.64 4.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 C-N-CA 123.684 0.794 . . . . 1.03 110.891 -173.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -105.95 123.92 48.76 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 119.314 -0.374 . . . . 0.17000000000000001 110.917 -173.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 mm -73.29 114.68 13.09 Favored 'Isoleucine or valine' 0 C--N 1.36 1.06 0 C-N-CA 125.755 1.622 . . . . 1.03 114.968 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -115.91 57.27 0.75 Allowed 'General case' 0 C--N 1.375 1.675 0 C-N-CA 124.172 0.989 . . . . 0.29999999999999999 113.669 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.62 123.14 48.58 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 126.08 1.752 . . . . 2.7599999999999998 109.059 171.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 24.6 p -72.66 -6.56 45.2 Favored 'General case' 0 C--N 1.368 1.412 0 C-N-CA 128.941 2.896 . . . . 0.46999999999999997 117.273 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -97.16 41.12 1.12 Allowed 'General case' 0 C--N 1.357 0.906 0 C-N-CA 128.54 2.736 . . . . 1.8899999999999999 112.27 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 35.3 t -164.8 166.19 19.98 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 119.97 -1.706 . . . . 1.3999999999999999 107.247 -178.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -89.59 -5.6 57.04 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 127.123 2.169 . . . . 1.1599999999999999 110.369 171.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 29.6 m0 -94.76 16.68 15.18 Favored 'General case' 0 C--N 1.372 1.573 0 C-N-CA 129.166 2.986 . . . . 0.94999999999999996 110.478 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -73.34 102.5 3.73 Favored 'General case' 0 C--N 1.364 1.221 0 C-N-CA 128.159 2.584 . . . . 0.95999999999999996 110.873 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.58 32.97 6.05 Favored Glycine 0 C--N 1.358 1.757 0 C-N-CA 126.203 1.859 . . . . 0.39000000000000001 112.602 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -106.93 135.19 48.9 Favored 'General case' 0 C--N 1.366 1.288 0 CA-C-N 119.255 1.528 . . . . 1.3999999999999999 112.255 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.72 145.84 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 C-N-CA 128.299 2.64 . . . . 1.03 107.257 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -174.03 178.1 46.02 Favored Glycine 0 CA--C 1.473 -2.563 0 N-CA-C 108.864 -1.694 . . . . 0.27000000000000002 108.864 172.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 20.7 m -86.18 125.4 33.5 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.505 1.122 . . . . 1.1000000000000001 112.002 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 12.6 p -80.92 95.87 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 126.078 1.751 . . . . 1.1100000000000001 111.473 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.74 51.43 1.85 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.067 2.147 . . . . 1.0600000000000001 112.803 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 2.6 p -73.08 -73.12 0.22 Allowed 'General case' 0 CA--C 1.504 -0.817 1 C-N-CA 136.257 5.823 . . . . 0.87 120.114 -173.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 4.4 m -81.23 18.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.553 0 C-N-CA 128.085 2.554 . . . . 0.60999999999999999 117.058 -163.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -98.26 -69.43 0.76 Allowed 'General case' 0 N--CA 1.431 -1.416 1 C-N-CA 132.011 4.125 . . . . 1.6100000000000001 107.693 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -106.81 -26.89 11.07 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 115.849 1.796 . . . . 4.3200000000000003 115.849 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.45 22.03 3.12 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 117.432 2.382 . . . . 4.7999999999999998 117.432 -170.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.25 46.49 0.81 Allowed Glycine 0 C--N 1.353 1.525 0 C-N-CA 127.97 2.7 . . . . 2.21 114.505 167.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 32' ' ' ILE . . . . . 0.439 ' CG2' ' H ' ' E' ' 33' ' ' LEU . 1.9 mt -122.32 -146.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 130.962 3.705 . . . . 1.6399999999999999 104.664 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 33' ' ' LEU . . . . . 0.439 ' H ' ' CG2' ' E' ' 32' ' ' ILE . 39.8 tp -62.08 -61.57 2.39 Favored 'General case' 0 C--N 1.345 0.379 0 C-N-CA 129.392 3.077 . . . . 0.64000000000000001 115.181 176.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -97.67 111.01 57.63 Favored Pre-proline 0 C--N 1.363 1.177 0 C-N-CA 124.208 1.003 . . . . 1.52 109.688 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.86 -38.52 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.727 1 C-N-CA 125.318 4.012 . . . . 0.67000000000000004 116.141 -173.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 59.4 t -88.44 94.21 4.62 Favored 'Isoleucine or valine' 0 C--N 1.349 0.553 0 N-CA-C 116.19 1.922 . . . . 1.1599999999999999 116.19 -169.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 96.4 mt -89.82 99.92 10.14 Favored 'Isoleucine or valine' 0 C--N 1.36 1.03 0 C-N-CA 126.461 1.904 . . . . 1.28 106.719 176.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 81.3 t -104.93 156.3 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 120.769 -1.207 . . . . 1.04 111.945 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 39' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -79.97 139.5 37.0 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 130.581 3.552 . . . . 3.1400000000000001 111.973 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -137.29 149.08 46.83 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.317 -1.49 . . . . 1.26 111.929 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -103.55 -23.76 13.47 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 127.071 2.148 . . . . 1.8100000000000001 111.282 172.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 67.2 mtt-85 -82.04 40.37 0.62 Allowed 'General case' 0 C--N 1.366 1.287 0 C-N-CA 129.397 3.079 . . . . 1.29 111.855 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 43' ' ' VAL . . . . . 0.416 ' HB ' ' CE2' ' E' ' 45' ' ' TYR . 10.3 t -91.81 168.48 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 126.925 2.09 . . . . 1.7 110.377 -175.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -119.49 87.87 2.82 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.118 -2.178 . . . . 2.1800000000000002 105.118 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 45' ' ' TYR . . . . . 0.416 ' CE2' ' HB ' ' E' ' 43' ' ' VAL . 0.1 OUTLIER -104.91 3.64 31.06 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 130.042 3.337 . . . . 2.6899999999999999 109.995 178.696 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -81.23 64.76 6.1 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 127.814 2.446 . . . . 4.6200000000000001 115.169 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.52 21.83 7.02 Favored Glycine 0 C--N 1.362 2.015 0 C-N-CA 126.87 2.176 . . . . 5.3300000000000001 116.802 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -116.76 14.85 15.36 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 127.243 2.217 . . . . 5.2699999999999996 109.622 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 77.7 p -100.53 -73.29 0.64 Allowed 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 129.133 2.973 . . . . 7.5999999999999996 107.416 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 179.52 -51.51 0.09 OUTLIER Glycine 0 CA--C 1.498 -1.015 0 C-N-CA 128.576 2.988 . . . . 6.8700000000000001 106.916 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 73.3 m -118.12 112.49 20.26 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 125.771 1.628 . . . . 7.5099999999999998 115.129 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -93.63 -92.6 0.17 Allowed 'General case' 0 C--N 1.365 1.254 0 C-N-CA 126.103 1.761 . . . . 5.5599999999999996 108.54 169.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 12.2 t 68.52 22.68 7.62 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 127.284 2.234 . . . . 4.4299999999999997 116.745 172.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -109.49 143.33 16.5 Favored Glycine 0 C--N 1.364 2.136 0 C-N-CA 126.653 2.073 . . . . 3.3900000000000001 113.629 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 t -103.79 147.79 9.54 Favored 'Isoleucine or valine' 0 C--N 1.364 1.2 0 C-N-CA 127.351 2.26 . . . . 1.79 112.62 -177.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -92.1 -33.96 14.56 Favored 'General case' 0 C--N 1.366 1.31 0 C-N-CA 127.987 2.515 . . . . 2.6800000000000002 112.893 -176.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 31.8 p -129.21 121.71 28.21 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 128.612 2.765 . . . . 1.1399999999999999 106.57 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.75 139.79 15.4 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 119.513 1.051 . . . . 1.9399999999999999 112.399 -175.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -63.05 119.78 10.15 Favored 'General case' 0 C--N 1.358 0.937 1 C-N-CA 132.035 4.134 . . . . 2.2200000000000002 119.9 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -124.67 170.26 11.15 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 123.514 1.626 . . . . 0.23999999999999999 113.44 174.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.92 92.32 6.05 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 129.765 3.226 . . . . 1.01 109.05 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -18.15 -21.72 0.0 OUTLIER 'General case' 0 C--N 1.358 0.95 1 C-N-CA 136.434 5.893 . . . . 1.72 121.68 173.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -73.58 -29.67 62.56 Favored 'General case' 0 C--N 1.362 1.149 0 C-N-CA 129.443 3.097 . . . . 0.20000000000000001 113.173 169.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -84.33 -14.81 48.64 Favored 'General case' 0 C--N 1.375 1.692 0 C-N-CA 127.217 2.207 . . . . 1.1799999999999999 108.351 -175.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.48 108.48 19.93 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 128.395 2.678 . . . . 1.0900000000000001 115.41 -176.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -89.9 149.4 22.64 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 129.735 3.214 . . . . 2.0499999999999998 112.076 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -82.77 141.61 32.22 Favored 'General case' 0 C--N 1.366 1.316 0 CA-C-N 121.638 2.017 . . . . 0.28999999999999998 115.677 174.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 18.9 t -130.61 -19.4 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.873 0 CA-C-O 123.528 1.632 . . . . 1.1799999999999999 108.226 171.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 69' ' ' GLN . . . . . 0.579 ' CB ' ' H ' ' E' ' 7' ' ' LYS . 4.9 tp-100 -110.28 155.24 22.33 Favored 'General case' 0 N--CA 1.424 -1.729 0 C-N-CA 127.173 2.189 . . . . 2.1899999999999999 111.848 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.02 42.06 1.26 Allowed 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 128.478 2.711 . . . . 0.0 114.316 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.95 63.11 7.9 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 125.243 1.417 . . . . 0.0 108.278 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.9 80.16 2.98 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 128.05 2.54 . . . . 0.0 112.097 -173.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? . . . . . 0 C--O 1.257 1.459 0 N-CA-C 103.039 -2.949 . . . . 0.0 103.039 172.196 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 110.133 -0.321 . . . . 2.6400000000000001 110.133 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 2' ' ' LEU . . . . . . . . . . . . 0.306 2.0 pp -103.64 -154.97 0.51 Allowed 'General case' 0 C--N 1.362 1.129 0 CA-C-O 123.489 1.614 . . . . 1.54 111.844 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -140.23 168.71 19.17 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 129.303 3.041 . . . . 1.0 111.7 -172.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -95.11 96.8 9.48 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 126.677 1.991 . . . . 3.9399999999999999 112.233 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.62 17.26 3.55 Favored Glycine 0 C--N 1.368 2.329 0 O-C-N 119.922 -1.736 . . . . 0.75 113.145 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 6' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -90.84 143.04 27.13 Favored 'General case' 0 N--CA 1.411 -2.375 1 C-N-CA 131.8 4.04 . . . . 0.45000000000000001 109.325 -178.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . 0.478 ' H ' ' HB3' ' E' ' 69' ' ' GLN . 63.7 mmtt -92.9 82.23 4.66 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 104.966 -2.235 . . . . 2.54 104.966 173.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 m -88.43 133.56 30.5 Favored 'Isoleucine or valine' 0 C--N 1.359 1.015 0 N-CA-C 105.078 -2.193 . . . . 1.03 105.078 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -91.71 110.38 21.71 Favored 'General case' 0 CA--C 1.502 -0.887 0 O-C-N 121.237 -0.915 . . . . 0.17000000000000001 111.354 -174.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . 0.502 HG21 ' CE2' ' E' ' 60' ' ' PHE . 5.4 mm -53.37 107.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.503 0 N-CA-C 119.839 3.274 . . . . 1.03 119.839 175.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 13.8 mtmm -119.02 49.77 1.29 Allowed 'General case' 0 C--N 1.379 1.887 0 C-N-CA 127.163 2.185 . . . . 0.29999999999999999 111.485 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -76.49 -118.54 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 120.178 3.399 . . . . 2.7599999999999998 120.178 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 3.5 m -150.55 -49.09 0.13 Allowed 'General case' 0 C--N 1.358 0.938 0 O-C-N 120.258 -1.526 . . . . 0.46999999999999997 108.553 -176.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -85.59 89.94 7.86 Favored 'General case' 0 C--N 1.363 1.167 0 N-CA-C 115.509 1.67 . . . . 1.8899999999999999 115.509 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 15' ' ' SER . . . . . . . . . . . . 0.285 1.4 m -53.68 28.96 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 1 N-CA-C 121.989 4.07 . . . . 1.3999999999999999 121.989 179.968 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.45 -51.26 4.42 Favored 'General case' 0 C--N 1.352 0.691 1 C-N-CA 131.788 4.035 . . . . 1.1599999999999999 102.274 163.284 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -114.97 35.15 4.45 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.66 1.584 . . . . 0.94999999999999996 111.186 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -139.42 133.82 31.54 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 106.418 -1.697 . . . . 0.95999999999999996 106.418 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.3 46.75 1.52 Allowed Glycine 0 C--N 1.358 1.779 0 C-N-CA 127.202 2.334 . . . . 0.39000000000000001 109.449 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -168.72 176.24 5.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.363 -1.717 . . . . 1.3999999999999999 106.363 -171.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 p -109.57 175.9 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 127.579 2.352 . . . . 1.03 108.348 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.79 169.49 41.48 Favored Glycine 0 CA--C 1.476 -2.381 0 N-CA-C 108.231 -1.948 . . . . 0.27000000000000002 108.231 173.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 23' ' ' THR . . . . . 0.522 ' HG1' ' CZ ' ' E' ' 39' ' ' ARG . 10.9 m -97.72 114.75 26.82 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 125.727 1.611 . . . . 1.1000000000000001 110.587 -177.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 24' ' ' VAL . . . . . 0.539 HG23 ' HG ' ' E' ' 26' ' ' SER . 12.3 p -76.35 86.84 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-O 125.974 2.797 . . . . 1.1100000000000001 112.097 176.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -94.72 57.4 2.17 Favored 'General case' 0 C--O 1.225 -0.213 0 O-C-N 119.172 -2.205 . . . . 1.0600000000000001 108.995 175.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 26' ' ' SER . . . . . 0.539 ' HG ' HG23 ' E' ' 24' ' ' VAL . 10.6 p -79.76 -81.45 0.12 Allowed 'General case' 0 CA--C 1.495 -1.165 1 C-N-CA 134.67 5.188 . . . . 0.87 118.705 -168.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 5.7 p -83.82 59.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 128.976 2.91 . . . . 0.60999999999999999 111.51 -169.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -145.71 -50.88 0.24 Allowed 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 127.329 2.252 . . . . 1.6100000000000001 106.4 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -105.42 -22.93 12.92 Favored 'General case' 0 C--N 1.37 1.483 0 C-N-CA 127.748 2.419 . . . . 4.3200000000000003 113.45 175.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 58.8 m -68.35 55.81 0.08 Allowed 'General case' 0 C--N 1.378 1.824 0 C-N-CA 128.698 2.799 . . . . 4.7999999999999998 117.831 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.71 32.88 5.91 Favored Glycine 0 C--O 1.222 -0.6 1 C-N-CA 131.608 4.432 . . . . 2.21 111.197 162.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 32' ' ' ILE . . . . . 0.427 ' CG2' ' H ' ' E' ' 33' ' ' LEU . 2.3 mt -112.19 -136.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.577 0 C-N-CA 129.014 2.925 . . . . 1.6399999999999999 107.405 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 33' ' ' LEU . . . . . 0.427 ' H ' ' CG2' ' E' ' 32' ' ' ILE . 12.5 tp -90.57 -69.45 0.73 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 128.731 2.812 . . . . 0.64000000000000001 112.822 177.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -96.94 156.99 35.79 Favored Pre-proline 0 C--N 1.372 1.571 0 O-C-N 120.185 -1.572 . . . . 1.52 110.809 -175.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.82 -51.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 123.809 3.006 . . . . 0.67000000000000004 116.595 -170.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 95.2 t -79.48 110.28 15.0 Favored 'Isoleucine or valine' 0 C--N 1.348 0.504 0 C-N-CA 129.426 3.09 . . . . 1.1599999999999999 113.068 -170.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 70.5 mt -107.81 97.55 5.83 Favored 'Isoleucine or valine' 0 C--N 1.372 1.578 0 N-CA-C 104.403 -2.443 . . . . 1.28 104.403 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 37.8 t -107.38 141.88 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 O-C-N 120.497 -1.377 . . . . 1.04 114.125 -167.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 39' ' ' ARG . . . . . 0.522 ' CZ ' ' HG1' ' E' ' 23' ' ' THR . 21.3 ttm180 -69.95 144.83 52.26 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 128.448 2.699 . . . . 3.1400000000000001 114.189 174.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -153.52 166.98 31.01 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 106.37 -1.715 . . . . 1.26 106.37 171.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -106.38 -27.92 10.68 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 129.357 3.063 . . . . 1.8100000000000001 108.888 165.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -75.77 45.18 0.32 Allowed 'General case' 0 C--N 1.371 1.536 0 C-N-CA 127.359 2.264 . . . . 1.29 115.169 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 8.7 m -91.81 176.83 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 123.877 1.798 . . . . 1.7 110.628 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -85.13 65.01 9.01 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 119.016 -2.302 . . . . 2.1800000000000002 112.534 -177.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -64.18 60.67 0.02 OUTLIER 'General case' 0 C--N 1.349 0.554 1 C-N-CA 132.039 4.135 . . . . 2.6899999999999999 115.828 176.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -101.82 26.63 7.25 Favored 'General case' 0 C--N 1.361 1.075 0 C-N-CA 128.441 2.696 . . . . 4.6200000000000001 108.053 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.15 128.55 9.61 Favored Glycine 0 C--N 1.357 1.749 0 C-N-CA 125.891 1.71 . . . . 5.3300000000000001 111.876 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -94.32 6.83 47.48 Favored 'General case' 0 C--N 1.367 1.353 0 CA-C-O 125.433 2.54 . . . . 5.2699999999999996 112.412 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 4.7 p -103.4 -59.78 1.66 Allowed 'General case' 0 N--CA 1.452 -0.373 1 C-N-CA 134.279 5.032 . . . . 7.5999999999999996 106.575 173.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.45 -73.99 0.16 Allowed Glycine 0 C--N 1.348 1.204 0 C-N-CA 127.04 2.257 . . . . 6.8700000000000001 108.201 173.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 15.8 m -102.08 92.79 4.92 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 125.622 1.569 . . . . 7.5099999999999998 113.709 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -98.42 -59.11 1.81 Allowed 'General case' 0 C--N 1.355 0.81 0 CA-C-O 123.525 1.631 . . . . 5.5599999999999996 110.902 174.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 17.7 p -118.64 19.54 13.2 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.804 1.242 . . . . 4.4299999999999997 109.97 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.41 97.18 0.93 Allowed Glycine 0 C--N 1.357 1.735 0 C-N-CA 124.807 1.194 . . . . 3.3900000000000001 113.926 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 34.2 m -93.15 111.73 25.16 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 C-N-CA 130.185 3.394 . . . . 1.79 107.25 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -86.03 27.55 0.89 Allowed 'General case' 0 C--N 1.352 0.701 0 O-C-N 119.193 -2.192 . . . . 2.6800000000000002 114.092 -170.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 2.8 p -150.83 149.33 29.58 Favored 'General case' 0 C--N 1.356 0.874 1 C-N-CA 133.708 4.803 . . . . 1.1399999999999999 107.371 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . 0.323 11.8 p30 -159.31 168.41 26.48 Favored 'General case' 0 C--N 1.364 1.225 0 CA-C-N 121.606 2.003 . . . . 1.9399999999999999 108.351 170.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -97.75 113.28 25.02 Favored 'General case' 0 C--N 1.363 1.175 0 C-N-CA 126.736 2.014 . . . . 2.2200000000000002 116.225 -172.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 60' ' ' PHE . . . . . 0.502 ' CE2' HG21 ' E' ' 10' ' ' ILE . 16.1 m-85 -118.16 170.22 9.05 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 127.529 2.332 . . . . 0.23999999999999999 113.243 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.34 113.27 19.17 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.992 2.117 . . . . 1.01 112.231 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -26.54 -18.08 0.0 OUTLIER 'General case' 0 C--N 1.371 1.532 1 C-N-CA 134.652 5.181 . . . . 1.72 121.309 174.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -59.39 -49.19 78.76 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 131.418 3.887 . . . . 0.20000000000000001 111.887 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -94.44 12.54 26.83 Favored 'General case' 0 C--N 1.361 1.107 0 CA-C-N 114.598 -1.183 . . . . 1.1799999999999999 112.836 -170.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.463 HD22 ' HB3' ' E' ' 60' ' ' PHE 0.261 1.0 OUTLIER -120.91 119.15 31.77 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 127.723 2.409 . . . . 1.0900000000000001 114.209 -177.601 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -111.03 136.47 49.99 Favored 'General case' 0 C--N 1.362 1.129 0 O-C-N 120.958 -1.089 . . . . 2.0499999999999998 111.482 171.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.69 140.51 51.14 Favored 'General case' 0 C--N 1.365 1.268 0 C-N-CA 130.84 3.656 . . . . 0.28999999999999998 120.096 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . 0.255 2.0 t -139.78 -33.95 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.373 1.593 0 C-N-CA 126.728 2.011 . . . . 1.1799999999999999 114.092 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 69' ' ' GLN . . . . . 0.478 ' HB3' ' H ' ' E' ' 7' ' ' LYS . 16.6 tt0 -112.53 104.81 12.92 Favored 'General case' 0 C--N 1.361 1.087 0 O-C-N 119.887 -1.758 . . . . 2.1899999999999999 109.585 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.77 62.52 0.07 Allowed 'General case' 0 C--N 1.349 0.546 0 C-N-CA 127.909 2.484 . . . . 0.0 114.808 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.05 67.67 9.76 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 128.939 2.896 . . . . 0.0 109.514 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.24 47.65 0.02 OUTLIER 'General case' 0 C--N 1.362 1.128 0 C-N-CA 130.201 3.401 . . . . 0.0 116.835 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 25.4 tptp . . . . . 0 N--CA 1.42 -1.944 1 C-N-CA 133.582 4.753 . . . . 0.0 104.878 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.804 0 N-CA-C 108.131 -1.063 . . . . 2.6400000000000001 108.131 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' E' E ' 2' ' ' LEU . . . . . . . . . . . . 0.31 0.0 OUTLIER -79.93 -169.19 1.9 Allowed 'General case' 0 C--N 1.357 0.924 0 N-CA-C 119.794 3.257 . . . . 1.54 119.794 -176.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.49 177.86 9.6 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 125.633 1.573 . . . . 1.0 110.805 -170.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 23.3 ptt-85 -65.88 67.85 0.05 OUTLIER 'General case' 0 C--N 1.365 1.249 1 C-N-CA 132.816 4.446 . . . . 3.9399999999999999 119.515 -174.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 125.38 25.38 1.46 Allowed Glycine 0 CA--C 1.491 -1.463 0 C-N-CA 126.72 2.105 . . . . 0.75 111.942 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 6' ' ' ASP . . . . . 0.514 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 20.8 t0 -71.04 129.88 40.13 Favored 'General case' 0 C--N 1.367 1.353 0 C-N-CA 125.302 1.441 . . . . 0.45000000000000001 111.553 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . 0.451 ' H ' ' CB ' ' E' ' 69' ' ' GLN . 31.6 mtmm -89.01 85.85 6.8 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 102.99 -2.967 . . . . 2.54 102.99 171.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 1.5 m -89.68 138.48 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 127.638 2.375 . . . . 1.03 106.323 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -101.5 86.1 2.9 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 121.438 -0.789 . . . . 0.17000000000000001 111.677 -174.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 mm -41.4 121.49 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.713 0 N-CA-C 120.751 3.611 . . . . 1.03 120.751 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -118.84 37.81 3.98 Favored 'General case' 0 C--N 1.373 1.609 0 C-N-CA 126.868 2.067 . . . . 0.29999999999999999 111.301 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.66 127.3 42.51 Favored 'General case' 0 C--N 1.365 1.255 0 C-N-CA 130.402 3.481 . . . . 2.7599999999999998 110.028 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 25.0 p -76.8 -55.95 5.04 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 129.585 3.154 . . . . 0.46999999999999997 113.819 -174.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -78.56 68.68 4.6 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 129.79 3.236 . . . . 1.8899999999999999 110.55 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 46.9 t -163.42 167.5 21.53 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 127.844 2.458 . . . . 1.3999999999999999 104.426 -175.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 16' ' ' TYR . . . . . 0.492 ' HH ' ' CZ ' ' E' ' 42' ' ' ARG . 53.1 t80 -94.37 -9.23 36.44 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 127.914 2.485 . . . . 1.1599999999999999 111.521 175.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -125.83 45.19 2.67 Favored 'General case' 0 C--N 1.366 1.287 0 O-C-N 120.703 -1.248 . . . . 0.94999999999999996 111.879 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -71.83 107.31 4.54 Favored 'General case' 0 C--N 1.367 1.329 0 C-N-CA 127.453 2.301 . . . . 0.95999999999999996 111.062 175.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.73 46.71 4.77 Favored Glycine 0 C--N 1.363 2.054 0 CA-C-O 122.196 0.887 . . . . 0.39000000000000001 111.995 -175.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -143.51 166.0 26.01 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 125.346 1.458 . . . . 1.3999999999999999 107.194 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.37 170.45 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.565 0 C-N-CA 126.357 1.863 . . . . 1.03 110.116 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.39 161.86 26.13 Favored Glycine 0 CA--C 1.483 -1.915 0 O-C-N 121.228 -0.92 . . . . 0.27000000000000002 111.924 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 23' ' ' THR . . . . . 0.482 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 12.8 m -94.98 135.26 36.72 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 128.359 2.664 . . . . 1.1000000000000001 115.959 -175.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 25.3 t -66.86 91.78 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.501 0 CA-C-O 124.711 2.196 . . . . 1.1100000000000001 116.308 170.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -99.35 15.8 25.1 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 130.737 3.615 . . . . 1.0600000000000001 108.777 170.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 26' ' ' SER . . . . . 0.455 ' HA ' ' HB ' ' E' ' 37' ' ' ILE . 0.9 OUTLIER -77.18 -15.02 59.68 Favored 'General case' 0 CA--C 1.48 -1.738 1 C-N-CA 135.391 5.476 . . . . 0.87 118.632 -176.947 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 24.8 t -86.18 59.72 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.495 0 CA-C-O 125.428 2.537 . . . . 0.60999999999999999 108.982 -173.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -145.13 -100.66 0.1 Allowed 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 111.262 -2.699 . . . . 1.6100000000000001 107.695 -174.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt -87.31 25.65 1.36 Allowed 'General case' 0 N--CA 1.437 -1.116 1 C-N-CA 132.032 4.133 . . . . 4.3200000000000003 115.303 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.08 -1.05 0.84 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 131.128 3.771 . . . . 4.7999999999999998 117.255 176.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.91 44.02 3.26 Favored Glycine 0 C--N 1.355 1.591 0 C-N-CA 128.472 2.939 . . . . 2.21 114.491 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 32' ' ' ILE . . . . . 0.447 HG21 ' H ' ' E' ' 33' ' ' LEU . 0.3 OUTLIER -137.5 -172.16 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.061 0 C-N-CA 128.072 2.549 . . . . 1.6399999999999999 109.538 -178.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 33' ' ' LEU . . . . . 0.447 ' H ' HG21 ' E' ' 32' ' ' ILE . 41.1 tp -82.87 -22.73 33.92 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 131.432 3.893 . . . . 0.64000000000000001 111.913 178.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -118.24 91.04 39.67 Favored Pre-proline 0 C--N 1.35 0.603 0 N-CA-C 103.286 -2.857 . . . . 1.52 103.286 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.64 -31.25 0.46 Allowed 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 124.919 3.746 . . . . 0.67000000000000004 116.675 -170.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . 0.265 75.3 t -96.91 98.38 7.46 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 C-N-CA 127.232 2.213 . . . . 1.1599999999999999 116.403 -166.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . 0.455 ' HB ' ' HA ' ' E' ' 26' ' ' SER . 3.8 mp -87.51 117.03 30.71 Favored 'Isoleucine or valine' 0 C--N 1.362 1.145 0 C-N-CA 128.11 2.564 . . . . 1.28 105.557 174.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 53.0 t -125.36 156.58 34.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.451 0 CA-C-N 119.424 1.011 . . . . 1.04 111.276 -173.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 39' ' ' ARG . . . . . 0.482 ' HB3' ' H ' ' E' ' 23' ' ' THR . 36.5 ttm-85 -82.39 156.75 24.01 Favored 'General case' 0 C--N 1.365 1.272 0 C-N-CA 130.661 3.584 . . . . 3.1400000000000001 110.888 175.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -151.01 -178.81 6.82 Favored 'General case' 0 CA--C 1.513 -0.462 0 O-C-N 119.467 -2.02 . . . . 1.26 106.953 174.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -98.62 -39.37 8.73 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 127.077 2.151 . . . . 1.8100000000000001 114.948 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 42' ' ' ARG . . . . . 0.492 ' CZ ' ' HH ' ' E' ' 16' ' ' TYR 0.269 20.8 mtm180 -69.18 -86.37 0.02 OUTLIER 'General case' 0 C--N 1.37 1.49 0 N-CA-C 121.602 3.927 . . . . 1.29 121.602 -170.243 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . 0.341 4.7 p -84.47 76.38 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.367 1.327 0 CA-C-O 127.15 3.357 . . . . 1.7 108.757 -176.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -162.62 -39.4 0.04 OUTLIER 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 108.431 -3.986 . . . . 2.1800000000000002 106.54 -158.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . 0.305 0.1 OUTLIER -77.69 -121.53 0.01 OUTLIER 'General case' 0 C--N 1.375 1.679 0 N-CA-C 117.859 2.54 . . . . 2.6899999999999999 117.859 -177.442 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -89.17 116.57 27.52 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 117.173 2.286 . . . . 4.6200000000000001 117.173 -169.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.53 52.29 3.09 Favored Glycine 0 C--N 1.37 2.465 0 C-N-CA 127.584 2.516 . . . . 5.3300000000000001 118.961 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -131.07 17.4 5.06 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-O 124.385 2.04 . . . . 5.2699999999999996 111.321 -176.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 37.7 t -102.7 -8.18 21.09 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 128.923 2.889 . . . . 7.5999999999999996 111.756 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 117.49 -147.93 18.76 Favored Glycine 0 C--N 1.351 1.416 1 N-CA-C 102.656 -4.177 . . . . 6.8700000000000001 102.656 -162.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 32.3 m -75.25 64.38 1.46 Allowed 'General case' 0 C--N 1.354 0.801 0 N-CA-C 116.337 1.977 . . . . 7.5099999999999998 116.337 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.17 -1.56 58.14 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 125.888 1.675 . . . . 5.5599999999999996 113.604 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 24.1 t -106.38 49.29 0.81 Allowed 'General case' 0 C--N 1.357 0.929 0 C-N-CA 127.6 2.36 . . . . 4.4299999999999997 108.248 173.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.8 -104.17 2.45 Favored Glycine 0 C--N 1.361 1.96 0 C-N-CA 127.061 2.267 . . . . 3.3900000000000001 114.271 -174.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -113.65 129.7 69.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 C-N-CA 124.353 1.061 . . . . 1.79 109.479 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -105.34 -42.2 5.32 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.506 1.523 . . . . 2.6800000000000002 112.432 173.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 57' ' ' THR . . . . . 0.429 ' HB ' HG21 ' E' ' 37' ' ' ILE . 40.2 p -86.61 106.83 17.85 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 125.899 1.68 . . . . 1.1399999999999999 113.99 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.61 132.66 47.16 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 128.695 2.798 . . . . 1.9399999999999999 106.283 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -100.31 103.38 14.8 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 124.829 1.252 . . . . 2.2200000000000002 109.639 -178.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 60' ' ' PHE . . . . . 0.406 ' CB ' HD23 ' E' ' 65' ' ' LEU . 24.4 m-85 -98.78 169.27 9.59 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 126.791 2.036 . . . . 0.23999999999999999 116.267 -174.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -102.86 101.86 11.93 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.857 2.463 . . . . 1.01 110.717 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -18.72 -29.65 0.0 OUTLIER 'General case' 0 C--N 1.373 1.624 1 C-N-CA 135.135 5.374 . . . . 1.72 120.914 173.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.68 -42.67 79.44 Favored 'General case' 0 C--N 1.369 1.449 0 C-N-CA 128.212 2.605 . . . . 0.20000000000000001 111.777 167.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -85.43 -7.48 58.9 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.126 -1.397 . . . . 1.1799999999999999 111.848 -171.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.406 HD23 ' CB ' ' E' ' 60' ' ' PHE . 0.2 OUTLIER -100.46 109.47 21.61 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 120.882 -1.136 . . . . 1.0900000000000001 110.568 178.504 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -90.7 128.63 36.72 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 123.659 0.784 . . . . 2.0499999999999998 112.407 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.62 137.35 57.78 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 120.542 3.534 . . . . 0.28999999999999998 120.542 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.79 -42.68 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.371 1.504 0 C-N-CA 125.738 1.615 . . . . 1.1799999999999999 111.342 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 69' ' ' GLN . . . . . 0.514 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 0.0 OUTLIER -112.12 97.54 6.72 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 126.504 1.922 . . . . 2.1899999999999999 114.134 -175.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.67 57.93 0.09 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.404 2.682 . . . . 0.0 114.804 175.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.76 53.45 0.45 Allowed 'General case' 0 C--N 1.353 0.734 0 C-N-CA 129.309 3.044 . . . . 0.0 116.475 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -100.09 94.51 6.29 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 127.556 2.342 . . . . 0.0 109.367 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt . . . . . 0 C--O 1.259 1.564 0 C-N-CA 125.502 1.521 . . . . 0.0 109.236 179.943 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.52 -0.548 . . . . 2.6400000000000001 109.52 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.96 -158.08 0.26 Allowed 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 128.003 2.521 . . . . 1.54 115.967 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -122.02 -173.8 2.74 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 128.658 2.783 . . . . 1.0 114.046 -170.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.92 104.86 17.24 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 128.638 2.775 . . . . 3.9399999999999999 111.757 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.99 -3.64 22.59 Favored Glycine 0 C--N 1.353 1.494 0 O-C-N 119.984 -1.698 . . . . 0.75 111.896 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 6' ' ' ASP . . . . . 0.413 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 3.6 t0 -77.85 72.02 4.36 Favored 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 130.529 3.531 . . . . 0.45000000000000001 114.115 -174.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -35.97 87.64 0.0 OUTLIER 'General case' 0 C--N 1.351 0.64 1 C-N-CA 132.78 4.432 . . . . 2.54 114.743 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.96 137.76 20.3 Favored 'Isoleucine or valine' 0 C--N 1.361 1.092 0 N-CA-C 107.102 -1.444 . . . . 1.03 107.102 -172.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -96.52 87.78 4.5 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 115.813 1.783 . . . . 0.17000000000000001 115.813 -170.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . 0.408 ' CD1' ' H ' ' E' ' 10' ' ' ILE . 0.9 OUTLIER -26.4 98.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 N-CA-C 119.517 3.154 . . . . 1.03 119.517 173.161 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -113.43 43.57 1.73 Allowed 'General case' 0 C--N 1.366 1.311 0 O-C-N 120.115 -1.615 . . . . 0.29999999999999999 113.261 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.79 137.16 39.55 Favored 'General case' 0 C--N 1.366 1.286 0 C-N-CA 125.902 1.681 . . . . 2.7599999999999998 111.006 174.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 22.3 p -73.02 -58.01 3.62 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 128.491 2.716 . . . . 0.46999999999999997 114.516 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -76.02 64.33 1.9 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 127.945 2.498 . . . . 1.8899999999999999 114.929 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 27.1 t -167.69 176.78 6.19 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 126.531 1.932 . . . . 1.3999999999999999 105.868 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -93.5 0.33 56.66 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 128.612 2.765 . . . . 1.1599999999999999 111.607 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -117.28 25.54 10.38 Favored 'General case' 0 C--N 1.36 1.034 0 O-C-N 120.48 -1.388 . . . . 0.94999999999999996 113.807 -172.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -70.04 108.94 4.29 Favored 'General case' 0 C--N 1.368 1.377 0 C-N-CA 126.338 1.855 . . . . 0.95999999999999996 114.228 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.66 30.36 18.65 Favored Glycine 0 C--N 1.366 2.206 0 CA-C-O 121.538 0.521 . . . . 0.39000000000000001 112.218 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -121.02 173.28 7.36 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 126.807 2.043 . . . . 1.3999999999999999 105.751 177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.59 175.75 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 C-N-CA 125.613 1.565 . . . . 1.03 110.042 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.07 175.21 40.22 Favored Glycine 0 CA--C 1.479 -2.211 1 N-CA-C 101.314 -4.714 . . . . 0.27000000000000002 101.314 165.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 23' ' ' THR . . . . . 0.6 ' H ' ' HB2' ' E' ' 39' ' ' ARG . 11.1 m -96.39 141.28 29.89 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 126.131 1.772 . . . . 1.1000000000000001 108.666 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 p -79.76 112.76 18.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 124.776 2.227 . . . . 1.1100000000000001 109.043 166.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.14 31.8 6.18 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 111.134 -2.757 . . . . 1.0600000000000001 108.573 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 26' ' ' SER . . . . . 0.513 ' CB ' ' H ' ' E' ' 37' ' ' ILE . 0.3 OUTLIER -86.62 -39.99 15.58 Favored 'General case' 0 CA--C 1.49 -1.329 0 C-N-CA 126.727 2.011 . . . . 0.87 115.874 178.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . 0.259 0.3 OUTLIER -83.23 70.21 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.915 0 CA-C-O 127.888 3.709 . . . . 0.60999999999999999 110.842 -172.133 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -161.2 -54.32 0.05 OUTLIER 'General case' 0 N--CA 1.424 -1.752 1 CA-C-N 107.896 -4.229 . . . . 1.6100000000000001 105.595 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp -109.43 -22.98 11.76 Favored 'General case' 0 C--N 1.364 1.228 0 N-CA-C 116.868 2.173 . . . . 4.3200000000000003 116.868 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -22.26 -15.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 2 C-N-CA 138.626 6.77 . . . . 4.7999999999999998 122.629 -168.59 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.51 43.37 2.74 Favored Glycine 0 C--N 1.338 0.685 1 C-N-CA 130.906 4.098 . . . . 2.21 115.757 -175.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.23 -170.18 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.752 0 C-N-CA 126.758 2.023 . . . . 1.6399999999999999 110.806 -177.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 46.6 tp -68.89 -30.87 69.45 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 128.639 2.776 . . . . 0.64000000000000001 114.965 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -108.06 117.96 53.78 Favored Pre-proline 0 C--N 1.36 1.033 0 N-CA-C 103.838 -2.653 . . . . 1.52 103.838 175.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -75.14 -39.58 1.12 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.475 3.45 . . . . 0.67000000000000004 113.584 -167.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 62.3 t -109.62 115.17 48.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.708 0 C-N-CA 125.681 1.592 . . . . 1.1599999999999999 112.881 -177.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . 0.513 ' H ' ' CB ' ' E' ' 26' ' ' SER . 6.5 mt -88.87 128.07 41.25 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 C-N-CA 127.091 2.156 . . . . 1.28 105.273 166.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 24.8 t -122.98 150.17 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 O-C-N 120.343 -1.473 . . . . 1.04 109.041 -178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 39' ' ' ARG . . . . . 0.6 ' HB2' ' H ' ' E' ' 23' ' ' THR . 42.5 mtp180 -74.28 168.62 19.28 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 127.34 2.256 . . . . 3.1400000000000001 111.322 172.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . 0.25 21.4 m-85 -139.66 123.83 17.88 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 124.269 1.985 . . . . 1.26 111.329 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -54.37 -43.8 71.66 Favored 'General case' 0 N--CA 1.439 -1.0 1 C-N-CA 137.565 6.346 . . . . 1.8100000000000001 119.109 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 46.6 mtm105 -131.9 93.61 3.33 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 107.486 -1.302 . . . . 1.29 107.486 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 t -78.67 71.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.418 0 CA-C-O 125.33 2.491 . . . . 1.7 109.912 174.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -139.57 40.69 2.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 128.214 2.606 . . . . 2.1800000000000002 106.934 -170.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -125.94 54.74 1.5 Allowed 'General case' 0 C--N 1.35 0.591 0 C-N-CA 127.977 2.511 . . . . 2.6899999999999999 105.347 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -48.94 70.73 0.0 OUTLIER 'General case' 0 C--N 1.361 1.086 1 C-N-CA 132.162 4.185 . . . . 4.6200000000000001 121.554 -172.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.17 75.85 2.24 Favored Glycine 0 C--N 1.358 1.775 0 C-N-CA 128.243 2.83 . . . . 5.3300000000000001 109.059 160.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -86.54 16.38 4.67 Favored 'General case' 0 C--N 1.364 1.214 0 C-N-CA 128.122 2.569 . . . . 5.2699999999999996 115.458 -173.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 9.2 t -96.31 -0.77 49.11 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 130.691 3.596 . . . . 7.5999999999999996 110.656 175.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.28 10.52 51.11 Favored Glycine 0 C--N 1.36 1.9 0 C-N-CA 125.661 1.601 . . . . 6.8700000000000001 114.68 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 53.4 p -104.0 -63.89 1.15 Allowed 'General case' 0 C--N 1.355 0.826 0 C-N-CA 125.773 1.629 . . . . 7.5099999999999998 113.87 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -92.48 -17.9 23.91 Favored 'General case' 0 C--N 1.367 1.355 0 N-CA-C 117.421 2.378 . . . . 5.5599999999999996 117.421 -173.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 3.3 m -95.95 21.9 8.1 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 119.864 -1.772 . . . . 4.4299999999999997 113.547 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.93 3.1 27.21 Favored Glycine 0 C--N 1.356 1.681 0 C-N-CA 127.069 2.271 . . . . 3.3900000000000001 110.867 170.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.24 109.15 25.55 Favored 'Isoleucine or valine' 0 C--N 1.362 1.142 0 CA-C-O 123.612 1.673 . . . . 1.79 112.365 -177.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -101.11 -37.71 8.46 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 130.026 3.33 . . . . 2.6800000000000002 109.065 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 12.2 p -125.67 123.46 39.0 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 130.747 3.619 . . . . 1.1399999999999999 109.592 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -116.83 151.78 35.8 Favored 'General case' 0 C--N 1.365 1.246 0 C-N-CA 126.714 2.005 . . . . 1.9399999999999999 109.887 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -78.28 129.37 34.97 Favored 'General case' 0 C--N 1.364 1.227 0 C-N-CA 126.386 1.874 . . . . 2.2200000000000002 112.56 176.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 60' ' ' PHE . . . . . 0.405 ' CE2' HG21 ' E' ' 10' ' ' ILE . 0.2 OUTLIER -127.78 169.6 13.68 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 117.177 2.288 . . . . 0.23999999999999999 117.177 -177.163 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.87 88.2 2.77 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 110.129 -3.214 . . . . 1.01 111.693 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -18.25 -24.77 0.0 OUTLIER 'General case' 0 C--N 1.355 0.811 1 C-N-CA 136.276 5.83 . . . . 1.72 120.377 171.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.03 -34.14 71.56 Favored 'General case' 0 C--N 1.371 1.531 0 C-N-CA 129.615 3.166 . . . . 0.20000000000000001 113.856 167.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.37 17.46 21.43 Favored 'General case' 0 C--N 1.368 1.378 0 C-N-CA 125.92 1.688 . . . . 1.1799999999999999 110.738 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 74.0 mt -128.27 113.44 15.65 Favored 'General case' 0 C--N 1.363 1.156 0 N-CA-C 115.301 1.593 . . . . 1.0900000000000001 115.301 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -100.46 129.83 46.46 Favored 'General case' 0 C--N 1.363 1.166 0 C-N-CA 124.837 1.255 . . . . 2.0499999999999998 111.731 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.1 128.24 35.99 Favored 'General case' 0 C--N 1.368 1.397 0 C-N-CA 130.255 3.422 . . . . 0.28999999999999998 116.49 172.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.3 -28.98 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.167 0 CA-C-N 120.639 1.563 . . . . 1.1799999999999999 113.607 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 69' ' ' GLN . . . . . 0.413 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 3.5 tp-100 -104.48 138.06 41.42 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 125.32 2.486 . . . . 2.1899999999999999 114.342 -175.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.01 57.94 4.57 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 128.918 2.887 . . . . 0.0 111.528 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.13 52.55 0.9 Allowed 'General case' 0 C--N 1.362 1.113 0 C-N-CA 126.369 1.868 . . . . 0.0 108.989 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.85 146.81 25.57 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 126.062 1.745 . . . . 0.0 110.928 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt . . . . . 0 C--O 1.261 1.686 0 C-N-CA 125.839 1.656 . . . . 0.0 108.548 177.059 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.009 0 N-CA-C 109.553 -0.536 . . . . 2.6400000000000001 109.553 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' E' E ' 2' ' ' LEU . . . . . . . . . . . . 0.318 2.5 pp -102.69 -147.25 0.37 Allowed 'General case' 0 C--N 1.355 0.828 0 C-N-CA 126.534 1.934 . . . . 1.54 114.344 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -143.82 173.39 11.73 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 130.56 3.544 . . . . 1.0 110.753 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . 0.51 ' HD2' ' HZ3' ' E' ' 73' ' ' LYS . 91.9 mtt180 -95.62 109.71 21.92 Favored 'General case' 0 C--N 1.367 1.356 0 C-N-CA 127.703 2.401 . . . . 3.9399999999999999 112.815 175.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.61 14.34 41.08 Favored Glycine 0 CA--C 1.473 -2.535 0 O-C-N 119.474 -2.016 . . . . 0.75 114.016 172.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 6' ' ' ASP . . . . . 0.468 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 19.8 t0 -84.02 146.96 27.68 Favored 'General case' 0 N--CA 1.421 -1.884 1 C-N-CA 132.106 4.162 . . . . 0.45000000000000001 105.559 178.019 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -93.65 89.82 6.37 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 105.283 -2.118 . . . . 2.54 105.283 173.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 5.4 m -86.33 142.85 12.53 Favored 'Isoleucine or valine' 0 C--N 1.366 1.31 0 N-CA-C 107.652 -1.24 . . . . 1.03 107.652 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -96.64 100.92 12.46 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 117.103 2.26 . . . . 0.17000000000000001 117.103 -169.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . 0.431 HG22 ' CE2' ' E' ' 60' ' ' PHE . 1.8 mm -38.33 97.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.575 1.909 0 C-N-CA 129.46 3.104 . . . . 1.03 119.07 171.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -117.1 45.33 1.9 Allowed 'General case' 0 C--N 1.372 1.583 0 O-C-N 118.642 -2.536 . . . . 0.29999999999999999 111.969 -175.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 12' ' ' ARG . . . . . 0.478 ' HD2' ' CE1' ' E' ' 60' ' ' PHE . 10.1 ptm180 -99.68 128.35 45.78 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 128.4 2.68 . . . . 2.7599999999999998 107.995 175.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 24.6 p -70.74 -62.18 1.49 Allowed 'General case' 0 C--N 1.359 0.989 0 C-N-CA 130.194 3.398 . . . . 0.46999999999999997 114.088 -175.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.71 72.15 0.52 Allowed 'General case' 0 C--N 1.362 1.129 0 C-N-CA 130.636 3.574 . . . . 1.8899999999999999 110.26 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 3.7 t -156.71 172.77 18.02 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 124.802 2.239 . . . . 1.3999999999999999 111.091 -170.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -97.02 -17.81 19.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 130.649 3.58 . . . . 1.1599999999999999 108.622 171.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -121.04 17.04 11.68 Favored 'General case' 0 C--N 1.367 1.367 0 N-CA-C 116.762 2.134 . . . . 0.94999999999999996 116.762 -167.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -60.66 113.14 2.3 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 117.717 2.488 . . . . 0.95999999999999996 117.717 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.47 25.94 22.05 Favored Glycine 0 C--N 1.365 2.141 0 C-N-CA 124.701 1.143 . . . . 0.39000000000000001 112.841 170.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -136.78 171.29 14.72 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 104.977 -2.231 . . . . 1.3999999999999999 104.977 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.96 176.91 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 125.124 1.37 . . . . 1.03 113.922 -173.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.78 168.75 41.6 Favored Glycine 0 C--N 1.36 1.89 0 N-CA-C 105.716 -2.954 . . . . 0.27000000000000002 105.716 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 23' ' ' THR . . . . . 0.612 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 7.5 m -89.69 137.69 32.11 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 124.692 1.197 . . . . 1.1000000000000001 110.208 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.22 113.05 20.9 Favored 'Isoleucine or valine' 0 C--N 1.348 0.517 0 CA-C-O 124.341 2.019 . . . . 1.1100000000000001 111.195 167.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.08 24.25 13.27 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 128.216 2.606 . . . . 1.0600000000000001 109.461 172.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 26' ' ' SER . . . . . 0.454 ' HB2' ' H ' ' E' ' 37' ' ' ILE . 21.1 t -81.21 -52.2 7.6 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 127.382 2.273 . . . . 0.87 116.203 -177.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.49 51.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-O 125.627 2.632 . . . . 0.60999999999999999 114.091 -164.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.89 -60.07 0.26 Allowed 'General case' 0 N--CA 1.424 -1.731 0 C-N-CA 129.269 3.028 . . . . 1.6100000000000001 105.086 -174.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -112.04 7.14 19.68 Favored 'General case' 0 C--N 1.364 1.237 0 N-CA-C 115.08 1.511 . . . . 4.3200000000000003 115.08 -177.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -35.82 -28.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 1 C-N-CA 134.193 4.997 . . . . 4.7999999999999998 119.787 -176.539 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.39 46.72 0.19 Allowed Glycine 0 C--N 1.35 1.352 1 C-N-CA 130.854 4.074 . . . . 2.21 117.606 -178.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -113.5 -155.76 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.502 0 CA-C-O 123.332 1.539 . . . . 1.6399999999999999 111.65 178.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 62.6 tp -72.55 -34.75 67.74 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 130.054 3.342 . . . . 0.64000000000000001 113.778 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -125.43 157.77 66.75 Favored Pre-proline 0 C--N 1.355 0.824 0 N-CA-C 101.736 -3.431 . . . . 1.52 101.736 174.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.96 -59.28 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 123.861 2.415 . . . . 0.67000000000000004 112.805 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 52.6 t -70.06 105.86 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.222 0 N-CA-C 117.762 2.504 . . . . 1.1599999999999999 117.762 -169.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . 0.454 ' H ' ' HB2' ' E' ' 26' ' ' SER . 18.0 mt -89.82 107.37 18.13 Favored 'Isoleucine or valine' 0 C--N 1.37 1.481 0 N-CA-C 105.748 -1.945 . . . . 1.28 105.748 170.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 38' ' ' VAL . . . . . . . . . . . . 0.26 19.4 t -112.18 149.24 14.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.473 0 CA-C-O 121.053 0.454 . . . . 1.04 110.132 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 39' ' ' ARG . . . . . 0.612 ' HB3' ' H ' ' E' ' 23' ' ' THR . 8.5 tmm_? -84.09 147.06 27.57 Favored 'General case' 0 C--N 1.366 1.311 0 C-N-CA 129.125 2.97 . . . . 3.1400000000000001 108.892 173.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -151.72 144.94 24.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 104.206 -2.516 . . . . 1.26 104.206 172.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -105.46 -2.75 23.33 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 125.523 1.529 . . . . 1.8100000000000001 112.191 175.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -86.44 45.72 1.27 Allowed 'General case' 0 C--N 1.357 0.898 0 C-N-CA 129.498 3.119 . . . . 1.29 110.49 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -96.38 167.98 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.788 1 C-N-CA 131.927 4.091 . . . . 1.7 110.467 177.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -131.34 92.92 3.26 Favored 'General case' 0 CA--C 1.5 -0.952 0 O-C-N 119.473 -2.017 . . . . 2.1800000000000002 106.226 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -76.67 4.62 9.08 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 128.465 2.706 . . . . 2.6899999999999999 116.298 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -101.34 78.83 1.92 Allowed 'General case' 0 C--N 1.366 1.286 0 C-N-CA 125.851 1.66 . . . . 4.6200000000000001 108.493 177.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.34 -22.12 65.75 Favored Glycine 0 C--N 1.362 1.994 0 O-C-N 120.532 -1.355 . . . . 5.3300000000000001 116.414 -172.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -82.93 7.48 15.32 Favored 'General case' 0 C--N 1.364 1.231 0 C-N-CA 127.011 2.124 . . . . 5.2699999999999996 114.6 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 15.0 m -101.5 -16.24 16.87 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 130.951 3.7 . . . . 7.5999999999999996 110.984 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.84 26.28 27.29 Favored Glycine 0 C--N 1.37 2.458 0 C-N-CA 126.859 2.171 . . . . 6.8700000000000001 115.008 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 30.3 t -140.49 48.08 1.75 Allowed 'General case' 0 C--N 1.357 0.911 0 O-C-N 121.115 -1.227 . . . . 7.5099999999999998 114.105 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -91.99 5.74 48.99 Favored 'General case' 0 C--N 1.367 1.349 0 O-C-N 119.543 -1.973 . . . . 5.5599999999999996 114.266 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 15.2 m -67.79 14.02 0.07 Allowed 'General case' 0 C--N 1.354 0.787 0 C-N-CA 130.475 3.51 . . . . 4.4299999999999997 117.704 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.49 125.58 7.18 Favored Glycine 0 C--N 1.351 1.366 0 C-N-CA 129.474 3.416 . . . . 3.3900000000000001 105.158 171.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.13 149.17 14.0 Favored 'Isoleucine or valine' 0 C--N 1.348 0.506 0 C-N-CA 126.092 1.757 . . . . 1.79 112.417 -170.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -89.68 -51.83 5.31 Favored 'General case' 0 C--N 1.36 1.065 0 C-N-CA 126.782 2.033 . . . . 2.6800000000000002 111.214 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 62.7 p -107.33 96.29 6.31 Favored 'General case' 0 C--N 1.363 1.185 0 C-N-CA 125.087 1.355 . . . . 1.1399999999999999 108.479 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -112.5 145.38 40.34 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 125.285 1.434 . . . . 1.9399999999999999 111.022 -174.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.76 95.5 9.59 Favored 'General case' 0 C--N 1.361 1.085 0 C-N-CA 127.43 2.292 . . . . 2.2200000000000002 110.392 -177.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 60' ' ' PHE . . . . . 0.478 ' CE1' ' HD2' ' E' ' 12' ' ' ARG . 0.5 OUTLIER -101.71 164.77 11.57 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 126.697 1.999 . . . . 0.23999999999999999 114.039 -171.494 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . 0.441 ' H ' ' HD1' ' E' ' 60' ' ' PHE . . . -97.63 90.32 4.97 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 127.656 2.382 . . . . 1.01 111.818 -177.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -16.39 -40.98 0.0 OUTLIER 'General case' 0 C--N 1.365 1.281 1 C-N-CA 134.308 5.043 . . . . 1.72 120.087 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.48 -26.4 42.32 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 128.507 2.723 . . . . 0.20000000000000001 115.964 171.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -97.55 5.21 49.85 Favored 'General case' 0 C--N 1.364 1.235 0 C-N-CA 127.171 2.188 . . . . 1.1799999999999999 111.712 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . 0.425 HD23 ' CZ ' ' E' ' 60' ' ' PHE . 0.6 OUTLIER -116.68 109.6 17.39 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 126.026 1.73 . . . . 1.0900000000000001 112.097 -175.922 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -106.08 147.7 28.64 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 124.748 1.219 . . . . 2.0499999999999998 110.383 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -75.17 142.54 43.51 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 127.323 2.249 . . . . 0.28999999999999998 116.459 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 t -127.2 -28.6 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.963 0 C-N-CA 125.646 1.578 . . . . 1.1799999999999999 108.386 173.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 69' ' ' GLN . . . . . 0.468 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 7.9 tt0 -114.02 142.39 46.23 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 124.933 2.302 . . . . 2.1899999999999999 113.173 -177.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.36 57.46 0.94 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 128.449 2.7 . . . . 0.0 111.189 174.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.07 53.23 0.6 Allowed 'General case' 0 C--N 1.367 1.355 0 C-N-CA 127.518 2.327 . . . . 0.0 115.312 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.2 137.24 40.72 Favored 'General case' 0 C--N 1.348 0.509 0 C-N-CA 127.447 2.299 . . . . 0.0 107.156 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 73' ' ' LYS . . . . . 0.51 ' HZ3' ' HD2' ' E' ' 4' ' ' ARG . 2.1 mppt? . . . . . 0 C--O 1.261 1.699 0 CA-C-O 118.477 -0.773 . . . . 0.0 110.114 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 107.874 -1.158 . . . . 2.6400000000000001 107.874 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.88 -156.28 0.55 Allowed 'General case' 0 C--N 1.353 0.732 0 N-CA-C 115.559 1.688 . . . . 1.54 115.559 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -134.63 -172.29 2.99 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 128.688 2.795 . . . . 1.0 108.954 -176.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -95.85 104.87 16.83 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 129.004 2.922 . . . . 3.9399999999999999 115.357 -176.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.37 3.51 33.09 Favored Glycine 0 C--N 1.366 2.23 0 CA-C-O 124.43 2.128 . . . . 0.75 111.45 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 6' ' ' ASP . . . . . . . . . . . . 0.34 16.2 t70 -90.35 51.41 2.02 Favored 'General case' 0 N--CA 1.424 -1.761 1 C-N-CA 132.96 4.504 . . . . 0.45000000000000001 108.945 -178.202 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -28.75 105.85 0.03 OUTLIER 'General case' 0 C--N 1.367 1.329 1 C-N-CA 133.666 4.786 . . . . 2.54 117.035 -174.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 35.1 m -90.62 150.49 3.72 Favored 'Isoleucine or valine' 0 C--N 1.36 1.036 0 C-N-CA 123.279 0.632 . . . . 1.03 111.111 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 19.4 ttm-85 -98.76 88.34 4.01 Favored 'General case' 0 C--N 1.36 1.025 0 O-C-N 120.629 -1.294 . . . . 0.17000000000000001 112.909 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -33.53 101.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.598 0 N-CA-C 119.988 3.329 . . . . 1.03 119.988 176.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 11' ' ' LYS . . . . . 0.681 ' HZ3' ' HH ' ' E' ' 18' ' ' TYR . 13.2 mmmt -103.01 42.74 1.13 Allowed 'General case' 0 C--N 1.368 1.374 0 C-N-CA 125.783 1.633 . . . . 0.29999999999999999 113.399 -174.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -98.49 123.53 42.7 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 129.389 3.075 . . . . 2.7599999999999998 111.226 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 26.4 p -71.42 -61.75 1.66 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 128.201 2.6 . . . . 0.46999999999999997 116.204 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -78.96 65.69 4.21 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 127.001 2.12 . . . . 1.8899999999999999 113.611 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 3.9 m -173.68 163.35 4.24 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 126.561 1.944 . . . . 1.3999999999999999 106.129 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -90.93 18.78 6.21 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 129.159 2.984 . . . . 1.1599999999999999 112.65 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 36.1 m0 -113.68 0.07 14.45 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 129.246 3.019 . . . . 0.94999999999999996 111.636 -175.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 18' ' ' TYR . . . . . 0.681 ' HH ' ' HZ3' ' E' ' 11' ' ' LYS . 1.2 t80 -58.3 105.57 0.3 Allowed 'General case' 0 C--N 1.37 1.49 0 C-N-CA 127.163 2.185 . . . . 0.95999999999999996 116.176 -174.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.82 26.33 53.89 Favored Glycine 0 C--N 1.366 2.243 0 O-C-N 121.137 -0.977 . . . . 0.39000000000000001 115.11 -177.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -106.34 152.94 22.91 Favored 'General case' 0 C--N 1.362 1.149 0 N-CA-C 105.989 -1.856 . . . . 1.3999999999999999 105.989 175.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -88.11 151.72 3.48 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-O 123.716 1.722 . . . . 1.03 109.969 174.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.95 167.7 28.26 Favored Glycine 0 CA--C 1.471 -2.712 0 N-CA-C 105.872 -2.891 . . . . 0.27000000000000002 105.872 170.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 23' ' ' THR . . . . . 0.45 ' HG1' ' CZ ' ' E' ' 39' ' ' ARG . 17.3 m -97.24 113.92 25.59 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 124.901 1.28 . . . . 1.1000000000000001 112.147 -175.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.16 71.79 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 128.729 2.811 . . . . 1.1100000000000001 118.307 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.01 53.93 2.96 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 116.699 -3.751 . . . . 1.0600000000000001 112.53 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 67.0 m -88.77 -58.03 2.69 Favored 'General case' 0 CA--C 1.477 -1.831 1 C-N-CA 133.549 4.74 . . . . 0.87 118.443 -173.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 m -82.51 49.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.368 1.393 0 CA-C-O 127.706 3.622 . . . . 0.60999999999999999 114.817 -163.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -135.39 -58.17 0.79 Allowed 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 110.817 -2.901 . . . . 1.6100000000000001 105.386 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -110.87 5.25 20.41 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 127.181 2.193 . . . . 4.3200000000000003 114.001 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 26.5 t -46.14 -26.35 0.75 Allowed 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 129.516 3.126 . . . . 4.7999999999999998 116.935 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.35 44.21 0.06 OUTLIER Glycine 0 C--N 1.357 1.709 1 C-N-CA 130.809 4.052 . . . . 2.21 118.327 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.54 -156.61 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.972 0 C-N-CA 128.972 2.909 . . . . 1.6399999999999999 113.144 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 25.6 tp -87.79 -12.95 43.56 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 130.849 3.66 . . . . 0.64000000000000001 114.248 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -135.25 141.62 38.53 Favored Pre-proline 0 C--N 1.358 0.966 0 N-CA-C 101.912 -3.366 . . . . 1.52 101.912 175.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -83.88 -45.1 0.06 OUTLIER 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.882 2.388 . . . . 0.67000000000000004 115.954 -168.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 36' ' ' VAL . . . . . . . . . . . . . 55.4 t -106.23 131.12 56.69 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 N-CA-C 115.597 1.702 . . . . 1.1599999999999999 115.597 -166.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 57.0 mt -105.72 126.08 61.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 C-N-CA 127.702 2.401 . . . . 1.28 105.302 172.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 74.3 t -134.43 144.4 35.22 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 O-C-N 120.703 -1.248 . . . . 1.04 109.161 -176.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 39' ' ' ARG . . . . . 0.45 ' CZ ' ' HG1' ' E' ' 23' ' ' THR . 8.1 mtm180 -69.79 163.48 25.7 Favored 'General case' 0 C--N 1.372 1.578 0 C-N-CA 127.815 2.446 . . . . 3.1400000000000001 115.827 173.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -149.02 139.12 22.19 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 124.543 1.137 . . . . 1.26 110.113 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -94.1 -32.6 13.69 Favored 'General case' 0 C--N 1.366 1.319 0 C-N-CA 125.995 1.718 . . . . 1.8100000000000001 111.508 171.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 -79.69 57.99 2.65 Favored 'General case' 0 C--N 1.373 1.59 0 C-N-CA 129.397 3.079 . . . . 1.29 112.617 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 22.2 t -94.48 162.79 2.37 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 C-N-CA 127.11 2.164 . . . . 1.7 110.225 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -101.59 71.61 1.34 Allowed 'General case' 0 C--N 1.352 0.713 0 C-N-CA 129.083 2.953 . . . . 2.1800000000000002 110.585 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -60.33 -22.06 62.78 Favored 'General case' 0 CA--C 1.536 0.415 1 C-N-CA 133.121 4.568 . . . . 2.6899999999999999 118.229 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -101.16 151.08 22.26 Favored 'General case' 0 C--N 1.361 1.08 0 O-C-N 120.28 -1.512 . . . . 4.6200000000000001 110.68 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.56 -8.84 76.48 Favored Glycine 0 C--N 1.358 1.793 0 N-CA-C 117.089 1.596 . . . . 5.3300000000000001 117.089 -169.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -75.91 -4.53 41.42 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 118.108 2.633 . . . . 5.2699999999999996 118.108 -174.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 36.1 t -102.71 -8.91 20.49 Favored 'General case' 0 C--N 1.315 -0.894 1 C-N-CA 131.886 4.074 . . . . 7.5999999999999996 111.835 174.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.91 -61.44 0.55 Allowed Glycine 0 C--N 1.361 1.952 0 CA-C-N 119.121 0.873 . . . . 6.8700000000000001 111.768 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 8.6 m -164.3 166.6 20.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 103.218 -2.882 . . . . 7.5099999999999998 103.218 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.6 8.53 30.88 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 127.92 2.488 . . . . 5.5599999999999996 115.971 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 13.8 t -106.37 38.18 2.11 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 125.979 1.712 . . . . 4.4299999999999997 111.066 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.2 50.72 2.77 Favored Glycine 0 C--N 1.359 1.815 0 C-N-CA 127.491 2.472 . . . . 3.3900000000000001 117.816 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . 0.446 5.6 p 63.2 126.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.852 1 C-N-CA 134.666 5.187 . . . . 1.79 118.048 178.157 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -98.62 -61.21 1.41 Allowed 'General case' 0 C--N 1.347 0.485 0 C-N-CA 125.974 1.71 . . . . 2.6800000000000002 109.442 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 72.7 p -105.0 115.95 31.14 Favored 'General case' 0 C--N 1.35 0.611 0 C-N-CA 126.891 2.077 . . . . 1.1399999999999999 108.585 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -105.95 147.11 29.18 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 108.639 -0.875 . . . . 1.9399999999999999 108.639 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -90.52 110.45 21.58 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 128.332 2.653 . . . . 2.2200000000000002 107.669 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -122.22 173.58 7.51 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 126.791 2.036 . . . . 0.23999999999999999 115.797 -172.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -108.15 97.31 7.02 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 130.077 3.351 . . . . 1.01 113.909 -176.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -14.34 -34.9 0.0 OUTLIER 'General case' 0 C--N 1.366 1.297 1 C-N-CA 134.683 5.193 . . . . 1.72 121.122 171.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -46.2 -46.74 17.72 Favored 'General case' 0 C--N 1.369 1.426 1 C-N-CA 132.661 4.384 . . . . 0.20000000000000001 112.606 170.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.97 16.6 25.49 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 112.744 -2.025 . . . . 1.1799999999999999 111.218 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . . 75.4 mt -129.65 98.01 4.7 Favored 'General case' 0 C--N 1.369 1.449 0 N-CA-C 114.942 1.46 . . . . 1.0900000000000001 114.942 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -105.97 143.87 33.49 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 125.692 1.597 . . . . 2.0499999999999998 111.638 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -62.45 137.23 58.22 Favored 'General case' 0 C--N 1.365 1.276 0 C-N-CA 129.307 3.043 . . . . 0.28999999999999998 117.481 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 39.3 t -132.75 -27.27 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.292 0 C-N-CA 126.815 2.046 . . . . 1.1799999999999999 110.104 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.95 146.82 41.77 Favored 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 125.9 1.68 . . . . 2.1899999999999999 108.156 177.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.67 79.75 1.39 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 129.622 3.169 . . . . 0.0 112.685 173.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.25 77.83 1.45 Allowed 'General case' 0 C--N 1.352 0.683 0 O-C-N 119.403 -2.061 . . . . 0.0 109.484 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.45 -165.89 0.77 Allowed 'General case' 0 C--N 1.353 0.723 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt . . . . . 0 C--O 1.262 1.739 0 C-N-CA 127.647 2.379 . . . . 0.0 108.399 176.1 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.724 0 CA-C-O 122.534 1.159 . . . . 0.98999999999999999 112.944 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 46.4 m-20 -123.86 -178.17 3.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 128.02 2.528 . . . . 0.80000000000000004 110.842 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -91.43 83.92 5.5 Favored 'General case' 0 C--N 1.364 1.235 0 C-N-CA 127.78 2.432 . . . . 3.3999999999999999 112.62 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 142.22 -9.06 2.44 Favored Glycine 0 CA--C 1.486 -1.74 0 CA-C-O 123.642 1.69 . . . . 0.53000000000000003 110.872 -173.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 6' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -81.63 47.98 1.13 Allowed 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 128.227 2.611 . . . . 0.45000000000000001 114.837 -172.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . 0.421 0.0 OUTLIER -11.91 97.33 0.01 OUTLIER 'General case' 0 C--N 1.361 1.089 1 C-N-CA 132.761 4.425 . . . . 2.0299999999999998 117.763 -176.161 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.8 151.54 4.1 Favored 'Isoleucine or valine' 0 C--N 1.364 1.232 0 O-C-N 119.738 -1.851 . . . . 0.13 111.18 -171.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 17.1 ttt85 -97.61 105.86 18.08 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 115.153 1.538 . . . . 0.17000000000000001 115.153 -176.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.689 HD11 HG11 ' E' ' 38' ' ' VAL . 1.3 mp -53.83 104.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.37 1.481 0 C-N-CA 129.108 2.963 . . . . 0.12 115.339 174.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -123.78 55.95 1.24 Allowed 'General case' 0 C--N 1.365 1.255 0 C-N-CA 123.762 0.825 . . . . 0.29999999999999999 109.131 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -72.75 -72.91 0.22 Allowed 'General case' 0 C--N 1.362 1.146 0 C-N-CA 126.053 1.741 . . . . 2.0899999999999999 115.188 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 84.9 m 127.44 -61.92 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.734 1 C-N-CA 133.077 4.551 . . . . 0.46999999999999997 104.774 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -77.1 72.24 3.63 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 128.241 2.616 . . . . 1.8899999999999999 111.383 173.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 42.6 t -167.44 159.79 12.68 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 106.823 -1.547 . . . . 1.1299999999999999 106.823 -174.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -90.15 -2.09 58.03 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 127.412 2.285 . . . . 0.79000000000000004 110.585 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -119.43 24.36 10.72 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 125.564 1.546 . . . . 0.75 111.082 -176.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -67.49 110.49 3.66 Favored 'General case' 0 C--N 1.369 1.425 0 C-N-CA 126.975 2.11 . . . . 0.40000000000000002 113.802 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.99 16.67 46.85 Favored Glycine 0 C--N 1.356 1.69 0 C-N-CA 125.819 1.676 . . . . 0.39000000000000001 111.272 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -108.91 164.2 12.61 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 126.305 1.842 . . . . 1.3999999999999999 110.155 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -110.27 173.29 2.21 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 C-N-CA 125.946 1.698 . . . . 0.31 108.257 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.55 174.92 42.65 Favored Glycine 0 CA--C 1.474 -2.523 0 N-CA-C 107.517 -2.233 . . . . 0.20999999999999999 107.517 167.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 23' ' ' THR . . . . . 0.78 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 23.5 m -90.21 120.05 31.05 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 126.293 1.837 . . . . 0.27000000000000002 112.219 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 24' ' ' VAL . . . . . 0.718 HG23 HG13 ' E' ' 36' ' ' VAL . 7.9 p -72.25 80.94 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 125.279 2.466 . . . . 0.28999999999999998 116.571 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.31 45.12 1.15 Allowed 'General case' 0 C--N 1.35 0.597 0 O-C-N 118.643 -2.535 . . . . 0.28999999999999998 111.885 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 13.7 t -85.08 -68.95 0.69 Allowed 'General case' 0 CA--C 1.498 -1.043 1 C-N-CA 133.149 4.58 . . . . 0.63 114.076 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 1.3 m -79.88 28.98 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.229 0 C-N-CA 127.69 2.396 . . . . 0.60999999999999999 116.04 -157.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -112.4 -60.67 1.83 Allowed 'General case' 0 N--CA 1.425 -1.675 1 C-N-CA 132.38 4.272 . . . . 1.6100000000000001 106.972 177.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.53 -27.63 8.51 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 115.422 1.638 . . . . 3.96 115.422 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.54 35.08 0.76 Allowed 'General case' 0 C--N 1.354 0.786 0 N-CA-C 115.477 1.658 . . . . 4.3399999999999999 115.477 -173.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.14 52.44 3.34 Favored Glycine 0 C--N 1.349 1.266 0 C-N-CA 129.053 3.216 . . . . 1.76 112.561 163.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 32' ' ' ILE . . . . . 0.487 HG22 ' H ' ' E' ' 33' ' ' LEU . 0.4 OUTLIER -133.94 -157.64 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.988 0 C-N-CA 129.311 3.044 . . . . 1.1100000000000001 109.93 -175.098 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 33' ' ' LEU . . . . . 0.487 ' H ' HG22 ' E' ' 32' ' ' ILE . 36.6 tp -62.93 -42.47 99.81 Favored 'General case' 0 C--N 1.358 0.935 1 C-N-CA 132.238 4.215 . . . . 0.56999999999999995 117.673 -177.3 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -110.17 134.61 20.7 Favored Pre-proline 0 C--N 1.366 1.302 0 N-CA-C 102.471 -3.159 . . . . 0.93999999999999995 102.471 172.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.4 -53.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.424 2.083 . . . . 0.67000000000000004 115.933 -167.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 36' ' ' VAL . . . . . 0.718 HG13 HG23 ' E' ' 24' ' ' VAL . 69.7 t -105.54 105.38 18.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.889 0 N-CA-C 119.316 3.08 . . . . 0.64000000000000001 119.316 -161.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 59.9 mt -83.1 125.08 40.04 Favored 'Isoleucine or valine' 0 C--N 1.38 1.895 0 O-C-N 119.247 -2.158 . . . . 0.65000000000000002 106.25 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 38' ' ' VAL . . . . . 0.689 HG11 HD11 ' E' ' 10' ' ' ILE . 55.2 t -122.72 162.64 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 119.333 0.97 . . . . 0.23000000000000001 108.927 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 39' ' ' ARG . . . . . 0.78 ' HB3' ' H ' ' E' ' 23' ' ' THR 0.256 30.8 ttp180 -82.16 147.39 29.05 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 129.825 3.25 . . . . 2.75 110.833 172.267 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -139.96 126.22 20.0 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 124.742 1.217 . . . . 1.26 107.987 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -82.48 -15.25 53.17 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 124.343 1.057 . . . . 1.02 112.051 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -115.59 75.07 0.92 Allowed 'General case' 0 C--N 1.368 1.375 0 C-N-CA 126.854 2.061 . . . . 1.29 112.285 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.366 1.306 0 C-N-CA 126.581 1.952 . . . . 1.23 115.729 -179.177 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 109.835 -0.432 . . . . 2.2000000000000002 109.835 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 21.4 p -104.29 117.15 33.52 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 129.864 3.265 . . . . 0.46999999999999997 107.269 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -148.22 136.94 21.68 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.734 1.214 . . . . 1.5700000000000001 108.253 -174.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -86.59 118.51 26.05 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 127.684 2.394 . . . . 2.0699999999999998 116.047 -175.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 60' ' ' PHE . . . . . 0.571 ' HB2' HD11 ' E' ' 65' ' ' LEU . 74.6 m-85 -105.95 171.53 7.29 Favored 'General case' 0 CA--C 1.507 -0.682 0 O-C-N 119.856 -1.778 . . . . 0.17000000000000001 112.547 177.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.42 101.53 10.88 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 129.649 3.179 . . . . 0.17000000000000001 108.711 169.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -19.94 -29.18 0.0 OUTLIER 'General case' 0 C--N 1.36 1.043 1 C-N-CA 136.467 5.907 . . . . 1.72 119.602 171.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.26 -30.69 66.78 Favored 'General case' 0 C--N 1.365 1.254 0 C-N-CA 128.629 2.772 . . . . 0.17000000000000001 113.958 171.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.52 20.47 18.49 Favored 'General case' 0 C--N 1.368 1.375 0 C-N-CA 125.777 1.631 . . . . 1.1799999999999999 110.788 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' E' ' 60' ' ' PHE . 52.0 mt -137.59 116.91 12.72 Favored 'General case' 0 C--N 1.374 1.667 0 N-CA-C 116.282 1.956 . . . . 0.19 116.282 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -106.83 138.12 43.6 Favored 'General case' 0 C--N 1.364 1.229 0 O-C-N 120.589 -1.32 . . . . 2.0499999999999998 111.604 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.35 136.72 53.41 Favored 'General case' 0 C--N 1.366 1.29 1 C-N-CA 131.909 4.084 . . . . 0.28999999999999998 118.434 174.65 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 10.0 t -132.7 -40.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.618 -1.301 . . . . 0.72999999999999998 114.121 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 69' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -104.83 120.87 42.43 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 123.486 1.612 . . . . 2.1899999999999999 114.883 -172.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.0 51.72 0.15 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.265 2.226 . . . . 0.0 115.511 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.49 60.66 6.15 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 127.036 2.134 . . . . 0.0 112.295 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.63 114.16 26.04 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 125.991 1.716 . . . . 0.0 110.179 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 50.5 mttp . . . . . 0 C--O 1.262 1.741 0 CA-C-O 117.351 -1.309 . . . . 0.0 111.484 178.135 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.409 0 N-CA-C 114.833 1.42 . . . . 0.98999999999999999 114.833 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . 0.257 1.0 OUTLIER -142.47 -175.56 4.51 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 104.62 -2.363 . . . . 0.80000000000000004 104.62 176.464 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.39 60.42 5.22 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 130.135 3.374 . . . . 3.3999999999999999 116.594 -175.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 5' ' ' GLY . . . . . 0.415 ' H ' ' H ' ' E' ' 6' ' ' ASP . . . 166.63 1.07 0.04 OUTLIER Glycine 0 CA--C 1.477 -2.341 0 O-C-N 120.088 -1.633 . . . . 0.53000000000000003 113.457 -175.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 6' ' ' ASP . . . . . 0.495 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 65.5 t0 -76.76 136.29 39.02 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.797 2.039 . . . . 0.45000000000000001 113.454 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -80.8 80.52 7.25 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 127.05 2.14 . . . . 2.0299999999999998 108.07 169.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 8' ' ' VAL . . . . . 0.4 ' H ' HG22 ' E' ' 8' ' ' VAL . 13.9 m -89.97 135.6 25.89 Favored 'Isoleucine or valine' 0 C--N 1.374 1.672 0 N-CA-C 103.365 -2.828 . . . . 0.13 103.365 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -95.52 110.38 22.46 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 120.89 1.677 . . . . 0.17000000000000001 114.544 -172.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.532 HD11 HG11 ' E' ' 38' ' ' VAL . 10.5 mm -52.18 108.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.378 1.807 0 N-CA-C 118.19 2.663 . . . . 0.12 118.19 175.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -117.9 48.82 1.32 Allowed 'General case' 0 C--N 1.37 1.486 0 CA-C-O 123.203 1.478 . . . . 0.29999999999999999 107.923 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -101.62 128.97 47.65 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 130.277 3.431 . . . . 2.0899999999999999 109.485 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 20.9 p -74.69 -58.67 3.14 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 128.8 2.84 . . . . 0.46999999999999997 113.268 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -66.07 48.75 0.03 OUTLIER 'General case' 0 C--N 1.359 0.998 0 C-N-CA 129.295 3.038 . . . . 1.8899999999999999 116.529 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 53.3 m -167.48 166.5 14.26 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 119.575 -1.953 . . . . 1.1299999999999999 106.631 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -92.96 15.56 14.65 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 119.645 -1.91 . . . . 0.79000000000000004 113.727 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -116.44 13.14 15.39 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 126.811 2.045 . . . . 0.75 111.86 -175.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -61.82 105.98 0.63 Allowed 'General case' 0 C--N 1.367 1.34 0 C-N-CA 127.519 2.328 . . . . 0.40000000000000002 114.598 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.58 9.01 44.88 Favored Glycine 0 C--N 1.363 2.047 0 C-N-CA 123.959 0.79 . . . . 0.39000000000000001 112.975 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -107.99 174.57 5.82 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 127.984 2.514 . . . . 1.3999999999999999 109.948 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 p -108.68 178.74 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.437 0 C-N-CA 125.482 1.513 . . . . 0.31 110.492 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.29 174.55 47.04 Favored Glycine 0 CA--C 1.477 -2.335 0 O-C-N 119.829 -1.795 . . . . 0.20999999999999999 108.918 171.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 23' ' ' THR . . . . . 0.56 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 8.3 m -106.65 115.09 29.6 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 125.054 1.342 . . . . 0.27000000000000002 110.43 -177.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 p -68.79 85.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 125.779 1.632 . . . . 0.28999999999999998 113.545 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.96 50.0 1.88 Allowed 'General case' 0 C--N 1.355 0.804 0 O-C-N 119.947 -1.721 . . . . 0.28999999999999998 110.967 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 26' ' ' SER . . . . . 0.561 ' HB3' ' H ' ' E' ' 37' ' ' ILE . 19.3 p -94.71 -71.8 0.65 Allowed 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 120.298 3.444 . . . . 0.63 120.298 -174.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 27' ' ' VAL . . . . . 0.406 HG12 ' H ' ' E' ' 27' ' ' VAL . 7.3 p -81.13 56.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.755 2 C-N-CA 132.84 4.456 . . . . 0.60999999999999999 111.823 -167.909 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -141.82 -45.62 0.35 Allowed 'General case' 0 N--CA 1.411 -2.399 2 CA-C-N 107.49 -4.414 . . . . 1.6100000000000001 102.126 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -109.3 -39.21 5.29 Favored 'General case' 0 C--N 1.368 1.41 0 C-N-CA 129.67 3.188 . . . . 3.96 113.643 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 23.6 m -69.87 53.36 0.12 Allowed 'General case' 0 C--N 1.364 1.216 0 C-N-CA 131.228 3.811 . . . . 4.3399999999999999 118.527 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.6 47.0 3.39 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 109.65 -3.432 . . . . 1.76 111.368 153.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 32' ' ' ILE . . . . . 0.435 HG22 ' H ' ' E' ' 33' ' ' LEU . 0.5 OUTLIER -140.15 -153.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.246 0 C-N-CA 126.98 2.112 . . . . 1.1100000000000001 110.031 -175.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 33' ' ' LEU . . . . . 0.435 ' H ' HG22 ' E' ' 32' ' ' ILE . 40.8 tp -65.8 -43.25 89.24 Favored 'General case' 0 C--N 1.354 0.798 1 C-N-CA 132.565 4.346 . . . . 0.56999999999999995 117.0 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -108.8 128.3 25.77 Favored Pre-proline 0 C--N 1.356 0.888 0 O-C-N 120.367 -1.458 . . . . 0.93999999999999995 107.176 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.19 -28.61 4.63 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 124.411 3.408 . . . . 0.67000000000000004 112.791 -174.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 36' ' ' VAL . . . . . 0.642 HG12 HG23 ' E' ' 38' ' ' VAL . 59.4 t -110.72 138.34 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 130.4 3.48 . . . . 0.64000000000000001 108.188 -177.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 37' ' ' ILE . . . . . 0.561 ' H ' ' HB3' ' E' ' 26' ' ' SER . 63.5 mt -138.29 121.92 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 2 N-CA-C 95.13 -5.878 . . . . 0.65000000000000002 95.13 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 38' ' ' VAL . . . . . 0.642 HG23 HG12 ' E' ' 36' ' ' VAL . 62.3 t -124.25 157.49 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 CA-C-N 122.492 2.406 . . . . 0.23000000000000001 111.901 -170.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 39' ' ' ARG . . . . . 0.56 ' HB3' ' H ' ' E' ' 23' ' ' THR . 0.0 OUTLIER -83.64 144.01 29.71 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 128.035 2.534 . . . . 2.75 112.176 174.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -129.78 128.57 42.66 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 114.636 -1.166 . . . . 1.26 107.933 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -98.35 -15.44 19.72 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 126.18 1.792 . . . . 1.02 110.805 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -115.35 60.56 0.7 Allowed 'General case' 0 C--N 1.355 0.823 0 C-N-CA 131.048 3.739 . . . . 1.29 110.424 -177.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 C--N 1.355 0.809 0 C-N-CA 126.494 1.918 . . . . 1.23 109.114 178.349 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 25.3 p30 . . . . . 0 C--O 1.224 -0.238 0 CA-C-O 121.267 0.556 . . . . 2.2000000000000002 112.415 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 2.9 p -132.17 129.28 39.58 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 130.202 3.401 . . . . 0.46999999999999997 105.582 -177.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -154.43 150.38 27.81 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 104.734 -2.321 . . . . 1.5700000000000001 104.734 -174.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -78.51 125.21 29.05 Favored 'General case' 0 C--N 1.353 0.717 1 C-N-CA 131.811 4.044 . . . . 2.0699999999999998 116.334 -169.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 60' ' ' PHE . . . . . 0.544 ' HB3' HD21 ' E' ' 65' ' ' LEU . 19.3 m-85 -128.89 154.91 46.04 Favored 'General case' 0 C--N 1.36 1.06 0 CA-C-O 124.042 1.877 . . . . 0.17000000000000001 114.036 -173.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.42 101.92 10.59 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 112.337 -2.21 . . . . 0.17000000000000001 109.941 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -27.27 -26.95 0.0 OUTLIER 'General case' 0 C--N 1.372 1.553 1 C-N-CA 132.155 4.182 . . . . 1.72 121.132 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -46.9 -49.64 20.07 Favored 'General case' 0 C--N 1.374 1.66 0 C-N-CA 131.028 3.731 . . . . 0.17000000000000001 113.601 167.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 11.6 pm0 -95.07 10.02 37.35 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-N 114.121 -1.399 . . . . 1.1799999999999999 112.942 -172.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' E' ' 60' ' ' PHE . 0.2 OUTLIER -115.3 120.64 40.32 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.824 1.65 . . . . 0.19 111.215 -177.603 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -100.15 115.15 29.16 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 125.763 1.625 . . . . 2.0499999999999998 111.116 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.56 132.02 46.75 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 129.087 2.955 . . . . 0.28999999999999998 118.535 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.63 -39.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.275 0 C-N-CA 124.407 1.083 . . . . 0.72999999999999998 113.436 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 69' ' ' GLN . . . . . 0.495 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 25.6 tt0 -112.22 106.86 15.54 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 116.327 1.973 . . . . 2.1899999999999999 116.327 -171.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.27 63.85 0.15 Allowed 'General case' 0 CA--C 1.557 1.225 0 O-C-N 119.734 -1.854 . . . . 0.0 115.957 170.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.35 53.72 0.41 Allowed 'General case' 0 C--N 1.369 1.453 0 C-N-CA 128.112 2.565 . . . . 0.0 117.12 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.74 160.07 15.13 Favored 'General case' 0 C--N 1.35 0.591 0 C-N-CA 128.313 2.645 . . . . 0.0 116.089 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt . . . . . 0 C--O 1.261 1.708 0 C-N-CA 128.905 2.882 . . . . 0.0 108.83 176.976 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.447 0 N-CA-C 116.718 2.118 . . . . 0.98999999999999999 116.718 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.31 153.85 44.21 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 129.1 2.96 . . . . 0.80000000000000004 104.43 177.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . 0.282 0.0 OUTLIER -86.29 121.62 29.13 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 119.55 3.167 . . . . 3.3999999999999999 119.55 -171.518 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.4 -0.69 14.24 Favored Glycine 0 C--N 1.365 2.19 0 C-N-CA 126.372 1.939 . . . . 0.53000000000000003 110.856 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 6' ' ' ASP . . . . . 0.421 ' HA ' ' HB2' ' E' ' 69' ' ' GLN . 56.2 t0 -70.26 146.16 50.84 Favored 'General case' 0 N--CA 1.423 -1.818 1 C-N-CA 132.937 4.495 . . . . 0.45000000000000001 112.054 -178.763 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -82.48 76.53 9.34 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 125.315 1.446 . . . . 2.0299999999999998 108.743 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 28.8 m -87.6 144.97 8.15 Favored 'Isoleucine or valine' 0 C--N 1.371 1.532 0 O-C-N 119.815 -1.803 . . . . 0.13 107.312 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -109.99 117.12 32.94 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 114.754 1.39 . . . . 0.17000000000000001 114.754 -169.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 14.2 mm -63.96 126.03 21.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.834 0 C-N-CA 128.508 2.723 . . . . 0.12 118.012 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.87 39.38 3.53 Favored 'General case' 0 C--N 1.365 1.281 0 N-CA-C 115.945 1.831 . . . . 0.29999999999999999 115.945 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -108.47 147.57 31.47 Favored 'General case' 0 C--N 1.368 1.371 0 O-C-N 118.942 -2.349 . . . . 2.0899999999999999 110.685 174.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 13.3 t -105.14 24.17 12.46 Favored 'General case' 0 C--N 1.364 1.231 0 C-N-CA 125.314 1.446 . . . . 0.46999999999999997 112.347 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -90.83 11.51 22.28 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 127.763 2.425 . . . . 1.8899999999999999 112.832 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 3.3 t -169.12 -173.66 1.82 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.012 1.325 . . . . 1.1299999999999999 107.657 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -92.77 21.12 5.82 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 130.001 3.321 . . . . 0.79000000000000004 112.266 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -111.51 6.96 20.5 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 127.99 2.516 . . . . 0.75 110.012 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -64.1 101.46 0.4 Allowed 'General case' 0 C--N 1.367 1.363 0 C-N-CA 127.988 2.515 . . . . 0.40000000000000002 114.911 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.77 40.36 4.69 Favored Glycine 0 C--N 1.359 1.809 0 C-N-CA 125.758 1.647 . . . . 0.39000000000000001 111.368 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -132.93 146.18 51.56 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 123.399 1.571 . . . . 1.3999999999999999 113.254 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.32 147.8 4.98 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 C-N-CA 130.211 3.404 . . . . 0.31 112.019 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.96 -179.21 34.6 Favored Glycine 0 CA--C 1.478 -2.225 0 N-CA-C 107.995 -2.042 . . . . 0.20999999999999999 107.995 173.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 23' ' ' THR . . . . . 0.659 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 30.1 m -88.93 129.12 35.68 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 124.861 1.264 . . . . 0.27000000000000002 109.711 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 24' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' E' ' 26' ' ' SER . 14.9 p -75.64 92.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 124.795 2.236 . . . . 0.28999999999999998 113.624 174.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.55 23.55 2.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.824 2.05 . . . . 0.28999999999999998 113.236 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 26' ' ' SER . . . . . 0.466 ' HB3' HG22 ' E' ' 24' ' ' VAL . 28.6 t -64.82 -66.09 0.59 Allowed 'General case' 0 C--N 1.364 1.211 1 C-N-CA 131.85 4.06 . . . . 0.63 115.315 178.747 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -85.44 53.88 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.745 0 CA-C-O 124.017 1.865 . . . . 0.60999999999999999 113.054 -166.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.81 -67.09 0.05 OUTLIER 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 127.377 2.271 . . . . 1.6100000000000001 107.422 -171.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -104.28 -9.17 18.77 Favored 'General case' 0 C--N 1.363 1.181 0 N-CA-C 115.083 1.512 . . . . 3.96 115.083 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.23 24.51 1.85 Allowed 'General case' 0 C--N 1.363 1.17 0 N-CA-C 115.532 1.679 . . . . 4.3399999999999999 115.532 -176.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.77 46.71 0.16 Allowed Glycine 0 C--N 1.364 2.124 0 C-N-CA 130.05 3.691 . . . . 1.76 115.806 168.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -130.94 -159.33 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.672 1 C-N-CA 132.995 4.518 . . . . 1.1100000000000001 107.418 -176.783 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 39.7 tp -69.24 -34.37 74.7 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 130.411 3.484 . . . . 0.56999999999999995 117.821 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -106.45 146.44 33.01 Favored Pre-proline 0 C--N 1.358 0.953 0 C-N-CA 125.092 1.357 . . . . 0.93999999999999995 109.211 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.52 -43.66 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.624 2.883 . . . . 0.67000000000000004 114.597 -170.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 36' ' ' VAL . . . . . 0.492 HG11 ' CD1' ' E' ' 65' ' ' LEU . 60.9 t -109.43 128.02 65.74 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 115.305 1.594 . . . . 0.64000000000000001 115.305 -170.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 19.0 mt -109.09 142.22 22.23 Favored 'Isoleucine or valine' 0 C--N 1.36 1.054 0 N-CA-C 103.7 -2.704 . . . . 0.65000000000000002 103.7 162.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 17.8 t -134.8 159.22 41.72 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 N-CA-C 107.308 -1.367 . . . . 0.23000000000000001 107.308 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 39' ' ' ARG . . . . . 0.659 ' HB3' ' H ' ' E' ' 23' ' ' THR . 41.1 ttp85 -83.82 147.48 27.54 Favored 'General case' 0 C--N 1.354 0.766 1 C-N-CA 131.854 4.062 . . . . 2.75 111.914 172.735 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -133.68 128.13 34.36 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 125.07 1.348 . . . . 1.26 108.218 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.24 -16.95 30.04 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 128.445 2.698 . . . . 1.02 112.299 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -99.03 61.6 1.26 Allowed 'General case' 0 C--N 1.356 0.863 1 C-N-CA 132.119 4.168 . . . . 1.29 110.765 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.361 1.106 0 C-N-CA 129.13 2.972 . . . . 1.23 104.153 169.087 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 . . . . . 0 CA--C 1.544 0.733 0 CA-C-O 119.654 -0.212 . . . . 2.2000000000000002 111.442 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 22.9 p -126.29 134.78 51.05 Favored 'General case' 0 C--N 1.362 1.128 0 O-C-N 119.927 -1.733 . . . . 0.46999999999999997 110.164 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -162.06 161.58 28.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.871 1.668 . . . . 1.5700000000000001 107.194 175.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -97.1 154.45 17.33 Favored 'General case' 0 C--N 1.361 1.101 0 CA-C-O 124.032 1.872 . . . . 2.0699999999999998 113.897 -176.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 60' ' ' PHE . . . . . 0.406 ' CB ' HD21 ' E' ' 65' ' ' LEU . 95.0 m-85 -135.94 169.55 17.41 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 112.481 -2.145 . . . . 0.17000000000000001 113.489 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -109.46 108.58 19.14 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 111.064 -2.789 . . . . 0.17000000000000001 107.788 172.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -25.66 -17.94 0.0 OUTLIER 'General case' 0 C--N 1.367 1.341 2 C-N-CA 134.395 5.078 . . . . 1.72 122.0 176.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -65.99 -32.41 73.88 Favored 'General case' 0 C--N 1.371 1.502 0 C-N-CA 130.97 3.708 . . . . 0.17000000000000001 110.937 166.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -84.85 -11.76 54.99 Favored 'General case' 0 C--N 1.364 1.217 0 O-C-N 120.742 -1.224 . . . . 1.1799999999999999 110.705 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.492 ' CD1' HG11 ' E' ' 36' ' ' VAL . 0.3 OUTLIER -106.81 108.57 20.14 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 115.708 1.744 . . . . 0.19 115.708 -171.555 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -96.43 133.17 41.19 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 125.596 1.558 . . . . 2.0499999999999998 108.772 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 67' ' ' LEU . . . . . 0.466 ' H ' HD23 ' E' ' 67' ' ' LEU 0.297 2.4 pt? -87.36 153.09 21.73 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-N 123.1 2.682 . . . . 0.28999999999999998 117.017 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 t -125.44 -27.42 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.121 0 C-N-CA 126.088 1.755 . . . . 0.72999999999999998 110.782 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 69' ' ' GLN . . . . . 0.421 ' HB2' ' HA ' ' E' ' 6' ' ' ASP . 2.5 mm-40 -113.85 160.98 18.15 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 127.018 3.294 . . . . 2.1899999999999999 114.786 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.73 56.36 0.7 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 108.886 -3.779 . . . . 0.0 111.651 173.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.71 58.78 1.89 Allowed 'General case' 0 C--N 1.365 1.253 0 O-C-N 120.205 -1.56 . . . . 0.0 114.553 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.95 91.93 7.13 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 128.753 2.821 . . . . 0.0 112.308 -176.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 75.7 mttt . . . . . 0 C--O 1.262 1.738 0 CA-C-O 117.624 -1.179 . . . . 0.0 109.104 174.463 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' E' E ' 2' ' ' LEU . . . . . 0.572 HD11 HG21 ' E' ' 36' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 117.998 2.592 . . . . 0.98999999999999999 117.998 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 3' ' ' ASN . . . . . 0.452 ' O ' HG11 ' E' ' 24' ' ' VAL . 1.0 OUTLIER -135.61 178.49 7.0 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 129.11 2.964 . . . . 0.80000000000000004 110.127 -175.66 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 4' ' ' ARG . . . . . 0.433 ' CZ ' ' H ' ' E' ' 4' ' ' ARG . 0.0 OUTLIER -94.65 104.98 16.91 Favored 'General case' 0 C--N 1.376 1.753 0 C-N-CA 128.699 2.8 . . . . 3.3999999999999999 114.423 173.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 5' ' ' GLY . . . . . 0.538 ' H ' ' CG1' ' E' ' 24' ' ' VAL . . . 113.34 -3.34 25.13 Favored Glycine 0 CA--C 1.485 -1.799 0 O-C-N 118.079 -2.888 . . . . 0.53000000000000003 110.175 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 6' ' ' ASP . . . . . 0.604 ' HA ' ' HB2' ' E' ' 69' ' ' GLN . 43.5 t0 -68.4 127.79 34.25 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 130.292 3.437 . . . . 0.45000000000000001 110.381 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -82.56 80.17 8.78 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 106.711 -1.588 . . . . 2.0299999999999998 106.711 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 8' ' ' VAL . . . . . 0.423 HG22 ' HB ' ' E' ' 24' ' ' VAL . 12.7 m -84.51 142.32 13.49 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 O-C-N 121.665 -0.647 . . . . 0.13 109.951 -173.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -108.02 129.28 55.14 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 118.322 -0.847 . . . . 0.17000000000000001 111.838 -172.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.439 HG21 ' CE1' ' E' ' 60' ' ' PHE . 3.7 mm -74.01 118.53 19.69 Favored 'Isoleucine or valine' 0 C--N 1.365 1.272 0 N-CA-C 115.141 1.534 . . . . 0.12 115.141 175.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -107.59 36.89 2.57 Favored 'General case' 0 C--N 1.373 1.621 0 O-C-N 119.574 -1.954 . . . . 0.29999999999999999 114.072 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -102.52 99.26 9.27 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 129.853 3.261 . . . . 2.0899999999999999 112.663 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 13' ' ' THR . . . . . 0.591 ' HA ' ' CG ' ' E' ' 18' ' ' TYR . 4.1 m -58.58 -34.37 71.0 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 129.081 2.953 . . . . 0.46999999999999997 117.912 -175.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.72 44.01 0.21 Allowed 'General case' 0 C--N 1.346 0.442 0 C-N-CA 129.199 2.999 . . . . 1.8899999999999999 115.003 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 17.1 t -172.2 175.1 3.8 Favored 'General case' 0 C--N 1.365 1.257 0 C-N-CA 125.343 1.457 . . . . 1.1299999999999999 107.4 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -92.19 7.13 43.99 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 129.975 3.31 . . . . 0.79000000000000004 111.124 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 38.5 m0 -106.32 10.51 31.63 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 127.247 2.219 . . . . 0.75 109.478 178.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 18' ' ' TYR . . . . . 0.591 ' CG ' ' HA ' ' E' ' 13' ' ' THR . 18.5 t80 -69.79 101.68 1.76 Allowed 'General case' 0 C--N 1.374 1.635 0 C-N-CA 126.333 1.853 . . . . 0.40000000000000002 113.276 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.18 39.69 6.34 Favored Glycine 0 C--N 1.356 1.667 0 C-N-CA 125.359 1.457 . . . . 0.39000000000000001 111.898 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -109.86 135.7 50.32 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 119.043 1.421 . . . . 1.3999999999999999 109.065 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -97.17 164.82 2.18 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 125.579 1.552 . . . . 0.31 110.582 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.19 177.67 47.08 Favored Glycine 0 CA--C 1.47 -2.772 0 N-CA-C 107.056 -2.418 . . . . 0.20999999999999999 107.056 170.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 23' ' ' THR . . . . . 0.481 ' H ' ' CB ' ' E' ' 39' ' ' ARG . 6.9 m -86.77 130.47 34.46 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 125.348 2.499 . . . . 0.27000000000000002 110.801 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 24' ' ' VAL . . . . . 0.538 ' CG1' ' H ' ' E' ' 5' ' ' GLY . 11.8 p -62.32 73.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 131.176 3.79 . . . . 0.28999999999999998 116.062 174.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.96 25.65 0.36 Allowed 'General case' 0 CA--C 1.551 1.012 0 O-C-N 116.475 -3.891 . . . . 0.28999999999999998 114.131 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 26' ' ' SER . . . . . . . . . . . . 0.271 1.5 m -73.86 -25.65 60.16 Favored 'General case' 0 CA--C 1.5 -0.964 1 C-N-CA 136.376 5.87 . . . . 0.63 117.155 175.488 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -114.27 49.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 124.778 1.231 . . . . 0.60999999999999999 109.083 -171.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.34 -56.93 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 124.024 0.93 . . . . 1.6100000000000001 108.905 -169.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -109.43 8.86 25.51 Favored 'General case' 0 C--N 1.36 1.049 0 C-N-CA 126.357 1.863 . . . . 3.96 111.799 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 4.9 m -27.22 -41.12 0.01 OUTLIER 'General case' 0 C--N 1.361 1.08 1 C-N-CA 135.909 5.684 . . . . 4.3399999999999999 121.05 -175.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.35 42.27 0.13 Allowed Glycine 0 C--N 1.348 1.244 1 C-N-CA 131.845 4.545 . . . . 1.76 118.172 -171.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.78 -167.24 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.457 0 C-N-CA 125.04 1.336 . . . . 1.1100000000000001 110.292 176.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 38.0 tp -65.34 -33.89 77.03 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 129.629 3.172 . . . . 0.56999999999999995 116.86 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -135.12 132.82 20.37 Favored Pre-proline 0 N--CA 1.469 0.499 0 N-CA-C 101.501 -3.518 . . . . 0.93999999999999995 101.501 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.02 -46.63 1.44 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.779 2.986 . . . . 0.67000000000000004 116.573 -160.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 36' ' ' VAL . . . . . 0.572 HG21 HD11 ' E' ' 2' ' ' LEU . 54.3 t -80.83 103.02 7.24 Favored 'Isoleucine or valine' 0 C--N 1.368 1.372 0 N-CA-C 114.417 1.266 . . . . 0.64000000000000001 114.417 -175.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 20.5 mt -89.82 118.72 35.65 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 N-CA-C 106.05 -1.833 . . . . 0.65000000000000002 106.05 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 37.7 t -109.7 145.56 16.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 O-C-N 119.685 -1.884 . . . . 0.23000000000000001 109.646 176.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 39' ' ' ARG . . . . . 0.481 ' CB ' ' H ' ' E' ' 23' ' ' THR . 8.1 tmm_? -42.85 -32.65 0.65 Allowed 'General case' 0 C--N 1.359 0.994 2 C-N-CA 134.467 5.107 . . . . 2.75 123.564 -177.243 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.22 129.44 34.5 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 120.794 3.627 . . . . 1.26 120.794 -162.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -88.53 38.02 0.85 Allowed 'General case' 0 C--N 1.356 0.875 0 C-N-CA 128.934 2.894 . . . . 1.02 113.324 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -96.08 36.13 1.35 Allowed 'General case' 0 C--N 1.348 0.535 1 C-N-CA 131.97 4.108 . . . . 1.29 110.428 -176.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . 0.263 10.9 m . . . . . 0 N--CA 1.449 -0.487 0 C-N-CA 127.725 2.41 . . . . 1.23 110.978 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 121.693 0.759 . . . . 2.2000000000000002 112.491 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 16.1 p -114.78 125.3 53.54 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 101.388 -3.56 . . . . 0.46999999999999997 101.388 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -122.8 133.48 54.45 Favored 'General case' 0 C--N 1.358 0.939 0 O-C-N 120.098 -1.626 . . . . 1.5700000000000001 113.131 -168.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -88.13 112.5 22.76 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 129.294 3.038 . . . . 2.0699999999999998 115.7 -174.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 60' ' ' PHE . . . . . 0.439 ' CE1' HG21 ' E' ' 10' ' ' ILE . 97.7 m-85 -115.46 173.5 6.49 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 115.47 1.655 . . . . 0.17000000000000001 115.47 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.53 85.85 4.65 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 129.503 3.121 . . . . 0.17000000000000001 110.755 172.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -15.91 -23.4 0.0 OUTLIER 'General case' 0 C--N 1.36 1.043 1 C-N-CA 138.108 6.563 . . . . 1.72 121.331 172.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.07 -37.26 69.66 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 130.366 3.466 . . . . 0.17000000000000001 113.831 171.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . 0.275 2.0 pp20? -97.46 16.03 21.43 Favored 'General case' 0 C--N 1.373 1.624 0 C-N-CA 126.35 1.86 . . . . 1.1799999999999999 111.331 -177.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.466 ' CD1' HG11 ' E' ' 36' ' ' VAL . 0.3 OUTLIER -112.96 104.58 12.55 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 128.427 2.691 . . . . 0.19 108.206 172.56 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -94.53 150.48 20.2 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 125.867 1.667 . . . . 2.0499999999999998 111.15 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -74.47 142.04 44.9 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 117.851 2.537 . . . . 0.28999999999999998 117.851 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 3.4 t -135.6 -27.9 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.072 0 C-N-CA 126.206 1.802 . . . . 0.72999999999999998 110.499 171.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 69' ' ' GLN . . . . . 0.604 ' HB2' ' HA ' ' E' ' 6' ' ' ASP 0.342 19.8 mt-30 -118.59 113.58 21.47 Favored 'General case' 0 C--N 1.361 1.075 0 CA-C-O 123.489 1.614 . . . . 2.1899999999999999 113.613 174.827 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.86 56.96 0.99 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 127.804 2.442 . . . . 0.0 111.523 169.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.02 58.2 0.22 Allowed 'General case' 0 C--N 1.355 0.834 0 C-N-CA 128.365 2.666 . . . . 0.0 117.796 -169.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.06 73.02 0.89 Allowed 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt . . . . . 0 C--O 1.262 1.746 0 C-N-CA 127.661 2.384 . . . . 0.0 111.704 177.969 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' E' E ' 2' ' ' LEU . . . . . 0.488 HD22 HG11 ' E' ' 8' ' ' VAL 0.328 1.8 pp . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 115.969 1.841 . . . . 0.98999999999999999 115.969 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -144.36 176.08 9.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 129.773 3.229 . . . . 0.80000000000000004 111.223 -171.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 4' ' ' ARG . . . . . 0.421 ' HG2' HG13 ' E' ' 27' ' ' VAL . 0.0 OUTLIER -96.59 102.7 14.52 Favored 'General case' 0 C--N 1.37 1.462 0 O-C-N 119.51 -1.994 . . . . 3.3999999999999999 112.165 174.527 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.47 4.58 11.9 Favored Glycine 0 C--N 1.363 2.059 0 CA-C-O 124.087 1.937 . . . . 0.53000000000000003 112.241 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 6' ' ' ASP . . . . . 0.469 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 65.3 t0 -74.89 136.81 41.46 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 130.446 3.498 . . . . 0.45000000000000001 109.508 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 7' ' ' LYS . . . . . 0.627 ' H ' ' HB2' ' E' ' 69' ' ' GLN . 41.1 mmtm -91.75 79.1 5.4 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 104.96 -2.237 . . . . 2.0299999999999998 104.96 176.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 8' ' ' VAL . . . . . 0.488 HG11 HD22 ' E' ' 2' ' ' LEU . 13.4 m -86.32 143.18 11.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 106.336 -1.727 . . . . 0.13 106.336 -177.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 9' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' E' ' 21' ' ' VAL . 23.4 ttt85 -104.16 117.74 34.97 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 113.495 0.924 . . . . 0.17000000000000001 113.495 -172.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 13.8 mm -56.66 111.66 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.376 0 N-CA-C 117.466 2.395 . . . . 0.12 117.466 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -115.35 47.63 1.29 Allowed 'General case' 0 C--N 1.368 1.408 0 C-N-CA 126.225 1.81 . . . . 0.29999999999999999 109.912 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -106.64 127.09 53.07 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 128.31 2.644 . . . . 2.0899999999999999 106.147 174.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 18.3 p -71.34 -58.67 3.31 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 129.74 3.216 . . . . 0.46999999999999997 113.496 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.11 67.43 2.41 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 130.944 3.698 . . . . 1.8899999999999999 110.04 174.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 27.8 t -163.43 159.9 22.79 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.344 -2.095 . . . . 1.1299999999999999 105.344 -172.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -92.49 -1.81 56.7 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 127.159 2.184 . . . . 0.79000000000000004 110.914 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 9.1 m0 -119.83 24.43 10.55 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 126.253 1.821 . . . . 0.75 111.721 -172.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -68.98 101.17 1.33 Allowed 'General case' 0 C--N 1.371 1.507 0 C-N-CA 125.637 1.575 . . . . 0.40000000000000002 112.758 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.96 14.66 35.92 Favored Glycine 0 C--N 1.358 1.805 0 C-N-CA 125.035 1.302 . . . . 0.39000000000000001 112.192 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -113.06 154.03 27.2 Favored 'General case' 0 C--N 1.362 1.145 0 C-N-CA 125.316 1.446 . . . . 1.3999999999999999 109.782 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 21' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' E' ' 9' ' ' ARG . 1.4 p -92.02 -176.8 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.383 0 C-N-CA 127.525 2.33 . . . . 0.31 113.423 -175.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.24 176.72 46.42 Favored Glycine 0 CA--C 1.479 -2.159 0 N-CA-C 108.839 -1.704 . . . . 0.20999999999999999 108.839 166.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 23' ' ' THR . . . . . 0.457 ' H ' ' CB ' ' E' ' 39' ' ' ARG . 29.0 m -101.89 120.73 40.85 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 124.516 1.127 . . . . 0.27000000000000002 109.99 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 24' ' ' VAL . . . . . 0.426 HG22 ' HB3' ' E' ' 26' ' ' SER . 7.1 p -75.29 88.02 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 123.292 1.52 . . . . 0.28999999999999998 113.272 178.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.6 43.95 1.15 Allowed 'General case' 0 C--N 1.353 0.75 0 C-N-CA 126.596 1.958 . . . . 0.28999999999999998 110.775 171.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 26' ' ' SER . . . . . 0.426 ' HB3' HG22 ' E' ' 24' ' ' VAL . 13.7 t -81.51 -73.27 0.39 Allowed 'General case' 0 CA--C 1.488 -1.429 1 C-N-CA 131.78 4.032 . . . . 0.63 113.753 -178.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 27' ' ' VAL . . . . . 0.421 HG13 ' HG2' ' E' ' 4' ' ' ARG . 3.8 p -82.1 54.11 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.571 0 CA-C-O 126.5 3.048 . . . . 0.60999999999999999 113.145 -160.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.57 -72.05 0.69 Allowed 'General case' 0 N--CA 1.418 -2.039 0 C-N-CA 130.663 3.585 . . . . 1.6100000000000001 103.053 175.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.34 -17.6 13.1 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 125.696 1.598 . . . . 3.96 112.754 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 30' ' ' SER . . . . . 0.455 ' HB2' ' CD1' ' E' ' 37' ' ' ILE . 1.8 t -92.41 46.92 1.27 Allowed 'General case' 0 C--N 1.367 1.344 0 O-C-N 119.435 -2.041 . . . . 4.3399999999999999 114.375 -176.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.14 51.09 4.51 Favored Glycine 0 C--N 1.341 0.809 1 C-N-CA 130.89 4.09 . . . . 1.76 111.537 162.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.84 -166.6 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.882 0 C-N-CA 130.045 3.338 . . . . 1.1100000000000001 108.695 -176.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 22.1 tp -61.37 -38.27 86.37 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 130.578 3.551 . . . . 0.56999999999999995 117.027 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -113.81 115.54 46.09 Favored Pre-proline 0 C--N 1.356 0.855 0 N-CA-C 101.521 -3.511 . . . . 0.93999999999999995 101.521 172.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -82.12 -55.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.905 2.403 . . . . 0.67000000000000004 115.533 -169.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 36' ' ' VAL . . . . . 0.643 HG12 HG23 ' E' ' 38' ' ' VAL . 24.9 t -75.21 95.69 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.019 0 N-CA-C 119.65 3.204 . . . . 0.64000000000000001 119.65 -166.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 37' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' E' ' 30' ' ' SER . 68.1 mt -87.34 119.45 35.03 Favored 'Isoleucine or valine' 0 C--N 1.368 1.41 0 N-CA-C 104.97 -2.233 . . . . 0.65000000000000002 104.97 172.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 38' ' ' VAL . . . . . 0.643 HG23 HG12 ' E' ' 36' ' ' VAL . 14.0 t -123.21 163.61 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-N 120.186 1.357 . . . . 0.23000000000000001 111.62 -172.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 39' ' ' ARG . . . . . 0.457 ' CB ' ' H ' ' E' ' 23' ' ' THR . 43.6 ttm-85 -84.43 142.09 30.35 Favored 'General case' 0 C--N 1.363 1.193 0 C-N-CA 128.859 2.864 . . . . 2.75 113.92 174.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -137.33 128.59 27.95 Favored 'General case' 0 CA--C 1.514 -0.437 0 O-C-N 121.301 -0.874 . . . . 1.26 111.474 173.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -90.27 -38.44 13.41 Favored 'General case' 0 C--N 1.366 1.325 0 C-N-CA 126.356 1.862 . . . . 1.02 111.38 172.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -77.97 59.59 2.18 Favored 'General case' 0 C--N 1.37 1.468 0 C-N-CA 129.459 3.104 . . . . 1.29 112.767 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.353 0.726 0 C-N-CA 127.125 2.17 . . . . 1.23 105.538 172.948 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 123.316 1.531 . . . . 2.2000000000000002 110.48 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 67.9 p -115.97 104.5 11.65 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 127.97 2.508 . . . . 0.46999999999999997 106.472 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -110.29 138.88 46.07 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 107.5 -1.296 . . . . 1.5700000000000001 107.5 -176.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -100.01 112.01 24.31 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-O 122.222 1.01 . . . . 2.0699999999999998 109.868 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -104.16 172.7 6.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 123.909 1.814 . . . . 0.17000000000000001 115.274 -175.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -102.42 94.13 5.52 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 112.218 -2.265 . . . . 0.17000000000000001 109.24 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -7.43 -37.79 0.0 OUTLIER 'General case' 0 C--N 1.367 1.351 1 C-N-CA 134.778 5.231 . . . . 1.72 121.21 172.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -45.61 -46.53 14.45 Favored 'General case' 0 C--N 1.364 1.212 1 C-N-CA 132.715 4.406 . . . . 0.17000000000000001 113.1 168.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -89.86 1.61 55.98 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 125.822 1.649 . . . . 1.1799999999999999 112.168 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.475 ' HG ' HG11 ' E' ' 36' ' ' VAL . 0.5 OUTLIER -115.96 108.53 16.37 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 126.664 1.986 . . . . 0.19 114.126 179.663 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -106.44 143.0 35.18 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 125.721 1.608 . . . . 2.0499999999999998 111.907 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -64.62 146.34 54.81 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 119.988 3.329 . . . . 0.28999999999999998 119.988 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -144.47 -29.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.372 1.585 0 C-N-CA 126.91 2.084 . . . . 0.72999999999999998 112.028 173.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 69' ' ' GLN . . . . . 0.627 ' HB2' ' H ' ' E' ' 7' ' ' LYS . 0.0 OUTLIER -114.51 116.47 28.88 Favored 'General case' 0 C--N 1.358 0.937 0 O-C-N 119.554 -1.966 . . . . 2.1899999999999999 111.849 177.574 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.33 59.57 1.05 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.254 2.622 . . . . 0.0 113.125 174.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.47 58.46 2.66 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 129.021 2.928 . . . . 0.0 113.51 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.0 78.66 1.18 Allowed 'General case' 0 C--N 1.356 0.879 0 C-N-CA 128.189 2.596 . . . . 0.0 115.32 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt . . . . . 0 C--O 1.262 1.716 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 176.124 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' E' E ' 2' ' ' LEU . . . . . . . . . . . . 0.271 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 118.11 2.633 . . . . 0.98999999999999999 118.11 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -136.3 -169.26 2.4 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 127.438 2.295 . . . . 0.80000000000000004 111.321 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 4' ' ' ARG . . . . . 0.499 ' HB3' HG13 ' E' ' 27' ' ' VAL . 14.4 ptm180 -96.44 110.27 22.66 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 127.568 2.347 . . . . 3.3999999999999999 114.528 176.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.25 -0.28 14.43 Favored Glycine 0 CA--C 1.477 -2.295 0 O-C-N 121.025 -1.047 . . . . 0.53000000000000003 111.998 165.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 6' ' ' ASP . . . . . 0.482 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 46.1 t0 -72.83 137.51 45.78 Favored 'General case' 0 N--CA 1.408 -2.555 1 C-N-CA 133.153 4.581 . . . . 0.45000000000000001 113.469 -176.233 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 7' ' ' LYS . . . . . 0.485 ' H ' ' CB ' ' E' ' 69' ' ' GLN . 13.7 mptt -87.87 77.37 8.54 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 106.485 -1.672 . . . . 2.0299999999999998 106.485 171.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 8' ' ' VAL . . . . . 0.4 ' H ' HG22 ' E' ' 8' ' ' VAL . 15.0 m -87.42 138.93 18.14 Favored 'Isoleucine or valine' 0 C--N 1.369 1.438 0 C-N-CA 127.168 2.187 . . . . 0.13 106.224 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -105.35 113.93 27.81 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 120.77 -1.206 . . . . 0.17000000000000001 112.55 -171.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.789 HD11 HG11 ' E' ' 38' ' ' VAL . 2.3 mm -52.89 120.89 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 N-CA-C 117.727 2.491 . . . . 0.12 117.727 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -121.06 48.48 1.64 Allowed 'General case' 0 C--N 1.372 1.563 0 C-N-CA 125.519 1.528 . . . . 0.29999999999999999 113.606 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 13.7 ttt180 -102.25 111.73 24.14 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 128.237 2.615 . . . . 2.0899999999999999 110.075 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 47.0 p -50.74 -59.13 4.41 Favored 'General case' 0 C--N 1.369 1.454 0 C-N-CA 131.279 3.831 . . . . 0.46999999999999997 119.742 -175.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -87.77 65.55 8.45 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 127.927 2.491 . . . . 1.8899999999999999 110.736 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 4.5 t -145.15 169.2 18.63 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-O 123.392 1.568 . . . . 1.1299999999999999 111.287 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -95.67 -1.49 50.0 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 124.996 1.318 . . . . 0.79000000000000004 109.561 166.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -118.13 23.67 11.47 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 126.347 1.859 . . . . 0.75 110.898 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -75.03 94.92 2.94 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 125.817 1.647 . . . . 0.40000000000000002 112.193 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.95 34.24 4.38 Favored Glycine 0 C--N 1.359 1.809 0 C-N-CA 126.077 1.799 . . . . 0.39000000000000001 110.16 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -110.66 152.16 26.84 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 126.829 2.052 . . . . 1.3999999999999999 108.537 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.06 170.26 3.59 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 CA-C-N 120.216 1.371 . . . . 0.31 108.456 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.98 176.49 44.24 Favored Glycine 0 CA--C 1.474 -2.5 0 O-C-N 120.079 -1.638 . . . . 0.20999999999999999 109.255 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 23' ' ' THR . . . . . 0.496 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 15.1 m -94.63 120.14 34.4 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 125.617 1.567 . . . . 0.27000000000000002 110.478 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 24' ' ' VAL . . . . . 0.507 HG23 HG13 ' E' ' 36' ' ' VAL . 6.9 p -76.66 101.84 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 124.395 2.045 . . . . 0.28999999999999998 112.69 173.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.89 46.1 1.3 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.167 1.387 . . . . 0.28999999999999998 114.232 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 62.0 p -73.18 -86.3 0.03 OUTLIER 'General case' 0 C--N 1.354 0.794 0 C-N-CA 130.203 3.401 . . . . 0.63 114.863 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 27' ' ' VAL . . . . . 0.499 HG13 ' HB3' ' E' ' 4' ' ' ARG . 2.4 p -79.54 59.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.616 0 CA-C-O 126.519 3.057 . . . . 0.60999999999999999 112.905 -169.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -160.62 -62.79 0.06 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.732 3.213 . . . . 1.6100000000000001 107.233 -173.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.56 -18.19 16.73 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 127.202 2.201 . . . . 3.96 115.802 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -26.82 0.3 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.039 2 C-N-CA 134.866 5.266 . . . . 4.3399999999999999 123.404 -172.707 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.54 43.54 1.86 Allowed Glycine 0 C--O 1.224 -0.496 1 C-N-CA 131.991 4.615 . . . . 1.76 114.939 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 32' ' ' ILE . . . . . 0.542 HG22 ' H ' ' E' ' 33' ' ' LEU . 1.1 mt -131.77 -169.68 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 127.984 2.514 . . . . 1.1100000000000001 105.853 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 33' ' ' LEU . . . . . 0.542 ' H ' HG22 ' E' ' 32' ' ' ILE . 32.2 tp -68.51 -44.49 74.53 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 117.287 2.328 . . . . 0.56999999999999995 117.287 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -123.02 157.9 59.14 Favored Pre-proline 0 C--N 1.356 0.887 0 N-CA-C 106.261 -1.755 . . . . 0.93999999999999995 106.261 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.68 -46.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.365 1.427 0 C-N-CA 123.439 2.759 . . . . 0.67000000000000004 115.568 -166.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 36' ' ' VAL . . . . . 0.564 HG12 HG23 ' E' ' 38' ' ' VAL . 73.3 t -90.51 97.04 6.76 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 CA-C-O 122.688 1.232 . . . . 0.64000000000000001 112.445 -170.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 56.9 mt -86.66 105.08 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 C-N-CA 127.958 2.503 . . . . 0.65000000000000002 104.34 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 38' ' ' VAL . . . . . 0.789 HG11 HD11 ' E' ' 10' ' ' ILE . 21.1 t -105.38 156.21 6.38 Favored 'Isoleucine or valine' 0 C--N 1.349 0.547 0 CA-C-N 121.058 1.754 . . . . 0.23000000000000001 111.546 -174.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 39' ' ' ARG . . . . . 0.496 ' HB3' ' H ' ' E' ' 23' ' ' THR . 17.5 tpp180 -81.8 131.83 35.27 Favored 'General case' 0 C--N 1.36 1.06 0 C-N-CA 127.785 2.434 . . . . 2.75 110.983 172.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -128.91 150.46 50.35 Favored 'General case' 0 CA--C 1.512 -0.489 0 O-C-N 121.743 -0.598 . . . . 1.26 110.648 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -96.16 -48.42 5.65 Favored 'General case' 0 C--N 1.36 1.045 0 C-N-CA 126.0 1.72 . . . . 1.02 109.81 173.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 86.4 mtm-85 -82.82 85.55 7.07 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 125.893 1.677 . . . . 1.29 114.837 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 14.4 t . . . . . 0 C--N 1.357 0.913 0 C-N-CA 127.111 2.164 . . . . 1.23 112.324 176.822 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' E' E ' 56' ' ' ASN . . . . . 0.476 HD21 ' N ' ' E' ' 56' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 112.634 0.605 . . . . 2.2000000000000002 112.634 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 7.2 p -126.15 121.39 32.68 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 128.723 2.809 . . . . 0.46999999999999997 104.764 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -150.32 144.45 25.53 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.695 0.798 . . . . 1.5700000000000001 109.561 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -81.46 106.27 13.3 Favored 'General case' 0 C--N 1.352 0.677 0 C-N-CA 130.812 3.645 . . . . 2.0699999999999998 120.117 -174.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 60' ' ' PHE . . . . . 0.436 ' CE2' HD12 ' E' ' 10' ' ' ILE . 26.1 m-85 -109.67 175.84 5.29 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 119.282 -2.136 . . . . 0.17000000000000001 113.793 174.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -114.27 115.7 27.82 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 113.958 -1.474 . . . . 0.17000000000000001 109.578 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -16.94 -38.13 0.0 OUTLIER 'General case' 0 C--N 1.367 1.351 1 C-N-CA 136.581 5.952 . . . . 1.72 118.496 173.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -49.84 -48.47 51.02 Favored 'General case' 0 C--N 1.37 1.492 0 C-N-CA 130.926 3.69 . . . . 0.17000000000000001 113.932 169.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 13.2 pm0 -95.32 17.44 14.41 Favored 'General case' 0 C--N 1.363 1.175 0 C-N-CA 124.202 1.001 . . . . 1.1799999999999999 112.16 -172.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.481 ' CD1' HG11 ' E' ' 36' ' ' VAL . 0.1 OUTLIER -120.76 138.15 54.15 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 107.524 -1.288 . . . . 0.19 107.524 173.445 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -110.39 126.28 54.11 Favored 'General case' 0 C--N 1.351 0.67 0 C-N-CA 124.501 1.12 . . . . 2.0499999999999998 111.717 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.14 139.56 58.15 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 128.301 2.64 . . . . 0.28999999999999998 117.695 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 t -135.26 -43.32 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.765 0 C-N-CA 126.35 1.86 . . . . 0.72999999999999998 109.691 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 69' ' ' GLN . . . . . 0.485 ' CB ' ' H ' ' E' ' 7' ' ' LYS . 1.6 tp60 -106.09 113.19 26.58 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 128.284 2.633 . . . . 2.1899999999999999 117.743 -168.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.76 68.1 6.88 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.958 171.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.31 53.39 0.07 Allowed 'General case' 0 C--N 1.373 1.594 0 N-CA-C 117.454 2.391 . . . . 0.0 117.454 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.05 130.96 35.42 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 126.92 2.088 . . . . 0.0 111.871 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 mptt . . . . . 0 C--O 1.262 1.729 0 C-N-CA 125.995 1.718 . . . . 0.0 110.356 179.019 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 2' ' ' LEU . . . . . 0.429 ' HB2' ' H ' ' E' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.722 0 CA-C-O 123.992 1.853 . . . . 0.98999999999999999 115.637 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 3' ' ' ASN . . . . . 0.429 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 0.0 OUTLIER -140.56 -166.11 2.06 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 127.755 2.422 . . . . 0.80000000000000004 109.417 -175.169 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -85.26 104.96 15.59 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 128.061 2.544 . . . . 3.3999999999999999 117.24 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 112.72 -9.5 25.75 Favored Glycine 0 CA--C 1.485 -1.84 0 O-C-N 119.409 -2.057 . . . . 0.53000000000000003 110.904 173.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.13 42.13 0.07 Allowed 'General case' 0 N--CA 1.438 -1.066 1 C-N-CA 133.903 4.881 . . . . 0.45000000000000001 115.596 -176.879 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -5.74 93.21 0.01 OUTLIER 'General case' 0 C--N 1.362 1.15 1 C-N-CA 133.777 4.831 . . . . 2.0299999999999998 117.058 -176.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 28.5 m -92.4 154.42 3.19 Favored 'Isoleucine or valine' 0 C--N 1.361 1.074 0 CA-C-N 121.149 1.795 . . . . 0.13 111.488 -172.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -103.17 109.0 20.42 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 121.446 -0.784 . . . . 0.17000000000000001 111.92 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.785 HD11 HG11 ' E' ' 38' ' ' VAL . 1.3 mp -56.96 103.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.213 0 C-N-CA 129.805 3.242 . . . . 0.12 114.494 174.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -120.48 52.36 1.16 Allowed 'General case' 0 C--N 1.37 1.493 0 C-N-CA 124.43 1.092 . . . . 0.29999999999999999 109.903 -172.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -72.17 -115.39 0.0 OUTLIER 'General case' 0 C--N 1.364 1.212 0 N-CA-C 118.792 2.886 . . . . 2.0899999999999999 118.792 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -170.71 142.58 2.01 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 101.719 -3.438 . . . . 0.46999999999999997 101.719 -174.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . 0.257 3.7 mm-40 -5.86 69.38 0.0 OUTLIER 'General case' 0 C--N 1.368 1.384 1 C-N-CA 134.343 5.057 . . . . 1.8899999999999999 119.316 -174.65 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 75.3 m -138.39 154.57 48.92 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 130.182 3.393 . . . . 1.1299999999999999 104.087 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -61.29 -11.17 8.67 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 130.127 3.371 . . . . 0.79000000000000004 117.151 -176.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 22.9 m0 -113.26 -3.5 13.85 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 128.882 2.873 . . . . 0.75 113.371 -177.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -80.26 88.7 5.49 Favored 'General case' 0 C--N 1.373 1.602 0 C-N-CA 126.337 1.855 . . . . 0.40000000000000002 110.291 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.34 -11.71 3.01 Favored Glycine 0 C--N 1.36 1.903 0 C-N-CA 126.74 2.114 . . . . 0.39000000000000001 111.285 -175.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -97.75 162.59 13.19 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 119.66 1.73 . . . . 1.3999999999999999 114.924 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -103.12 169.79 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.208 0 C-N-CA 126.717 2.007 . . . . 0.31 108.444 172.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.99 -179.78 41.25 Favored Glycine 0 CA--C 1.476 -2.406 0 N-CA-C 108.491 -1.844 . . . . 0.20999999999999999 108.491 170.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 23' ' ' THR . . . . . 0.674 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 4.0 m -94.33 120.3 34.36 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 125.323 1.449 . . . . 0.27000000000000002 111.496 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 24' ' ' VAL . . . . . 0.542 HG23 HG13 ' E' ' 36' ' ' VAL . 14.5 p -68.02 69.57 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 131.571 3.948 . . . . 0.28999999999999998 112.862 175.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.58 45.15 1.21 Allowed 'General case' 0 C--N 1.362 1.149 0 O-C-N 118.401 -2.687 . . . . 0.28999999999999998 110.095 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 26' ' ' SER . . . . . 0.418 ' HA ' ' HB ' ' E' ' 37' ' ' ILE . 13.2 m -87.96 -62.1 1.57 Allowed 'General case' 0 CA--C 1.465 -2.29 1 C-N-CA 135.959 5.704 . . . . 0.63 119.323 -171.523 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 m -80.23 19.14 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.093 0 N-CA-C 116.586 2.069 . . . . 0.60999999999999999 116.586 -156.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -111.28 -50.27 2.95 Favored 'General case' 0 N--CA 1.43 -1.473 1 C-N-CA 135.187 5.395 . . . . 1.6100000000000001 109.311 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 29' ' ' LYS . . . . . 0.557 ' HB2' HD13 ' E' ' 37' ' ' ILE . 27.8 mmmt -103.19 -12.4 17.36 Favored 'General case' 0 C--N 1.366 1.283 0 C-N-CA 128.232 2.613 . . . . 3.96 113.194 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 8.4 t -43.53 -17.91 0.02 OUTLIER 'General case' 0 C--N 1.376 1.744 1 C-N-CA 132.084 4.153 . . . . 4.3399999999999999 117.97 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.53 45.46 0.27 Allowed Glycine 0 C--N 1.355 1.589 0 C-N-CA 130.221 3.772 . . . . 1.76 117.058 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 32' ' ' ILE . . . . . 0.445 HG22 ' H ' ' E' ' 33' ' ' LEU . 0.3 OUTLIER -135.78 -159.36 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.913 0 C-N-CA 129.005 2.922 . . . . 1.1100000000000001 111.031 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 33' ' ' LEU . . . . . 0.445 ' H ' HG22 ' E' ' 32' ' ' ILE . 22.0 tp -69.31 -23.06 63.75 Favored 'General case' 0 C--N 1.355 0.839 1 C-N-CA 133.335 4.654 . . . . 0.56999999999999995 118.378 -177.753 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -134.55 152.72 78.32 Favored Pre-proline 0 C--N 1.362 1.131 0 N-CA-C 105.735 -1.95 . . . . 0.93999999999999995 105.735 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.8 -45.74 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.9 3.067 . . . . 0.67000000000000004 117.65 -173.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 36' ' ' VAL . . . . . 0.605 HG12 HG23 ' E' ' 38' ' ' VAL . 54.6 t -109.01 106.11 20.08 Favored 'Isoleucine or valine' 0 C--N 1.353 0.748 0 N-CA-C 115.296 1.591 . . . . 0.64000000000000001 115.296 -167.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 37' ' ' ILE . . . . . 0.557 HD13 ' HB2' ' E' ' 29' ' ' LYS . 3.3 mp -85.33 118.31 31.97 Favored 'Isoleucine or valine' 0 C--N 1.37 1.492 0 C-N-CA 125.977 1.711 . . . . 0.65000000000000002 106.921 173.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 38' ' ' VAL . . . . . 0.785 HG11 HD11 ' E' ' 10' ' ' ILE . 92.8 t -115.81 155.59 17.09 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 CA-C-O 122.128 0.966 . . . . 0.23000000000000001 112.256 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 39' ' ' ARG . . . . . 0.674 ' HB3' ' H ' ' E' ' 23' ' ' THR . 1.9 tpm_? -75.47 139.55 42.32 Favored 'General case' 0 C--N 1.362 1.136 0 C-N-CA 130.118 3.367 . . . . 2.75 112.932 173.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 40' ' ' PHE . . . . . 0.454 ' H ' ' NH2' ' E' ' 39' ' ' ARG . 60.9 m-85 -145.66 109.17 4.7 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 129.16 2.984 . . . . 1.26 107.915 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -104.71 -11.11 17.03 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 129.116 2.966 . . . . 1.02 113.875 -176.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -94.16 9.7 36.84 Favored 'General case' 0 C--N 1.366 1.284 0 C-N-CA 126.503 1.921 . . . . 1.29 113.226 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.351 0.638 0 C-N-CA 128.16 2.584 . . . . 1.23 111.522 178.631 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 27.7 t30 . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 113.515 0.931 . . . . 2.2000000000000002 113.515 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 71.4 p -109.43 108.02 18.38 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.139 1.376 . . . . 0.46999999999999997 108.653 176.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.83 146.99 36.69 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 125.828 1.651 . . . . 1.5700000000000001 109.548 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -89.27 113.93 25.24 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 129.812 3.245 . . . . 2.0699999999999998 111.226 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 60' ' ' PHE . . . . . 0.423 ' HB2' HD11 ' E' ' 65' ' ' LEU . 19.5 m-85 -107.0 174.39 5.91 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.95 1.7 . . . . 0.17000000000000001 113.66 -176.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.7 89.38 3.67 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 130.195 3.398 . . . . 0.17000000000000001 110.643 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -26.16 -18.39 0.0 OUTLIER 'General case' 0 C--N 1.354 0.797 1 C-N-CA 136.072 5.749 . . . . 1.72 120.39 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.89 -32.8 72.25 Favored 'General case' 0 C--N 1.367 1.335 0 C-N-CA 129.148 2.979 . . . . 0.17000000000000001 112.729 168.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.27 18.07 21.88 Favored 'General case' 0 C--N 1.371 1.516 0 C-N-CA 125.832 1.653 . . . . 1.1799999999999999 110.285 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.447 HD13 HG11 ' E' ' 36' ' ' VAL . 74.1 mt -128.18 118.81 24.03 Favored 'General case' 0 C--N 1.366 1.295 0 CA-C-O 123.526 1.631 . . . . 0.19 111.934 177.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -111.18 134.5 52.73 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.863 1.665 . . . . 2.0499999999999998 109.145 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.65 133.76 36.22 Favored 'General case' 0 C--N 1.366 1.318 1 C-N-CA 132.161 4.185 . . . . 0.28999999999999998 118.547 175.468 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . 0.269 3.1 t -132.13 -33.43 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.372 1.556 0 N-CA-C 114.758 1.392 . . . . 0.72999999999999998 114.758 178.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 69' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -111.13 139.69 46.3 Favored 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 119.443 -2.036 . . . . 2.1899999999999999 109.685 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.12 64.61 6.88 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.55 1.94 . . . . 0.0 114.045 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.9 68.25 2.77 Favored 'General case' 0 C--N 1.362 1.129 0 CA-C-O 123.444 1.592 . . . . 0.0 110.792 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.08 64.66 4.62 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 125.717 1.607 . . . . 0.0 109.849 176.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 19.0 pttm . . . . . 0 C--O 1.261 1.694 0 C-N-CA 127.486 2.314 . . . . 0.0 107.143 176.252 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' E' E ' 2' ' ' LEU . . . . . 0.716 HD22 HG11 ' E' ' 8' ' ' VAL 0.279 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 123.773 1.749 . . . . 0.98999999999999999 111.957 . . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.09 172.79 12.58 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 124.2 1.952 . . . . 0.80000000000000004 114.418 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.09 94.34 7.89 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 127.124 2.17 . . . . 3.3999999999999999 112.86 176.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.27 3.44 9.61 Favored Glycine 0 C--N 1.365 2.172 0 O-C-N 120.697 -1.252 . . . . 0.53000000000000003 111.388 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 6' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -69.28 143.94 53.72 Favored 'General case' 0 N--CA 1.417 -2.092 0 C-N-CA 130.739 3.615 . . . . 0.45000000000000001 112.752 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -94.15 83.72 4.32 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 104.93 -2.248 . . . . 2.0299999999999998 104.93 171.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 8' ' ' VAL . . . . . 0.716 HG11 HD22 ' E' ' 2' ' ' LEU . 17.5 m -89.79 144.31 9.37 Favored 'Isoleucine or valine' 0 C--N 1.365 1.252 0 N-CA-C 107.517 -1.29 . . . . 0.13 107.517 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 9' ' ' ARG . . . . . 0.422 HH21 ' HA2' ' E' ' 19' ' ' GLY . 69.1 ttt-85 -104.05 122.68 45.77 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 120.154 -1.591 . . . . 0.17000000000000001 110.817 -175.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.613 HD11 HG11 ' E' ' 38' ' ' VAL . 0.5 OUTLIER -67.75 120.93 15.96 Favored 'Isoleucine or valine' 0 C--N 1.363 1.165 0 C-N-CA 126.939 2.096 . . . . 0.12 113.808 177.217 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -126.96 52.82 1.75 Allowed 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 127.997 2.519 . . . . 0.29999999999999999 110.481 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -92.46 -138.86 0.18 Allowed 'General case' 0 C--N 1.372 1.564 0 O-C-N 120.221 -1.549 . . . . 2.0899999999999999 109.946 172.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 13' ' ' THR . . . . . 0.407 ' HA ' ' CD2' ' E' ' 18' ' ' TYR 0.251 23.0 m -152.76 -60.43 0.15 Allowed 'General case' 0 C--N 1.357 0.899 0 O-C-N 118.256 -2.777 . . . . 0.46999999999999997 108.764 174.352 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -75.23 67.34 1.84 Allowed 'General case' 0 C--N 1.354 0.796 0 O-C-N 119.962 -1.711 . . . . 1.8899999999999999 114.453 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 23.8 t -162.12 159.68 26.34 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 125.459 1.504 . . . . 1.1299999999999999 111.746 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -77.03 -27.45 54.53 Favored 'General case' 0 C--N 1.363 1.153 0 C-N-CA 130.941 3.697 . . . . 0.79000000000000004 110.179 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 24.5 m0 -93.71 17.97 10.97 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 129.368 3.067 . . . . 0.75 113.052 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 18' ' ' TYR . . . . . 0.407 ' CD2' ' HA ' ' E' ' 13' ' ' THR . 2.6 t80 -74.63 112.17 10.55 Favored 'General case' 0 C--N 1.368 1.411 0 C-N-CA 126.362 1.865 . . . . 0.40000000000000002 108.421 173.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 19' ' ' GLY . . . . . 0.422 ' HA2' HH21 ' E' ' 9' ' ' ARG . . . 94.53 34.14 6.47 Favored Glycine 0 C--N 1.354 1.534 0 C-N-CA 128.651 3.025 . . . . 0.39000000000000001 113.923 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -105.42 163.86 12.31 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 118.968 1.384 . . . . 1.3999999999999999 113.09 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.25 149.47 25.67 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 N-CA-C 105.603 -1.999 . . . . 0.31 105.603 175.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.08 178.35 47.54 Favored Glycine 0 CA--C 1.472 -2.629 0 C-N-CA 118.146 -1.978 . . . . 0.20999999999999999 110.226 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 7.0 m -90.01 120.93 31.63 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 124.844 1.258 . . . . 0.27000000000000002 113.222 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 24' ' ' VAL . . . . . 0.413 HG12 ' H ' ' E' ' 24' ' ' VAL . 7.3 p -77.57 91.54 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 125.374 2.512 . . . . 0.28999999999999998 110.768 175.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.62 53.76 2.9 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 119.879 -1.763 . . . . 0.28999999999999998 111.268 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 22.1 m -87.69 -59.82 2.14 Favored 'General case' 0 CA--C 1.476 -1.868 0 C-N-CA 130.169 3.387 . . . . 0.63 117.667 -174.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -84.41 62.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.767 0 CA-C-O 126.421 3.01 . . . . 0.60999999999999999 112.843 -164.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -148.27 -66.51 0.24 Allowed 'General case' 0 N--CA 1.415 -2.209 2 C-N-CA 132.282 4.233 . . . . 1.6100000000000001 104.988 -177.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -110.31 5.02 21.32 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 128.089 2.556 . . . . 3.96 114.642 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 3.8 t -50.96 -18.96 0.87 Allowed 'General case' 0 C--N 1.369 1.44 0 C-N-CA 130.043 3.337 . . . . 4.3399999999999999 118.304 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.59 43.89 0.47 Allowed Glycine 0 C--N 1.349 1.295 0 C-N-CA 129.856 3.598 . . . . 1.76 116.949 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 32' ' ' ILE . . . . . 0.564 HG22 ' H ' ' E' ' 33' ' ' LEU . 0.7 OUTLIER -133.1 -166.02 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.834 0 C-N-CA 128.651 2.78 . . . . 1.1100000000000001 109.599 -179.472 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 33' ' ' LEU . . . . . 0.564 ' H ' HG22 ' E' ' 32' ' ' ILE . 49.1 tp -69.85 -22.55 63.26 Favored 'General case' 0 C--N 1.359 0.98 1 C-N-CA 131.829 4.052 . . . . 0.56999999999999995 116.786 -177.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -137.28 127.75 15.92 Favored Pre-proline 0 C--N 1.359 0.989 0 N-CA-C 105.316 -2.105 . . . . 0.93999999999999995 105.316 176.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -82.3 -42.68 0.1 OUTLIER 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 124.702 3.601 . . . . 0.67000000000000004 117.111 -171.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 36' ' ' VAL . . . . . 0.536 HG12 HG23 ' E' ' 38' ' ' VAL . 76.4 t -84.18 101.37 8.67 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 C-N-CA 127.728 2.411 . . . . 0.64000000000000001 113.4 -168.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 78.5 mt -101.68 81.04 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.206 0 C-N-CA 124.973 1.309 . . . . 0.65000000000000002 107.692 -176.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 38' ' ' VAL . . . . . 0.613 HG11 HD11 ' E' ' 10' ' ' ILE . 57.0 t -89.23 164.82 2.13 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 O-C-N 119.488 -2.008 . . . . 0.23000000000000001 112.644 -173.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 39' ' ' ARG . . . . . . . . . . . . . 29.1 mmt85 -82.25 142.05 32.44 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 128.729 2.812 . . . . 2.75 113.461 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -132.09 138.63 48.19 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.413 1.085 . . . . 1.26 111.9 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -101.19 -34.79 9.54 Favored 'General case' 0 C--N 1.374 1.638 0 C-N-CA 125.836 1.654 . . . . 1.02 113.094 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 34.4 mtt180 -83.91 49.87 1.71 Allowed 'General case' 0 C--N 1.36 1.049 0 C-N-CA 128.494 2.718 . . . . 1.29 116.242 -170.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . 0.308 4.3 p . . . . . 0 CA--C 1.541 0.601 0 O-C-N 119.4 -2.062 . . . . 1.23 105.79 167.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 30.5 m120 . . . . . 0 N--CA 1.469 0.518 0 CA-C-O 121.132 0.491 . . . . 2.2000000000000002 111.733 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 1.9 p -121.63 128.57 52.05 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 104.056 -2.572 . . . . 0.46999999999999997 104.056 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.74 132.03 11.96 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 108.119 -1.067 . . . . 1.5700000000000001 108.119 -168.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -80.69 110.82 16.55 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 130.071 3.348 . . . . 2.0699999999999998 116.018 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 60' ' ' PHE . . . . . 0.416 ' CZ ' HG21 ' E' ' 10' ' ' ILE . 24.7 m-85 -114.31 179.86 3.83 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 127.422 2.289 . . . . 0.17000000000000001 114.035 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.82 109.41 16.54 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 114.706 1.373 . . . . 0.17000000000000001 114.706 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -19.74 0.4 0.0 OUTLIER 'General case' 0 C--N 1.374 1.638 2 C-N-CA 137.357 6.263 . . . . 1.72 124.489 172.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -99.09 -45.04 6.06 Favored 'General case' 0 N--CA 1.438 -1.055 1 C-N-CA 132.241 4.217 . . . . 0.17000000000000001 106.322 171.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -88.68 18.25 4.84 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 120.083 -1.635 . . . . 1.1799999999999999 110.867 -170.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 65' ' ' LEU . . . . . . . . . . . . 0.313 0.1 OUTLIER -134.17 157.7 45.55 Favored 'General case' 0 N--CA 1.43 -1.464 1 C-N-CA 132.768 4.427 . . . . 0.19 106.317 172.186 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -137.39 149.25 46.8 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 105.665 -1.976 . . . . 2.0499999999999998 105.665 162.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 67' ' ' LEU . . . . . 0.492 ' H ' HD23 ' E' ' 67' ' ' LEU 0.252 2.5 pt? -91.54 149.01 21.87 Favored 'General case' 0 C--N 1.363 1.187 0 O-C-N 118.798 -2.439 . . . . 0.28999999999999998 117.511 -177.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 4.4 t -112.09 -37.48 2.84 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 C-N-CA 126.794 2.038 . . . . 0.72999999999999998 110.346 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 69' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -103.41 153.78 20.12 Favored 'General case' 0 C--N 1.356 0.875 0 CA-C-O 126.916 3.246 . . . . 2.1899999999999999 115.286 -174.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.26 68.74 0.77 Allowed 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 108.476 -3.966 . . . . 0.0 109.584 170.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.5 74.3 3.23 Favored 'General case' 0 C--N 1.362 1.137 0 O-C-N 120.076 -1.64 . . . . 0.0 112.465 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.1 80.21 7.72 Favored 'General case' 0 C--N 1.36 1.065 0 C-N-CA 129.08 2.952 . . . . 0.0 111.753 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 71.7 tttt . . . . . 0 C--O 1.264 1.826 0 C-N-CA 127.089 2.156 . . . . 0.0 107.93 176.02 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' E' E ' 2' ' ' LEU . . . . . 0.51 HD12 ' HB3' ' E' ' 65' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.169 0 N-CA-C 117.93 2.567 . . . . 0.98999999999999999 117.93 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 3' ' ' ASN . . . . . 0.445 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 0.2 OUTLIER -146.97 177.06 9.44 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 130.794 3.638 . . . . 0.80000000000000004 107.298 -178.84 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -78.66 117.74 20.1 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 120.69 3.589 . . . . 3.3999999999999999 120.69 -172.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.63 5.93 53.33 Favored Glycine 0 C--N 1.376 2.784 0 O-C-N 118.184 -2.823 . . . . 0.53000000000000003 114.332 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.65 145.89 30.34 Favored 'General case' 0 N--CA 1.411 -2.4 1 C-N-CA 132.024 4.13 . . . . 0.45000000000000001 110.983 -176.788 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 7' ' ' LYS . . . . . 0.611 ' H ' ' CB ' ' E' ' 69' ' ' GLN . 49.3 mttm -93.08 71.76 4.62 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 128.524 2.73 . . . . 2.0299999999999998 107.973 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 15.8 m -88.69 148.64 4.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 C-N-CA 123.684 0.794 . . . . 0.13 110.891 -173.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -105.95 123.92 48.76 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 119.314 -0.374 . . . . 0.17000000000000001 110.917 -173.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.681 HD11 HG11 ' E' ' 38' ' ' VAL . 2.2 mm -73.29 114.68 13.09 Favored 'Isoleucine or valine' 0 C--N 1.36 1.06 0 C-N-CA 125.755 1.622 . . . . 0.12 114.968 177.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -115.91 57.27 0.75 Allowed 'General case' 0 C--N 1.375 1.675 0 C-N-CA 124.172 0.989 . . . . 0.29999999999999999 113.669 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.62 123.14 48.58 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 126.08 1.752 . . . . 2.0899999999999999 109.059 171.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 24.6 p -72.66 -6.56 45.2 Favored 'General case' 0 C--N 1.368 1.412 0 C-N-CA 128.941 2.896 . . . . 0.46999999999999997 117.273 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -97.16 41.12 1.12 Allowed 'General case' 0 C--N 1.357 0.906 0 C-N-CA 128.54 2.736 . . . . 1.8899999999999999 112.27 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 35.3 t -164.8 166.19 19.98 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 119.97 -1.706 . . . . 1.1299999999999999 107.247 -178.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -89.59 -5.6 57.04 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 127.123 2.169 . . . . 0.79000000000000004 110.369 171.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 29.6 m0 -94.76 16.68 15.18 Favored 'General case' 0 C--N 1.372 1.573 0 C-N-CA 129.166 2.986 . . . . 0.75 110.478 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -73.34 102.5 3.73 Favored 'General case' 0 C--N 1.364 1.221 0 C-N-CA 128.159 2.584 . . . . 0.40000000000000002 110.873 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.58 32.97 6.05 Favored Glycine 0 C--N 1.358 1.757 0 C-N-CA 126.203 1.859 . . . . 0.39000000000000001 112.602 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -106.93 135.19 48.9 Favored 'General case' 0 C--N 1.366 1.288 0 CA-C-N 119.255 1.528 . . . . 1.3999999999999999 112.255 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.72 145.84 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 C-N-CA 128.299 2.64 . . . . 0.31 107.257 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 22' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' E' ' 7' ' ' LYS . . . -174.03 178.1 46.02 Favored Glycine 0 CA--C 1.473 -2.563 0 N-CA-C 108.864 -1.694 . . . . 0.20999999999999999 108.864 172.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 20.7 m -86.18 125.4 33.5 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.505 1.122 . . . . 0.27000000000000002 112.002 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 24' ' ' VAL . . . . . 0.481 HG23 HG13 ' E' ' 36' ' ' VAL . 12.6 p -80.92 95.87 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 126.078 1.751 . . . . 0.28999999999999998 111.473 175.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.74 51.43 1.85 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.067 2.147 . . . . 0.28999999999999998 112.803 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 2.6 p -73.08 -73.12 0.22 Allowed 'General case' 0 CA--C 1.504 -0.817 1 C-N-CA 136.257 5.823 . . . . 0.63 120.114 -173.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 4.4 m -81.23 18.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.553 0 C-N-CA 128.085 2.554 . . . . 0.60999999999999999 117.058 -163.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -98.26 -69.43 0.76 Allowed 'General case' 0 N--CA 1.431 -1.416 1 C-N-CA 132.011 4.125 . . . . 1.6100000000000001 107.693 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -106.81 -26.89 11.07 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 115.849 1.796 . . . . 3.96 115.849 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.45 22.03 3.12 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 117.432 2.382 . . . . 4.3399999999999999 117.432 -170.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.25 46.49 0.81 Allowed Glycine 0 C--N 1.353 1.525 0 C-N-CA 127.97 2.7 . . . . 1.76 114.505 167.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 32' ' ' ILE . . . . . 0.521 HG22 ' H ' ' E' ' 33' ' ' LEU . 1.9 mt -122.32 -146.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 130.962 3.705 . . . . 1.1100000000000001 104.664 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 33' ' ' LEU . . . . . 0.521 ' H ' HG22 ' E' ' 32' ' ' ILE . 39.8 tp -62.08 -61.57 2.39 Favored 'General case' 0 C--N 1.345 0.379 0 C-N-CA 129.392 3.077 . . . . 0.56999999999999995 115.181 176.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -97.67 111.01 57.63 Favored Pre-proline 0 C--N 1.363 1.177 0 C-N-CA 124.208 1.003 . . . . 0.93999999999999995 109.688 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.86 -38.52 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.727 1 C-N-CA 125.318 4.012 . . . . 0.67000000000000004 116.141 -173.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 36' ' ' VAL . . . . . 0.674 HG11 ' HG ' ' E' ' 65' ' ' LEU . 59.4 t -88.44 94.21 4.62 Favored 'Isoleucine or valine' 0 C--N 1.349 0.553 0 N-CA-C 116.19 1.922 . . . . 0.64000000000000001 116.19 -169.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 96.4 mt -89.82 99.92 10.14 Favored 'Isoleucine or valine' 0 C--N 1.36 1.03 0 C-N-CA 126.461 1.904 . . . . 0.65000000000000002 106.719 176.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 38' ' ' VAL . . . . . 0.681 HG11 HD11 ' E' ' 10' ' ' ILE . 81.3 t -104.93 156.3 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 120.769 -1.207 . . . . 0.23000000000000001 111.945 -173.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 39' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -79.97 139.5 37.0 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 130.581 3.552 . . . . 2.75 111.973 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -137.29 149.08 46.83 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.317 -1.49 . . . . 1.26 111.929 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -103.55 -23.76 13.47 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 127.071 2.148 . . . . 1.02 111.282 172.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 67.2 mtt-85 -82.04 40.37 0.62 Allowed 'General case' 0 C--N 1.366 1.287 0 C-N-CA 129.397 3.079 . . . . 1.29 111.855 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.448 -0.549 0 C-N-CA 126.925 2.09 . . . . 1.23 110.377 -175.114 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 14.6 t30 . . . . . 0 CA--C 1.532 0.254 0 CA-C-O 121.683 0.754 . . . . 2.2000000000000002 112.893 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 31.8 p -129.21 121.71 28.21 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 128.612 2.765 . . . . 0.46999999999999997 106.57 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.75 139.79 15.4 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 119.513 1.051 . . . . 1.5700000000000001 112.399 -175.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -63.05 119.78 10.15 Favored 'General case' 0 C--N 1.358 0.937 1 C-N-CA 132.035 4.134 . . . . 2.0699999999999998 119.9 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 60' ' ' PHE . . . . . 0.432 ' CD2' HD12 ' E' ' 10' ' ' ILE . 39.5 m-85 -124.67 170.26 11.15 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 123.514 1.626 . . . . 0.17000000000000001 113.44 174.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.92 92.32 6.05 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 129.765 3.226 . . . . 0.17000000000000001 109.05 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -18.15 -21.72 0.0 OUTLIER 'General case' 0 C--N 1.358 0.95 1 C-N-CA 136.434 5.893 . . . . 1.72 121.68 173.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -73.58 -29.67 62.56 Favored 'General case' 0 C--N 1.362 1.149 0 C-N-CA 129.443 3.097 . . . . 0.17000000000000001 113.173 169.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -84.33 -14.81 48.64 Favored 'General case' 0 C--N 1.375 1.692 0 C-N-CA 127.217 2.207 . . . . 1.1799999999999999 108.351 -175.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.674 ' HG ' HG11 ' E' ' 36' ' ' VAL . 0.6 OUTLIER -104.48 108.48 19.93 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 128.395 2.678 . . . . 0.19 115.41 -176.614 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -89.9 149.4 22.64 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 129.735 3.214 . . . . 2.0499999999999998 112.076 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -82.77 141.61 32.22 Favored 'General case' 0 C--N 1.366 1.316 0 CA-C-N 121.638 2.017 . . . . 0.28999999999999998 115.677 174.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 18.9 t -130.61 -19.4 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.873 0 CA-C-O 123.528 1.632 . . . . 0.72999999999999998 108.226 171.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 69' ' ' GLN . . . . . 0.611 ' CB ' ' H ' ' E' ' 7' ' ' LYS . 4.9 tp-100 -110.28 155.24 22.33 Favored 'General case' 0 N--CA 1.424 -1.729 0 C-N-CA 127.173 2.189 . . . . 2.1899999999999999 111.848 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.02 42.06 1.26 Allowed 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 128.478 2.711 . . . . 0.0 114.316 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.95 63.11 7.9 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 125.243 1.417 . . . . 0.0 108.278 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.9 80.16 2.98 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 128.05 2.54 . . . . 0.0 112.097 -173.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? . . . . . 0 C--O 1.257 1.459 0 N-CA-C 103.039 -2.949 . . . . 0.0 103.039 172.196 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' E' E ' 2' ' ' LEU . . . . . 0.503 HD22 HG11 ' E' ' 8' ' ' VAL 0.306 2.0 pp . . . . . 0 N--CA 1.446 -0.627 0 CA-C-O 123.489 1.614 . . . . 0.98999999999999999 111.844 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 3' ' ' ASN . . . . . 0.417 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 9.2 m120 -140.23 168.71 19.17 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 129.303 3.041 . . . . 0.80000000000000004 111.7 -172.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -95.11 96.8 9.48 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 126.677 1.991 . . . . 3.3999999999999999 112.233 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.62 17.26 3.55 Favored Glycine 0 C--N 1.368 2.329 0 O-C-N 119.922 -1.736 . . . . 0.53000000000000003 113.145 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 6' ' ' ASP . . . . . 0.435 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 53.8 t0 -90.84 143.04 27.13 Favored 'General case' 0 N--CA 1.411 -2.375 1 C-N-CA 131.8 4.04 . . . . 0.45000000000000001 109.325 -178.342 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 7' ' ' LYS . . . . . 0.582 ' H ' ' HB3' ' E' ' 69' ' ' GLN . 63.7 mmtt -92.9 82.23 4.66 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 104.966 -2.235 . . . . 2.0299999999999998 104.966 173.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 8' ' ' VAL . . . . . 0.503 HG11 HD22 ' E' ' 2' ' ' LEU . 15.6 m -88.43 133.56 30.5 Favored 'Isoleucine or valine' 0 C--N 1.359 1.015 0 N-CA-C 105.078 -2.193 . . . . 0.13 105.078 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -91.71 110.38 21.71 Favored 'General case' 0 CA--C 1.502 -0.887 0 O-C-N 121.237 -0.915 . . . . 0.17000000000000001 111.354 -174.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.539 HG23 ' CE2' ' E' ' 60' ' ' PHE . 5.4 mm -53.37 107.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.503 0 N-CA-C 119.839 3.274 . . . . 0.12 119.839 175.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 11' ' ' LYS . . . . . 0.4 ' HA ' ' CE1' ' E' ' 18' ' ' TYR . 13.8 mtmm -119.02 49.77 1.29 Allowed 'General case' 0 C--N 1.379 1.887 0 C-N-CA 127.163 2.185 . . . . 0.29999999999999999 111.485 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -76.49 -118.54 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 120.178 3.399 . . . . 2.0899999999999999 120.178 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 3.5 m -150.55 -49.09 0.13 Allowed 'General case' 0 C--N 1.358 0.938 0 O-C-N 120.258 -1.526 . . . . 0.46999999999999997 108.553 -176.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -85.59 89.94 7.86 Favored 'General case' 0 C--N 1.363 1.167 0 N-CA-C 115.509 1.67 . . . . 1.8899999999999999 115.509 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 15' ' ' SER . . . . . 0.419 ' HA ' ' HB3' ' E' ' 18' ' ' TYR 0.285 1.4 m -53.68 28.96 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 1 N-CA-C 121.989 4.07 . . . . 1.1299999999999999 121.989 179.968 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.45 -51.26 4.42 Favored 'General case' 0 C--N 1.352 0.691 1 C-N-CA 131.788 4.035 . . . . 0.79000000000000004 102.274 163.284 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 17' ' ' TRP . . . . . 0.412 ' O ' HG21 ' E' ' 10' ' ' ILE . 15.8 m0 -114.97 35.15 4.45 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.66 1.584 . . . . 0.75 111.186 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 18' ' ' TYR . . . . . 0.419 ' HB3' ' HA ' ' E' ' 15' ' ' SER . 1.2 t80 -139.42 133.82 31.54 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 106.418 -1.697 . . . . 0.40000000000000002 106.418 175.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.3 46.75 1.52 Allowed Glycine 0 C--N 1.358 1.779 0 C-N-CA 127.202 2.334 . . . . 0.39000000000000001 109.449 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -168.72 176.24 5.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.363 -1.717 . . . . 1.3999999999999999 106.363 -171.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 p -109.57 175.9 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 127.579 2.352 . . . . 0.31 108.348 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.79 169.49 41.48 Favored Glycine 0 CA--C 1.476 -2.381 0 N-CA-C 108.231 -1.948 . . . . 0.20999999999999999 108.231 173.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 10.9 m -97.72 114.75 26.82 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 125.727 1.611 . . . . 0.27000000000000002 110.587 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 12.3 p -76.35 86.84 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-O 125.974 2.797 . . . . 0.28999999999999998 112.097 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -94.72 57.4 2.17 Favored 'General case' 0 C--O 1.225 -0.213 0 O-C-N 119.172 -2.205 . . . . 0.28999999999999998 108.995 175.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 26' ' ' SER . . . . . 0.439 ' HB3' ' HA ' ' E' ' 36' ' ' VAL . 10.6 p -79.76 -81.45 0.12 Allowed 'General case' 0 CA--C 1.495 -1.165 1 C-N-CA 134.67 5.188 . . . . 0.63 118.705 -168.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 27' ' ' VAL . . . . . 0.406 HG12 ' H ' ' E' ' 27' ' ' VAL . 5.7 p -83.82 59.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 128.976 2.91 . . . . 0.60999999999999999 111.51 -169.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -145.71 -50.88 0.24 Allowed 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 127.329 2.252 . . . . 1.6100000000000001 106.4 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -105.42 -22.93 12.92 Favored 'General case' 0 C--N 1.37 1.483 0 C-N-CA 127.748 2.419 . . . . 3.96 113.45 175.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 58.8 m -68.35 55.81 0.08 Allowed 'General case' 0 C--N 1.378 1.824 0 C-N-CA 128.698 2.799 . . . . 4.3399999999999999 117.831 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.71 32.88 5.91 Favored Glycine 0 C--O 1.222 -0.6 1 C-N-CA 131.608 4.432 . . . . 1.76 111.197 162.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 2.3 mt -112.19 -136.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.577 0 C-N-CA 129.014 2.925 . . . . 1.1100000000000001 107.405 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 12.5 tp -90.57 -69.45 0.73 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 128.731 2.812 . . . . 0.56999999999999995 112.822 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -96.94 156.99 35.79 Favored Pre-proline 0 C--N 1.372 1.571 0 O-C-N 120.185 -1.572 . . . . 0.93999999999999995 110.809 -175.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.82 -51.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 123.809 3.006 . . . . 0.67000000000000004 116.595 -170.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 36' ' ' VAL . . . . . 0.591 HG12 HG23 ' E' ' 38' ' ' VAL . 95.2 t -79.48 110.28 15.0 Favored 'Isoleucine or valine' 0 C--N 1.348 0.504 0 C-N-CA 129.426 3.09 . . . . 0.64000000000000001 113.068 -170.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 70.5 mt -107.81 97.55 5.83 Favored 'Isoleucine or valine' 0 C--N 1.372 1.578 0 N-CA-C 104.403 -2.443 . . . . 0.65000000000000002 104.403 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 38' ' ' VAL . . . . . 0.591 HG23 HG12 ' E' ' 36' ' ' VAL . 37.8 t -107.38 141.88 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 O-C-N 120.497 -1.377 . . . . 0.23000000000000001 114.125 -167.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 39' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -69.95 144.83 52.26 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 128.448 2.699 . . . . 2.75 114.189 174.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 40' ' ' PHE . . . . . 0.444 ' CE1' HG12 ' E' ' 38' ' ' VAL . 84.8 m-85 -153.52 166.98 31.01 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 106.37 -1.715 . . . . 1.26 106.37 171.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -106.38 -27.92 10.68 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 129.357 3.063 . . . . 1.02 108.888 165.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -75.77 45.18 0.32 Allowed 'General case' 0 C--N 1.371 1.536 0 C-N-CA 127.359 2.264 . . . . 1.29 115.169 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 8.7 m . . . . . 0 N--CA 1.446 -0.627 0 CA-C-O 123.877 1.798 . . . . 1.23 110.628 178.344 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 . . . . . 0 N--CA 1.473 0.692 0 CA-C-O 122.736 1.255 . . . . 2.2000000000000002 114.092 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 2.8 p -150.83 149.33 29.58 Favored 'General case' 0 C--N 1.356 0.874 1 C-N-CA 133.708 4.803 . . . . 0.46999999999999997 107.371 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . 0.323 0.7 OUTLIER -159.31 168.41 26.48 Favored 'General case' 0 C--N 1.364 1.225 0 CA-C-N 121.606 2.003 . . . . 1.5700000000000001 108.351 170.422 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -97.75 113.28 25.02 Favored 'General case' 0 C--N 1.363 1.175 0 C-N-CA 126.736 2.014 . . . . 2.0699999999999998 116.225 -172.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 60' ' ' PHE . . . . . 0.539 ' CE2' HG23 ' E' ' 10' ' ' ILE . 16.1 m-85 -118.16 170.22 9.05 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 127.529 2.332 . . . . 0.17000000000000001 113.243 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.34 113.27 19.17 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.992 2.117 . . . . 0.17000000000000001 112.231 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -26.54 -18.08 0.0 OUTLIER 'General case' 0 C--N 1.371 1.532 1 C-N-CA 134.652 5.181 . . . . 1.72 121.309 174.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -59.39 -49.19 78.76 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 131.418 3.887 . . . . 0.17000000000000001 111.887 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -94.44 12.54 26.83 Favored 'General case' 0 C--N 1.361 1.107 0 CA-C-N 114.598 -1.183 . . . . 1.1799999999999999 112.836 -170.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 65' ' ' LEU . . . . . . . . . . . . 0.261 1.0 OUTLIER -120.91 119.15 31.77 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 127.723 2.409 . . . . 0.19 114.209 -177.601 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -111.03 136.47 49.99 Favored 'General case' 0 C--N 1.362 1.129 0 O-C-N 120.958 -1.089 . . . . 2.0499999999999998 111.482 171.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.69 140.51 51.14 Favored 'General case' 0 C--N 1.365 1.268 0 C-N-CA 130.84 3.656 . . . . 0.28999999999999998 120.096 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . 0.255 2.0 t -139.78 -33.95 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.373 1.593 0 C-N-CA 126.728 2.011 . . . . 0.72999999999999998 114.092 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 69' ' ' GLN . . . . . 0.582 ' HB3' ' H ' ' E' ' 7' ' ' LYS . 16.6 tt0 -112.53 104.81 12.92 Favored 'General case' 0 C--N 1.361 1.087 0 O-C-N 119.887 -1.758 . . . . 2.1899999999999999 109.585 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.77 62.52 0.07 Allowed 'General case' 0 C--N 1.349 0.546 0 C-N-CA 127.909 2.484 . . . . 0.0 114.808 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.05 67.67 9.76 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 128.939 2.896 . . . . 0.0 109.514 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.24 47.65 0.02 OUTLIER 'General case' 0 C--N 1.362 1.128 0 C-N-CA 130.201 3.401 . . . . 0.0 116.835 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 25.4 tptp . . . . . 0 N--CA 1.42 -1.944 1 C-N-CA 133.582 4.753 . . . . 0.0 104.878 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 2' ' ' LEU . . . . . 0.497 HD11 HG21 ' E' ' 36' ' ' VAL 0.31 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.686 0 N-CA-C 119.794 3.257 . . . . 0.98999999999999999 119.794 . . . . . . . . . 3 3 . 1 . 011 nuclear build core ' E' E ' 3' ' ' ASN . . . . . 0.407 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 0.0 OUTLIER -150.49 177.86 9.6 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 125.633 1.573 . . . . 0.80000000000000004 110.805 -170.043 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 23.3 ptt-85 -65.88 67.85 0.05 OUTLIER 'General case' 0 C--N 1.365 1.249 1 C-N-CA 132.816 4.446 . . . . 3.3999999999999999 119.515 -174.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 125.38 25.38 1.46 Allowed Glycine 0 CA--C 1.491 -1.463 0 C-N-CA 126.72 2.105 . . . . 0.53000000000000003 111.942 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 6' ' ' ASP . . . . . 0.505 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 20.8 t0 -71.04 129.88 40.13 Favored 'General case' 0 C--N 1.367 1.353 0 C-N-CA 125.302 1.441 . . . . 0.45000000000000001 111.553 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 7' ' ' LYS . . . . . 0.493 ' H ' ' CB ' ' E' ' 69' ' ' GLN . 31.6 mtmm -89.01 85.85 6.8 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 102.99 -2.967 . . . . 2.0299999999999998 102.99 171.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 8' ' ' VAL . . . . . 0.46 HG21 HD12 ' E' ' 65' ' ' LEU . 1.5 m -89.68 138.48 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 127.638 2.375 . . . . 0.13 106.323 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 9' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' E' ' 21' ' ' VAL . 1.5 tmt_? -101.5 86.1 2.9 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 121.438 -0.789 . . . . 0.17000000000000001 111.677 -174.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.718 HD11 HG11 ' E' ' 38' ' ' VAL . 1.1 mm -41.4 121.49 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.713 0 N-CA-C 120.751 3.611 . . . . 0.12 120.751 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -118.84 37.81 3.98 Favored 'General case' 0 C--N 1.373 1.609 0 C-N-CA 126.868 2.067 . . . . 0.29999999999999999 111.301 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.66 127.3 42.51 Favored 'General case' 0 C--N 1.365 1.255 0 C-N-CA 130.402 3.481 . . . . 2.0899999999999999 110.028 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 25.0 p -76.8 -55.95 5.04 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 129.585 3.154 . . . . 0.46999999999999997 113.819 -174.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -78.56 68.68 4.6 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 129.79 3.236 . . . . 1.8899999999999999 110.55 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 46.9 t -163.42 167.5 21.53 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 127.844 2.458 . . . . 1.1299999999999999 104.426 -175.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -94.37 -9.23 36.44 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 127.914 2.485 . . . . 0.79000000000000004 111.521 175.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -125.83 45.19 2.67 Favored 'General case' 0 C--N 1.366 1.287 0 O-C-N 120.703 -1.248 . . . . 0.75 111.879 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -71.83 107.31 4.54 Favored 'General case' 0 C--N 1.367 1.329 0 C-N-CA 127.453 2.301 . . . . 0.40000000000000002 111.062 175.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.73 46.71 4.77 Favored Glycine 0 C--N 1.363 2.054 0 CA-C-O 122.196 0.887 . . . . 0.39000000000000001 111.995 -175.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -143.51 166.0 26.01 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 125.346 1.458 . . . . 1.3999999999999999 107.194 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 21' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' E' ' 9' ' ' ARG . 0.4 OUTLIER -103.37 170.45 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.565 0 C-N-CA 126.357 1.863 . . . . 0.31 110.116 178.506 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.39 161.86 26.13 Favored Glycine 0 CA--C 1.483 -1.915 0 O-C-N 121.228 -0.92 . . . . 0.20999999999999999 111.924 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 23' ' ' THR . . . . . 0.418 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 12.8 m -94.98 135.26 36.72 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 128.359 2.664 . . . . 0.27000000000000002 115.959 -175.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 25.3 t -66.86 91.78 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.501 0 CA-C-O 124.711 2.196 . . . . 0.28999999999999998 116.308 170.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -99.35 15.8 25.1 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 130.737 3.615 . . . . 0.28999999999999998 108.777 170.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 26' ' ' SER . . . . . 0.545 ' HA ' ' HB ' ' E' ' 37' ' ' ILE . 0.9 OUTLIER -77.18 -15.02 59.68 Favored 'General case' 0 CA--C 1.48 -1.738 1 C-N-CA 135.391 5.476 . . . . 0.63 118.632 -176.947 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 24.8 t -86.18 59.72 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.495 0 CA-C-O 125.428 2.537 . . . . 0.60999999999999999 108.982 -173.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 28' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' E' ' 29' ' ' LYS . 3.1 pt-20 -145.13 -100.66 0.1 Allowed 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 111.262 -2.699 . . . . 1.6100000000000001 107.695 -174.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 29' ' ' LYS . . . . . 0.414 ' H ' ' HG3' ' E' ' 28' ' ' GLU . 38.1 mmtt -87.31 25.65 1.36 Allowed 'General case' 0 N--CA 1.437 -1.116 1 C-N-CA 132.032 4.133 . . . . 3.96 115.303 -176.297 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.08 -1.05 0.84 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 131.128 3.771 . . . . 4.3399999999999999 117.255 176.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.91 44.02 3.26 Favored Glycine 0 C--N 1.355 1.591 0 C-N-CA 128.472 2.939 . . . . 1.76 114.491 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 32' ' ' ILE . . . . . 0.529 HG22 ' H ' ' E' ' 33' ' ' LEU . 0.3 OUTLIER -137.5 -172.16 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.061 0 C-N-CA 128.072 2.549 . . . . 1.1100000000000001 109.538 -178.844 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' E' E ' 33' ' ' LEU . . . . . 0.529 ' H ' HG22 ' E' ' 32' ' ' ILE . 41.1 tp -82.87 -22.73 33.92 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 131.432 3.893 . . . . 0.56999999999999995 111.913 178.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -118.24 91.04 39.67 Favored Pre-proline 0 C--N 1.35 0.603 0 N-CA-C 103.286 -2.857 . . . . 0.93999999999999995 103.286 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.64 -31.25 0.46 Allowed 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 124.919 3.746 . . . . 0.67000000000000004 116.675 -170.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 36' ' ' VAL . . . . . 0.497 HG21 HD11 ' E' ' 2' ' ' LEU 0.265 75.3 t -96.91 98.38 7.46 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 C-N-CA 127.232 2.213 . . . . 0.64000000000000001 116.403 -166.759 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' E' E ' 37' ' ' ILE . . . . . 0.545 ' HB ' ' HA ' ' E' ' 26' ' ' SER . 3.8 mp -87.51 117.03 30.71 Favored 'Isoleucine or valine' 0 C--N 1.362 1.145 0 C-N-CA 128.11 2.564 . . . . 0.65000000000000002 105.557 174.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 38' ' ' VAL . . . . . 0.718 HG11 HD11 ' E' ' 10' ' ' ILE . 53.0 t -125.36 156.58 34.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.451 0 CA-C-N 119.424 1.011 . . . . 0.23000000000000001 111.276 -173.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 39' ' ' ARG . . . . . 0.418 ' HB3' ' H ' ' E' ' 23' ' ' THR . 36.5 ttm-85 -82.39 156.75 24.01 Favored 'General case' 0 C--N 1.365 1.272 0 C-N-CA 130.661 3.584 . . . . 2.75 110.888 175.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 40' ' ' PHE . . . . . 0.42 ' HE1' HG13 ' E' ' 10' ' ' ILE . 33.2 m-85 -151.01 -178.81 6.82 Favored 'General case' 0 CA--C 1.513 -0.462 0 O-C-N 119.467 -2.02 . . . . 1.26 106.953 174.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -98.62 -39.37 8.73 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 127.077 2.151 . . . . 1.02 114.948 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . 0.269 20.8 mtm180 -69.18 -86.37 0.02 OUTLIER 'General case' 0 C--N 1.37 1.49 0 N-CA-C 121.602 3.927 . . . . 1.29 121.602 -170.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . 0.341 4.7 p . . . . . 0 C--N 1.367 1.327 0 CA-C-O 127.15 3.357 . . . . 1.23 108.757 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 . . . . . 0 CA--C 1.534 0.334 0 CA-C-O 122.894 1.33 . . . . 2.2000000000000002 112.432 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' E' E ' 57' ' ' THR . . . . . 0.428 ' HB ' HG23 ' E' ' 37' ' ' ILE . 40.2 p -86.61 106.83 17.85 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 125.899 1.68 . . . . 0.46999999999999997 113.99 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.61 132.66 47.16 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 128.695 2.798 . . . . 1.5700000000000001 106.283 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -100.31 103.38 14.8 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 124.829 1.252 . . . . 2.0699999999999998 109.639 -178.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 60' ' ' PHE . . . . . 0.5 ' CB ' HD21 ' E' ' 65' ' ' LEU . 24.4 m-85 -98.78 169.27 9.59 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 126.791 2.036 . . . . 0.17000000000000001 116.267 -174.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -102.86 101.86 11.93 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.857 2.463 . . . . 0.17000000000000001 110.717 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -18.72 -29.65 0.0 OUTLIER 'General case' 0 C--N 1.373 1.624 1 C-N-CA 135.135 5.374 . . . . 1.72 120.914 173.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -56.68 -42.67 79.44 Favored 'General case' 0 C--N 1.369 1.449 0 C-N-CA 128.212 2.605 . . . . 0.17000000000000001 111.777 167.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -85.43 -7.48 58.9 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.126 -1.397 . . . . 1.1799999999999999 111.848 -171.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.5 HD21 ' CB ' ' E' ' 60' ' ' PHE . 0.2 OUTLIER -100.46 109.47 21.61 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 120.882 -1.136 . . . . 0.19 110.568 178.504 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -90.7 128.63 36.72 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 123.659 0.784 . . . . 2.0499999999999998 112.407 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.62 137.35 57.78 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 120.542 3.534 . . . . 0.28999999999999998 120.542 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.79 -42.68 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.371 1.504 0 C-N-CA 125.738 1.615 . . . . 0.72999999999999998 111.342 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 69' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 0.0 OUTLIER -112.12 97.54 6.72 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 126.504 1.922 . . . . 2.1899999999999999 114.134 -175.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.67 57.93 0.09 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.404 2.682 . . . . 0.0 114.804 175.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.76 53.45 0.45 Allowed 'General case' 0 C--N 1.353 0.734 0 C-N-CA 129.309 3.044 . . . . 0.0 116.475 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -100.09 94.51 6.29 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 127.556 2.342 . . . . 0.0 109.367 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt . . . . . 0 C--O 1.259 1.564 0 C-N-CA 125.502 1.521 . . . . 0.0 109.236 179.943 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' E' E ' 2' ' ' LEU . . . . . 0.446 ' HB2' ' H ' ' E' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.795 0 N-CA-C 115.967 1.84 . . . . 0.98999999999999999 115.967 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 3' ' ' ASN . . . . . 0.446 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 75.0 m-80 -122.02 -173.8 2.74 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 128.658 2.783 . . . . 0.80000000000000004 114.046 -170.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.92 104.86 17.24 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 128.638 2.775 . . . . 3.3999999999999999 111.757 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.99 -3.64 22.59 Favored Glycine 0 C--N 1.353 1.494 0 O-C-N 119.984 -1.698 . . . . 0.53000000000000003 111.896 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 6' ' ' ASP . . . . . 0.508 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 3.6 t0 -77.85 72.02 4.36 Favored 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 130.529 3.531 . . . . 0.45000000000000001 114.115 -174.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 7' ' ' LYS . . . . . 0.408 ' H ' ' HG3' ' E' ' 7' ' ' LYS . 23.2 mtpp -35.97 87.64 0.0 OUTLIER 'General case' 0 C--N 1.351 0.64 1 C-N-CA 132.78 4.432 . . . . 2.0299999999999998 114.743 177.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 8' ' ' VAL . . . . . 0.428 HG22 ' H ' ' E' ' 8' ' ' VAL . 0.0 OUTLIER -86.96 137.76 20.3 Favored 'Isoleucine or valine' 0 C--N 1.361 1.092 0 N-CA-C 107.102 -1.444 . . . . 0.13 107.102 -172.563 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -96.52 87.78 4.5 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 115.813 1.783 . . . . 0.17000000000000001 115.813 -170.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.531 HD13 ' H ' ' E' ' 10' ' ' ILE . 0.9 OUTLIER -26.4 98.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 N-CA-C 119.517 3.154 . . . . 0.12 119.517 173.161 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -113.43 43.57 1.73 Allowed 'General case' 0 C--N 1.366 1.311 0 O-C-N 120.115 -1.615 . . . . 0.29999999999999999 113.261 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.79 137.16 39.55 Favored 'General case' 0 C--N 1.366 1.286 0 C-N-CA 125.902 1.681 . . . . 2.0899999999999999 111.006 174.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 22.3 p -73.02 -58.01 3.62 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 128.491 2.716 . . . . 0.46999999999999997 114.516 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -76.02 64.33 1.9 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 127.945 2.498 . . . . 1.8899999999999999 114.929 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 27.1 t -167.69 176.78 6.19 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 126.531 1.932 . . . . 1.1299999999999999 105.868 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -93.5 0.33 56.66 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 128.612 2.765 . . . . 0.79000000000000004 111.607 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -117.28 25.54 10.38 Favored 'General case' 0 C--N 1.36 1.034 0 O-C-N 120.48 -1.388 . . . . 0.75 113.807 -172.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -70.04 108.94 4.29 Favored 'General case' 0 C--N 1.368 1.377 0 C-N-CA 126.338 1.855 . . . . 0.40000000000000002 114.228 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.66 30.36 18.65 Favored Glycine 0 C--N 1.366 2.206 0 CA-C-O 121.538 0.521 . . . . 0.39000000000000001 112.218 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -121.02 173.28 7.36 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 126.807 2.043 . . . . 1.3999999999999999 105.751 177.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.59 175.75 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 C-N-CA 125.613 1.565 . . . . 0.31 110.042 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.07 175.21 40.22 Favored Glycine 0 CA--C 1.479 -2.211 1 N-CA-C 101.314 -4.714 . . . . 0.20999999999999999 101.314 165.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 23' ' ' THR . . . . . 0.622 ' H ' ' HB2' ' E' ' 39' ' ' ARG . 11.1 m -96.39 141.28 29.89 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 126.131 1.772 . . . . 0.27000000000000002 108.666 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 p -79.76 112.76 18.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 124.776 2.227 . . . . 0.28999999999999998 109.043 166.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.14 31.8 6.18 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 111.134 -2.757 . . . . 0.28999999999999998 108.573 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 26' ' ' SER . . . . . 0.505 ' CB ' ' H ' ' E' ' 37' ' ' ILE . 0.3 OUTLIER -86.62 -39.99 15.58 Favored 'General case' 0 CA--C 1.49 -1.329 0 C-N-CA 126.727 2.011 . . . . 0.63 115.874 178.544 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . 0.259 0.3 OUTLIER -83.23 70.21 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.915 0 CA-C-O 127.888 3.709 . . . . 0.60999999999999999 110.842 -172.133 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -161.2 -54.32 0.05 OUTLIER 'General case' 0 N--CA 1.424 -1.752 1 CA-C-N 107.896 -4.229 . . . . 1.6100000000000001 105.595 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp -109.43 -22.98 11.76 Favored 'General case' 0 C--N 1.364 1.228 0 N-CA-C 116.868 2.173 . . . . 3.96 116.868 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -22.26 -15.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 2 C-N-CA 138.626 6.77 . . . . 4.3399999999999999 122.629 -168.59 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.51 43.37 2.74 Favored Glycine 0 C--N 1.338 0.685 1 C-N-CA 130.906 4.098 . . . . 1.76 115.757 -175.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.23 -170.18 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.752 0 C-N-CA 126.758 2.023 . . . . 1.1100000000000001 110.806 -177.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 46.6 tp -68.89 -30.87 69.45 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 128.639 2.776 . . . . 0.56999999999999995 114.965 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -108.06 117.96 53.78 Favored Pre-proline 0 C--N 1.36 1.033 0 N-CA-C 103.838 -2.653 . . . . 0.93999999999999995 103.838 175.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -75.14 -39.58 1.12 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.475 3.45 . . . . 0.67000000000000004 113.584 -167.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 36' ' ' VAL . . . . . 0.608 HG12 HG23 ' E' ' 38' ' ' VAL . 62.3 t -109.62 115.17 48.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.708 0 C-N-CA 125.681 1.592 . . . . 0.64000000000000001 112.881 -177.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 37' ' ' ILE . . . . . 0.505 ' H ' ' CB ' ' E' ' 26' ' ' SER . 6.5 mt -88.87 128.07 41.25 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 C-N-CA 127.091 2.156 . . . . 0.65000000000000002 105.273 166.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 38' ' ' VAL . . . . . 0.608 HG23 HG12 ' E' ' 36' ' ' VAL . 24.8 t -122.98 150.17 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 O-C-N 120.343 -1.473 . . . . 0.23000000000000001 109.041 -178.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 39' ' ' ARG . . . . . 0.622 ' HB2' ' H ' ' E' ' 23' ' ' THR . 42.5 mtp180 -74.28 168.62 19.28 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 127.34 2.256 . . . . 2.75 111.322 172.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . 0.25 21.4 m-85 -139.66 123.83 17.88 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 124.269 1.985 . . . . 1.26 111.329 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -54.37 -43.8 71.66 Favored 'General case' 0 N--CA 1.439 -1.0 1 C-N-CA 137.565 6.346 . . . . 1.02 119.109 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 46.6 mtm105 -131.9 93.61 3.33 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 107.486 -1.302 . . . . 1.29 107.486 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 C--N 1.369 1.418 0 CA-C-O 125.33 2.491 . . . . 1.23 109.912 174.86 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 20.7 m120 . . . . . 0 C--O 1.224 -0.242 0 N-CA-C 109.065 -0.717 . . . . 2.2000000000000002 109.065 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 12.2 p -125.67 123.46 39.0 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 130.747 3.619 . . . . 0.46999999999999997 109.592 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -116.83 151.78 35.8 Favored 'General case' 0 C--N 1.365 1.246 0 C-N-CA 126.714 2.005 . . . . 1.5700000000000001 109.887 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -78.28 129.37 34.97 Favored 'General case' 0 C--N 1.364 1.227 0 C-N-CA 126.386 1.874 . . . . 2.0699999999999998 112.56 176.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 60' ' ' PHE . . . . . 0.522 ' HE2' HD12 ' E' ' 10' ' ' ILE . 0.2 OUTLIER -127.78 169.6 13.68 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 117.177 2.288 . . . . 0.17000000000000001 117.177 -177.163 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.87 88.2 2.77 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 110.129 -3.214 . . . . 0.17000000000000001 111.693 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -18.25 -24.77 0.0 OUTLIER 'General case' 0 C--N 1.355 0.811 1 C-N-CA 136.276 5.83 . . . . 1.72 120.377 171.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.03 -34.14 71.56 Favored 'General case' 0 C--N 1.371 1.531 0 C-N-CA 129.615 3.166 . . . . 0.17000000000000001 113.856 167.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.37 17.46 21.43 Favored 'General case' 0 C--N 1.368 1.378 0 C-N-CA 125.92 1.688 . . . . 1.1799999999999999 110.738 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.478 HD13 HG11 ' E' ' 36' ' ' VAL . 74.0 mt -128.27 113.44 15.65 Favored 'General case' 0 C--N 1.363 1.156 0 N-CA-C 115.301 1.593 . . . . 0.19 115.301 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -100.46 129.83 46.46 Favored 'General case' 0 C--N 1.363 1.166 0 C-N-CA 124.837 1.255 . . . . 2.0499999999999998 111.731 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.1 128.24 35.99 Favored 'General case' 0 C--N 1.368 1.397 0 C-N-CA 130.255 3.422 . . . . 0.28999999999999998 116.49 172.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.3 -28.98 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.167 0 CA-C-N 120.639 1.563 . . . . 0.72999999999999998 113.607 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 69' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 3.5 tp-100 -104.48 138.06 41.42 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 125.32 2.486 . . . . 2.1899999999999999 114.342 -175.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.01 57.94 4.57 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 128.918 2.887 . . . . 0.0 111.528 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.13 52.55 0.9 Allowed 'General case' 0 C--N 1.362 1.113 0 C-N-CA 126.369 1.868 . . . . 0.0 108.989 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.85 146.81 25.57 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 126.062 1.745 . . . . 0.0 110.928 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt . . . . . 0 C--O 1.261 1.686 0 C-N-CA 125.839 1.656 . . . . 0.0 108.548 177.059 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' E' E ' 2' ' ' LEU . . . . . 0.401 ' HB2' ' H ' ' E' ' 3' ' ' ASN 0.318 2.5 pp . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 123.017 1.389 . . . . 0.98999999999999999 114.344 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 3' ' ' ASN . . . . . 0.401 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 1.5 m120 -143.82 173.39 11.73 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 130.56 3.544 . . . . 0.80000000000000004 110.753 -176.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -95.62 109.71 21.92 Favored 'General case' 0 C--N 1.367 1.356 0 C-N-CA 127.703 2.401 . . . . 3.3999999999999999 112.815 175.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.61 14.34 41.08 Favored Glycine 0 CA--C 1.473 -2.535 0 O-C-N 119.474 -2.016 . . . . 0.53000000000000003 114.016 172.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 6' ' ' ASP . . . . . 0.52 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 19.8 t0 -84.02 146.96 27.68 Favored 'General case' 0 N--CA 1.421 -1.884 1 C-N-CA 132.106 4.162 . . . . 0.45000000000000001 105.559 178.019 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -93.65 89.82 6.37 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 105.283 -2.118 . . . . 2.0299999999999998 105.283 173.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 8' ' ' VAL . . . . . 0.421 HG22 ' H ' ' E' ' 8' ' ' VAL . 5.4 m -86.33 142.85 12.53 Favored 'Isoleucine or valine' 0 C--N 1.366 1.31 0 N-CA-C 107.652 -1.24 . . . . 0.13 107.652 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -96.64 100.92 12.46 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 117.103 2.26 . . . . 0.17000000000000001 117.103 -169.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.528 HG23 ' CE2' ' E' ' 60' ' ' PHE . 1.8 mm -38.33 97.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.575 1.909 0 C-N-CA 129.46 3.104 . . . . 0.12 119.07 171.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -117.1 45.33 1.9 Allowed 'General case' 0 C--N 1.372 1.583 0 O-C-N 118.642 -2.536 . . . . 0.29999999999999999 111.969 -175.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 12' ' ' ARG . . . . . 0.463 ' HD2' ' CE1' ' E' ' 60' ' ' PHE . 10.1 ptm180 -99.68 128.35 45.78 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 128.4 2.68 . . . . 2.0899999999999999 107.995 175.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 24.6 p -70.74 -62.18 1.49 Allowed 'General case' 0 C--N 1.359 0.989 0 C-N-CA 130.194 3.398 . . . . 0.46999999999999997 114.088 -175.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.71 72.15 0.52 Allowed 'General case' 0 C--N 1.362 1.129 0 C-N-CA 130.636 3.574 . . . . 1.8899999999999999 110.26 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 3.7 t -156.71 172.77 18.02 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 124.802 2.239 . . . . 1.1299999999999999 111.091 -170.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -97.02 -17.81 19.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 130.649 3.58 . . . . 0.79000000000000004 108.622 171.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -121.04 17.04 11.68 Favored 'General case' 0 C--N 1.367 1.367 0 N-CA-C 116.762 2.134 . . . . 0.75 116.762 -167.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -60.66 113.14 2.3 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 117.717 2.488 . . . . 0.40000000000000002 117.717 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.47 25.94 22.05 Favored Glycine 0 C--N 1.365 2.141 0 C-N-CA 124.701 1.143 . . . . 0.39000000000000001 112.841 170.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -136.78 171.29 14.72 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 104.977 -2.231 . . . . 1.3999999999999999 104.977 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.96 176.91 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 125.124 1.37 . . . . 0.31 113.922 -173.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.78 168.75 41.6 Favored Glycine 0 C--N 1.36 1.89 0 N-CA-C 105.716 -2.954 . . . . 0.20999999999999999 105.716 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 23' ' ' THR . . . . . 0.646 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 7.5 m -89.69 137.69 32.11 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 124.692 1.197 . . . . 0.27000000000000002 110.208 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 24' ' ' VAL . . . . . 0.492 HG22 ' H ' ' E' ' 26' ' ' SER . 10.2 p -82.22 113.05 20.9 Favored 'Isoleucine or valine' 0 C--N 1.348 0.517 0 CA-C-O 124.341 2.019 . . . . 0.28999999999999998 111.195 167.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.08 24.25 13.27 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 128.216 2.606 . . . . 0.28999999999999998 109.461 172.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 26' ' ' SER . . . . . 0.492 ' H ' HG22 ' E' ' 24' ' ' VAL . 21.1 t -81.21 -52.2 7.6 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 127.382 2.273 . . . . 0.63 116.203 -177.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.49 51.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-O 125.627 2.632 . . . . 0.60999999999999999 114.091 -164.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.89 -60.07 0.26 Allowed 'General case' 0 N--CA 1.424 -1.731 0 C-N-CA 129.269 3.028 . . . . 1.6100000000000001 105.086 -174.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -112.04 7.14 19.68 Favored 'General case' 0 C--N 1.364 1.237 0 N-CA-C 115.08 1.511 . . . . 3.96 115.08 -177.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -35.82 -28.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 1 C-N-CA 134.193 4.997 . . . . 4.3399999999999999 119.787 -176.539 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.39 46.72 0.19 Allowed Glycine 0 C--N 1.35 1.352 1 C-N-CA 130.854 4.074 . . . . 1.76 117.606 -178.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 32' ' ' ILE . . . . . 0.453 HD12 HD21 ' E' ' 59' ' ' ASN . 0.3 OUTLIER -113.5 -155.76 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.502 0 CA-C-O 123.332 1.539 . . . . 1.1100000000000001 111.65 178.069 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 62.6 tp -72.55 -34.75 67.74 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 130.054 3.342 . . . . 0.56999999999999995 113.778 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -125.43 157.77 66.75 Favored Pre-proline 0 C--N 1.355 0.824 0 N-CA-C 101.736 -3.431 . . . . 0.93999999999999995 101.736 174.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.96 -59.28 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 123.861 2.415 . . . . 0.67000000000000004 112.805 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 36' ' ' VAL . . . . . 0.536 HG12 HG23 ' E' ' 38' ' ' VAL . 52.6 t -70.06 105.86 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.222 0 N-CA-C 117.762 2.504 . . . . 0.64000000000000001 117.762 -169.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 37' ' ' ILE . . . . . 0.424 ' H ' ' HB2' ' E' ' 26' ' ' SER . 18.0 mt -89.82 107.37 18.13 Favored 'Isoleucine or valine' 0 C--N 1.37 1.481 0 N-CA-C 105.748 -1.945 . . . . 0.65000000000000002 105.748 170.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 38' ' ' VAL . . . . . 0.536 HG23 HG12 ' E' ' 36' ' ' VAL 0.26 19.4 t -112.18 149.24 14.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.473 0 CA-C-O 121.053 0.454 . . . . 0.23000000000000001 110.132 -179.16 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 39' ' ' ARG . . . . . 0.646 ' HB3' ' H ' ' E' ' 23' ' ' THR . 8.5 tmm_? -84.09 147.06 27.57 Favored 'General case' 0 C--N 1.366 1.311 0 C-N-CA 129.125 2.97 . . . . 2.75 108.892 173.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -151.72 144.94 24.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 104.206 -2.516 . . . . 1.26 104.206 172.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -105.46 -2.75 23.33 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 125.523 1.529 . . . . 1.02 112.191 175.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -86.44 45.72 1.27 Allowed 'General case' 0 C--N 1.357 0.898 0 C-N-CA 129.498 3.119 . . . . 1.29 110.49 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 C--N 1.354 0.788 1 C-N-CA 131.927 4.091 . . . . 1.23 110.467 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 . . . . . 0 CA--C 1.531 0.213 0 CA-C-O 119.822 -0.132 . . . . 2.2000000000000002 111.214 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 62.7 p -107.33 96.29 6.31 Favored 'General case' 0 C--N 1.363 1.185 0 C-N-CA 125.087 1.355 . . . . 0.46999999999999997 108.479 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -112.5 145.38 40.34 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 125.285 1.434 . . . . 1.5700000000000001 111.022 -174.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 59' ' ' ASN . . . . . 0.453 HD21 HD12 ' E' ' 32' ' ' ILE . 0.4 OUTLIER -92.76 95.5 9.59 Favored 'General case' 0 C--N 1.361 1.085 0 C-N-CA 127.43 2.292 . . . . 2.0699999999999998 110.392 -177.27 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 60' ' ' PHE . . . . . 0.528 ' CE2' HG23 ' E' ' 10' ' ' ILE . 0.5 OUTLIER -101.71 164.77 11.57 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 126.697 1.999 . . . . 0.17000000000000001 114.039 -171.494 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 61' ' ' ALA . . . . . 0.419 ' H ' ' HD1' ' E' ' 60' ' ' PHE . . . -97.63 90.32 4.97 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 127.656 2.382 . . . . 0.17000000000000001 111.818 -177.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -16.39 -40.98 0.0 OUTLIER 'General case' 0 C--N 1.365 1.281 1 C-N-CA 134.308 5.043 . . . . 1.72 120.087 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.48 -26.4 42.32 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 128.507 2.723 . . . . 0.17000000000000001 115.964 171.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -97.55 5.21 49.85 Favored 'General case' 0 C--N 1.364 1.235 0 C-N-CA 127.171 2.188 . . . . 1.1799999999999999 111.712 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.525 HD21 ' CG ' ' E' ' 60' ' ' PHE . 0.6 OUTLIER -116.68 109.6 17.39 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 126.026 1.73 . . . . 0.19 112.097 -175.922 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -106.08 147.7 28.64 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 124.748 1.219 . . . . 2.0499999999999998 110.383 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -75.17 142.54 43.51 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 127.323 2.249 . . . . 0.28999999999999998 116.459 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 t -127.2 -28.6 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.963 0 C-N-CA 125.646 1.578 . . . . 0.72999999999999998 108.386 173.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 69' ' ' GLN . . . . . 0.52 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 7.9 tt0 -114.02 142.39 46.23 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 124.933 2.302 . . . . 2.1899999999999999 113.173 -177.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.36 57.46 0.94 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 128.449 2.7 . . . . 0.0 111.189 174.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.07 53.23 0.6 Allowed 'General case' 0 C--N 1.367 1.355 0 C-N-CA 127.518 2.327 . . . . 0.0 115.312 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.2 137.24 40.72 Favored 'General case' 0 C--N 1.348 0.509 0 C-N-CA 127.447 2.299 . . . . 0.0 107.156 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? . . . . . 0 C--O 1.261 1.699 0 CA-C-O 118.477 -0.773 . . . . 0.0 110.114 178.73 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' E' E ' 2' ' ' LEU . . . . . 0.404 ' HB2' ' H ' ' E' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.616 0 N-CA-C 115.559 1.688 . . . . 0.98999999999999999 115.559 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 3' ' ' ASN . . . . . 0.404 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 42.9 m-80 -134.63 -172.29 2.99 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 128.688 2.795 . . . . 0.80000000000000004 108.954 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -95.85 104.87 16.83 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 129.004 2.922 . . . . 3.3999999999999999 115.357 -176.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.37 3.51 33.09 Favored Glycine 0 C--N 1.366 2.23 0 CA-C-O 124.43 2.128 . . . . 0.53000000000000003 111.45 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 6' ' ' ASP . . . . . . . . . . . . 0.34 16.2 t70 -90.35 51.41 2.02 Favored 'General case' 0 N--CA 1.424 -1.761 1 C-N-CA 132.96 4.504 . . . . 0.45000000000000001 108.945 -178.202 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -28.75 105.85 0.03 OUTLIER 'General case' 0 C--N 1.367 1.329 1 C-N-CA 133.666 4.786 . . . . 2.0299999999999998 117.035 -174.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 35.1 m -90.62 150.49 3.72 Favored 'Isoleucine or valine' 0 C--N 1.36 1.036 0 C-N-CA 123.279 0.632 . . . . 0.13 111.111 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 19.4 ttm-85 -98.76 88.34 4.01 Favored 'General case' 0 C--N 1.36 1.025 0 O-C-N 120.629 -1.294 . . . . 0.17000000000000001 112.909 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 10' ' ' ILE . . . . . 0.832 HD11 HG11 ' E' ' 38' ' ' VAL . 0.5 OUTLIER -33.53 101.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.598 0 N-CA-C 119.988 3.329 . . . . 0.12 119.988 176.423 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -103.01 42.74 1.13 Allowed 'General case' 0 C--N 1.368 1.374 0 C-N-CA 125.783 1.633 . . . . 0.29999999999999999 113.399 -174.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -98.49 123.53 42.7 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 129.389 3.075 . . . . 2.0899999999999999 111.226 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 26.4 p -71.42 -61.75 1.66 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 128.201 2.6 . . . . 0.46999999999999997 116.204 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -78.96 65.69 4.21 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 127.001 2.12 . . . . 1.8899999999999999 113.611 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 3.9 m -173.68 163.35 4.24 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 126.561 1.944 . . . . 1.1299999999999999 106.129 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -90.93 18.78 6.21 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 129.159 2.984 . . . . 0.79000000000000004 112.65 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 36.1 m0 -113.68 0.07 14.45 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 129.246 3.019 . . . . 0.75 111.636 -175.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -58.3 105.57 0.3 Allowed 'General case' 0 C--N 1.37 1.49 0 C-N-CA 127.163 2.185 . . . . 0.40000000000000002 116.176 -174.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.82 26.33 53.89 Favored Glycine 0 C--N 1.366 2.243 0 O-C-N 121.137 -0.977 . . . . 0.39000000000000001 115.11 -177.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -106.34 152.94 22.91 Favored 'General case' 0 C--N 1.362 1.149 0 N-CA-C 105.989 -1.856 . . . . 1.3999999999999999 105.989 175.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -88.11 151.72 3.48 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-O 123.716 1.722 . . . . 0.31 109.969 174.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.95 167.7 28.26 Favored Glycine 0 CA--C 1.471 -2.712 0 N-CA-C 105.872 -2.891 . . . . 0.20999999999999999 105.872 170.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 23' ' ' THR . . . . . 0.5 ' H ' ' HB2' ' E' ' 39' ' ' ARG . 17.3 m -97.24 113.92 25.59 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 124.901 1.28 . . . . 0.27000000000000002 112.147 -175.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 24' ' ' VAL . . . . . 0.424 HG23 HG13 ' E' ' 36' ' ' VAL . 9.8 p -66.16 71.79 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 128.729 2.811 . . . . 0.28999999999999998 118.307 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.01 53.93 2.96 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 116.699 -3.751 . . . . 0.28999999999999998 112.53 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 26' ' ' SER . . . . . 0.441 ' HA ' ' HB ' ' E' ' 37' ' ' ILE . 67.0 m -88.77 -58.03 2.69 Favored 'General case' 0 CA--C 1.477 -1.831 1 C-N-CA 133.549 4.74 . . . . 0.63 118.443 -173.792 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 m -82.51 49.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.368 1.393 0 CA-C-O 127.706 3.622 . . . . 0.60999999999999999 114.817 -163.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -135.39 -58.17 0.79 Allowed 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 110.817 -2.901 . . . . 1.6100000000000001 105.386 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -110.87 5.25 20.41 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 127.181 2.193 . . . . 3.96 114.001 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 26.5 t -46.14 -26.35 0.75 Allowed 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 129.516 3.126 . . . . 4.3399999999999999 116.935 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.35 44.21 0.06 OUTLIER Glycine 0 C--N 1.357 1.709 1 C-N-CA 130.809 4.052 . . . . 1.76 118.327 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.54 -156.61 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.972 0 C-N-CA 128.972 2.909 . . . . 1.1100000000000001 113.144 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 25.6 tp -87.79 -12.95 43.56 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 130.849 3.66 . . . . 0.56999999999999995 114.248 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -135.25 141.62 38.53 Favored Pre-proline 0 C--N 1.358 0.966 0 N-CA-C 101.912 -3.366 . . . . 0.93999999999999995 101.912 175.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -83.88 -45.1 0.06 OUTLIER 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.882 2.388 . . . . 0.67000000000000004 115.954 -168.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 36' ' ' VAL . . . . . 0.567 HG11 HD13 ' E' ' 65' ' ' LEU . 55.4 t -106.23 131.12 56.69 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 N-CA-C 115.597 1.702 . . . . 0.64000000000000001 115.597 -166.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 37' ' ' ILE . . . . . 0.441 ' HB ' ' HA ' ' E' ' 26' ' ' SER . 57.0 mt -105.72 126.08 61.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 C-N-CA 127.702 2.401 . . . . 0.65000000000000002 105.302 172.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 38' ' ' VAL . . . . . 0.832 HG11 HD11 ' E' ' 10' ' ' ILE . 74.3 t -134.43 144.4 35.22 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 O-C-N 120.703 -1.248 . . . . 0.23000000000000001 109.161 -176.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 39' ' ' ARG . . . . . 0.5 ' HB2' ' H ' ' E' ' 23' ' ' THR . 8.1 mtm180 -69.79 163.48 25.7 Favored 'General case' 0 C--N 1.372 1.578 0 C-N-CA 127.815 2.446 . . . . 2.75 115.827 173.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -149.02 139.12 22.19 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 124.543 1.137 . . . . 1.26 110.113 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -94.1 -32.6 13.69 Favored 'General case' 0 C--N 1.366 1.319 0 C-N-CA 125.995 1.718 . . . . 1.02 111.508 171.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 -79.69 57.99 2.65 Favored 'General case' 0 C--N 1.373 1.59 0 C-N-CA 129.397 3.079 . . . . 1.29 112.617 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 C--N 1.351 0.664 0 C-N-CA 127.11 2.164 . . . . 1.23 110.225 -178.893 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 . . . . . 0 C--O 1.225 -0.235 0 CA-C-O 121.403 0.621 . . . . 2.2000000000000002 109.442 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 72.7 p -105.0 115.95 31.14 Favored 'General case' 0 C--N 1.35 0.611 0 C-N-CA 126.891 2.077 . . . . 0.46999999999999997 108.585 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -105.95 147.11 29.18 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 108.639 -0.875 . . . . 1.5700000000000001 108.639 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -90.52 110.45 21.58 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 128.332 2.653 . . . . 2.0699999999999998 107.669 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -122.22 173.58 7.51 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 126.791 2.036 . . . . 0.17000000000000001 115.797 -172.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -108.15 97.31 7.02 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 130.077 3.351 . . . . 0.17000000000000001 113.909 -176.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -14.34 -34.9 0.0 OUTLIER 'General case' 0 C--N 1.366 1.297 1 C-N-CA 134.683 5.193 . . . . 1.72 121.122 171.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -46.2 -46.74 17.72 Favored 'General case' 0 C--N 1.369 1.426 1 C-N-CA 132.661 4.384 . . . . 0.17000000000000001 112.606 170.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.97 16.6 25.49 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 112.744 -2.025 . . . . 1.1799999999999999 111.218 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 65' ' ' LEU . . . . . 0.567 HD13 HG11 ' E' ' 36' ' ' VAL . 75.4 mt -129.65 98.01 4.7 Favored 'General case' 0 C--N 1.369 1.449 0 N-CA-C 114.942 1.46 . . . . 0.19 114.942 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -105.97 143.87 33.49 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 125.692 1.597 . . . . 2.0499999999999998 111.638 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -62.45 137.23 58.22 Favored 'General case' 0 C--N 1.365 1.276 0 C-N-CA 129.307 3.043 . . . . 0.28999999999999998 117.481 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 39.3 t -132.75 -27.27 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.292 0 C-N-CA 126.815 2.046 . . . . 0.72999999999999998 110.104 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.95 146.82 41.77 Favored 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 125.9 1.68 . . . . 2.1899999999999999 108.156 177.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.67 79.75 1.39 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 129.622 3.169 . . . . 0.0 112.685 173.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.25 77.83 1.45 Allowed 'General case' 0 C--N 1.352 0.683 0 O-C-N 119.403 -2.061 . . . . 0.0 109.484 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.45 -165.89 0.77 Allowed 'General case' 0 C--N 1.353 0.723 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt . . . . . 0 C--O 1.262 1.739 0 C-N-CA 127.647 2.379 . . . . 0.0 108.399 176.1 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 108.015 -1.106 . . . . 2.1299999999999999 108.015 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.26 -161.02 0.73 Allowed 'General case' 0 C--N 1.353 0.734 0 C-N-CA 125.331 1.452 . . . . 0.98999999999999999 112.944 176.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 46.4 m-20 -123.86 -178.17 3.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 128.02 2.528 . . . . 0.80000000000000004 110.842 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -91.43 83.92 5.5 Favored 'General case' 0 C--N 1.364 1.235 0 C-N-CA 127.78 2.432 . . . . 3.3999999999999999 112.62 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 142.22 -9.06 2.44 Favored Glycine 0 CA--C 1.486 -1.74 0 CA-C-O 123.642 1.69 . . . . 0.53000000000000003 110.872 -173.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 6' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -81.63 47.98 1.13 Allowed 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 128.227 2.611 . . . . 0.45000000000000001 114.837 -172.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . 0.421 0.0 OUTLIER -11.91 97.33 0.01 OUTLIER 'General case' 0 C--N 1.361 1.089 1 C-N-CA 132.761 4.425 . . . . 2.0299999999999998 117.763 -176.161 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.8 151.54 4.1 Favored 'Isoleucine or valine' 0 C--N 1.364 1.232 0 O-C-N 119.738 -1.851 . . . . 0.13 111.18 -171.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 17.1 ttt85 -97.61 105.86 18.08 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 115.153 1.538 . . . . 0.17000000000000001 115.153 -176.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.689 HD11 HG11 ' E' ' 38' ' ' VAL . 1.3 mp -53.83 104.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.37 1.481 0 C-N-CA 129.108 2.963 . . . . 0.12 115.339 174.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -123.78 55.95 1.24 Allowed 'General case' 0 C--N 1.365 1.255 0 C-N-CA 123.762 0.825 . . . . 0.29999999999999999 109.131 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -72.75 -72.91 0.22 Allowed 'General case' 0 C--N 1.362 1.146 0 C-N-CA 126.053 1.741 . . . . 2.0899999999999999 115.188 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 84.9 m 127.44 -61.92 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.734 1 C-N-CA 133.077 4.551 . . . . 0.46999999999999997 104.774 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -77.1 72.24 3.63 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 128.241 2.616 . . . . 1.8899999999999999 111.383 173.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 42.6 t -167.44 159.79 12.68 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 106.823 -1.547 . . . . 1.1299999999999999 106.823 -174.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -90.15 -2.09 58.03 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 127.412 2.285 . . . . 0.79000000000000004 110.585 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -119.43 24.36 10.72 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 125.564 1.546 . . . . 0.75 111.082 -176.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -67.49 110.49 3.66 Favored 'General case' 0 C--N 1.369 1.425 0 C-N-CA 126.975 2.11 . . . . 0.40000000000000002 113.802 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.99 16.67 46.85 Favored Glycine 0 C--N 1.356 1.69 0 C-N-CA 125.819 1.676 . . . . 0.39000000000000001 111.272 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -108.91 164.2 12.61 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 126.305 1.842 . . . . 1.3999999999999999 110.155 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -110.27 173.29 2.21 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 C-N-CA 125.946 1.698 . . . . 0.31 108.257 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.55 174.92 42.65 Favored Glycine 0 CA--C 1.474 -2.523 0 N-CA-C 107.517 -2.233 . . . . 0.20999999999999999 107.517 167.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 23' ' ' THR . . . . . 0.78 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 23.5 m -90.21 120.05 31.05 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 126.293 1.837 . . . . 0.27000000000000002 112.219 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 24' ' ' VAL . . . . . 0.718 HG23 HG13 ' E' ' 36' ' ' VAL . 7.9 p -72.25 80.94 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 125.279 2.466 . . . . 0.28999999999999998 116.571 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.31 45.12 1.15 Allowed 'General case' 0 C--N 1.35 0.597 0 O-C-N 118.643 -2.535 . . . . 0.28999999999999998 111.885 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 13.7 t -85.08 -68.95 0.69 Allowed 'General case' 0 CA--C 1.498 -1.043 1 C-N-CA 133.149 4.58 . . . . 0.63 114.076 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 1.3 m -79.88 28.98 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.229 0 C-N-CA 127.69 2.396 . . . . 0.60999999999999999 116.04 -157.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -112.4 -60.67 1.83 Allowed 'General case' 0 N--CA 1.425 -1.675 1 C-N-CA 132.38 4.272 . . . . 1.6100000000000001 106.972 177.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.53 -27.63 8.51 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 115.422 1.638 . . . . 3.96 115.422 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.54 35.08 0.76 Allowed 'General case' 0 C--N 1.354 0.786 0 N-CA-C 115.477 1.658 . . . . 4.3399999999999999 115.477 -173.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.14 52.44 3.34 Favored Glycine 0 C--N 1.349 1.266 0 C-N-CA 129.053 3.216 . . . . 1.76 112.561 163.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 32' ' ' ILE . . . . . 0.487 HG22 ' H ' ' E' ' 33' ' ' LEU . 0.4 OUTLIER -133.94 -157.64 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.988 0 C-N-CA 129.311 3.044 . . . . 1.1100000000000001 109.93 -175.098 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 33' ' ' LEU . . . . . 0.487 ' H ' HG22 ' E' ' 32' ' ' ILE . 36.6 tp -62.93 -42.47 99.81 Favored 'General case' 0 C--N 1.358 0.935 1 C-N-CA 132.238 4.215 . . . . 0.56999999999999995 117.673 -177.3 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -110.17 134.61 20.7 Favored Pre-proline 0 C--N 1.366 1.302 0 N-CA-C 102.471 -3.159 . . . . 0.93999999999999995 102.471 172.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.4 -53.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.424 2.083 . . . . 0.67000000000000004 115.933 -167.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 36' ' ' VAL . . . . . 0.718 HG13 HG23 ' E' ' 24' ' ' VAL . 69.7 t -105.54 105.38 18.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.889 0 N-CA-C 119.316 3.08 . . . . 0.64000000000000001 119.316 -161.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 59.9 mt -83.1 125.08 40.04 Favored 'Isoleucine or valine' 0 C--N 1.38 1.895 0 O-C-N 119.247 -2.158 . . . . 0.65000000000000002 106.25 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 38' ' ' VAL . . . . . 0.689 HG11 HD11 ' E' ' 10' ' ' ILE . 55.2 t -122.72 162.64 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 119.333 0.97 . . . . 0.23000000000000001 108.927 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 39' ' ' ARG . . . . . 0.78 ' HB3' ' H ' ' E' ' 23' ' ' THR 0.256 30.8 ttp180 -82.16 147.39 29.05 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 129.825 3.25 . . . . 2.75 110.833 172.267 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -139.96 126.22 20.0 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 124.742 1.217 . . . . 1.26 107.987 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -82.48 -15.25 53.17 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 124.343 1.057 . . . . 1.02 112.051 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -115.59 75.07 0.92 Allowed 'General case' 0 C--N 1.368 1.375 0 C-N-CA 126.854 2.061 . . . . 1.29 112.285 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 43' ' ' VAL . . . . . 0.407 HG22 ' CE1' ' E' ' 45' ' ' TYR . 3.3 m -92.93 21.65 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.306 0 C-N-CA 126.581 1.952 . . . . 1.23 115.729 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . 0.436 0.3 OUTLIER 47.68 72.7 0.24 Allowed 'General case' 0 N--CA 1.443 -0.798 1 C-N-CA 132.122 4.169 . . . . 2.0499999999999998 119.079 -177.42 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' E' E ' 45' ' ' TYR . . . . . 0.407 ' CE1' HG22 ' E' ' 43' ' ' VAL . 38.0 m-85 -56.24 36.45 0.0 OUTLIER 'General case' 0 C--N 1.365 1.248 1 C-N-CA 134.615 5.166 . . . . 2.52 118.667 -177.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -101.69 76.35 1.65 Allowed 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 128.781 2.832 . . . . 4.1600000000000001 106.142 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -46.77 -22.81 1.24 Allowed Glycine 0 C--N 1.369 2.362 0 C-N-CA 129.528 3.442 . . . . 5.3300000000000001 121.378 -170.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -104.19 -0.02 28.97 Favored 'General case' 0 C--N 1.361 1.085 0 C-N-CA 125.449 1.5 . . . . 5.0899999999999999 113.916 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 2.5 t -105.84 -51.28 3.02 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.193 1.797 . . . . 7.1799999999999997 110.912 172.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . -127.0 -95.29 0.91 Allowed Glycine 0 C--N 1.365 2.152 0 N-CA-C 110.414 -1.074 . . . . 6.5099999999999998 110.414 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 8.0 t -168.24 175.63 6.39 Favored 'General case' 0 C--N 1.358 0.953 0 N-CA-C 108.298 -1.001 . . . . 7.2000000000000002 108.298 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.97 -5.65 23.22 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 126.968 2.107 . . . . 5.0800000000000001 112.557 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 12.0 t -141.68 37.94 1.65 Allowed 'General case' 0 C--N 1.35 0.591 0 O-C-N 121.141 -0.975 . . . . 3.8599999999999999 109.626 -176.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.66 -102.59 0.47 Allowed Glycine 0 C--N 1.359 1.809 0 N-CA-C 118.118 2.007 . . . . 2.8500000000000001 118.118 -169.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . 0.314 4.0 p -108.55 86.67 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.611 0 CA-C-O 124.955 2.312 . . . . 1.72 113.921 -175.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -92.24 -38.01 12.34 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 129.685 3.194 . . . . 2.2000000000000002 109.835 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 21.4 p -104.29 117.15 33.52 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 129.864 3.265 . . . . 0.46999999999999997 107.269 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -148.22 136.94 21.68 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.734 1.214 . . . . 1.5700000000000001 108.253 -174.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -86.59 118.51 26.05 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 127.684 2.394 . . . . 2.0699999999999998 116.047 -175.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 60' ' ' PHE . . . . . 0.571 ' HB2' HD11 ' E' ' 65' ' ' LEU . 74.6 m-85 -105.95 171.53 7.29 Favored 'General case' 0 CA--C 1.507 -0.682 0 O-C-N 119.856 -1.778 . . . . 0.17000000000000001 112.547 177.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.42 101.53 10.88 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 129.649 3.179 . . . . 0.17000000000000001 108.711 169.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -19.94 -29.18 0.0 OUTLIER 'General case' 0 C--N 1.36 1.043 1 C-N-CA 136.467 5.907 . . . . 1.72 119.602 171.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.26 -30.69 66.78 Favored 'General case' 0 C--N 1.365 1.254 0 C-N-CA 128.629 2.772 . . . . 0.17000000000000001 113.958 171.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.52 20.47 18.49 Favored 'General case' 0 C--N 1.368 1.375 0 C-N-CA 125.777 1.631 . . . . 1.1799999999999999 110.788 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' E' ' 60' ' ' PHE . 52.0 mt -137.59 116.91 12.72 Favored 'General case' 0 C--N 1.374 1.667 0 N-CA-C 116.282 1.956 . . . . 0.19 116.282 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -106.83 138.12 43.6 Favored 'General case' 0 C--N 1.364 1.229 0 O-C-N 120.589 -1.32 . . . . 2.0499999999999998 111.604 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.35 136.72 53.41 Favored 'General case' 0 C--N 1.366 1.29 1 C-N-CA 131.909 4.084 . . . . 0.28999999999999998 118.434 174.65 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 10.0 t -132.7 -40.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.618 -1.301 . . . . 0.72999999999999998 114.121 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 69' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -104.83 120.87 42.43 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 123.486 1.612 . . . . 2.1899999999999999 114.883 -172.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.0 51.72 0.15 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.265 2.226 . . . . 0.0 115.511 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.49 60.66 6.15 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 127.036 2.134 . . . . 0.0 112.295 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.63 114.16 26.04 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 125.991 1.716 . . . . 0.0 110.179 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 50.5 mttp . . . . . 0 C--O 1.262 1.741 0 CA-C-O 117.351 -1.309 . . . . 0.0 111.484 178.135 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 107.302 -1.37 . . . . 2.1299999999999999 107.302 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.73 -157.83 0.62 Allowed 'General case' 0 C--N 1.351 0.646 0 C-N-CA 126.564 1.946 . . . . 0.98999999999999999 114.833 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . 0.257 1.0 OUTLIER -142.47 -175.56 4.51 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 104.62 -2.363 . . . . 0.80000000000000004 104.62 176.464 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.39 60.42 5.22 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 130.135 3.374 . . . . 3.3999999999999999 116.594 -175.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 5' ' ' GLY . . . . . 0.415 ' H ' ' H ' ' E' ' 6' ' ' ASP . . . 166.63 1.07 0.04 OUTLIER Glycine 0 CA--C 1.477 -2.341 0 O-C-N 120.088 -1.633 . . . . 0.53000000000000003 113.457 -175.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 6' ' ' ASP . . . . . 0.495 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 65.5 t0 -76.76 136.29 39.02 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.797 2.039 . . . . 0.45000000000000001 113.454 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -80.8 80.52 7.25 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 127.05 2.14 . . . . 2.0299999999999998 108.07 169.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 8' ' ' VAL . . . . . 0.4 ' H ' HG22 ' E' ' 8' ' ' VAL . 13.9 m -89.97 135.6 25.89 Favored 'Isoleucine or valine' 0 C--N 1.374 1.672 0 N-CA-C 103.365 -2.828 . . . . 0.13 103.365 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -95.52 110.38 22.46 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 120.89 1.677 . . . . 0.17000000000000001 114.544 -172.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.532 HD11 HG11 ' E' ' 38' ' ' VAL . 10.5 mm -52.18 108.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.378 1.807 0 N-CA-C 118.19 2.663 . . . . 0.12 118.19 175.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -117.9 48.82 1.32 Allowed 'General case' 0 C--N 1.37 1.486 0 CA-C-O 123.203 1.478 . . . . 0.29999999999999999 107.923 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -101.62 128.97 47.65 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 130.277 3.431 . . . . 2.0899999999999999 109.485 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 20.9 p -74.69 -58.67 3.14 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 128.8 2.84 . . . . 0.46999999999999997 113.268 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -66.07 48.75 0.03 OUTLIER 'General case' 0 C--N 1.359 0.998 0 C-N-CA 129.295 3.038 . . . . 1.8899999999999999 116.529 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 53.3 m -167.48 166.5 14.26 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 119.575 -1.953 . . . . 1.1299999999999999 106.631 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -92.96 15.56 14.65 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 119.645 -1.91 . . . . 0.79000000000000004 113.727 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -116.44 13.14 15.39 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 126.811 2.045 . . . . 0.75 111.86 -175.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -61.82 105.98 0.63 Allowed 'General case' 0 C--N 1.367 1.34 0 C-N-CA 127.519 2.328 . . . . 0.40000000000000002 114.598 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.58 9.01 44.88 Favored Glycine 0 C--N 1.363 2.047 0 C-N-CA 123.959 0.79 . . . . 0.39000000000000001 112.975 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -107.99 174.57 5.82 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 127.984 2.514 . . . . 1.3999999999999999 109.948 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 p -108.68 178.74 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.437 0 C-N-CA 125.482 1.513 . . . . 0.31 110.492 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.29 174.55 47.04 Favored Glycine 0 CA--C 1.477 -2.335 0 O-C-N 119.829 -1.795 . . . . 0.20999999999999999 108.918 171.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 23' ' ' THR . . . . . 0.56 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 8.3 m -106.65 115.09 29.6 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 125.054 1.342 . . . . 0.27000000000000002 110.43 -177.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 p -68.79 85.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 125.779 1.632 . . . . 0.28999999999999998 113.545 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.96 50.0 1.88 Allowed 'General case' 0 C--N 1.355 0.804 0 O-C-N 119.947 -1.721 . . . . 0.28999999999999998 110.967 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 26' ' ' SER . . . . . 0.561 ' HB3' ' H ' ' E' ' 37' ' ' ILE . 19.3 p -94.71 -71.8 0.65 Allowed 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 120.298 3.444 . . . . 0.63 120.298 -174.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 27' ' ' VAL . . . . . 0.406 HG12 ' H ' ' E' ' 27' ' ' VAL . 7.3 p -81.13 56.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.755 2 C-N-CA 132.84 4.456 . . . . 0.60999999999999999 111.823 -167.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -141.82 -45.62 0.35 Allowed 'General case' 0 N--CA 1.411 -2.399 2 CA-C-N 107.49 -4.414 . . . . 1.6100000000000001 102.126 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -109.3 -39.21 5.29 Favored 'General case' 0 C--N 1.368 1.41 0 C-N-CA 129.67 3.188 . . . . 3.96 113.643 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 23.6 m -69.87 53.36 0.12 Allowed 'General case' 0 C--N 1.364 1.216 0 C-N-CA 131.228 3.811 . . . . 4.3399999999999999 118.527 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.6 47.0 3.39 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 109.65 -3.432 . . . . 1.76 111.368 153.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 32' ' ' ILE . . . . . 0.435 HG22 ' H ' ' E' ' 33' ' ' LEU . 0.5 OUTLIER -140.15 -153.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.246 0 C-N-CA 126.98 2.112 . . . . 1.1100000000000001 110.031 -175.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 33' ' ' LEU . . . . . 0.435 ' H ' HG22 ' E' ' 32' ' ' ILE . 40.8 tp -65.8 -43.25 89.24 Favored 'General case' 0 C--N 1.354 0.798 1 C-N-CA 132.565 4.346 . . . . 0.56999999999999995 117.0 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -108.8 128.3 25.77 Favored Pre-proline 0 C--N 1.356 0.888 0 O-C-N 120.367 -1.458 . . . . 0.93999999999999995 107.176 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.19 -28.61 4.63 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 124.411 3.408 . . . . 0.67000000000000004 112.791 -174.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 36' ' ' VAL . . . . . 0.642 HG12 HG23 ' E' ' 38' ' ' VAL . 59.4 t -110.72 138.34 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 130.4 3.48 . . . . 0.64000000000000001 108.188 -177.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 37' ' ' ILE . . . . . 0.561 ' H ' ' HB3' ' E' ' 26' ' ' SER . 63.5 mt -138.29 121.92 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 2 N-CA-C 95.13 -5.878 . . . . 0.65000000000000002 95.13 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 38' ' ' VAL . . . . . 0.642 HG23 HG12 ' E' ' 36' ' ' VAL . 62.3 t -124.25 157.49 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 CA-C-N 122.492 2.406 . . . . 0.23000000000000001 111.901 -170.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 39' ' ' ARG . . . . . 0.56 ' HB3' ' H ' ' E' ' 23' ' ' THR . 0.0 OUTLIER -83.64 144.01 29.71 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 128.035 2.534 . . . . 2.75 112.176 174.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -129.78 128.57 42.66 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 114.636 -1.166 . . . . 1.26 107.933 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -98.35 -15.44 19.72 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 126.18 1.792 . . . . 1.02 110.805 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -115.35 60.56 0.7 Allowed 'General case' 0 C--N 1.355 0.823 0 C-N-CA 131.048 3.739 . . . . 1.29 110.424 -177.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -88.85 175.78 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.809 0 C-N-CA 126.494 1.918 . . . . 1.23 109.114 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -85.77 69.63 10.61 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 127.473 2.309 . . . . 2.0499999999999998 108.443 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -50.42 -8.33 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.537 1 C-N-CA 132.083 4.153 . . . . 2.52 119.028 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -97.63 125.17 42.24 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 129.102 2.961 . . . . 4.1600000000000001 108.211 175.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.92 105.22 1.77 Allowed Glycine 0 C--N 1.36 1.877 0 N-CA-C 120.069 2.788 . . . . 5.3300000000000001 120.069 -170.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -92.43 -162.59 0.94 Allowed 'General case' 0 C--N 1.355 0.805 0 C-N-CA 127.138 2.175 . . . . 5.0899999999999999 112.565 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 19.7 m -51.83 -39.3 58.58 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 131.351 3.861 . . . . 7.1799999999999997 116.924 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . -104.1 30.88 9.37 Favored Glycine 0 C--N 1.356 1.647 0 C-N-CA 126.109 1.814 . . . . 6.5099999999999998 111.247 171.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 51' ' ' SER . . . . . . . . . . . . 0.338 15.3 p 76.36 -156.68 0.04 OUTLIER 'General case' 0 C--N 1.355 0.829 0 C-N-CA 126.988 2.115 . . . . 7.2000000000000002 116.439 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -96.59 -105.64 0.17 Allowed 'General case' 0 C--N 1.354 0.768 0 C-N-CA 124.817 1.247 . . . . 5.0800000000000001 113.584 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 9.8 m -68.51 43.73 0.04 OUTLIER 'General case' 0 C--N 1.35 0.61 0 C-N-CA 129.778 3.231 . . . . 3.8599999999999999 117.306 -173.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.53 -54.93 5.26 Favored Glycine 0 C--N 1.357 1.7 0 C-N-CA 126.395 1.95 . . . . 2.8500000000000001 115.706 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . 0.348 7.8 p -84.28 75.98 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.533 0 CA-C-O 126.62 3.105 . . . . 1.72 114.884 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -94.48 -28.77 15.29 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 110.056 -3.247 . . . . 2.2000000000000002 112.415 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 2.9 p -132.17 129.28 39.58 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 130.202 3.401 . . . . 0.46999999999999997 105.582 -177.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -154.43 150.38 27.81 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 104.734 -2.321 . . . . 1.5700000000000001 104.734 -174.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -78.51 125.21 29.05 Favored 'General case' 0 C--N 1.353 0.717 1 C-N-CA 131.811 4.044 . . . . 2.0699999999999998 116.334 -169.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 60' ' ' PHE . . . . . 0.544 ' HB3' HD21 ' E' ' 65' ' ' LEU . 19.3 m-85 -128.89 154.91 46.04 Favored 'General case' 0 C--N 1.36 1.06 0 CA-C-O 124.042 1.877 . . . . 0.17000000000000001 114.036 -173.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.42 101.92 10.59 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 112.337 -2.21 . . . . 0.17000000000000001 109.941 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -27.27 -26.95 0.0 OUTLIER 'General case' 0 C--N 1.372 1.553 1 C-N-CA 132.155 4.182 . . . . 1.72 121.132 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -46.9 -49.64 20.07 Favored 'General case' 0 C--N 1.374 1.66 0 C-N-CA 131.028 3.731 . . . . 0.17000000000000001 113.601 167.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 11.6 pm0 -95.07 10.02 37.35 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-N 114.121 -1.399 . . . . 1.1799999999999999 112.942 -172.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' E' ' 60' ' ' PHE . 0.2 OUTLIER -115.3 120.64 40.32 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.824 1.65 . . . . 0.19 111.215 -177.603 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -100.15 115.15 29.16 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 125.763 1.625 . . . . 2.0499999999999998 111.116 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.56 132.02 46.75 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 129.087 2.955 . . . . 0.28999999999999998 118.535 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.63 -39.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.275 0 C-N-CA 124.407 1.083 . . . . 0.72999999999999998 113.436 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 69' ' ' GLN . . . . . 0.495 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 25.6 tt0 -112.22 106.86 15.54 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 116.327 1.973 . . . . 2.1899999999999999 116.327 -171.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.27 63.85 0.15 Allowed 'General case' 0 CA--C 1.557 1.225 0 O-C-N 119.734 -1.854 . . . . 0.0 115.957 170.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.35 53.72 0.41 Allowed 'General case' 0 C--N 1.369 1.453 0 C-N-CA 128.112 2.565 . . . . 0.0 117.12 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.74 160.07 15.13 Favored 'General case' 0 C--N 1.35 0.591 0 C-N-CA 128.313 2.645 . . . . 0.0 116.089 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt . . . . . 0 C--O 1.261 1.708 0 C-N-CA 128.905 2.882 . . . . 0.0 108.83 176.976 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 108.605 -0.887 . . . . 2.1299999999999999 108.605 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -156.51 0.51 Allowed 'General case' 0 C--N 1.352 0.713 0 N-CA-C 116.718 2.118 . . . . 0.98999999999999999 116.718 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.31 153.85 44.21 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 129.1 2.96 . . . . 0.80000000000000004 104.43 177.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . 0.282 0.0 OUTLIER -86.29 121.62 29.13 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 119.55 3.167 . . . . 3.3999999999999999 119.55 -171.518 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.4 -0.69 14.24 Favored Glycine 0 C--N 1.365 2.19 0 C-N-CA 126.372 1.939 . . . . 0.53000000000000003 110.856 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 6' ' ' ASP . . . . . 0.421 ' HA ' ' HB2' ' E' ' 69' ' ' GLN . 56.2 t0 -70.26 146.16 50.84 Favored 'General case' 0 N--CA 1.423 -1.818 1 C-N-CA 132.937 4.495 . . . . 0.45000000000000001 112.054 -178.763 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -82.48 76.53 9.34 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 125.315 1.446 . . . . 2.0299999999999998 108.743 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 28.8 m -87.6 144.97 8.15 Favored 'Isoleucine or valine' 0 C--N 1.371 1.532 0 O-C-N 119.815 -1.803 . . . . 0.13 107.312 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -109.99 117.12 32.94 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 114.754 1.39 . . . . 0.17000000000000001 114.754 -169.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 14.2 mm -63.96 126.03 21.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.834 0 C-N-CA 128.508 2.723 . . . . 0.12 118.012 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.87 39.38 3.53 Favored 'General case' 0 C--N 1.365 1.281 0 N-CA-C 115.945 1.831 . . . . 0.29999999999999999 115.945 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -108.47 147.57 31.47 Favored 'General case' 0 C--N 1.368 1.371 0 O-C-N 118.942 -2.349 . . . . 2.0899999999999999 110.685 174.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 13.3 t -105.14 24.17 12.46 Favored 'General case' 0 C--N 1.364 1.231 0 C-N-CA 125.314 1.446 . . . . 0.46999999999999997 112.347 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -90.83 11.51 22.28 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 127.763 2.425 . . . . 1.8899999999999999 112.832 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 3.3 t -169.12 -173.66 1.82 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.012 1.325 . . . . 1.1299999999999999 107.657 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -92.77 21.12 5.82 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 130.001 3.321 . . . . 0.79000000000000004 112.266 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -111.51 6.96 20.5 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 127.99 2.516 . . . . 0.75 110.012 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -64.1 101.46 0.4 Allowed 'General case' 0 C--N 1.367 1.363 0 C-N-CA 127.988 2.515 . . . . 0.40000000000000002 114.911 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.77 40.36 4.69 Favored Glycine 0 C--N 1.359 1.809 0 C-N-CA 125.758 1.647 . . . . 0.39000000000000001 111.368 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -132.93 146.18 51.56 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 123.399 1.571 . . . . 1.3999999999999999 113.254 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.32 147.8 4.98 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 C-N-CA 130.211 3.404 . . . . 0.31 112.019 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.96 -179.21 34.6 Favored Glycine 0 CA--C 1.478 -2.225 0 N-CA-C 107.995 -2.042 . . . . 0.20999999999999999 107.995 173.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 23' ' ' THR . . . . . 0.659 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 30.1 m -88.93 129.12 35.68 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 124.861 1.264 . . . . 0.27000000000000002 109.711 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 24' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' E' ' 26' ' ' SER . 14.9 p -75.64 92.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 124.795 2.236 . . . . 0.28999999999999998 113.624 174.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.55 23.55 2.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.824 2.05 . . . . 0.28999999999999998 113.236 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 26' ' ' SER . . . . . 0.466 ' HB3' HG22 ' E' ' 24' ' ' VAL . 28.6 t -64.82 -66.09 0.59 Allowed 'General case' 0 C--N 1.364 1.211 1 C-N-CA 131.85 4.06 . . . . 0.63 115.315 178.747 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -85.44 53.88 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.745 0 CA-C-O 124.017 1.865 . . . . 0.60999999999999999 113.054 -166.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.81 -67.09 0.05 OUTLIER 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 127.377 2.271 . . . . 1.6100000000000001 107.422 -171.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -104.28 -9.17 18.77 Favored 'General case' 0 C--N 1.363 1.181 0 N-CA-C 115.083 1.512 . . . . 3.96 115.083 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.23 24.51 1.85 Allowed 'General case' 0 C--N 1.363 1.17 0 N-CA-C 115.532 1.679 . . . . 4.3399999999999999 115.532 -176.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.77 46.71 0.16 Allowed Glycine 0 C--N 1.364 2.124 0 C-N-CA 130.05 3.691 . . . . 1.76 115.806 168.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -130.94 -159.33 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.672 1 C-N-CA 132.995 4.518 . . . . 1.1100000000000001 107.418 -176.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 39.7 tp -69.24 -34.37 74.7 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 130.411 3.484 . . . . 0.56999999999999995 117.821 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -106.45 146.44 33.01 Favored Pre-proline 0 C--N 1.358 0.953 0 C-N-CA 125.092 1.357 . . . . 0.93999999999999995 109.211 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.52 -43.66 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.624 2.883 . . . . 0.67000000000000004 114.597 -170.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 36' ' ' VAL . . . . . 0.492 HG11 ' CD1' ' E' ' 65' ' ' LEU . 60.9 t -109.43 128.02 65.74 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 115.305 1.594 . . . . 0.64000000000000001 115.305 -170.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 19.0 mt -109.09 142.22 22.23 Favored 'Isoleucine or valine' 0 C--N 1.36 1.054 0 N-CA-C 103.7 -2.704 . . . . 0.65000000000000002 103.7 162.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 17.8 t -134.8 159.22 41.72 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 N-CA-C 107.308 -1.367 . . . . 0.23000000000000001 107.308 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 39' ' ' ARG . . . . . 0.659 ' HB3' ' H ' ' E' ' 23' ' ' THR . 41.1 ttp85 -83.82 147.48 27.54 Favored 'General case' 0 C--N 1.354 0.766 1 C-N-CA 131.854 4.062 . . . . 2.75 111.914 172.735 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -133.68 128.13 34.36 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 125.07 1.348 . . . . 1.26 108.218 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.24 -16.95 30.04 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 128.445 2.698 . . . . 1.02 112.299 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -99.03 61.6 1.26 Allowed 'General case' 0 C--N 1.356 0.863 1 C-N-CA 132.119 4.168 . . . . 1.29 110.765 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 p -95.96 128.61 47.0 Favored 'Isoleucine or valine' 0 C--N 1.361 1.106 0 C-N-CA 129.13 2.972 . . . . 1.23 104.153 169.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -79.16 45.42 0.64 Allowed 'General case' 0 C--N 1.356 0.864 0 O-C-N 117.47 -3.269 . . . . 2.0499999999999998 115.759 -169.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 9.85 -18.6 0.0 OUTLIER 'General case' 0 C--N 1.367 1.327 2 C-N-CA 140.943 7.697 . . . . 2.52 121.881 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -76.28 40.79 0.22 Allowed 'General case' 0 C--N 1.346 0.422 0 C-N-CA 131.365 3.866 . . . . 4.1600000000000001 115.35 -173.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.99 -10.25 83.18 Favored Glycine 0 C--N 1.359 1.831 0 C-N-CA 127.992 2.71 . . . . 5.3300000000000001 113.93 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -106.95 1.36 24.45 Favored 'General case' 0 C--N 1.361 1.109 0 CA-C-O 124.256 1.979 . . . . 5.0899999999999999 110.645 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 20.0 m -106.23 -56.26 2.21 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 128.72 2.808 . . . . 7.1799999999999997 110.093 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.66 -76.71 0.03 OUTLIER Glycine 0 C--N 1.357 1.704 0 O-C-N 120.999 -1.063 . . . . 6.5099999999999998 113.122 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 21.2 t -131.89 130.25 41.39 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 124.982 1.313 . . . . 7.2000000000000002 111.058 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.45 -2.53 51.69 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 125.882 1.673 . . . . 5.0800000000000001 111.534 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 53' ' ' SER . . . . . . . . . . . . 0.277 13.8 m 41.95 -25.8 0.0 OUTLIER 'General case' 0 C--N 1.359 1.017 1 C-N-CA 137.76 6.424 . . . . 3.8599999999999999 121.084 177.127 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.94 -154.46 11.71 Favored Glycine 0 CA--C 1.501 -0.799 0 C-N-CA 130.214 3.769 . . . . 2.8500000000000001 108.025 171.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 55' ' ' VAL . . . . . 0.61 HG22 ' H ' ' E' ' 56' ' ' ASN . 13.9 p -155.66 -175.61 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 N-CA-C 106.529 -1.656 . . . . 1.72 106.529 -176.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 56' ' ' ASN . . . . . 0.61 ' H ' HG22 ' E' ' 55' ' ' VAL . 9.5 t-20 -101.26 -29.84 11.85 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 128.103 2.561 . . . . 2.2000000000000002 111.442 176.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 22.9 p -126.29 134.78 51.05 Favored 'General case' 0 C--N 1.362 1.128 0 O-C-N 119.927 -1.733 . . . . 0.46999999999999997 110.164 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -162.06 161.58 28.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.871 1.668 . . . . 1.5700000000000001 107.194 175.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -97.1 154.45 17.33 Favored 'General case' 0 C--N 1.361 1.101 0 CA-C-O 124.032 1.872 . . . . 2.0699999999999998 113.897 -176.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 60' ' ' PHE . . . . . 0.406 ' CB ' HD21 ' E' ' 65' ' ' LEU . 95.0 m-85 -135.94 169.55 17.41 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 112.481 -2.145 . . . . 0.17000000000000001 113.489 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -109.46 108.58 19.14 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 111.064 -2.789 . . . . 0.17000000000000001 107.788 172.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -25.66 -17.94 0.0 OUTLIER 'General case' 0 C--N 1.367 1.341 2 C-N-CA 134.395 5.078 . . . . 1.72 122.0 176.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -65.99 -32.41 73.88 Favored 'General case' 0 C--N 1.371 1.502 0 C-N-CA 130.97 3.708 . . . . 0.17000000000000001 110.937 166.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -84.85 -11.76 54.99 Favored 'General case' 0 C--N 1.364 1.217 0 O-C-N 120.742 -1.224 . . . . 1.1799999999999999 110.705 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.492 ' CD1' HG11 ' E' ' 36' ' ' VAL . 0.3 OUTLIER -106.81 108.57 20.14 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 115.708 1.744 . . . . 0.19 115.708 -171.555 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -96.43 133.17 41.19 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 125.596 1.558 . . . . 2.0499999999999998 108.772 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 67' ' ' LEU . . . . . 0.466 ' H ' HD23 ' E' ' 67' ' ' LEU 0.297 2.4 pt? -87.36 153.09 21.73 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-N 123.1 2.682 . . . . 0.28999999999999998 117.017 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 t -125.44 -27.42 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.121 0 C-N-CA 126.088 1.755 . . . . 0.72999999999999998 110.782 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 69' ' ' GLN . . . . . 0.421 ' HB2' ' HA ' ' E' ' 6' ' ' ASP . 2.5 mm-40 -113.85 160.98 18.15 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 127.018 3.294 . . . . 2.1899999999999999 114.786 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.73 56.36 0.7 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 108.886 -3.779 . . . . 0.0 111.651 173.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.71 58.78 1.89 Allowed 'General case' 0 C--N 1.365 1.253 0 O-C-N 120.205 -1.56 . . . . 0.0 114.553 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.95 91.93 7.13 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 128.753 2.821 . . . . 0.0 112.308 -176.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 75.7 mttt . . . . . 0 C--O 1.262 1.738 0 CA-C-O 117.624 -1.179 . . . . 0.0 109.104 174.463 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.996 0 N-CA-C 108.306 -0.998 . . . . 2.1299999999999999 108.306 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 2' ' ' LEU . . . . . 0.572 HD11 HG21 ' E' ' 36' ' ' VAL . 0.0 OUTLIER -99.69 -154.86 0.48 Allowed 'General case' 0 C--N 1.351 0.647 0 N-CA-C 117.998 2.592 . . . . 0.98999999999999999 117.998 -175.66 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 3' ' ' ASN . . . . . 0.452 ' O ' HG11 ' E' ' 24' ' ' VAL . 1.0 OUTLIER -135.61 178.49 7.0 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 129.11 2.964 . . . . 0.80000000000000004 110.127 -175.66 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 4' ' ' ARG . . . . . 0.433 ' CZ ' ' H ' ' E' ' 4' ' ' ARG . 0.0 OUTLIER -94.65 104.98 16.91 Favored 'General case' 0 C--N 1.376 1.753 0 C-N-CA 128.699 2.8 . . . . 3.3999999999999999 114.423 173.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 5' ' ' GLY . . . . . 0.538 ' H ' ' CG1' ' E' ' 24' ' ' VAL . . . 113.34 -3.34 25.13 Favored Glycine 0 CA--C 1.485 -1.799 0 O-C-N 118.079 -2.888 . . . . 0.53000000000000003 110.175 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 6' ' ' ASP . . . . . 0.604 ' HA ' ' HB2' ' E' ' 69' ' ' GLN . 43.5 t0 -68.4 127.79 34.25 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 130.292 3.437 . . . . 0.45000000000000001 110.381 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -82.56 80.17 8.78 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 106.711 -1.588 . . . . 2.0299999999999998 106.711 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 8' ' ' VAL . . . . . 0.423 HG22 ' HB ' ' E' ' 24' ' ' VAL . 12.7 m -84.51 142.32 13.49 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 O-C-N 121.665 -0.647 . . . . 0.13 109.951 -173.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -108.02 129.28 55.14 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 118.322 -0.847 . . . . 0.17000000000000001 111.838 -172.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.439 HG21 ' CE1' ' E' ' 60' ' ' PHE . 3.7 mm -74.01 118.53 19.69 Favored 'Isoleucine or valine' 0 C--N 1.365 1.272 0 N-CA-C 115.141 1.534 . . . . 0.12 115.141 175.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -107.59 36.89 2.57 Favored 'General case' 0 C--N 1.373 1.621 0 O-C-N 119.574 -1.954 . . . . 0.29999999999999999 114.072 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -102.52 99.26 9.27 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 129.853 3.261 . . . . 2.0899999999999999 112.663 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 13' ' ' THR . . . . . 0.591 ' HA ' ' CG ' ' E' ' 18' ' ' TYR . 4.1 m -58.58 -34.37 71.0 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 129.081 2.953 . . . . 0.46999999999999997 117.912 -175.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.72 44.01 0.21 Allowed 'General case' 0 C--N 1.346 0.442 0 C-N-CA 129.199 2.999 . . . . 1.8899999999999999 115.003 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 17.1 t -172.2 175.1 3.8 Favored 'General case' 0 C--N 1.365 1.257 0 C-N-CA 125.343 1.457 . . . . 1.1299999999999999 107.4 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -92.19 7.13 43.99 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 129.975 3.31 . . . . 0.79000000000000004 111.124 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 38.5 m0 -106.32 10.51 31.63 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 127.247 2.219 . . . . 0.75 109.478 178.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 18' ' ' TYR . . . . . 0.591 ' CG ' ' HA ' ' E' ' 13' ' ' THR . 18.5 t80 -69.79 101.68 1.76 Allowed 'General case' 0 C--N 1.374 1.635 0 C-N-CA 126.333 1.853 . . . . 0.40000000000000002 113.276 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.18 39.69 6.34 Favored Glycine 0 C--N 1.356 1.667 0 C-N-CA 125.359 1.457 . . . . 0.39000000000000001 111.898 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -109.86 135.7 50.32 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 119.043 1.421 . . . . 1.3999999999999999 109.065 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -97.17 164.82 2.18 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 125.579 1.552 . . . . 0.31 110.582 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.19 177.67 47.08 Favored Glycine 0 CA--C 1.47 -2.772 0 N-CA-C 107.056 -2.418 . . . . 0.20999999999999999 107.056 170.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 23' ' ' THR . . . . . 0.481 ' H ' ' CB ' ' E' ' 39' ' ' ARG . 6.9 m -86.77 130.47 34.46 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 125.348 2.499 . . . . 0.27000000000000002 110.801 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 24' ' ' VAL . . . . . 0.538 ' CG1' ' H ' ' E' ' 5' ' ' GLY . 11.8 p -62.32 73.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 131.176 3.79 . . . . 0.28999999999999998 116.062 174.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.96 25.65 0.36 Allowed 'General case' 0 CA--C 1.551 1.012 0 O-C-N 116.475 -3.891 . . . . 0.28999999999999998 114.131 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 26' ' ' SER . . . . . . . . . . . . 0.271 1.5 m -73.86 -25.65 60.16 Favored 'General case' 0 CA--C 1.5 -0.964 1 C-N-CA 136.376 5.87 . . . . 0.63 117.155 175.488 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -114.27 49.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 124.778 1.231 . . . . 0.60999999999999999 109.083 -171.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.34 -56.93 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 124.024 0.93 . . . . 1.6100000000000001 108.905 -169.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -109.43 8.86 25.51 Favored 'General case' 0 C--N 1.36 1.049 0 C-N-CA 126.357 1.863 . . . . 3.96 111.799 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 4.9 m -27.22 -41.12 0.01 OUTLIER 'General case' 0 C--N 1.361 1.08 1 C-N-CA 135.909 5.684 . . . . 4.3399999999999999 121.05 -175.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.35 42.27 0.13 Allowed Glycine 0 C--N 1.348 1.244 1 C-N-CA 131.845 4.545 . . . . 1.76 118.172 -171.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.78 -167.24 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.457 0 C-N-CA 125.04 1.336 . . . . 1.1100000000000001 110.292 176.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 38.0 tp -65.34 -33.89 77.03 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 129.629 3.172 . . . . 0.56999999999999995 116.86 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -135.12 132.82 20.37 Favored Pre-proline 0 N--CA 1.469 0.499 0 N-CA-C 101.501 -3.518 . . . . 0.93999999999999995 101.501 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.02 -46.63 1.44 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.779 2.986 . . . . 0.67000000000000004 116.573 -160.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 36' ' ' VAL . . . . . 0.572 HG21 HD11 ' E' ' 2' ' ' LEU . 54.3 t -80.83 103.02 7.24 Favored 'Isoleucine or valine' 0 C--N 1.368 1.372 0 N-CA-C 114.417 1.266 . . . . 0.64000000000000001 114.417 -175.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 20.5 mt -89.82 118.72 35.65 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 N-CA-C 106.05 -1.833 . . . . 0.65000000000000002 106.05 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 37.7 t -109.7 145.56 16.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 O-C-N 119.685 -1.884 . . . . 0.23000000000000001 109.646 176.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 39' ' ' ARG . . . . . 0.481 ' CB ' ' H ' ' E' ' 23' ' ' THR . 8.1 tmm_? -42.85 -32.65 0.65 Allowed 'General case' 0 C--N 1.359 0.994 2 C-N-CA 134.467 5.107 . . . . 2.75 123.564 -177.243 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.22 129.44 34.5 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 120.794 3.627 . . . . 1.26 120.794 -162.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -88.53 38.02 0.85 Allowed 'General case' 0 C--N 1.356 0.875 0 C-N-CA 128.934 2.894 . . . . 1.02 113.324 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -96.08 36.13 1.35 Allowed 'General case' 0 C--N 1.348 0.535 1 C-N-CA 131.97 4.108 . . . . 1.29 110.428 -176.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . 0.263 10.9 m -88.55 -162.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 127.725 2.41 . . . . 1.23 110.978 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.52 83.57 1.91 Allowed 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 119.361 -2.087 . . . . 2.0499999999999998 112.49 -176.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -40.28 17.16 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.563 2 C-N-CA 136.664 5.985 . . . . 2.52 121.853 -176.89 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -102.9 75.36 1.39 Allowed 'General case' 0 C--N 1.359 0.984 0 C-N-CA 127.125 2.17 . . . . 4.1600000000000001 105.975 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.11 -8.15 61.1 Favored Glycine 0 C--N 1.357 1.711 0 N-CA-C 119.979 2.751 . . . . 5.3300000000000001 119.979 -173.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -95.19 -9.35 33.62 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 126.671 1.988 . . . . 5.0899999999999999 115.796 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 17.8 t -101.31 -12.2 18.85 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 128.208 2.603 . . . . 7.1799999999999997 111.507 175.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 159.96 125.55 0.8 Allowed Glycine 0 C--N 1.353 1.476 0 N-CA-C 106.295 -2.722 . . . . 6.5099999999999998 106.295 -175.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 2.8 m -68.39 63.57 0.1 Allowed 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 119.729 3.233 . . . . 7.2000000000000002 119.729 -173.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -101.28 0.68 37.75 Favored 'General case' 0 C--N 1.372 1.562 0 C-N-CA 127.353 2.261 . . . . 5.0800000000000001 116.157 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 8.0 p -84.75 -34.86 22.76 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 127.603 2.361 . . . . 3.8599999999999999 115.678 -175.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -102.66 9.89 55.74 Favored Glycine 0 C--N 1.354 1.54 0 C-N-CA 126.547 2.022 . . . . 2.8500000000000001 112.797 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 p -128.11 75.46 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.383 0 N-CA-C 103.788 -2.671 . . . . 1.72 103.788 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -93.79 -11.34 31.51 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 130.061 3.344 . . . . 2.2000000000000002 112.491 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 16.1 p -114.78 125.3 53.54 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 101.388 -3.56 . . . . 0.46999999999999997 101.388 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -122.8 133.48 54.45 Favored 'General case' 0 C--N 1.358 0.939 0 O-C-N 120.098 -1.626 . . . . 1.5700000000000001 113.131 -168.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -88.13 112.5 22.76 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 129.294 3.038 . . . . 2.0699999999999998 115.7 -174.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 60' ' ' PHE . . . . . 0.439 ' CE1' HG21 ' E' ' 10' ' ' ILE . 97.7 m-85 -115.46 173.5 6.49 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 115.47 1.655 . . . . 0.17000000000000001 115.47 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.53 85.85 4.65 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 129.503 3.121 . . . . 0.17000000000000001 110.755 172.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -15.91 -23.4 0.0 OUTLIER 'General case' 0 C--N 1.36 1.043 1 C-N-CA 138.108 6.563 . . . . 1.72 121.331 172.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.07 -37.26 69.66 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 130.366 3.466 . . . . 0.17000000000000001 113.831 171.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . 0.275 2.0 pp20? -97.46 16.03 21.43 Favored 'General case' 0 C--N 1.373 1.624 0 C-N-CA 126.35 1.86 . . . . 1.1799999999999999 111.331 -177.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.466 ' CD1' HG11 ' E' ' 36' ' ' VAL . 0.3 OUTLIER -112.96 104.58 12.55 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 128.427 2.691 . . . . 0.19 108.206 172.56 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -94.53 150.48 20.2 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 125.867 1.667 . . . . 2.0499999999999998 111.15 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -74.47 142.04 44.9 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 117.851 2.537 . . . . 0.28999999999999998 117.851 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 3.4 t -135.6 -27.9 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.072 0 C-N-CA 126.206 1.802 . . . . 0.72999999999999998 110.499 171.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 69' ' ' GLN . . . . . 0.604 ' HB2' ' HA ' ' E' ' 6' ' ' ASP 0.342 19.8 mt-30 -118.59 113.58 21.47 Favored 'General case' 0 C--N 1.361 1.075 0 CA-C-O 123.489 1.614 . . . . 2.1899999999999999 113.613 174.827 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.86 56.96 0.99 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 127.804 2.442 . . . . 0.0 111.523 169.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.02 58.2 0.22 Allowed 'General case' 0 C--N 1.355 0.834 0 C-N-CA 128.365 2.666 . . . . 0.0 117.796 -169.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.06 73.02 0.89 Allowed 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt . . . . . 0 C--O 1.262 1.746 0 C-N-CA 127.661 2.384 . . . . 0.0 111.704 177.969 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.956 0 N-CA-C 109.102 -0.703 . . . . 2.1299999999999999 109.102 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 2' ' ' LEU . . . . . 0.488 HD22 HG11 ' E' ' 8' ' ' VAL 0.328 1.8 pp -101.85 -154.87 0.5 Allowed 'General case' 0 C--N 1.356 0.867 0 N-CA-C 115.969 1.841 . . . . 0.98999999999999999 115.969 -174.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -144.36 176.08 9.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 129.773 3.229 . . . . 0.80000000000000004 111.223 -171.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 4' ' ' ARG . . . . . 0.421 ' HG2' HG13 ' E' ' 27' ' ' VAL . 0.0 OUTLIER -96.59 102.7 14.52 Favored 'General case' 0 C--N 1.37 1.462 0 O-C-N 119.51 -1.994 . . . . 3.3999999999999999 112.165 174.527 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.47 4.58 11.9 Favored Glycine 0 C--N 1.363 2.059 0 CA-C-O 124.087 1.937 . . . . 0.53000000000000003 112.241 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 6' ' ' ASP . . . . . 0.469 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 65.3 t0 -74.89 136.81 41.46 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 130.446 3.498 . . . . 0.45000000000000001 109.508 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 7' ' ' LYS . . . . . 0.627 ' H ' ' HB2' ' E' ' 69' ' ' GLN . 41.1 mmtm -91.75 79.1 5.4 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 104.96 -2.237 . . . . 2.0299999999999998 104.96 176.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 8' ' ' VAL . . . . . 0.488 HG11 HD22 ' E' ' 2' ' ' LEU . 13.4 m -86.32 143.18 11.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 106.336 -1.727 . . . . 0.13 106.336 -177.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 9' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' E' ' 21' ' ' VAL . 23.4 ttt85 -104.16 117.74 34.97 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 113.495 0.924 . . . . 0.17000000000000001 113.495 -172.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 13.8 mm -56.66 111.66 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.376 0 N-CA-C 117.466 2.395 . . . . 0.12 117.466 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -115.35 47.63 1.29 Allowed 'General case' 0 C--N 1.368 1.408 0 C-N-CA 126.225 1.81 . . . . 0.29999999999999999 109.912 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -106.64 127.09 53.07 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 128.31 2.644 . . . . 2.0899999999999999 106.147 174.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 18.3 p -71.34 -58.67 3.31 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 129.74 3.216 . . . . 0.46999999999999997 113.496 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.11 67.43 2.41 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 130.944 3.698 . . . . 1.8899999999999999 110.04 174.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 27.8 t -163.43 159.9 22.79 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.344 -2.095 . . . . 1.1299999999999999 105.344 -172.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -92.49 -1.81 56.7 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 127.159 2.184 . . . . 0.79000000000000004 110.914 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 9.1 m0 -119.83 24.43 10.55 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 126.253 1.821 . . . . 0.75 111.721 -172.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -68.98 101.17 1.33 Allowed 'General case' 0 C--N 1.371 1.507 0 C-N-CA 125.637 1.575 . . . . 0.40000000000000002 112.758 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.96 14.66 35.92 Favored Glycine 0 C--N 1.358 1.805 0 C-N-CA 125.035 1.302 . . . . 0.39000000000000001 112.192 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -113.06 154.03 27.2 Favored 'General case' 0 C--N 1.362 1.145 0 C-N-CA 125.316 1.446 . . . . 1.3999999999999999 109.782 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 21' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' E' ' 9' ' ' ARG . 1.4 p -92.02 -176.8 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.383 0 C-N-CA 127.525 2.33 . . . . 0.31 113.423 -175.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.24 176.72 46.42 Favored Glycine 0 CA--C 1.479 -2.159 0 N-CA-C 108.839 -1.704 . . . . 0.20999999999999999 108.839 166.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 23' ' ' THR . . . . . 0.457 ' H ' ' CB ' ' E' ' 39' ' ' ARG . 29.0 m -101.89 120.73 40.85 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 124.516 1.127 . . . . 0.27000000000000002 109.99 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 24' ' ' VAL . . . . . 0.426 HG22 ' HB3' ' E' ' 26' ' ' SER . 7.1 p -75.29 88.02 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 123.292 1.52 . . . . 0.28999999999999998 113.272 178.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.6 43.95 1.15 Allowed 'General case' 0 C--N 1.353 0.75 0 C-N-CA 126.596 1.958 . . . . 0.28999999999999998 110.775 171.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 26' ' ' SER . . . . . 0.426 ' HB3' HG22 ' E' ' 24' ' ' VAL . 13.7 t -81.51 -73.27 0.39 Allowed 'General case' 0 CA--C 1.488 -1.429 1 C-N-CA 131.78 4.032 . . . . 0.63 113.753 -178.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 27' ' ' VAL . . . . . 0.421 HG13 ' HG2' ' E' ' 4' ' ' ARG . 3.8 p -82.1 54.11 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.571 0 CA-C-O 126.5 3.048 . . . . 0.60999999999999999 113.145 -160.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.57 -72.05 0.69 Allowed 'General case' 0 N--CA 1.418 -2.039 0 C-N-CA 130.663 3.585 . . . . 1.6100000000000001 103.053 175.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.34 -17.6 13.1 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 125.696 1.598 . . . . 3.96 112.754 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 30' ' ' SER . . . . . 0.455 ' HB2' ' CD1' ' E' ' 37' ' ' ILE . 1.8 t -92.41 46.92 1.27 Allowed 'General case' 0 C--N 1.367 1.344 0 O-C-N 119.435 -2.041 . . . . 4.3399999999999999 114.375 -176.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.14 51.09 4.51 Favored Glycine 0 C--N 1.341 0.809 1 C-N-CA 130.89 4.09 . . . . 1.76 111.537 162.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.84 -166.6 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.882 0 C-N-CA 130.045 3.338 . . . . 1.1100000000000001 108.695 -176.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 22.1 tp -61.37 -38.27 86.37 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 130.578 3.551 . . . . 0.56999999999999995 117.027 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -113.81 115.54 46.09 Favored Pre-proline 0 C--N 1.356 0.855 0 N-CA-C 101.521 -3.511 . . . . 0.93999999999999995 101.521 172.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -82.12 -55.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.905 2.403 . . . . 0.67000000000000004 115.533 -169.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 36' ' ' VAL . . . . . 0.643 HG12 HG23 ' E' ' 38' ' ' VAL . 24.9 t -75.21 95.69 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.019 0 N-CA-C 119.65 3.204 . . . . 0.64000000000000001 119.65 -166.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 37' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' E' ' 30' ' ' SER . 68.1 mt -87.34 119.45 35.03 Favored 'Isoleucine or valine' 0 C--N 1.368 1.41 0 N-CA-C 104.97 -2.233 . . . . 0.65000000000000002 104.97 172.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 38' ' ' VAL . . . . . 0.643 HG23 HG12 ' E' ' 36' ' ' VAL . 14.0 t -123.21 163.61 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-N 120.186 1.357 . . . . 0.23000000000000001 111.62 -172.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 39' ' ' ARG . . . . . 0.457 ' CB ' ' H ' ' E' ' 23' ' ' THR . 43.6 ttm-85 -84.43 142.09 30.35 Favored 'General case' 0 C--N 1.363 1.193 0 C-N-CA 128.859 2.864 . . . . 2.75 113.92 174.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -137.33 128.59 27.95 Favored 'General case' 0 CA--C 1.514 -0.437 0 O-C-N 121.301 -0.874 . . . . 1.26 111.474 173.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -90.27 -38.44 13.41 Favored 'General case' 0 C--N 1.366 1.325 0 C-N-CA 126.356 1.862 . . . . 1.02 111.38 172.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -77.97 59.59 2.18 Favored 'General case' 0 C--N 1.37 1.468 0 C-N-CA 129.459 3.104 . . . . 1.29 112.767 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.85 158.78 3.01 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 127.125 2.17 . . . . 1.23 105.538 172.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -80.11 -31.0 39.18 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 127.307 2.243 . . . . 2.0499999999999998 113.187 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 64.74 44.6 3.7 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 117.371 2.359 . . . . 2.52 117.371 174.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -98.01 52.7 1.06 Allowed 'General case' 0 C--N 1.365 1.241 0 C-N-CA 125.237 1.415 . . . . 4.1600000000000001 110.283 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.67 70.59 3.15 Favored Glycine 0 C--N 1.363 2.06 0 O-C-N 120.489 -1.382 . . . . 5.3300000000000001 116.198 -170.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -92.72 -172.12 2.94 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 127.161 2.184 . . . . 5.0899999999999999 109.906 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 8.2 t -39.65 16.59 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.353 2 C-N-CA 133.777 4.831 . . . . 7.1799999999999997 122.318 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . -146.58 -74.65 0.02 OUTLIER Glycine 0 C--N 1.34 0.76 0 C-N-CA 129.143 3.259 . . . . 6.5099999999999998 109.041 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 5.8 t -162.29 -174.5 4.09 Favored 'General case' 0 C--N 1.358 0.936 0 O-C-N 121.006 -1.291 . . . . 7.2000000000000002 108.83 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.9 -12.0 59.94 Favored 'General case' 0 C--N 1.366 1.318 1 C-N-CA 131.87 4.068 . . . . 5.0800000000000001 117.167 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 53' ' ' SER . . . . . . . . . . . . 0.295 5.4 t 75.31 -24.28 0.22 Allowed 'General case' 0 C--N 1.358 0.96 0 C-N-CA 129.091 2.957 . . . . 3.8599999999999999 116.76 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -110.92 -174.68 20.21 Favored Glycine 0 C--N 1.35 1.353 0 C-N-CA 125.478 1.513 . . . . 2.8500000000000001 111.026 167.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.09 149.38 20.48 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 C-N-CA 125.523 1.529 . . . . 1.72 108.697 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -101.97 -44.66 5.42 Favored 'General case' 0 C--N 1.365 1.25 0 C-N-CA 128.493 2.717 . . . . 2.2000000000000002 110.48 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 67.9 p -115.97 104.5 11.65 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 127.97 2.508 . . . . 0.46999999999999997 106.472 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -110.29 138.88 46.07 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 107.5 -1.296 . . . . 1.5700000000000001 107.5 -176.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -100.01 112.01 24.31 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-O 122.222 1.01 . . . . 2.0699999999999998 109.868 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -104.16 172.7 6.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 123.909 1.814 . . . . 0.17000000000000001 115.274 -175.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -102.42 94.13 5.52 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 112.218 -2.265 . . . . 0.17000000000000001 109.24 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -7.43 -37.79 0.0 OUTLIER 'General case' 0 C--N 1.367 1.351 1 C-N-CA 134.778 5.231 . . . . 1.72 121.21 172.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -45.61 -46.53 14.45 Favored 'General case' 0 C--N 1.364 1.212 1 C-N-CA 132.715 4.406 . . . . 0.17000000000000001 113.1 168.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -89.86 1.61 55.98 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 125.822 1.649 . . . . 1.1799999999999999 112.168 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.475 ' HG ' HG11 ' E' ' 36' ' ' VAL . 0.5 OUTLIER -115.96 108.53 16.37 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 126.664 1.986 . . . . 0.19 114.126 179.663 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -106.44 143.0 35.18 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 125.721 1.608 . . . . 2.0499999999999998 111.907 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -64.62 146.34 54.81 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 119.988 3.329 . . . . 0.28999999999999998 119.988 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -144.47 -29.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.372 1.585 0 C-N-CA 126.91 2.084 . . . . 0.72999999999999998 112.028 173.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 69' ' ' GLN . . . . . 0.627 ' HB2' ' H ' ' E' ' 7' ' ' LYS . 0.0 OUTLIER -114.51 116.47 28.88 Favored 'General case' 0 C--N 1.358 0.937 0 O-C-N 119.554 -1.966 . . . . 2.1899999999999999 111.849 177.574 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.33 59.57 1.05 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.254 2.622 . . . . 0.0 113.125 174.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.47 58.46 2.66 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 129.021 2.928 . . . . 0.0 113.51 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.0 78.66 1.18 Allowed 'General case' 0 C--N 1.356 0.879 0 C-N-CA 128.189 2.596 . . . . 0.0 115.32 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt . . . . . 0 C--O 1.262 1.716 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 176.124 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 2.432 0 N-CA-C 108.684 -0.858 . . . . 2.1299999999999999 108.684 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 2' ' ' LEU . . . . . . . . . . . . 0.271 0.0 OUTLIER -95.59 -165.8 1.35 Allowed 'General case' 0 C--N 1.358 0.961 0 N-CA-C 118.11 2.633 . . . . 0.98999999999999999 118.11 -175.171 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -136.3 -169.26 2.4 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 127.438 2.295 . . . . 0.80000000000000004 111.321 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 4' ' ' ARG . . . . . 0.499 ' HB3' HG13 ' E' ' 27' ' ' VAL . 14.4 ptm180 -96.44 110.27 22.66 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 127.568 2.347 . . . . 3.3999999999999999 114.528 176.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.25 -0.28 14.43 Favored Glycine 0 CA--C 1.477 -2.295 0 O-C-N 121.025 -1.047 . . . . 0.53000000000000003 111.998 165.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 6' ' ' ASP . . . . . 0.482 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 46.1 t0 -72.83 137.51 45.78 Favored 'General case' 0 N--CA 1.408 -2.555 1 C-N-CA 133.153 4.581 . . . . 0.45000000000000001 113.469 -176.233 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 7' ' ' LYS . . . . . 0.485 ' H ' ' CB ' ' E' ' 69' ' ' GLN . 13.7 mptt -87.87 77.37 8.54 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 106.485 -1.672 . . . . 2.0299999999999998 106.485 171.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 8' ' ' VAL . . . . . 0.4 ' H ' HG22 ' E' ' 8' ' ' VAL . 15.0 m -87.42 138.93 18.14 Favored 'Isoleucine or valine' 0 C--N 1.369 1.438 0 C-N-CA 127.168 2.187 . . . . 0.13 106.224 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -105.35 113.93 27.81 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 120.77 -1.206 . . . . 0.17000000000000001 112.55 -171.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.789 HD11 HG11 ' E' ' 38' ' ' VAL . 2.3 mm -52.89 120.89 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 N-CA-C 117.727 2.491 . . . . 0.12 117.727 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -121.06 48.48 1.64 Allowed 'General case' 0 C--N 1.372 1.563 0 C-N-CA 125.519 1.528 . . . . 0.29999999999999999 113.606 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 13.7 ttt180 -102.25 111.73 24.14 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 128.237 2.615 . . . . 2.0899999999999999 110.075 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 47.0 p -50.74 -59.13 4.41 Favored 'General case' 0 C--N 1.369 1.454 0 C-N-CA 131.279 3.831 . . . . 0.46999999999999997 119.742 -175.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -87.77 65.55 8.45 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 127.927 2.491 . . . . 1.8899999999999999 110.736 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 4.5 t -145.15 169.2 18.63 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-O 123.392 1.568 . . . . 1.1299999999999999 111.287 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -95.67 -1.49 50.0 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 124.996 1.318 . . . . 0.79000000000000004 109.561 166.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 17' ' ' TRP . . . . . 0.479 ' CZ2' ' HA2' ' E' ' 54' ' ' GLY . 20.9 m0 -118.13 23.67 11.47 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 126.347 1.859 . . . . 0.75 110.898 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -75.03 94.92 2.94 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 125.817 1.647 . . . . 0.40000000000000002 112.193 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.95 34.24 4.38 Favored Glycine 0 C--N 1.359 1.809 0 C-N-CA 126.077 1.799 . . . . 0.39000000000000001 110.16 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -110.66 152.16 26.84 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 126.829 2.052 . . . . 1.3999999999999999 108.537 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.06 170.26 3.59 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 CA-C-N 120.216 1.371 . . . . 0.31 108.456 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.98 176.49 44.24 Favored Glycine 0 CA--C 1.474 -2.5 0 O-C-N 120.079 -1.638 . . . . 0.20999999999999999 109.255 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 23' ' ' THR . . . . . 0.496 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 15.1 m -94.63 120.14 34.4 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 125.617 1.567 . . . . 0.27000000000000002 110.478 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 24' ' ' VAL . . . . . 0.507 HG23 HG13 ' E' ' 36' ' ' VAL . 6.9 p -76.66 101.84 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 124.395 2.045 . . . . 0.28999999999999998 112.69 173.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.89 46.1 1.3 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.167 1.387 . . . . 0.28999999999999998 114.232 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 62.0 p -73.18 -86.3 0.03 OUTLIER 'General case' 0 C--N 1.354 0.794 0 C-N-CA 130.203 3.401 . . . . 0.63 114.863 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 27' ' ' VAL . . . . . 0.499 HG13 ' HB3' ' E' ' 4' ' ' ARG . 2.4 p -79.54 59.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.616 0 CA-C-O 126.519 3.057 . . . . 0.60999999999999999 112.905 -169.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -160.62 -62.79 0.06 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.732 3.213 . . . . 1.6100000000000001 107.233 -173.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.56 -18.19 16.73 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 127.202 2.201 . . . . 3.96 115.802 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -26.82 0.3 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.039 2 C-N-CA 134.866 5.266 . . . . 4.3399999999999999 123.404 -172.707 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.54 43.54 1.86 Allowed Glycine 0 C--O 1.224 -0.496 1 C-N-CA 131.991 4.615 . . . . 1.76 114.939 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 32' ' ' ILE . . . . . 0.542 HG22 ' H ' ' E' ' 33' ' ' LEU . 1.1 mt -131.77 -169.68 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 127.984 2.514 . . . . 1.1100000000000001 105.853 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 33' ' ' LEU . . . . . 0.542 ' H ' HG22 ' E' ' 32' ' ' ILE . 32.2 tp -68.51 -44.49 74.53 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 117.287 2.328 . . . . 0.56999999999999995 117.287 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -123.02 157.9 59.14 Favored Pre-proline 0 C--N 1.356 0.887 0 N-CA-C 106.261 -1.755 . . . . 0.93999999999999995 106.261 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.68 -46.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.365 1.427 0 C-N-CA 123.439 2.759 . . . . 0.67000000000000004 115.568 -166.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 36' ' ' VAL . . . . . 0.564 HG12 HG23 ' E' ' 38' ' ' VAL . 73.3 t -90.51 97.04 6.76 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 CA-C-O 122.688 1.232 . . . . 0.64000000000000001 112.445 -170.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 56.9 mt -86.66 105.08 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 C-N-CA 127.958 2.503 . . . . 0.65000000000000002 104.34 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 38' ' ' VAL . . . . . 0.789 HG11 HD11 ' E' ' 10' ' ' ILE . 21.1 t -105.38 156.21 6.38 Favored 'Isoleucine or valine' 0 C--N 1.349 0.547 0 CA-C-N 121.058 1.754 . . . . 0.23000000000000001 111.546 -174.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 39' ' ' ARG . . . . . 0.496 ' HB3' ' H ' ' E' ' 23' ' ' THR . 17.5 tpp180 -81.8 131.83 35.27 Favored 'General case' 0 C--N 1.36 1.06 0 C-N-CA 127.785 2.434 . . . . 2.75 110.983 172.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -128.91 150.46 50.35 Favored 'General case' 0 CA--C 1.512 -0.489 0 O-C-N 121.743 -0.598 . . . . 1.26 110.648 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -96.16 -48.42 5.65 Favored 'General case' 0 C--N 1.36 1.045 0 C-N-CA 126.0 1.72 . . . . 1.02 109.81 173.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 86.4 mtm-85 -82.82 85.55 7.07 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 125.893 1.677 . . . . 1.29 114.837 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 14.4 t -88.09 81.85 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.913 0 C-N-CA 127.111 2.164 . . . . 1.23 112.324 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . 0.429 0.0 OUTLIER 47.04 74.36 0.16 Allowed 'General case' 0 C--N 1.355 0.84 0 C-N-CA 131.626 3.971 . . . . 2.0499999999999998 120.743 175.608 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -98.71 -60.54 1.52 Allowed 'General case' 0 C--N 1.345 0.379 0 C-N-CA 124.347 1.059 . . . . 2.52 110.37 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -101.36 151.99 21.25 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 125.821 1.648 . . . . 4.1600000000000001 107.959 173.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.45 159.89 19.16 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 110.747 -0.941 . . . . 5.3300000000000001 110.747 168.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -133.48 -169.96 2.39 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 128.714 2.806 . . . . 5.0899999999999999 107.643 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 5.2 t -54.59 -7.34 0.15 Allowed 'General case' 0 C--N 1.36 1.022 0 C-N-CA 131.21 3.804 . . . . 7.1799999999999997 120.577 -174.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.17 43.62 0.52 Allowed Glycine 0 CA--C 1.49 -1.494 0 N-CA-C 105.754 -2.938 . . . . 6.5099999999999998 105.754 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 24.0 p 80.6 -169.22 0.03 OUTLIER 'General case' 0 C--N 1.362 1.147 0 C-N-CA 129.038 2.935 . . . . 7.2000000000000002 114.364 -176.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.61 -14.42 32.46 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 125.887 1.675 . . . . 5.0800000000000001 112.544 173.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m 67.49 -29.2 0.15 Allowed 'General case' 0 C--N 1.358 0.976 0 N-CA-C 119.178 3.029 . . . . 3.8599999999999999 119.178 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 54' ' ' GLY . . . . . 0.479 ' HA2' ' CZ2' ' E' ' 17' ' ' TRP . . . -28.94 121.62 0.08 OUTLIER Glycine 0 C--N 1.355 1.588 2 C-N-CA 136.775 6.893 . . . . 2.8500000000000001 123.638 -174.506 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 48.8 t -153.15 167.86 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.634 1 N-CA-C 99.895 -4.113 . . . . 1.72 99.895 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -80.06 -43.63 21.51 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 127.647 2.379 . . . . 2.2000000000000002 112.634 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 7.2 p -126.15 121.39 32.68 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 128.723 2.809 . . . . 0.46999999999999997 104.764 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -150.32 144.45 25.53 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.695 0.798 . . . . 1.5700000000000001 109.561 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -81.46 106.27 13.3 Favored 'General case' 0 C--N 1.352 0.677 0 C-N-CA 130.812 3.645 . . . . 2.0699999999999998 120.117 -174.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 60' ' ' PHE . . . . . 0.436 ' CE2' HD12 ' E' ' 10' ' ' ILE . 26.1 m-85 -109.67 175.84 5.29 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 119.282 -2.136 . . . . 0.17000000000000001 113.793 174.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -114.27 115.7 27.82 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 113.958 -1.474 . . . . 0.17000000000000001 109.578 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -16.94 -38.13 0.0 OUTLIER 'General case' 0 C--N 1.367 1.351 1 C-N-CA 136.581 5.952 . . . . 1.72 118.496 173.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -49.84 -48.47 51.02 Favored 'General case' 0 C--N 1.37 1.492 0 C-N-CA 130.926 3.69 . . . . 0.17000000000000001 113.932 169.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 13.2 pm0 -95.32 17.44 14.41 Favored 'General case' 0 C--N 1.363 1.175 0 C-N-CA 124.202 1.001 . . . . 1.1799999999999999 112.16 -172.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.481 ' CD1' HG11 ' E' ' 36' ' ' VAL . 0.1 OUTLIER -120.76 138.15 54.15 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 107.524 -1.288 . . . . 0.19 107.524 173.445 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -110.39 126.28 54.11 Favored 'General case' 0 C--N 1.351 0.67 0 C-N-CA 124.501 1.12 . . . . 2.0499999999999998 111.717 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.14 139.56 58.15 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 128.301 2.64 . . . . 0.28999999999999998 117.695 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 t -135.26 -43.32 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.765 0 C-N-CA 126.35 1.86 . . . . 0.72999999999999998 109.691 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 69' ' ' GLN . . . . . 0.485 ' CB ' ' H ' ' E' ' 7' ' ' LYS . 1.6 tp60 -106.09 113.19 26.58 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 128.284 2.633 . . . . 2.1899999999999999 117.743 -168.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.76 68.1 6.88 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.958 171.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.31 53.39 0.07 Allowed 'General case' 0 C--N 1.373 1.594 0 N-CA-C 117.454 2.391 . . . . 0.0 117.454 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.05 130.96 35.42 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 126.92 2.088 . . . . 0.0 111.871 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 mptt . . . . . 0 C--O 1.262 1.729 0 C-N-CA 125.995 1.718 . . . . 0.0 110.356 179.019 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 108.752 -0.833 . . . . 2.1299999999999999 108.752 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 2' ' ' LEU . . . . . 0.429 ' HB2' ' H ' ' E' ' 3' ' ' ASN . 0.0 OUTLIER -82.08 -164.19 0.78 Allowed 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.506 1.922 . . . . 0.98999999999999999 115.637 177.663 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 3' ' ' ASN . . . . . 0.429 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 0.0 OUTLIER -140.56 -166.11 2.06 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 127.755 2.422 . . . . 0.80000000000000004 109.417 -175.169 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -85.26 104.96 15.59 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 128.061 2.544 . . . . 3.3999999999999999 117.24 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 112.72 -9.5 25.75 Favored Glycine 0 CA--C 1.485 -1.84 0 O-C-N 119.409 -2.057 . . . . 0.53000000000000003 110.904 173.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.13 42.13 0.07 Allowed 'General case' 0 N--CA 1.438 -1.066 1 C-N-CA 133.903 4.881 . . . . 0.45000000000000001 115.596 -176.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -5.74 93.21 0.01 OUTLIER 'General case' 0 C--N 1.362 1.15 1 C-N-CA 133.777 4.831 . . . . 2.0299999999999998 117.058 -176.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 28.5 m -92.4 154.42 3.19 Favored 'Isoleucine or valine' 0 C--N 1.361 1.074 0 CA-C-N 121.149 1.795 . . . . 0.13 111.488 -172.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -103.17 109.0 20.42 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 121.446 -0.784 . . . . 0.17000000000000001 111.92 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.785 HD11 HG11 ' E' ' 38' ' ' VAL . 1.3 mp -56.96 103.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.213 0 C-N-CA 129.805 3.242 . . . . 0.12 114.494 174.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -120.48 52.36 1.16 Allowed 'General case' 0 C--N 1.37 1.493 0 C-N-CA 124.43 1.092 . . . . 0.29999999999999999 109.903 -172.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -72.17 -115.39 0.0 OUTLIER 'General case' 0 C--N 1.364 1.212 0 N-CA-C 118.792 2.886 . . . . 2.0899999999999999 118.792 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -170.71 142.58 2.01 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 101.719 -3.438 . . . . 0.46999999999999997 101.719 -174.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . 0.257 3.7 mm-40 -5.86 69.38 0.0 OUTLIER 'General case' 0 C--N 1.368 1.384 1 C-N-CA 134.343 5.057 . . . . 1.8899999999999999 119.316 -174.65 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 75.3 m -138.39 154.57 48.92 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 130.182 3.393 . . . . 1.1299999999999999 104.087 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -61.29 -11.17 8.67 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 130.127 3.371 . . . . 0.79000000000000004 117.151 -176.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 22.9 m0 -113.26 -3.5 13.85 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 128.882 2.873 . . . . 0.75 113.371 -177.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -80.26 88.7 5.49 Favored 'General case' 0 C--N 1.373 1.602 0 C-N-CA 126.337 1.855 . . . . 0.40000000000000002 110.291 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.34 -11.71 3.01 Favored Glycine 0 C--N 1.36 1.903 0 C-N-CA 126.74 2.114 . . . . 0.39000000000000001 111.285 -175.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -97.75 162.59 13.19 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 119.66 1.73 . . . . 1.3999999999999999 114.924 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -103.12 169.79 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.208 0 C-N-CA 126.717 2.007 . . . . 0.31 108.444 172.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.99 -179.78 41.25 Favored Glycine 0 CA--C 1.476 -2.406 0 N-CA-C 108.491 -1.844 . . . . 0.20999999999999999 108.491 170.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 23' ' ' THR . . . . . 0.674 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 4.0 m -94.33 120.3 34.36 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 125.323 1.449 . . . . 0.27000000000000002 111.496 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 24' ' ' VAL . . . . . 0.542 HG23 HG13 ' E' ' 36' ' ' VAL . 14.5 p -68.02 69.57 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 131.571 3.948 . . . . 0.28999999999999998 112.862 175.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.58 45.15 1.21 Allowed 'General case' 0 C--N 1.362 1.149 0 O-C-N 118.401 -2.687 . . . . 0.28999999999999998 110.095 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 26' ' ' SER . . . . . 0.418 ' HA ' ' HB ' ' E' ' 37' ' ' ILE . 13.2 m -87.96 -62.1 1.57 Allowed 'General case' 0 CA--C 1.465 -2.29 1 C-N-CA 135.959 5.704 . . . . 0.63 119.323 -171.523 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 m -80.23 19.14 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.093 0 N-CA-C 116.586 2.069 . . . . 0.60999999999999999 116.586 -156.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -111.28 -50.27 2.95 Favored 'General case' 0 N--CA 1.43 -1.473 1 C-N-CA 135.187 5.395 . . . . 1.6100000000000001 109.311 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 29' ' ' LYS . . . . . 0.557 ' HB2' HD13 ' E' ' 37' ' ' ILE . 27.8 mmmt -103.19 -12.4 17.36 Favored 'General case' 0 C--N 1.366 1.283 0 C-N-CA 128.232 2.613 . . . . 3.96 113.194 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 8.4 t -43.53 -17.91 0.02 OUTLIER 'General case' 0 C--N 1.376 1.744 1 C-N-CA 132.084 4.153 . . . . 4.3399999999999999 117.97 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.53 45.46 0.27 Allowed Glycine 0 C--N 1.355 1.589 0 C-N-CA 130.221 3.772 . . . . 1.76 117.058 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 32' ' ' ILE . . . . . 0.445 HG22 ' H ' ' E' ' 33' ' ' LEU . 0.3 OUTLIER -135.78 -159.36 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.913 0 C-N-CA 129.005 2.922 . . . . 1.1100000000000001 111.031 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 33' ' ' LEU . . . . . 0.445 ' H ' HG22 ' E' ' 32' ' ' ILE . 22.0 tp -69.31 -23.06 63.75 Favored 'General case' 0 C--N 1.355 0.839 1 C-N-CA 133.335 4.654 . . . . 0.56999999999999995 118.378 -177.753 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -134.55 152.72 78.32 Favored Pre-proline 0 C--N 1.362 1.131 0 N-CA-C 105.735 -1.95 . . . . 0.93999999999999995 105.735 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.8 -45.74 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.9 3.067 . . . . 0.67000000000000004 117.65 -173.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 36' ' ' VAL . . . . . 0.605 HG12 HG23 ' E' ' 38' ' ' VAL . 54.6 t -109.01 106.11 20.08 Favored 'Isoleucine or valine' 0 C--N 1.353 0.748 0 N-CA-C 115.296 1.591 . . . . 0.64000000000000001 115.296 -167.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 37' ' ' ILE . . . . . 0.557 HD13 ' HB2' ' E' ' 29' ' ' LYS . 3.3 mp -85.33 118.31 31.97 Favored 'Isoleucine or valine' 0 C--N 1.37 1.492 0 C-N-CA 125.977 1.711 . . . . 0.65000000000000002 106.921 173.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 38' ' ' VAL . . . . . 0.785 HG11 HD11 ' E' ' 10' ' ' ILE . 92.8 t -115.81 155.59 17.09 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 CA-C-O 122.128 0.966 . . . . 0.23000000000000001 112.256 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 39' ' ' ARG . . . . . 0.674 ' HB3' ' H ' ' E' ' 23' ' ' THR . 1.9 tpm_? -75.47 139.55 42.32 Favored 'General case' 0 C--N 1.362 1.136 0 C-N-CA 130.118 3.367 . . . . 2.75 112.932 173.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 40' ' ' PHE . . . . . 0.454 ' H ' ' NH2' ' E' ' 39' ' ' ARG . 60.9 m-85 -145.66 109.17 4.7 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 129.16 2.984 . . . . 1.26 107.915 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -104.71 -11.11 17.03 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 129.116 2.966 . . . . 1.02 113.875 -176.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -94.16 9.7 36.84 Favored 'General case' 0 C--N 1.366 1.284 0 C-N-CA 126.503 1.921 . . . . 1.29 113.226 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.39 149.62 7.52 Favored 'Isoleucine or valine' 0 C--N 1.351 0.638 0 C-N-CA 128.16 2.584 . . . . 1.23 111.522 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -69.99 42.97 0.05 Allowed 'General case' 0 C--N 1.353 0.75 0 C-N-CA 131.582 3.953 . . . . 2.0499999999999998 115.748 -172.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -38.7 -42.4 0.8 Allowed 'General case' 0 C--N 1.359 0.998 1 C-N-CA 135.462 5.505 . . . . 2.52 117.747 -175.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -101.26 135.22 43.1 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.079 -1.013 . . . . 4.1600000000000001 108.345 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.22 38.22 2.58 Favored Glycine 0 C--N 1.364 2.139 0 C-N-CA 127.143 2.306 . . . . 5.3300000000000001 114.734 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -135.1 21.4 3.47 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 128.27 2.628 . . . . 5.0899999999999999 107.463 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 76.2 p -102.45 -95.88 0.29 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 128.749 2.82 . . . . 7.1799999999999997 109.441 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . -125.33 -60.37 0.17 Allowed Glycine 0 C--N 1.35 1.345 0 C-N-CA 127.04 2.257 . . . . 6.5099999999999998 109.772 176.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 17.2 t -165.11 146.23 7.49 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 102.699 -3.075 . . . . 7.2000000000000002 102.699 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.91 31.72 1.05 Allowed 'General case' 0 C--N 1.36 1.034 0 CA-C-O 124.402 2.049 . . . . 5.0800000000000001 113.149 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 20.4 m -85.39 49.64 1.79 Allowed 'General case' 0 C--N 1.344 0.351 0 C-N-CA 131.121 3.768 . . . . 3.8599999999999999 113.292 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -115.63 165.4 12.16 Favored Glycine 0 C--N 1.353 1.48 0 C-N-CA 126.016 1.769 . . . . 2.8500000000000001 112.171 176.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 22.2 t -107.18 153.78 8.3 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 105.044 -2.206 . . . . 1.72 105.044 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -96.63 -76.55 0.51 Allowed 'General case' 0 C--N 1.355 0.82 0 O-C-N 120.31 -1.494 . . . . 2.2000000000000002 113.515 -173.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 71.4 p -109.43 108.02 18.38 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.139 1.376 . . . . 0.46999999999999997 108.653 176.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.83 146.99 36.69 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 125.828 1.651 . . . . 1.5700000000000001 109.548 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -89.27 113.93 25.24 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 129.812 3.245 . . . . 2.0699999999999998 111.226 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 60' ' ' PHE . . . . . 0.423 ' HB2' HD11 ' E' ' 65' ' ' LEU . 19.5 m-85 -107.0 174.39 5.91 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.95 1.7 . . . . 0.17000000000000001 113.66 -176.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.7 89.38 3.67 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 130.195 3.398 . . . . 0.17000000000000001 110.643 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -26.16 -18.39 0.0 OUTLIER 'General case' 0 C--N 1.354 0.797 1 C-N-CA 136.072 5.749 . . . . 1.72 120.39 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.89 -32.8 72.25 Favored 'General case' 0 C--N 1.367 1.335 0 C-N-CA 129.148 2.979 . . . . 0.17000000000000001 112.729 168.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.27 18.07 21.88 Favored 'General case' 0 C--N 1.371 1.516 0 C-N-CA 125.832 1.653 . . . . 1.1799999999999999 110.285 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.447 HD13 HG11 ' E' ' 36' ' ' VAL . 74.1 mt -128.18 118.81 24.03 Favored 'General case' 0 C--N 1.366 1.295 0 CA-C-O 123.526 1.631 . . . . 0.19 111.934 177.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -111.18 134.5 52.73 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.863 1.665 . . . . 2.0499999999999998 109.145 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.65 133.76 36.22 Favored 'General case' 0 C--N 1.366 1.318 1 C-N-CA 132.161 4.185 . . . . 0.28999999999999998 118.547 175.468 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . 0.269 3.1 t -132.13 -33.43 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.372 1.556 0 N-CA-C 114.758 1.392 . . . . 0.72999999999999998 114.758 178.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 69' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -111.13 139.69 46.3 Favored 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 119.443 -2.036 . . . . 2.1899999999999999 109.685 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.12 64.61 6.88 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.55 1.94 . . . . 0.0 114.045 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.9 68.25 2.77 Favored 'General case' 0 C--N 1.362 1.129 0 CA-C-O 123.444 1.592 . . . . 0.0 110.792 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.08 64.66 4.62 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 125.717 1.607 . . . . 0.0 109.849 176.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 19.0 pttm . . . . . 0 C--O 1.261 1.694 0 C-N-CA 127.486 2.314 . . . . 0.0 107.143 176.252 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.851 0 N-CA-C 111.563 0.209 . . . . 2.1299999999999999 111.563 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 2' ' ' LEU . . . . . 0.716 HD22 HG11 ' E' ' 8' ' ' VAL 0.279 1.0 OUTLIER -103.85 -140.91 0.36 Allowed 'General case' 0 C--N 1.356 0.85 0 C-N-CA 127.495 2.318 . . . . 0.98999999999999999 111.957 175.922 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.09 172.79 12.58 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 124.2 1.952 . . . . 0.80000000000000004 114.418 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.09 94.34 7.89 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 127.124 2.17 . . . . 3.3999999999999999 112.86 176.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.27 3.44 9.61 Favored Glycine 0 C--N 1.365 2.172 0 O-C-N 120.697 -1.252 . . . . 0.53000000000000003 111.388 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 6' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -69.28 143.94 53.72 Favored 'General case' 0 N--CA 1.417 -2.092 0 C-N-CA 130.739 3.615 . . . . 0.45000000000000001 112.752 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -94.15 83.72 4.32 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 104.93 -2.248 . . . . 2.0299999999999998 104.93 171.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 8' ' ' VAL . . . . . 0.716 HG11 HD22 ' E' ' 2' ' ' LEU . 17.5 m -89.79 144.31 9.37 Favored 'Isoleucine or valine' 0 C--N 1.365 1.252 0 N-CA-C 107.517 -1.29 . . . . 0.13 107.517 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 9' ' ' ARG . . . . . 0.422 HH21 ' HA2' ' E' ' 19' ' ' GLY . 69.1 ttt-85 -104.05 122.68 45.77 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 120.154 -1.591 . . . . 0.17000000000000001 110.817 -175.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.613 HD11 HG11 ' E' ' 38' ' ' VAL . 0.5 OUTLIER -67.75 120.93 15.96 Favored 'Isoleucine or valine' 0 C--N 1.363 1.165 0 C-N-CA 126.939 2.096 . . . . 0.12 113.808 177.217 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -126.96 52.82 1.75 Allowed 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 127.997 2.519 . . . . 0.29999999999999999 110.481 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -92.46 -138.86 0.18 Allowed 'General case' 0 C--N 1.372 1.564 0 O-C-N 120.221 -1.549 . . . . 2.0899999999999999 109.946 172.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 13' ' ' THR . . . . . 0.407 ' HA ' ' CD2' ' E' ' 18' ' ' TYR 0.251 23.0 m -152.76 -60.43 0.15 Allowed 'General case' 0 C--N 1.357 0.899 0 O-C-N 118.256 -2.777 . . . . 0.46999999999999997 108.764 174.352 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -75.23 67.34 1.84 Allowed 'General case' 0 C--N 1.354 0.796 0 O-C-N 119.962 -1.711 . . . . 1.8899999999999999 114.453 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 23.8 t -162.12 159.68 26.34 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 125.459 1.504 . . . . 1.1299999999999999 111.746 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -77.03 -27.45 54.53 Favored 'General case' 0 C--N 1.363 1.153 0 C-N-CA 130.941 3.697 . . . . 0.79000000000000004 110.179 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 24.5 m0 -93.71 17.97 10.97 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 129.368 3.067 . . . . 0.75 113.052 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 18' ' ' TYR . . . . . 0.407 ' CD2' ' HA ' ' E' ' 13' ' ' THR . 2.6 t80 -74.63 112.17 10.55 Favored 'General case' 0 C--N 1.368 1.411 0 C-N-CA 126.362 1.865 . . . . 0.40000000000000002 108.421 173.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 19' ' ' GLY . . . . . 0.422 ' HA2' HH21 ' E' ' 9' ' ' ARG . . . 94.53 34.14 6.47 Favored Glycine 0 C--N 1.354 1.534 0 C-N-CA 128.651 3.025 . . . . 0.39000000000000001 113.923 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -105.42 163.86 12.31 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 118.968 1.384 . . . . 1.3999999999999999 113.09 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.25 149.47 25.67 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 N-CA-C 105.603 -1.999 . . . . 0.31 105.603 175.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.08 178.35 47.54 Favored Glycine 0 CA--C 1.472 -2.629 0 C-N-CA 118.146 -1.978 . . . . 0.20999999999999999 110.226 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 7.0 m -90.01 120.93 31.63 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 124.844 1.258 . . . . 0.27000000000000002 113.222 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 24' ' ' VAL . . . . . 0.413 HG12 ' H ' ' E' ' 24' ' ' VAL . 7.3 p -77.57 91.54 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 125.374 2.512 . . . . 0.28999999999999998 110.768 175.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.62 53.76 2.9 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 119.879 -1.763 . . . . 0.28999999999999998 111.268 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 22.1 m -87.69 -59.82 2.14 Favored 'General case' 0 CA--C 1.476 -1.868 0 C-N-CA 130.169 3.387 . . . . 0.63 117.667 -174.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -84.41 62.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.767 0 CA-C-O 126.421 3.01 . . . . 0.60999999999999999 112.843 -164.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -148.27 -66.51 0.24 Allowed 'General case' 0 N--CA 1.415 -2.209 2 C-N-CA 132.282 4.233 . . . . 1.6100000000000001 104.988 -177.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -110.31 5.02 21.32 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 128.089 2.556 . . . . 3.96 114.642 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 3.8 t -50.96 -18.96 0.87 Allowed 'General case' 0 C--N 1.369 1.44 0 C-N-CA 130.043 3.337 . . . . 4.3399999999999999 118.304 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.59 43.89 0.47 Allowed Glycine 0 C--N 1.349 1.295 0 C-N-CA 129.856 3.598 . . . . 1.76 116.949 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 32' ' ' ILE . . . . . 0.564 HG22 ' H ' ' E' ' 33' ' ' LEU . 0.7 OUTLIER -133.1 -166.02 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.834 0 C-N-CA 128.651 2.78 . . . . 1.1100000000000001 109.599 -179.472 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 33' ' ' LEU . . . . . 0.564 ' H ' HG22 ' E' ' 32' ' ' ILE . 49.1 tp -69.85 -22.55 63.26 Favored 'General case' 0 C--N 1.359 0.98 1 C-N-CA 131.829 4.052 . . . . 0.56999999999999995 116.786 -177.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -137.28 127.75 15.92 Favored Pre-proline 0 C--N 1.359 0.989 0 N-CA-C 105.316 -2.105 . . . . 0.93999999999999995 105.316 176.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -82.3 -42.68 0.1 OUTLIER 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 124.702 3.601 . . . . 0.67000000000000004 117.111 -171.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 36' ' ' VAL . . . . . 0.536 HG12 HG23 ' E' ' 38' ' ' VAL . 76.4 t -84.18 101.37 8.67 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 C-N-CA 127.728 2.411 . . . . 0.64000000000000001 113.4 -168.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 78.5 mt -101.68 81.04 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.206 0 C-N-CA 124.973 1.309 . . . . 0.65000000000000002 107.692 -176.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 38' ' ' VAL . . . . . 0.613 HG11 HD11 ' E' ' 10' ' ' ILE . 57.0 t -89.23 164.82 2.13 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 O-C-N 119.488 -2.008 . . . . 0.23000000000000001 112.644 -173.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 39' ' ' ARG . . . . . . . . . . . . . 29.1 mmt85 -82.25 142.05 32.44 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 128.729 2.812 . . . . 2.75 113.461 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -132.09 138.63 48.19 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.413 1.085 . . . . 1.26 111.9 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -101.19 -34.79 9.54 Favored 'General case' 0 C--N 1.374 1.638 0 C-N-CA 125.836 1.654 . . . . 1.02 113.094 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 34.4 mtt180 -83.91 49.87 1.71 Allowed 'General case' 0 C--N 1.36 1.049 0 C-N-CA 128.494 2.718 . . . . 1.29 116.242 -170.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 43' ' ' VAL . . . . . 0.405 HG13 ' CE1' ' E' ' 45' ' ' TYR 0.308 4.3 p -98.8 151.47 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 119.4 -2.062 . . . . 1.23 105.79 167.387 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -89.1 5.67 43.47 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 119.064 -2.272 . . . . 2.0499999999999998 115.067 -174.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 45' ' ' TYR . . . . . 0.405 ' CE1' HG13 ' E' ' 43' ' ' VAL . 80.2 m-85 53.76 -47.18 0.02 OUTLIER 'General case' 0 C--N 1.363 1.195 0 C-N-CA 131.449 3.899 . . . . 2.52 121.479 173.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -102.09 120.77 40.98 Favored 'General case' 0 C--N 1.355 0.804 0 C-N-CA 126.929 2.092 . . . . 4.1600000000000001 114.556 -172.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.31 27.12 8.82 Favored Glycine 0 C--N 1.364 2.133 0 O-C-N 119.88 -1.763 . . . . 5.3300000000000001 116.816 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -117.01 -22.14 8.58 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-O 124.036 1.874 . . . . 5.0899999999999999 114.521 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 8.1 t -104.03 0.02 29.35 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 130.994 3.717 . . . . 7.1799999999999997 113.219 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.04 -123.86 1.5 Allowed Glycine 0 C--N 1.346 1.114 0 N-CA-C 106.172 -2.771 . . . . 6.5099999999999998 106.172 -173.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 8.6 t -153.4 166.27 33.19 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 104.39 -2.448 . . . . 7.2000000000000002 104.39 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.61 -53.15 37.36 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 126.898 2.079 . . . . 5.0800000000000001 113.976 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 4.8 t 69.02 -21.96 0.15 Allowed 'General case' 0 C--N 1.351 0.638 0 N-CA-C 118.878 2.918 . . . . 3.8599999999999999 118.878 174.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.77 -166.72 16.97 Favored Glycine 0 C--N 1.347 1.171 0 C-N-CA 128.336 2.874 . . . . 2.8500000000000001 112.992 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -138.62 175.95 7.39 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 C-N-CA 128.696 2.798 . . . . 1.72 105.667 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -105.77 -34.09 7.79 Favored 'General case' 0 C--N 1.365 1.257 0 C-N-CA 124.696 1.198 . . . . 2.2000000000000002 111.733 174.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 1.9 p -121.63 128.57 52.05 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 104.056 -2.572 . . . . 0.46999999999999997 104.056 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.74 132.03 11.96 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 108.119 -1.067 . . . . 1.5700000000000001 108.119 -168.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -80.69 110.82 16.55 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 130.071 3.348 . . . . 2.0699999999999998 116.018 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 60' ' ' PHE . . . . . 0.416 ' CZ ' HG21 ' E' ' 10' ' ' ILE . 24.7 m-85 -114.31 179.86 3.83 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 127.422 2.289 . . . . 0.17000000000000001 114.035 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.82 109.41 16.54 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 114.706 1.373 . . . . 0.17000000000000001 114.706 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -19.74 0.4 0.0 OUTLIER 'General case' 0 C--N 1.374 1.638 2 C-N-CA 137.357 6.263 . . . . 1.72 124.489 172.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -99.09 -45.04 6.06 Favored 'General case' 0 N--CA 1.438 -1.055 1 C-N-CA 132.241 4.217 . . . . 0.17000000000000001 106.322 171.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -88.68 18.25 4.84 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 120.083 -1.635 . . . . 1.1799999999999999 110.867 -170.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . 0.313 0.1 OUTLIER -134.17 157.7 45.55 Favored 'General case' 0 N--CA 1.43 -1.464 1 C-N-CA 132.768 4.427 . . . . 0.19 106.317 172.186 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -137.39 149.25 46.8 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 105.665 -1.976 . . . . 2.0499999999999998 105.665 162.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 67' ' ' LEU . . . . . 0.492 ' H ' HD23 ' E' ' 67' ' ' LEU 0.252 2.5 pt? -91.54 149.01 21.87 Favored 'General case' 0 C--N 1.363 1.187 0 O-C-N 118.798 -2.439 . . . . 0.28999999999999998 117.511 -177.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 4.4 t -112.09 -37.48 2.84 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 C-N-CA 126.794 2.038 . . . . 0.72999999999999998 110.346 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 69' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -103.41 153.78 20.12 Favored 'General case' 0 C--N 1.356 0.875 0 CA-C-O 126.916 3.246 . . . . 2.1899999999999999 115.286 -174.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.26 68.74 0.77 Allowed 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 108.476 -3.966 . . . . 0.0 109.584 170.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.5 74.3 3.23 Favored 'General case' 0 C--N 1.362 1.137 0 O-C-N 120.076 -1.64 . . . . 0.0 112.465 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.1 80.21 7.72 Favored 'General case' 0 C--N 1.36 1.065 0 C-N-CA 129.08 2.952 . . . . 0.0 111.753 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 71.7 tttt . . . . . 0 C--O 1.264 1.826 0 C-N-CA 127.089 2.156 . . . . 0.0 107.93 176.02 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 2.613 0 N-CA-C 114.336 1.235 . . . . 2.1299999999999999 114.336 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 2' ' ' LEU . . . . . 0.554 HD13 ' H ' ' E' ' 2' ' ' LEU . 0.0 OUTLIER -102.12 -158.05 0.65 Allowed 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 131.693 3.997 . . . . 0.98999999999999999 117.93 -175.215 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 3' ' ' ASN . . . . . 0.445 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 0.2 OUTLIER -146.97 177.06 9.44 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 130.794 3.638 . . . . 0.80000000000000004 107.298 -178.84 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -78.66 117.74 20.1 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 120.69 3.589 . . . . 3.3999999999999999 120.69 -172.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.63 5.93 53.33 Favored Glycine 0 C--N 1.376 2.784 0 O-C-N 118.184 -2.823 . . . . 0.53000000000000003 114.332 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.65 145.89 30.34 Favored 'General case' 0 N--CA 1.411 -2.4 1 C-N-CA 132.024 4.13 . . . . 0.45000000000000001 110.983 -176.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 7' ' ' LYS . . . . . 0.611 ' H ' ' CB ' ' E' ' 69' ' ' GLN . 49.3 mttm -93.08 71.76 4.62 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 128.524 2.73 . . . . 2.0299999999999998 107.973 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 15.8 m -88.69 148.64 4.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 C-N-CA 123.684 0.794 . . . . 0.13 110.891 -173.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -105.95 123.92 48.76 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 119.314 -0.374 . . . . 0.17000000000000001 110.917 -173.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.681 HD11 HG11 ' E' ' 38' ' ' VAL . 2.2 mm -73.29 114.68 13.09 Favored 'Isoleucine or valine' 0 C--N 1.36 1.06 0 C-N-CA 125.755 1.622 . . . . 0.12 114.968 177.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -115.91 57.27 0.75 Allowed 'General case' 0 C--N 1.375 1.675 0 C-N-CA 124.172 0.989 . . . . 0.29999999999999999 113.669 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.62 123.14 48.58 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 126.08 1.752 . . . . 2.0899999999999999 109.059 171.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 24.6 p -72.66 -6.56 45.2 Favored 'General case' 0 C--N 1.368 1.412 0 C-N-CA 128.941 2.896 . . . . 0.46999999999999997 117.273 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -97.16 41.12 1.12 Allowed 'General case' 0 C--N 1.357 0.906 0 C-N-CA 128.54 2.736 . . . . 1.8899999999999999 112.27 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 35.3 t -164.8 166.19 19.98 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 119.97 -1.706 . . . . 1.1299999999999999 107.247 -178.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -89.59 -5.6 57.04 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 127.123 2.169 . . . . 0.79000000000000004 110.369 171.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 29.6 m0 -94.76 16.68 15.18 Favored 'General case' 0 C--N 1.372 1.573 0 C-N-CA 129.166 2.986 . . . . 0.75 110.478 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -73.34 102.5 3.73 Favored 'General case' 0 C--N 1.364 1.221 0 C-N-CA 128.159 2.584 . . . . 0.40000000000000002 110.873 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.58 32.97 6.05 Favored Glycine 0 C--N 1.358 1.757 0 C-N-CA 126.203 1.859 . . . . 0.39000000000000001 112.602 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -106.93 135.19 48.9 Favored 'General case' 0 C--N 1.366 1.288 0 CA-C-N 119.255 1.528 . . . . 1.3999999999999999 112.255 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.72 145.84 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 C-N-CA 128.299 2.64 . . . . 0.31 107.257 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 22' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' E' ' 7' ' ' LYS . . . -174.03 178.1 46.02 Favored Glycine 0 CA--C 1.473 -2.563 0 N-CA-C 108.864 -1.694 . . . . 0.20999999999999999 108.864 172.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 20.7 m -86.18 125.4 33.5 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.505 1.122 . . . . 0.27000000000000002 112.002 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 24' ' ' VAL . . . . . 0.481 HG23 HG13 ' E' ' 36' ' ' VAL . 12.6 p -80.92 95.87 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 126.078 1.751 . . . . 0.28999999999999998 111.473 175.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.74 51.43 1.85 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.067 2.147 . . . . 0.28999999999999998 112.803 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 2.6 p -73.08 -73.12 0.22 Allowed 'General case' 0 CA--C 1.504 -0.817 1 C-N-CA 136.257 5.823 . . . . 0.63 120.114 -173.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 4.4 m -81.23 18.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.553 0 C-N-CA 128.085 2.554 . . . . 0.60999999999999999 117.058 -163.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -98.26 -69.43 0.76 Allowed 'General case' 0 N--CA 1.431 -1.416 1 C-N-CA 132.011 4.125 . . . . 1.6100000000000001 107.693 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -106.81 -26.89 11.07 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 115.849 1.796 . . . . 3.96 115.849 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.45 22.03 3.12 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 117.432 2.382 . . . . 4.3399999999999999 117.432 -170.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.25 46.49 0.81 Allowed Glycine 0 C--N 1.353 1.525 0 C-N-CA 127.97 2.7 . . . . 1.76 114.505 167.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 32' ' ' ILE . . . . . 0.521 HG22 ' H ' ' E' ' 33' ' ' LEU . 1.9 mt -122.32 -146.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 130.962 3.705 . . . . 1.1100000000000001 104.664 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 33' ' ' LEU . . . . . 0.521 ' H ' HG22 ' E' ' 32' ' ' ILE . 39.8 tp -62.08 -61.57 2.39 Favored 'General case' 0 C--N 1.345 0.379 0 C-N-CA 129.392 3.077 . . . . 0.56999999999999995 115.181 176.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -97.67 111.01 57.63 Favored Pre-proline 0 C--N 1.363 1.177 0 C-N-CA 124.208 1.003 . . . . 0.93999999999999995 109.688 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.86 -38.52 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.727 1 C-N-CA 125.318 4.012 . . . . 0.67000000000000004 116.141 -173.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 36' ' ' VAL . . . . . 0.674 HG11 ' HG ' ' E' ' 65' ' ' LEU . 59.4 t -88.44 94.21 4.62 Favored 'Isoleucine or valine' 0 C--N 1.349 0.553 0 N-CA-C 116.19 1.922 . . . . 0.64000000000000001 116.19 -169.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 96.4 mt -89.82 99.92 10.14 Favored 'Isoleucine or valine' 0 C--N 1.36 1.03 0 C-N-CA 126.461 1.904 . . . . 0.65000000000000002 106.719 176.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 38' ' ' VAL . . . . . 0.681 HG11 HD11 ' E' ' 10' ' ' ILE . 81.3 t -104.93 156.3 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 120.769 -1.207 . . . . 0.23000000000000001 111.945 -173.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 39' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -79.97 139.5 37.0 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 130.581 3.552 . . . . 2.75 111.973 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -137.29 149.08 46.83 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.317 -1.49 . . . . 1.26 111.929 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -103.55 -23.76 13.47 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 127.071 2.148 . . . . 1.02 111.282 172.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 67.2 mtt-85 -82.04 40.37 0.62 Allowed 'General case' 0 C--N 1.366 1.287 0 C-N-CA 129.397 3.079 . . . . 1.29 111.855 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 10.3 t -91.81 168.48 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 126.925 2.09 . . . . 1.23 110.377 -175.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -119.49 87.87 2.82 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.118 -2.178 . . . . 2.0499999999999998 105.118 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.91 3.64 31.06 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 130.042 3.337 . . . . 2.52 109.995 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -81.23 64.76 6.1 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 127.814 2.446 . . . . 4.1600000000000001 115.169 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.52 21.83 7.02 Favored Glycine 0 C--N 1.362 2.015 0 C-N-CA 126.87 2.176 . . . . 5.3300000000000001 116.802 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -116.76 14.85 15.36 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 127.243 2.217 . . . . 5.0899999999999999 109.622 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 77.7 p -100.53 -73.29 0.64 Allowed 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 129.133 2.973 . . . . 7.1799999999999997 107.416 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 179.52 -51.51 0.09 OUTLIER Glycine 0 CA--C 1.498 -1.015 0 C-N-CA 128.576 2.988 . . . . 6.5099999999999998 106.916 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 73.3 m -118.12 112.49 20.26 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 125.771 1.628 . . . . 7.2000000000000002 115.129 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -93.63 -92.6 0.17 Allowed 'General case' 0 C--N 1.365 1.254 0 C-N-CA 126.103 1.761 . . . . 5.0800000000000001 108.54 169.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 12.2 t 68.52 22.68 7.62 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 127.284 2.234 . . . . 3.8599999999999999 116.745 172.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -109.49 143.33 16.5 Favored Glycine 0 C--N 1.364 2.136 0 C-N-CA 126.653 2.073 . . . . 2.8500000000000001 113.629 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 t -103.79 147.79 9.54 Favored 'Isoleucine or valine' 0 C--N 1.364 1.2 0 C-N-CA 127.351 2.26 . . . . 1.72 112.62 -177.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -92.1 -33.96 14.56 Favored 'General case' 0 C--N 1.366 1.31 0 C-N-CA 127.987 2.515 . . . . 2.2000000000000002 112.893 -176.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 31.8 p -129.21 121.71 28.21 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 128.612 2.765 . . . . 0.46999999999999997 106.57 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.75 139.79 15.4 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 119.513 1.051 . . . . 1.5700000000000001 112.399 -175.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -63.05 119.78 10.15 Favored 'General case' 0 C--N 1.358 0.937 1 C-N-CA 132.035 4.134 . . . . 2.0699999999999998 119.9 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 60' ' ' PHE . . . . . 0.432 ' CD2' HD12 ' E' ' 10' ' ' ILE . 39.5 m-85 -124.67 170.26 11.15 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 123.514 1.626 . . . . 0.17000000000000001 113.44 174.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.92 92.32 6.05 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 129.765 3.226 . . . . 0.17000000000000001 109.05 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -18.15 -21.72 0.0 OUTLIER 'General case' 0 C--N 1.358 0.95 1 C-N-CA 136.434 5.893 . . . . 1.72 121.68 173.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -73.58 -29.67 62.56 Favored 'General case' 0 C--N 1.362 1.149 0 C-N-CA 129.443 3.097 . . . . 0.17000000000000001 113.173 169.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -84.33 -14.81 48.64 Favored 'General case' 0 C--N 1.375 1.692 0 C-N-CA 127.217 2.207 . . . . 1.1799999999999999 108.351 -175.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.674 ' HG ' HG11 ' E' ' 36' ' ' VAL . 0.6 OUTLIER -104.48 108.48 19.93 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 128.395 2.678 . . . . 0.19 115.41 -176.614 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -89.9 149.4 22.64 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 129.735 3.214 . . . . 2.0499999999999998 112.076 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -82.77 141.61 32.22 Favored 'General case' 0 C--N 1.366 1.316 0 CA-C-N 121.638 2.017 . . . . 0.28999999999999998 115.677 174.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 18.9 t -130.61 -19.4 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.873 0 CA-C-O 123.528 1.632 . . . . 0.72999999999999998 108.226 171.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 69' ' ' GLN . . . . . 0.611 ' CB ' ' H ' ' E' ' 7' ' ' LYS . 4.9 tp-100 -110.28 155.24 22.33 Favored 'General case' 0 N--CA 1.424 -1.729 0 C-N-CA 127.173 2.189 . . . . 2.1899999999999999 111.848 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.02 42.06 1.26 Allowed 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 128.478 2.711 . . . . 0.0 114.316 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.95 63.11 7.9 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 125.243 1.417 . . . . 0.0 108.278 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.9 80.16 2.98 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 128.05 2.54 . . . . 0.0 112.097 -173.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? . . . . . 0 C--O 1.257 1.459 0 N-CA-C 103.039 -2.949 . . . . 0.0 103.039 172.196 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 110.133 -0.321 . . . . 2.1299999999999999 110.133 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 2' ' ' LEU . . . . . 0.503 HD22 HG11 ' E' ' 8' ' ' VAL 0.306 2.0 pp -103.64 -154.97 0.51 Allowed 'General case' 0 C--N 1.362 1.129 0 CA-C-O 123.489 1.614 . . . . 0.98999999999999999 111.844 177.177 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 3' ' ' ASN . . . . . 0.417 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 9.2 m120 -140.23 168.71 19.17 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 129.303 3.041 . . . . 0.80000000000000004 111.7 -172.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -95.11 96.8 9.48 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 126.677 1.991 . . . . 3.3999999999999999 112.233 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.62 17.26 3.55 Favored Glycine 0 C--N 1.368 2.329 0 O-C-N 119.922 -1.736 . . . . 0.53000000000000003 113.145 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 6' ' ' ASP . . . . . 0.435 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 53.8 t0 -90.84 143.04 27.13 Favored 'General case' 0 N--CA 1.411 -2.375 1 C-N-CA 131.8 4.04 . . . . 0.45000000000000001 109.325 -178.342 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 7' ' ' LYS . . . . . 0.582 ' H ' ' HB3' ' E' ' 69' ' ' GLN . 63.7 mmtt -92.9 82.23 4.66 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 104.966 -2.235 . . . . 2.0299999999999998 104.966 173.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 8' ' ' VAL . . . . . 0.503 HG11 HD22 ' E' ' 2' ' ' LEU . 15.6 m -88.43 133.56 30.5 Favored 'Isoleucine or valine' 0 C--N 1.359 1.015 0 N-CA-C 105.078 -2.193 . . . . 0.13 105.078 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -91.71 110.38 21.71 Favored 'General case' 0 CA--C 1.502 -0.887 0 O-C-N 121.237 -0.915 . . . . 0.17000000000000001 111.354 -174.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.539 HG23 ' CE2' ' E' ' 60' ' ' PHE . 5.4 mm -53.37 107.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.503 0 N-CA-C 119.839 3.274 . . . . 0.12 119.839 175.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 11' ' ' LYS . . . . . 0.4 ' HA ' ' CE1' ' E' ' 18' ' ' TYR . 13.8 mtmm -119.02 49.77 1.29 Allowed 'General case' 0 C--N 1.379 1.887 0 C-N-CA 127.163 2.185 . . . . 0.29999999999999999 111.485 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -76.49 -118.54 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 120.178 3.399 . . . . 2.0899999999999999 120.178 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 3.5 m -150.55 -49.09 0.13 Allowed 'General case' 0 C--N 1.358 0.938 0 O-C-N 120.258 -1.526 . . . . 0.46999999999999997 108.553 -176.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -85.59 89.94 7.86 Favored 'General case' 0 C--N 1.363 1.167 0 N-CA-C 115.509 1.67 . . . . 1.8899999999999999 115.509 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 15' ' ' SER . . . . . 0.419 ' HA ' ' HB3' ' E' ' 18' ' ' TYR 0.285 1.4 m -53.68 28.96 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 1 N-CA-C 121.989 4.07 . . . . 1.1299999999999999 121.989 179.968 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.45 -51.26 4.42 Favored 'General case' 0 C--N 1.352 0.691 1 C-N-CA 131.788 4.035 . . . . 0.79000000000000004 102.274 163.284 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 17' ' ' TRP . . . . . 0.412 ' O ' HG21 ' E' ' 10' ' ' ILE . 15.8 m0 -114.97 35.15 4.45 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.66 1.584 . . . . 0.75 111.186 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 18' ' ' TYR . . . . . 0.419 ' HB3' ' HA ' ' E' ' 15' ' ' SER . 1.2 t80 -139.42 133.82 31.54 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 106.418 -1.697 . . . . 0.40000000000000002 106.418 175.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.3 46.75 1.52 Allowed Glycine 0 C--N 1.358 1.779 0 C-N-CA 127.202 2.334 . . . . 0.39000000000000001 109.449 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -168.72 176.24 5.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.363 -1.717 . . . . 1.3999999999999999 106.363 -171.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 p -109.57 175.9 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 127.579 2.352 . . . . 0.31 108.348 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.79 169.49 41.48 Favored Glycine 0 CA--C 1.476 -2.381 0 N-CA-C 108.231 -1.948 . . . . 0.20999999999999999 108.231 173.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 10.9 m -97.72 114.75 26.82 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 125.727 1.611 . . . . 0.27000000000000002 110.587 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 12.3 p -76.35 86.84 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-O 125.974 2.797 . . . . 0.28999999999999998 112.097 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -94.72 57.4 2.17 Favored 'General case' 0 C--O 1.225 -0.213 0 O-C-N 119.172 -2.205 . . . . 0.28999999999999998 108.995 175.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 26' ' ' SER . . . . . 0.439 ' HB3' ' HA ' ' E' ' 36' ' ' VAL . 10.6 p -79.76 -81.45 0.12 Allowed 'General case' 0 CA--C 1.495 -1.165 1 C-N-CA 134.67 5.188 . . . . 0.63 118.705 -168.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 27' ' ' VAL . . . . . 0.406 HG12 ' H ' ' E' ' 27' ' ' VAL . 5.7 p -83.82 59.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 128.976 2.91 . . . . 0.60999999999999999 111.51 -169.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -145.71 -50.88 0.24 Allowed 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 127.329 2.252 . . . . 1.6100000000000001 106.4 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -105.42 -22.93 12.92 Favored 'General case' 0 C--N 1.37 1.483 0 C-N-CA 127.748 2.419 . . . . 3.96 113.45 175.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 58.8 m -68.35 55.81 0.08 Allowed 'General case' 0 C--N 1.378 1.824 0 C-N-CA 128.698 2.799 . . . . 4.3399999999999999 117.831 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.71 32.88 5.91 Favored Glycine 0 C--O 1.222 -0.6 1 C-N-CA 131.608 4.432 . . . . 1.76 111.197 162.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 2.3 mt -112.19 -136.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.577 0 C-N-CA 129.014 2.925 . . . . 1.1100000000000001 107.405 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 12.5 tp -90.57 -69.45 0.73 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 128.731 2.812 . . . . 0.56999999999999995 112.822 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -96.94 156.99 35.79 Favored Pre-proline 0 C--N 1.372 1.571 0 O-C-N 120.185 -1.572 . . . . 0.93999999999999995 110.809 -175.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.82 -51.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 123.809 3.006 . . . . 0.67000000000000004 116.595 -170.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 36' ' ' VAL . . . . . 0.591 HG12 HG23 ' E' ' 38' ' ' VAL . 95.2 t -79.48 110.28 15.0 Favored 'Isoleucine or valine' 0 C--N 1.348 0.504 0 C-N-CA 129.426 3.09 . . . . 0.64000000000000001 113.068 -170.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 70.5 mt -107.81 97.55 5.83 Favored 'Isoleucine or valine' 0 C--N 1.372 1.578 0 N-CA-C 104.403 -2.443 . . . . 0.65000000000000002 104.403 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 38' ' ' VAL . . . . . 0.591 HG23 HG12 ' E' ' 36' ' ' VAL . 37.8 t -107.38 141.88 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 O-C-N 120.497 -1.377 . . . . 0.23000000000000001 114.125 -167.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 39' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -69.95 144.83 52.26 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 128.448 2.699 . . . . 2.75 114.189 174.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 40' ' ' PHE . . . . . 0.444 ' CE1' HG12 ' E' ' 38' ' ' VAL . 84.8 m-85 -153.52 166.98 31.01 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 106.37 -1.715 . . . . 1.26 106.37 171.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -106.38 -27.92 10.68 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 129.357 3.063 . . . . 1.02 108.888 165.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -75.77 45.18 0.32 Allowed 'General case' 0 C--N 1.371 1.536 0 C-N-CA 127.359 2.264 . . . . 1.29 115.169 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 8.7 m -91.81 176.83 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 123.877 1.798 . . . . 1.23 110.628 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -85.13 65.01 9.01 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 119.016 -2.302 . . . . 2.0499999999999998 112.534 -177.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -64.18 60.67 0.02 OUTLIER 'General case' 0 C--N 1.349 0.554 1 C-N-CA 132.039 4.135 . . . . 2.52 115.828 176.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -101.82 26.63 7.25 Favored 'General case' 0 C--N 1.361 1.075 0 C-N-CA 128.441 2.696 . . . . 4.1600000000000001 108.053 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.15 128.55 9.61 Favored Glycine 0 C--N 1.357 1.749 0 C-N-CA 125.891 1.71 . . . . 5.3300000000000001 111.876 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -94.32 6.83 47.48 Favored 'General case' 0 C--N 1.367 1.353 0 CA-C-O 125.433 2.54 . . . . 5.0899999999999999 112.412 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 4.7 p -103.4 -59.78 1.66 Allowed 'General case' 0 N--CA 1.452 -0.373 1 C-N-CA 134.279 5.032 . . . . 7.1799999999999997 106.575 173.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.45 -73.99 0.16 Allowed Glycine 0 C--N 1.348 1.204 0 C-N-CA 127.04 2.257 . . . . 6.5099999999999998 108.201 173.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 15.8 m -102.08 92.79 4.92 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 125.622 1.569 . . . . 7.2000000000000002 113.709 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -98.42 -59.11 1.81 Allowed 'General case' 0 C--N 1.355 0.81 0 CA-C-O 123.525 1.631 . . . . 5.0800000000000001 110.902 174.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 17.7 p -118.64 19.54 13.2 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.804 1.242 . . . . 3.8599999999999999 109.97 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.41 97.18 0.93 Allowed Glycine 0 C--N 1.357 1.735 0 C-N-CA 124.807 1.194 . . . . 2.8500000000000001 113.926 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 34.2 m -93.15 111.73 25.16 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 C-N-CA 130.185 3.394 . . . . 1.72 107.25 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -86.03 27.55 0.89 Allowed 'General case' 0 C--N 1.352 0.701 0 O-C-N 119.193 -2.192 . . . . 2.2000000000000002 114.092 -170.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 2.8 p -150.83 149.33 29.58 Favored 'General case' 0 C--N 1.356 0.874 1 C-N-CA 133.708 4.803 . . . . 0.46999999999999997 107.371 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . 0.323 0.7 OUTLIER -159.31 168.41 26.48 Favored 'General case' 0 C--N 1.364 1.225 0 CA-C-N 121.606 2.003 . . . . 1.5700000000000001 108.351 170.422 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -97.75 113.28 25.02 Favored 'General case' 0 C--N 1.363 1.175 0 C-N-CA 126.736 2.014 . . . . 2.0699999999999998 116.225 -172.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 60' ' ' PHE . . . . . 0.539 ' CE2' HG23 ' E' ' 10' ' ' ILE . 16.1 m-85 -118.16 170.22 9.05 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 127.529 2.332 . . . . 0.17000000000000001 113.243 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.34 113.27 19.17 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.992 2.117 . . . . 0.17000000000000001 112.231 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -26.54 -18.08 0.0 OUTLIER 'General case' 0 C--N 1.371 1.532 1 C-N-CA 134.652 5.181 . . . . 1.72 121.309 174.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -59.39 -49.19 78.76 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 131.418 3.887 . . . . 0.17000000000000001 111.887 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -94.44 12.54 26.83 Favored 'General case' 0 C--N 1.361 1.107 0 CA-C-N 114.598 -1.183 . . . . 1.1799999999999999 112.836 -170.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . 0.261 1.0 OUTLIER -120.91 119.15 31.77 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 127.723 2.409 . . . . 0.19 114.209 -177.601 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -111.03 136.47 49.99 Favored 'General case' 0 C--N 1.362 1.129 0 O-C-N 120.958 -1.089 . . . . 2.0499999999999998 111.482 171.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.69 140.51 51.14 Favored 'General case' 0 C--N 1.365 1.268 0 C-N-CA 130.84 3.656 . . . . 0.28999999999999998 120.096 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . 0.255 2.0 t -139.78 -33.95 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.373 1.593 0 C-N-CA 126.728 2.011 . . . . 0.72999999999999998 114.092 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 69' ' ' GLN . . . . . 0.582 ' HB3' ' H ' ' E' ' 7' ' ' LYS . 16.6 tt0 -112.53 104.81 12.92 Favored 'General case' 0 C--N 1.361 1.087 0 O-C-N 119.887 -1.758 . . . . 2.1899999999999999 109.585 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.77 62.52 0.07 Allowed 'General case' 0 C--N 1.349 0.546 0 C-N-CA 127.909 2.484 . . . . 0.0 114.808 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.05 67.67 9.76 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 128.939 2.896 . . . . 0.0 109.514 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.24 47.65 0.02 OUTLIER 'General case' 0 C--N 1.362 1.128 0 C-N-CA 130.201 3.401 . . . . 0.0 116.835 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 25.4 tptp . . . . . 0 N--CA 1.42 -1.944 1 C-N-CA 133.582 4.753 . . . . 0.0 104.878 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.804 0 N-CA-C 108.131 -1.063 . . . . 2.1299999999999999 108.131 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' E' E ' 2' ' ' LEU . . . . . 0.504 HD13 ' H ' ' E' ' 2' ' ' LEU 0.31 0.0 OUTLIER -79.93 -169.19 1.9 Allowed 'General case' 0 C--N 1.357 0.924 0 N-CA-C 119.794 3.257 . . . . 0.98999999999999999 119.794 -176.878 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' E' E ' 3' ' ' ASN . . . . . 0.407 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 0.0 OUTLIER -150.49 177.86 9.6 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 125.633 1.573 . . . . 0.80000000000000004 110.805 -170.043 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 23.3 ptt-85 -65.88 67.85 0.05 OUTLIER 'General case' 0 C--N 1.365 1.249 1 C-N-CA 132.816 4.446 . . . . 3.3999999999999999 119.515 -174.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 125.38 25.38 1.46 Allowed Glycine 0 CA--C 1.491 -1.463 0 C-N-CA 126.72 2.105 . . . . 0.53000000000000003 111.942 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 6' ' ' ASP . . . . . 0.505 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 20.8 t0 -71.04 129.88 40.13 Favored 'General case' 0 C--N 1.367 1.353 0 C-N-CA 125.302 1.441 . . . . 0.45000000000000001 111.553 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 7' ' ' LYS . . . . . 0.493 ' H ' ' CB ' ' E' ' 69' ' ' GLN . 31.6 mtmm -89.01 85.85 6.8 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 102.99 -2.967 . . . . 2.0299999999999998 102.99 171.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 8' ' ' VAL . . . . . 0.46 HG21 HD12 ' E' ' 65' ' ' LEU . 1.5 m -89.68 138.48 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 127.638 2.375 . . . . 0.13 106.323 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 9' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' E' ' 21' ' ' VAL . 1.5 tmt_? -101.5 86.1 2.9 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 121.438 -0.789 . . . . 0.17000000000000001 111.677 -174.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.718 HD11 HG11 ' E' ' 38' ' ' VAL . 1.1 mm -41.4 121.49 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.713 0 N-CA-C 120.751 3.611 . . . . 0.12 120.751 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -118.84 37.81 3.98 Favored 'General case' 0 C--N 1.373 1.609 0 C-N-CA 126.868 2.067 . . . . 0.29999999999999999 111.301 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.66 127.3 42.51 Favored 'General case' 0 C--N 1.365 1.255 0 C-N-CA 130.402 3.481 . . . . 2.0899999999999999 110.028 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 25.0 p -76.8 -55.95 5.04 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 129.585 3.154 . . . . 0.46999999999999997 113.819 -174.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -78.56 68.68 4.6 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 129.79 3.236 . . . . 1.8899999999999999 110.55 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 46.9 t -163.42 167.5 21.53 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 127.844 2.458 . . . . 1.1299999999999999 104.426 -175.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -94.37 -9.23 36.44 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 127.914 2.485 . . . . 0.79000000000000004 111.521 175.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -125.83 45.19 2.67 Favored 'General case' 0 C--N 1.366 1.287 0 O-C-N 120.703 -1.248 . . . . 0.75 111.879 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -71.83 107.31 4.54 Favored 'General case' 0 C--N 1.367 1.329 0 C-N-CA 127.453 2.301 . . . . 0.40000000000000002 111.062 175.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.73 46.71 4.77 Favored Glycine 0 C--N 1.363 2.054 0 CA-C-O 122.196 0.887 . . . . 0.39000000000000001 111.995 -175.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -143.51 166.0 26.01 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 125.346 1.458 . . . . 1.3999999999999999 107.194 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 21' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' E' ' 9' ' ' ARG . 0.4 OUTLIER -103.37 170.45 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.565 0 C-N-CA 126.357 1.863 . . . . 0.31 110.116 178.506 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.39 161.86 26.13 Favored Glycine 0 CA--C 1.483 -1.915 0 O-C-N 121.228 -0.92 . . . . 0.20999999999999999 111.924 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 23' ' ' THR . . . . . 0.418 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 12.8 m -94.98 135.26 36.72 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 128.359 2.664 . . . . 0.27000000000000002 115.959 -175.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 25.3 t -66.86 91.78 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.501 0 CA-C-O 124.711 2.196 . . . . 0.28999999999999998 116.308 170.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -99.35 15.8 25.1 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 130.737 3.615 . . . . 0.28999999999999998 108.777 170.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 26' ' ' SER . . . . . 0.545 ' HA ' ' HB ' ' E' ' 37' ' ' ILE . 0.9 OUTLIER -77.18 -15.02 59.68 Favored 'General case' 0 CA--C 1.48 -1.738 1 C-N-CA 135.391 5.476 . . . . 0.63 118.632 -176.947 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 24.8 t -86.18 59.72 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.495 0 CA-C-O 125.428 2.537 . . . . 0.60999999999999999 108.982 -173.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 28' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' E' ' 29' ' ' LYS . 3.1 pt-20 -145.13 -100.66 0.1 Allowed 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 111.262 -2.699 . . . . 1.6100000000000001 107.695 -174.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 29' ' ' LYS . . . . . 0.414 ' H ' ' HG3' ' E' ' 28' ' ' GLU . 38.1 mmtt -87.31 25.65 1.36 Allowed 'General case' 0 N--CA 1.437 -1.116 1 C-N-CA 132.032 4.133 . . . . 3.96 115.303 -176.297 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.08 -1.05 0.84 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 131.128 3.771 . . . . 4.3399999999999999 117.255 176.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.91 44.02 3.26 Favored Glycine 0 C--N 1.355 1.591 0 C-N-CA 128.472 2.939 . . . . 1.76 114.491 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 32' ' ' ILE . . . . . 0.529 HG22 ' H ' ' E' ' 33' ' ' LEU . 0.3 OUTLIER -137.5 -172.16 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.061 0 C-N-CA 128.072 2.549 . . . . 1.1100000000000001 109.538 -178.844 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 33' ' ' LEU . . . . . 0.529 ' H ' HG22 ' E' ' 32' ' ' ILE . 41.1 tp -82.87 -22.73 33.92 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 131.432 3.893 . . . . 0.56999999999999995 111.913 178.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -118.24 91.04 39.67 Favored Pre-proline 0 C--N 1.35 0.603 0 N-CA-C 103.286 -2.857 . . . . 0.93999999999999995 103.286 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.64 -31.25 0.46 Allowed 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 124.919 3.746 . . . . 0.67000000000000004 116.675 -170.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 36' ' ' VAL . . . . . 0.497 HG21 HD11 ' E' ' 2' ' ' LEU 0.265 75.3 t -96.91 98.38 7.46 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 C-N-CA 127.232 2.213 . . . . 0.64000000000000001 116.403 -166.759 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 37' ' ' ILE . . . . . 0.545 ' HB ' ' HA ' ' E' ' 26' ' ' SER . 3.8 mp -87.51 117.03 30.71 Favored 'Isoleucine or valine' 0 C--N 1.362 1.145 0 C-N-CA 128.11 2.564 . . . . 0.65000000000000002 105.557 174.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 38' ' ' VAL . . . . . 0.718 HG11 HD11 ' E' ' 10' ' ' ILE . 53.0 t -125.36 156.58 34.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.451 0 CA-C-N 119.424 1.011 . . . . 0.23000000000000001 111.276 -173.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 39' ' ' ARG . . . . . 0.418 ' HB3' ' H ' ' E' ' 23' ' ' THR . 36.5 ttm-85 -82.39 156.75 24.01 Favored 'General case' 0 C--N 1.365 1.272 0 C-N-CA 130.661 3.584 . . . . 2.75 110.888 175.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 40' ' ' PHE . . . . . 0.42 ' HE1' HG13 ' E' ' 10' ' ' ILE . 33.2 m-85 -151.01 -178.81 6.82 Favored 'General case' 0 CA--C 1.513 -0.462 0 O-C-N 119.467 -2.02 . . . . 1.26 106.953 174.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -98.62 -39.37 8.73 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 127.077 2.151 . . . . 1.02 114.948 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . 0.269 20.8 mtm180 -69.18 -86.37 0.02 OUTLIER 'General case' 0 C--N 1.37 1.49 0 N-CA-C 121.602 3.927 . . . . 1.29 121.602 -170.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . 0.341 4.7 p -84.47 76.38 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.367 1.327 0 CA-C-O 127.15 3.357 . . . . 1.23 108.757 -176.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -162.62 -39.4 0.04 OUTLIER 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 108.431 -3.986 . . . . 2.0499999999999998 106.54 -158.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . 0.305 0.1 OUTLIER -77.69 -121.53 0.01 OUTLIER 'General case' 0 C--N 1.375 1.679 0 N-CA-C 117.859 2.54 . . . . 2.52 117.859 -177.442 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -89.17 116.57 27.52 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 117.173 2.286 . . . . 4.1600000000000001 117.173 -169.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.53 52.29 3.09 Favored Glycine 0 C--N 1.37 2.465 0 C-N-CA 127.584 2.516 . . . . 5.3300000000000001 118.961 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -131.07 17.4 5.06 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-O 124.385 2.04 . . . . 5.0899999999999999 111.321 -176.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 37.7 t -102.7 -8.18 21.09 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 128.923 2.889 . . . . 7.1799999999999997 111.756 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 117.49 -147.93 18.76 Favored Glycine 0 C--N 1.351 1.416 1 N-CA-C 102.656 -4.177 . . . . 6.5099999999999998 102.656 -162.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 32.3 m -75.25 64.38 1.46 Allowed 'General case' 0 C--N 1.354 0.801 0 N-CA-C 116.337 1.977 . . . . 7.2000000000000002 116.337 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.17 -1.56 58.14 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 125.888 1.675 . . . . 5.0800000000000001 113.604 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 24.1 t -106.38 49.29 0.81 Allowed 'General case' 0 C--N 1.357 0.929 0 C-N-CA 127.6 2.36 . . . . 3.8599999999999999 108.248 173.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.8 -104.17 2.45 Favored Glycine 0 C--N 1.361 1.96 0 C-N-CA 127.061 2.267 . . . . 2.8500000000000001 114.271 -174.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -113.65 129.7 69.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 C-N-CA 124.353 1.061 . . . . 1.72 109.479 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -105.34 -42.2 5.32 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.506 1.523 . . . . 2.2000000000000002 112.432 173.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 57' ' ' THR . . . . . 0.428 ' HB ' HG23 ' E' ' 37' ' ' ILE . 40.2 p -86.61 106.83 17.85 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 125.899 1.68 . . . . 0.46999999999999997 113.99 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.61 132.66 47.16 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 128.695 2.798 . . . . 1.5700000000000001 106.283 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -100.31 103.38 14.8 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 124.829 1.252 . . . . 2.0699999999999998 109.639 -178.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 60' ' ' PHE . . . . . 0.5 ' CB ' HD21 ' E' ' 65' ' ' LEU . 24.4 m-85 -98.78 169.27 9.59 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 126.791 2.036 . . . . 0.17000000000000001 116.267 -174.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -102.86 101.86 11.93 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.857 2.463 . . . . 0.17000000000000001 110.717 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -18.72 -29.65 0.0 OUTLIER 'General case' 0 C--N 1.373 1.624 1 C-N-CA 135.135 5.374 . . . . 1.72 120.914 173.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -56.68 -42.67 79.44 Favored 'General case' 0 C--N 1.369 1.449 0 C-N-CA 128.212 2.605 . . . . 0.17000000000000001 111.777 167.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -85.43 -7.48 58.9 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.126 -1.397 . . . . 1.1799999999999999 111.848 -171.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.5 HD21 ' CB ' ' E' ' 60' ' ' PHE . 0.2 OUTLIER -100.46 109.47 21.61 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 120.882 -1.136 . . . . 0.19 110.568 178.504 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -90.7 128.63 36.72 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 123.659 0.784 . . . . 2.0499999999999998 112.407 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.62 137.35 57.78 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 120.542 3.534 . . . . 0.28999999999999998 120.542 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.79 -42.68 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.371 1.504 0 C-N-CA 125.738 1.615 . . . . 0.72999999999999998 111.342 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 69' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 0.0 OUTLIER -112.12 97.54 6.72 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 126.504 1.922 . . . . 2.1899999999999999 114.134 -175.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.67 57.93 0.09 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.404 2.682 . . . . 0.0 114.804 175.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.76 53.45 0.45 Allowed 'General case' 0 C--N 1.353 0.734 0 C-N-CA 129.309 3.044 . . . . 0.0 116.475 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -100.09 94.51 6.29 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 127.556 2.342 . . . . 0.0 109.367 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt . . . . . 0 C--O 1.259 1.564 0 C-N-CA 125.502 1.521 . . . . 0.0 109.236 179.943 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.52 -0.548 . . . . 2.1299999999999999 109.52 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' E' E ' 2' ' ' LEU . . . . . 0.446 ' HB2' ' H ' ' E' ' 3' ' ' ASN . 0.0 OUTLIER -82.96 -158.08 0.26 Allowed 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 128.003 2.521 . . . . 0.98999999999999999 115.967 -179.631 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 3' ' ' ASN . . . . . 0.446 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 75.0 m-80 -122.02 -173.8 2.74 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 128.658 2.783 . . . . 0.80000000000000004 114.046 -170.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.92 104.86 17.24 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 128.638 2.775 . . . . 3.3999999999999999 111.757 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.99 -3.64 22.59 Favored Glycine 0 C--N 1.353 1.494 0 O-C-N 119.984 -1.698 . . . . 0.53000000000000003 111.896 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 6' ' ' ASP . . . . . 0.508 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 3.6 t0 -77.85 72.02 4.36 Favored 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 130.529 3.531 . . . . 0.45000000000000001 114.115 -174.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 7' ' ' LYS . . . . . 0.408 ' H ' ' HG3' ' E' ' 7' ' ' LYS . 23.2 mtpp -35.97 87.64 0.0 OUTLIER 'General case' 0 C--N 1.351 0.64 1 C-N-CA 132.78 4.432 . . . . 2.0299999999999998 114.743 177.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 8' ' ' VAL . . . . . 0.428 HG22 ' H ' ' E' ' 8' ' ' VAL . 0.0 OUTLIER -86.96 137.76 20.3 Favored 'Isoleucine or valine' 0 C--N 1.361 1.092 0 N-CA-C 107.102 -1.444 . . . . 0.13 107.102 -172.563 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -96.52 87.78 4.5 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 115.813 1.783 . . . . 0.17000000000000001 115.813 -170.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.531 HD13 ' H ' ' E' ' 10' ' ' ILE . 0.9 OUTLIER -26.4 98.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 N-CA-C 119.517 3.154 . . . . 0.12 119.517 173.161 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -113.43 43.57 1.73 Allowed 'General case' 0 C--N 1.366 1.311 0 O-C-N 120.115 -1.615 . . . . 0.29999999999999999 113.261 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.79 137.16 39.55 Favored 'General case' 0 C--N 1.366 1.286 0 C-N-CA 125.902 1.681 . . . . 2.0899999999999999 111.006 174.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 22.3 p -73.02 -58.01 3.62 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 128.491 2.716 . . . . 0.46999999999999997 114.516 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -76.02 64.33 1.9 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 127.945 2.498 . . . . 1.8899999999999999 114.929 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 27.1 t -167.69 176.78 6.19 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 126.531 1.932 . . . . 1.1299999999999999 105.868 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -93.5 0.33 56.66 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 128.612 2.765 . . . . 0.79000000000000004 111.607 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -117.28 25.54 10.38 Favored 'General case' 0 C--N 1.36 1.034 0 O-C-N 120.48 -1.388 . . . . 0.75 113.807 -172.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -70.04 108.94 4.29 Favored 'General case' 0 C--N 1.368 1.377 0 C-N-CA 126.338 1.855 . . . . 0.40000000000000002 114.228 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.66 30.36 18.65 Favored Glycine 0 C--N 1.366 2.206 0 CA-C-O 121.538 0.521 . . . . 0.39000000000000001 112.218 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -121.02 173.28 7.36 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 126.807 2.043 . . . . 1.3999999999999999 105.751 177.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.59 175.75 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 C-N-CA 125.613 1.565 . . . . 0.31 110.042 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.07 175.21 40.22 Favored Glycine 0 CA--C 1.479 -2.211 1 N-CA-C 101.314 -4.714 . . . . 0.20999999999999999 101.314 165.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 23' ' ' THR . . . . . 0.622 ' H ' ' HB2' ' E' ' 39' ' ' ARG . 11.1 m -96.39 141.28 29.89 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 126.131 1.772 . . . . 0.27000000000000002 108.666 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 p -79.76 112.76 18.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 124.776 2.227 . . . . 0.28999999999999998 109.043 166.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.14 31.8 6.18 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 111.134 -2.757 . . . . 0.28999999999999998 108.573 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 26' ' ' SER . . . . . 0.505 ' CB ' ' H ' ' E' ' 37' ' ' ILE . 0.3 OUTLIER -86.62 -39.99 15.58 Favored 'General case' 0 CA--C 1.49 -1.329 0 C-N-CA 126.727 2.011 . . . . 0.63 115.874 178.544 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . 0.259 0.3 OUTLIER -83.23 70.21 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.915 0 CA-C-O 127.888 3.709 . . . . 0.60999999999999999 110.842 -172.133 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -161.2 -54.32 0.05 OUTLIER 'General case' 0 N--CA 1.424 -1.752 1 CA-C-N 107.896 -4.229 . . . . 1.6100000000000001 105.595 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp -109.43 -22.98 11.76 Favored 'General case' 0 C--N 1.364 1.228 0 N-CA-C 116.868 2.173 . . . . 3.96 116.868 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -22.26 -15.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 2 C-N-CA 138.626 6.77 . . . . 4.3399999999999999 122.629 -168.59 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.51 43.37 2.74 Favored Glycine 0 C--N 1.338 0.685 1 C-N-CA 130.906 4.098 . . . . 1.76 115.757 -175.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.23 -170.18 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.752 0 C-N-CA 126.758 2.023 . . . . 1.1100000000000001 110.806 -177.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 46.6 tp -68.89 -30.87 69.45 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 128.639 2.776 . . . . 0.56999999999999995 114.965 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -108.06 117.96 53.78 Favored Pre-proline 0 C--N 1.36 1.033 0 N-CA-C 103.838 -2.653 . . . . 0.93999999999999995 103.838 175.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -75.14 -39.58 1.12 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.475 3.45 . . . . 0.67000000000000004 113.584 -167.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 36' ' ' VAL . . . . . 0.608 HG12 HG23 ' E' ' 38' ' ' VAL . 62.3 t -109.62 115.17 48.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.708 0 C-N-CA 125.681 1.592 . . . . 0.64000000000000001 112.881 -177.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 37' ' ' ILE . . . . . 0.505 ' H ' ' CB ' ' E' ' 26' ' ' SER . 6.5 mt -88.87 128.07 41.25 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 C-N-CA 127.091 2.156 . . . . 0.65000000000000002 105.273 166.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 38' ' ' VAL . . . . . 0.608 HG23 HG12 ' E' ' 36' ' ' VAL . 24.8 t -122.98 150.17 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 O-C-N 120.343 -1.473 . . . . 0.23000000000000001 109.041 -178.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 39' ' ' ARG . . . . . 0.622 ' HB2' ' H ' ' E' ' 23' ' ' THR . 42.5 mtp180 -74.28 168.62 19.28 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 127.34 2.256 . . . . 2.75 111.322 172.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . 0.25 21.4 m-85 -139.66 123.83 17.88 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 124.269 1.985 . . . . 1.26 111.329 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -54.37 -43.8 71.66 Favored 'General case' 0 N--CA 1.439 -1.0 1 C-N-CA 137.565 6.346 . . . . 1.02 119.109 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 46.6 mtm105 -131.9 93.61 3.33 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 107.486 -1.302 . . . . 1.29 107.486 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 t -78.67 71.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.418 0 CA-C-O 125.33 2.491 . . . . 1.23 109.912 174.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -139.57 40.69 2.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 128.214 2.606 . . . . 2.0499999999999998 106.934 -170.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -125.94 54.74 1.5 Allowed 'General case' 0 C--N 1.35 0.591 0 C-N-CA 127.977 2.511 . . . . 2.52 105.347 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -48.94 70.73 0.0 OUTLIER 'General case' 0 C--N 1.361 1.086 1 C-N-CA 132.162 4.185 . . . . 4.1600000000000001 121.554 -172.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 47' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' E' ' 52' ' ' ALA . . . -81.17 75.85 2.24 Favored Glycine 0 C--N 1.358 1.775 0 C-N-CA 128.243 2.83 . . . . 5.3300000000000001 109.059 160.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -86.54 16.38 4.67 Favored 'General case' 0 C--N 1.364 1.214 0 C-N-CA 128.122 2.569 . . . . 5.0899999999999999 115.458 -173.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 9.2 t -96.31 -0.77 49.11 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 130.691 3.596 . . . . 7.1799999999999997 110.656 175.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.28 10.52 51.11 Favored Glycine 0 C--N 1.36 1.9 0 C-N-CA 125.661 1.601 . . . . 6.5099999999999998 114.68 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 53.4 p -104.0 -63.89 1.15 Allowed 'General case' 0 C--N 1.355 0.826 0 C-N-CA 125.773 1.629 . . . . 7.2000000000000002 113.87 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 52' ' ' ALA . . . . . 0.444 ' HB3' ' HA3' ' E' ' 47' ' ' GLY . . . -92.48 -17.9 23.91 Favored 'General case' 0 C--N 1.367 1.355 0 N-CA-C 117.421 2.378 . . . . 5.0800000000000001 117.421 -173.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 3.3 m -95.95 21.9 8.1 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 119.864 -1.772 . . . . 3.8599999999999999 113.547 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.93 3.1 27.21 Favored Glycine 0 C--N 1.356 1.681 0 C-N-CA 127.069 2.271 . . . . 2.8500000000000001 110.867 170.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.24 109.15 25.55 Favored 'Isoleucine or valine' 0 C--N 1.362 1.142 0 CA-C-O 123.612 1.673 . . . . 1.72 112.365 -177.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -101.11 -37.71 8.46 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 130.026 3.33 . . . . 2.2000000000000002 109.065 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 12.2 p -125.67 123.46 39.0 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 130.747 3.619 . . . . 0.46999999999999997 109.592 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -116.83 151.78 35.8 Favored 'General case' 0 C--N 1.365 1.246 0 C-N-CA 126.714 2.005 . . . . 1.5700000000000001 109.887 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -78.28 129.37 34.97 Favored 'General case' 0 C--N 1.364 1.227 0 C-N-CA 126.386 1.874 . . . . 2.0699999999999998 112.56 176.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 60' ' ' PHE . . . . . 0.522 ' HE2' HD12 ' E' ' 10' ' ' ILE . 0.2 OUTLIER -127.78 169.6 13.68 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 117.177 2.288 . . . . 0.17000000000000001 117.177 -177.163 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.87 88.2 2.77 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 110.129 -3.214 . . . . 0.17000000000000001 111.693 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -18.25 -24.77 0.0 OUTLIER 'General case' 0 C--N 1.355 0.811 1 C-N-CA 136.276 5.83 . . . . 1.72 120.377 171.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.03 -34.14 71.56 Favored 'General case' 0 C--N 1.371 1.531 0 C-N-CA 129.615 3.166 . . . . 0.17000000000000001 113.856 167.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.37 17.46 21.43 Favored 'General case' 0 C--N 1.368 1.378 0 C-N-CA 125.92 1.688 . . . . 1.1799999999999999 110.738 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.478 HD13 HG11 ' E' ' 36' ' ' VAL . 74.0 mt -128.27 113.44 15.65 Favored 'General case' 0 C--N 1.363 1.156 0 N-CA-C 115.301 1.593 . . . . 0.19 115.301 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -100.46 129.83 46.46 Favored 'General case' 0 C--N 1.363 1.166 0 C-N-CA 124.837 1.255 . . . . 2.0499999999999998 111.731 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.1 128.24 35.99 Favored 'General case' 0 C--N 1.368 1.397 0 C-N-CA 130.255 3.422 . . . . 0.28999999999999998 116.49 172.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.3 -28.98 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.167 0 CA-C-N 120.639 1.563 . . . . 0.72999999999999998 113.607 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 69' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 3.5 tp-100 -104.48 138.06 41.42 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 125.32 2.486 . . . . 2.1899999999999999 114.342 -175.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.01 57.94 4.57 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 128.918 2.887 . . . . 0.0 111.528 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.13 52.55 0.9 Allowed 'General case' 0 C--N 1.362 1.113 0 C-N-CA 126.369 1.868 . . . . 0.0 108.989 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.85 146.81 25.57 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 126.062 1.745 . . . . 0.0 110.928 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt . . . . . 0 C--O 1.261 1.686 0 C-N-CA 125.839 1.656 . . . . 0.0 108.548 177.059 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.009 0 N-CA-C 109.553 -0.536 . . . . 2.1299999999999999 109.553 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' E' E ' 2' ' ' LEU . . . . . 0.401 ' HB2' ' H ' ' E' ' 3' ' ' ASN 0.318 2.5 pp -102.69 -147.25 0.37 Allowed 'General case' 0 C--N 1.355 0.828 0 C-N-CA 126.534 1.934 . . . . 0.98999999999999999 114.344 -179.334 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 3' ' ' ASN . . . . . 0.401 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 1.5 m120 -143.82 173.39 11.73 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 130.56 3.544 . . . . 0.80000000000000004 110.753 -176.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -95.62 109.71 21.92 Favored 'General case' 0 C--N 1.367 1.356 0 C-N-CA 127.703 2.401 . . . . 3.3999999999999999 112.815 175.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.61 14.34 41.08 Favored Glycine 0 CA--C 1.473 -2.535 0 O-C-N 119.474 -2.016 . . . . 0.53000000000000003 114.016 172.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 6' ' ' ASP . . . . . 0.52 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 19.8 t0 -84.02 146.96 27.68 Favored 'General case' 0 N--CA 1.421 -1.884 1 C-N-CA 132.106 4.162 . . . . 0.45000000000000001 105.559 178.019 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -93.65 89.82 6.37 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 105.283 -2.118 . . . . 2.0299999999999998 105.283 173.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 8' ' ' VAL . . . . . 0.421 HG22 ' H ' ' E' ' 8' ' ' VAL . 5.4 m -86.33 142.85 12.53 Favored 'Isoleucine or valine' 0 C--N 1.366 1.31 0 N-CA-C 107.652 -1.24 . . . . 0.13 107.652 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -96.64 100.92 12.46 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 117.103 2.26 . . . . 0.17000000000000001 117.103 -169.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.528 HG23 ' CE2' ' E' ' 60' ' ' PHE . 1.8 mm -38.33 97.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.575 1.909 0 C-N-CA 129.46 3.104 . . . . 0.12 119.07 171.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -117.1 45.33 1.9 Allowed 'General case' 0 C--N 1.372 1.583 0 O-C-N 118.642 -2.536 . . . . 0.29999999999999999 111.969 -175.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 12' ' ' ARG . . . . . 0.463 ' HD2' ' CE1' ' E' ' 60' ' ' PHE . 10.1 ptm180 -99.68 128.35 45.78 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 128.4 2.68 . . . . 2.0899999999999999 107.995 175.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 24.6 p -70.74 -62.18 1.49 Allowed 'General case' 0 C--N 1.359 0.989 0 C-N-CA 130.194 3.398 . . . . 0.46999999999999997 114.088 -175.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.71 72.15 0.52 Allowed 'General case' 0 C--N 1.362 1.129 0 C-N-CA 130.636 3.574 . . . . 1.8899999999999999 110.26 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 3.7 t -156.71 172.77 18.02 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 124.802 2.239 . . . . 1.1299999999999999 111.091 -170.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -97.02 -17.81 19.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 130.649 3.58 . . . . 0.79000000000000004 108.622 171.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -121.04 17.04 11.68 Favored 'General case' 0 C--N 1.367 1.367 0 N-CA-C 116.762 2.134 . . . . 0.75 116.762 -167.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -60.66 113.14 2.3 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 117.717 2.488 . . . . 0.40000000000000002 117.717 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.47 25.94 22.05 Favored Glycine 0 C--N 1.365 2.141 0 C-N-CA 124.701 1.143 . . . . 0.39000000000000001 112.841 170.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -136.78 171.29 14.72 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 104.977 -2.231 . . . . 1.3999999999999999 104.977 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.96 176.91 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 125.124 1.37 . . . . 0.31 113.922 -173.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.78 168.75 41.6 Favored Glycine 0 C--N 1.36 1.89 0 N-CA-C 105.716 -2.954 . . . . 0.20999999999999999 105.716 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 23' ' ' THR . . . . . 0.646 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 7.5 m -89.69 137.69 32.11 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 124.692 1.197 . . . . 0.27000000000000002 110.208 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 24' ' ' VAL . . . . . 0.492 HG22 ' H ' ' E' ' 26' ' ' SER . 10.2 p -82.22 113.05 20.9 Favored 'Isoleucine or valine' 0 C--N 1.348 0.517 0 CA-C-O 124.341 2.019 . . . . 0.28999999999999998 111.195 167.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.08 24.25 13.27 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 128.216 2.606 . . . . 0.28999999999999998 109.461 172.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 26' ' ' SER . . . . . 0.492 ' H ' HG22 ' E' ' 24' ' ' VAL . 21.1 t -81.21 -52.2 7.6 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 127.382 2.273 . . . . 0.63 116.203 -177.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.49 51.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-O 125.627 2.632 . . . . 0.60999999999999999 114.091 -164.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.89 -60.07 0.26 Allowed 'General case' 0 N--CA 1.424 -1.731 0 C-N-CA 129.269 3.028 . . . . 1.6100000000000001 105.086 -174.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -112.04 7.14 19.68 Favored 'General case' 0 C--N 1.364 1.237 0 N-CA-C 115.08 1.511 . . . . 3.96 115.08 -177.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -35.82 -28.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 1 C-N-CA 134.193 4.997 . . . . 4.3399999999999999 119.787 -176.539 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.39 46.72 0.19 Allowed Glycine 0 C--N 1.35 1.352 1 C-N-CA 130.854 4.074 . . . . 1.76 117.606 -178.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 32' ' ' ILE . . . . . 0.453 HD12 HD21 ' E' ' 59' ' ' ASN . 0.3 OUTLIER -113.5 -155.76 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.502 0 CA-C-O 123.332 1.539 . . . . 1.1100000000000001 111.65 178.069 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 62.6 tp -72.55 -34.75 67.74 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 130.054 3.342 . . . . 0.56999999999999995 113.778 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -125.43 157.77 66.75 Favored Pre-proline 0 C--N 1.355 0.824 0 N-CA-C 101.736 -3.431 . . . . 0.93999999999999995 101.736 174.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.96 -59.28 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 123.861 2.415 . . . . 0.67000000000000004 112.805 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 36' ' ' VAL . . . . . 0.536 HG12 HG23 ' E' ' 38' ' ' VAL . 52.6 t -70.06 105.86 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.222 0 N-CA-C 117.762 2.504 . . . . 0.64000000000000001 117.762 -169.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 37' ' ' ILE . . . . . 0.424 ' H ' ' HB2' ' E' ' 26' ' ' SER . 18.0 mt -89.82 107.37 18.13 Favored 'Isoleucine or valine' 0 C--N 1.37 1.481 0 N-CA-C 105.748 -1.945 . . . . 0.65000000000000002 105.748 170.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 38' ' ' VAL . . . . . 0.536 HG23 HG12 ' E' ' 36' ' ' VAL 0.26 19.4 t -112.18 149.24 14.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.473 0 CA-C-O 121.053 0.454 . . . . 0.23000000000000001 110.132 -179.16 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 39' ' ' ARG . . . . . 0.646 ' HB3' ' H ' ' E' ' 23' ' ' THR . 8.5 tmm_? -84.09 147.06 27.57 Favored 'General case' 0 C--N 1.366 1.311 0 C-N-CA 129.125 2.97 . . . . 2.75 108.892 173.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -151.72 144.94 24.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 104.206 -2.516 . . . . 1.26 104.206 172.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -105.46 -2.75 23.33 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 125.523 1.529 . . . . 1.02 112.191 175.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -86.44 45.72 1.27 Allowed 'General case' 0 C--N 1.357 0.898 0 C-N-CA 129.498 3.119 . . . . 1.29 110.49 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -96.38 167.98 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.788 1 C-N-CA 131.927 4.091 . . . . 1.23 110.467 177.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -131.34 92.92 3.26 Favored 'General case' 0 CA--C 1.5 -0.952 0 O-C-N 119.473 -2.017 . . . . 2.0499999999999998 106.226 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -76.67 4.62 9.08 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 128.465 2.706 . . . . 2.52 116.298 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -101.34 78.83 1.92 Allowed 'General case' 0 C--N 1.366 1.286 0 C-N-CA 125.851 1.66 . . . . 4.1600000000000001 108.493 177.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.34 -22.12 65.75 Favored Glycine 0 C--N 1.362 1.994 0 O-C-N 120.532 -1.355 . . . . 5.3300000000000001 116.414 -172.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -82.93 7.48 15.32 Favored 'General case' 0 C--N 1.364 1.231 0 C-N-CA 127.011 2.124 . . . . 5.0899999999999999 114.6 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 15.0 m -101.5 -16.24 16.87 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 130.951 3.7 . . . . 7.1799999999999997 110.984 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.84 26.28 27.29 Favored Glycine 0 C--N 1.37 2.458 0 C-N-CA 126.859 2.171 . . . . 6.5099999999999998 115.008 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 30.3 t -140.49 48.08 1.75 Allowed 'General case' 0 C--N 1.357 0.911 0 O-C-N 121.115 -1.227 . . . . 7.2000000000000002 114.105 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -91.99 5.74 48.99 Favored 'General case' 0 C--N 1.367 1.349 0 O-C-N 119.543 -1.973 . . . . 5.0800000000000001 114.266 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 15.2 m -67.79 14.02 0.07 Allowed 'General case' 0 C--N 1.354 0.787 0 C-N-CA 130.475 3.51 . . . . 3.8599999999999999 117.704 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.49 125.58 7.18 Favored Glycine 0 C--N 1.351 1.366 0 C-N-CA 129.474 3.416 . . . . 2.8500000000000001 105.158 171.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.13 149.17 14.0 Favored 'Isoleucine or valine' 0 C--N 1.348 0.506 0 C-N-CA 126.092 1.757 . . . . 1.72 112.417 -170.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.68 -51.83 5.31 Favored 'General case' 0 C--N 1.36 1.065 0 C-N-CA 126.782 2.033 . . . . 2.2000000000000002 111.214 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 62.7 p -107.33 96.29 6.31 Favored 'General case' 0 C--N 1.363 1.185 0 C-N-CA 125.087 1.355 . . . . 0.46999999999999997 108.479 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -112.5 145.38 40.34 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 125.285 1.434 . . . . 1.5700000000000001 111.022 -174.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 59' ' ' ASN . . . . . 0.453 HD21 HD12 ' E' ' 32' ' ' ILE . 0.4 OUTLIER -92.76 95.5 9.59 Favored 'General case' 0 C--N 1.361 1.085 0 C-N-CA 127.43 2.292 . . . . 2.0699999999999998 110.392 -177.27 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 60' ' ' PHE . . . . . 0.528 ' CE2' HG23 ' E' ' 10' ' ' ILE . 0.5 OUTLIER -101.71 164.77 11.57 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 126.697 1.999 . . . . 0.17000000000000001 114.039 -171.494 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 61' ' ' ALA . . . . . 0.419 ' H ' ' HD1' ' E' ' 60' ' ' PHE . . . -97.63 90.32 4.97 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 127.656 2.382 . . . . 0.17000000000000001 111.818 -177.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -16.39 -40.98 0.0 OUTLIER 'General case' 0 C--N 1.365 1.281 1 C-N-CA 134.308 5.043 . . . . 1.72 120.087 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.48 -26.4 42.32 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 128.507 2.723 . . . . 0.17000000000000001 115.964 171.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -97.55 5.21 49.85 Favored 'General case' 0 C--N 1.364 1.235 0 C-N-CA 127.171 2.188 . . . . 1.1799999999999999 111.712 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.525 HD21 ' CG ' ' E' ' 60' ' ' PHE . 0.6 OUTLIER -116.68 109.6 17.39 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 126.026 1.73 . . . . 0.19 112.097 -175.922 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -106.08 147.7 28.64 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 124.748 1.219 . . . . 2.0499999999999998 110.383 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -75.17 142.54 43.51 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 127.323 2.249 . . . . 0.28999999999999998 116.459 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 t -127.2 -28.6 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.963 0 C-N-CA 125.646 1.578 . . . . 0.72999999999999998 108.386 173.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 69' ' ' GLN . . . . . 0.52 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 7.9 tt0 -114.02 142.39 46.23 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 124.933 2.302 . . . . 2.1899999999999999 113.173 -177.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.36 57.46 0.94 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 128.449 2.7 . . . . 0.0 111.189 174.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.07 53.23 0.6 Allowed 'General case' 0 C--N 1.367 1.355 0 C-N-CA 127.518 2.327 . . . . 0.0 115.312 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.2 137.24 40.72 Favored 'General case' 0 C--N 1.348 0.509 0 C-N-CA 127.447 2.299 . . . . 0.0 107.156 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? . . . . . 0 C--O 1.261 1.699 0 CA-C-O 118.477 -0.773 . . . . 0.0 110.114 178.73 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 107.874 -1.158 . . . . 2.1299999999999999 107.874 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' E' E ' 2' ' ' LEU . . . . . 0.404 ' HB2' ' H ' ' E' ' 3' ' ' ASN . 0.0 OUTLIER -100.88 -156.28 0.55 Allowed 'General case' 0 C--N 1.353 0.732 0 N-CA-C 115.559 1.688 . . . . 0.98999999999999999 115.559 -178.323 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 3' ' ' ASN . . . . . 0.404 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 42.9 m-80 -134.63 -172.29 2.99 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 128.688 2.795 . . . . 0.80000000000000004 108.954 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -95.85 104.87 16.83 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 129.004 2.922 . . . . 3.3999999999999999 115.357 -176.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.37 3.51 33.09 Favored Glycine 0 C--N 1.366 2.23 0 CA-C-O 124.43 2.128 . . . . 0.53000000000000003 111.45 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 6' ' ' ASP . . . . . . . . . . . . 0.34 16.2 t70 -90.35 51.41 2.02 Favored 'General case' 0 N--CA 1.424 -1.761 1 C-N-CA 132.96 4.504 . . . . 0.45000000000000001 108.945 -178.202 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -28.75 105.85 0.03 OUTLIER 'General case' 0 C--N 1.367 1.329 1 C-N-CA 133.666 4.786 . . . . 2.0299999999999998 117.035 -174.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 35.1 m -90.62 150.49 3.72 Favored 'Isoleucine or valine' 0 C--N 1.36 1.036 0 C-N-CA 123.279 0.632 . . . . 0.13 111.111 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 19.4 ttm-85 -98.76 88.34 4.01 Favored 'General case' 0 C--N 1.36 1.025 0 O-C-N 120.629 -1.294 . . . . 0.17000000000000001 112.909 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.832 HD11 HG11 ' E' ' 38' ' ' VAL . 0.5 OUTLIER -33.53 101.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.598 0 N-CA-C 119.988 3.329 . . . . 0.12 119.988 176.423 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -103.01 42.74 1.13 Allowed 'General case' 0 C--N 1.368 1.374 0 C-N-CA 125.783 1.633 . . . . 0.29999999999999999 113.399 -174.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -98.49 123.53 42.7 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 129.389 3.075 . . . . 2.0899999999999999 111.226 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 26.4 p -71.42 -61.75 1.66 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 128.201 2.6 . . . . 0.46999999999999997 116.204 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -78.96 65.69 4.21 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 127.001 2.12 . . . . 1.8899999999999999 113.611 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 3.9 m -173.68 163.35 4.24 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 126.561 1.944 . . . . 1.1299999999999999 106.129 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -90.93 18.78 6.21 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 129.159 2.984 . . . . 0.79000000000000004 112.65 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 36.1 m0 -113.68 0.07 14.45 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 129.246 3.019 . . . . 0.75 111.636 -175.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -58.3 105.57 0.3 Allowed 'General case' 0 C--N 1.37 1.49 0 C-N-CA 127.163 2.185 . . . . 0.40000000000000002 116.176 -174.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.82 26.33 53.89 Favored Glycine 0 C--N 1.366 2.243 0 O-C-N 121.137 -0.977 . . . . 0.39000000000000001 115.11 -177.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -106.34 152.94 22.91 Favored 'General case' 0 C--N 1.362 1.149 0 N-CA-C 105.989 -1.856 . . . . 1.3999999999999999 105.989 175.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -88.11 151.72 3.48 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-O 123.716 1.722 . . . . 0.31 109.969 174.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.95 167.7 28.26 Favored Glycine 0 CA--C 1.471 -2.712 0 N-CA-C 105.872 -2.891 . . . . 0.20999999999999999 105.872 170.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 23' ' ' THR . . . . . 0.5 ' H ' ' HB2' ' E' ' 39' ' ' ARG . 17.3 m -97.24 113.92 25.59 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 124.901 1.28 . . . . 0.27000000000000002 112.147 -175.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 24' ' ' VAL . . . . . 0.424 HG23 HG13 ' E' ' 36' ' ' VAL . 9.8 p -66.16 71.79 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 128.729 2.811 . . . . 0.28999999999999998 118.307 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.01 53.93 2.96 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 116.699 -3.751 . . . . 0.28999999999999998 112.53 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 26' ' ' SER . . . . . 0.441 ' HA ' ' HB ' ' E' ' 37' ' ' ILE . 67.0 m -88.77 -58.03 2.69 Favored 'General case' 0 CA--C 1.477 -1.831 1 C-N-CA 133.549 4.74 . . . . 0.63 118.443 -173.792 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 m -82.51 49.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.368 1.393 0 CA-C-O 127.706 3.622 . . . . 0.60999999999999999 114.817 -163.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -135.39 -58.17 0.79 Allowed 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 110.817 -2.901 . . . . 1.6100000000000001 105.386 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -110.87 5.25 20.41 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 127.181 2.193 . . . . 3.96 114.001 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 26.5 t -46.14 -26.35 0.75 Allowed 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 129.516 3.126 . . . . 4.3399999999999999 116.935 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.35 44.21 0.06 OUTLIER Glycine 0 C--N 1.357 1.709 1 C-N-CA 130.809 4.052 . . . . 1.76 118.327 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.54 -156.61 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.972 0 C-N-CA 128.972 2.909 . . . . 1.1100000000000001 113.144 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 25.6 tp -87.79 -12.95 43.56 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 130.849 3.66 . . . . 0.56999999999999995 114.248 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -135.25 141.62 38.53 Favored Pre-proline 0 C--N 1.358 0.966 0 N-CA-C 101.912 -3.366 . . . . 0.93999999999999995 101.912 175.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -83.88 -45.1 0.06 OUTLIER 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.882 2.388 . . . . 0.67000000000000004 115.954 -168.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 36' ' ' VAL . . . . . 0.567 HG11 HD13 ' E' ' 65' ' ' LEU . 55.4 t -106.23 131.12 56.69 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 N-CA-C 115.597 1.702 . . . . 0.64000000000000001 115.597 -166.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 37' ' ' ILE . . . . . 0.441 ' HB ' ' HA ' ' E' ' 26' ' ' SER . 57.0 mt -105.72 126.08 61.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 C-N-CA 127.702 2.401 . . . . 0.65000000000000002 105.302 172.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 38' ' ' VAL . . . . . 0.832 HG11 HD11 ' E' ' 10' ' ' ILE . 74.3 t -134.43 144.4 35.22 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 O-C-N 120.703 -1.248 . . . . 0.23000000000000001 109.161 -176.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 39' ' ' ARG . . . . . 0.5 ' HB2' ' H ' ' E' ' 23' ' ' THR . 8.1 mtm180 -69.79 163.48 25.7 Favored 'General case' 0 C--N 1.372 1.578 0 C-N-CA 127.815 2.446 . . . . 2.75 115.827 173.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -149.02 139.12 22.19 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 124.543 1.137 . . . . 1.26 110.113 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -94.1 -32.6 13.69 Favored 'General case' 0 C--N 1.366 1.319 0 C-N-CA 125.995 1.718 . . . . 1.02 111.508 171.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 -79.69 57.99 2.65 Favored 'General case' 0 C--N 1.373 1.59 0 C-N-CA 129.397 3.079 . . . . 1.29 112.617 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 22.2 t -94.48 162.79 2.37 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 C-N-CA 127.11 2.164 . . . . 1.23 110.225 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -101.59 71.61 1.34 Allowed 'General case' 0 C--N 1.352 0.713 0 C-N-CA 129.083 2.953 . . . . 2.0499999999999998 110.585 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -60.33 -22.06 62.78 Favored 'General case' 0 CA--C 1.536 0.415 1 C-N-CA 133.121 4.568 . . . . 2.52 118.229 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -101.16 151.08 22.26 Favored 'General case' 0 C--N 1.361 1.08 0 O-C-N 120.28 -1.512 . . . . 4.1600000000000001 110.68 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.56 -8.84 76.48 Favored Glycine 0 C--N 1.358 1.793 0 N-CA-C 117.089 1.596 . . . . 5.3300000000000001 117.089 -169.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -75.91 -4.53 41.42 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 118.108 2.633 . . . . 5.0899999999999999 118.108 -174.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 36.1 t -102.71 -8.91 20.49 Favored 'General case' 0 C--N 1.315 -0.894 1 C-N-CA 131.886 4.074 . . . . 7.1799999999999997 111.835 174.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.91 -61.44 0.55 Allowed Glycine 0 C--N 1.361 1.952 0 CA-C-N 119.121 0.873 . . . . 6.5099999999999998 111.768 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 8.6 m -164.3 166.6 20.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 103.218 -2.882 . . . . 7.2000000000000002 103.218 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.6 8.53 30.88 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 127.92 2.488 . . . . 5.0800000000000001 115.971 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 13.8 t -106.37 38.18 2.11 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 125.979 1.712 . . . . 3.8599999999999999 111.066 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.2 50.72 2.77 Favored Glycine 0 C--N 1.359 1.815 0 C-N-CA 127.491 2.472 . . . . 2.8500000000000001 117.816 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . 0.446 5.6 p 63.2 126.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.852 1 C-N-CA 134.666 5.187 . . . . 1.72 118.048 178.157 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -98.62 -61.21 1.41 Allowed 'General case' 0 C--N 1.347 0.485 0 C-N-CA 125.974 1.71 . . . . 2.2000000000000002 109.442 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 72.7 p -105.0 115.95 31.14 Favored 'General case' 0 C--N 1.35 0.611 0 C-N-CA 126.891 2.077 . . . . 0.46999999999999997 108.585 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -105.95 147.11 29.18 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 108.639 -0.875 . . . . 1.5700000000000001 108.639 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -90.52 110.45 21.58 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 128.332 2.653 . . . . 2.0699999999999998 107.669 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -122.22 173.58 7.51 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 126.791 2.036 . . . . 0.17000000000000001 115.797 -172.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -108.15 97.31 7.02 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 130.077 3.351 . . . . 0.17000000000000001 113.909 -176.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -14.34 -34.9 0.0 OUTLIER 'General case' 0 C--N 1.366 1.297 1 C-N-CA 134.683 5.193 . . . . 1.72 121.122 171.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -46.2 -46.74 17.72 Favored 'General case' 0 C--N 1.369 1.426 1 C-N-CA 132.661 4.384 . . . . 0.17000000000000001 112.606 170.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.97 16.6 25.49 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 112.744 -2.025 . . . . 1.1799999999999999 111.218 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 65' ' ' LEU . . . . . 0.567 HD13 HG11 ' E' ' 36' ' ' VAL . 75.4 mt -129.65 98.01 4.7 Favored 'General case' 0 C--N 1.369 1.449 0 N-CA-C 114.942 1.46 . . . . 0.19 114.942 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -105.97 143.87 33.49 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 125.692 1.597 . . . . 2.0499999999999998 111.638 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -62.45 137.23 58.22 Favored 'General case' 0 C--N 1.365 1.276 0 C-N-CA 129.307 3.043 . . . . 0.28999999999999998 117.481 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 39.3 t -132.75 -27.27 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.292 0 C-N-CA 126.815 2.046 . . . . 0.72999999999999998 110.104 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.95 146.82 41.77 Favored 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 125.9 1.68 . . . . 2.1899999999999999 108.156 177.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.67 79.75 1.39 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 129.622 3.169 . . . . 0.0 112.685 173.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.25 77.83 1.45 Allowed 'General case' 0 C--N 1.352 0.683 0 O-C-N 119.403 -2.061 . . . . 0.0 109.484 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.45 -165.89 0.77 Allowed 'General case' 0 C--N 1.353 0.723 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt . . . . . 0 C--O 1.262 1.739 0 C-N-CA 127.647 2.379 . . . . 0.0 108.399 176.1 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.724 0 CA-C-O 122.534 1.159 . . . . 0.99 112.944 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 46.4 m-20 -123.86 -178.17 3.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 128.02 2.528 . . . . 0.8 110.842 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -91.43 83.92 5.5 Favored 'General case' 0 C--N 1.364 1.235 0 C-N-CA 127.78 2.432 . . . . 3.4 112.62 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 142.22 -9.06 2.44 Favored Glycine 0 CA--C 1.486 -1.74 0 CA-C-O 123.642 1.69 . . . . 0.53 110.872 -173.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 6' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -81.63 47.98 1.13 Allowed 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 128.227 2.611 . . . . 0.45 114.837 -172.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . 0.421 0.0 OUTLIER -11.91 97.33 0.01 OUTLIER 'General case' 0 C--N 1.361 1.089 1 C-N-CA 132.761 4.425 . . . . 2.03 117.763 -176.161 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.8 151.54 4.1 Favored 'Isoleucine or valine' 0 C--N 1.364 1.232 0 O-C-N 119.738 -1.851 . . . . 0.13 111.18 -171.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 17.1 ttt85 -97.61 105.86 18.08 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 115.153 1.538 . . . . 0.17 115.153 -176.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.689 HD11 HG11 ' E' ' 38' ' ' VAL . 1.3 mp -53.83 104.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.37 1.481 0 C-N-CA 129.108 2.963 . . . . 0.12 115.339 174.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -123.78 55.95 1.24 Allowed 'General case' 0 C--N 1.365 1.255 0 C-N-CA 123.762 0.825 . . . . 0.3 109.131 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -72.75 -72.91 0.22 Allowed 'General case' 0 C--N 1.362 1.146 0 C-N-CA 126.053 1.741 . . . . 2.09 115.188 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 84.9 m 127.44 -61.92 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.734 1 C-N-CA 133.077 4.551 . . . . 0.47 104.774 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -77.1 72.24 3.63 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 128.241 2.616 . . . . 1.89 111.383 173.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 42.6 t -167.44 159.79 12.68 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 106.823 -1.547 . . . . 1.13 106.823 -174.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -90.15 -2.09 58.03 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 127.412 2.285 . . . . 0.79 110.585 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -119.43 24.36 10.72 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 125.564 1.546 . . . . 0.75 111.082 -176.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -67.49 110.49 3.66 Favored 'General case' 0 C--N 1.369 1.425 0 C-N-CA 126.975 2.11 . . . . 0.4 113.802 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.99 16.67 46.85 Favored Glycine 0 C--N 1.356 1.69 0 C-N-CA 125.819 1.676 . . . . 0.39 111.272 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -108.91 164.2 12.61 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 126.305 1.842 . . . . 1.4 110.155 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -110.27 173.29 2.21 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 C-N-CA 125.946 1.698 . . . . 0.31 108.257 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.55 174.92 42.65 Favored Glycine 0 CA--C 1.474 -2.523 0 N-CA-C 107.517 -2.233 . . . . 0.21 107.517 167.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 23' ' ' THR . . . . . 0.78 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 23.5 m -90.21 120.05 31.05 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 126.293 1.837 . . . . 0.27 112.219 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 24' ' ' VAL . . . . . 0.718 HG23 HG13 ' E' ' 36' ' ' VAL . 7.9 p -72.25 80.94 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 125.279 2.466 . . . . 0.29 116.571 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.31 45.12 1.15 Allowed 'General case' 0 C--N 1.35 0.597 0 O-C-N 118.643 -2.535 . . . . 0.29 111.885 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 13.7 t -85.08 -68.95 0.69 Allowed 'General case' 0 CA--C 1.498 -1.043 1 C-N-CA 133.149 4.58 . . . . 0.63 114.076 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 1.3 m -79.88 28.98 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.229 0 C-N-CA 127.69 2.396 . . . . 0.61 116.04 -157.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -112.4 -60.67 1.83 Allowed 'General case' 0 N--CA 1.425 -1.675 1 C-N-CA 132.38 4.272 . . . . 1.61 106.972 177.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.53 -27.63 8.51 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 115.422 1.638 . . . . 3.96 115.422 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.54 35.08 0.76 Allowed 'General case' 0 C--N 1.354 0.786 0 N-CA-C 115.477 1.658 . . . . 4.34 115.477 -173.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.14 52.44 3.34 Favored Glycine 0 C--N 1.349 1.266 0 C-N-CA 129.053 3.216 . . . . 1.76 112.561 163.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 32' ' ' ILE . . . . . 0.487 HG22 ' H ' ' E' ' 33' ' ' LEU . 0.4 OUTLIER -133.94 -157.64 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.988 0 C-N-CA 129.311 3.044 . . . . 1.11 109.93 -175.098 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 33' ' ' LEU . . . . . 0.487 ' H ' HG22 ' E' ' 32' ' ' ILE . 36.6 tp -62.93 -42.47 99.81 Favored 'General case' 0 C--N 1.358 0.935 1 C-N-CA 132.238 4.215 . . . . 0.57 117.673 -177.3 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -110.17 134.61 20.7 Favored Pre-proline 0 C--N 1.366 1.302 0 N-CA-C 102.471 -3.159 . . . . 0.94 102.471 172.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.4 -53.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.424 2.083 . . . . 0.67 115.933 -167.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . 0.718 HG13 HG23 ' E' ' 24' ' ' VAL . 69.7 t -105.54 105.38 18.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.889 0 N-CA-C 119.316 3.08 . . . . 0.64 119.316 -161.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 59.9 mt -83.1 125.08 40.04 Favored 'Isoleucine or valine' 0 C--N 1.38 1.895 0 O-C-N 119.247 -2.158 . . . . 0.65 106.25 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 38' ' ' VAL . . . . . 0.689 HG11 HD11 ' E' ' 10' ' ' ILE . 55.2 t -122.72 162.64 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 119.333 0.97 . . . . 0.23 108.927 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 39' ' ' ARG . . . . . 0.78 ' HB3' ' H ' ' E' ' 23' ' ' THR 0.256 30.8 ttp180 -82.16 147.39 29.05 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 129.825 3.25 . . . . 2.75 110.833 172.267 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -139.96 126.22 20.0 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 124.742 1.217 . . . . 1.26 107.987 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -82.48 -15.25 53.17 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 124.343 1.057 . . . . 1.02 112.051 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -115.59 75.07 0.92 Allowed 'General case' 0 C--N 1.368 1.375 0 C-N-CA 126.854 2.061 . . . . 1.29 112.285 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.366 1.306 0 C-N-CA 126.581 1.952 . . . . 1.23 115.729 -179.177 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 109.835 -0.432 . . . . 2.2 109.835 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 21.4 p -104.29 117.15 33.52 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 129.864 3.265 . . . . 0.47 107.269 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -148.22 136.94 21.68 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.734 1.214 . . . . 1.57 108.253 -174.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -86.59 118.51 26.05 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 127.684 2.394 . . . . 2.07 116.047 -175.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 60' ' ' PHE . . . . . 0.571 ' HB2' HD11 ' E' ' 65' ' ' LEU . 74.6 m-85 -105.95 171.53 7.29 Favored 'General case' 0 CA--C 1.507 -0.682 0 O-C-N 119.856 -1.778 . . . . 0.17 112.547 177.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.42 101.53 10.88 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 129.649 3.179 . . . . 0.17 108.711 169.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -19.94 -29.18 0.0 OUTLIER 'General case' 0 C--N 1.36 1.043 1 C-N-CA 136.467 5.907 . . . . 1.72 119.602 171.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.26 -30.69 66.78 Favored 'General case' 0 C--N 1.365 1.254 0 C-N-CA 128.629 2.772 . . . . 0.17 113.958 171.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.52 20.47 18.49 Favored 'General case' 0 C--N 1.368 1.375 0 C-N-CA 125.777 1.631 . . . . 1.18 110.788 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' E' ' 60' ' ' PHE . 52.0 mt -137.59 116.91 12.72 Favored 'General case' 0 C--N 1.374 1.667 0 N-CA-C 116.282 1.956 . . . . 0.19 116.282 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -106.83 138.12 43.6 Favored 'General case' 0 C--N 1.364 1.229 0 O-C-N 120.589 -1.32 . . . . 2.05 111.604 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.35 136.72 53.41 Favored 'General case' 0 C--N 1.366 1.29 1 C-N-CA 131.909 4.084 . . . . 0.29 118.434 174.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 10.0 t -132.7 -40.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.618 -1.301 . . . . 0.73 114.121 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 69' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -104.83 120.87 42.43 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 123.486 1.612 . . . . 2.19 114.883 -172.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.0 51.72 0.15 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.265 2.226 . . . . 0.0 115.511 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.49 60.66 6.15 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 127.036 2.134 . . . . 0.0 112.295 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.63 114.16 26.04 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 125.991 1.716 . . . . 0.0 110.179 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 50.5 mttp . . . . . 0 C--O 1.262 1.741 0 CA-C-O 117.351 -1.309 . . . . 0.0 111.484 178.135 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.409 0 N-CA-C 114.833 1.42 . . . . 0.99 114.833 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . 0.257 1.0 OUTLIER -142.47 -175.56 4.51 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 104.62 -2.363 . . . . 0.8 104.62 176.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.39 60.42 5.22 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 130.135 3.374 . . . . 3.4 116.594 -175.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 5' ' ' GLY . . . . . 0.415 ' H ' ' H ' ' E' ' 6' ' ' ASP . . . 166.63 1.07 0.04 OUTLIER Glycine 0 CA--C 1.477 -2.341 0 O-C-N 120.088 -1.633 . . . . 0.53 113.457 -175.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 6' ' ' ASP . . . . . 0.495 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 65.5 t0 -76.76 136.29 39.02 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.797 2.039 . . . . 0.45 113.454 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -80.8 80.52 7.25 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 127.05 2.14 . . . . 2.03 108.07 169.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 8' ' ' VAL . . . . . 0.4 ' H ' HG22 ' E' ' 8' ' ' VAL . 13.9 m -89.97 135.6 25.89 Favored 'Isoleucine or valine' 0 C--N 1.374 1.672 0 N-CA-C 103.365 -2.828 . . . . 0.13 103.365 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -95.52 110.38 22.46 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 120.89 1.677 . . . . 0.17 114.544 -172.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.532 HD11 HG11 ' E' ' 38' ' ' VAL . 10.5 mm -52.18 108.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.378 1.807 0 N-CA-C 118.19 2.663 . . . . 0.12 118.19 175.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -117.9 48.82 1.32 Allowed 'General case' 0 C--N 1.37 1.486 0 CA-C-O 123.203 1.478 . . . . 0.3 107.923 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -101.62 128.97 47.65 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 130.277 3.431 . . . . 2.09 109.485 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 20.9 p -74.69 -58.67 3.14 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 128.8 2.84 . . . . 0.47 113.268 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -66.07 48.75 0.03 OUTLIER 'General case' 0 C--N 1.359 0.998 0 C-N-CA 129.295 3.038 . . . . 1.89 116.529 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 53.3 m -167.48 166.5 14.26 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 119.575 -1.953 . . . . 1.13 106.631 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -92.96 15.56 14.65 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 119.645 -1.91 . . . . 0.79 113.727 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -116.44 13.14 15.39 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 126.811 2.045 . . . . 0.75 111.86 -175.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -61.82 105.98 0.63 Allowed 'General case' 0 C--N 1.367 1.34 0 C-N-CA 127.519 2.328 . . . . 0.4 114.598 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.58 9.01 44.88 Favored Glycine 0 C--N 1.363 2.047 0 C-N-CA 123.959 0.79 . . . . 0.39 112.975 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -107.99 174.57 5.82 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 127.984 2.514 . . . . 1.4 109.948 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 p -108.68 178.74 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.437 0 C-N-CA 125.482 1.513 . . . . 0.31 110.492 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.29 174.55 47.04 Favored Glycine 0 CA--C 1.477 -2.335 0 O-C-N 119.829 -1.795 . . . . 0.21 108.918 171.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 23' ' ' THR . . . . . 0.56 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 8.3 m -106.65 115.09 29.6 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 125.054 1.342 . . . . 0.27 110.43 -177.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 p -68.79 85.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 125.779 1.632 . . . . 0.29 113.545 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.96 50.0 1.88 Allowed 'General case' 0 C--N 1.355 0.804 0 O-C-N 119.947 -1.721 . . . . 0.29 110.967 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . 0.561 ' HB3' ' H ' ' E' ' 37' ' ' ILE . 19.3 p -94.71 -71.8 0.65 Allowed 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 120.298 3.444 . . . . 0.63 120.298 -174.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 27' ' ' VAL . . . . . 0.406 HG12 ' H ' ' E' ' 27' ' ' VAL . 7.3 p -81.13 56.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.755 2 C-N-CA 132.84 4.456 . . . . 0.61 111.823 -167.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -141.82 -45.62 0.35 Allowed 'General case' 0 N--CA 1.411 -2.399 2 CA-C-N 107.49 -4.414 . . . . 1.61 102.126 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -109.3 -39.21 5.29 Favored 'General case' 0 C--N 1.368 1.41 0 C-N-CA 129.67 3.188 . . . . 3.96 113.643 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 23.6 m -69.87 53.36 0.12 Allowed 'General case' 0 C--N 1.364 1.216 0 C-N-CA 131.228 3.811 . . . . 4.34 118.527 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.6 47.0 3.39 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 109.65 -3.432 . . . . 1.76 111.368 153.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 32' ' ' ILE . . . . . 0.435 HG22 ' H ' ' E' ' 33' ' ' LEU . 0.5 OUTLIER -140.15 -153.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.246 0 C-N-CA 126.98 2.112 . . . . 1.11 110.031 -175.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 33' ' ' LEU . . . . . 0.435 ' H ' HG22 ' E' ' 32' ' ' ILE . 40.8 tp -65.8 -43.25 89.24 Favored 'General case' 0 C--N 1.354 0.798 1 C-N-CA 132.565 4.346 . . . . 0.57 117.0 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -108.8 128.3 25.77 Favored Pre-proline 0 C--N 1.356 0.888 0 O-C-N 120.367 -1.458 . . . . 0.94 107.176 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.19 -28.61 4.63 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 124.411 3.408 . . . . 0.67 112.791 -174.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . 0.642 HG12 HG23 ' E' ' 38' ' ' VAL . 59.4 t -110.72 138.34 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 130.4 3.48 . . . . 0.64 108.188 -177.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . 0.561 ' H ' ' HB3' ' E' ' 26' ' ' SER . 63.5 mt -138.29 121.92 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 2 N-CA-C 95.13 -5.878 . . . . 0.65 95.13 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 38' ' ' VAL . . . . . 0.642 HG23 HG12 ' E' ' 36' ' ' VAL . 62.3 t -124.25 157.49 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 CA-C-N 122.492 2.406 . . . . 0.23 111.901 -170.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 39' ' ' ARG . . . . . 0.56 ' HB3' ' H ' ' E' ' 23' ' ' THR . 0.0 OUTLIER -83.64 144.01 29.71 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 128.035 2.534 . . . . 2.75 112.176 174.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -129.78 128.57 42.66 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 114.636 -1.166 . . . . 1.26 107.933 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -98.35 -15.44 19.72 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 126.18 1.792 . . . . 1.02 110.805 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -115.35 60.56 0.7 Allowed 'General case' 0 C--N 1.355 0.823 0 C-N-CA 131.048 3.739 . . . . 1.29 110.424 -177.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 C--N 1.355 0.809 0 C-N-CA 126.494 1.918 . . . . 1.23 109.114 178.349 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 25.3 p30 . . . . . 0 C--O 1.224 -0.238 0 CA-C-O 121.267 0.556 . . . . 2.2 112.415 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 2.9 p -132.17 129.28 39.58 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 130.202 3.401 . . . . 0.47 105.582 -177.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -154.43 150.38 27.81 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 104.734 -2.321 . . . . 1.57 104.734 -174.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -78.51 125.21 29.05 Favored 'General case' 0 C--N 1.353 0.717 1 C-N-CA 131.811 4.044 . . . . 2.07 116.334 -169.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 60' ' ' PHE . . . . . 0.544 ' HB3' HD21 ' E' ' 65' ' ' LEU . 19.3 m-85 -128.89 154.91 46.04 Favored 'General case' 0 C--N 1.36 1.06 0 CA-C-O 124.042 1.877 . . . . 0.17 114.036 -173.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.42 101.92 10.59 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 112.337 -2.21 . . . . 0.17 109.941 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -27.27 -26.95 0.0 OUTLIER 'General case' 0 C--N 1.372 1.553 1 C-N-CA 132.155 4.182 . . . . 1.72 121.132 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -46.9 -49.64 20.07 Favored 'General case' 0 C--N 1.374 1.66 0 C-N-CA 131.028 3.731 . . . . 0.17 113.601 167.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 11.6 pm0 -95.07 10.02 37.35 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-N 114.121 -1.399 . . . . 1.18 112.942 -172.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' E' ' 60' ' ' PHE . 0.2 OUTLIER -115.3 120.64 40.32 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.824 1.65 . . . . 0.19 111.215 -177.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -100.15 115.15 29.16 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 125.763 1.625 . . . . 2.05 111.116 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.56 132.02 46.75 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 129.087 2.955 . . . . 0.29 118.535 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.63 -39.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.275 0 C-N-CA 124.407 1.083 . . . . 0.73 113.436 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 69' ' ' GLN . . . . . 0.495 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 25.6 tt0 -112.22 106.86 15.54 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 116.327 1.973 . . . . 2.19 116.327 -171.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.27 63.85 0.15 Allowed 'General case' 0 CA--C 1.557 1.225 0 O-C-N 119.734 -1.854 . . . . 0.0 115.957 170.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.35 53.72 0.41 Allowed 'General case' 0 C--N 1.369 1.453 0 C-N-CA 128.112 2.565 . . . . 0.0 117.12 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.74 160.07 15.13 Favored 'General case' 0 C--N 1.35 0.591 0 C-N-CA 128.313 2.645 . . . . 0.0 116.089 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt . . . . . 0 C--O 1.261 1.708 0 C-N-CA 128.905 2.882 . . . . 0.0 108.83 176.976 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.447 0 N-CA-C 116.718 2.118 . . . . 0.99 116.718 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.31 153.85 44.21 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 129.1 2.96 . . . . 0.8 104.43 177.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . 0.282 0.0 OUTLIER -86.29 121.62 29.13 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 119.55 3.167 . . . . 3.4 119.55 -171.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.4 -0.69 14.24 Favored Glycine 0 C--N 1.365 2.19 0 C-N-CA 126.372 1.939 . . . . 0.53 110.856 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 6' ' ' ASP . . . . . 0.421 ' HA ' ' HB2' ' E' ' 69' ' ' GLN . 56.2 t0 -70.26 146.16 50.84 Favored 'General case' 0 N--CA 1.423 -1.818 1 C-N-CA 132.937 4.495 . . . . 0.45 112.054 -178.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -82.48 76.53 9.34 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 125.315 1.446 . . . . 2.03 108.743 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 28.8 m -87.6 144.97 8.15 Favored 'Isoleucine or valine' 0 C--N 1.371 1.532 0 O-C-N 119.815 -1.803 . . . . 0.13 107.312 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -109.99 117.12 32.94 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 114.754 1.39 . . . . 0.17 114.754 -169.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 14.2 mm -63.96 126.03 21.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.834 0 C-N-CA 128.508 2.723 . . . . 0.12 118.012 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.87 39.38 3.53 Favored 'General case' 0 C--N 1.365 1.281 0 N-CA-C 115.945 1.831 . . . . 0.3 115.945 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -108.47 147.57 31.47 Favored 'General case' 0 C--N 1.368 1.371 0 O-C-N 118.942 -2.349 . . . . 2.09 110.685 174.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 13.3 t -105.14 24.17 12.46 Favored 'General case' 0 C--N 1.364 1.231 0 C-N-CA 125.314 1.446 . . . . 0.47 112.347 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -90.83 11.51 22.28 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 127.763 2.425 . . . . 1.89 112.832 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 3.3 t -169.12 -173.66 1.82 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.012 1.325 . . . . 1.13 107.657 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -92.77 21.12 5.82 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 130.001 3.321 . . . . 0.79 112.266 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -111.51 6.96 20.5 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 127.99 2.516 . . . . 0.75 110.012 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -64.1 101.46 0.4 Allowed 'General case' 0 C--N 1.367 1.363 0 C-N-CA 127.988 2.515 . . . . 0.4 114.911 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.77 40.36 4.69 Favored Glycine 0 C--N 1.359 1.809 0 C-N-CA 125.758 1.647 . . . . 0.39 111.368 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -132.93 146.18 51.56 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 123.399 1.571 . . . . 1.4 113.254 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.32 147.8 4.98 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 C-N-CA 130.211 3.404 . . . . 0.31 112.019 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.96 -179.21 34.6 Favored Glycine 0 CA--C 1.478 -2.225 0 N-CA-C 107.995 -2.042 . . . . 0.21 107.995 173.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 23' ' ' THR . . . . . 0.659 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 30.1 m -88.93 129.12 35.68 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 124.861 1.264 . . . . 0.27 109.711 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 24' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' E' ' 26' ' ' SER . 14.9 p -75.64 92.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 124.795 2.236 . . . . 0.29 113.624 174.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.55 23.55 2.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.824 2.05 . . . . 0.29 113.236 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . 0.466 ' HB3' HG22 ' E' ' 24' ' ' VAL . 28.6 t -64.82 -66.09 0.59 Allowed 'General case' 0 C--N 1.364 1.211 1 C-N-CA 131.85 4.06 . . . . 0.63 115.315 178.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -85.44 53.88 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.745 0 CA-C-O 124.017 1.865 . . . . 0.61 113.054 -166.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.81 -67.09 0.05 OUTLIER 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 127.377 2.271 . . . . 1.61 107.422 -171.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -104.28 -9.17 18.77 Favored 'General case' 0 C--N 1.363 1.181 0 N-CA-C 115.083 1.512 . . . . 3.96 115.083 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.23 24.51 1.85 Allowed 'General case' 0 C--N 1.363 1.17 0 N-CA-C 115.532 1.679 . . . . 4.34 115.532 -176.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.77 46.71 0.16 Allowed Glycine 0 C--N 1.364 2.124 0 C-N-CA 130.05 3.691 . . . . 1.76 115.806 168.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -130.94 -159.33 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.672 1 C-N-CA 132.995 4.518 . . . . 1.11 107.418 -176.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 39.7 tp -69.24 -34.37 74.7 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 130.411 3.484 . . . . 0.57 117.821 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -106.45 146.44 33.01 Favored Pre-proline 0 C--N 1.358 0.953 0 C-N-CA 125.092 1.357 . . . . 0.94 109.211 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.52 -43.66 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.624 2.883 . . . . 0.67 114.597 -170.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . 0.492 HG11 ' CD1' ' E' ' 65' ' ' LEU . 60.9 t -109.43 128.02 65.74 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 115.305 1.594 . . . . 0.64 115.305 -170.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 19.0 mt -109.09 142.22 22.23 Favored 'Isoleucine or valine' 0 C--N 1.36 1.054 0 N-CA-C 103.7 -2.704 . . . . 0.65 103.7 162.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 17.8 t -134.8 159.22 41.72 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 N-CA-C 107.308 -1.367 . . . . 0.23 107.308 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 39' ' ' ARG . . . . . 0.659 ' HB3' ' H ' ' E' ' 23' ' ' THR . 41.1 ttp85 -83.82 147.48 27.54 Favored 'General case' 0 C--N 1.354 0.766 1 C-N-CA 131.854 4.062 . . . . 2.75 111.914 172.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -133.68 128.13 34.36 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 125.07 1.348 . . . . 1.26 108.218 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.24 -16.95 30.04 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 128.445 2.698 . . . . 1.02 112.299 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -99.03 61.6 1.26 Allowed 'General case' 0 C--N 1.356 0.863 1 C-N-CA 132.119 4.168 . . . . 1.29 110.765 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.361 1.106 0 C-N-CA 129.13 2.972 . . . . 1.23 104.153 169.087 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.544 0.733 0 CA-C-O 119.654 -0.212 . . . . 2.2 111.442 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 22.9 p -126.29 134.78 51.05 Favored 'General case' 0 C--N 1.362 1.128 0 O-C-N 119.927 -1.733 . . . . 0.47 110.164 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -162.06 161.58 28.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.871 1.668 . . . . 1.57 107.194 175.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -97.1 154.45 17.33 Favored 'General case' 0 C--N 1.361 1.101 0 CA-C-O 124.032 1.872 . . . . 2.07 113.897 -176.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 60' ' ' PHE . . . . . 0.406 ' CB ' HD21 ' E' ' 65' ' ' LEU . 95.0 m-85 -135.94 169.55 17.41 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 112.481 -2.145 . . . . 0.17 113.489 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -109.46 108.58 19.14 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 111.064 -2.789 . . . . 0.17 107.788 172.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -25.66 -17.94 0.0 OUTLIER 'General case' 0 C--N 1.367 1.341 2 C-N-CA 134.395 5.078 . . . . 1.72 122.0 176.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -65.99 -32.41 73.88 Favored 'General case' 0 C--N 1.371 1.502 0 C-N-CA 130.97 3.708 . . . . 0.17 110.937 166.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -84.85 -11.76 54.99 Favored 'General case' 0 C--N 1.364 1.217 0 O-C-N 120.742 -1.224 . . . . 1.18 110.705 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.492 ' CD1' HG11 ' E' ' 36' ' ' VAL . 0.3 OUTLIER -106.81 108.57 20.14 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 115.708 1.744 . . . . 0.19 115.708 -171.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -96.43 133.17 41.19 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 125.596 1.558 . . . . 2.05 108.772 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . 0.466 ' H ' HD23 ' E' ' 67' ' ' LEU 0.297 2.4 pt? -87.36 153.09 21.73 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-N 123.1 2.682 . . . . 0.29 117.017 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 t -125.44 -27.42 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.121 0 C-N-CA 126.088 1.755 . . . . 0.73 110.782 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 69' ' ' GLN . . . . . 0.421 ' HB2' ' HA ' ' E' ' 6' ' ' ASP . 2.5 mm-40 -113.85 160.98 18.15 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 127.018 3.294 . . . . 2.19 114.786 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.73 56.36 0.7 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 108.886 -3.779 . . . . 0.0 111.651 173.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.71 58.78 1.89 Allowed 'General case' 0 C--N 1.365 1.253 0 O-C-N 120.205 -1.56 . . . . 0.0 114.553 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.95 91.93 7.13 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 128.753 2.821 . . . . 0.0 112.308 -176.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 75.7 mttt . . . . . 0 C--O 1.262 1.738 0 CA-C-O 117.624 -1.179 . . . . 0.0 109.104 174.463 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' E' E ' 2' ' ' LEU . . . . . 0.572 HD11 HG21 ' E' ' 36' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.27 0 N-CA-C 117.998 2.592 . . . . 0.99 117.998 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . 0.452 ' O ' HG11 ' E' ' 24' ' ' VAL . 1.0 OUTLIER -135.61 178.49 7.0 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 129.11 2.964 . . . . 0.8 110.127 -175.66 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . 0.433 ' H ' ' CZ ' ' E' ' 4' ' ' ARG . 0.0 OUTLIER -94.65 104.98 16.91 Favored 'General case' 0 C--N 1.376 1.753 0 C-N-CA 128.699 2.8 . . . . 3.4 114.423 173.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 5' ' ' GLY . . . . . 0.538 ' H ' ' CG1' ' E' ' 24' ' ' VAL . . . 113.34 -3.34 25.13 Favored Glycine 0 CA--C 1.485 -1.799 0 O-C-N 118.079 -2.888 . . . . 0.53 110.175 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 6' ' ' ASP . . . . . 0.604 ' HA ' ' HB2' ' E' ' 69' ' ' GLN . 43.5 t0 -68.4 127.79 34.25 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 130.292 3.437 . . . . 0.45 110.381 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -82.56 80.17 8.78 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 106.711 -1.588 . . . . 2.03 106.711 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 8' ' ' VAL . . . . . 0.423 HG22 ' HB ' ' E' ' 24' ' ' VAL . 12.7 m -84.51 142.32 13.49 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 O-C-N 121.665 -0.647 . . . . 0.13 109.951 -173.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -108.02 129.28 55.14 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 118.322 -0.847 . . . . 0.17 111.838 -172.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.439 HG21 ' CE1' ' E' ' 60' ' ' PHE . 3.7 mm -74.01 118.53 19.69 Favored 'Isoleucine or valine' 0 C--N 1.365 1.272 0 N-CA-C 115.141 1.534 . . . . 0.12 115.141 175.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -107.59 36.89 2.57 Favored 'General case' 0 C--N 1.373 1.621 0 O-C-N 119.574 -1.954 . . . . 0.3 114.072 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -102.52 99.26 9.27 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 129.853 3.261 . . . . 2.09 112.663 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 13' ' ' THR . . . . . 0.591 ' HA ' ' CG ' ' E' ' 18' ' ' TYR . 4.1 m -58.58 -34.37 71.0 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 129.081 2.953 . . . . 0.47 117.912 -175.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.72 44.01 0.21 Allowed 'General case' 0 C--N 1.346 0.442 0 C-N-CA 129.199 2.999 . . . . 1.89 115.003 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 17.1 t -172.2 175.1 3.8 Favored 'General case' 0 C--N 1.365 1.257 0 C-N-CA 125.343 1.457 . . . . 1.13 107.4 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -92.19 7.13 43.99 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 129.975 3.31 . . . . 0.79 111.124 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 38.5 m0 -106.32 10.51 31.63 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 127.247 2.219 . . . . 0.75 109.478 178.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 18' ' ' TYR . . . . . 0.591 ' CG ' ' HA ' ' E' ' 13' ' ' THR . 18.5 t80 -69.79 101.68 1.76 Allowed 'General case' 0 C--N 1.374 1.635 0 C-N-CA 126.333 1.853 . . . . 0.4 113.276 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.18 39.69 6.34 Favored Glycine 0 C--N 1.356 1.667 0 C-N-CA 125.359 1.457 . . . . 0.39 111.898 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -109.86 135.7 50.32 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 119.043 1.421 . . . . 1.4 109.065 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -97.17 164.82 2.18 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 125.579 1.552 . . . . 0.31 110.582 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.19 177.67 47.08 Favored Glycine 0 CA--C 1.47 -2.772 0 N-CA-C 107.056 -2.418 . . . . 0.21 107.056 170.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 23' ' ' THR . . . . . 0.481 ' H ' ' CB ' ' E' ' 39' ' ' ARG . 6.9 m -86.77 130.47 34.46 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 125.348 2.499 . . . . 0.27 110.801 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 24' ' ' VAL . . . . . 0.538 ' CG1' ' H ' ' E' ' 5' ' ' GLY . 11.8 p -62.32 73.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 131.176 3.79 . . . . 0.29 116.062 174.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.96 25.65 0.36 Allowed 'General case' 0 CA--C 1.551 1.012 0 O-C-N 116.475 -3.891 . . . . 0.29 114.131 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . . . . . . . . 0.271 1.5 m -73.86 -25.65 60.16 Favored 'General case' 0 CA--C 1.5 -0.964 1 C-N-CA 136.376 5.87 . . . . 0.63 117.155 175.488 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -114.27 49.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 124.778 1.231 . . . . 0.61 109.083 -171.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.34 -56.93 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 124.024 0.93 . . . . 1.61 108.905 -169.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -109.43 8.86 25.51 Favored 'General case' 0 C--N 1.36 1.049 0 C-N-CA 126.357 1.863 . . . . 3.96 111.799 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 4.9 m -27.22 -41.12 0.01 OUTLIER 'General case' 0 C--N 1.361 1.08 1 C-N-CA 135.909 5.684 . . . . 4.34 121.05 -175.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.35 42.27 0.13 Allowed Glycine 0 C--N 1.348 1.244 1 C-N-CA 131.845 4.545 . . . . 1.76 118.172 -171.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 32' ' ' ILE . . . . . 0.653 HD12 HD21 ' E' ' 59' ' ' ASN . 0.0 OUTLIER -116.78 -167.24 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.457 0 C-N-CA 125.04 1.336 . . . . 1.11 110.292 176.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 38.0 tp -65.34 -33.89 77.03 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 129.629 3.172 . . . . 0.57 116.86 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -135.12 132.82 20.37 Favored Pre-proline 0 N--CA 1.469 0.499 0 N-CA-C 101.501 -3.518 . . . . 0.94 101.501 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.02 -46.63 1.44 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.779 2.986 . . . . 0.67 116.573 -160.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . 0.572 HG21 HD11 ' E' ' 2' ' ' LEU . 54.3 t -80.83 103.02 7.24 Favored 'Isoleucine or valine' 0 C--N 1.368 1.372 0 N-CA-C 114.417 1.266 . . . . 0.64 114.417 -175.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 20.5 mt -89.82 118.72 35.65 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 N-CA-C 106.05 -1.833 . . . . 0.65 106.05 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 37.7 t -109.7 145.56 16.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 O-C-N 119.685 -1.884 . . . . 0.23 109.646 176.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 39' ' ' ARG . . . . . 0.481 ' CB ' ' H ' ' E' ' 23' ' ' THR . 8.1 tmm_? -42.85 -32.65 0.65 Allowed 'General case' 0 C--N 1.359 0.994 2 C-N-CA 134.467 5.107 . . . . 2.75 123.564 -177.243 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.22 129.44 34.5 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 120.794 3.627 . . . . 1.26 120.794 -162.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -88.53 38.02 0.85 Allowed 'General case' 0 C--N 1.356 0.875 0 C-N-CA 128.934 2.894 . . . . 1.02 113.324 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -96.08 36.13 1.35 Allowed 'General case' 0 C--N 1.348 0.535 1 C-N-CA 131.97 4.108 . . . . 1.29 110.428 -176.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . 0.263 10.9 m . . . . . 0 N--CA 1.449 -0.487 0 C-N-CA 127.725 2.41 . . . . 1.23 110.978 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 121.693 0.759 . . . . 2.2 112.491 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 16.1 p -114.78 125.3 53.54 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 101.388 -3.56 . . . . 0.47 101.388 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -122.8 133.48 54.45 Favored 'General case' 0 C--N 1.358 0.939 0 O-C-N 120.098 -1.626 . . . . 1.57 113.131 -168.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 59' ' ' ASN . . . . . 0.653 HD21 HD12 ' E' ' 32' ' ' ILE . 20.1 m120 -88.13 112.5 22.76 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 129.294 3.038 . . . . 2.07 115.7 -174.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 60' ' ' PHE . . . . . 0.439 ' CE1' HG21 ' E' ' 10' ' ' ILE . 97.7 m-85 -115.46 173.5 6.49 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 115.47 1.655 . . . . 0.17 115.47 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.53 85.85 4.65 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 129.503 3.121 . . . . 0.17 110.755 172.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -15.91 -23.4 0.0 OUTLIER 'General case' 0 C--N 1.36 1.043 1 C-N-CA 138.108 6.563 . . . . 1.72 121.331 172.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.07 -37.26 69.66 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 130.366 3.466 . . . . 0.17 113.831 171.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . 0.275 2.0 pp20? -97.46 16.03 21.43 Favored 'General case' 0 C--N 1.373 1.624 0 C-N-CA 126.35 1.86 . . . . 1.18 111.331 -177.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.466 ' CD1' HG11 ' E' ' 36' ' ' VAL . 0.3 OUTLIER -112.96 104.58 12.55 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 128.427 2.691 . . . . 0.19 108.206 172.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -94.53 150.48 20.2 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 125.867 1.667 . . . . 2.05 111.15 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -74.47 142.04 44.9 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 117.851 2.537 . . . . 0.29 117.851 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 3.4 t -135.6 -27.9 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.072 0 C-N-CA 126.206 1.802 . . . . 0.73 110.499 171.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 69' ' ' GLN . . . . . 0.604 ' HB2' ' HA ' ' E' ' 6' ' ' ASP 0.342 19.8 mt-30 -118.59 113.58 21.47 Favored 'General case' 0 C--N 1.361 1.075 0 CA-C-O 123.489 1.614 . . . . 2.19 113.613 174.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.86 56.96 0.99 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 127.804 2.442 . . . . 0.0 111.523 169.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.02 58.2 0.22 Allowed 'General case' 0 C--N 1.355 0.834 0 C-N-CA 128.365 2.666 . . . . 0.0 117.796 -169.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.06 73.02 0.89 Allowed 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt . . . . . 0 C--O 1.262 1.746 0 C-N-CA 127.661 2.384 . . . . 0.0 111.704 177.969 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' E' E ' 2' ' ' LEU . . . . . 0.488 HD22 HG11 ' E' ' 8' ' ' VAL 0.328 1.8 pp . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 115.969 1.841 . . . . 0.99 115.969 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -144.36 176.08 9.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 129.773 3.229 . . . . 0.8 111.223 -171.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . 0.421 ' HG2' HG13 ' E' ' 27' ' ' VAL . 0.0 OUTLIER -96.59 102.7 14.52 Favored 'General case' 0 C--N 1.37 1.462 0 O-C-N 119.51 -1.994 . . . . 3.4 112.165 174.527 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.47 4.58 11.9 Favored Glycine 0 C--N 1.363 2.059 0 CA-C-O 124.087 1.937 . . . . 0.53 112.241 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 6' ' ' ASP . . . . . 0.469 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 65.3 t0 -74.89 136.81 41.46 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 130.446 3.498 . . . . 0.45 109.508 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . 0.627 ' H ' ' HB2' ' E' ' 69' ' ' GLN . 41.1 mmtm -91.75 79.1 5.4 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 104.96 -2.237 . . . . 2.03 104.96 176.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 8' ' ' VAL . . . . . 0.488 HG11 HD22 ' E' ' 2' ' ' LEU . 13.4 m -86.32 143.18 11.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 106.336 -1.727 . . . . 0.13 106.336 -177.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' E' ' 21' ' ' VAL . 23.4 ttt85 -104.16 117.74 34.97 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 113.495 0.924 . . . . 0.17 113.495 -172.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 13.8 mm -56.66 111.66 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.376 0 N-CA-C 117.466 2.395 . . . . 0.12 117.466 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -115.35 47.63 1.29 Allowed 'General case' 0 C--N 1.368 1.408 0 C-N-CA 126.225 1.81 . . . . 0.3 109.912 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -106.64 127.09 53.07 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 128.31 2.644 . . . . 2.09 106.147 174.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 18.3 p -71.34 -58.67 3.31 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 129.74 3.216 . . . . 0.47 113.496 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.11 67.43 2.41 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 130.944 3.698 . . . . 1.89 110.04 174.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 27.8 t -163.43 159.9 22.79 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.344 -2.095 . . . . 1.13 105.344 -172.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -92.49 -1.81 56.7 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 127.159 2.184 . . . . 0.79 110.914 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 9.1 m0 -119.83 24.43 10.55 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 126.253 1.821 . . . . 0.75 111.721 -172.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -68.98 101.17 1.33 Allowed 'General case' 0 C--N 1.371 1.507 0 C-N-CA 125.637 1.575 . . . . 0.4 112.758 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.96 14.66 35.92 Favored Glycine 0 C--N 1.358 1.805 0 C-N-CA 125.035 1.302 . . . . 0.39 112.192 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -113.06 154.03 27.2 Favored 'General case' 0 C--N 1.362 1.145 0 C-N-CA 125.316 1.446 . . . . 1.4 109.782 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' E' ' 9' ' ' ARG . 1.4 p -92.02 -176.8 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.383 0 C-N-CA 127.525 2.33 . . . . 0.31 113.423 -175.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.24 176.72 46.42 Favored Glycine 0 CA--C 1.479 -2.159 0 N-CA-C 108.839 -1.704 . . . . 0.21 108.839 166.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 23' ' ' THR . . . . . 0.457 ' H ' ' CB ' ' E' ' 39' ' ' ARG . 29.0 m -101.89 120.73 40.85 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 124.516 1.127 . . . . 0.27 109.99 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 24' ' ' VAL . . . . . 0.426 HG22 ' HB3' ' E' ' 26' ' ' SER . 7.1 p -75.29 88.02 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 123.292 1.52 . . . . 0.29 113.272 178.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.6 43.95 1.15 Allowed 'General case' 0 C--N 1.353 0.75 0 C-N-CA 126.596 1.958 . . . . 0.29 110.775 171.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . 0.426 ' HB3' HG22 ' E' ' 24' ' ' VAL . 13.7 t -81.51 -73.27 0.39 Allowed 'General case' 0 CA--C 1.488 -1.429 1 C-N-CA 131.78 4.032 . . . . 0.63 113.753 -178.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 27' ' ' VAL . . . . . 0.421 HG13 ' HG2' ' E' ' 4' ' ' ARG . 3.8 p -82.1 54.11 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.571 0 CA-C-O 126.5 3.048 . . . . 0.61 113.145 -160.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.57 -72.05 0.69 Allowed 'General case' 0 N--CA 1.418 -2.039 0 C-N-CA 130.663 3.585 . . . . 1.61 103.053 175.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.34 -17.6 13.1 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 125.696 1.598 . . . . 3.96 112.754 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . 0.455 ' HB2' ' CD1' ' E' ' 37' ' ' ILE . 1.8 t -92.41 46.92 1.27 Allowed 'General case' 0 C--N 1.367 1.344 0 O-C-N 119.435 -2.041 . . . . 4.34 114.375 -176.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.14 51.09 4.51 Favored Glycine 0 C--N 1.341 0.809 1 C-N-CA 130.89 4.09 . . . . 1.76 111.537 162.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.84 -166.6 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.882 0 C-N-CA 130.045 3.338 . . . . 1.11 108.695 -176.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 22.1 tp -61.37 -38.27 86.37 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 130.578 3.551 . . . . 0.57 117.027 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -113.81 115.54 46.09 Favored Pre-proline 0 C--N 1.356 0.855 0 N-CA-C 101.521 -3.511 . . . . 0.94 101.521 172.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -82.12 -55.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.905 2.403 . . . . 0.67 115.533 -169.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . 0.643 HG12 HG23 ' E' ' 38' ' ' VAL . 24.9 t -75.21 95.69 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.019 0 N-CA-C 119.65 3.204 . . . . 0.64 119.65 -166.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' E' ' 30' ' ' SER . 68.1 mt -87.34 119.45 35.03 Favored 'Isoleucine or valine' 0 C--N 1.368 1.41 0 N-CA-C 104.97 -2.233 . . . . 0.65 104.97 172.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 38' ' ' VAL . . . . . 0.643 HG23 HG12 ' E' ' 36' ' ' VAL . 14.0 t -123.21 163.61 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-N 120.186 1.357 . . . . 0.23 111.62 -172.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 39' ' ' ARG . . . . . 0.457 ' CB ' ' H ' ' E' ' 23' ' ' THR . 43.6 ttm-85 -84.43 142.09 30.35 Favored 'General case' 0 C--N 1.363 1.193 0 C-N-CA 128.859 2.864 . . . . 2.75 113.92 174.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -137.33 128.59 27.95 Favored 'General case' 0 CA--C 1.514 -0.437 0 O-C-N 121.301 -0.874 . . . . 1.26 111.474 173.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -90.27 -38.44 13.41 Favored 'General case' 0 C--N 1.366 1.325 0 C-N-CA 126.356 1.862 . . . . 1.02 111.38 172.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -77.97 59.59 2.18 Favored 'General case' 0 C--N 1.37 1.468 0 C-N-CA 129.459 3.104 . . . . 1.29 112.767 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.353 0.726 0 C-N-CA 127.125 2.17 . . . . 1.23 105.538 172.948 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 123.316 1.531 . . . . 2.2 110.48 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 67.9 p -115.97 104.5 11.65 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 127.97 2.508 . . . . 0.47 106.472 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -110.29 138.88 46.07 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 107.5 -1.296 . . . . 1.57 107.5 -176.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -100.01 112.01 24.31 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-O 122.222 1.01 . . . . 2.07 109.868 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -104.16 172.7 6.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 123.909 1.814 . . . . 0.17 115.274 -175.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -102.42 94.13 5.52 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 112.218 -2.265 . . . . 0.17 109.24 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -7.43 -37.79 0.0 OUTLIER 'General case' 0 C--N 1.367 1.351 1 C-N-CA 134.778 5.231 . . . . 1.72 121.21 172.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -45.61 -46.53 14.45 Favored 'General case' 0 C--N 1.364 1.212 1 C-N-CA 132.715 4.406 . . . . 0.17 113.1 168.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -89.86 1.61 55.98 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 125.822 1.649 . . . . 1.18 112.168 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.475 ' HG ' HG11 ' E' ' 36' ' ' VAL . 0.5 OUTLIER -115.96 108.53 16.37 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 126.664 1.986 . . . . 0.19 114.126 179.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -106.44 143.0 35.18 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 125.721 1.608 . . . . 2.05 111.907 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -64.62 146.34 54.81 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 119.988 3.329 . . . . 0.29 119.988 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -144.47 -29.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.372 1.585 0 C-N-CA 126.91 2.084 . . . . 0.73 112.028 173.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 69' ' ' GLN . . . . . 0.627 ' HB2' ' H ' ' E' ' 7' ' ' LYS . 0.0 OUTLIER -114.51 116.47 28.88 Favored 'General case' 0 C--N 1.358 0.937 0 O-C-N 119.554 -1.966 . . . . 2.19 111.849 177.574 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.33 59.57 1.05 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.254 2.622 . . . . 0.0 113.125 174.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.47 58.46 2.66 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 129.021 2.928 . . . . 0.0 113.51 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.0 78.66 1.18 Allowed 'General case' 0 C--N 1.356 0.879 0 C-N-CA 128.189 2.596 . . . . 0.0 115.32 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt . . . . . 0 C--O 1.262 1.716 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 176.124 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' E' E ' 2' ' ' LEU . . . . . . . . . . . . 0.271 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 118.11 2.633 . . . . 0.99 118.11 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -136.3 -169.26 2.4 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 127.438 2.295 . . . . 0.8 111.321 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . 0.499 ' HB3' HG13 ' E' ' 27' ' ' VAL . 14.4 ptm180 -96.44 110.27 22.66 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 127.568 2.347 . . . . 3.4 114.528 176.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.25 -0.28 14.43 Favored Glycine 0 CA--C 1.477 -2.295 0 O-C-N 121.025 -1.047 . . . . 0.53 111.998 165.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 6' ' ' ASP . . . . . 0.482 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 46.1 t0 -72.83 137.51 45.78 Favored 'General case' 0 N--CA 1.408 -2.555 1 C-N-CA 133.153 4.581 . . . . 0.45 113.469 -176.233 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . 0.485 ' H ' ' CB ' ' E' ' 69' ' ' GLN . 13.7 mptt -87.87 77.37 8.54 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 106.485 -1.672 . . . . 2.03 106.485 171.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 8' ' ' VAL . . . . . 0.4 ' H ' HG22 ' E' ' 8' ' ' VAL . 15.0 m -87.42 138.93 18.14 Favored 'Isoleucine or valine' 0 C--N 1.369 1.438 0 C-N-CA 127.168 2.187 . . . . 0.13 106.224 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -105.35 113.93 27.81 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 120.77 -1.206 . . . . 0.17 112.55 -171.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.789 HD11 HG11 ' E' ' 38' ' ' VAL . 2.3 mm -52.89 120.89 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 N-CA-C 117.727 2.491 . . . . 0.12 117.727 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -121.06 48.48 1.64 Allowed 'General case' 0 C--N 1.372 1.563 0 C-N-CA 125.519 1.528 . . . . 0.3 113.606 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 13.7 ttt180 -102.25 111.73 24.14 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 128.237 2.615 . . . . 2.09 110.075 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 47.0 p -50.74 -59.13 4.41 Favored 'General case' 0 C--N 1.369 1.454 0 C-N-CA 131.279 3.831 . . . . 0.47 119.742 -175.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -87.77 65.55 8.45 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 127.927 2.491 . . . . 1.89 110.736 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 4.5 t -145.15 169.2 18.63 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-O 123.392 1.568 . . . . 1.13 111.287 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -95.67 -1.49 50.0 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 124.996 1.318 . . . . 0.79 109.561 166.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -118.13 23.67 11.47 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 126.347 1.859 . . . . 0.75 110.898 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -75.03 94.92 2.94 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 125.817 1.647 . . . . 0.4 112.193 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.95 34.24 4.38 Favored Glycine 0 C--N 1.359 1.809 0 C-N-CA 126.077 1.799 . . . . 0.39 110.16 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -110.66 152.16 26.84 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 126.829 2.052 . . . . 1.4 108.537 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.06 170.26 3.59 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 CA-C-N 120.216 1.371 . . . . 0.31 108.456 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.98 176.49 44.24 Favored Glycine 0 CA--C 1.474 -2.5 0 O-C-N 120.079 -1.638 . . . . 0.21 109.255 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 23' ' ' THR . . . . . 0.496 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 15.1 m -94.63 120.14 34.4 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 125.617 1.567 . . . . 0.27 110.478 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 24' ' ' VAL . . . . . 0.507 HG23 HG13 ' E' ' 36' ' ' VAL . 6.9 p -76.66 101.84 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 124.395 2.045 . . . . 0.29 112.69 173.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.89 46.1 1.3 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.167 1.387 . . . . 0.29 114.232 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 62.0 p -73.18 -86.3 0.03 OUTLIER 'General case' 0 C--N 1.354 0.794 0 C-N-CA 130.203 3.401 . . . . 0.63 114.863 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 27' ' ' VAL . . . . . 0.499 HG13 ' HB3' ' E' ' 4' ' ' ARG . 2.4 p -79.54 59.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.616 0 CA-C-O 126.519 3.057 . . . . 0.61 112.905 -169.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -160.62 -62.79 0.06 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.732 3.213 . . . . 1.61 107.233 -173.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.56 -18.19 16.73 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 127.202 2.201 . . . . 3.96 115.802 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -26.82 0.3 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.039 2 C-N-CA 134.866 5.266 . . . . 4.34 123.404 -172.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.54 43.54 1.86 Allowed Glycine 0 C--O 1.224 -0.496 1 C-N-CA 131.991 4.615 . . . . 1.76 114.939 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 32' ' ' ILE . . . . . 0.56 HD12 HD21 ' E' ' 59' ' ' ASN . 1.1 mt -131.77 -169.68 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 127.984 2.514 . . . . 1.11 105.853 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 33' ' ' LEU . . . . . 0.542 ' H ' HG22 ' E' ' 32' ' ' ILE . 32.2 tp -68.51 -44.49 74.53 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 117.287 2.328 . . . . 0.57 117.287 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -123.02 157.9 59.14 Favored Pre-proline 0 C--N 1.356 0.887 0 N-CA-C 106.261 -1.755 . . . . 0.94 106.261 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.68 -46.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.365 1.427 0 C-N-CA 123.439 2.759 . . . . 0.67 115.568 -166.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . 0.564 HG12 HG23 ' E' ' 38' ' ' VAL . 73.3 t -90.51 97.04 6.76 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 CA-C-O 122.688 1.232 . . . . 0.64 112.445 -170.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 56.9 mt -86.66 105.08 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 C-N-CA 127.958 2.503 . . . . 0.65 104.34 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 38' ' ' VAL . . . . . 0.789 HG11 HD11 ' E' ' 10' ' ' ILE . 21.1 t -105.38 156.21 6.38 Favored 'Isoleucine or valine' 0 C--N 1.349 0.547 0 CA-C-N 121.058 1.754 . . . . 0.23 111.546 -174.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 39' ' ' ARG . . . . . 0.496 ' HB3' ' H ' ' E' ' 23' ' ' THR . 17.5 tpp180 -81.8 131.83 35.27 Favored 'General case' 0 C--N 1.36 1.06 0 C-N-CA 127.785 2.434 . . . . 2.75 110.983 172.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -128.91 150.46 50.35 Favored 'General case' 0 CA--C 1.512 -0.489 0 O-C-N 121.743 -0.598 . . . . 1.26 110.648 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -96.16 -48.42 5.65 Favored 'General case' 0 C--N 1.36 1.045 0 C-N-CA 126.0 1.72 . . . . 1.02 109.81 173.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 86.4 mtm-85 -82.82 85.55 7.07 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 125.893 1.677 . . . . 1.29 114.837 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 14.4 t . . . . . 0 C--N 1.357 0.913 0 C-N-CA 127.111 2.164 . . . . 1.23 112.324 176.822 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 112.634 0.605 . . . . 2.2 112.634 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 7.2 p -126.15 121.39 32.68 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 128.723 2.809 . . . . 0.47 104.764 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -150.32 144.45 25.53 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.695 0.798 . . . . 1.57 109.561 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 59' ' ' ASN . . . . . 0.56 HD21 HD12 ' E' ' 32' ' ' ILE . 11.2 m120 -81.46 106.27 13.3 Favored 'General case' 0 C--N 1.352 0.677 0 C-N-CA 130.812 3.645 . . . . 2.07 120.117 -174.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 60' ' ' PHE . . . . . 0.436 ' CE2' HD12 ' E' ' 10' ' ' ILE . 26.1 m-85 -109.67 175.84 5.29 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 119.282 -2.136 . . . . 0.17 113.793 174.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -114.27 115.7 27.82 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 113.958 -1.474 . . . . 0.17 109.578 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -16.94 -38.13 0.0 OUTLIER 'General case' 0 C--N 1.367 1.351 1 C-N-CA 136.581 5.952 . . . . 1.72 118.496 173.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -49.84 -48.47 51.02 Favored 'General case' 0 C--N 1.37 1.492 0 C-N-CA 130.926 3.69 . . . . 0.17 113.932 169.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 13.2 pm0 -95.32 17.44 14.41 Favored 'General case' 0 C--N 1.363 1.175 0 C-N-CA 124.202 1.001 . . . . 1.18 112.16 -172.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.481 ' CD1' HG11 ' E' ' 36' ' ' VAL . 0.1 OUTLIER -120.76 138.15 54.15 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 107.524 -1.288 . . . . 0.19 107.524 173.445 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -110.39 126.28 54.11 Favored 'General case' 0 C--N 1.351 0.67 0 C-N-CA 124.501 1.12 . . . . 2.05 111.717 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.14 139.56 58.15 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 128.301 2.64 . . . . 0.29 117.695 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 t -135.26 -43.32 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.765 0 C-N-CA 126.35 1.86 . . . . 0.73 109.691 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 69' ' ' GLN . . . . . 0.485 ' CB ' ' H ' ' E' ' 7' ' ' LYS . 1.6 tp60 -106.09 113.19 26.58 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 128.284 2.633 . . . . 2.19 117.743 -168.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.76 68.1 6.88 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.958 171.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.31 53.39 0.07 Allowed 'General case' 0 C--N 1.373 1.594 0 N-CA-C 117.454 2.391 . . . . 0.0 117.454 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.05 130.96 35.42 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 126.92 2.088 . . . . 0.0 111.871 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 mptt . . . . . 0 C--O 1.262 1.729 0 C-N-CA 125.995 1.718 . . . . 0.0 110.356 179.019 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 2' ' ' LEU . . . . . 0.429 ' HB2' ' H ' ' E' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.722 0 CA-C-O 123.992 1.853 . . . . 0.99 115.637 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . 0.429 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 0.0 OUTLIER -140.56 -166.11 2.06 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 127.755 2.422 . . . . 0.8 109.417 -175.169 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -85.26 104.96 15.59 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 128.061 2.544 . . . . 3.4 117.24 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 112.72 -9.5 25.75 Favored Glycine 0 CA--C 1.485 -1.84 0 O-C-N 119.409 -2.057 . . . . 0.53 110.904 173.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.13 42.13 0.07 Allowed 'General case' 0 N--CA 1.438 -1.066 1 C-N-CA 133.903 4.881 . . . . 0.45 115.596 -176.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -5.74 93.21 0.01 OUTLIER 'General case' 0 C--N 1.362 1.15 1 C-N-CA 133.777 4.831 . . . . 2.03 117.058 -176.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 28.5 m -92.4 154.42 3.19 Favored 'Isoleucine or valine' 0 C--N 1.361 1.074 0 CA-C-N 121.149 1.795 . . . . 0.13 111.488 -172.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -103.17 109.0 20.42 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 121.446 -0.784 . . . . 0.17 111.92 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.785 HD11 HG11 ' E' ' 38' ' ' VAL . 1.3 mp -56.96 103.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.213 0 C-N-CA 129.805 3.242 . . . . 0.12 114.494 174.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -120.48 52.36 1.16 Allowed 'General case' 0 C--N 1.37 1.493 0 C-N-CA 124.43 1.092 . . . . 0.3 109.903 -172.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -72.17 -115.39 0.0 OUTLIER 'General case' 0 C--N 1.364 1.212 0 N-CA-C 118.792 2.886 . . . . 2.09 118.792 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -170.71 142.58 2.01 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 101.719 -3.438 . . . . 0.47 101.719 -174.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . 0.257 3.7 mm-40 -5.86 69.38 0.0 OUTLIER 'General case' 0 C--N 1.368 1.384 1 C-N-CA 134.343 5.057 . . . . 1.89 119.316 -174.65 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 75.3 m -138.39 154.57 48.92 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 130.182 3.393 . . . . 1.13 104.087 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -61.29 -11.17 8.67 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 130.127 3.371 . . . . 0.79 117.151 -176.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 22.9 m0 -113.26 -3.5 13.85 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 128.882 2.873 . . . . 0.75 113.371 -177.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -80.26 88.7 5.49 Favored 'General case' 0 C--N 1.373 1.602 0 C-N-CA 126.337 1.855 . . . . 0.4 110.291 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.34 -11.71 3.01 Favored Glycine 0 C--N 1.36 1.903 0 C-N-CA 126.74 2.114 . . . . 0.39 111.285 -175.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -97.75 162.59 13.19 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 119.66 1.73 . . . . 1.4 114.924 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -103.12 169.79 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.208 0 C-N-CA 126.717 2.007 . . . . 0.31 108.444 172.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.99 -179.78 41.25 Favored Glycine 0 CA--C 1.476 -2.406 0 N-CA-C 108.491 -1.844 . . . . 0.21 108.491 170.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 23' ' ' THR . . . . . 0.674 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 4.0 m -94.33 120.3 34.36 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 125.323 1.449 . . . . 0.27 111.496 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 24' ' ' VAL . . . . . 0.542 HG23 HG13 ' E' ' 36' ' ' VAL . 14.5 p -68.02 69.57 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 131.571 3.948 . . . . 0.29 112.862 175.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.58 45.15 1.21 Allowed 'General case' 0 C--N 1.362 1.149 0 O-C-N 118.401 -2.687 . . . . 0.29 110.095 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . 0.418 ' HA ' ' HB ' ' E' ' 37' ' ' ILE . 13.2 m -87.96 -62.1 1.57 Allowed 'General case' 0 CA--C 1.465 -2.29 1 C-N-CA 135.959 5.704 . . . . 0.63 119.323 -171.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 m -80.23 19.14 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.093 0 N-CA-C 116.586 2.069 . . . . 0.61 116.586 -156.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -111.28 -50.27 2.95 Favored 'General case' 0 N--CA 1.43 -1.473 1 C-N-CA 135.187 5.395 . . . . 1.61 109.311 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . 0.557 ' HB2' HD13 ' E' ' 37' ' ' ILE . 27.8 mmmt -103.19 -12.4 17.36 Favored 'General case' 0 C--N 1.366 1.283 0 C-N-CA 128.232 2.613 . . . . 3.96 113.194 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 8.4 t -43.53 -17.91 0.02 OUTLIER 'General case' 0 C--N 1.376 1.744 1 C-N-CA 132.084 4.153 . . . . 4.34 117.97 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.53 45.46 0.27 Allowed Glycine 0 C--N 1.355 1.589 0 C-N-CA 130.221 3.772 . . . . 1.76 117.058 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 32' ' ' ILE . . . . . 0.445 HG22 ' H ' ' E' ' 33' ' ' LEU . 0.3 OUTLIER -135.78 -159.36 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.913 0 C-N-CA 129.005 2.922 . . . . 1.11 111.031 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 33' ' ' LEU . . . . . 0.445 ' H ' HG22 ' E' ' 32' ' ' ILE . 22.0 tp -69.31 -23.06 63.75 Favored 'General case' 0 C--N 1.355 0.839 1 C-N-CA 133.335 4.654 . . . . 0.57 118.378 -177.753 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -134.55 152.72 78.32 Favored Pre-proline 0 C--N 1.362 1.131 0 N-CA-C 105.735 -1.95 . . . . 0.94 105.735 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.8 -45.74 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.9 3.067 . . . . 0.67 117.65 -173.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . 0.605 HG12 HG23 ' E' ' 38' ' ' VAL . 54.6 t -109.01 106.11 20.08 Favored 'Isoleucine or valine' 0 C--N 1.353 0.748 0 N-CA-C 115.296 1.591 . . . . 0.64 115.296 -167.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . 0.557 HD13 ' HB2' ' E' ' 29' ' ' LYS . 3.3 mp -85.33 118.31 31.97 Favored 'Isoleucine or valine' 0 C--N 1.37 1.492 0 C-N-CA 125.977 1.711 . . . . 0.65 106.921 173.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 38' ' ' VAL . . . . . 0.785 HG11 HD11 ' E' ' 10' ' ' ILE . 92.8 t -115.81 155.59 17.09 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 CA-C-O 122.128 0.966 . . . . 0.23 112.256 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 39' ' ' ARG . . . . . 0.674 ' HB3' ' H ' ' E' ' 23' ' ' THR . 1.9 tpm_? -75.47 139.55 42.32 Favored 'General case' 0 C--N 1.362 1.136 0 C-N-CA 130.118 3.367 . . . . 2.75 112.932 173.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 40' ' ' PHE . . . . . 0.454 ' H ' ' NH2' ' E' ' 39' ' ' ARG . 60.9 m-85 -145.66 109.17 4.7 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 129.16 2.984 . . . . 1.26 107.915 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -104.71 -11.11 17.03 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 129.116 2.966 . . . . 1.02 113.875 -176.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -94.16 9.7 36.84 Favored 'General case' 0 C--N 1.366 1.284 0 C-N-CA 126.503 1.921 . . . . 1.29 113.226 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.351 0.638 0 C-N-CA 128.16 2.584 . . . . 1.23 111.522 178.631 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 27.7 t30 . . . . . 0 CA--C 1.534 0.328 0 N-CA-C 113.515 0.931 . . . . 2.2 113.515 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 71.4 p -109.43 108.02 18.38 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.139 1.376 . . . . 0.47 108.653 176.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.83 146.99 36.69 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 125.828 1.651 . . . . 1.57 109.548 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -89.27 113.93 25.24 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 129.812 3.245 . . . . 2.07 111.226 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 60' ' ' PHE . . . . . 0.423 ' HB2' HD11 ' E' ' 65' ' ' LEU . 19.5 m-85 -107.0 174.39 5.91 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.95 1.7 . . . . 0.17 113.66 -176.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.7 89.38 3.67 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 130.195 3.398 . . . . 0.17 110.643 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -26.16 -18.39 0.0 OUTLIER 'General case' 0 C--N 1.354 0.797 1 C-N-CA 136.072 5.749 . . . . 1.72 120.39 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.89 -32.8 72.25 Favored 'General case' 0 C--N 1.367 1.335 0 C-N-CA 129.148 2.979 . . . . 0.17 112.729 168.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.27 18.07 21.88 Favored 'General case' 0 C--N 1.371 1.516 0 C-N-CA 125.832 1.653 . . . . 1.18 110.285 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.447 HD13 HG11 ' E' ' 36' ' ' VAL . 74.1 mt -128.18 118.81 24.03 Favored 'General case' 0 C--N 1.366 1.295 0 CA-C-O 123.526 1.631 . . . . 0.19 111.934 177.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -111.18 134.5 52.73 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.863 1.665 . . . . 2.05 109.145 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.65 133.76 36.22 Favored 'General case' 0 C--N 1.366 1.318 1 C-N-CA 132.161 4.185 . . . . 0.29 118.547 175.468 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . 0.269 3.1 t -132.13 -33.43 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.372 1.556 0 N-CA-C 114.758 1.392 . . . . 0.73 114.758 178.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 69' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -111.13 139.69 46.3 Favored 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 119.443 -2.036 . . . . 2.19 109.685 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.12 64.61 6.88 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.55 1.94 . . . . 0.0 114.045 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.9 68.25 2.77 Favored 'General case' 0 C--N 1.362 1.129 0 CA-C-O 123.444 1.592 . . . . 0.0 110.792 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.08 64.66 4.62 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 125.717 1.607 . . . . 0.0 109.849 176.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 19.0 pttm . . . . . 0 C--O 1.261 1.694 0 C-N-CA 127.486 2.314 . . . . 0.0 107.143 176.252 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' E' E ' 2' ' ' LEU . . . . . 0.716 HD22 HG11 ' E' ' 8' ' ' VAL 0.279 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 123.773 1.749 . . . . 0.99 111.957 . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.09 172.79 12.58 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 124.2 1.952 . . . . 0.8 114.418 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.09 94.34 7.89 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 127.124 2.17 . . . . 3.4 112.86 176.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.27 3.44 9.61 Favored Glycine 0 C--N 1.365 2.172 0 O-C-N 120.697 -1.252 . . . . 0.53 111.388 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 6' ' ' ASP . . . . . 0.509 ' HA ' HE21 ' E' ' 69' ' ' GLN . 18.3 t0 -69.28 143.94 53.72 Favored 'General case' 0 N--CA 1.417 -2.092 0 C-N-CA 130.739 3.615 . . . . 0.45 112.752 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -94.15 83.72 4.32 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 104.93 -2.248 . . . . 2.03 104.93 171.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 8' ' ' VAL . . . . . 0.716 HG11 HD22 ' E' ' 2' ' ' LEU . 17.5 m -89.79 144.31 9.37 Favored 'Isoleucine or valine' 0 C--N 1.365 1.252 0 N-CA-C 107.517 -1.29 . . . . 0.13 107.517 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . 0.422 HH21 ' HA2' ' E' ' 19' ' ' GLY . 69.1 ttt-85 -104.05 122.68 45.77 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 120.154 -1.591 . . . . 0.17 110.817 -175.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.613 HD11 HG11 ' E' ' 38' ' ' VAL . 0.5 OUTLIER -67.75 120.93 15.96 Favored 'Isoleucine or valine' 0 C--N 1.363 1.165 0 C-N-CA 126.939 2.096 . . . . 0.12 113.808 177.217 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -126.96 52.82 1.75 Allowed 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 127.997 2.519 . . . . 0.3 110.481 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -92.46 -138.86 0.18 Allowed 'General case' 0 C--N 1.372 1.564 0 O-C-N 120.221 -1.549 . . . . 2.09 109.946 172.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 13' ' ' THR . . . . . 0.407 ' HA ' ' CD2' ' E' ' 18' ' ' TYR 0.251 23.0 m -152.76 -60.43 0.15 Allowed 'General case' 0 C--N 1.357 0.899 0 O-C-N 118.256 -2.777 . . . . 0.47 108.764 174.352 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -75.23 67.34 1.84 Allowed 'General case' 0 C--N 1.354 0.796 0 O-C-N 119.962 -1.711 . . . . 1.89 114.453 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 23.8 t -162.12 159.68 26.34 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 125.459 1.504 . . . . 1.13 111.746 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -77.03 -27.45 54.53 Favored 'General case' 0 C--N 1.363 1.153 0 C-N-CA 130.941 3.697 . . . . 0.79 110.179 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 24.5 m0 -93.71 17.97 10.97 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 129.368 3.067 . . . . 0.75 113.052 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 18' ' ' TYR . . . . . 0.407 ' CD2' ' HA ' ' E' ' 13' ' ' THR . 2.6 t80 -74.63 112.17 10.55 Favored 'General case' 0 C--N 1.368 1.411 0 C-N-CA 126.362 1.865 . . . . 0.4 108.421 173.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 19' ' ' GLY . . . . . 0.422 ' HA2' HH21 ' E' ' 9' ' ' ARG . . . 94.53 34.14 6.47 Favored Glycine 0 C--N 1.354 1.534 0 C-N-CA 128.651 3.025 . . . . 0.39 113.923 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -105.42 163.86 12.31 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 118.968 1.384 . . . . 1.4 113.09 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.25 149.47 25.67 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 N-CA-C 105.603 -1.999 . . . . 0.31 105.603 175.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.08 178.35 47.54 Favored Glycine 0 CA--C 1.472 -2.629 0 C-N-CA 118.146 -1.978 . . . . 0.21 110.226 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 7.0 m -90.01 120.93 31.63 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 124.844 1.258 . . . . 0.27 113.222 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 24' ' ' VAL . . . . . 0.413 HG12 ' H ' ' E' ' 24' ' ' VAL . 7.3 p -77.57 91.54 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 125.374 2.512 . . . . 0.29 110.768 175.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.62 53.76 2.9 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 119.879 -1.763 . . . . 0.29 111.268 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 22.1 m -87.69 -59.82 2.14 Favored 'General case' 0 CA--C 1.476 -1.868 0 C-N-CA 130.169 3.387 . . . . 0.63 117.667 -174.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -84.41 62.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.767 0 CA-C-O 126.421 3.01 . . . . 0.61 112.843 -164.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -148.27 -66.51 0.24 Allowed 'General case' 0 N--CA 1.415 -2.209 2 C-N-CA 132.282 4.233 . . . . 1.61 104.988 -177.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -110.31 5.02 21.32 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 128.089 2.556 . . . . 3.96 114.642 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 3.8 t -50.96 -18.96 0.87 Allowed 'General case' 0 C--N 1.369 1.44 0 C-N-CA 130.043 3.337 . . . . 4.34 118.304 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.59 43.89 0.47 Allowed Glycine 0 C--N 1.349 1.295 0 C-N-CA 129.856 3.598 . . . . 1.76 116.949 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 32' ' ' ILE . . . . . 0.564 HG22 ' H ' ' E' ' 33' ' ' LEU . 0.7 OUTLIER -133.1 -166.02 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.834 0 C-N-CA 128.651 2.78 . . . . 1.11 109.599 -179.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 33' ' ' LEU . . . . . 0.564 ' H ' HG22 ' E' ' 32' ' ' ILE . 49.1 tp -69.85 -22.55 63.26 Favored 'General case' 0 C--N 1.359 0.98 1 C-N-CA 131.829 4.052 . . . . 0.57 116.786 -177.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -137.28 127.75 15.92 Favored Pre-proline 0 C--N 1.359 0.989 0 N-CA-C 105.316 -2.105 . . . . 0.94 105.316 176.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -82.3 -42.68 0.1 OUTLIER 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 124.702 3.601 . . . . 0.67 117.111 -171.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . 0.536 HG12 HG23 ' E' ' 38' ' ' VAL . 76.4 t -84.18 101.37 8.67 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 C-N-CA 127.728 2.411 . . . . 0.64 113.4 -168.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 78.5 mt -101.68 81.04 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.206 0 C-N-CA 124.973 1.309 . . . . 0.65 107.692 -176.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 38' ' ' VAL . . . . . 0.613 HG11 HD11 ' E' ' 10' ' ' ILE . 57.0 t -89.23 164.82 2.13 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 O-C-N 119.488 -2.008 . . . . 0.23 112.644 -173.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 39' ' ' ARG . . . . . . . . . . . . . 29.1 mmt85 -82.25 142.05 32.44 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 128.729 2.812 . . . . 2.75 113.461 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -132.09 138.63 48.19 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.413 1.085 . . . . 1.26 111.9 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -101.19 -34.79 9.54 Favored 'General case' 0 C--N 1.374 1.638 0 C-N-CA 125.836 1.654 . . . . 1.02 113.094 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 34.4 mtt180 -83.91 49.87 1.71 Allowed 'General case' 0 C--N 1.36 1.049 0 C-N-CA 128.494 2.718 . . . . 1.29 116.242 -170.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . 0.308 4.3 p . . . . . 0 CA--C 1.541 0.601 0 O-C-N 119.4 -2.062 . . . . 1.23 105.79 167.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 30.5 m120 . . . . . 0 N--CA 1.469 0.518 0 CA-C-O 121.132 0.491 . . . . 2.2 111.733 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 1.9 p -121.63 128.57 52.05 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 104.056 -2.572 . . . . 0.47 104.056 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.74 132.03 11.96 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 108.119 -1.067 . . . . 1.57 108.119 -168.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -80.69 110.82 16.55 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 130.071 3.348 . . . . 2.07 116.018 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 60' ' ' PHE . . . . . 0.416 ' CZ ' HG21 ' E' ' 10' ' ' ILE . 24.7 m-85 -114.31 179.86 3.83 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 127.422 2.289 . . . . 0.17 114.035 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.82 109.41 16.54 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 114.706 1.373 . . . . 0.17 114.706 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -19.74 0.4 0.0 OUTLIER 'General case' 0 C--N 1.374 1.638 2 C-N-CA 137.357 6.263 . . . . 1.72 124.489 172.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.09 -45.04 6.06 Favored 'General case' 0 N--CA 1.438 -1.055 1 C-N-CA 132.241 4.217 . . . . 0.17 106.322 171.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -88.68 18.25 4.84 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 120.083 -1.635 . . . . 1.18 110.867 -170.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . . . . . . . . 0.313 0.1 OUTLIER -134.17 157.7 45.55 Favored 'General case' 0 N--CA 1.43 -1.464 1 C-N-CA 132.768 4.427 . . . . 0.19 106.317 172.186 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -137.39 149.25 46.8 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 105.665 -1.976 . . . . 2.05 105.665 162.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . 0.492 ' H ' HD23 ' E' ' 67' ' ' LEU 0.252 2.5 pt? -91.54 149.01 21.87 Favored 'General case' 0 C--N 1.363 1.187 0 O-C-N 118.798 -2.439 . . . . 0.29 117.511 -177.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 4.4 t -112.09 -37.48 2.84 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 C-N-CA 126.794 2.038 . . . . 0.73 110.346 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 69' ' ' GLN . . . . . 0.509 HE21 ' HA ' ' E' ' 6' ' ' ASP . 24.7 mt-30 -103.41 153.78 20.12 Favored 'General case' 0 C--N 1.356 0.875 0 CA-C-O 126.916 3.246 . . . . 2.19 115.286 -174.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.26 68.74 0.77 Allowed 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 108.476 -3.966 . . . . 0.0 109.584 170.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.5 74.3 3.23 Favored 'General case' 0 C--N 1.362 1.137 0 O-C-N 120.076 -1.64 . . . . 0.0 112.465 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.1 80.21 7.72 Favored 'General case' 0 C--N 1.36 1.065 0 C-N-CA 129.08 2.952 . . . . 0.0 111.753 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 71.7 tttt . . . . . 0 C--O 1.264 1.826 0 C-N-CA 127.089 2.156 . . . . 0.0 107.93 176.02 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' E' E ' 2' ' ' LEU . . . . . 0.51 HD12 ' HB3' ' E' ' 65' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.169 0 N-CA-C 117.93 2.567 . . . . 0.99 117.93 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . 0.445 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 0.2 OUTLIER -146.97 177.06 9.44 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 130.794 3.638 . . . . 0.8 107.298 -178.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -78.66 117.74 20.1 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 120.69 3.589 . . . . 3.4 120.69 -172.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.63 5.93 53.33 Favored Glycine 0 C--N 1.376 2.784 0 O-C-N 118.184 -2.823 . . . . 0.53 114.332 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.65 145.89 30.34 Favored 'General case' 0 N--CA 1.411 -2.4 1 C-N-CA 132.024 4.13 . . . . 0.45 110.983 -176.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . 0.611 ' H ' ' CB ' ' E' ' 69' ' ' GLN . 49.3 mttm -93.08 71.76 4.62 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 128.524 2.73 . . . . 2.03 107.973 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 15.8 m -88.69 148.64 4.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 C-N-CA 123.684 0.794 . . . . 0.13 110.891 -173.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -105.95 123.92 48.76 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 119.314 -0.374 . . . . 0.17 110.917 -173.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.681 HD11 HG11 ' E' ' 38' ' ' VAL . 2.2 mm -73.29 114.68 13.09 Favored 'Isoleucine or valine' 0 C--N 1.36 1.06 0 C-N-CA 125.755 1.622 . . . . 0.12 114.968 177.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -115.91 57.27 0.75 Allowed 'General case' 0 C--N 1.375 1.675 0 C-N-CA 124.172 0.989 . . . . 0.3 113.669 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.62 123.14 48.58 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 126.08 1.752 . . . . 2.09 109.059 171.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 24.6 p -72.66 -6.56 45.2 Favored 'General case' 0 C--N 1.368 1.412 0 C-N-CA 128.941 2.896 . . . . 0.47 117.273 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -97.16 41.12 1.12 Allowed 'General case' 0 C--N 1.357 0.906 0 C-N-CA 128.54 2.736 . . . . 1.89 112.27 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 35.3 t -164.8 166.19 19.98 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 119.97 -1.706 . . . . 1.13 107.247 -178.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -89.59 -5.6 57.04 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 127.123 2.169 . . . . 0.79 110.369 171.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 29.6 m0 -94.76 16.68 15.18 Favored 'General case' 0 C--N 1.372 1.573 0 C-N-CA 129.166 2.986 . . . . 0.75 110.478 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -73.34 102.5 3.73 Favored 'General case' 0 C--N 1.364 1.221 0 C-N-CA 128.159 2.584 . . . . 0.4 110.873 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.58 32.97 6.05 Favored Glycine 0 C--N 1.358 1.757 0 C-N-CA 126.203 1.859 . . . . 0.39 112.602 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -106.93 135.19 48.9 Favored 'General case' 0 C--N 1.366 1.288 0 CA-C-N 119.255 1.528 . . . . 1.4 112.255 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.72 145.84 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 C-N-CA 128.299 2.64 . . . . 0.31 107.257 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' E' ' 7' ' ' LYS . . . -174.03 178.1 46.02 Favored Glycine 0 CA--C 1.473 -2.563 0 N-CA-C 108.864 -1.694 . . . . 0.21 108.864 172.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 20.7 m -86.18 125.4 33.5 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.505 1.122 . . . . 0.27 112.002 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 24' ' ' VAL . . . . . 0.481 HG23 HG13 ' E' ' 36' ' ' VAL . 12.6 p -80.92 95.87 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 126.078 1.751 . . . . 0.29 111.473 175.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.74 51.43 1.85 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.067 2.147 . . . . 0.29 112.803 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 2.6 p -73.08 -73.12 0.22 Allowed 'General case' 0 CA--C 1.504 -0.817 1 C-N-CA 136.257 5.823 . . . . 0.63 120.114 -173.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 4.4 m -81.23 18.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.553 0 C-N-CA 128.085 2.554 . . . . 0.61 117.058 -163.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -98.26 -69.43 0.76 Allowed 'General case' 0 N--CA 1.431 -1.416 1 C-N-CA 132.011 4.125 . . . . 1.61 107.693 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -106.81 -26.89 11.07 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 115.849 1.796 . . . . 3.96 115.849 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.45 22.03 3.12 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 117.432 2.382 . . . . 4.34 117.432 -170.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.25 46.49 0.81 Allowed Glycine 0 C--N 1.353 1.525 0 C-N-CA 127.97 2.7 . . . . 1.76 114.505 167.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 32' ' ' ILE . . . . . 0.521 HG22 ' H ' ' E' ' 33' ' ' LEU . 1.9 mt -122.32 -146.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 130.962 3.705 . . . . 1.11 104.664 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 33' ' ' LEU . . . . . 0.521 ' H ' HG22 ' E' ' 32' ' ' ILE . 39.8 tp -62.08 -61.57 2.39 Favored 'General case' 0 C--N 1.345 0.379 0 C-N-CA 129.392 3.077 . . . . 0.57 115.181 176.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -97.67 111.01 57.63 Favored Pre-proline 0 C--N 1.363 1.177 0 C-N-CA 124.208 1.003 . . . . 0.94 109.688 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.86 -38.52 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.727 1 C-N-CA 125.318 4.012 . . . . 0.67 116.141 -173.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . 0.674 HG11 ' HG ' ' E' ' 65' ' ' LEU . 59.4 t -88.44 94.21 4.62 Favored 'Isoleucine or valine' 0 C--N 1.349 0.553 0 N-CA-C 116.19 1.922 . . . . 0.64 116.19 -169.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 96.4 mt -89.82 99.92 10.14 Favored 'Isoleucine or valine' 0 C--N 1.36 1.03 0 C-N-CA 126.461 1.904 . . . . 0.65 106.719 176.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 38' ' ' VAL . . . . . 0.681 HG11 HD11 ' E' ' 10' ' ' ILE . 81.3 t -104.93 156.3 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 120.769 -1.207 . . . . 0.23 111.945 -173.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 39' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -79.97 139.5 37.0 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 130.581 3.552 . . . . 2.75 111.973 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -137.29 149.08 46.83 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.317 -1.49 . . . . 1.26 111.929 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -103.55 -23.76 13.47 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 127.071 2.148 . . . . 1.02 111.282 172.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 67.2 mtt-85 -82.04 40.37 0.62 Allowed 'General case' 0 C--N 1.366 1.287 0 C-N-CA 129.397 3.079 . . . . 1.29 111.855 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.448 -0.549 0 C-N-CA 126.925 2.09 . . . . 1.23 110.377 -175.114 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 14.6 t30 . . . . . 0 CA--C 1.532 0.254 0 CA-C-O 121.683 0.754 . . . . 2.2 112.893 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 31.8 p -129.21 121.71 28.21 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 128.612 2.765 . . . . 0.47 106.57 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.75 139.79 15.4 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 119.513 1.051 . . . . 1.57 112.399 -175.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -63.05 119.78 10.15 Favored 'General case' 0 C--N 1.358 0.937 1 C-N-CA 132.035 4.134 . . . . 2.07 119.9 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 60' ' ' PHE . . . . . 0.432 ' CD2' HD12 ' E' ' 10' ' ' ILE . 39.5 m-85 -124.67 170.26 11.15 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 123.514 1.626 . . . . 0.17 113.44 174.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.92 92.32 6.05 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 129.765 3.226 . . . . 0.17 109.05 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -18.15 -21.72 0.0 OUTLIER 'General case' 0 C--N 1.358 0.95 1 C-N-CA 136.434 5.893 . . . . 1.72 121.68 173.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -73.58 -29.67 62.56 Favored 'General case' 0 C--N 1.362 1.149 0 C-N-CA 129.443 3.097 . . . . 0.17 113.173 169.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -84.33 -14.81 48.64 Favored 'General case' 0 C--N 1.375 1.692 0 C-N-CA 127.217 2.207 . . . . 1.18 108.351 -175.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.674 ' HG ' HG11 ' E' ' 36' ' ' VAL . 0.6 OUTLIER -104.48 108.48 19.93 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 128.395 2.678 . . . . 0.19 115.41 -176.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -89.9 149.4 22.64 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 129.735 3.214 . . . . 2.05 112.076 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -82.77 141.61 32.22 Favored 'General case' 0 C--N 1.366 1.316 0 CA-C-N 121.638 2.017 . . . . 0.29 115.677 174.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 18.9 t -130.61 -19.4 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.873 0 CA-C-O 123.528 1.632 . . . . 0.73 108.226 171.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 69' ' ' GLN . . . . . 0.611 ' CB ' ' H ' ' E' ' 7' ' ' LYS . 4.9 tp-100 -110.28 155.24 22.33 Favored 'General case' 0 N--CA 1.424 -1.729 0 C-N-CA 127.173 2.189 . . . . 2.19 111.848 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.02 42.06 1.26 Allowed 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 128.478 2.711 . . . . 0.0 114.316 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.95 63.11 7.9 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 125.243 1.417 . . . . 0.0 108.278 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.9 80.16 2.98 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 128.05 2.54 . . . . 0.0 112.097 -173.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? . . . . . 0 C--O 1.257 1.459 0 N-CA-C 103.039 -2.949 . . . . 0.0 103.039 172.196 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' E' E ' 2' ' ' LEU . . . . . 0.503 HD22 HG11 ' E' ' 8' ' ' VAL 0.306 2.0 pp . . . . . 0 N--CA 1.446 -0.627 0 CA-C-O 123.489 1.614 . . . . 0.99 111.844 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . 0.417 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 9.2 m120 -140.23 168.71 19.17 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 129.303 3.041 . . . . 0.8 111.7 -172.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -95.11 96.8 9.48 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 126.677 1.991 . . . . 3.4 112.233 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.62 17.26 3.55 Favored Glycine 0 C--N 1.368 2.329 0 O-C-N 119.922 -1.736 . . . . 0.53 113.145 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 6' ' ' ASP . . . . . 0.435 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 53.8 t0 -90.84 143.04 27.13 Favored 'General case' 0 N--CA 1.411 -2.375 1 C-N-CA 131.8 4.04 . . . . 0.45 109.325 -178.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . 0.582 ' H ' ' HB3' ' E' ' 69' ' ' GLN . 63.7 mmtt -92.9 82.23 4.66 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 104.966 -2.235 . . . . 2.03 104.966 173.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 8' ' ' VAL . . . . . 0.503 HG11 HD22 ' E' ' 2' ' ' LEU . 15.6 m -88.43 133.56 30.5 Favored 'Isoleucine or valine' 0 C--N 1.359 1.015 0 N-CA-C 105.078 -2.193 . . . . 0.13 105.078 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -91.71 110.38 21.71 Favored 'General case' 0 CA--C 1.502 -0.887 0 O-C-N 121.237 -0.915 . . . . 0.17 111.354 -174.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.539 HG23 ' CE2' ' E' ' 60' ' ' PHE . 5.4 mm -53.37 107.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.503 0 N-CA-C 119.839 3.274 . . . . 0.12 119.839 175.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . 0.4 ' HA ' ' CE1' ' E' ' 18' ' ' TYR . 13.8 mtmm -119.02 49.77 1.29 Allowed 'General case' 0 C--N 1.379 1.887 0 C-N-CA 127.163 2.185 . . . . 0.3 111.485 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -76.49 -118.54 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 120.178 3.399 . . . . 2.09 120.178 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 3.5 m -150.55 -49.09 0.13 Allowed 'General case' 0 C--N 1.358 0.938 0 O-C-N 120.258 -1.526 . . . . 0.47 108.553 -176.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -85.59 89.94 7.86 Favored 'General case' 0 C--N 1.363 1.167 0 N-CA-C 115.509 1.67 . . . . 1.89 115.509 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 15' ' ' SER . . . . . 0.419 ' HA ' ' HB3' ' E' ' 18' ' ' TYR 0.285 1.4 m -53.68 28.96 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 1 N-CA-C 121.989 4.07 . . . . 1.13 121.989 179.968 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.45 -51.26 4.42 Favored 'General case' 0 C--N 1.352 0.691 1 C-N-CA 131.788 4.035 . . . . 0.79 102.274 163.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 17' ' ' TRP . . . . . 0.412 ' O ' HG21 ' E' ' 10' ' ' ILE . 15.8 m0 -114.97 35.15 4.45 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.66 1.584 . . . . 0.75 111.186 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 18' ' ' TYR . . . . . 0.419 ' HB3' ' HA ' ' E' ' 15' ' ' SER . 1.2 t80 -139.42 133.82 31.54 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 106.418 -1.697 . . . . 0.4 106.418 175.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.3 46.75 1.52 Allowed Glycine 0 C--N 1.358 1.779 0 C-N-CA 127.202 2.334 . . . . 0.39 109.449 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -168.72 176.24 5.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.363 -1.717 . . . . 1.4 106.363 -171.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 p -109.57 175.9 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 127.579 2.352 . . . . 0.31 108.348 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.79 169.49 41.48 Favored Glycine 0 CA--C 1.476 -2.381 0 N-CA-C 108.231 -1.948 . . . . 0.21 108.231 173.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 10.9 m -97.72 114.75 26.82 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 125.727 1.611 . . . . 0.27 110.587 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 12.3 p -76.35 86.84 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-O 125.974 2.797 . . . . 0.29 112.097 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -94.72 57.4 2.17 Favored 'General case' 0 C--O 1.225 -0.213 0 O-C-N 119.172 -2.205 . . . . 0.29 108.995 175.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . 0.439 ' HB3' ' HA ' ' E' ' 36' ' ' VAL . 10.6 p -79.76 -81.45 0.12 Allowed 'General case' 0 CA--C 1.495 -1.165 1 C-N-CA 134.67 5.188 . . . . 0.63 118.705 -168.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 27' ' ' VAL . . . . . 0.406 HG12 ' H ' ' E' ' 27' ' ' VAL . 5.7 p -83.82 59.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 128.976 2.91 . . . . 0.61 111.51 -169.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -145.71 -50.88 0.24 Allowed 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 127.329 2.252 . . . . 1.61 106.4 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -105.42 -22.93 12.92 Favored 'General case' 0 C--N 1.37 1.483 0 C-N-CA 127.748 2.419 . . . . 3.96 113.45 175.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 58.8 m -68.35 55.81 0.08 Allowed 'General case' 0 C--N 1.378 1.824 0 C-N-CA 128.698 2.799 . . . . 4.34 117.831 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.71 32.88 5.91 Favored Glycine 0 C--O 1.222 -0.6 1 C-N-CA 131.608 4.432 . . . . 1.76 111.197 162.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 2.3 mt -112.19 -136.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.577 0 C-N-CA 129.014 2.925 . . . . 1.11 107.405 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 12.5 tp -90.57 -69.45 0.73 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 128.731 2.812 . . . . 0.57 112.822 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -96.94 156.99 35.79 Favored Pre-proline 0 C--N 1.372 1.571 0 O-C-N 120.185 -1.572 . . . . 0.94 110.809 -175.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.82 -51.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 123.809 3.006 . . . . 0.67 116.595 -170.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . 0.591 HG12 HG23 ' E' ' 38' ' ' VAL . 95.2 t -79.48 110.28 15.0 Favored 'Isoleucine or valine' 0 C--N 1.348 0.504 0 C-N-CA 129.426 3.09 . . . . 0.64 113.068 -170.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 70.5 mt -107.81 97.55 5.83 Favored 'Isoleucine or valine' 0 C--N 1.372 1.578 0 N-CA-C 104.403 -2.443 . . . . 0.65 104.403 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 38' ' ' VAL . . . . . 0.591 HG23 HG12 ' E' ' 36' ' ' VAL . 37.8 t -107.38 141.88 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 O-C-N 120.497 -1.377 . . . . 0.23 114.125 -167.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 39' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -69.95 144.83 52.26 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 128.448 2.699 . . . . 2.75 114.189 174.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 40' ' ' PHE . . . . . 0.444 ' CE1' HG12 ' E' ' 38' ' ' VAL . 84.8 m-85 -153.52 166.98 31.01 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 106.37 -1.715 . . . . 1.26 106.37 171.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -106.38 -27.92 10.68 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 129.357 3.063 . . . . 1.02 108.888 165.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -75.77 45.18 0.32 Allowed 'General case' 0 C--N 1.371 1.536 0 C-N-CA 127.359 2.264 . . . . 1.29 115.169 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 8.7 m . . . . . 0 N--CA 1.446 -0.627 0 CA-C-O 123.877 1.798 . . . . 1.23 110.628 178.344 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 . . . . . 0 N--CA 1.473 0.692 0 CA-C-O 122.736 1.255 . . . . 2.2 114.092 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 2.8 p -150.83 149.33 29.58 Favored 'General case' 0 C--N 1.356 0.874 1 C-N-CA 133.708 4.803 . . . . 0.47 107.371 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . 0.323 11.8 p30 -159.31 168.41 26.48 Favored 'General case' 0 C--N 1.364 1.225 0 CA-C-N 121.606 2.003 . . . . 1.57 108.351 170.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -97.75 113.28 25.02 Favored 'General case' 0 C--N 1.363 1.175 0 C-N-CA 126.736 2.014 . . . . 2.07 116.225 -172.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 60' ' ' PHE . . . . . 0.539 ' CE2' HG23 ' E' ' 10' ' ' ILE . 16.1 m-85 -118.16 170.22 9.05 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 127.529 2.332 . . . . 0.17 113.243 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.34 113.27 19.17 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.992 2.117 . . . . 0.17 112.231 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -26.54 -18.08 0.0 OUTLIER 'General case' 0 C--N 1.371 1.532 1 C-N-CA 134.652 5.181 . . . . 1.72 121.309 174.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -59.39 -49.19 78.76 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 131.418 3.887 . . . . 0.17 111.887 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -94.44 12.54 26.83 Favored 'General case' 0 C--N 1.361 1.107 0 CA-C-N 114.598 -1.183 . . . . 1.18 112.836 -170.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . . . . . . . . 0.261 1.0 OUTLIER -120.91 119.15 31.77 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 127.723 2.409 . . . . 0.19 114.209 -177.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -111.03 136.47 49.99 Favored 'General case' 0 C--N 1.362 1.129 0 O-C-N 120.958 -1.089 . . . . 2.05 111.482 171.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.69 140.51 51.14 Favored 'General case' 0 C--N 1.365 1.268 0 C-N-CA 130.84 3.656 . . . . 0.29 120.096 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . 0.255 2.0 t -139.78 -33.95 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.373 1.593 0 C-N-CA 126.728 2.011 . . . . 0.73 114.092 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 69' ' ' GLN . . . . . 0.582 ' HB3' ' H ' ' E' ' 7' ' ' LYS . 16.6 tt0 -112.53 104.81 12.92 Favored 'General case' 0 C--N 1.361 1.087 0 O-C-N 119.887 -1.758 . . . . 2.19 109.585 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.77 62.52 0.07 Allowed 'General case' 0 C--N 1.349 0.546 0 C-N-CA 127.909 2.484 . . . . 0.0 114.808 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.05 67.67 9.76 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 128.939 2.896 . . . . 0.0 109.514 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.24 47.65 0.02 OUTLIER 'General case' 0 C--N 1.362 1.128 0 C-N-CA 130.201 3.401 . . . . 0.0 116.835 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 25.4 tptp . . . . . 0 N--CA 1.42 -1.944 1 C-N-CA 133.582 4.753 . . . . 0.0 104.878 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 2' ' ' LEU . . . . . 0.497 HD11 HG21 ' E' ' 36' ' ' VAL 0.31 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.686 0 N-CA-C 119.794 3.257 . . . . 0.99 119.794 . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . 0.407 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 0.0 OUTLIER -150.49 177.86 9.6 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 125.633 1.573 . . . . 0.8 110.805 -170.043 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 23.3 ptt-85 -65.88 67.85 0.05 OUTLIER 'General case' 0 C--N 1.365 1.249 1 C-N-CA 132.816 4.446 . . . . 3.4 119.515 -174.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 125.38 25.38 1.46 Allowed Glycine 0 CA--C 1.491 -1.463 0 C-N-CA 126.72 2.105 . . . . 0.53 111.942 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 6' ' ' ASP . . . . . 0.505 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 20.8 t0 -71.04 129.88 40.13 Favored 'General case' 0 C--N 1.367 1.353 0 C-N-CA 125.302 1.441 . . . . 0.45 111.553 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . 0.493 ' H ' ' CB ' ' E' ' 69' ' ' GLN . 31.6 mtmm -89.01 85.85 6.8 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 102.99 -2.967 . . . . 2.03 102.99 171.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 8' ' ' VAL . . . . . 0.46 HG21 HD12 ' E' ' 65' ' ' LEU . 1.5 m -89.68 138.48 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 127.638 2.375 . . . . 0.13 106.323 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' E' ' 21' ' ' VAL . 1.5 tmt_? -101.5 86.1 2.9 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 121.438 -0.789 . . . . 0.17 111.677 -174.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.718 HD11 HG11 ' E' ' 38' ' ' VAL . 1.1 mm -41.4 121.49 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.713 0 N-CA-C 120.751 3.611 . . . . 0.12 120.751 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -118.84 37.81 3.98 Favored 'General case' 0 C--N 1.373 1.609 0 C-N-CA 126.868 2.067 . . . . 0.3 111.301 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.66 127.3 42.51 Favored 'General case' 0 C--N 1.365 1.255 0 C-N-CA 130.402 3.481 . . . . 2.09 110.028 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 25.0 p -76.8 -55.95 5.04 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 129.585 3.154 . . . . 0.47 113.819 -174.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -78.56 68.68 4.6 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 129.79 3.236 . . . . 1.89 110.55 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 46.9 t -163.42 167.5 21.53 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 127.844 2.458 . . . . 1.13 104.426 -175.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -94.37 -9.23 36.44 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 127.914 2.485 . . . . 0.79 111.521 175.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -125.83 45.19 2.67 Favored 'General case' 0 C--N 1.366 1.287 0 O-C-N 120.703 -1.248 . . . . 0.75 111.879 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -71.83 107.31 4.54 Favored 'General case' 0 C--N 1.367 1.329 0 C-N-CA 127.453 2.301 . . . . 0.4 111.062 175.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.73 46.71 4.77 Favored Glycine 0 C--N 1.363 2.054 0 CA-C-O 122.196 0.887 . . . . 0.39 111.995 -175.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -143.51 166.0 26.01 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 125.346 1.458 . . . . 1.4 107.194 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' E' ' 9' ' ' ARG . 0.4 OUTLIER -103.37 170.45 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.565 0 C-N-CA 126.357 1.863 . . . . 0.31 110.116 178.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.39 161.86 26.13 Favored Glycine 0 CA--C 1.483 -1.915 0 O-C-N 121.228 -0.92 . . . . 0.21 111.924 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 23' ' ' THR . . . . . 0.418 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 12.8 m -94.98 135.26 36.72 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 128.359 2.664 . . . . 0.27 115.959 -175.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 25.3 t -66.86 91.78 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.501 0 CA-C-O 124.711 2.196 . . . . 0.29 116.308 170.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -99.35 15.8 25.1 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 130.737 3.615 . . . . 0.29 108.777 170.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . 0.545 ' HA ' ' HB ' ' E' ' 37' ' ' ILE . 0.9 OUTLIER -77.18 -15.02 59.68 Favored 'General case' 0 CA--C 1.48 -1.738 1 C-N-CA 135.391 5.476 . . . . 0.63 118.632 -176.947 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 24.8 t -86.18 59.72 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.495 0 CA-C-O 125.428 2.537 . . . . 0.61 108.982 -173.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 28' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' E' ' 29' ' ' LYS . 3.1 pt-20 -145.13 -100.66 0.1 Allowed 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 111.262 -2.699 . . . . 1.61 107.695 -174.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . 0.414 ' H ' ' HG3' ' E' ' 28' ' ' GLU . 38.1 mmtt -87.31 25.65 1.36 Allowed 'General case' 0 N--CA 1.437 -1.116 1 C-N-CA 132.032 4.133 . . . . 3.96 115.303 -176.297 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.08 -1.05 0.84 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 131.128 3.771 . . . . 4.34 117.255 176.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.91 44.02 3.26 Favored Glycine 0 C--N 1.355 1.591 0 C-N-CA 128.472 2.939 . . . . 1.76 114.491 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 32' ' ' ILE . . . . . 0.529 HG22 ' H ' ' E' ' 33' ' ' LEU . 0.3 OUTLIER -137.5 -172.16 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.061 0 C-N-CA 128.072 2.549 . . . . 1.11 109.538 -178.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' E' E ' 33' ' ' LEU . . . . . 0.529 ' H ' HG22 ' E' ' 32' ' ' ILE . 41.1 tp -82.87 -22.73 33.92 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 131.432 3.893 . . . . 0.57 111.913 178.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -118.24 91.04 39.67 Favored Pre-proline 0 C--N 1.35 0.603 0 N-CA-C 103.286 -2.857 . . . . 0.94 103.286 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.64 -31.25 0.46 Allowed 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 124.919 3.746 . . . . 0.67 116.675 -170.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . 0.497 HG21 HD11 ' E' ' 2' ' ' LEU 0.265 75.3 t -96.91 98.38 7.46 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 C-N-CA 127.232 2.213 . . . . 0.64 116.403 -166.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . 0.545 ' HB ' ' HA ' ' E' ' 26' ' ' SER . 3.8 mp -87.51 117.03 30.71 Favored 'Isoleucine or valine' 0 C--N 1.362 1.145 0 C-N-CA 128.11 2.564 . . . . 0.65 105.557 174.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 38' ' ' VAL . . . . . 0.718 HG11 HD11 ' E' ' 10' ' ' ILE . 53.0 t -125.36 156.58 34.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.451 0 CA-C-N 119.424 1.011 . . . . 0.23 111.276 -173.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 39' ' ' ARG . . . . . 0.418 ' HB3' ' H ' ' E' ' 23' ' ' THR . 36.5 ttm-85 -82.39 156.75 24.01 Favored 'General case' 0 C--N 1.365 1.272 0 C-N-CA 130.661 3.584 . . . . 2.75 110.888 175.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 40' ' ' PHE . . . . . 0.42 ' HE1' HG13 ' E' ' 10' ' ' ILE . 33.2 m-85 -151.01 -178.81 6.82 Favored 'General case' 0 CA--C 1.513 -0.462 0 O-C-N 119.467 -2.02 . . . . 1.26 106.953 174.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -98.62 -39.37 8.73 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 127.077 2.151 . . . . 1.02 114.948 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . 0.269 20.8 mtm180 -69.18 -86.37 0.02 OUTLIER 'General case' 0 C--N 1.37 1.49 0 N-CA-C 121.602 3.927 . . . . 1.29 121.602 -170.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . 0.341 4.7 p . . . . . 0 C--N 1.367 1.327 0 CA-C-O 127.15 3.357 . . . . 1.23 108.757 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 . . . . . 0 CA--C 1.534 0.334 0 CA-C-O 122.894 1.33 . . . . 2.2 112.432 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . 0.428 ' HB ' HG23 ' E' ' 37' ' ' ILE . 40.2 p -86.61 106.83 17.85 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 125.899 1.68 . . . . 0.47 113.99 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.61 132.66 47.16 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 128.695 2.798 . . . . 1.57 106.283 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -100.31 103.38 14.8 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 124.829 1.252 . . . . 2.07 109.639 -178.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 60' ' ' PHE . . . . . 0.5 ' CB ' HD21 ' E' ' 65' ' ' LEU . 24.4 m-85 -98.78 169.27 9.59 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 126.791 2.036 . . . . 0.17 116.267 -174.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -102.86 101.86 11.93 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.857 2.463 . . . . 0.17 110.717 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -18.72 -29.65 0.0 OUTLIER 'General case' 0 C--N 1.373 1.624 1 C-N-CA 135.135 5.374 . . . . 1.72 120.914 173.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.68 -42.67 79.44 Favored 'General case' 0 C--N 1.369 1.449 0 C-N-CA 128.212 2.605 . . . . 0.17 111.777 167.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -85.43 -7.48 58.9 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.126 -1.397 . . . . 1.18 111.848 -171.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.5 HD21 ' CB ' ' E' ' 60' ' ' PHE . 0.2 OUTLIER -100.46 109.47 21.61 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 120.882 -1.136 . . . . 0.19 110.568 178.504 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -90.7 128.63 36.72 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 123.659 0.784 . . . . 2.05 112.407 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.62 137.35 57.78 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 120.542 3.534 . . . . 0.29 120.542 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.79 -42.68 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.371 1.504 0 C-N-CA 125.738 1.615 . . . . 0.73 111.342 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 69' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 0.0 OUTLIER -112.12 97.54 6.72 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 126.504 1.922 . . . . 2.19 114.134 -175.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.67 57.93 0.09 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.404 2.682 . . . . 0.0 114.804 175.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.76 53.45 0.45 Allowed 'General case' 0 C--N 1.353 0.734 0 C-N-CA 129.309 3.044 . . . . 0.0 116.475 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -100.09 94.51 6.29 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 127.556 2.342 . . . . 0.0 109.367 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt . . . . . 0 C--O 1.259 1.564 0 C-N-CA 125.502 1.521 . . . . 0.0 109.236 179.943 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' E' E ' 2' ' ' LEU . . . . . 0.446 ' HB2' ' H ' ' E' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.795 0 N-CA-C 115.967 1.84 . . . . 0.99 115.967 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . 0.446 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 75.0 m-80 -122.02 -173.8 2.74 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 128.658 2.783 . . . . 0.8 114.046 -170.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.92 104.86 17.24 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 128.638 2.775 . . . . 3.4 111.757 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.99 -3.64 22.59 Favored Glycine 0 C--N 1.353 1.494 0 O-C-N 119.984 -1.698 . . . . 0.53 111.896 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 6' ' ' ASP . . . . . 0.508 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 3.6 t0 -77.85 72.02 4.36 Favored 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 130.529 3.531 . . . . 0.45 114.115 -174.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . 0.408 ' H ' ' HG3' ' E' ' 7' ' ' LYS . 23.2 mtpp -35.97 87.64 0.0 OUTLIER 'General case' 0 C--N 1.351 0.64 1 C-N-CA 132.78 4.432 . . . . 2.03 114.743 177.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 8' ' ' VAL . . . . . 0.428 HG22 ' H ' ' E' ' 8' ' ' VAL . 0.0 OUTLIER -86.96 137.76 20.3 Favored 'Isoleucine or valine' 0 C--N 1.361 1.092 0 N-CA-C 107.102 -1.444 . . . . 0.13 107.102 -172.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -96.52 87.78 4.5 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 115.813 1.783 . . . . 0.17 115.813 -170.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.531 HD13 ' H ' ' E' ' 10' ' ' ILE . 0.9 OUTLIER -26.4 98.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 N-CA-C 119.517 3.154 . . . . 0.12 119.517 173.161 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -113.43 43.57 1.73 Allowed 'General case' 0 C--N 1.366 1.311 0 O-C-N 120.115 -1.615 . . . . 0.3 113.261 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.79 137.16 39.55 Favored 'General case' 0 C--N 1.366 1.286 0 C-N-CA 125.902 1.681 . . . . 2.09 111.006 174.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 22.3 p -73.02 -58.01 3.62 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 128.491 2.716 . . . . 0.47 114.516 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -76.02 64.33 1.9 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 127.945 2.498 . . . . 1.89 114.929 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 27.1 t -167.69 176.78 6.19 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 126.531 1.932 . . . . 1.13 105.868 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -93.5 0.33 56.66 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 128.612 2.765 . . . . 0.79 111.607 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -117.28 25.54 10.38 Favored 'General case' 0 C--N 1.36 1.034 0 O-C-N 120.48 -1.388 . . . . 0.75 113.807 -172.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -70.04 108.94 4.29 Favored 'General case' 0 C--N 1.368 1.377 0 C-N-CA 126.338 1.855 . . . . 0.4 114.228 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.66 30.36 18.65 Favored Glycine 0 C--N 1.366 2.206 0 CA-C-O 121.538 0.521 . . . . 0.39 112.218 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -121.02 173.28 7.36 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 126.807 2.043 . . . . 1.4 105.751 177.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.59 175.75 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 C-N-CA 125.613 1.565 . . . . 0.31 110.042 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.07 175.21 40.22 Favored Glycine 0 CA--C 1.479 -2.211 1 N-CA-C 101.314 -4.714 . . . . 0.21 101.314 165.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 23' ' ' THR . . . . . 0.622 ' H ' ' HB2' ' E' ' 39' ' ' ARG . 11.1 m -96.39 141.28 29.89 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 126.131 1.772 . . . . 0.27 108.666 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 p -79.76 112.76 18.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 124.776 2.227 . . . . 0.29 109.043 166.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.14 31.8 6.18 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 111.134 -2.757 . . . . 0.29 108.573 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . 0.505 ' CB ' ' H ' ' E' ' 37' ' ' ILE . 0.3 OUTLIER -86.62 -39.99 15.58 Favored 'General case' 0 CA--C 1.49 -1.329 0 C-N-CA 126.727 2.011 . . . . 0.63 115.874 178.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . 0.259 0.3 OUTLIER -83.23 70.21 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.915 0 CA-C-O 127.888 3.709 . . . . 0.61 110.842 -172.133 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -161.2 -54.32 0.05 OUTLIER 'General case' 0 N--CA 1.424 -1.752 1 CA-C-N 107.896 -4.229 . . . . 1.61 105.595 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp -109.43 -22.98 11.76 Favored 'General case' 0 C--N 1.364 1.228 0 N-CA-C 116.868 2.173 . . . . 3.96 116.868 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -22.26 -15.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 2 C-N-CA 138.626 6.77 . . . . 4.34 122.629 -168.59 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.51 43.37 2.74 Favored Glycine 0 C--N 1.338 0.685 1 C-N-CA 130.906 4.098 . . . . 1.76 115.757 -175.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.23 -170.18 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.752 0 C-N-CA 126.758 2.023 . . . . 1.11 110.806 -177.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 46.6 tp -68.89 -30.87 69.45 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 128.639 2.776 . . . . 0.57 114.965 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -108.06 117.96 53.78 Favored Pre-proline 0 C--N 1.36 1.033 0 N-CA-C 103.838 -2.653 . . . . 0.94 103.838 175.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -75.14 -39.58 1.12 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.475 3.45 . . . . 0.67 113.584 -167.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . 0.608 HG12 HG23 ' E' ' 38' ' ' VAL . 62.3 t -109.62 115.17 48.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.708 0 C-N-CA 125.681 1.592 . . . . 0.64 112.881 -177.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . 0.505 ' H ' ' CB ' ' E' ' 26' ' ' SER . 6.5 mt -88.87 128.07 41.25 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 C-N-CA 127.091 2.156 . . . . 0.65 105.273 166.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 38' ' ' VAL . . . . . 0.608 HG23 HG12 ' E' ' 36' ' ' VAL . 24.8 t -122.98 150.17 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 O-C-N 120.343 -1.473 . . . . 0.23 109.041 -178.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 39' ' ' ARG . . . . . 0.622 ' HB2' ' H ' ' E' ' 23' ' ' THR . 42.5 mtp180 -74.28 168.62 19.28 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 127.34 2.256 . . . . 2.75 111.322 172.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . 0.25 21.4 m-85 -139.66 123.83 17.88 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 124.269 1.985 . . . . 1.26 111.329 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -54.37 -43.8 71.66 Favored 'General case' 0 N--CA 1.439 -1.0 1 C-N-CA 137.565 6.346 . . . . 1.02 119.109 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 46.6 mtm105 -131.9 93.61 3.33 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 107.486 -1.302 . . . . 1.29 107.486 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 C--N 1.369 1.418 0 CA-C-O 125.33 2.491 . . . . 1.23 109.912 174.86 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 20.7 m120 . . . . . 0 C--O 1.224 -0.242 0 N-CA-C 109.065 -0.717 . . . . 2.2 109.065 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 12.2 p -125.67 123.46 39.0 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 130.747 3.619 . . . . 0.47 109.592 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -116.83 151.78 35.8 Favored 'General case' 0 C--N 1.365 1.246 0 C-N-CA 126.714 2.005 . . . . 1.57 109.887 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -78.28 129.37 34.97 Favored 'General case' 0 C--N 1.364 1.227 0 C-N-CA 126.386 1.874 . . . . 2.07 112.56 176.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 60' ' ' PHE . . . . . 0.522 ' HE2' HD12 ' E' ' 10' ' ' ILE . 0.2 OUTLIER -127.78 169.6 13.68 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 117.177 2.288 . . . . 0.17 117.177 -177.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.87 88.2 2.77 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 110.129 -3.214 . . . . 0.17 111.693 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -18.25 -24.77 0.0 OUTLIER 'General case' 0 C--N 1.355 0.811 1 C-N-CA 136.276 5.83 . . . . 1.72 120.377 171.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.03 -34.14 71.56 Favored 'General case' 0 C--N 1.371 1.531 0 C-N-CA 129.615 3.166 . . . . 0.17 113.856 167.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.37 17.46 21.43 Favored 'General case' 0 C--N 1.368 1.378 0 C-N-CA 125.92 1.688 . . . . 1.18 110.738 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.478 HD13 HG11 ' E' ' 36' ' ' VAL . 74.0 mt -128.27 113.44 15.65 Favored 'General case' 0 C--N 1.363 1.156 0 N-CA-C 115.301 1.593 . . . . 0.19 115.301 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -100.46 129.83 46.46 Favored 'General case' 0 C--N 1.363 1.166 0 C-N-CA 124.837 1.255 . . . . 2.05 111.731 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.1 128.24 35.99 Favored 'General case' 0 C--N 1.368 1.397 0 C-N-CA 130.255 3.422 . . . . 0.29 116.49 172.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.3 -28.98 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.167 0 CA-C-N 120.639 1.563 . . . . 0.73 113.607 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 69' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 3.5 tp-100 -104.48 138.06 41.42 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 125.32 2.486 . . . . 2.19 114.342 -175.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.01 57.94 4.57 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 128.918 2.887 . . . . 0.0 111.528 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.13 52.55 0.9 Allowed 'General case' 0 C--N 1.362 1.113 0 C-N-CA 126.369 1.868 . . . . 0.0 108.989 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.85 146.81 25.57 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 126.062 1.745 . . . . 0.0 110.928 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt . . . . . 0 C--O 1.261 1.686 0 C-N-CA 125.839 1.656 . . . . 0.0 108.548 177.059 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' E' E ' 2' ' ' LEU . . . . . 0.401 ' HB2' ' H ' ' E' ' 3' ' ' ASN 0.318 2.5 pp . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 123.017 1.389 . . . . 0.99 114.344 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . 0.401 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 1.5 m120 -143.82 173.39 11.73 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 130.56 3.544 . . . . 0.8 110.753 -176.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -95.62 109.71 21.92 Favored 'General case' 0 C--N 1.367 1.356 0 C-N-CA 127.703 2.401 . . . . 3.4 112.815 175.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.61 14.34 41.08 Favored Glycine 0 CA--C 1.473 -2.535 0 O-C-N 119.474 -2.016 . . . . 0.53 114.016 172.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 6' ' ' ASP . . . . . 0.52 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 19.8 t0 -84.02 146.96 27.68 Favored 'General case' 0 N--CA 1.421 -1.884 1 C-N-CA 132.106 4.162 . . . . 0.45 105.559 178.019 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -93.65 89.82 6.37 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 105.283 -2.118 . . . . 2.03 105.283 173.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 8' ' ' VAL . . . . . 0.421 HG22 ' H ' ' E' ' 8' ' ' VAL . 5.4 m -86.33 142.85 12.53 Favored 'Isoleucine or valine' 0 C--N 1.366 1.31 0 N-CA-C 107.652 -1.24 . . . . 0.13 107.652 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -96.64 100.92 12.46 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 117.103 2.26 . . . . 0.17 117.103 -169.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.528 HG23 ' CE2' ' E' ' 60' ' ' PHE . 1.8 mm -38.33 97.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.575 1.909 0 C-N-CA 129.46 3.104 . . . . 0.12 119.07 171.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -117.1 45.33 1.9 Allowed 'General case' 0 C--N 1.372 1.583 0 O-C-N 118.642 -2.536 . . . . 0.3 111.969 -175.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 12' ' ' ARG . . . . . 0.463 ' HD2' ' CE1' ' E' ' 60' ' ' PHE . 10.1 ptm180 -99.68 128.35 45.78 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 128.4 2.68 . . . . 2.09 107.995 175.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 24.6 p -70.74 -62.18 1.49 Allowed 'General case' 0 C--N 1.359 0.989 0 C-N-CA 130.194 3.398 . . . . 0.47 114.088 -175.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.71 72.15 0.52 Allowed 'General case' 0 C--N 1.362 1.129 0 C-N-CA 130.636 3.574 . . . . 1.89 110.26 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 3.7 t -156.71 172.77 18.02 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 124.802 2.239 . . . . 1.13 111.091 -170.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -97.02 -17.81 19.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 130.649 3.58 . . . . 0.79 108.622 171.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -121.04 17.04 11.68 Favored 'General case' 0 C--N 1.367 1.367 0 N-CA-C 116.762 2.134 . . . . 0.75 116.762 -167.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -60.66 113.14 2.3 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 117.717 2.488 . . . . 0.4 117.717 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.47 25.94 22.05 Favored Glycine 0 C--N 1.365 2.141 0 C-N-CA 124.701 1.143 . . . . 0.39 112.841 170.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -136.78 171.29 14.72 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 104.977 -2.231 . . . . 1.4 104.977 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.96 176.91 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 125.124 1.37 . . . . 0.31 113.922 -173.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.78 168.75 41.6 Favored Glycine 0 C--N 1.36 1.89 0 N-CA-C 105.716 -2.954 . . . . 0.21 105.716 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 23' ' ' THR . . . . . 0.646 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 7.5 m -89.69 137.69 32.11 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 124.692 1.197 . . . . 0.27 110.208 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 24' ' ' VAL . . . . . 0.492 HG22 ' H ' ' E' ' 26' ' ' SER . 10.2 p -82.22 113.05 20.9 Favored 'Isoleucine or valine' 0 C--N 1.348 0.517 0 CA-C-O 124.341 2.019 . . . . 0.29 111.195 167.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.08 24.25 13.27 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 128.216 2.606 . . . . 0.29 109.461 172.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . 0.492 ' H ' HG22 ' E' ' 24' ' ' VAL . 21.1 t -81.21 -52.2 7.6 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 127.382 2.273 . . . . 0.63 116.203 -177.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.49 51.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-O 125.627 2.632 . . . . 0.61 114.091 -164.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.89 -60.07 0.26 Allowed 'General case' 0 N--CA 1.424 -1.731 0 C-N-CA 129.269 3.028 . . . . 1.61 105.086 -174.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -112.04 7.14 19.68 Favored 'General case' 0 C--N 1.364 1.237 0 N-CA-C 115.08 1.511 . . . . 3.96 115.08 -177.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -35.82 -28.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 1 C-N-CA 134.193 4.997 . . . . 4.34 119.787 -176.539 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.39 46.72 0.19 Allowed Glycine 0 C--N 1.35 1.352 1 C-N-CA 130.854 4.074 . . . . 1.76 117.606 -178.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 32' ' ' ILE . . . . . 0.453 HD12 HD21 ' E' ' 59' ' ' ASN . 0.3 OUTLIER -113.5 -155.76 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.502 0 CA-C-O 123.332 1.539 . . . . 1.11 111.65 178.069 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 62.6 tp -72.55 -34.75 67.74 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 130.054 3.342 . . . . 0.57 113.778 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -125.43 157.77 66.75 Favored Pre-proline 0 C--N 1.355 0.824 0 N-CA-C 101.736 -3.431 . . . . 0.94 101.736 174.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.96 -59.28 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 123.861 2.415 . . . . 0.67 112.805 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . 0.536 HG12 HG23 ' E' ' 38' ' ' VAL . 52.6 t -70.06 105.86 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.222 0 N-CA-C 117.762 2.504 . . . . 0.64 117.762 -169.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . 0.424 ' H ' ' HB2' ' E' ' 26' ' ' SER . 18.0 mt -89.82 107.37 18.13 Favored 'Isoleucine or valine' 0 C--N 1.37 1.481 0 N-CA-C 105.748 -1.945 . . . . 0.65 105.748 170.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 38' ' ' VAL . . . . . 0.536 HG23 HG12 ' E' ' 36' ' ' VAL 0.26 19.4 t -112.18 149.24 14.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.473 0 CA-C-O 121.053 0.454 . . . . 0.23 110.132 -179.16 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 39' ' ' ARG . . . . . 0.646 ' HB3' ' H ' ' E' ' 23' ' ' THR . 8.5 tmm_? -84.09 147.06 27.57 Favored 'General case' 0 C--N 1.366 1.311 0 C-N-CA 129.125 2.97 . . . . 2.75 108.892 173.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -151.72 144.94 24.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 104.206 -2.516 . . . . 1.26 104.206 172.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -105.46 -2.75 23.33 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 125.523 1.529 . . . . 1.02 112.191 175.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -86.44 45.72 1.27 Allowed 'General case' 0 C--N 1.357 0.898 0 C-N-CA 129.498 3.119 . . . . 1.29 110.49 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 C--N 1.354 0.788 1 C-N-CA 131.927 4.091 . . . . 1.23 110.467 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 . . . . . 0 CA--C 1.531 0.213 0 CA-C-O 119.822 -0.132 . . . . 2.2 111.214 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 62.7 p -107.33 96.29 6.31 Favored 'General case' 0 C--N 1.363 1.185 0 C-N-CA 125.087 1.355 . . . . 0.47 108.479 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -112.5 145.38 40.34 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 125.285 1.434 . . . . 1.57 111.022 -174.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 59' ' ' ASN . . . . . 0.453 HD21 HD12 ' E' ' 32' ' ' ILE . 0.4 OUTLIER -92.76 95.5 9.59 Favored 'General case' 0 C--N 1.361 1.085 0 C-N-CA 127.43 2.292 . . . . 2.07 110.392 -177.27 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 60' ' ' PHE . . . . . 0.528 ' CE2' HG23 ' E' ' 10' ' ' ILE . 0.5 OUTLIER -101.71 164.77 11.57 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 126.697 1.999 . . . . 0.17 114.039 -171.494 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . 0.419 ' H ' ' HD1' ' E' ' 60' ' ' PHE . . . -97.63 90.32 4.97 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 127.656 2.382 . . . . 0.17 111.818 -177.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -16.39 -40.98 0.0 OUTLIER 'General case' 0 C--N 1.365 1.281 1 C-N-CA 134.308 5.043 . . . . 1.72 120.087 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.48 -26.4 42.32 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 128.507 2.723 . . . . 0.17 115.964 171.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -97.55 5.21 49.85 Favored 'General case' 0 C--N 1.364 1.235 0 C-N-CA 127.171 2.188 . . . . 1.18 111.712 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.525 HD21 ' CG ' ' E' ' 60' ' ' PHE . 0.6 OUTLIER -116.68 109.6 17.39 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 126.026 1.73 . . . . 0.19 112.097 -175.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -106.08 147.7 28.64 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 124.748 1.219 . . . . 2.05 110.383 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -75.17 142.54 43.51 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 127.323 2.249 . . . . 0.29 116.459 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 t -127.2 -28.6 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.963 0 C-N-CA 125.646 1.578 . . . . 0.73 108.386 173.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 69' ' ' GLN . . . . . 0.52 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 7.9 tt0 -114.02 142.39 46.23 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 124.933 2.302 . . . . 2.19 113.173 -177.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.36 57.46 0.94 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 128.449 2.7 . . . . 0.0 111.189 174.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.07 53.23 0.6 Allowed 'General case' 0 C--N 1.367 1.355 0 C-N-CA 127.518 2.327 . . . . 0.0 115.312 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.2 137.24 40.72 Favored 'General case' 0 C--N 1.348 0.509 0 C-N-CA 127.447 2.299 . . . . 0.0 107.156 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? . . . . . 0 C--O 1.261 1.699 0 CA-C-O 118.477 -0.773 . . . . 0.0 110.114 178.73 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' E' E ' 2' ' ' LEU . . . . . 0.404 ' HB2' ' H ' ' E' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.616 0 N-CA-C 115.559 1.688 . . . . 0.99 115.559 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 3' ' ' ASN . . . . . 0.404 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 42.9 m-80 -134.63 -172.29 2.99 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 128.688 2.795 . . . . 0.8 108.954 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -95.85 104.87 16.83 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 129.004 2.922 . . . . 3.4 115.357 -176.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.37 3.51 33.09 Favored Glycine 0 C--N 1.366 2.23 0 CA-C-O 124.43 2.128 . . . . 0.53 111.45 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 6' ' ' ASP . . . . . . . . . . . . 0.34 16.2 t70 -90.35 51.41 2.02 Favored 'General case' 0 N--CA 1.424 -1.761 1 C-N-CA 132.96 4.504 . . . . 0.45 108.945 -178.202 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -28.75 105.85 0.03 OUTLIER 'General case' 0 C--N 1.367 1.329 1 C-N-CA 133.666 4.786 . . . . 2.03 117.035 -174.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 35.1 m -90.62 150.49 3.72 Favored 'Isoleucine or valine' 0 C--N 1.36 1.036 0 C-N-CA 123.279 0.632 . . . . 0.13 111.111 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 19.4 ttm-85 -98.76 88.34 4.01 Favored 'General case' 0 C--N 1.36 1.025 0 O-C-N 120.629 -1.294 . . . . 0.17 112.909 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 10' ' ' ILE . . . . . 0.832 HD11 HG11 ' E' ' 38' ' ' VAL . 0.5 OUTLIER -33.53 101.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.598 0 N-CA-C 119.988 3.329 . . . . 0.12 119.988 176.423 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -103.01 42.74 1.13 Allowed 'General case' 0 C--N 1.368 1.374 0 C-N-CA 125.783 1.633 . . . . 0.3 113.399 -174.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -98.49 123.53 42.7 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 129.389 3.075 . . . . 2.09 111.226 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 26.4 p -71.42 -61.75 1.66 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 128.201 2.6 . . . . 0.47 116.204 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -78.96 65.69 4.21 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 127.001 2.12 . . . . 1.89 113.611 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 3.9 m -173.68 163.35 4.24 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 126.561 1.944 . . . . 1.13 106.129 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -90.93 18.78 6.21 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 129.159 2.984 . . . . 0.79 112.65 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 36.1 m0 -113.68 0.07 14.45 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 129.246 3.019 . . . . 0.75 111.636 -175.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -58.3 105.57 0.3 Allowed 'General case' 0 C--N 1.37 1.49 0 C-N-CA 127.163 2.185 . . . . 0.4 116.176 -174.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.82 26.33 53.89 Favored Glycine 0 C--N 1.366 2.243 0 O-C-N 121.137 -0.977 . . . . 0.39 115.11 -177.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -106.34 152.94 22.91 Favored 'General case' 0 C--N 1.362 1.149 0 N-CA-C 105.989 -1.856 . . . . 1.4 105.989 175.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -88.11 151.72 3.48 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-O 123.716 1.722 . . . . 0.31 109.969 174.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.95 167.7 28.26 Favored Glycine 0 CA--C 1.471 -2.712 0 N-CA-C 105.872 -2.891 . . . . 0.21 105.872 170.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 23' ' ' THR . . . . . 0.5 ' H ' ' HB2' ' E' ' 39' ' ' ARG . 17.3 m -97.24 113.92 25.59 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 124.901 1.28 . . . . 0.27 112.147 -175.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 24' ' ' VAL . . . . . 0.424 HG23 HG13 ' E' ' 36' ' ' VAL . 9.8 p -66.16 71.79 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 128.729 2.811 . . . . 0.29 118.307 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.01 53.93 2.96 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 116.699 -3.751 . . . . 0.29 112.53 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 26' ' ' SER . . . . . 0.441 ' HA ' ' HB ' ' E' ' 37' ' ' ILE . 67.0 m -88.77 -58.03 2.69 Favored 'General case' 0 CA--C 1.477 -1.831 1 C-N-CA 133.549 4.74 . . . . 0.63 118.443 -173.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 m -82.51 49.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.368 1.393 0 CA-C-O 127.706 3.622 . . . . 0.61 114.817 -163.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -135.39 -58.17 0.79 Allowed 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 110.817 -2.901 . . . . 1.61 105.386 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -110.87 5.25 20.41 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 127.181 2.193 . . . . 3.96 114.001 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 26.5 t -46.14 -26.35 0.75 Allowed 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 129.516 3.126 . . . . 4.34 116.935 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.35 44.21 0.06 OUTLIER Glycine 0 C--N 1.357 1.709 1 C-N-CA 130.809 4.052 . . . . 1.76 118.327 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.54 -156.61 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.972 0 C-N-CA 128.972 2.909 . . . . 1.11 113.144 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 25.6 tp -87.79 -12.95 43.56 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 130.849 3.66 . . . . 0.57 114.248 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -135.25 141.62 38.53 Favored Pre-proline 0 C--N 1.358 0.966 0 N-CA-C 101.912 -3.366 . . . . 0.94 101.912 175.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -83.88 -45.1 0.06 OUTLIER 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.882 2.388 . . . . 0.67 115.954 -168.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 36' ' ' VAL . . . . . 0.567 HG11 HD13 ' E' ' 65' ' ' LEU . 55.4 t -106.23 131.12 56.69 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 N-CA-C 115.597 1.702 . . . . 0.64 115.597 -166.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 37' ' ' ILE . . . . . 0.441 ' HB ' ' HA ' ' E' ' 26' ' ' SER . 57.0 mt -105.72 126.08 61.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 C-N-CA 127.702 2.401 . . . . 0.65 105.302 172.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 38' ' ' VAL . . . . . 0.832 HG11 HD11 ' E' ' 10' ' ' ILE . 74.3 t -134.43 144.4 35.22 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 O-C-N 120.703 -1.248 . . . . 0.23 109.161 -176.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 39' ' ' ARG . . . . . 0.5 ' HB2' ' H ' ' E' ' 23' ' ' THR . 8.1 mtm180 -69.79 163.48 25.7 Favored 'General case' 0 C--N 1.372 1.578 0 C-N-CA 127.815 2.446 . . . . 2.75 115.827 173.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -149.02 139.12 22.19 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 124.543 1.137 . . . . 1.26 110.113 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -94.1 -32.6 13.69 Favored 'General case' 0 C--N 1.366 1.319 0 C-N-CA 125.995 1.718 . . . . 1.02 111.508 171.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 -79.69 57.99 2.65 Favored 'General case' 0 C--N 1.373 1.59 0 C-N-CA 129.397 3.079 . . . . 1.29 112.617 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 C--N 1.351 0.664 0 C-N-CA 127.11 2.164 . . . . 1.23 110.225 -178.893 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 . . . . . 0 C--O 1.225 -0.235 0 CA-C-O 121.403 0.621 . . . . 2.2 109.442 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 72.7 p -105.0 115.95 31.14 Favored 'General case' 0 C--N 1.35 0.611 0 C-N-CA 126.891 2.077 . . . . 0.47 108.585 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -105.95 147.11 29.18 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 108.639 -0.875 . . . . 1.57 108.639 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -90.52 110.45 21.58 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 128.332 2.653 . . . . 2.07 107.669 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -122.22 173.58 7.51 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 126.791 2.036 . . . . 0.17 115.797 -172.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -108.15 97.31 7.02 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 130.077 3.351 . . . . 0.17 113.909 -176.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -14.34 -34.9 0.0 OUTLIER 'General case' 0 C--N 1.366 1.297 1 C-N-CA 134.683 5.193 . . . . 1.72 121.122 171.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -46.2 -46.74 17.72 Favored 'General case' 0 C--N 1.369 1.426 1 C-N-CA 132.661 4.384 . . . . 0.17 112.606 170.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.97 16.6 25.49 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 112.744 -2.025 . . . . 1.18 111.218 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 65' ' ' LEU . . . . . 0.567 HD13 HG11 ' E' ' 36' ' ' VAL . 75.4 mt -129.65 98.01 4.7 Favored 'General case' 0 C--N 1.369 1.449 0 N-CA-C 114.942 1.46 . . . . 0.19 114.942 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -105.97 143.87 33.49 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 125.692 1.597 . . . . 2.05 111.638 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -62.45 137.23 58.22 Favored 'General case' 0 C--N 1.365 1.276 0 C-N-CA 129.307 3.043 . . . . 0.29 117.481 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 39.3 t -132.75 -27.27 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.292 0 C-N-CA 126.815 2.046 . . . . 0.73 110.104 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.95 146.82 41.77 Favored 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 125.9 1.68 . . . . 2.19 108.156 177.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.67 79.75 1.39 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 129.622 3.169 . . . . 0.0 112.685 173.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.25 77.83 1.45 Allowed 'General case' 0 C--N 1.352 0.683 0 O-C-N 119.403 -2.061 . . . . 0.0 109.484 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.45 -165.89 0.77 Allowed 'General case' 0 C--N 1.353 0.723 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt . . . . . 0 C--O 1.262 1.739 0 C-N-CA 127.647 2.379 . . . . 0.0 108.399 176.1 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 108.015 -1.106 . . . . 2.13 108.015 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.26 -161.02 0.73 Allowed 'General case' 0 C--N 1.353 0.734 0 C-N-CA 125.331 1.452 . . . . 0.99 112.944 176.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 46.4 m-20 -123.86 -178.17 3.97 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 128.02 2.528 . . . . 0.8 110.842 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -91.43 83.92 5.5 Favored 'General case' 0 C--N 1.364 1.235 0 C-N-CA 127.78 2.432 . . . . 3.4 112.62 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 142.22 -9.06 2.44 Favored Glycine 0 CA--C 1.486 -1.74 0 CA-C-O 123.642 1.69 . . . . 0.53 110.872 -173.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 6' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -81.63 47.98 1.13 Allowed 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 128.227 2.611 . . . . 0.45 114.837 -172.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . 0.421 0.0 OUTLIER -11.91 97.33 0.01 OUTLIER 'General case' 0 C--N 1.361 1.089 1 C-N-CA 132.761 4.425 . . . . 2.03 117.763 -176.161 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.8 151.54 4.1 Favored 'Isoleucine or valine' 0 C--N 1.364 1.232 0 O-C-N 119.738 -1.851 . . . . 0.13 111.18 -171.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 17.1 ttt85 -97.61 105.86 18.08 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 115.153 1.538 . . . . 0.17 115.153 -176.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.689 HD11 HG11 ' E' ' 38' ' ' VAL . 1.3 mp -53.83 104.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.37 1.481 0 C-N-CA 129.108 2.963 . . . . 0.12 115.339 174.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -123.78 55.95 1.24 Allowed 'General case' 0 C--N 1.365 1.255 0 C-N-CA 123.762 0.825 . . . . 0.3 109.131 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -72.75 -72.91 0.22 Allowed 'General case' 0 C--N 1.362 1.146 0 C-N-CA 126.053 1.741 . . . . 2.09 115.188 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 84.9 m 127.44 -61.92 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.734 1 C-N-CA 133.077 4.551 . . . . 0.47 104.774 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -77.1 72.24 3.63 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 128.241 2.616 . . . . 1.89 111.383 173.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 42.6 t -167.44 159.79 12.68 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 106.823 -1.547 . . . . 1.13 106.823 -174.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -90.15 -2.09 58.03 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 127.412 2.285 . . . . 0.79 110.585 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -119.43 24.36 10.72 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 125.564 1.546 . . . . 0.75 111.082 -176.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -67.49 110.49 3.66 Favored 'General case' 0 C--N 1.369 1.425 0 C-N-CA 126.975 2.11 . . . . 0.4 113.802 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.99 16.67 46.85 Favored Glycine 0 C--N 1.356 1.69 0 C-N-CA 125.819 1.676 . . . . 0.39 111.272 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -108.91 164.2 12.61 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 126.305 1.842 . . . . 1.4 110.155 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -110.27 173.29 2.21 Favored 'Isoleucine or valine' 0 C--N 1.352 0.675 0 C-N-CA 125.946 1.698 . . . . 0.31 108.257 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.55 174.92 42.65 Favored Glycine 0 CA--C 1.474 -2.523 0 N-CA-C 107.517 -2.233 . . . . 0.21 107.517 167.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . 0.78 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 23.5 m -90.21 120.05 31.05 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 126.293 1.837 . . . . 0.27 112.219 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 24' ' ' VAL . . . . . 0.718 HG23 HG13 ' E' ' 36' ' ' VAL . 7.9 p -72.25 80.94 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 125.279 2.466 . . . . 0.29 116.571 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.31 45.12 1.15 Allowed 'General case' 0 C--N 1.35 0.597 0 O-C-N 118.643 -2.535 . . . . 0.29 111.885 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 13.7 t -85.08 -68.95 0.69 Allowed 'General case' 0 CA--C 1.498 -1.043 1 C-N-CA 133.149 4.58 . . . . 0.63 114.076 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 1.3 m -79.88 28.98 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.229 0 C-N-CA 127.69 2.396 . . . . 0.61 116.04 -157.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -112.4 -60.67 1.83 Allowed 'General case' 0 N--CA 1.425 -1.675 1 C-N-CA 132.38 4.272 . . . . 1.61 106.972 177.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.53 -27.63 8.51 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 115.422 1.638 . . . . 3.96 115.422 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.54 35.08 0.76 Allowed 'General case' 0 C--N 1.354 0.786 0 N-CA-C 115.477 1.658 . . . . 4.34 115.477 -173.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.14 52.44 3.34 Favored Glycine 0 C--N 1.349 1.266 0 C-N-CA 129.053 3.216 . . . . 1.76 112.561 163.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 32' ' ' ILE . . . . . 0.487 HG22 ' H ' ' E' ' 33' ' ' LEU . 0.4 OUTLIER -133.94 -157.64 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.988 0 C-N-CA 129.311 3.044 . . . . 1.11 109.93 -175.098 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 33' ' ' LEU . . . . . 0.487 ' H ' HG22 ' E' ' 32' ' ' ILE . 36.6 tp -62.93 -42.47 99.81 Favored 'General case' 0 C--N 1.358 0.935 1 C-N-CA 132.238 4.215 . . . . 0.57 117.673 -177.3 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -110.17 134.61 20.7 Favored Pre-proline 0 C--N 1.366 1.302 0 N-CA-C 102.471 -3.159 . . . . 0.94 102.471 172.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.4 -53.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.424 2.083 . . . . 0.67 115.933 -167.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . 0.718 HG13 HG23 ' E' ' 24' ' ' VAL . 69.7 t -105.54 105.38 18.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.889 0 N-CA-C 119.316 3.08 . . . . 0.64 119.316 -161.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 59.9 mt -83.1 125.08 40.04 Favored 'Isoleucine or valine' 0 C--N 1.38 1.895 0 O-C-N 119.247 -2.158 . . . . 0.65 106.25 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 38' ' ' VAL . . . . . 0.689 HG11 HD11 ' E' ' 10' ' ' ILE . 55.2 t -122.72 162.64 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 119.333 0.97 . . . . 0.23 108.927 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 39' ' ' ARG . . . . . 0.78 ' HB3' ' H ' ' E' ' 23' ' ' THR 0.256 30.8 ttp180 -82.16 147.39 29.05 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 129.825 3.25 . . . . 2.75 110.833 172.267 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -139.96 126.22 20.0 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 124.742 1.217 . . . . 1.26 107.987 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -82.48 -15.25 53.17 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 124.343 1.057 . . . . 1.02 112.051 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -115.59 75.07 0.92 Allowed 'General case' 0 C--N 1.368 1.375 0 C-N-CA 126.854 2.061 . . . . 1.29 112.285 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 43' ' ' VAL . . . . . 0.407 HG22 ' CE1' ' E' ' 45' ' ' TYR . 3.3 m -92.93 21.65 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.306 0 C-N-CA 126.581 1.952 . . . . 1.23 115.729 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . 0.436 0.3 OUTLIER 47.68 72.7 0.24 Allowed 'General case' 0 N--CA 1.443 -0.798 1 C-N-CA 132.122 4.169 . . . . 2.05 119.079 -177.42 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' E' E ' 45' ' ' TYR . . . . . 0.407 ' CE1' HG22 ' E' ' 43' ' ' VAL . 38.0 m-85 -56.24 36.45 0.0 OUTLIER 'General case' 0 C--N 1.365 1.248 1 C-N-CA 134.615 5.166 . . . . 2.52 118.667 -177.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -101.69 76.35 1.65 Allowed 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 128.781 2.832 . . . . 4.16 106.142 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -46.77 -22.81 1.24 Allowed Glycine 0 C--N 1.369 2.362 0 C-N-CA 129.528 3.442 . . . . 5.33 121.378 -170.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -104.19 -0.02 28.97 Favored 'General case' 0 C--N 1.361 1.085 0 C-N-CA 125.449 1.5 . . . . 5.09 113.916 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 2.5 t -105.84 -51.28 3.02 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.193 1.797 . . . . 7.18 110.912 172.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . -127.0 -95.29 0.91 Allowed Glycine 0 C--N 1.365 2.152 0 N-CA-C 110.414 -1.074 . . . . 6.51 110.414 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 8.0 t -168.24 175.63 6.39 Favored 'General case' 0 C--N 1.358 0.953 0 N-CA-C 108.298 -1.001 . . . . 7.2 108.298 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.97 -5.65 23.22 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 126.968 2.107 . . . . 5.08 112.557 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 12.0 t -141.68 37.94 1.65 Allowed 'General case' 0 C--N 1.35 0.591 0 O-C-N 121.141 -0.975 . . . . 3.86 109.626 -176.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.66 -102.59 0.47 Allowed Glycine 0 C--N 1.359 1.809 0 N-CA-C 118.118 2.007 . . . . 2.85 118.118 -169.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . 0.314 4.0 p -108.55 86.67 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.611 0 CA-C-O 124.955 2.312 . . . . 1.72 113.921 -175.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -92.24 -38.01 12.34 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 129.685 3.194 . . . . 2.2 109.835 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 21.4 p -104.29 117.15 33.52 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 129.864 3.265 . . . . 0.47 107.269 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -148.22 136.94 21.68 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.734 1.214 . . . . 1.57 108.253 -174.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -86.59 118.51 26.05 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 127.684 2.394 . . . . 2.07 116.047 -175.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 60' ' ' PHE . . . . . 0.571 ' HB2' HD11 ' E' ' 65' ' ' LEU . 74.6 m-85 -105.95 171.53 7.29 Favored 'General case' 0 CA--C 1.507 -0.682 0 O-C-N 119.856 -1.778 . . . . 0.17 112.547 177.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.42 101.53 10.88 Favored 'General case' 0 N--CA 1.427 -1.592 0 C-N-CA 129.649 3.179 . . . . 0.17 108.711 169.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -19.94 -29.18 0.0 OUTLIER 'General case' 0 C--N 1.36 1.043 1 C-N-CA 136.467 5.907 . . . . 1.72 119.602 171.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.26 -30.69 66.78 Favored 'General case' 0 C--N 1.365 1.254 0 C-N-CA 128.629 2.772 . . . . 0.17 113.958 171.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.52 20.47 18.49 Favored 'General case' 0 C--N 1.368 1.375 0 C-N-CA 125.777 1.631 . . . . 1.18 110.788 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' E' ' 60' ' ' PHE . 52.0 mt -137.59 116.91 12.72 Favored 'General case' 0 C--N 1.374 1.667 0 N-CA-C 116.282 1.956 . . . . 0.19 116.282 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -106.83 138.12 43.6 Favored 'General case' 0 C--N 1.364 1.229 0 O-C-N 120.589 -1.32 . . . . 2.05 111.604 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.35 136.72 53.41 Favored 'General case' 0 C--N 1.366 1.29 1 C-N-CA 131.909 4.084 . . . . 0.29 118.434 174.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 10.0 t -132.7 -40.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.618 -1.301 . . . . 0.73 114.121 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 69' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -104.83 120.87 42.43 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 123.486 1.612 . . . . 2.19 114.883 -172.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.0 51.72 0.15 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.265 2.226 . . . . 0.0 115.511 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.49 60.66 6.15 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 127.036 2.134 . . . . 0.0 112.295 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.63 114.16 26.04 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 125.991 1.716 . . . . 0.0 110.179 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 50.5 mttp . . . . . 0 C--O 1.262 1.741 0 CA-C-O 117.351 -1.309 . . . . 0.0 111.484 178.135 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 107.302 -1.37 . . . . 2.13 107.302 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.73 -157.83 0.62 Allowed 'General case' 0 C--N 1.351 0.646 0 C-N-CA 126.564 1.946 . . . . 0.99 114.833 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . 0.257 1.0 OUTLIER -142.47 -175.56 4.51 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 104.62 -2.363 . . . . 0.8 104.62 176.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.39 60.42 5.22 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 130.135 3.374 . . . . 3.4 116.594 -175.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 5' ' ' GLY . . . . . 0.415 ' H ' ' H ' ' E' ' 6' ' ' ASP . . . 166.63 1.07 0.04 OUTLIER Glycine 0 CA--C 1.477 -2.341 0 O-C-N 120.088 -1.633 . . . . 0.53 113.457 -175.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 6' ' ' ASP . . . . . 0.495 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 65.5 t0 -76.76 136.29 39.02 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.797 2.039 . . . . 0.45 113.454 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -80.8 80.52 7.25 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 127.05 2.14 . . . . 2.03 108.07 169.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 8' ' ' VAL . . . . . 0.4 ' H ' HG22 ' E' ' 8' ' ' VAL . 13.9 m -89.97 135.6 25.89 Favored 'Isoleucine or valine' 0 C--N 1.374 1.672 0 N-CA-C 103.365 -2.828 . . . . 0.13 103.365 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -95.52 110.38 22.46 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 120.89 1.677 . . . . 0.17 114.544 -172.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.532 HD11 HG11 ' E' ' 38' ' ' VAL . 10.5 mm -52.18 108.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.378 1.807 0 N-CA-C 118.19 2.663 . . . . 0.12 118.19 175.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -117.9 48.82 1.32 Allowed 'General case' 0 C--N 1.37 1.486 0 CA-C-O 123.203 1.478 . . . . 0.3 107.923 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -101.62 128.97 47.65 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 130.277 3.431 . . . . 2.09 109.485 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 20.9 p -74.69 -58.67 3.14 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 128.8 2.84 . . . . 0.47 113.268 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -66.07 48.75 0.03 OUTLIER 'General case' 0 C--N 1.359 0.998 0 C-N-CA 129.295 3.038 . . . . 1.89 116.529 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 53.3 m -167.48 166.5 14.26 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 119.575 -1.953 . . . . 1.13 106.631 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -92.96 15.56 14.65 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 119.645 -1.91 . . . . 0.79 113.727 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -116.44 13.14 15.39 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 126.811 2.045 . . . . 0.75 111.86 -175.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -61.82 105.98 0.63 Allowed 'General case' 0 C--N 1.367 1.34 0 C-N-CA 127.519 2.328 . . . . 0.4 114.598 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.58 9.01 44.88 Favored Glycine 0 C--N 1.363 2.047 0 C-N-CA 123.959 0.79 . . . . 0.39 112.975 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -107.99 174.57 5.82 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 127.984 2.514 . . . . 1.4 109.948 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 p -108.68 178.74 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.437 0 C-N-CA 125.482 1.513 . . . . 0.31 110.492 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.29 174.55 47.04 Favored Glycine 0 CA--C 1.477 -2.335 0 O-C-N 119.829 -1.795 . . . . 0.21 108.918 171.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . 0.56 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 8.3 m -106.65 115.09 29.6 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 125.054 1.342 . . . . 0.27 110.43 -177.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 p -68.79 85.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 125.779 1.632 . . . . 0.29 113.545 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.96 50.0 1.88 Allowed 'General case' 0 C--N 1.355 0.804 0 O-C-N 119.947 -1.721 . . . . 0.29 110.967 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . 0.561 ' HB3' ' H ' ' E' ' 37' ' ' ILE . 19.3 p -94.71 -71.8 0.65 Allowed 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 120.298 3.444 . . . . 0.63 120.298 -174.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 27' ' ' VAL . . . . . 0.406 HG12 ' H ' ' E' ' 27' ' ' VAL . 7.3 p -81.13 56.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.755 2 C-N-CA 132.84 4.456 . . . . 0.61 111.823 -167.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -141.82 -45.62 0.35 Allowed 'General case' 0 N--CA 1.411 -2.399 2 CA-C-N 107.49 -4.414 . . . . 1.61 102.126 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -109.3 -39.21 5.29 Favored 'General case' 0 C--N 1.368 1.41 0 C-N-CA 129.67 3.188 . . . . 3.96 113.643 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 23.6 m -69.87 53.36 0.12 Allowed 'General case' 0 C--N 1.364 1.216 0 C-N-CA 131.228 3.811 . . . . 4.34 118.527 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -88.6 47.0 3.39 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 109.65 -3.432 . . . . 1.76 111.368 153.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 32' ' ' ILE . . . . . 0.435 HG22 ' H ' ' E' ' 33' ' ' LEU . 0.5 OUTLIER -140.15 -153.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.246 0 C-N-CA 126.98 2.112 . . . . 1.11 110.031 -175.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 33' ' ' LEU . . . . . 0.435 ' H ' HG22 ' E' ' 32' ' ' ILE . 40.8 tp -65.8 -43.25 89.24 Favored 'General case' 0 C--N 1.354 0.798 1 C-N-CA 132.565 4.346 . . . . 0.57 117.0 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -108.8 128.3 25.77 Favored Pre-proline 0 C--N 1.356 0.888 0 O-C-N 120.367 -1.458 . . . . 0.94 107.176 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.19 -28.61 4.63 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 124.411 3.408 . . . . 0.67 112.791 -174.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . 0.642 HG12 HG23 ' E' ' 38' ' ' VAL . 59.4 t -110.72 138.34 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 130.4 3.48 . . . . 0.64 108.188 -177.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . 0.561 ' H ' ' HB3' ' E' ' 26' ' ' SER . 63.5 mt -138.29 121.92 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 2 N-CA-C 95.13 -5.878 . . . . 0.65 95.13 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 38' ' ' VAL . . . . . 0.642 HG23 HG12 ' E' ' 36' ' ' VAL . 62.3 t -124.25 157.49 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 CA-C-N 122.492 2.406 . . . . 0.23 111.901 -170.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 39' ' ' ARG . . . . . 0.56 ' HB3' ' H ' ' E' ' 23' ' ' THR . 0.0 OUTLIER -83.64 144.01 29.71 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 128.035 2.534 . . . . 2.75 112.176 174.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -129.78 128.57 42.66 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 114.636 -1.166 . . . . 1.26 107.933 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -98.35 -15.44 19.72 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 126.18 1.792 . . . . 1.02 110.805 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -115.35 60.56 0.7 Allowed 'General case' 0 C--N 1.355 0.823 0 C-N-CA 131.048 3.739 . . . . 1.29 110.424 -177.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -88.85 175.78 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.809 0 C-N-CA 126.494 1.918 . . . . 1.23 109.114 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -85.77 69.63 10.61 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 127.473 2.309 . . . . 2.05 108.443 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -50.42 -8.33 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.537 1 C-N-CA 132.083 4.153 . . . . 2.52 119.028 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -97.63 125.17 42.24 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 129.102 2.961 . . . . 4.16 108.211 175.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.92 105.22 1.77 Allowed Glycine 0 C--N 1.36 1.877 0 N-CA-C 120.069 2.788 . . . . 5.33 120.069 -170.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -92.43 -162.59 0.94 Allowed 'General case' 0 C--N 1.355 0.805 0 C-N-CA 127.138 2.175 . . . . 5.09 112.565 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 19.7 m -51.83 -39.3 58.58 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 131.351 3.861 . . . . 7.18 116.924 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . -104.1 30.88 9.37 Favored Glycine 0 C--N 1.356 1.647 0 C-N-CA 126.109 1.814 . . . . 6.51 111.247 171.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 51' ' ' SER . . . . . . . . . . . . 0.338 15.3 p 76.36 -156.68 0.04 OUTLIER 'General case' 0 C--N 1.355 0.829 0 C-N-CA 126.988 2.115 . . . . 7.2 116.439 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -96.59 -105.64 0.17 Allowed 'General case' 0 C--N 1.354 0.768 0 C-N-CA 124.817 1.247 . . . . 5.08 113.584 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 9.8 m -68.51 43.73 0.04 OUTLIER 'General case' 0 C--N 1.35 0.61 0 C-N-CA 129.778 3.231 . . . . 3.86 117.306 -173.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.53 -54.93 5.26 Favored Glycine 0 C--N 1.357 1.7 0 C-N-CA 126.395 1.95 . . . . 2.85 115.706 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . 0.348 7.8 p -84.28 75.98 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.533 0 CA-C-O 126.62 3.105 . . . . 1.72 114.884 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -94.48 -28.77 15.29 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 110.056 -3.247 . . . . 2.2 112.415 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 2.9 p -132.17 129.28 39.58 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 130.202 3.401 . . . . 0.47 105.582 -177.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -154.43 150.38 27.81 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 104.734 -2.321 . . . . 1.57 104.734 -174.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -78.51 125.21 29.05 Favored 'General case' 0 C--N 1.353 0.717 1 C-N-CA 131.811 4.044 . . . . 2.07 116.334 -169.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 60' ' ' PHE . . . . . 0.544 ' HB3' HD21 ' E' ' 65' ' ' LEU . 19.3 m-85 -128.89 154.91 46.04 Favored 'General case' 0 C--N 1.36 1.06 0 CA-C-O 124.042 1.877 . . . . 0.17 114.036 -173.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.42 101.92 10.59 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 112.337 -2.21 . . . . 0.17 109.941 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -27.27 -26.95 0.0 OUTLIER 'General case' 0 C--N 1.372 1.553 1 C-N-CA 132.155 4.182 . . . . 1.72 121.132 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -46.9 -49.64 20.07 Favored 'General case' 0 C--N 1.374 1.66 0 C-N-CA 131.028 3.731 . . . . 0.17 113.601 167.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 11.6 pm0 -95.07 10.02 37.35 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-N 114.121 -1.399 . . . . 1.18 112.942 -172.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' E' ' 60' ' ' PHE . 0.2 OUTLIER -115.3 120.64 40.32 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.824 1.65 . . . . 0.19 111.215 -177.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -100.15 115.15 29.16 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 125.763 1.625 . . . . 2.05 111.116 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.56 132.02 46.75 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 129.087 2.955 . . . . 0.29 118.535 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.63 -39.28 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.275 0 C-N-CA 124.407 1.083 . . . . 0.73 113.436 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 69' ' ' GLN . . . . . 0.495 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 25.6 tt0 -112.22 106.86 15.54 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 116.327 1.973 . . . . 2.19 116.327 -171.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.27 63.85 0.15 Allowed 'General case' 0 CA--C 1.557 1.225 0 O-C-N 119.734 -1.854 . . . . 0.0 115.957 170.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.35 53.72 0.41 Allowed 'General case' 0 C--N 1.369 1.453 0 C-N-CA 128.112 2.565 . . . . 0.0 117.12 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.74 160.07 15.13 Favored 'General case' 0 C--N 1.35 0.591 0 C-N-CA 128.313 2.645 . . . . 0.0 116.089 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt . . . . . 0 C--O 1.261 1.708 0 C-N-CA 128.905 2.882 . . . . 0.0 108.83 176.976 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 108.605 -0.887 . . . . 2.13 108.605 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -156.51 0.51 Allowed 'General case' 0 C--N 1.352 0.713 0 N-CA-C 116.718 2.118 . . . . 0.99 116.718 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.31 153.85 44.21 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 129.1 2.96 . . . . 0.8 104.43 177.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . 0.282 0.0 OUTLIER -86.29 121.62 29.13 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 119.55 3.167 . . . . 3.4 119.55 -171.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.4 -0.69 14.24 Favored Glycine 0 C--N 1.365 2.19 0 C-N-CA 126.372 1.939 . . . . 0.53 110.856 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 6' ' ' ASP . . . . . 0.421 ' HA ' ' HB2' ' E' ' 69' ' ' GLN . 56.2 t0 -70.26 146.16 50.84 Favored 'General case' 0 N--CA 1.423 -1.818 1 C-N-CA 132.937 4.495 . . . . 0.45 112.054 -178.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -82.48 76.53 9.34 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 125.315 1.446 . . . . 2.03 108.743 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 28.8 m -87.6 144.97 8.15 Favored 'Isoleucine or valine' 0 C--N 1.371 1.532 0 O-C-N 119.815 -1.803 . . . . 0.13 107.312 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -109.99 117.12 32.94 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 114.754 1.39 . . . . 0.17 114.754 -169.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 14.2 mm -63.96 126.03 21.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.834 0 C-N-CA 128.508 2.723 . . . . 0.12 118.012 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.87 39.38 3.53 Favored 'General case' 0 C--N 1.365 1.281 0 N-CA-C 115.945 1.831 . . . . 0.3 115.945 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -108.47 147.57 31.47 Favored 'General case' 0 C--N 1.368 1.371 0 O-C-N 118.942 -2.349 . . . . 2.09 110.685 174.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 13.3 t -105.14 24.17 12.46 Favored 'General case' 0 C--N 1.364 1.231 0 C-N-CA 125.314 1.446 . . . . 0.47 112.347 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -90.83 11.51 22.28 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 127.763 2.425 . . . . 1.89 112.832 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 3.3 t -169.12 -173.66 1.82 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.012 1.325 . . . . 1.13 107.657 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -92.77 21.12 5.82 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 130.001 3.321 . . . . 0.79 112.266 177.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -111.51 6.96 20.5 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 127.99 2.516 . . . . 0.75 110.012 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -64.1 101.46 0.4 Allowed 'General case' 0 C--N 1.367 1.363 0 C-N-CA 127.988 2.515 . . . . 0.4 114.911 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.77 40.36 4.69 Favored Glycine 0 C--N 1.359 1.809 0 C-N-CA 125.758 1.647 . . . . 0.39 111.368 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -132.93 146.18 51.56 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 123.399 1.571 . . . . 1.4 113.254 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.32 147.8 4.98 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 C-N-CA 130.211 3.404 . . . . 0.31 112.019 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.96 -179.21 34.6 Favored Glycine 0 CA--C 1.478 -2.225 0 N-CA-C 107.995 -2.042 . . . . 0.21 107.995 173.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . 0.659 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 30.1 m -88.93 129.12 35.68 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 124.861 1.264 . . . . 0.27 109.711 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 24' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' E' ' 26' ' ' SER . 14.9 p -75.64 92.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 124.795 2.236 . . . . 0.29 113.624 174.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.55 23.55 2.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.824 2.05 . . . . 0.29 113.236 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . 0.466 ' HB3' HG22 ' E' ' 24' ' ' VAL . 28.6 t -64.82 -66.09 0.59 Allowed 'General case' 0 C--N 1.364 1.211 1 C-N-CA 131.85 4.06 . . . . 0.63 115.315 178.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -85.44 53.88 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.745 0 CA-C-O 124.017 1.865 . . . . 0.61 113.054 -166.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.81 -67.09 0.05 OUTLIER 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 127.377 2.271 . . . . 1.61 107.422 -171.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -104.28 -9.17 18.77 Favored 'General case' 0 C--N 1.363 1.181 0 N-CA-C 115.083 1.512 . . . . 3.96 115.083 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.23 24.51 1.85 Allowed 'General case' 0 C--N 1.363 1.17 0 N-CA-C 115.532 1.679 . . . . 4.34 115.532 -176.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.77 46.71 0.16 Allowed Glycine 0 C--N 1.364 2.124 0 C-N-CA 130.05 3.691 . . . . 1.76 115.806 168.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -130.94 -159.33 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.672 1 C-N-CA 132.995 4.518 . . . . 1.11 107.418 -176.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 39.7 tp -69.24 -34.37 74.7 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 130.411 3.484 . . . . 0.57 117.821 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -106.45 146.44 33.01 Favored Pre-proline 0 C--N 1.358 0.953 0 C-N-CA 125.092 1.357 . . . . 0.94 109.211 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.52 -43.66 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.624 2.883 . . . . 0.67 114.597 -170.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . 0.492 HG11 ' CD1' ' E' ' 65' ' ' LEU . 60.9 t -109.43 128.02 65.74 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 115.305 1.594 . . . . 0.64 115.305 -170.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 19.0 mt -109.09 142.22 22.23 Favored 'Isoleucine or valine' 0 C--N 1.36 1.054 0 N-CA-C 103.7 -2.704 . . . . 0.65 103.7 162.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 17.8 t -134.8 159.22 41.72 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 N-CA-C 107.308 -1.367 . . . . 0.23 107.308 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 39' ' ' ARG . . . . . 0.659 ' HB3' ' H ' ' E' ' 23' ' ' THR . 41.1 ttp85 -83.82 147.48 27.54 Favored 'General case' 0 C--N 1.354 0.766 1 C-N-CA 131.854 4.062 . . . . 2.75 111.914 172.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -133.68 128.13 34.36 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 125.07 1.348 . . . . 1.26 108.218 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.24 -16.95 30.04 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 128.445 2.698 . . . . 1.02 112.299 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -99.03 61.6 1.26 Allowed 'General case' 0 C--N 1.356 0.863 1 C-N-CA 132.119 4.168 . . . . 1.29 110.765 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 p -95.96 128.61 47.0 Favored 'Isoleucine or valine' 0 C--N 1.361 1.106 0 C-N-CA 129.13 2.972 . . . . 1.23 104.153 169.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -79.16 45.42 0.64 Allowed 'General case' 0 C--N 1.356 0.864 0 O-C-N 117.47 -3.269 . . . . 2.05 115.759 -169.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 9.85 -18.6 0.0 OUTLIER 'General case' 0 C--N 1.367 1.327 2 C-N-CA 140.943 7.697 . . . . 2.52 121.881 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -76.28 40.79 0.22 Allowed 'General case' 0 C--N 1.346 0.422 0 C-N-CA 131.365 3.866 . . . . 4.16 115.35 -173.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.99 -10.25 83.18 Favored Glycine 0 C--N 1.359 1.831 0 C-N-CA 127.992 2.71 . . . . 5.33 113.93 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -106.95 1.36 24.45 Favored 'General case' 0 C--N 1.361 1.109 0 CA-C-O 124.256 1.979 . . . . 5.09 110.645 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 20.0 m -106.23 -56.26 2.21 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 128.72 2.808 . . . . 7.18 110.093 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.66 -76.71 0.03 OUTLIER Glycine 0 C--N 1.357 1.704 0 O-C-N 120.999 -1.063 . . . . 6.51 113.122 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 21.2 t -131.89 130.25 41.39 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 124.982 1.313 . . . . 7.2 111.058 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.45 -2.53 51.69 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 125.882 1.673 . . . . 5.08 111.534 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 53' ' ' SER . . . . . . . . . . . . 0.277 13.8 m 41.95 -25.8 0.0 OUTLIER 'General case' 0 C--N 1.359 1.017 1 C-N-CA 137.76 6.424 . . . . 3.86 121.084 177.127 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.94 -154.46 11.71 Favored Glycine 0 CA--C 1.501 -0.799 0 C-N-CA 130.214 3.769 . . . . 2.85 108.025 171.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . 0.61 HG22 ' H ' ' E' ' 56' ' ' ASN . 13.9 p -155.66 -175.61 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 N-CA-C 106.529 -1.656 . . . . 1.72 106.529 -176.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 56' ' ' ASN . . . . . 0.61 ' H ' HG22 ' E' ' 55' ' ' VAL . 0.3 OUTLIER -101.26 -29.84 11.85 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 128.103 2.561 . . . . 2.2 111.442 176.478 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 22.9 p -126.29 134.78 51.05 Favored 'General case' 0 C--N 1.362 1.128 0 O-C-N 119.927 -1.733 . . . . 0.47 110.164 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -162.06 161.58 28.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.871 1.668 . . . . 1.57 107.194 175.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -97.1 154.45 17.33 Favored 'General case' 0 C--N 1.361 1.101 0 CA-C-O 124.032 1.872 . . . . 2.07 113.897 -176.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 60' ' ' PHE . . . . . 0.406 ' CB ' HD21 ' E' ' 65' ' ' LEU . 95.0 m-85 -135.94 169.55 17.41 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 112.481 -2.145 . . . . 0.17 113.489 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -109.46 108.58 19.14 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 111.064 -2.789 . . . . 0.17 107.788 172.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -25.66 -17.94 0.0 OUTLIER 'General case' 0 C--N 1.367 1.341 2 C-N-CA 134.395 5.078 . . . . 1.72 122.0 176.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -65.99 -32.41 73.88 Favored 'General case' 0 C--N 1.371 1.502 0 C-N-CA 130.97 3.708 . . . . 0.17 110.937 166.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -84.85 -11.76 54.99 Favored 'General case' 0 C--N 1.364 1.217 0 O-C-N 120.742 -1.224 . . . . 1.18 110.705 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.492 ' CD1' HG11 ' E' ' 36' ' ' VAL . 0.3 OUTLIER -106.81 108.57 20.14 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 115.708 1.744 . . . . 0.19 115.708 -171.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -96.43 133.17 41.19 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 125.596 1.558 . . . . 2.05 108.772 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . 0.466 ' H ' HD23 ' E' ' 67' ' ' LEU 0.297 2.4 pt? -87.36 153.09 21.73 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-N 123.1 2.682 . . . . 0.29 117.017 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 t -125.44 -27.42 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.121 0 C-N-CA 126.088 1.755 . . . . 0.73 110.782 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 69' ' ' GLN . . . . . 0.421 ' HB2' ' HA ' ' E' ' 6' ' ' ASP . 2.5 mm-40 -113.85 160.98 18.15 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 127.018 3.294 . . . . 2.19 114.786 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -104.73 56.36 0.7 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 108.886 -3.779 . . . . 0.0 111.651 173.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.71 58.78 1.89 Allowed 'General case' 0 C--N 1.365 1.253 0 O-C-N 120.205 -1.56 . . . . 0.0 114.553 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.95 91.93 7.13 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 128.753 2.821 . . . . 0.0 112.308 -176.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 75.7 mttt . . . . . 0 C--O 1.262 1.738 0 CA-C-O 117.624 -1.179 . . . . 0.0 109.104 174.463 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.996 0 N-CA-C 108.306 -0.998 . . . . 2.13 108.306 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 2' ' ' LEU . . . . . 0.572 HD11 HG21 ' E' ' 36' ' ' VAL . 0.0 OUTLIER -99.69 -154.86 0.48 Allowed 'General case' 0 C--N 1.351 0.647 0 N-CA-C 117.998 2.592 . . . . 0.99 117.998 -175.66 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . 0.452 ' O ' HG11 ' E' ' 24' ' ' VAL . 1.0 OUTLIER -135.61 178.49 7.0 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 129.11 2.964 . . . . 0.8 110.127 -175.66 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . 0.433 ' H ' ' CZ ' ' E' ' 4' ' ' ARG . 0.0 OUTLIER -94.65 104.98 16.91 Favored 'General case' 0 C--N 1.376 1.753 0 C-N-CA 128.699 2.8 . . . . 3.4 114.423 173.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 5' ' ' GLY . . . . . 0.538 ' H ' ' CG1' ' E' ' 24' ' ' VAL . . . 113.34 -3.34 25.13 Favored Glycine 0 CA--C 1.485 -1.799 0 O-C-N 118.079 -2.888 . . . . 0.53 110.175 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 6' ' ' ASP . . . . . 0.604 ' HA ' ' HB2' ' E' ' 69' ' ' GLN . 43.5 t0 -68.4 127.79 34.25 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 130.292 3.437 . . . . 0.45 110.381 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -82.56 80.17 8.78 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 106.711 -1.588 . . . . 2.03 106.711 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 8' ' ' VAL . . . . . 0.423 HG22 ' HB ' ' E' ' 24' ' ' VAL . 12.7 m -84.51 142.32 13.49 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 O-C-N 121.665 -0.647 . . . . 0.13 109.951 -173.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -108.02 129.28 55.14 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 118.322 -0.847 . . . . 0.17 111.838 -172.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.439 HG21 ' CE1' ' E' ' 60' ' ' PHE . 3.7 mm -74.01 118.53 19.69 Favored 'Isoleucine or valine' 0 C--N 1.365 1.272 0 N-CA-C 115.141 1.534 . . . . 0.12 115.141 175.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -107.59 36.89 2.57 Favored 'General case' 0 C--N 1.373 1.621 0 O-C-N 119.574 -1.954 . . . . 0.3 114.072 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -102.52 99.26 9.27 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 129.853 3.261 . . . . 2.09 112.663 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 13' ' ' THR . . . . . 0.591 ' HA ' ' CG ' ' E' ' 18' ' ' TYR . 4.1 m -58.58 -34.37 71.0 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 129.081 2.953 . . . . 0.47 117.912 -175.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -74.72 44.01 0.21 Allowed 'General case' 0 C--N 1.346 0.442 0 C-N-CA 129.199 2.999 . . . . 1.89 115.003 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 17.1 t -172.2 175.1 3.8 Favored 'General case' 0 C--N 1.365 1.257 0 C-N-CA 125.343 1.457 . . . . 1.13 107.4 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -92.19 7.13 43.99 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 129.975 3.31 . . . . 0.79 111.124 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 38.5 m0 -106.32 10.51 31.63 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 127.247 2.219 . . . . 0.75 109.478 178.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 18' ' ' TYR . . . . . 0.591 ' CG ' ' HA ' ' E' ' 13' ' ' THR . 18.5 t80 -69.79 101.68 1.76 Allowed 'General case' 0 C--N 1.374 1.635 0 C-N-CA 126.333 1.853 . . . . 0.4 113.276 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.18 39.69 6.34 Favored Glycine 0 C--N 1.356 1.667 0 C-N-CA 125.359 1.457 . . . . 0.39 111.898 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -109.86 135.7 50.32 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 119.043 1.421 . . . . 1.4 109.065 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -97.17 164.82 2.18 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 125.579 1.552 . . . . 0.31 110.582 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.19 177.67 47.08 Favored Glycine 0 CA--C 1.47 -2.772 0 N-CA-C 107.056 -2.418 . . . . 0.21 107.056 170.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . 0.481 ' H ' ' CB ' ' E' ' 39' ' ' ARG . 6.9 m -86.77 130.47 34.46 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 125.348 2.499 . . . . 0.27 110.801 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 24' ' ' VAL . . . . . 0.538 ' CG1' ' H ' ' E' ' 5' ' ' GLY . 11.8 p -62.32 73.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 131.176 3.79 . . . . 0.29 116.062 174.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.96 25.65 0.36 Allowed 'General case' 0 CA--C 1.551 1.012 0 O-C-N 116.475 -3.891 . . . . 0.29 114.131 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . . . . . . . . 0.271 1.5 m -73.86 -25.65 60.16 Favored 'General case' 0 CA--C 1.5 -0.964 1 C-N-CA 136.376 5.87 . . . . 0.63 117.155 175.488 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -114.27 49.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 124.778 1.231 . . . . 0.61 109.083 -171.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.34 -56.93 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 124.024 0.93 . . . . 1.61 108.905 -169.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -109.43 8.86 25.51 Favored 'General case' 0 C--N 1.36 1.049 0 C-N-CA 126.357 1.863 . . . . 3.96 111.799 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 4.9 m -27.22 -41.12 0.01 OUTLIER 'General case' 0 C--N 1.361 1.08 1 C-N-CA 135.909 5.684 . . . . 4.34 121.05 -175.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.35 42.27 0.13 Allowed Glycine 0 C--N 1.348 1.244 1 C-N-CA 131.845 4.545 . . . . 1.76 118.172 -171.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 32' ' ' ILE . . . . . 0.653 HD12 HD21 ' E' ' 59' ' ' ASN . 0.0 OUTLIER -116.78 -167.24 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.457 0 C-N-CA 125.04 1.336 . . . . 1.11 110.292 176.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 38.0 tp -65.34 -33.89 77.03 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 129.629 3.172 . . . . 0.57 116.86 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -135.12 132.82 20.37 Favored Pre-proline 0 N--CA 1.469 0.499 0 N-CA-C 101.501 -3.518 . . . . 0.94 101.501 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.02 -46.63 1.44 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.779 2.986 . . . . 0.67 116.573 -160.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . 0.572 HG21 HD11 ' E' ' 2' ' ' LEU . 54.3 t -80.83 103.02 7.24 Favored 'Isoleucine or valine' 0 C--N 1.368 1.372 0 N-CA-C 114.417 1.266 . . . . 0.64 114.417 -175.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 20.5 mt -89.82 118.72 35.65 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 N-CA-C 106.05 -1.833 . . . . 0.65 106.05 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 38' ' ' VAL . . . . . . . . . . . . . 37.7 t -109.7 145.56 16.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 O-C-N 119.685 -1.884 . . . . 0.23 109.646 176.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 39' ' ' ARG . . . . . 0.481 ' CB ' ' H ' ' E' ' 23' ' ' THR . 8.1 tmm_? -42.85 -32.65 0.65 Allowed 'General case' 0 C--N 1.359 0.994 2 C-N-CA 134.467 5.107 . . . . 2.75 123.564 -177.243 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.22 129.44 34.5 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 120.794 3.627 . . . . 1.26 120.794 -162.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -88.53 38.02 0.85 Allowed 'General case' 0 C--N 1.356 0.875 0 C-N-CA 128.934 2.894 . . . . 1.02 113.324 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -96.08 36.13 1.35 Allowed 'General case' 0 C--N 1.348 0.535 1 C-N-CA 131.97 4.108 . . . . 1.29 110.428 -176.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . 0.263 10.9 m -88.55 -162.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 127.725 2.41 . . . . 1.23 110.978 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.52 83.57 1.91 Allowed 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 119.361 -2.087 . . . . 2.05 112.49 -176.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -40.28 17.16 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.563 2 C-N-CA 136.664 5.985 . . . . 2.52 121.853 -176.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -102.9 75.36 1.39 Allowed 'General case' 0 C--N 1.359 0.984 0 C-N-CA 127.125 2.17 . . . . 4.16 105.975 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.11 -8.15 61.1 Favored Glycine 0 C--N 1.357 1.711 0 N-CA-C 119.979 2.751 . . . . 5.33 119.979 -173.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -95.19 -9.35 33.62 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 126.671 1.988 . . . . 5.09 115.796 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 17.8 t -101.31 -12.2 18.85 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 128.208 2.603 . . . . 7.18 111.507 175.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 159.96 125.55 0.8 Allowed Glycine 0 C--N 1.353 1.476 0 N-CA-C 106.295 -2.722 . . . . 6.51 106.295 -175.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 2.8 m -68.39 63.57 0.1 Allowed 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 119.729 3.233 . . . . 7.2 119.729 -173.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -101.28 0.68 37.75 Favored 'General case' 0 C--N 1.372 1.562 0 C-N-CA 127.353 2.261 . . . . 5.08 116.157 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 8.0 p -84.75 -34.86 22.76 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 127.603 2.361 . . . . 3.86 115.678 -175.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -102.66 9.89 55.74 Favored Glycine 0 C--N 1.354 1.54 0 C-N-CA 126.547 2.022 . . . . 2.85 112.797 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 p -128.11 75.46 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.383 0 N-CA-C 103.788 -2.671 . . . . 1.72 103.788 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -93.79 -11.34 31.51 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 130.061 3.344 . . . . 2.2 112.491 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 16.1 p -114.78 125.3 53.54 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 101.388 -3.56 . . . . 0.47 101.388 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -122.8 133.48 54.45 Favored 'General case' 0 C--N 1.358 0.939 0 O-C-N 120.098 -1.626 . . . . 1.57 113.131 -168.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 59' ' ' ASN . . . . . 0.653 HD21 HD12 ' E' ' 32' ' ' ILE . 20.1 m120 -88.13 112.5 22.76 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 129.294 3.038 . . . . 2.07 115.7 -174.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 60' ' ' PHE . . . . . 0.439 ' CE1' HG21 ' E' ' 10' ' ' ILE . 97.7 m-85 -115.46 173.5 6.49 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 115.47 1.655 . . . . 0.17 115.47 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.53 85.85 4.65 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 129.503 3.121 . . . . 0.17 110.755 172.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -15.91 -23.4 0.0 OUTLIER 'General case' 0 C--N 1.36 1.043 1 C-N-CA 138.108 6.563 . . . . 1.72 121.331 172.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.07 -37.26 69.66 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 130.366 3.466 . . . . 0.17 113.831 171.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . 0.275 2.0 pp20? -97.46 16.03 21.43 Favored 'General case' 0 C--N 1.373 1.624 0 C-N-CA 126.35 1.86 . . . . 1.18 111.331 -177.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.466 ' CD1' HG11 ' E' ' 36' ' ' VAL . 0.3 OUTLIER -112.96 104.58 12.55 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 128.427 2.691 . . . . 0.19 108.206 172.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -94.53 150.48 20.2 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 125.867 1.667 . . . . 2.05 111.15 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -74.47 142.04 44.9 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 117.851 2.537 . . . . 0.29 117.851 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 3.4 t -135.6 -27.9 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.072 0 C-N-CA 126.206 1.802 . . . . 0.73 110.499 171.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 69' ' ' GLN . . . . . 0.604 ' HB2' ' HA ' ' E' ' 6' ' ' ASP 0.342 19.8 mt-30 -118.59 113.58 21.47 Favored 'General case' 0 C--N 1.361 1.075 0 CA-C-O 123.489 1.614 . . . . 2.19 113.613 174.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.86 56.96 0.99 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 127.804 2.442 . . . . 0.0 111.523 169.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.02 58.2 0.22 Allowed 'General case' 0 C--N 1.355 0.834 0 C-N-CA 128.365 2.666 . . . . 0.0 117.796 -169.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.06 73.02 0.89 Allowed 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt . . . . . 0 C--O 1.262 1.746 0 C-N-CA 127.661 2.384 . . . . 0.0 111.704 177.969 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.956 0 N-CA-C 109.102 -0.703 . . . . 2.13 109.102 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 2' ' ' LEU . . . . . 0.488 HD22 HG11 ' E' ' 8' ' ' VAL 0.328 1.8 pp -101.85 -154.87 0.5 Allowed 'General case' 0 C--N 1.356 0.867 0 N-CA-C 115.969 1.841 . . . . 0.99 115.969 -174.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -144.36 176.08 9.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 129.773 3.229 . . . . 0.8 111.223 -171.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . 0.421 ' HG2' HG13 ' E' ' 27' ' ' VAL . 0.0 OUTLIER -96.59 102.7 14.52 Favored 'General case' 0 C--N 1.37 1.462 0 O-C-N 119.51 -1.994 . . . . 3.4 112.165 174.527 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.47 4.58 11.9 Favored Glycine 0 C--N 1.363 2.059 0 CA-C-O 124.087 1.937 . . . . 0.53 112.241 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 6' ' ' ASP . . . . . 0.469 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 65.3 t0 -74.89 136.81 41.46 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 130.446 3.498 . . . . 0.45 109.508 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . 0.627 ' H ' ' HB2' ' E' ' 69' ' ' GLN . 41.1 mmtm -91.75 79.1 5.4 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 104.96 -2.237 . . . . 2.03 104.96 176.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 8' ' ' VAL . . . . . 0.488 HG11 HD22 ' E' ' 2' ' ' LEU . 13.4 m -86.32 143.18 11.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 106.336 -1.727 . . . . 0.13 106.336 -177.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' E' ' 21' ' ' VAL . 23.4 ttt85 -104.16 117.74 34.97 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 113.495 0.924 . . . . 0.17 113.495 -172.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 13.8 mm -56.66 111.66 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.376 0 N-CA-C 117.466 2.395 . . . . 0.12 117.466 173.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -115.35 47.63 1.29 Allowed 'General case' 0 C--N 1.368 1.408 0 C-N-CA 126.225 1.81 . . . . 0.3 109.912 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -106.64 127.09 53.07 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 128.31 2.644 . . . . 2.09 106.147 174.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 18.3 p -71.34 -58.67 3.31 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 129.74 3.216 . . . . 0.47 113.496 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.11 67.43 2.41 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 130.944 3.698 . . . . 1.89 110.04 174.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 27.8 t -163.43 159.9 22.79 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.344 -2.095 . . . . 1.13 105.344 -172.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -92.49 -1.81 56.7 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 127.159 2.184 . . . . 0.79 110.914 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 9.1 m0 -119.83 24.43 10.55 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 126.253 1.821 . . . . 0.75 111.721 -172.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -68.98 101.17 1.33 Allowed 'General case' 0 C--N 1.371 1.507 0 C-N-CA 125.637 1.575 . . . . 0.4 112.758 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.96 14.66 35.92 Favored Glycine 0 C--N 1.358 1.805 0 C-N-CA 125.035 1.302 . . . . 0.39 112.192 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -113.06 154.03 27.2 Favored 'General case' 0 C--N 1.362 1.145 0 C-N-CA 125.316 1.446 . . . . 1.4 109.782 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' E' ' 9' ' ' ARG . 1.4 p -92.02 -176.8 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.383 0 C-N-CA 127.525 2.33 . . . . 0.31 113.423 -175.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.24 176.72 46.42 Favored Glycine 0 CA--C 1.479 -2.159 0 N-CA-C 108.839 -1.704 . . . . 0.21 108.839 166.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . 0.457 ' H ' ' CB ' ' E' ' 39' ' ' ARG . 29.0 m -101.89 120.73 40.85 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 124.516 1.127 . . . . 0.27 109.99 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 24' ' ' VAL . . . . . 0.426 HG22 ' HB3' ' E' ' 26' ' ' SER . 7.1 p -75.29 88.02 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 123.292 1.52 . . . . 0.29 113.272 178.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.6 43.95 1.15 Allowed 'General case' 0 C--N 1.353 0.75 0 C-N-CA 126.596 1.958 . . . . 0.29 110.775 171.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . 0.426 ' HB3' HG22 ' E' ' 24' ' ' VAL . 13.7 t -81.51 -73.27 0.39 Allowed 'General case' 0 CA--C 1.488 -1.429 1 C-N-CA 131.78 4.032 . . . . 0.63 113.753 -178.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 27' ' ' VAL . . . . . 0.421 HG13 ' HG2' ' E' ' 4' ' ' ARG . 3.8 p -82.1 54.11 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.571 0 CA-C-O 126.5 3.048 . . . . 0.61 113.145 -160.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.57 -72.05 0.69 Allowed 'General case' 0 N--CA 1.418 -2.039 0 C-N-CA 130.663 3.585 . . . . 1.61 103.053 175.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.34 -17.6 13.1 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 125.696 1.598 . . . . 3.96 112.754 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . 0.455 ' HB2' ' CD1' ' E' ' 37' ' ' ILE . 1.8 t -92.41 46.92 1.27 Allowed 'General case' 0 C--N 1.367 1.344 0 O-C-N 119.435 -2.041 . . . . 4.34 114.375 -176.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.14 51.09 4.51 Favored Glycine 0 C--N 1.341 0.809 1 C-N-CA 130.89 4.09 . . . . 1.76 111.537 162.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.84 -166.6 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.882 0 C-N-CA 130.045 3.338 . . . . 1.11 108.695 -176.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 22.1 tp -61.37 -38.27 86.37 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 130.578 3.551 . . . . 0.57 117.027 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -113.81 115.54 46.09 Favored Pre-proline 0 C--N 1.356 0.855 0 N-CA-C 101.521 -3.511 . . . . 0.94 101.521 172.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -82.12 -55.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.905 2.403 . . . . 0.67 115.533 -169.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . 0.643 HG12 HG23 ' E' ' 38' ' ' VAL . 24.9 t -75.21 95.69 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.019 0 N-CA-C 119.65 3.204 . . . . 0.64 119.65 -166.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' E' ' 30' ' ' SER . 68.1 mt -87.34 119.45 35.03 Favored 'Isoleucine or valine' 0 C--N 1.368 1.41 0 N-CA-C 104.97 -2.233 . . . . 0.65 104.97 172.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 38' ' ' VAL . . . . . 0.643 HG23 HG12 ' E' ' 36' ' ' VAL . 14.0 t -123.21 163.61 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-N 120.186 1.357 . . . . 0.23 111.62 -172.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 39' ' ' ARG . . . . . 0.457 ' CB ' ' H ' ' E' ' 23' ' ' THR . 43.6 ttm-85 -84.43 142.09 30.35 Favored 'General case' 0 C--N 1.363 1.193 0 C-N-CA 128.859 2.864 . . . . 2.75 113.92 174.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -137.33 128.59 27.95 Favored 'General case' 0 CA--C 1.514 -0.437 0 O-C-N 121.301 -0.874 . . . . 1.26 111.474 173.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -90.27 -38.44 13.41 Favored 'General case' 0 C--N 1.366 1.325 0 C-N-CA 126.356 1.862 . . . . 1.02 111.38 172.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -77.97 59.59 2.18 Favored 'General case' 0 C--N 1.37 1.468 0 C-N-CA 129.459 3.104 . . . . 1.29 112.767 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.85 158.78 3.01 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 C-N-CA 127.125 2.17 . . . . 1.23 105.538 172.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -80.11 -31.0 39.18 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 127.307 2.243 . . . . 2.05 113.187 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 64.74 44.6 3.7 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 117.371 2.359 . . . . 2.52 117.371 174.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -98.01 52.7 1.06 Allowed 'General case' 0 C--N 1.365 1.241 0 C-N-CA 125.237 1.415 . . . . 4.16 110.283 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.67 70.59 3.15 Favored Glycine 0 C--N 1.363 2.06 0 O-C-N 120.489 -1.382 . . . . 5.33 116.198 -170.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -92.72 -172.12 2.94 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 127.161 2.184 . . . . 5.09 109.906 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 8.2 t -39.65 16.59 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.353 2 C-N-CA 133.777 4.831 . . . . 7.18 122.318 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . -146.58 -74.65 0.02 OUTLIER Glycine 0 C--N 1.34 0.76 0 C-N-CA 129.143 3.259 . . . . 6.51 109.041 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 5.8 t -162.29 -174.5 4.09 Favored 'General case' 0 C--N 1.358 0.936 0 O-C-N 121.006 -1.291 . . . . 7.2 108.83 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.9 -12.0 59.94 Favored 'General case' 0 C--N 1.366 1.318 1 C-N-CA 131.87 4.068 . . . . 5.08 117.167 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 53' ' ' SER . . . . . . . . . . . . 0.295 5.4 t 75.31 -24.28 0.22 Allowed 'General case' 0 C--N 1.358 0.96 0 C-N-CA 129.091 2.957 . . . . 3.86 116.76 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -110.92 -174.68 20.21 Favored Glycine 0 C--N 1.35 1.353 0 C-N-CA 125.478 1.513 . . . . 2.85 111.026 167.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.09 149.38 20.48 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 C-N-CA 125.523 1.529 . . . . 1.72 108.697 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -101.97 -44.66 5.42 Favored 'General case' 0 C--N 1.365 1.25 0 C-N-CA 128.493 2.717 . . . . 2.2 110.48 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 67.9 p -115.97 104.5 11.65 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 127.97 2.508 . . . . 0.47 106.472 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -110.29 138.88 46.07 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 107.5 -1.296 . . . . 1.57 107.5 -176.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -100.01 112.01 24.31 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-O 122.222 1.01 . . . . 2.07 109.868 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -104.16 172.7 6.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 123.909 1.814 . . . . 0.17 115.274 -175.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -102.42 94.13 5.52 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 112.218 -2.265 . . . . 0.17 109.24 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -7.43 -37.79 0.0 OUTLIER 'General case' 0 C--N 1.367 1.351 1 C-N-CA 134.778 5.231 . . . . 1.72 121.21 172.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -45.61 -46.53 14.45 Favored 'General case' 0 C--N 1.364 1.212 1 C-N-CA 132.715 4.406 . . . . 0.17 113.1 168.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -89.86 1.61 55.98 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 125.822 1.649 . . . . 1.18 112.168 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.475 ' HG ' HG11 ' E' ' 36' ' ' VAL . 0.5 OUTLIER -115.96 108.53 16.37 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 126.664 1.986 . . . . 0.19 114.126 179.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -106.44 143.0 35.18 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 125.721 1.608 . . . . 2.05 111.907 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -64.62 146.34 54.81 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 119.988 3.329 . . . . 0.29 119.988 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -144.47 -29.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.372 1.585 0 C-N-CA 126.91 2.084 . . . . 0.73 112.028 173.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 69' ' ' GLN . . . . . 0.627 ' HB2' ' H ' ' E' ' 7' ' ' LYS . 0.0 OUTLIER -114.51 116.47 28.88 Favored 'General case' 0 C--N 1.358 0.937 0 O-C-N 119.554 -1.966 . . . . 2.19 111.849 177.574 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.33 59.57 1.05 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 128.254 2.622 . . . . 0.0 113.125 174.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.47 58.46 2.66 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 129.021 2.928 . . . . 0.0 113.51 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.0 78.66 1.18 Allowed 'General case' 0 C--N 1.356 0.879 0 C-N-CA 128.189 2.596 . . . . 0.0 115.32 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt . . . . . 0 C--O 1.262 1.716 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 176.124 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 2.432 0 N-CA-C 108.684 -0.858 . . . . 2.13 108.684 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 2' ' ' LEU . . . . . . . . . . . . 0.271 0.0 OUTLIER -95.59 -165.8 1.35 Allowed 'General case' 0 C--N 1.358 0.961 0 N-CA-C 118.11 2.633 . . . . 0.99 118.11 -175.171 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -136.3 -169.26 2.4 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 127.438 2.295 . . . . 0.8 111.321 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . 0.499 ' HB3' HG13 ' E' ' 27' ' ' VAL . 14.4 ptm180 -96.44 110.27 22.66 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 127.568 2.347 . . . . 3.4 114.528 176.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.25 -0.28 14.43 Favored Glycine 0 CA--C 1.477 -2.295 0 O-C-N 121.025 -1.047 . . . . 0.53 111.998 165.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 6' ' ' ASP . . . . . 0.482 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 46.1 t0 -72.83 137.51 45.78 Favored 'General case' 0 N--CA 1.408 -2.555 1 C-N-CA 133.153 4.581 . . . . 0.45 113.469 -176.233 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . 0.485 ' H ' ' CB ' ' E' ' 69' ' ' GLN . 13.7 mptt -87.87 77.37 8.54 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 106.485 -1.672 . . . . 2.03 106.485 171.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 8' ' ' VAL . . . . . 0.4 ' H ' HG22 ' E' ' 8' ' ' VAL . 15.0 m -87.42 138.93 18.14 Favored 'Isoleucine or valine' 0 C--N 1.369 1.438 0 C-N-CA 127.168 2.187 . . . . 0.13 106.224 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -105.35 113.93 27.81 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 120.77 -1.206 . . . . 0.17 112.55 -171.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.789 HD11 HG11 ' E' ' 38' ' ' VAL . 2.3 mm -52.89 120.89 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 N-CA-C 117.727 2.491 . . . . 0.12 117.727 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -121.06 48.48 1.64 Allowed 'General case' 0 C--N 1.372 1.563 0 C-N-CA 125.519 1.528 . . . . 0.3 113.606 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 13.7 ttt180 -102.25 111.73 24.14 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 128.237 2.615 . . . . 2.09 110.075 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 47.0 p -50.74 -59.13 4.41 Favored 'General case' 0 C--N 1.369 1.454 0 C-N-CA 131.279 3.831 . . . . 0.47 119.742 -175.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -87.77 65.55 8.45 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 127.927 2.491 . . . . 1.89 110.736 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 4.5 t -145.15 169.2 18.63 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-O 123.392 1.568 . . . . 1.13 111.287 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -95.67 -1.49 50.0 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 124.996 1.318 . . . . 0.79 109.561 166.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 17' ' ' TRP . . . . . 0.479 ' CZ2' ' HA2' ' E' ' 54' ' ' GLY . 20.9 m0 -118.13 23.67 11.47 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 126.347 1.859 . . . . 0.75 110.898 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -75.03 94.92 2.94 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 125.817 1.647 . . . . 0.4 112.193 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.95 34.24 4.38 Favored Glycine 0 C--N 1.359 1.809 0 C-N-CA 126.077 1.799 . . . . 0.39 110.16 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -110.66 152.16 26.84 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 126.829 2.052 . . . . 1.4 108.537 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.06 170.26 3.59 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 CA-C-N 120.216 1.371 . . . . 0.31 108.456 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.98 176.49 44.24 Favored Glycine 0 CA--C 1.474 -2.5 0 O-C-N 120.079 -1.638 . . . . 0.21 109.255 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . 0.496 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 15.1 m -94.63 120.14 34.4 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 125.617 1.567 . . . . 0.27 110.478 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 24' ' ' VAL . . . . . 0.507 HG23 HG13 ' E' ' 36' ' ' VAL . 6.9 p -76.66 101.84 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 124.395 2.045 . . . . 0.29 112.69 173.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.89 46.1 1.3 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.167 1.387 . . . . 0.29 114.232 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 62.0 p -73.18 -86.3 0.03 OUTLIER 'General case' 0 C--N 1.354 0.794 0 C-N-CA 130.203 3.401 . . . . 0.63 114.863 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 27' ' ' VAL . . . . . 0.499 HG13 ' HB3' ' E' ' 4' ' ' ARG . 2.4 p -79.54 59.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.616 0 CA-C-O 126.519 3.057 . . . . 0.61 112.905 -169.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -160.62 -62.79 0.06 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.732 3.213 . . . . 1.61 107.233 -173.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.56 -18.19 16.73 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 127.202 2.201 . . . . 3.96 115.802 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -26.82 0.3 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.039 2 C-N-CA 134.866 5.266 . . . . 4.34 123.404 -172.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.54 43.54 1.86 Allowed Glycine 0 C--O 1.224 -0.496 1 C-N-CA 131.991 4.615 . . . . 1.76 114.939 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 32' ' ' ILE . . . . . 0.56 HD12 HD21 ' E' ' 59' ' ' ASN . 1.1 mt -131.77 -169.68 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 127.984 2.514 . . . . 1.11 105.853 -178.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 33' ' ' LEU . . . . . 0.542 ' H ' HG22 ' E' ' 32' ' ' ILE . 32.2 tp -68.51 -44.49 74.53 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 117.287 2.328 . . . . 0.57 117.287 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -123.02 157.9 59.14 Favored Pre-proline 0 C--N 1.356 0.887 0 N-CA-C 106.261 -1.755 . . . . 0.94 106.261 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.68 -46.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.365 1.427 0 C-N-CA 123.439 2.759 . . . . 0.67 115.568 -166.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . 0.564 HG12 HG23 ' E' ' 38' ' ' VAL . 73.3 t -90.51 97.04 6.76 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 CA-C-O 122.688 1.232 . . . . 0.64 112.445 -170.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 56.9 mt -86.66 105.08 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 C-N-CA 127.958 2.503 . . . . 0.65 104.34 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 38' ' ' VAL . . . . . 0.789 HG11 HD11 ' E' ' 10' ' ' ILE . 21.1 t -105.38 156.21 6.38 Favored 'Isoleucine or valine' 0 C--N 1.349 0.547 0 CA-C-N 121.058 1.754 . . . . 0.23 111.546 -174.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 39' ' ' ARG . . . . . 0.496 ' HB3' ' H ' ' E' ' 23' ' ' THR . 17.5 tpp180 -81.8 131.83 35.27 Favored 'General case' 0 C--N 1.36 1.06 0 C-N-CA 127.785 2.434 . . . . 2.75 110.983 172.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -128.91 150.46 50.35 Favored 'General case' 0 CA--C 1.512 -0.489 0 O-C-N 121.743 -0.598 . . . . 1.26 110.648 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -96.16 -48.42 5.65 Favored 'General case' 0 C--N 1.36 1.045 0 C-N-CA 126.0 1.72 . . . . 1.02 109.81 173.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 86.4 mtm-85 -82.82 85.55 7.07 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 125.893 1.677 . . . . 1.29 114.837 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 14.4 t -88.09 81.85 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.913 0 C-N-CA 127.111 2.164 . . . . 1.23 112.324 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . 0.429 0.0 OUTLIER 47.04 74.36 0.16 Allowed 'General case' 0 C--N 1.355 0.84 0 C-N-CA 131.626 3.971 . . . . 2.05 120.743 175.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -98.71 -60.54 1.52 Allowed 'General case' 0 C--N 1.345 0.379 0 C-N-CA 124.347 1.059 . . . . 2.52 110.37 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -101.36 151.99 21.25 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 125.821 1.648 . . . . 4.16 107.959 173.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.45 159.89 19.16 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 110.747 -0.941 . . . . 5.33 110.747 168.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -133.48 -169.96 2.39 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 128.714 2.806 . . . . 5.09 107.643 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 5.2 t -54.59 -7.34 0.15 Allowed 'General case' 0 C--N 1.36 1.022 0 C-N-CA 131.21 3.804 . . . . 7.18 120.577 -174.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.17 43.62 0.52 Allowed Glycine 0 CA--C 1.49 -1.494 0 N-CA-C 105.754 -2.938 . . . . 6.51 105.754 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 24.0 p 80.6 -169.22 0.03 OUTLIER 'General case' 0 C--N 1.362 1.147 0 C-N-CA 129.038 2.935 . . . . 7.2 114.364 -176.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.61 -14.42 32.46 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 125.887 1.675 . . . . 5.08 112.544 173.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m 67.49 -29.2 0.15 Allowed 'General case' 0 C--N 1.358 0.976 0 N-CA-C 119.178 3.029 . . . . 3.86 119.178 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 54' ' ' GLY . . . . . 0.479 ' HA2' ' CZ2' ' E' ' 17' ' ' TRP . . . -28.94 121.62 0.08 OUTLIER Glycine 0 C--N 1.355 1.588 2 C-N-CA 136.775 6.893 . . . . 2.85 123.638 -174.506 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 48.8 t -153.15 167.86 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.634 1 N-CA-C 99.895 -4.113 . . . . 1.72 99.895 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -80.06 -43.63 21.51 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 127.647 2.379 . . . . 2.2 112.634 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 7.2 p -126.15 121.39 32.68 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 128.723 2.809 . . . . 0.47 104.764 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -150.32 144.45 25.53 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.695 0.798 . . . . 1.57 109.561 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 59' ' ' ASN . . . . . 0.56 HD21 HD12 ' E' ' 32' ' ' ILE . 11.2 m120 -81.46 106.27 13.3 Favored 'General case' 0 C--N 1.352 0.677 0 C-N-CA 130.812 3.645 . . . . 2.07 120.117 -174.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 60' ' ' PHE . . . . . 0.436 ' CE2' HD12 ' E' ' 10' ' ' ILE . 26.1 m-85 -109.67 175.84 5.29 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 119.282 -2.136 . . . . 0.17 113.793 174.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -114.27 115.7 27.82 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 113.958 -1.474 . . . . 0.17 109.578 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -16.94 -38.13 0.0 OUTLIER 'General case' 0 C--N 1.367 1.351 1 C-N-CA 136.581 5.952 . . . . 1.72 118.496 173.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -49.84 -48.47 51.02 Favored 'General case' 0 C--N 1.37 1.492 0 C-N-CA 130.926 3.69 . . . . 0.17 113.932 169.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 13.2 pm0 -95.32 17.44 14.41 Favored 'General case' 0 C--N 1.363 1.175 0 C-N-CA 124.202 1.001 . . . . 1.18 112.16 -172.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.481 ' CD1' HG11 ' E' ' 36' ' ' VAL . 0.1 OUTLIER -120.76 138.15 54.15 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 107.524 -1.288 . . . . 0.19 107.524 173.445 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -110.39 126.28 54.11 Favored 'General case' 0 C--N 1.351 0.67 0 C-N-CA 124.501 1.12 . . . . 2.05 111.717 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.14 139.56 58.15 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 128.301 2.64 . . . . 0.29 117.695 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 t -135.26 -43.32 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.765 0 C-N-CA 126.35 1.86 . . . . 0.73 109.691 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 69' ' ' GLN . . . . . 0.485 ' CB ' ' H ' ' E' ' 7' ' ' LYS . 1.6 tp60 -106.09 113.19 26.58 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 128.284 2.633 . . . . 2.19 117.743 -168.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.76 68.1 6.88 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.958 171.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.31 53.39 0.07 Allowed 'General case' 0 C--N 1.373 1.594 0 N-CA-C 117.454 2.391 . . . . 0.0 117.454 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.05 130.96 35.42 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 126.92 2.088 . . . . 0.0 111.871 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 mptt . . . . . 0 C--O 1.262 1.729 0 C-N-CA 125.995 1.718 . . . . 0.0 110.356 179.019 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 108.752 -0.833 . . . . 2.13 108.752 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 2' ' ' LEU . . . . . 0.429 ' HB2' ' H ' ' E' ' 3' ' ' ASN . 0.0 OUTLIER -82.08 -164.19 0.78 Allowed 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 126.506 1.922 . . . . 0.99 115.637 177.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . 0.429 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 0.0 OUTLIER -140.56 -166.11 2.06 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 127.755 2.422 . . . . 0.8 109.417 -175.169 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -85.26 104.96 15.59 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 128.061 2.544 . . . . 3.4 117.24 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 112.72 -9.5 25.75 Favored Glycine 0 CA--C 1.485 -1.84 0 O-C-N 119.409 -2.057 . . . . 0.53 110.904 173.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.13 42.13 0.07 Allowed 'General case' 0 N--CA 1.438 -1.066 1 C-N-CA 133.903 4.881 . . . . 0.45 115.596 -176.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -5.74 93.21 0.01 OUTLIER 'General case' 0 C--N 1.362 1.15 1 C-N-CA 133.777 4.831 . . . . 2.03 117.058 -176.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 28.5 m -92.4 154.42 3.19 Favored 'Isoleucine or valine' 0 C--N 1.361 1.074 0 CA-C-N 121.149 1.795 . . . . 0.13 111.488 -172.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -103.17 109.0 20.42 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 121.446 -0.784 . . . . 0.17 111.92 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.785 HD11 HG11 ' E' ' 38' ' ' VAL . 1.3 mp -56.96 103.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.213 0 C-N-CA 129.805 3.242 . . . . 0.12 114.494 174.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -120.48 52.36 1.16 Allowed 'General case' 0 C--N 1.37 1.493 0 C-N-CA 124.43 1.092 . . . . 0.3 109.903 -172.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -72.17 -115.39 0.0 OUTLIER 'General case' 0 C--N 1.364 1.212 0 N-CA-C 118.792 2.886 . . . . 2.09 118.792 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -170.71 142.58 2.01 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 101.719 -3.438 . . . . 0.47 101.719 -174.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . 0.257 3.7 mm-40 -5.86 69.38 0.0 OUTLIER 'General case' 0 C--N 1.368 1.384 1 C-N-CA 134.343 5.057 . . . . 1.89 119.316 -174.65 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 75.3 m -138.39 154.57 48.92 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 130.182 3.393 . . . . 1.13 104.087 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -61.29 -11.17 8.67 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 130.127 3.371 . . . . 0.79 117.151 -176.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 22.9 m0 -113.26 -3.5 13.85 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 128.882 2.873 . . . . 0.75 113.371 -177.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -80.26 88.7 5.49 Favored 'General case' 0 C--N 1.373 1.602 0 C-N-CA 126.337 1.855 . . . . 0.4 110.291 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.34 -11.71 3.01 Favored Glycine 0 C--N 1.36 1.903 0 C-N-CA 126.74 2.114 . . . . 0.39 111.285 -175.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -97.75 162.59 13.19 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 119.66 1.73 . . . . 1.4 114.924 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -103.12 169.79 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.208 0 C-N-CA 126.717 2.007 . . . . 0.31 108.444 172.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.99 -179.78 41.25 Favored Glycine 0 CA--C 1.476 -2.406 0 N-CA-C 108.491 -1.844 . . . . 0.21 108.491 170.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . 0.674 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 4.0 m -94.33 120.3 34.36 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 125.323 1.449 . . . . 0.27 111.496 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 24' ' ' VAL . . . . . 0.542 HG23 HG13 ' E' ' 36' ' ' VAL . 14.5 p -68.02 69.57 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 131.571 3.948 . . . . 0.29 112.862 175.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.58 45.15 1.21 Allowed 'General case' 0 C--N 1.362 1.149 0 O-C-N 118.401 -2.687 . . . . 0.29 110.095 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . 0.418 ' HA ' ' HB ' ' E' ' 37' ' ' ILE . 13.2 m -87.96 -62.1 1.57 Allowed 'General case' 0 CA--C 1.465 -2.29 1 C-N-CA 135.959 5.704 . . . . 0.63 119.323 -171.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 m -80.23 19.14 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.093 0 N-CA-C 116.586 2.069 . . . . 0.61 116.586 -156.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -111.28 -50.27 2.95 Favored 'General case' 0 N--CA 1.43 -1.473 1 C-N-CA 135.187 5.395 . . . . 1.61 109.311 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . 0.557 ' HB2' HD13 ' E' ' 37' ' ' ILE . 27.8 mmmt -103.19 -12.4 17.36 Favored 'General case' 0 C--N 1.366 1.283 0 C-N-CA 128.232 2.613 . . . . 3.96 113.194 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 8.4 t -43.53 -17.91 0.02 OUTLIER 'General case' 0 C--N 1.376 1.744 1 C-N-CA 132.084 4.153 . . . . 4.34 117.97 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.53 45.46 0.27 Allowed Glycine 0 C--N 1.355 1.589 0 C-N-CA 130.221 3.772 . . . . 1.76 117.058 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 32' ' ' ILE . . . . . 0.445 HG22 ' H ' ' E' ' 33' ' ' LEU . 0.3 OUTLIER -135.78 -159.36 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.913 0 C-N-CA 129.005 2.922 . . . . 1.11 111.031 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 33' ' ' LEU . . . . . 0.445 ' H ' HG22 ' E' ' 32' ' ' ILE . 22.0 tp -69.31 -23.06 63.75 Favored 'General case' 0 C--N 1.355 0.839 1 C-N-CA 133.335 4.654 . . . . 0.57 118.378 -177.753 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -134.55 152.72 78.32 Favored Pre-proline 0 C--N 1.362 1.131 0 N-CA-C 105.735 -1.95 . . . . 0.94 105.735 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.8 -45.74 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.9 3.067 . . . . 0.67 117.65 -173.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . 0.605 HG12 HG23 ' E' ' 38' ' ' VAL . 54.6 t -109.01 106.11 20.08 Favored 'Isoleucine or valine' 0 C--N 1.353 0.748 0 N-CA-C 115.296 1.591 . . . . 0.64 115.296 -167.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . 0.557 HD13 ' HB2' ' E' ' 29' ' ' LYS . 3.3 mp -85.33 118.31 31.97 Favored 'Isoleucine or valine' 0 C--N 1.37 1.492 0 C-N-CA 125.977 1.711 . . . . 0.65 106.921 173.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 38' ' ' VAL . . . . . 0.785 HG11 HD11 ' E' ' 10' ' ' ILE . 92.8 t -115.81 155.59 17.09 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 CA-C-O 122.128 0.966 . . . . 0.23 112.256 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 39' ' ' ARG . . . . . 0.674 ' HB3' ' H ' ' E' ' 23' ' ' THR . 1.9 tpm_? -75.47 139.55 42.32 Favored 'General case' 0 C--N 1.362 1.136 0 C-N-CA 130.118 3.367 . . . . 2.75 112.932 173.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 40' ' ' PHE . . . . . 0.454 ' H ' ' NH2' ' E' ' 39' ' ' ARG . 60.9 m-85 -145.66 109.17 4.7 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 129.16 2.984 . . . . 1.26 107.915 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -104.71 -11.11 17.03 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 129.116 2.966 . . . . 1.02 113.875 -176.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -94.16 9.7 36.84 Favored 'General case' 0 C--N 1.366 1.284 0 C-N-CA 126.503 1.921 . . . . 1.29 113.226 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.39 149.62 7.52 Favored 'Isoleucine or valine' 0 C--N 1.351 0.638 0 C-N-CA 128.16 2.584 . . . . 1.23 111.522 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -69.99 42.97 0.05 Allowed 'General case' 0 C--N 1.353 0.75 0 C-N-CA 131.582 3.953 . . . . 2.05 115.748 -172.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -38.7 -42.4 0.8 Allowed 'General case' 0 C--N 1.359 0.998 1 C-N-CA 135.462 5.505 . . . . 2.52 117.747 -175.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -101.26 135.22 43.1 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.079 -1.013 . . . . 4.16 108.345 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.22 38.22 2.58 Favored Glycine 0 C--N 1.364 2.139 0 C-N-CA 127.143 2.306 . . . . 5.33 114.734 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -135.1 21.4 3.47 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 128.27 2.628 . . . . 5.09 107.463 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 76.2 p -102.45 -95.88 0.29 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 128.749 2.82 . . . . 7.18 109.441 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . -125.33 -60.37 0.17 Allowed Glycine 0 C--N 1.35 1.345 0 C-N-CA 127.04 2.257 . . . . 6.51 109.772 176.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 17.2 t -165.11 146.23 7.49 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 102.699 -3.075 . . . . 7.2 102.699 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.91 31.72 1.05 Allowed 'General case' 0 C--N 1.36 1.034 0 CA-C-O 124.402 2.049 . . . . 5.08 113.149 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 20.4 m -85.39 49.64 1.79 Allowed 'General case' 0 C--N 1.344 0.351 0 C-N-CA 131.121 3.768 . . . . 3.86 113.292 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -115.63 165.4 12.16 Favored Glycine 0 C--N 1.353 1.48 0 C-N-CA 126.016 1.769 . . . . 2.85 112.171 176.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 22.2 t -107.18 153.78 8.3 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 105.044 -2.206 . . . . 1.72 105.044 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -96.63 -76.55 0.51 Allowed 'General case' 0 C--N 1.355 0.82 0 O-C-N 120.31 -1.494 . . . . 2.2 113.515 -173.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 71.4 p -109.43 108.02 18.38 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.139 1.376 . . . . 0.47 108.653 176.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.83 146.99 36.69 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 125.828 1.651 . . . . 1.57 109.548 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -89.27 113.93 25.24 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 129.812 3.245 . . . . 2.07 111.226 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 60' ' ' PHE . . . . . 0.423 ' HB2' HD11 ' E' ' 65' ' ' LEU . 19.5 m-85 -107.0 174.39 5.91 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.95 1.7 . . . . 0.17 113.66 -176.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.7 89.38 3.67 Favored 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 130.195 3.398 . . . . 0.17 110.643 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -26.16 -18.39 0.0 OUTLIER 'General case' 0 C--N 1.354 0.797 1 C-N-CA 136.072 5.749 . . . . 1.72 120.39 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.89 -32.8 72.25 Favored 'General case' 0 C--N 1.367 1.335 0 C-N-CA 129.148 2.979 . . . . 0.17 112.729 168.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.27 18.07 21.88 Favored 'General case' 0 C--N 1.371 1.516 0 C-N-CA 125.832 1.653 . . . . 1.18 110.285 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.447 HD13 HG11 ' E' ' 36' ' ' VAL . 74.1 mt -128.18 118.81 24.03 Favored 'General case' 0 C--N 1.366 1.295 0 CA-C-O 123.526 1.631 . . . . 0.19 111.934 177.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -111.18 134.5 52.73 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 125.863 1.665 . . . . 2.05 109.145 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.65 133.76 36.22 Favored 'General case' 0 C--N 1.366 1.318 1 C-N-CA 132.161 4.185 . . . . 0.29 118.547 175.468 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . 0.269 3.1 t -132.13 -33.43 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.372 1.556 0 N-CA-C 114.758 1.392 . . . . 0.73 114.758 178.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 69' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -111.13 139.69 46.3 Favored 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 119.443 -2.036 . . . . 2.19 109.685 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.12 64.61 6.88 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.55 1.94 . . . . 0.0 114.045 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.9 68.25 2.77 Favored 'General case' 0 C--N 1.362 1.129 0 CA-C-O 123.444 1.592 . . . . 0.0 110.792 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.08 64.66 4.62 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 125.717 1.607 . . . . 0.0 109.849 176.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 19.0 pttm . . . . . 0 C--O 1.261 1.694 0 C-N-CA 127.486 2.314 . . . . 0.0 107.143 176.252 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.851 0 N-CA-C 111.563 0.209 . . . . 2.13 111.563 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 2' ' ' LEU . . . . . 0.716 HD22 HG11 ' E' ' 8' ' ' VAL 0.279 1.0 OUTLIER -103.85 -140.91 0.36 Allowed 'General case' 0 C--N 1.356 0.85 0 C-N-CA 127.495 2.318 . . . . 0.99 111.957 175.922 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.09 172.79 12.58 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 124.2 1.952 . . . . 0.8 114.418 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.09 94.34 7.89 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 127.124 2.17 . . . . 3.4 112.86 176.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.27 3.44 9.61 Favored Glycine 0 C--N 1.365 2.172 0 O-C-N 120.697 -1.252 . . . . 0.53 111.388 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 6' ' ' ASP . . . . . 0.509 ' HA ' HE21 ' E' ' 69' ' ' GLN . 18.3 t0 -69.28 143.94 53.72 Favored 'General case' 0 N--CA 1.417 -2.092 0 C-N-CA 130.739 3.615 . . . . 0.45 112.752 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -94.15 83.72 4.32 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 104.93 -2.248 . . . . 2.03 104.93 171.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 8' ' ' VAL . . . . . 0.716 HG11 HD22 ' E' ' 2' ' ' LEU . 17.5 m -89.79 144.31 9.37 Favored 'Isoleucine or valine' 0 C--N 1.365 1.252 0 N-CA-C 107.517 -1.29 . . . . 0.13 107.517 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . 0.422 HH21 ' HA2' ' E' ' 19' ' ' GLY . 69.1 ttt-85 -104.05 122.68 45.77 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 120.154 -1.591 . . . . 0.17 110.817 -175.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.613 HD11 HG11 ' E' ' 38' ' ' VAL . 0.5 OUTLIER -67.75 120.93 15.96 Favored 'Isoleucine or valine' 0 C--N 1.363 1.165 0 C-N-CA 126.939 2.096 . . . . 0.12 113.808 177.217 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -126.96 52.82 1.75 Allowed 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 127.997 2.519 . . . . 0.3 110.481 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -92.46 -138.86 0.18 Allowed 'General case' 0 C--N 1.372 1.564 0 O-C-N 120.221 -1.549 . . . . 2.09 109.946 172.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 13' ' ' THR . . . . . 0.407 ' HA ' ' CD2' ' E' ' 18' ' ' TYR 0.251 23.0 m -152.76 -60.43 0.15 Allowed 'General case' 0 C--N 1.357 0.899 0 O-C-N 118.256 -2.777 . . . . 0.47 108.764 174.352 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -75.23 67.34 1.84 Allowed 'General case' 0 C--N 1.354 0.796 0 O-C-N 119.962 -1.711 . . . . 1.89 114.453 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 23.8 t -162.12 159.68 26.34 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 125.459 1.504 . . . . 1.13 111.746 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -77.03 -27.45 54.53 Favored 'General case' 0 C--N 1.363 1.153 0 C-N-CA 130.941 3.697 . . . . 0.79 110.179 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 24.5 m0 -93.71 17.97 10.97 Favored 'General case' 0 C--N 1.365 1.26 0 C-N-CA 129.368 3.067 . . . . 0.75 113.052 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 18' ' ' TYR . . . . . 0.407 ' CD2' ' HA ' ' E' ' 13' ' ' THR . 2.6 t80 -74.63 112.17 10.55 Favored 'General case' 0 C--N 1.368 1.411 0 C-N-CA 126.362 1.865 . . . . 0.4 108.421 173.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 19' ' ' GLY . . . . . 0.422 ' HA2' HH21 ' E' ' 9' ' ' ARG . . . 94.53 34.14 6.47 Favored Glycine 0 C--N 1.354 1.534 0 C-N-CA 128.651 3.025 . . . . 0.39 113.923 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -105.42 163.86 12.31 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 118.968 1.384 . . . . 1.4 113.09 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.25 149.47 25.67 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 N-CA-C 105.603 -1.999 . . . . 0.31 105.603 175.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.08 178.35 47.54 Favored Glycine 0 CA--C 1.472 -2.629 0 C-N-CA 118.146 -1.978 . . . . 0.21 110.226 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 7.0 m -90.01 120.93 31.63 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 124.844 1.258 . . . . 0.27 113.222 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 24' ' ' VAL . . . . . 0.413 HG12 ' H ' ' E' ' 24' ' ' VAL . 7.3 p -77.57 91.54 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-O 125.374 2.512 . . . . 0.29 110.768 175.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.62 53.76 2.9 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 119.879 -1.763 . . . . 0.29 111.268 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 22.1 m -87.69 -59.82 2.14 Favored 'General case' 0 CA--C 1.476 -1.868 0 C-N-CA 130.169 3.387 . . . . 0.63 117.667 -174.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -84.41 62.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.767 0 CA-C-O 126.421 3.01 . . . . 0.61 112.843 -164.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -148.27 -66.51 0.24 Allowed 'General case' 0 N--CA 1.415 -2.209 2 C-N-CA 132.282 4.233 . . . . 1.61 104.988 -177.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -110.31 5.02 21.32 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 128.089 2.556 . . . . 3.96 114.642 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 3.8 t -50.96 -18.96 0.87 Allowed 'General case' 0 C--N 1.369 1.44 0 C-N-CA 130.043 3.337 . . . . 4.34 118.304 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.59 43.89 0.47 Allowed Glycine 0 C--N 1.349 1.295 0 C-N-CA 129.856 3.598 . . . . 1.76 116.949 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 32' ' ' ILE . . . . . 0.564 HG22 ' H ' ' E' ' 33' ' ' LEU . 0.7 OUTLIER -133.1 -166.02 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.834 0 C-N-CA 128.651 2.78 . . . . 1.11 109.599 -179.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 33' ' ' LEU . . . . . 0.564 ' H ' HG22 ' E' ' 32' ' ' ILE . 49.1 tp -69.85 -22.55 63.26 Favored 'General case' 0 C--N 1.359 0.98 1 C-N-CA 131.829 4.052 . . . . 0.57 116.786 -177.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -137.28 127.75 15.92 Favored Pre-proline 0 C--N 1.359 0.989 0 N-CA-C 105.316 -2.105 . . . . 0.94 105.316 176.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -82.3 -42.68 0.1 OUTLIER 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 124.702 3.601 . . . . 0.67 117.111 -171.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . 0.536 HG12 HG23 ' E' ' 38' ' ' VAL . 76.4 t -84.18 101.37 8.67 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 C-N-CA 127.728 2.411 . . . . 0.64 113.4 -168.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 78.5 mt -101.68 81.04 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.206 0 C-N-CA 124.973 1.309 . . . . 0.65 107.692 -176.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 38' ' ' VAL . . . . . 0.613 HG11 HD11 ' E' ' 10' ' ' ILE . 57.0 t -89.23 164.82 2.13 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 O-C-N 119.488 -2.008 . . . . 0.23 112.644 -173.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 39' ' ' ARG . . . . . . . . . . . . . 29.1 mmt85 -82.25 142.05 32.44 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 128.729 2.812 . . . . 2.75 113.461 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -132.09 138.63 48.19 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.413 1.085 . . . . 1.26 111.9 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -101.19 -34.79 9.54 Favored 'General case' 0 C--N 1.374 1.638 0 C-N-CA 125.836 1.654 . . . . 1.02 113.094 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 34.4 mtt180 -83.91 49.87 1.71 Allowed 'General case' 0 C--N 1.36 1.049 0 C-N-CA 128.494 2.718 . . . . 1.29 116.242 -170.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 43' ' ' VAL . . . . . 0.405 HG13 ' CE1' ' E' ' 45' ' ' TYR 0.308 4.3 p -98.8 151.47 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 119.4 -2.062 . . . . 1.23 105.79 167.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -89.1 5.67 43.47 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 119.064 -2.272 . . . . 2.05 115.067 -174.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 45' ' ' TYR . . . . . 0.405 ' CE1' HG13 ' E' ' 43' ' ' VAL . 80.2 m-85 53.76 -47.18 0.02 OUTLIER 'General case' 0 C--N 1.363 1.195 0 C-N-CA 131.449 3.899 . . . . 2.52 121.479 173.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -102.09 120.77 40.98 Favored 'General case' 0 C--N 1.355 0.804 0 C-N-CA 126.929 2.092 . . . . 4.16 114.556 -172.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.31 27.12 8.82 Favored Glycine 0 C--N 1.364 2.133 0 O-C-N 119.88 -1.763 . . . . 5.33 116.816 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -117.01 -22.14 8.58 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-O 124.036 1.874 . . . . 5.09 114.521 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 8.1 t -104.03 0.02 29.35 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 130.994 3.717 . . . . 7.18 113.219 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.04 -123.86 1.5 Allowed Glycine 0 C--N 1.346 1.114 0 N-CA-C 106.172 -2.771 . . . . 6.51 106.172 -173.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 8.6 t -153.4 166.27 33.19 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 104.39 -2.448 . . . . 7.2 104.39 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.61 -53.15 37.36 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 126.898 2.079 . . . . 5.08 113.976 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 4.8 t 69.02 -21.96 0.15 Allowed 'General case' 0 C--N 1.351 0.638 0 N-CA-C 118.878 2.918 . . . . 3.86 118.878 174.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.77 -166.72 16.97 Favored Glycine 0 C--N 1.347 1.171 0 C-N-CA 128.336 2.874 . . . . 2.85 112.992 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -138.62 175.95 7.39 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 C-N-CA 128.696 2.798 . . . . 1.72 105.667 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -105.77 -34.09 7.79 Favored 'General case' 0 C--N 1.365 1.257 0 C-N-CA 124.696 1.198 . . . . 2.2 111.733 174.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 1.9 p -121.63 128.57 52.05 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 104.056 -2.572 . . . . 0.47 104.056 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.74 132.03 11.96 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 108.119 -1.067 . . . . 1.57 108.119 -168.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -80.69 110.82 16.55 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 130.071 3.348 . . . . 2.07 116.018 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 60' ' ' PHE . . . . . 0.416 ' CZ ' HG21 ' E' ' 10' ' ' ILE . 24.7 m-85 -114.31 179.86 3.83 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 127.422 2.289 . . . . 0.17 114.035 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.82 109.41 16.54 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 114.706 1.373 . . . . 0.17 114.706 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -19.74 0.4 0.0 OUTLIER 'General case' 0 C--N 1.374 1.638 2 C-N-CA 137.357 6.263 . . . . 1.72 124.489 172.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.09 -45.04 6.06 Favored 'General case' 0 N--CA 1.438 -1.055 1 C-N-CA 132.241 4.217 . . . . 0.17 106.322 171.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -88.68 18.25 4.84 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 120.083 -1.635 . . . . 1.18 110.867 -170.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . 0.313 0.1 OUTLIER -134.17 157.7 45.55 Favored 'General case' 0 N--CA 1.43 -1.464 1 C-N-CA 132.768 4.427 . . . . 0.19 106.317 172.186 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -137.39 149.25 46.8 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 105.665 -1.976 . . . . 2.05 105.665 162.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . 0.492 ' H ' HD23 ' E' ' 67' ' ' LEU 0.252 2.5 pt? -91.54 149.01 21.87 Favored 'General case' 0 C--N 1.363 1.187 0 O-C-N 118.798 -2.439 . . . . 0.29 117.511 -177.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 4.4 t -112.09 -37.48 2.84 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 C-N-CA 126.794 2.038 . . . . 0.73 110.346 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 69' ' ' GLN . . . . . 0.509 HE21 ' HA ' ' E' ' 6' ' ' ASP . 24.7 mt-30 -103.41 153.78 20.12 Favored 'General case' 0 C--N 1.356 0.875 0 CA-C-O 126.916 3.246 . . . . 2.19 115.286 -174.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.26 68.74 0.77 Allowed 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 108.476 -3.966 . . . . 0.0 109.584 170.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.5 74.3 3.23 Favored 'General case' 0 C--N 1.362 1.137 0 O-C-N 120.076 -1.64 . . . . 0.0 112.465 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.1 80.21 7.72 Favored 'General case' 0 C--N 1.36 1.065 0 C-N-CA 129.08 2.952 . . . . 0.0 111.753 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 71.7 tttt . . . . . 0 C--O 1.264 1.826 0 C-N-CA 127.089 2.156 . . . . 0.0 107.93 176.02 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 2.613 0 N-CA-C 114.336 1.235 . . . . 2.13 114.336 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 2' ' ' LEU . . . . . 0.554 ' H ' HD13 ' E' ' 2' ' ' LEU . 0.0 OUTLIER -102.12 -158.05 0.65 Allowed 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 131.693 3.997 . . . . 0.99 117.93 -175.215 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . 0.445 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 0.2 OUTLIER -146.97 177.06 9.44 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 130.794 3.638 . . . . 0.8 107.298 -178.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -78.66 117.74 20.1 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 120.69 3.589 . . . . 3.4 120.69 -172.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.63 5.93 53.33 Favored Glycine 0 C--N 1.376 2.784 0 O-C-N 118.184 -2.823 . . . . 0.53 114.332 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.65 145.89 30.34 Favored 'General case' 0 N--CA 1.411 -2.4 1 C-N-CA 132.024 4.13 . . . . 0.45 110.983 -176.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . 0.611 ' H ' ' CB ' ' E' ' 69' ' ' GLN . 49.3 mttm -93.08 71.76 4.62 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 128.524 2.73 . . . . 2.03 107.973 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 15.8 m -88.69 148.64 4.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 C-N-CA 123.684 0.794 . . . . 0.13 110.891 -173.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -105.95 123.92 48.76 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 119.314 -0.374 . . . . 0.17 110.917 -173.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.681 HD11 HG11 ' E' ' 38' ' ' VAL . 2.2 mm -73.29 114.68 13.09 Favored 'Isoleucine or valine' 0 C--N 1.36 1.06 0 C-N-CA 125.755 1.622 . . . . 0.12 114.968 177.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -115.91 57.27 0.75 Allowed 'General case' 0 C--N 1.375 1.675 0 C-N-CA 124.172 0.989 . . . . 0.3 113.669 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.62 123.14 48.58 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 126.08 1.752 . . . . 2.09 109.059 171.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 24.6 p -72.66 -6.56 45.2 Favored 'General case' 0 C--N 1.368 1.412 0 C-N-CA 128.941 2.896 . . . . 0.47 117.273 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -97.16 41.12 1.12 Allowed 'General case' 0 C--N 1.357 0.906 0 C-N-CA 128.54 2.736 . . . . 1.89 112.27 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 35.3 t -164.8 166.19 19.98 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 119.97 -1.706 . . . . 1.13 107.247 -178.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -89.59 -5.6 57.04 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 127.123 2.169 . . . . 0.79 110.369 171.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 29.6 m0 -94.76 16.68 15.18 Favored 'General case' 0 C--N 1.372 1.573 0 C-N-CA 129.166 2.986 . . . . 0.75 110.478 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -73.34 102.5 3.73 Favored 'General case' 0 C--N 1.364 1.221 0 C-N-CA 128.159 2.584 . . . . 0.4 110.873 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.58 32.97 6.05 Favored Glycine 0 C--N 1.358 1.757 0 C-N-CA 126.203 1.859 . . . . 0.39 112.602 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -106.93 135.19 48.9 Favored 'General case' 0 C--N 1.366 1.288 0 CA-C-N 119.255 1.528 . . . . 1.4 112.255 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.72 145.84 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 C-N-CA 128.299 2.64 . . . . 0.31 107.257 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' E' ' 7' ' ' LYS . . . -174.03 178.1 46.02 Favored Glycine 0 CA--C 1.473 -2.563 0 N-CA-C 108.864 -1.694 . . . . 0.21 108.864 172.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 20.7 m -86.18 125.4 33.5 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.505 1.122 . . . . 0.27 112.002 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 24' ' ' VAL . . . . . 0.481 HG23 HG13 ' E' ' 36' ' ' VAL . 12.6 p -80.92 95.87 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 126.078 1.751 . . . . 0.29 111.473 175.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.74 51.43 1.85 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.067 2.147 . . . . 0.29 112.803 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . . . . . . . . . 2.6 p -73.08 -73.12 0.22 Allowed 'General case' 0 CA--C 1.504 -0.817 1 C-N-CA 136.257 5.823 . . . . 0.63 120.114 -173.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 4.4 m -81.23 18.96 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.553 0 C-N-CA 128.085 2.554 . . . . 0.61 117.058 -163.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -98.26 -69.43 0.76 Allowed 'General case' 0 N--CA 1.431 -1.416 1 C-N-CA 132.011 4.125 . . . . 1.61 107.693 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -106.81 -26.89 11.07 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 115.849 1.796 . . . . 3.96 115.849 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.45 22.03 3.12 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 117.432 2.382 . . . . 4.34 117.432 -170.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.25 46.49 0.81 Allowed Glycine 0 C--N 1.353 1.525 0 C-N-CA 127.97 2.7 . . . . 1.76 114.505 167.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 32' ' ' ILE . . . . . 0.521 HG22 ' H ' ' E' ' 33' ' ' LEU . 1.9 mt -122.32 -146.71 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 130.962 3.705 . . . . 1.11 104.664 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 33' ' ' LEU . . . . . 0.521 ' H ' HG22 ' E' ' 32' ' ' ILE . 39.8 tp -62.08 -61.57 2.39 Favored 'General case' 0 C--N 1.345 0.379 0 C-N-CA 129.392 3.077 . . . . 0.57 115.181 176.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -97.67 111.01 57.63 Favored Pre-proline 0 C--N 1.363 1.177 0 C-N-CA 124.208 1.003 . . . . 0.94 109.688 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.86 -38.52 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.727 1 C-N-CA 125.318 4.012 . . . . 0.67 116.141 -173.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . 0.674 HG11 ' HG ' ' E' ' 65' ' ' LEU . 59.4 t -88.44 94.21 4.62 Favored 'Isoleucine or valine' 0 C--N 1.349 0.553 0 N-CA-C 116.19 1.922 . . . . 0.64 116.19 -169.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 96.4 mt -89.82 99.92 10.14 Favored 'Isoleucine or valine' 0 C--N 1.36 1.03 0 C-N-CA 126.461 1.904 . . . . 0.65 106.719 176.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 38' ' ' VAL . . . . . 0.681 HG11 HD11 ' E' ' 10' ' ' ILE . 81.3 t -104.93 156.3 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 120.769 -1.207 . . . . 0.23 111.945 -173.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 39' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -79.97 139.5 37.0 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 130.581 3.552 . . . . 2.75 111.973 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -137.29 149.08 46.83 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.317 -1.49 . . . . 1.26 111.929 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -103.55 -23.76 13.47 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 127.071 2.148 . . . . 1.02 111.282 172.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 67.2 mtt-85 -82.04 40.37 0.62 Allowed 'General case' 0 C--N 1.366 1.287 0 C-N-CA 129.397 3.079 . . . . 1.29 111.855 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 10.3 t -91.81 168.48 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 126.925 2.09 . . . . 1.23 110.377 -175.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -119.49 87.87 2.82 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.118 -2.178 . . . . 2.05 105.118 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.91 3.64 31.06 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 130.042 3.337 . . . . 2.52 109.995 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -81.23 64.76 6.1 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 127.814 2.446 . . . . 4.16 115.169 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.52 21.83 7.02 Favored Glycine 0 C--N 1.362 2.015 0 C-N-CA 126.87 2.176 . . . . 5.33 116.802 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -116.76 14.85 15.36 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 127.243 2.217 . . . . 5.09 109.622 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 77.7 p -100.53 -73.29 0.64 Allowed 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 129.133 2.973 . . . . 7.18 107.416 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 179.52 -51.51 0.09 OUTLIER Glycine 0 CA--C 1.498 -1.015 0 C-N-CA 128.576 2.988 . . . . 6.51 106.916 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 73.3 m -118.12 112.49 20.26 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 125.771 1.628 . . . . 7.2 115.129 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -93.63 -92.6 0.17 Allowed 'General case' 0 C--N 1.365 1.254 0 C-N-CA 126.103 1.761 . . . . 5.08 108.54 169.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 12.2 t 68.52 22.68 7.62 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 127.284 2.234 . . . . 3.86 116.745 172.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -109.49 143.33 16.5 Favored Glycine 0 C--N 1.364 2.136 0 C-N-CA 126.653 2.073 . . . . 2.85 113.629 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 t -103.79 147.79 9.54 Favored 'Isoleucine or valine' 0 C--N 1.364 1.2 0 C-N-CA 127.351 2.26 . . . . 1.72 112.62 -177.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -92.1 -33.96 14.56 Favored 'General case' 0 C--N 1.366 1.31 0 C-N-CA 127.987 2.515 . . . . 2.2 112.893 -176.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 31.8 p -129.21 121.71 28.21 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 128.612 2.765 . . . . 0.47 106.57 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.75 139.79 15.4 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 119.513 1.051 . . . . 1.57 112.399 -175.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -63.05 119.78 10.15 Favored 'General case' 0 C--N 1.358 0.937 1 C-N-CA 132.035 4.134 . . . . 2.07 119.9 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 60' ' ' PHE . . . . . 0.432 ' CD2' HD12 ' E' ' 10' ' ' ILE . 39.5 m-85 -124.67 170.26 11.15 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 123.514 1.626 . . . . 0.17 113.44 174.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.92 92.32 6.05 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 129.765 3.226 . . . . 0.17 109.05 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -18.15 -21.72 0.0 OUTLIER 'General case' 0 C--N 1.358 0.95 1 C-N-CA 136.434 5.893 . . . . 1.72 121.68 173.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -73.58 -29.67 62.56 Favored 'General case' 0 C--N 1.362 1.149 0 C-N-CA 129.443 3.097 . . . . 0.17 113.173 169.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -84.33 -14.81 48.64 Favored 'General case' 0 C--N 1.375 1.692 0 C-N-CA 127.217 2.207 . . . . 1.18 108.351 -175.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.674 ' HG ' HG11 ' E' ' 36' ' ' VAL . 0.6 OUTLIER -104.48 108.48 19.93 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 128.395 2.678 . . . . 0.19 115.41 -176.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -89.9 149.4 22.64 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 129.735 3.214 . . . . 2.05 112.076 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -82.77 141.61 32.22 Favored 'General case' 0 C--N 1.366 1.316 0 CA-C-N 121.638 2.017 . . . . 0.29 115.677 174.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 18.9 t -130.61 -19.4 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.873 0 CA-C-O 123.528 1.632 . . . . 0.73 108.226 171.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 69' ' ' GLN . . . . . 0.611 ' CB ' ' H ' ' E' ' 7' ' ' LYS . 4.9 tp-100 -110.28 155.24 22.33 Favored 'General case' 0 N--CA 1.424 -1.729 0 C-N-CA 127.173 2.189 . . . . 2.19 111.848 -177.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.02 42.06 1.26 Allowed 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 128.478 2.711 . . . . 0.0 114.316 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.95 63.11 7.9 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 125.243 1.417 . . . . 0.0 108.278 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.9 80.16 2.98 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 128.05 2.54 . . . . 0.0 112.097 -173.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? . . . . . 0 C--O 1.257 1.459 0 N-CA-C 103.039 -2.949 . . . . 0.0 103.039 172.196 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 110.133 -0.321 . . . . 2.13 110.133 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 2' ' ' LEU . . . . . 0.503 HD22 HG11 ' E' ' 8' ' ' VAL 0.306 2.0 pp -103.64 -154.97 0.51 Allowed 'General case' 0 C--N 1.362 1.129 0 CA-C-O 123.489 1.614 . . . . 0.99 111.844 177.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . 0.417 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 9.2 m120 -140.23 168.71 19.17 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 129.303 3.041 . . . . 0.8 111.7 -172.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -95.11 96.8 9.48 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 126.677 1.991 . . . . 3.4 112.233 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.62 17.26 3.55 Favored Glycine 0 C--N 1.368 2.329 0 O-C-N 119.922 -1.736 . . . . 0.53 113.145 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 6' ' ' ASP . . . . . 0.435 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 53.8 t0 -90.84 143.04 27.13 Favored 'General case' 0 N--CA 1.411 -2.375 1 C-N-CA 131.8 4.04 . . . . 0.45 109.325 -178.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . 0.582 ' H ' ' HB3' ' E' ' 69' ' ' GLN . 63.7 mmtt -92.9 82.23 4.66 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 104.966 -2.235 . . . . 2.03 104.966 173.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 8' ' ' VAL . . . . . 0.503 HG11 HD22 ' E' ' 2' ' ' LEU . 15.6 m -88.43 133.56 30.5 Favored 'Isoleucine or valine' 0 C--N 1.359 1.015 0 N-CA-C 105.078 -2.193 . . . . 0.13 105.078 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 3.5 ttm-85 -91.71 110.38 21.71 Favored 'General case' 0 CA--C 1.502 -0.887 0 O-C-N 121.237 -0.915 . . . . 0.17 111.354 -174.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.539 HG23 ' CE2' ' E' ' 60' ' ' PHE . 5.4 mm -53.37 107.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.503 0 N-CA-C 119.839 3.274 . . . . 0.12 119.839 175.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . 0.4 ' HA ' ' CE1' ' E' ' 18' ' ' TYR . 13.8 mtmm -119.02 49.77 1.29 Allowed 'General case' 0 C--N 1.379 1.887 0 C-N-CA 127.163 2.185 . . . . 0.3 111.485 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -76.49 -118.54 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 120.178 3.399 . . . . 2.09 120.178 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 3.5 m -150.55 -49.09 0.13 Allowed 'General case' 0 C--N 1.358 0.938 0 O-C-N 120.258 -1.526 . . . . 0.47 108.553 -176.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -85.59 89.94 7.86 Favored 'General case' 0 C--N 1.363 1.167 0 N-CA-C 115.509 1.67 . . . . 1.89 115.509 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 15' ' ' SER . . . . . 0.419 ' HA ' ' HB3' ' E' ' 18' ' ' TYR 0.285 1.4 m -53.68 28.96 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 1 N-CA-C 121.989 4.07 . . . . 1.13 121.989 179.968 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.45 -51.26 4.42 Favored 'General case' 0 C--N 1.352 0.691 1 C-N-CA 131.788 4.035 . . . . 0.79 102.274 163.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 17' ' ' TRP . . . . . 0.412 ' O ' HG21 ' E' ' 10' ' ' ILE . 15.8 m0 -114.97 35.15 4.45 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.66 1.584 . . . . 0.75 111.186 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 18' ' ' TYR . . . . . 0.419 ' HB3' ' HA ' ' E' ' 15' ' ' SER . 1.2 t80 -139.42 133.82 31.54 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 106.418 -1.697 . . . . 0.4 106.418 175.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.3 46.75 1.52 Allowed Glycine 0 C--N 1.358 1.779 0 C-N-CA 127.202 2.334 . . . . 0.39 109.449 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -168.72 176.24 5.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.363 -1.717 . . . . 1.4 106.363 -171.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 p -109.57 175.9 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 127.579 2.352 . . . . 0.31 108.348 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.79 169.49 41.48 Favored Glycine 0 CA--C 1.476 -2.381 0 N-CA-C 108.231 -1.948 . . . . 0.21 108.231 173.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . . . . . . . . . 10.9 m -97.72 114.75 26.82 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 125.727 1.611 . . . . 0.27 110.587 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 12.3 p -76.35 86.84 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-O 125.974 2.797 . . . . 0.29 112.097 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -94.72 57.4 2.17 Favored 'General case' 0 C--O 1.225 -0.213 0 O-C-N 119.172 -2.205 . . . . 0.29 108.995 175.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . 0.439 ' HB3' ' HA ' ' E' ' 36' ' ' VAL . 10.6 p -79.76 -81.45 0.12 Allowed 'General case' 0 CA--C 1.495 -1.165 1 C-N-CA 134.67 5.188 . . . . 0.63 118.705 -168.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 27' ' ' VAL . . . . . 0.406 HG12 ' H ' ' E' ' 27' ' ' VAL . 5.7 p -83.82 59.09 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 128.976 2.91 . . . . 0.61 111.51 -169.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -145.71 -50.88 0.24 Allowed 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 127.329 2.252 . . . . 1.61 106.4 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -105.42 -22.93 12.92 Favored 'General case' 0 C--N 1.37 1.483 0 C-N-CA 127.748 2.419 . . . . 3.96 113.45 175.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 58.8 m -68.35 55.81 0.08 Allowed 'General case' 0 C--N 1.378 1.824 0 C-N-CA 128.698 2.799 . . . . 4.34 117.831 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.71 32.88 5.91 Favored Glycine 0 C--O 1.222 -0.6 1 C-N-CA 131.608 4.432 . . . . 1.76 111.197 162.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 2.3 mt -112.19 -136.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.577 0 C-N-CA 129.014 2.925 . . . . 1.11 107.405 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 12.5 tp -90.57 -69.45 0.73 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 128.731 2.812 . . . . 0.57 112.822 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -96.94 156.99 35.79 Favored Pre-proline 0 C--N 1.372 1.571 0 O-C-N 120.185 -1.572 . . . . 0.94 110.809 -175.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.82 -51.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 123.809 3.006 . . . . 0.67 116.595 -170.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . 0.591 HG12 HG23 ' E' ' 38' ' ' VAL . 95.2 t -79.48 110.28 15.0 Favored 'Isoleucine or valine' 0 C--N 1.348 0.504 0 C-N-CA 129.426 3.09 . . . . 0.64 113.068 -170.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 70.5 mt -107.81 97.55 5.83 Favored 'Isoleucine or valine' 0 C--N 1.372 1.578 0 N-CA-C 104.403 -2.443 . . . . 0.65 104.403 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 38' ' ' VAL . . . . . 0.591 HG23 HG12 ' E' ' 36' ' ' VAL . 37.8 t -107.38 141.88 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 O-C-N 120.497 -1.377 . . . . 0.23 114.125 -167.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 39' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -69.95 144.83 52.26 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 128.448 2.699 . . . . 2.75 114.189 174.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 40' ' ' PHE . . . . . 0.444 ' CE1' HG12 ' E' ' 38' ' ' VAL . 84.8 m-85 -153.52 166.98 31.01 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 106.37 -1.715 . . . . 1.26 106.37 171.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -106.38 -27.92 10.68 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 129.357 3.063 . . . . 1.02 108.888 165.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -75.77 45.18 0.32 Allowed 'General case' 0 C--N 1.371 1.536 0 C-N-CA 127.359 2.264 . . . . 1.29 115.169 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 8.7 m -91.81 176.83 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 123.877 1.798 . . . . 1.23 110.628 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -85.13 65.01 9.01 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 119.016 -2.302 . . . . 2.05 112.534 -177.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -64.18 60.67 0.02 OUTLIER 'General case' 0 C--N 1.349 0.554 1 C-N-CA 132.039 4.135 . . . . 2.52 115.828 176.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -101.82 26.63 7.25 Favored 'General case' 0 C--N 1.361 1.075 0 C-N-CA 128.441 2.696 . . . . 4.16 108.053 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.15 128.55 9.61 Favored Glycine 0 C--N 1.357 1.749 0 C-N-CA 125.891 1.71 . . . . 5.33 111.876 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -94.32 6.83 47.48 Favored 'General case' 0 C--N 1.367 1.353 0 CA-C-O 125.433 2.54 . . . . 5.09 112.412 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 4.7 p -103.4 -59.78 1.66 Allowed 'General case' 0 N--CA 1.452 -0.373 1 C-N-CA 134.279 5.032 . . . . 7.18 106.575 173.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.45 -73.99 0.16 Allowed Glycine 0 C--N 1.348 1.204 0 C-N-CA 127.04 2.257 . . . . 6.51 108.201 173.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 15.8 m -102.08 92.79 4.92 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 125.622 1.569 . . . . 7.2 113.709 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -98.42 -59.11 1.81 Allowed 'General case' 0 C--N 1.355 0.81 0 CA-C-O 123.525 1.631 . . . . 5.08 110.902 174.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 17.7 p -118.64 19.54 13.2 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.804 1.242 . . . . 3.86 109.97 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.41 97.18 0.93 Allowed Glycine 0 C--N 1.357 1.735 0 C-N-CA 124.807 1.194 . . . . 2.85 113.926 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 34.2 m -93.15 111.73 25.16 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 C-N-CA 130.185 3.394 . . . . 1.72 107.25 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -86.03 27.55 0.89 Allowed 'General case' 0 C--N 1.352 0.701 0 O-C-N 119.193 -2.192 . . . . 2.2 114.092 -170.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 2.8 p -150.83 149.33 29.58 Favored 'General case' 0 C--N 1.356 0.874 1 C-N-CA 133.708 4.803 . . . . 0.47 107.371 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . 0.323 11.8 p30 -159.31 168.41 26.48 Favored 'General case' 0 C--N 1.364 1.225 0 CA-C-N 121.606 2.003 . . . . 1.57 108.351 170.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -97.75 113.28 25.02 Favored 'General case' 0 C--N 1.363 1.175 0 C-N-CA 126.736 2.014 . . . . 2.07 116.225 -172.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 60' ' ' PHE . . . . . 0.539 ' CE2' HG23 ' E' ' 10' ' ' ILE . 16.1 m-85 -118.16 170.22 9.05 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 127.529 2.332 . . . . 0.17 113.243 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.34 113.27 19.17 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.992 2.117 . . . . 0.17 112.231 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -26.54 -18.08 0.0 OUTLIER 'General case' 0 C--N 1.371 1.532 1 C-N-CA 134.652 5.181 . . . . 1.72 121.309 174.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -59.39 -49.19 78.76 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 131.418 3.887 . . . . 0.17 111.887 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -94.44 12.54 26.83 Favored 'General case' 0 C--N 1.361 1.107 0 CA-C-N 114.598 -1.183 . . . . 1.18 112.836 -170.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . . . . . . . . 0.261 1.0 OUTLIER -120.91 119.15 31.77 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 127.723 2.409 . . . . 0.19 114.209 -177.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -111.03 136.47 49.99 Favored 'General case' 0 C--N 1.362 1.129 0 O-C-N 120.958 -1.089 . . . . 2.05 111.482 171.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.69 140.51 51.14 Favored 'General case' 0 C--N 1.365 1.268 0 C-N-CA 130.84 3.656 . . . . 0.29 120.096 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . 0.255 2.0 t -139.78 -33.95 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.373 1.593 0 C-N-CA 126.728 2.011 . . . . 0.73 114.092 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 69' ' ' GLN . . . . . 0.582 ' HB3' ' H ' ' E' ' 7' ' ' LYS . 16.6 tt0 -112.53 104.81 12.92 Favored 'General case' 0 C--N 1.361 1.087 0 O-C-N 119.887 -1.758 . . . . 2.19 109.585 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.77 62.52 0.07 Allowed 'General case' 0 C--N 1.349 0.546 0 C-N-CA 127.909 2.484 . . . . 0.0 114.808 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.05 67.67 9.76 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 128.939 2.896 . . . . 0.0 109.514 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.24 47.65 0.02 OUTLIER 'General case' 0 C--N 1.362 1.128 0 C-N-CA 130.201 3.401 . . . . 0.0 116.835 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 25.4 tptp . . . . . 0 N--CA 1.42 -1.944 1 C-N-CA 133.582 4.753 . . . . 0.0 104.878 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.804 0 N-CA-C 108.131 -1.063 . . . . 2.13 108.131 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' E' E ' 2' ' ' LEU . . . . . 0.504 HD13 ' H ' ' E' ' 2' ' ' LEU 0.31 0.0 OUTLIER -79.93 -169.19 1.9 Allowed 'General case' 0 C--N 1.357 0.924 0 N-CA-C 119.794 3.257 . . . . 0.99 119.794 -176.878 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . 0.407 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 0.0 OUTLIER -150.49 177.86 9.6 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 125.633 1.573 . . . . 0.8 110.805 -170.043 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 23.3 ptt-85 -65.88 67.85 0.05 OUTLIER 'General case' 0 C--N 1.365 1.249 1 C-N-CA 132.816 4.446 . . . . 3.4 119.515 -174.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 125.38 25.38 1.46 Allowed Glycine 0 CA--C 1.491 -1.463 0 C-N-CA 126.72 2.105 . . . . 0.53 111.942 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 6' ' ' ASP . . . . . 0.505 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 20.8 t0 -71.04 129.88 40.13 Favored 'General case' 0 C--N 1.367 1.353 0 C-N-CA 125.302 1.441 . . . . 0.45 111.553 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . 0.493 ' H ' ' CB ' ' E' ' 69' ' ' GLN . 31.6 mtmm -89.01 85.85 6.8 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 102.99 -2.967 . . . . 2.03 102.99 171.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 8' ' ' VAL . . . . . 0.46 HG21 HD12 ' E' ' 65' ' ' LEU . 1.5 m -89.68 138.48 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 127.638 2.375 . . . . 0.13 106.323 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' E' ' 21' ' ' VAL . 1.5 tmt_? -101.5 86.1 2.9 Favored 'General case' 0 CA--C 1.501 -0.936 0 O-C-N 121.438 -0.789 . . . . 0.17 111.677 -174.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.718 HD11 HG11 ' E' ' 38' ' ' VAL . 1.1 mm -41.4 121.49 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.713 0 N-CA-C 120.751 3.611 . . . . 0.12 120.751 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -118.84 37.81 3.98 Favored 'General case' 0 C--N 1.373 1.609 0 C-N-CA 126.868 2.067 . . . . 0.3 111.301 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.66 127.3 42.51 Favored 'General case' 0 C--N 1.365 1.255 0 C-N-CA 130.402 3.481 . . . . 2.09 110.028 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 25.0 p -76.8 -55.95 5.04 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 129.585 3.154 . . . . 0.47 113.819 -174.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -78.56 68.68 4.6 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 129.79 3.236 . . . . 1.89 110.55 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 46.9 t -163.42 167.5 21.53 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 127.844 2.458 . . . . 1.13 104.426 -175.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -94.37 -9.23 36.44 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 127.914 2.485 . . . . 0.79 111.521 175.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -125.83 45.19 2.67 Favored 'General case' 0 C--N 1.366 1.287 0 O-C-N 120.703 -1.248 . . . . 0.75 111.879 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -71.83 107.31 4.54 Favored 'General case' 0 C--N 1.367 1.329 0 C-N-CA 127.453 2.301 . . . . 0.4 111.062 175.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.73 46.71 4.77 Favored Glycine 0 C--N 1.363 2.054 0 CA-C-O 122.196 0.887 . . . . 0.39 111.995 -175.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -143.51 166.0 26.01 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 125.346 1.458 . . . . 1.4 107.194 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' E' ' 9' ' ' ARG . 0.4 OUTLIER -103.37 170.45 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.565 0 C-N-CA 126.357 1.863 . . . . 0.31 110.116 178.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.39 161.86 26.13 Favored Glycine 0 CA--C 1.483 -1.915 0 O-C-N 121.228 -0.92 . . . . 0.21 111.924 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . 0.418 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 12.8 m -94.98 135.26 36.72 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 128.359 2.664 . . . . 0.27 115.959 -175.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 25.3 t -66.86 91.78 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.501 0 CA-C-O 124.711 2.196 . . . . 0.29 116.308 170.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -99.35 15.8 25.1 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 130.737 3.615 . . . . 0.29 108.777 170.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . 0.545 ' HA ' ' HB ' ' E' ' 37' ' ' ILE . 0.9 OUTLIER -77.18 -15.02 59.68 Favored 'General case' 0 CA--C 1.48 -1.738 1 C-N-CA 135.391 5.476 . . . . 0.63 118.632 -176.947 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 24.8 t -86.18 59.72 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.495 0 CA-C-O 125.428 2.537 . . . . 0.61 108.982 -173.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 28' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' E' ' 29' ' ' LYS . 3.1 pt-20 -145.13 -100.66 0.1 Allowed 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 111.262 -2.699 . . . . 1.61 107.695 -174.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . 0.414 ' H ' ' HG3' ' E' ' 28' ' ' GLU . 38.1 mmtt -87.31 25.65 1.36 Allowed 'General case' 0 N--CA 1.437 -1.116 1 C-N-CA 132.032 4.133 . . . . 3.96 115.303 -176.297 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.08 -1.05 0.84 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 131.128 3.771 . . . . 4.34 117.255 176.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.91 44.02 3.26 Favored Glycine 0 C--N 1.355 1.591 0 C-N-CA 128.472 2.939 . . . . 1.76 114.491 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 32' ' ' ILE . . . . . 0.529 HG22 ' H ' ' E' ' 33' ' ' LEU . 0.3 OUTLIER -137.5 -172.16 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.061 0 C-N-CA 128.072 2.549 . . . . 1.11 109.538 -178.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 33' ' ' LEU . . . . . 0.529 ' H ' HG22 ' E' ' 32' ' ' ILE . 41.1 tp -82.87 -22.73 33.92 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 131.432 3.893 . . . . 0.57 111.913 178.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -118.24 91.04 39.67 Favored Pre-proline 0 C--N 1.35 0.603 0 N-CA-C 103.286 -2.857 . . . . 0.94 103.286 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.64 -31.25 0.46 Allowed 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 124.919 3.746 . . . . 0.67 116.675 -170.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . 0.497 HG21 HD11 ' E' ' 2' ' ' LEU 0.265 75.3 t -96.91 98.38 7.46 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 C-N-CA 127.232 2.213 . . . . 0.64 116.403 -166.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . 0.545 ' HB ' ' HA ' ' E' ' 26' ' ' SER . 3.8 mp -87.51 117.03 30.71 Favored 'Isoleucine or valine' 0 C--N 1.362 1.145 0 C-N-CA 128.11 2.564 . . . . 0.65 105.557 174.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 38' ' ' VAL . . . . . 0.718 HG11 HD11 ' E' ' 10' ' ' ILE . 53.0 t -125.36 156.58 34.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.451 0 CA-C-N 119.424 1.011 . . . . 0.23 111.276 -173.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 39' ' ' ARG . . . . . 0.418 ' HB3' ' H ' ' E' ' 23' ' ' THR . 36.5 ttm-85 -82.39 156.75 24.01 Favored 'General case' 0 C--N 1.365 1.272 0 C-N-CA 130.661 3.584 . . . . 2.75 110.888 175.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 40' ' ' PHE . . . . . 0.42 ' HE1' HG13 ' E' ' 10' ' ' ILE . 33.2 m-85 -151.01 -178.81 6.82 Favored 'General case' 0 CA--C 1.513 -0.462 0 O-C-N 119.467 -2.02 . . . . 1.26 106.953 174.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -98.62 -39.37 8.73 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 127.077 2.151 . . . . 1.02 114.948 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . 0.269 20.8 mtm180 -69.18 -86.37 0.02 OUTLIER 'General case' 0 C--N 1.37 1.49 0 N-CA-C 121.602 3.927 . . . . 1.29 121.602 -170.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . 0.341 4.7 p -84.47 76.38 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.367 1.327 0 CA-C-O 127.15 3.357 . . . . 1.23 108.757 -176.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -162.62 -39.4 0.04 OUTLIER 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 108.431 -3.986 . . . . 2.05 106.54 -158.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . 0.305 0.1 OUTLIER -77.69 -121.53 0.01 OUTLIER 'General case' 0 C--N 1.375 1.679 0 N-CA-C 117.859 2.54 . . . . 2.52 117.859 -177.442 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -89.17 116.57 27.52 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 117.173 2.286 . . . . 4.16 117.173 -169.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.53 52.29 3.09 Favored Glycine 0 C--N 1.37 2.465 0 C-N-CA 127.584 2.516 . . . . 5.33 118.961 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -131.07 17.4 5.06 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-O 124.385 2.04 . . . . 5.09 111.321 -176.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 37.7 t -102.7 -8.18 21.09 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 128.923 2.889 . . . . 7.18 111.756 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 117.49 -147.93 18.76 Favored Glycine 0 C--N 1.351 1.416 1 N-CA-C 102.656 -4.177 . . . . 6.51 102.656 -162.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 32.3 m -75.25 64.38 1.46 Allowed 'General case' 0 C--N 1.354 0.801 0 N-CA-C 116.337 1.977 . . . . 7.2 116.337 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.17 -1.56 58.14 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 125.888 1.675 . . . . 5.08 113.604 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 24.1 t -106.38 49.29 0.81 Allowed 'General case' 0 C--N 1.357 0.929 0 C-N-CA 127.6 2.36 . . . . 3.86 108.248 173.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.8 -104.17 2.45 Favored Glycine 0 C--N 1.361 1.96 0 C-N-CA 127.061 2.267 . . . . 2.85 114.271 -174.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -113.65 129.7 69.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 C-N-CA 124.353 1.061 . . . . 1.72 109.479 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -105.34 -42.2 5.32 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.506 1.523 . . . . 2.2 112.432 173.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . 0.428 ' HB ' HG23 ' E' ' 37' ' ' ILE . 40.2 p -86.61 106.83 17.85 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 125.899 1.68 . . . . 0.47 113.99 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.61 132.66 47.16 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 128.695 2.798 . . . . 1.57 106.283 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -100.31 103.38 14.8 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 124.829 1.252 . . . . 2.07 109.639 -178.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 60' ' ' PHE . . . . . 0.5 ' CB ' HD21 ' E' ' 65' ' ' LEU . 24.4 m-85 -98.78 169.27 9.59 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 126.791 2.036 . . . . 0.17 116.267 -174.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -102.86 101.86 11.93 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.857 2.463 . . . . 0.17 110.717 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -18.72 -29.65 0.0 OUTLIER 'General case' 0 C--N 1.373 1.624 1 C-N-CA 135.135 5.374 . . . . 1.72 120.914 173.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.68 -42.67 79.44 Favored 'General case' 0 C--N 1.369 1.449 0 C-N-CA 128.212 2.605 . . . . 0.17 111.777 167.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -85.43 -7.48 58.9 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.126 -1.397 . . . . 1.18 111.848 -171.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.5 HD21 ' CB ' ' E' ' 60' ' ' PHE . 0.2 OUTLIER -100.46 109.47 21.61 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 120.882 -1.136 . . . . 0.19 110.568 178.504 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -90.7 128.63 36.72 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 123.659 0.784 . . . . 2.05 112.407 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.62 137.35 57.78 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 120.542 3.534 . . . . 0.29 120.542 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.79 -42.68 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.371 1.504 0 C-N-CA 125.738 1.615 . . . . 0.73 111.342 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 69' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 0.0 OUTLIER -112.12 97.54 6.72 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 126.504 1.922 . . . . 2.19 114.134 -175.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.67 57.93 0.09 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.404 2.682 . . . . 0.0 114.804 175.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.76 53.45 0.45 Allowed 'General case' 0 C--N 1.353 0.734 0 C-N-CA 129.309 3.044 . . . . 0.0 116.475 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -100.09 94.51 6.29 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 127.556 2.342 . . . . 0.0 109.367 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt . . . . . 0 C--O 1.259 1.564 0 C-N-CA 125.502 1.521 . . . . 0.0 109.236 179.943 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.52 -0.548 . . . . 2.13 109.52 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' E' E ' 2' ' ' LEU . . . . . 0.446 ' HB2' ' H ' ' E' ' 3' ' ' ASN . 0.0 OUTLIER -82.96 -158.08 0.26 Allowed 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 128.003 2.521 . . . . 0.99 115.967 -179.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . 0.446 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 75.0 m-80 -122.02 -173.8 2.74 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 128.658 2.783 . . . . 0.8 114.046 -170.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.92 104.86 17.24 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 128.638 2.775 . . . . 3.4 111.757 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.99 -3.64 22.59 Favored Glycine 0 C--N 1.353 1.494 0 O-C-N 119.984 -1.698 . . . . 0.53 111.896 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 6' ' ' ASP . . . . . 0.508 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 3.6 t0 -77.85 72.02 4.36 Favored 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 130.529 3.531 . . . . 0.45 114.115 -174.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . 0.408 ' H ' ' HG3' ' E' ' 7' ' ' LYS . 23.2 mtpp -35.97 87.64 0.0 OUTLIER 'General case' 0 C--N 1.351 0.64 1 C-N-CA 132.78 4.432 . . . . 2.03 114.743 177.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 8' ' ' VAL . . . . . 0.428 HG22 ' H ' ' E' ' 8' ' ' VAL . 0.0 OUTLIER -86.96 137.76 20.3 Favored 'Isoleucine or valine' 0 C--N 1.361 1.092 0 N-CA-C 107.102 -1.444 . . . . 0.13 107.102 -172.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -96.52 87.78 4.5 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 115.813 1.783 . . . . 0.17 115.813 -170.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.531 HD13 ' H ' ' E' ' 10' ' ' ILE . 0.9 OUTLIER -26.4 98.33 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 N-CA-C 119.517 3.154 . . . . 0.12 119.517 173.161 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -113.43 43.57 1.73 Allowed 'General case' 0 C--N 1.366 1.311 0 O-C-N 120.115 -1.615 . . . . 0.3 113.261 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.79 137.16 39.55 Favored 'General case' 0 C--N 1.366 1.286 0 C-N-CA 125.902 1.681 . . . . 2.09 111.006 174.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 22.3 p -73.02 -58.01 3.62 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 128.491 2.716 . . . . 0.47 114.516 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -76.02 64.33 1.9 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 127.945 2.498 . . . . 1.89 114.929 -178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 27.1 t -167.69 176.78 6.19 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 126.531 1.932 . . . . 1.13 105.868 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -93.5 0.33 56.66 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 128.612 2.765 . . . . 0.79 111.607 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -117.28 25.54 10.38 Favored 'General case' 0 C--N 1.36 1.034 0 O-C-N 120.48 -1.388 . . . . 0.75 113.807 -172.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -70.04 108.94 4.29 Favored 'General case' 0 C--N 1.368 1.377 0 C-N-CA 126.338 1.855 . . . . 0.4 114.228 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.66 30.36 18.65 Favored Glycine 0 C--N 1.366 2.206 0 CA-C-O 121.538 0.521 . . . . 0.39 112.218 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -121.02 173.28 7.36 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 126.807 2.043 . . . . 1.4 105.751 177.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.59 175.75 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 C-N-CA 125.613 1.565 . . . . 0.31 110.042 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.07 175.21 40.22 Favored Glycine 0 CA--C 1.479 -2.211 1 N-CA-C 101.314 -4.714 . . . . 0.21 101.314 165.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . 0.622 ' H ' ' HB2' ' E' ' 39' ' ' ARG . 11.1 m -96.39 141.28 29.89 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 126.131 1.772 . . . . 0.27 108.666 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 p -79.76 112.76 18.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 124.776 2.227 . . . . 0.29 109.043 166.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.14 31.8 6.18 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 111.134 -2.757 . . . . 0.29 108.573 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . 0.505 ' CB ' ' H ' ' E' ' 37' ' ' ILE . 0.3 OUTLIER -86.62 -39.99 15.58 Favored 'General case' 0 CA--C 1.49 -1.329 0 C-N-CA 126.727 2.011 . . . . 0.63 115.874 178.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . 0.259 0.3 OUTLIER -83.23 70.21 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.915 0 CA-C-O 127.888 3.709 . . . . 0.61 110.842 -172.133 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -161.2 -54.32 0.05 OUTLIER 'General case' 0 N--CA 1.424 -1.752 1 CA-C-N 107.896 -4.229 . . . . 1.61 105.595 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp -109.43 -22.98 11.76 Favored 'General case' 0 C--N 1.364 1.228 0 N-CA-C 116.868 2.173 . . . . 3.96 116.868 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -22.26 -15.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 2 C-N-CA 138.626 6.77 . . . . 4.34 122.629 -168.59 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.51 43.37 2.74 Favored Glycine 0 C--N 1.338 0.685 1 C-N-CA 130.906 4.098 . . . . 1.76 115.757 -175.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.23 -170.18 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.752 0 C-N-CA 126.758 2.023 . . . . 1.11 110.806 -177.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 46.6 tp -68.89 -30.87 69.45 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 128.639 2.776 . . . . 0.57 114.965 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -108.06 117.96 53.78 Favored Pre-proline 0 C--N 1.36 1.033 0 N-CA-C 103.838 -2.653 . . . . 0.94 103.838 175.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -75.14 -39.58 1.12 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.475 3.45 . . . . 0.67 113.584 -167.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . 0.608 HG12 HG23 ' E' ' 38' ' ' VAL . 62.3 t -109.62 115.17 48.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.708 0 C-N-CA 125.681 1.592 . . . . 0.64 112.881 -177.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . 0.505 ' H ' ' CB ' ' E' ' 26' ' ' SER . 6.5 mt -88.87 128.07 41.25 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 C-N-CA 127.091 2.156 . . . . 0.65 105.273 166.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 38' ' ' VAL . . . . . 0.608 HG23 HG12 ' E' ' 36' ' ' VAL . 24.8 t -122.98 150.17 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.777 0 O-C-N 120.343 -1.473 . . . . 0.23 109.041 -178.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 39' ' ' ARG . . . . . 0.622 ' HB2' ' H ' ' E' ' 23' ' ' THR . 42.5 mtp180 -74.28 168.62 19.28 Favored 'General case' 0 C--N 1.363 1.177 0 C-N-CA 127.34 2.256 . . . . 2.75 111.322 172.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . 0.25 21.4 m-85 -139.66 123.83 17.88 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 124.269 1.985 . . . . 1.26 111.329 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -54.37 -43.8 71.66 Favored 'General case' 0 N--CA 1.439 -1.0 1 C-N-CA 137.565 6.346 . . . . 1.02 119.109 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 46.6 mtm105 -131.9 93.61 3.33 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 107.486 -1.302 . . . . 1.29 107.486 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 t -78.67 71.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.418 0 CA-C-O 125.33 2.491 . . . . 1.23 109.912 174.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -139.57 40.69 2.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 128.214 2.606 . . . . 2.05 106.934 -170.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -125.94 54.74 1.5 Allowed 'General case' 0 C--N 1.35 0.591 0 C-N-CA 127.977 2.511 . . . . 2.52 105.347 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -48.94 70.73 0.0 OUTLIER 'General case' 0 C--N 1.361 1.086 1 C-N-CA 132.162 4.185 . . . . 4.16 121.554 -172.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 47' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' E' ' 52' ' ' ALA . . . -81.17 75.85 2.24 Favored Glycine 0 C--N 1.358 1.775 0 C-N-CA 128.243 2.83 . . . . 5.33 109.059 160.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -86.54 16.38 4.67 Favored 'General case' 0 C--N 1.364 1.214 0 C-N-CA 128.122 2.569 . . . . 5.09 115.458 -173.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 9.2 t -96.31 -0.77 49.11 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 130.691 3.596 . . . . 7.18 110.656 175.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.28 10.52 51.11 Favored Glycine 0 C--N 1.36 1.9 0 C-N-CA 125.661 1.601 . . . . 6.51 114.68 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 53.4 p -104.0 -63.89 1.15 Allowed 'General case' 0 C--N 1.355 0.826 0 C-N-CA 125.773 1.629 . . . . 7.2 113.87 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . 0.444 ' HB3' ' HA3' ' E' ' 47' ' ' GLY . . . -92.48 -17.9 23.91 Favored 'General case' 0 C--N 1.367 1.355 0 N-CA-C 117.421 2.378 . . . . 5.08 117.421 -173.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 3.3 m -95.95 21.9 8.1 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 119.864 -1.772 . . . . 3.86 113.547 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.93 3.1 27.21 Favored Glycine 0 C--N 1.356 1.681 0 C-N-CA 127.069 2.271 . . . . 2.85 110.867 170.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.24 109.15 25.55 Favored 'Isoleucine or valine' 0 C--N 1.362 1.142 0 CA-C-O 123.612 1.673 . . . . 1.72 112.365 -177.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -101.11 -37.71 8.46 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 130.026 3.33 . . . . 2.2 109.065 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 12.2 p -125.67 123.46 39.0 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 130.747 3.619 . . . . 0.47 109.592 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -116.83 151.78 35.8 Favored 'General case' 0 C--N 1.365 1.246 0 C-N-CA 126.714 2.005 . . . . 1.57 109.887 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -78.28 129.37 34.97 Favored 'General case' 0 C--N 1.364 1.227 0 C-N-CA 126.386 1.874 . . . . 2.07 112.56 176.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 60' ' ' PHE . . . . . 0.522 ' HE2' HD12 ' E' ' 10' ' ' ILE . 0.2 OUTLIER -127.78 169.6 13.68 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 117.177 2.288 . . . . 0.17 117.177 -177.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.87 88.2 2.77 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 110.129 -3.214 . . . . 0.17 111.693 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -18.25 -24.77 0.0 OUTLIER 'General case' 0 C--N 1.355 0.811 1 C-N-CA 136.276 5.83 . . . . 1.72 120.377 171.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.03 -34.14 71.56 Favored 'General case' 0 C--N 1.371 1.531 0 C-N-CA 129.615 3.166 . . . . 0.17 113.856 167.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.37 17.46 21.43 Favored 'General case' 0 C--N 1.368 1.378 0 C-N-CA 125.92 1.688 . . . . 1.18 110.738 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.478 HD13 HG11 ' E' ' 36' ' ' VAL . 74.0 mt -128.27 113.44 15.65 Favored 'General case' 0 C--N 1.363 1.156 0 N-CA-C 115.301 1.593 . . . . 0.19 115.301 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -100.46 129.83 46.46 Favored 'General case' 0 C--N 1.363 1.166 0 C-N-CA 124.837 1.255 . . . . 2.05 111.731 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.1 128.24 35.99 Favored 'General case' 0 C--N 1.368 1.397 0 C-N-CA 130.255 3.422 . . . . 0.29 116.49 172.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.3 -28.98 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.167 0 CA-C-N 120.639 1.563 . . . . 0.73 113.607 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 69' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 3.5 tp-100 -104.48 138.06 41.42 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 125.32 2.486 . . . . 2.19 114.342 -175.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.01 57.94 4.57 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 128.918 2.887 . . . . 0.0 111.528 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.13 52.55 0.9 Allowed 'General case' 0 C--N 1.362 1.113 0 C-N-CA 126.369 1.868 . . . . 0.0 108.989 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.85 146.81 25.57 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 126.062 1.745 . . . . 0.0 110.928 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt . . . . . 0 C--O 1.261 1.686 0 C-N-CA 125.839 1.656 . . . . 0.0 108.548 177.059 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.009 0 N-CA-C 109.553 -0.536 . . . . 2.13 109.553 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' E' E ' 2' ' ' LEU . . . . . 0.401 ' HB2' ' H ' ' E' ' 3' ' ' ASN 0.318 2.5 pp -102.69 -147.25 0.37 Allowed 'General case' 0 C--N 1.355 0.828 0 C-N-CA 126.534 1.934 . . . . 0.99 114.344 -179.334 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . 0.401 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 1.5 m120 -143.82 173.39 11.73 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 130.56 3.544 . . . . 0.8 110.753 -176.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -95.62 109.71 21.92 Favored 'General case' 0 C--N 1.367 1.356 0 C-N-CA 127.703 2.401 . . . . 3.4 112.815 175.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.61 14.34 41.08 Favored Glycine 0 CA--C 1.473 -2.535 0 O-C-N 119.474 -2.016 . . . . 0.53 114.016 172.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 6' ' ' ASP . . . . . 0.52 ' HA ' ' HB3' ' E' ' 69' ' ' GLN . 19.8 t0 -84.02 146.96 27.68 Favored 'General case' 0 N--CA 1.421 -1.884 1 C-N-CA 132.106 4.162 . . . . 0.45 105.559 178.019 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -93.65 89.82 6.37 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 105.283 -2.118 . . . . 2.03 105.283 173.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 8' ' ' VAL . . . . . 0.421 HG22 ' H ' ' E' ' 8' ' ' VAL . 5.4 m -86.33 142.85 12.53 Favored 'Isoleucine or valine' 0 C--N 1.366 1.31 0 N-CA-C 107.652 -1.24 . . . . 0.13 107.652 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -96.64 100.92 12.46 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 117.103 2.26 . . . . 0.17 117.103 -169.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.528 HG23 ' CE2' ' E' ' 60' ' ' PHE . 1.8 mm -38.33 97.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.575 1.909 0 C-N-CA 129.46 3.104 . . . . 0.12 119.07 171.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -117.1 45.33 1.9 Allowed 'General case' 0 C--N 1.372 1.583 0 O-C-N 118.642 -2.536 . . . . 0.3 111.969 -175.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 12' ' ' ARG . . . . . 0.463 ' HD2' ' CE1' ' E' ' 60' ' ' PHE . 10.1 ptm180 -99.68 128.35 45.78 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 128.4 2.68 . . . . 2.09 107.995 175.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 24.6 p -70.74 -62.18 1.49 Allowed 'General case' 0 C--N 1.359 0.989 0 C-N-CA 130.194 3.398 . . . . 0.47 114.088 -175.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.71 72.15 0.52 Allowed 'General case' 0 C--N 1.362 1.129 0 C-N-CA 130.636 3.574 . . . . 1.89 110.26 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 3.7 t -156.71 172.77 18.02 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 124.802 2.239 . . . . 1.13 111.091 -170.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -97.02 -17.81 19.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 130.649 3.58 . . . . 0.79 108.622 171.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -121.04 17.04 11.68 Favored 'General case' 0 C--N 1.367 1.367 0 N-CA-C 116.762 2.134 . . . . 0.75 116.762 -167.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -60.66 113.14 2.3 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 117.717 2.488 . . . . 0.4 117.717 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.47 25.94 22.05 Favored Glycine 0 C--N 1.365 2.141 0 C-N-CA 124.701 1.143 . . . . 0.39 112.841 170.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -136.78 171.29 14.72 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 104.977 -2.231 . . . . 1.4 104.977 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.96 176.91 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 125.124 1.37 . . . . 0.31 113.922 -173.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.78 168.75 41.6 Favored Glycine 0 C--N 1.36 1.89 0 N-CA-C 105.716 -2.954 . . . . 0.21 105.716 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . 0.646 ' H ' ' HB3' ' E' ' 39' ' ' ARG . 7.5 m -89.69 137.69 32.11 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 124.692 1.197 . . . . 0.27 110.208 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 24' ' ' VAL . . . . . 0.492 HG22 ' H ' ' E' ' 26' ' ' SER . 10.2 p -82.22 113.05 20.9 Favored 'Isoleucine or valine' 0 C--N 1.348 0.517 0 CA-C-O 124.341 2.019 . . . . 0.29 111.195 167.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.08 24.25 13.27 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 128.216 2.606 . . . . 0.29 109.461 172.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . 0.492 ' H ' HG22 ' E' ' 24' ' ' VAL . 21.1 t -81.21 -52.2 7.6 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 127.382 2.273 . . . . 0.63 116.203 -177.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.49 51.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-O 125.627 2.632 . . . . 0.61 114.091 -164.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.89 -60.07 0.26 Allowed 'General case' 0 N--CA 1.424 -1.731 0 C-N-CA 129.269 3.028 . . . . 1.61 105.086 -174.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -112.04 7.14 19.68 Favored 'General case' 0 C--N 1.364 1.237 0 N-CA-C 115.08 1.511 . . . . 3.96 115.08 -177.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -35.82 -28.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 1 C-N-CA 134.193 4.997 . . . . 4.34 119.787 -176.539 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.39 46.72 0.19 Allowed Glycine 0 C--N 1.35 1.352 1 C-N-CA 130.854 4.074 . . . . 1.76 117.606 -178.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 32' ' ' ILE . . . . . 0.453 HD12 HD21 ' E' ' 59' ' ' ASN . 0.3 OUTLIER -113.5 -155.76 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.502 0 CA-C-O 123.332 1.539 . . . . 1.11 111.65 178.069 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 62.6 tp -72.55 -34.75 67.74 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 130.054 3.342 . . . . 0.57 113.778 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -125.43 157.77 66.75 Favored Pre-proline 0 C--N 1.355 0.824 0 N-CA-C 101.736 -3.431 . . . . 0.94 101.736 174.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.96 -59.28 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 123.861 2.415 . . . . 0.67 112.805 -178.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . 0.536 HG12 HG23 ' E' ' 38' ' ' VAL . 52.6 t -70.06 105.86 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.222 0 N-CA-C 117.762 2.504 . . . . 0.64 117.762 -169.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . 0.424 ' H ' ' HB2' ' E' ' 26' ' ' SER . 18.0 mt -89.82 107.37 18.13 Favored 'Isoleucine or valine' 0 C--N 1.37 1.481 0 N-CA-C 105.748 -1.945 . . . . 0.65 105.748 170.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 38' ' ' VAL . . . . . 0.536 HG23 HG12 ' E' ' 36' ' ' VAL 0.26 19.4 t -112.18 149.24 14.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.473 0 CA-C-O 121.053 0.454 . . . . 0.23 110.132 -179.16 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 39' ' ' ARG . . . . . 0.646 ' HB3' ' H ' ' E' ' 23' ' ' THR . 8.5 tmm_? -84.09 147.06 27.57 Favored 'General case' 0 C--N 1.366 1.311 0 C-N-CA 129.125 2.97 . . . . 2.75 108.892 173.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -151.72 144.94 24.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 104.206 -2.516 . . . . 1.26 104.206 172.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -105.46 -2.75 23.33 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 125.523 1.529 . . . . 1.02 112.191 175.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -86.44 45.72 1.27 Allowed 'General case' 0 C--N 1.357 0.898 0 C-N-CA 129.498 3.119 . . . . 1.29 110.49 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -96.38 167.98 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.788 1 C-N-CA 131.927 4.091 . . . . 1.23 110.467 177.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -131.34 92.92 3.26 Favored 'General case' 0 CA--C 1.5 -0.952 0 O-C-N 119.473 -2.017 . . . . 2.05 106.226 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -76.67 4.62 9.08 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 128.465 2.706 . . . . 2.52 116.298 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -101.34 78.83 1.92 Allowed 'General case' 0 C--N 1.366 1.286 0 C-N-CA 125.851 1.66 . . . . 4.16 108.493 177.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.34 -22.12 65.75 Favored Glycine 0 C--N 1.362 1.994 0 O-C-N 120.532 -1.355 . . . . 5.33 116.414 -172.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -82.93 7.48 15.32 Favored 'General case' 0 C--N 1.364 1.231 0 C-N-CA 127.011 2.124 . . . . 5.09 114.6 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 15.0 m -101.5 -16.24 16.87 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 130.951 3.7 . . . . 7.18 110.984 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.84 26.28 27.29 Favored Glycine 0 C--N 1.37 2.458 0 C-N-CA 126.859 2.171 . . . . 6.51 115.008 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 30.3 t -140.49 48.08 1.75 Allowed 'General case' 0 C--N 1.357 0.911 0 O-C-N 121.115 -1.227 . . . . 7.2 114.105 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -91.99 5.74 48.99 Favored 'General case' 0 C--N 1.367 1.349 0 O-C-N 119.543 -1.973 . . . . 5.08 114.266 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 15.2 m -67.79 14.02 0.07 Allowed 'General case' 0 C--N 1.354 0.787 0 C-N-CA 130.475 3.51 . . . . 3.86 117.704 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.49 125.58 7.18 Favored Glycine 0 C--N 1.351 1.366 0 C-N-CA 129.474 3.416 . . . . 2.85 105.158 171.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.13 149.17 14.0 Favored 'Isoleucine or valine' 0 C--N 1.348 0.506 0 C-N-CA 126.092 1.757 . . . . 1.72 112.417 -170.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -89.68 -51.83 5.31 Favored 'General case' 0 C--N 1.36 1.065 0 C-N-CA 126.782 2.033 . . . . 2.2 111.214 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 62.7 p -107.33 96.29 6.31 Favored 'General case' 0 C--N 1.363 1.185 0 C-N-CA 125.087 1.355 . . . . 0.47 108.479 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -112.5 145.38 40.34 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 125.285 1.434 . . . . 1.57 111.022 -174.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 59' ' ' ASN . . . . . 0.453 HD21 HD12 ' E' ' 32' ' ' ILE . 0.4 OUTLIER -92.76 95.5 9.59 Favored 'General case' 0 C--N 1.361 1.085 0 C-N-CA 127.43 2.292 . . . . 2.07 110.392 -177.27 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 60' ' ' PHE . . . . . 0.528 ' CE2' HG23 ' E' ' 10' ' ' ILE . 0.5 OUTLIER -101.71 164.77 11.57 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 126.697 1.999 . . . . 0.17 114.039 -171.494 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . 0.419 ' H ' ' HD1' ' E' ' 60' ' ' PHE . . . -97.63 90.32 4.97 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 127.656 2.382 . . . . 0.17 111.818 -177.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -16.39 -40.98 0.0 OUTLIER 'General case' 0 C--N 1.365 1.281 1 C-N-CA 134.308 5.043 . . . . 1.72 120.087 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.48 -26.4 42.32 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 128.507 2.723 . . . . 0.17 115.964 171.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -97.55 5.21 49.85 Favored 'General case' 0 C--N 1.364 1.235 0 C-N-CA 127.171 2.188 . . . . 1.18 111.712 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.525 HD21 ' CG ' ' E' ' 60' ' ' PHE . 0.6 OUTLIER -116.68 109.6 17.39 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 126.026 1.73 . . . . 0.19 112.097 -175.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -106.08 147.7 28.64 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 124.748 1.219 . . . . 2.05 110.383 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -75.17 142.54 43.51 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 127.323 2.249 . . . . 0.29 116.459 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 t -127.2 -28.6 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.963 0 C-N-CA 125.646 1.578 . . . . 0.73 108.386 173.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 69' ' ' GLN . . . . . 0.52 ' HB3' ' HA ' ' E' ' 6' ' ' ASP . 7.9 tt0 -114.02 142.39 46.23 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 124.933 2.302 . . . . 2.19 113.173 -177.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.36 57.46 0.94 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 128.449 2.7 . . . . 0.0 111.189 174.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.07 53.23 0.6 Allowed 'General case' 0 C--N 1.367 1.355 0 C-N-CA 127.518 2.327 . . . . 0.0 115.312 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.2 137.24 40.72 Favored 'General case' 0 C--N 1.348 0.509 0 C-N-CA 127.447 2.299 . . . . 0.0 107.156 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? . . . . . 0 C--O 1.261 1.699 0 CA-C-O 118.477 -0.773 . . . . 0.0 110.114 178.73 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 107.874 -1.158 . . . . 2.13 107.874 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' E' E ' 2' ' ' LEU . . . . . 0.404 ' HB2' ' H ' ' E' ' 3' ' ' ASN . 0.0 OUTLIER -100.88 -156.28 0.55 Allowed 'General case' 0 C--N 1.353 0.732 0 N-CA-C 115.559 1.688 . . . . 0.99 115.559 -178.323 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 3' ' ' ASN . . . . . 0.404 ' H ' ' HB2' ' E' ' 2' ' ' LEU . 42.9 m-80 -134.63 -172.29 2.99 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 128.688 2.795 . . . . 0.8 108.954 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -95.85 104.87 16.83 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 129.004 2.922 . . . . 3.4 115.357 -176.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.37 3.51 33.09 Favored Glycine 0 C--N 1.366 2.23 0 CA-C-O 124.43 2.128 . . . . 0.53 111.45 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 6' ' ' ASP . . . . . . . . . . . . 0.34 16.2 t70 -90.35 51.41 2.02 Favored 'General case' 0 N--CA 1.424 -1.761 1 C-N-CA 132.96 4.504 . . . . 0.45 108.945 -178.202 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' E' E ' 7' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -28.75 105.85 0.03 OUTLIER 'General case' 0 C--N 1.367 1.329 1 C-N-CA 133.666 4.786 . . . . 2.03 117.035 -174.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 8' ' ' VAL . . . . . . . . . . . . . 35.1 m -90.62 150.49 3.72 Favored 'Isoleucine or valine' 0 C--N 1.36 1.036 0 C-N-CA 123.279 0.632 . . . . 0.13 111.111 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 9' ' ' ARG . . . . . . . . . . . . . 19.4 ttm-85 -98.76 88.34 4.01 Favored 'General case' 0 C--N 1.36 1.025 0 O-C-N 120.629 -1.294 . . . . 0.17 112.909 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.832 HD11 HG11 ' E' ' 38' ' ' VAL . 0.5 OUTLIER -33.53 101.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.598 0 N-CA-C 119.988 3.329 . . . . 0.12 119.988 176.423 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -103.01 42.74 1.13 Allowed 'General case' 0 C--N 1.368 1.374 0 C-N-CA 125.783 1.633 . . . . 0.3 113.399 -174.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 12' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -98.49 123.53 42.7 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 129.389 3.075 . . . . 2.09 111.226 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 13' ' ' THR . . . . . . . . . . . . . 26.4 p -71.42 -61.75 1.66 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 128.201 2.6 . . . . 0.47 116.204 -174.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 14' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -78.96 65.69 4.21 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 127.001 2.12 . . . . 1.89 113.611 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 15' ' ' SER . . . . . . . . . . . . . 3.9 m -173.68 163.35 4.24 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 126.561 1.944 . . . . 1.13 106.129 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 16' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -90.93 18.78 6.21 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 129.159 2.984 . . . . 0.79 112.65 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 17' ' ' TRP . . . . . . . . . . . . . 36.1 m0 -113.68 0.07 14.45 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 129.246 3.019 . . . . 0.75 111.636 -175.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 18' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -58.3 105.57 0.3 Allowed 'General case' 0 C--N 1.37 1.49 0 C-N-CA 127.163 2.185 . . . . 0.4 116.176 -174.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.82 26.33 53.89 Favored Glycine 0 C--N 1.366 2.243 0 O-C-N 121.137 -0.977 . . . . 0.39 115.11 -177.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -106.34 152.94 22.91 Favored 'General case' 0 C--N 1.362 1.149 0 N-CA-C 105.989 -1.856 . . . . 1.4 105.989 175.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -88.11 151.72 3.48 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-O 123.716 1.722 . . . . 0.31 109.969 174.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.95 167.7 28.26 Favored Glycine 0 CA--C 1.471 -2.712 0 N-CA-C 105.872 -2.891 . . . . 0.21 105.872 170.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 23' ' ' THR . . . . . 0.5 ' H ' ' HB2' ' E' ' 39' ' ' ARG . 17.3 m -97.24 113.92 25.59 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 124.901 1.28 . . . . 0.27 112.147 -175.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 24' ' ' VAL . . . . . 0.424 HG23 HG13 ' E' ' 36' ' ' VAL . 9.8 p -66.16 71.79 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 128.729 2.811 . . . . 0.29 118.307 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.01 53.93 2.96 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 116.699 -3.751 . . . . 0.29 112.53 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 26' ' ' SER . . . . . 0.441 ' HA ' ' HB ' ' E' ' 37' ' ' ILE . 67.0 m -88.77 -58.03 2.69 Favored 'General case' 0 CA--C 1.477 -1.831 1 C-N-CA 133.549 4.74 . . . . 0.63 118.443 -173.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 m -82.51 49.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.368 1.393 0 CA-C-O 127.706 3.622 . . . . 0.61 114.817 -163.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -135.39 -58.17 0.79 Allowed 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 110.817 -2.901 . . . . 1.61 105.386 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 29' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -110.87 5.25 20.41 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 127.181 2.193 . . . . 3.96 114.001 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 30' ' ' SER . . . . . . . . . . . . . 26.5 t -46.14 -26.35 0.75 Allowed 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 129.516 3.126 . . . . 4.34 116.935 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.35 44.21 0.06 OUTLIER Glycine 0 C--N 1.357 1.709 1 C-N-CA 130.809 4.052 . . . . 1.76 118.327 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.54 -156.61 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.972 0 C-N-CA 128.972 2.909 . . . . 1.11 113.144 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 33' ' ' LEU . . . . . . . . . . . . . 25.6 tp -87.79 -12.95 43.56 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 130.849 3.66 . . . . 0.57 114.248 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 34' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -135.25 141.62 38.53 Favored Pre-proline 0 C--N 1.358 0.966 0 N-CA-C 101.912 -3.366 . . . . 0.94 101.912 175.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 35' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -83.88 -45.1 0.06 OUTLIER 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.882 2.388 . . . . 0.67 115.954 -168.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 36' ' ' VAL . . . . . 0.567 HG11 HD13 ' E' ' 65' ' ' LEU . 55.4 t -106.23 131.12 56.69 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 N-CA-C 115.597 1.702 . . . . 0.64 115.597 -166.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . 0.441 ' HB ' ' HA ' ' E' ' 26' ' ' SER . 57.0 mt -105.72 126.08 61.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.127 0 C-N-CA 127.702 2.401 . . . . 0.65 105.302 172.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 38' ' ' VAL . . . . . 0.832 HG11 HD11 ' E' ' 10' ' ' ILE . 74.3 t -134.43 144.4 35.22 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 O-C-N 120.703 -1.248 . . . . 0.23 109.161 -176.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 39' ' ' ARG . . . . . 0.5 ' HB2' ' H ' ' E' ' 23' ' ' THR . 8.1 mtm180 -69.79 163.48 25.7 Favored 'General case' 0 C--N 1.372 1.578 0 C-N-CA 127.815 2.446 . . . . 2.75 115.827 173.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 40' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -149.02 139.12 22.19 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 124.543 1.137 . . . . 1.26 110.113 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 41' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -94.1 -32.6 13.69 Favored 'General case' 0 C--N 1.366 1.319 0 C-N-CA 125.995 1.718 . . . . 1.02 111.508 171.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 42' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 -79.69 57.99 2.65 Favored 'General case' 0 C--N 1.373 1.59 0 C-N-CA 129.397 3.079 . . . . 1.29 112.617 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 43' ' ' VAL . . . . . . . . . . . . . 22.2 t -94.48 162.79 2.37 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 C-N-CA 127.11 2.164 . . . . 1.23 110.225 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 44' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -101.59 71.61 1.34 Allowed 'General case' 0 C--N 1.352 0.713 0 C-N-CA 129.083 2.953 . . . . 2.05 110.585 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 45' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -60.33 -22.06 62.78 Favored 'General case' 0 CA--C 1.536 0.415 1 C-N-CA 133.121 4.568 . . . . 2.52 118.229 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 46' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -101.16 151.08 22.26 Favored 'General case' 0 C--N 1.361 1.08 0 O-C-N 120.28 -1.512 . . . . 4.16 110.68 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.56 -8.84 76.48 Favored Glycine 0 C--N 1.358 1.793 0 N-CA-C 117.089 1.596 . . . . 5.33 117.089 -169.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 48' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -75.91 -4.53 41.42 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 118.108 2.633 . . . . 5.09 118.108 -174.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 36.1 t -102.71 -8.91 20.49 Favored 'General case' 0 C--N 1.315 -0.894 1 C-N-CA 131.886 4.074 . . . . 7.18 111.835 174.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.91 -61.44 0.55 Allowed Glycine 0 C--N 1.361 1.952 0 CA-C-N 119.121 0.873 . . . . 6.51 111.768 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 51' ' ' SER . . . . . . . . . . . . . 8.6 m -164.3 166.6 20.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 103.218 -2.882 . . . . 7.2 103.218 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.6 8.53 30.88 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 127.92 2.488 . . . . 5.08 115.971 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 53' ' ' SER . . . . . . . . . . . . . 13.8 t -106.37 38.18 2.11 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 125.979 1.712 . . . . 3.86 111.066 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.2 50.72 2.77 Favored Glycine 0 C--N 1.359 1.815 0 C-N-CA 127.491 2.472 . . . . 2.85 117.816 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 55' ' ' VAL . . . . . . . . . . . . 0.446 5.6 p 63.2 126.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.852 1 C-N-CA 134.666 5.187 . . . . 1.72 118.048 178.157 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' E' E ' 56' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -98.62 -61.21 1.41 Allowed 'General case' 0 C--N 1.347 0.485 0 C-N-CA 125.974 1.71 . . . . 2.2 109.442 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 57' ' ' THR . . . . . . . . . . . . . 72.7 p -105.0 115.95 31.14 Favored 'General case' 0 C--N 1.35 0.611 0 C-N-CA 126.891 2.077 . . . . 0.47 108.585 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 58' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -105.95 147.11 29.18 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 108.639 -0.875 . . . . 1.57 108.639 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -90.52 110.45 21.58 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 128.332 2.653 . . . . 2.07 107.669 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 60' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -122.22 173.58 7.51 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 126.791 2.036 . . . . 0.17 115.797 -172.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -108.15 97.31 7.02 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 130.077 3.351 . . . . 0.17 113.909 -176.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -14.34 -34.9 0.0 OUTLIER 'General case' 0 C--N 1.366 1.297 1 C-N-CA 134.683 5.193 . . . . 1.72 121.122 171.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -46.2 -46.74 17.72 Favored 'General case' 0 C--N 1.369 1.426 1 C-N-CA 132.661 4.384 . . . . 0.17 112.606 170.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.97 16.6 25.49 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 112.744 -2.025 . . . . 1.18 111.218 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 65' ' ' LEU . . . . . 0.567 HD13 HG11 ' E' ' 36' ' ' VAL . 75.4 mt -129.65 98.01 4.7 Favored 'General case' 0 C--N 1.369 1.449 0 N-CA-C 114.942 1.46 . . . . 0.19 114.942 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 66' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -105.97 143.87 33.49 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 125.692 1.597 . . . . 2.05 111.638 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -62.45 137.23 58.22 Favored 'General case' 0 C--N 1.365 1.276 0 C-N-CA 129.307 3.043 . . . . 0.29 117.481 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 68' ' ' VAL . . . . . . . . . . . . . 39.3 t -132.75 -27.27 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.292 0 C-N-CA 126.815 2.046 . . . . 0.73 110.104 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.95 146.82 41.77 Favored 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 125.9 1.68 . . . . 2.19 108.156 177.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.67 79.75 1.39 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 129.622 3.169 . . . . 0.0 112.685 173.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.25 77.83 1.45 Allowed 'General case' 0 C--N 1.352 0.683 0 O-C-N 119.403 -2.061 . . . . 0.0 109.484 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.45 -165.89 0.77 Allowed 'General case' 0 C--N 1.353 0.723 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 73' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt . . . . . 0 C--O 1.262 1.739 0 C-N-CA 127.647 2.379 . . . . 0.0 108.399 176.1 . . . . . . . . 0 0 . 1 stop_ save_